data_2dha_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2dha _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.852 0.358 . . . . 0.0 110.903 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.412 ' CG1' HD11 ' A' ' 160' ' ' LEU . 94.1 t -59.32 -47.43 90.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.145 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -37.52 -56.79 0.99 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.072 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -61.59 -40.23 94.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.914 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -59.71 -41.17 90.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.849 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.412 HD11 ' CG1' ' A' ' 156' ' ' VAL . 88.1 mt -87.95 -19.17 27.61 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.915 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 29.5 t -61.62 -22.28 65.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.844 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 39.5 mmtm -72.37 118.55 15.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.931 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -97.46 155.67 16.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.92 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 2.8 m120 63.34 45.64 4.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.884 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 24.0 mm-40 -132.05 149.22 52.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.9 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 55.9 t -103.27 108.04 23.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.129 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 86.8 mt -78.04 141.79 15.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.135 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.541 HG21 ' CE1' ' A' ' 217' ' ' PHE . 92.9 t -122.23 129.28 75.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.113 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 32.5 ttp180 -88.33 106.94 18.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.888 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 96.9 mtp -94.9 126.35 40.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.858 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 26.1 mtt180 -128.03 142.79 51.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.882 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 79.36 45.19 8.94 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.436 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 21.1 mt -93.42 133.68 27.96 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.553 0.692 . . . . 0.0 110.953 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . 0.446 ' HG3' ' CB ' ' A' ' 237' ' ' ARG . 64.9 Cg_exo -47.98 133.57 23.26 Favored 'Trans proline' 0 N--CA 1.465 -0.168 0 C-N-CA 122.737 2.291 . . . . 0.0 112.318 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -53.99 -19.26 4.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.836 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 74.7 p -96.29 -22.41 17.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.16 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -60.7 125.97 25.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.078 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -125.89 178.26 5.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.127 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -45.87 -42.69 12.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.069 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -58.21 -41.8 84.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.926 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -61.82 -42.28 98.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.886 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.449 ' O ' ' C ' ' A' ' 183' ' ' VAL . 47.1 t -65.06 -54.4 29.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.099 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . 0.449 ' C ' ' O ' ' A' ' 182' ' ' VAL . 91.4 t -33.99 -52.02 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.131 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . 0.419 ' O ' ' C ' ' A' ' 185' ' ' PHE . . . -72.89 -45.74 56.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.093 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . 0.511 ' CE1' ' CE1' ' A' ' 186' ' ' PHE . 35.2 t80 -36.89 -62.46 0.48 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.875 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' PHE . . . . . 0.511 ' CE1' ' CE1' ' A' ' 185' ' ' PHE . 55.3 m-85 -91.38 -20.81 21.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.869 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -49.01 -23.32 3.62 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.54 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 30.2 mm-40 -50.64 -74.03 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.827 0.346 . . . . 0.0 110.952 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 29.4 m170 -118.19 -18.17 9.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.877 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 58.6 m -115.05 84.24 10.65 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.635 0.731 . . . . 0.0 110.867 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' PRO . . . . . 0.426 ' HD2' ' CD1' ' A' ' 222' ' ' TYR . 53.3 Cg_endo -69.77 142.89 49.12 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.705 2.27 . . . . 0.0 112.31 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 62.6 mt -94.11 144.99 8.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.113 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 87.1 m -70.38 96.5 1.15 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.183 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 95.85 -2.74 64.48 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.508 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 52.8 -120.01 11.14 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.499 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.27 -27.43 2.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.765 0.316 . . . . 0.0 110.893 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 43.9 mm-40 -80.02 -29.98 39.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.85 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -95.23 41.29 2.52 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.497 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 61.9 mt -141.88 140.54 30.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.828 0.347 . . . . 0.0 111.112 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 13.2 tp -135.91 117.49 14.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.972 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -97.15 115.65 27.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.917 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 14.2 t -70.01 121.92 20.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.151 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -131.45 137.99 48.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.151 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -46.45 158.57 0.39 Allowed Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.673 0.749 . . . . 0.0 110.932 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 2.87 3.13 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.689 2.259 . . . . 0.0 112.372 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -109.37 -21.3 12.58 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.875 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 112.01 49.27 0.63 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.466 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -133.7 144.02 50.18 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.645 0.736 . . . . 0.0 110.862 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 101.79 0.96 Allowed 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.664 2.243 . . . . 0.0 112.354 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 46.0 p -66.45 -25.18 66.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.128 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 104.74 -37.71 3.65 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.471 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -78.09 155.7 30.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.771 0.32 . . . . 0.0 110.929 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -157.5 -179.1 7.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.119 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . 0.453 ' CD2' HG13 ' A' ' 249' ' ' VAL . 77.6 m-85 -144.5 140.36 28.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.819 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 4.6 t -124.28 158.99 30.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.133 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 30.4 mt -111.3 142.54 43.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.958 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . 0.541 ' CE1' HG21 ' A' ' 168' ' ' VAL . 77.3 m-85 -135.44 129.52 33.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.916 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -39.64 -64.48 0.48 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.075 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' CYS . . . . . . . . . . . . . 85.3 m -138.93 -175.34 4.11 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.89 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -71.2 -8.74 55.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.917 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -68.28 -34.62 76.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.922 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 222' ' ' TYR . . . . . 0.426 ' CD1' ' HD2' ' A' ' 191' ' ' PRO . 19.6 m-85 -92.42 -48.88 6.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.92 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -49.76 -53.59 24.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.075 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -52.76 -60.16 3.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.897 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -49.76 -28.57 6.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.915 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -76.23 -36.04 58.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.078 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 43.8 mt -55.35 -36.51 66.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.93 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 3.9 mtp-105 -58.23 -18.98 30.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.883 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . 0.459 ' O ' ' C ' ' A' ' 230' ' ' HIS . 23.7 mtpp -78.78 -2.54 40.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.872 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 230' ' ' HIS . . . . . 0.519 ' CD2' ' HG2' ' A' ' 231' ' ' LYS . 78.5 t60 -33.89 136.88 0.11 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.857 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . 0.519 ' HG2' ' CD2' ' A' ' 230' ' ' HIS . 23.1 mmtm 62.16 31.08 17.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.857 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -59.69 -176.24 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.823 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.526 HD21 ' CD1' ' A' ' 238' ' ' TYR . 31.6 mt -140.06 110.42 6.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.93 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 6.8 tt -119.64 114.16 21.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.91 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 58.26 36.1 81.36 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.497 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 38.7 mttp 71.21 52.13 0.26 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.744 0.306 . . . . 0.0 110.912 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 237' ' ' ARG . . . . . 0.446 ' CB ' ' HG3' ' A' ' 174' ' ' PRO . 19.6 mmt180 -155.79 115.46 3.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.901 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 238' ' ' TYR . . . . . 0.526 ' CD1' HD21 ' A' ' 233' ' ' LEU . 83.5 m-85 -69.72 133.0 47.0 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.955 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 70.7 mt -131.69 141.04 46.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.134 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 240' ' ' GLU . . . . . 0.564 ' HB3' ' CZ ' ' A' ' 242' ' ' PHE . 24.6 mt-10 -92.89 178.33 5.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.906 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . 0.593 ' O ' ' CD1' ' A' ' 242' ' ' PHE . 51.0 mt -157.64 137.35 12.21 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.893 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 242' ' ' PHE . . . . . 0.593 ' CD1' ' O ' ' A' ' 241' ' ' LEU . 5.2 m-85 -157.53 122.8 4.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.871 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . 0.492 ' CG ' ' O ' ' A' ' 243' ' ' ARG . 19.9 ptt180 -59.57 112.58 1.84 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.873 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 1.7 t -106.98 164.32 12.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.866 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 33.7 p -110.19 166.51 10.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.166 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -54.38 -61.53 2.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.079 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -45.44 -56.26 5.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.083 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -45.7 -55.78 6.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.89 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . 0.453 HG13 ' CD2' ' A' ' 214' ' ' PHE . 99.8 t -41.72 -59.88 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.138 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -47.83 -42.56 26.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.882 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 251' ' ' GLN . . . . . 0.494 ' O ' ' ND2' ' A' ' 254' ' ' ASN . 35.4 mm-40 -68.46 -22.6 64.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.952 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 76.7 t -85.1 -21.1 8.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.11 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 10.9 mt -87.38 -42.18 13.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.945 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 254' ' ' ASN . . . . . 0.494 ' ND2' ' O ' ' A' ' 251' ' ' GLN . 0.5 OUTLIER -64.47 -43.41 94.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.898 179.906 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -53.76 -42.36 68.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.888 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -80.87 -34.02 33.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.848 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 20.6 m . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.875 -179.774 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.898 0.38 . . . . 0.0 110.9 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 76.8 t -66.43 -36.75 78.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.151 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -44.32 -51.37 8.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.079 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -61.37 -51.11 70.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.929 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' PHE . . . . . 0.499 ' CE1' ' HG ' ' A' ' 216' ' ' LEU . 85.3 t80 -46.24 -46.1 17.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.875 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 92.0 mt -84.5 -18.55 35.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.918 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 17.6 t -56.82 -25.38 55.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.845 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . 0.456 ' HG3' ' CD1' ' A' ' 216' ' ' LEU . 28.3 mmtt -71.04 131.78 44.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.886 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -110.01 156.97 19.79 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.847 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 3.5 m120 65.03 36.17 7.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.882 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 22.2 mm-40 -124.95 160.08 29.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.91 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.469 HG11 ' CB ' ' A' ' 223' ' ' ALA . 25.3 t -111.6 115.71 50.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.174 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 19.3 mt -86.99 140.27 16.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.14 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 30.0 t -122.17 137.26 56.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.157 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 51.4 ttp180 -92.29 112.51 24.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.84 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 98.9 mtp -107.29 111.64 24.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.917 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 10.3 ptm180 -118.92 133.96 55.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.835 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 100.6 18.21 21.58 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.47 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.423 HD23 ' CD1' ' A' ' 239' ' ' ILE . 31.0 mt -73.85 133.16 79.47 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.633 0.73 . . . . 0.0 110.91 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . 0.429 ' HG3' ' CB ' ' A' ' 237' ' ' ARG . 65.8 Cg_exo -48.0 135.08 23.92 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.642 2.228 . . . . 0.0 112.369 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 3.3 m-30 -49.71 -35.11 20.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.884 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' THR . . . . . 0.421 ' O ' ' C ' ' A' ' 177' ' ' ALA . 22.8 p -77.68 -43.96 29.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.153 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . 0.422 ' HA ' ' CD ' ' A' ' 181' ' ' GLU . . . -35.55 128.97 0.59 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.087 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 3.9 p -124.54 -178.7 4.21 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.132 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -56.75 -41.78 78.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.098 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -58.84 -34.97 72.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.904 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . 0.422 ' CD ' ' HA ' ' A' ' 177' ' ' ALA . 36.4 mt-10 -69.52 -37.37 77.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.885 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.465 HG12 ' CD1' ' A' ' 192' ' ' ILE . 26.1 t -68.93 -47.01 78.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.176 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 37.7 t -37.95 -49.4 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.096 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . 0.423 ' O ' ' C ' ' A' ' 185' ' ' PHE . . . -74.28 -44.84 51.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.105 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . 0.619 ' CE1' ' CE1' ' A' ' 186' ' ' PHE . 5.7 t80 -36.89 -64.07 0.38 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.829 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' PHE . . . . . 0.619 ' CE1' ' CE1' ' A' ' 185' ' ' PHE . 59.9 m-85 -89.19 -21.64 23.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.899 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -49.62 -26.15 7.36 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.514 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 16.5 tt0 -48.98 -70.91 0.08 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.863 0.363 . . . . 0.0 110.971 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 65.9 m80 -118.27 -16.6 9.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.869 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' CYS . . . . . 0.438 ' N ' ' O ' ' A' ' 186' ' ' PHE . 74.4 m -120.11 85.36 35.35 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.569 0.699 . . . . 0.0 110.818 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' PRO . . . . . 0.445 ' HD2' ' CD1' ' A' ' 222' ' ' TYR . 53.8 Cg_endo -69.78 130.04 18.62 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.701 2.268 . . . . 0.0 112.338 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . 0.465 ' CD1' HG12 ' A' ' 182' ' ' VAL . 53.2 mt -79.03 142.92 13.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.122 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 21.9 m -66.74 98.66 0.54 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.164 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 89.22 -3.92 84.3 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.465 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . 0.412 ' O ' ' N ' ' A' ' 198' ' ' GLY . . . 58.24 -117.46 10.56 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.497 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 4.3 ptpp? -47.38 -28.67 2.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.779 0.323 . . . . 0.0 110.924 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -78.48 -29.85 46.99 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.932 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 195' ' ' GLY . . . -95.69 41.43 2.46 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.469 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . 0.54 HG22 ' CE2' ' A' ' 201' ' ' PHE . 75.9 mt -140.7 138.3 35.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.833 0.349 . . . . 0.0 111.128 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 14.3 tp -132.99 113.03 12.34 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.915 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' PHE . . . . . 0.54 ' CE2' HG22 ' A' ' 199' ' ' ILE . 81.3 m-85 -96.58 110.81 23.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.855 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 22.0 t -67.41 127.36 28.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.128 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -132.48 141.57 48.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.168 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . 0.471 ' CD2' HG21 ' A' ' 210' ' ' THR . 35.6 m-85 -45.78 158.12 0.36 Allowed Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.686 0.755 . . . . 0.0 110.964 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 3.21 2.92 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.707 2.271 . . . . 0.0 112.355 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -112.68 -16.07 12.87 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.891 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 106.94 62.98 0.58 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.501 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 35.2 mtt180 -151.77 151.15 27.85 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.646 0.736 . . . . 0.0 110.861 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 122.42 9.09 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.701 2.268 . . . . 0.0 112.352 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' THR . . . . . 0.471 HG21 ' CD2' ' A' ' 204' ' ' TYR . 42.9 p -90.84 -21.42 21.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.123 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 104.35 -35.49 5.01 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.494 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -80.68 156.54 26.26 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.838 0.351 . . . . 0.0 110.829 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -160.74 172.87 16.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.099 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -140.23 149.13 42.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.869 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' VAL . . . . . 0.4 ' CG1' HG23 ' A' ' 192' ' ' ILE . 8.1 t -131.49 159.34 43.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.179 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . 0.499 ' HG ' ' CE1' ' A' ' 159' ' ' PHE . 36.9 mt -108.79 143.2 38.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.918 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -136.4 145.24 45.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.895 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -59.03 -62.35 1.95 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.072 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' CYS . . . . . . . . . . . . . 66.7 m -141.14 179.34 6.81 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.918 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -57.83 -36.48 72.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.877 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -40.07 -45.76 2.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.897 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 222' ' ' TYR . . . . . 0.445 ' CD1' ' HD2' ' A' ' 191' ' ' PRO . 24.0 m-85 -84.44 -49.9 8.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.919 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . 0.469 ' CB ' HG11 ' A' ' 166' ' ' VAL . . . -53.49 -63.29 1.2 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.098 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 85.9 mm-40 -49.28 -52.65 26.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.882 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 61.8 m-20 -59.18 -26.33 64.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.92 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -75.27 -28.51 59.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.117 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 26.8 mt -62.37 -29.41 70.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.897 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 65.0 mtp180 -60.87 -19.5 60.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.871 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . 0.539 ' HD2' ' CE1' ' A' ' 185' ' ' PHE . 20.3 mtmm -83.02 0.69 43.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.881 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 230' ' ' HIS . . . . . 0.466 ' C ' ' O ' ' A' ' 229' ' ' LYS . 67.9 t60 -33.4 135.13 0.12 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.866 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . 0.406 ' HG3' ' NE2' ' A' ' 230' ' ' HIS . 13.2 mttm 60.8 32.2 20.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.897 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . 0.475 ' OD2' ' CE2' ' A' ' 185' ' ' PHE . 15.3 t0 -55.64 175.47 0.08 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.838 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.563 HD23 ' CE1' ' A' ' 238' ' ' TYR . 30.5 mt -130.88 106.57 8.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.909 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 6.5 tt -114.38 114.31 25.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.903 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 56.49 42.72 90.23 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.526 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 22.8 mmtp 65.54 52.55 1.34 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.767 0.318 . . . . 0.0 110.877 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 237' ' ' ARG . . . . . 0.429 ' CB ' ' HG3' ' A' ' 174' ' ' PRO . 19.1 mmt180 -156.27 115.38 3.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.876 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 238' ' ' TYR . . . . . 0.563 ' CE1' HD23 ' A' ' 233' ' ' LEU . 97.6 m-85 -68.49 131.48 45.34 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.916 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . 0.423 ' CD1' HD23 ' A' ' 173' ' ' LEU . 56.5 mt -129.1 128.28 66.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.13 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 240' ' ' GLU . . . . . 0.479 ' HB3' ' CZ ' ' A' ' 242' ' ' PHE . 36.7 mt-10 -88.22 159.71 18.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.9 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . 0.511 ' O ' ' CD1' ' A' ' 242' ' ' PHE . 15.2 mt -141.7 146.3 35.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.899 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 242' ' ' PHE . . . . . 0.511 ' CD1' ' O ' ' A' ' 241' ' ' LEU . 9.7 m-85 -158.49 155.33 28.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.825 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 72.9 mtm180 -69.29 135.61 50.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.873 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 11.2 t -134.89 163.64 29.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.834 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 245' ' ' THR . . . . . 0.413 ' O ' ' C ' ' A' ' 246' ' ' ALA . 72.6 p -139.77 156.57 46.69 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.136 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 246' ' ' ALA . . . . . 0.413 ' C ' ' O ' ' A' ' 245' ' ' THR . . . -36.24 -52.23 0.8 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.07 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -56.87 -52.39 65.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.081 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -49.78 -49.91 46.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.959 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 97.0 t -49.47 -66.48 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.129 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -40.69 -42.98 1.85 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.91 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -63.87 -48.12 77.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.92 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 96.0 t -57.83 -46.05 87.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.148 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 16.5 mt -57.32 -49.59 75.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.942 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 14.4 m-20 -60.11 -51.17 70.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.861 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 30.6 ttt180 -38.91 -52.11 1.77 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.905 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -69.63 -50.4 44.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.912 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 8.6 m . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.828 -179.797 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.905 0.383 . . . . 0.0 110.836 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.425 ' O ' ' C ' ' A' ' 157' ' ' ALA . 69.0 t -68.12 -44.51 84.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.15 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.425 ' C ' ' O ' ' A' ' 156' ' ' VAL . . . -36.11 -59.71 0.6 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.073 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 41.7 mm-40 -57.27 -49.88 74.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.891 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -46.33 -39.96 11.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.878 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 83.6 mt -91.33 -18.0 25.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.929 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 28.4 t -58.5 -22.65 55.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.839 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 19.8 mmtp -73.22 120.77 19.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.877 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -96.15 158.32 15.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.871 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 59.93 47.67 9.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.856 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 25.3 mm-40 -131.74 156.28 46.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.921 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 29.9 t -111.14 105.66 19.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.101 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' ILE . . . . . 0.417 HG23 ' N ' ' A' ' 168' ' ' VAL . 66.4 mt -77.71 135.18 26.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.141 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.417 ' N ' HG23 ' A' ' 167' ' ' ILE . 91.1 t -114.15 128.79 70.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.08 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 7.7 ttp-105 -88.35 106.09 18.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.857 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' MET . . . . . 0.437 ' HE1' ' CD2' ' A' ' 173' ' ' LEU . 99.3 mtp -95.57 138.32 33.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.88 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 73.7 mtt-85 -134.4 139.89 45.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.869 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 83.91 39.39 9.46 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.493 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.437 ' CD2' ' HE1' ' A' ' 170' ' ' MET . 24.1 mt -89.34 126.25 59.14 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.665 0.745 . . . . 0.0 110.889 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . 0.416 ' HG3' ' CB ' ' A' ' 237' ' ' ARG . 65.7 Cg_exo -47.99 132.78 22.84 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.684 2.256 . . . . 0.0 112.326 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . 0.567 ' CD1' ' HG3' ' A' ' 209' ' ' PRO . 10.3 t80 -45.19 -34.78 2.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.899 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 9.2 p -82.46 -30.34 30.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.14 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -52.84 107.0 0.19 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.116 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 5.7 p -113.02 178.16 4.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.155 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -46.48 -39.63 11.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.071 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -60.2 -34.63 73.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.875 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 38.5 mm-40 -75.38 -23.74 57.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.883 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 74.8 t -83.23 -47.2 18.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.17 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 54.8 t -41.47 -44.12 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.125 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -81.47 -37.06 28.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.08 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . 0.507 ' CE1' ' CE1' ' A' ' 186' ' ' PHE . 19.9 t80 -45.69 -62.96 1.08 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.858 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' PHE . . . . . 0.507 ' CE1' ' CE1' ' A' ' 185' ' ' PHE . 68.7 m-85 -89.41 -20.9 23.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.911 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -49.67 -16.9 1.19 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.461 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 25.1 tp60 -58.94 -72.85 0.09 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.825 0.345 . . . . 0.0 110.878 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 23.3 m80 -118.28 -9.31 10.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.878 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 71.3 m -125.46 86.94 56.47 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.543 0.687 . . . . 0.0 110.9 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 141.35 45.04 Favored 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.708 2.272 . . . . 0.0 112.381 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . 0.439 HG23 ' N ' ' A' ' 193' ' ' THR . 61.4 mt -95.78 141.99 14.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.116 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' THR . . . . . 0.439 ' N ' HG23 ' A' ' 192' ' ' ILE . 14.8 m -65.38 102.98 0.74 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.168 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 89.15 -16.96 54.41 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.485 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . 0.4 ' O ' ' N ' ' A' ' 198' ' ' GLY . . . 72.85 -122.43 8.25 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.456 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 15.4 ptmt -46.38 -36.15 6.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.746 0.308 . . . . 0.0 110.903 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -69.85 -31.01 68.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.871 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 195' ' ' GLY . . . -91.99 39.55 3.01 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.52 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 48.5 mt -139.99 145.49 26.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.824 0.345 . . . . 0.0 111.116 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 15.2 tp -143.33 124.32 14.38 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.926 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -103.5 123.66 47.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.875 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . 0.441 HG11 ' N ' ' A' ' 203' ' ' THR . 44.6 t -78.96 140.09 17.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.142 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' THR . . . . . 0.441 ' N ' HG11 ' A' ' 202' ' ' VAL . 0.8 OUTLIER -144.79 139.15 27.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.155 -179.986 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -49.48 159.13 0.7 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.657 0.741 . . . . 0.0 110.914 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 3.24 2.88 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.673 2.248 . . . . 0.0 112.346 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -110.51 -20.83 12.43 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.863 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 114.15 34.27 1.67 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.427 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -116.16 143.62 31.34 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.621 0.724 . . . . 0.0 110.848 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' PRO . . . . . 0.567 ' HG3' ' CD1' ' A' ' 175' ' ' PHE . 53.9 Cg_endo -69.77 107.79 1.94 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.699 2.266 . . . . 0.0 112.348 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' THR . . . . . 0.43 ' HB ' ' CE1' ' A' ' 256' ' ' PHE . 44.9 p -73.18 -5.65 40.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.117 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 79.42 -40.56 2.21 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.48 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -69.42 161.5 29.29 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.787 0.327 . . . . 0.0 110.852 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . 0.406 ' HB3' ' CD1' ' A' ' 173' ' ' LEU . . . -164.28 -179.15 5.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.105 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . 0.408 ' CD2' HG11 ' A' ' 249' ' ' VAL . 65.0 m-85 -144.88 144.95 31.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.886 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 6.1 t -131.69 160.14 42.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.147 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 37.6 mt -108.8 140.92 41.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.924 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -135.81 125.19 24.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.884 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -38.1 -73.44 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.081 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' CYS . . . . . . . . . . . . . 69.5 m -123.63 174.05 7.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.873 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -64.56 -32.91 74.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.932 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -41.28 -44.65 2.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.896 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 222' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -77.7 -43.92 29.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.906 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -50.8 -54.96 19.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.063 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 -50.55 -54.57 21.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.894 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . 0.423 ' HA ' ' NE ' ' A' ' 228' ' ' ARG . 55.0 m-20 -54.98 -27.62 45.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.912 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -76.68 -39.83 50.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.073 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 86.4 mt -55.18 -38.32 68.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.9 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 228' ' ' ARG . . . . . 0.423 ' NE ' ' HA ' ' A' ' 225' ' ' ASN . 50.4 mtm180 -57.99 -24.26 57.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.883 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . 0.463 ' O ' ' C ' ' A' ' 230' ' ' HIS . 28.1 mtpt -77.01 -1.52 29.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.907 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 230' ' ' HIS . . . . . 0.463 ' C ' ' O ' ' A' ' 229' ' ' LYS . 85.9 t60 -33.6 138.15 0.08 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.856 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . 0.442 ' HG2' ' CD2' ' A' ' 230' ' ' HIS . 37.4 mmtt 62.37 25.67 15.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.937 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -52.25 -179.02 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.876 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.552 HD21 ' CE1' ' A' ' 238' ' ' TYR . 31.2 mt -139.5 107.34 5.66 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.951 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 234' ' ' LEU . . . . . 0.449 ' C ' ' CD2' ' A' ' 234' ' ' LEU . 5.4 tt -117.64 114.63 23.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.895 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 59.77 37.0 91.8 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.466 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 28.0 mmtt 68.47 52.24 0.62 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.742 0.306 . . . . 0.0 110.893 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 237' ' ' ARG . . . . . 0.416 ' CB ' ' HG3' ' A' ' 174' ' ' PRO . 43.6 mmt-85 -156.19 115.36 3.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.883 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 238' ' ' TYR . . . . . 0.552 ' CE1' HD21 ' A' ' 233' ' ' LEU . 93.8 m-85 -67.84 134.81 51.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.933 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 60.2 mt -132.98 136.32 55.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.133 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 240' ' ' GLU . . . . . 0.545 ' HB3' ' CE2' ' A' ' 242' ' ' PHE . 66.3 mt-10 -89.33 172.6 8.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.921 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . 0.599 ' O ' ' CD1' ' A' ' 242' ' ' PHE . 18.4 mt -153.99 139.24 17.51 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.905 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 242' ' ' PHE . . . . . 0.599 ' CD1' ' O ' ' A' ' 241' ' ' LEU . 5.7 m-85 -159.13 122.87 3.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.865 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . 0.493 ' CG ' ' O ' ' A' ' 243' ' ' ARG . 19.0 ptt-85 -61.05 118.06 6.29 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.861 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 16.3 t -114.08 -179.22 3.57 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.86 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 71.3 p -127.83 162.2 27.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.137 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -50.58 -56.13 13.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.058 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -50.2 -52.31 36.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.145 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -49.79 -57.77 6.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.879 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . 0.408 HG11 ' CD2' ' A' ' 214' ' ' PHE . 95.1 t -38.78 -66.81 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.135 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -38.64 -48.79 1.5 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.948 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -60.32 -44.56 95.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.93 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 98.7 t -60.76 -44.93 98.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.146 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 17.3 mt -58.39 -49.43 77.28 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.915 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -61.07 -47.02 88.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.89 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 57.2 ttt180 -41.93 -44.04 3.3 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.883 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 256' ' ' PHE . . . . . 0.43 ' CE1' ' HB ' ' A' ' 210' ' ' THR . 49.9 m-85 -73.44 -40.08 64.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.911 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 5.4 m . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.896 -179.827 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.94 0.4 . . . . 0.0 110.916 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 73.7 t -79.55 -43.07 23.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.156 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -41.07 -58.05 1.86 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.112 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -59.66 -44.42 93.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.94 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 28.1 t80 -53.49 -42.61 67.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.897 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 86.6 mt -88.97 -16.44 31.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.93 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 8.5 t -61.38 -32.29 72.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.843 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 43.3 mmtt -61.05 126.45 27.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.872 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -102.33 152.87 20.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.858 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 11.3 m-20 68.92 38.82 1.97 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.888 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 5.4 mm-40 -128.8 146.08 51.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.923 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 60.8 t -100.31 106.48 19.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.125 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 36.0 mt -77.19 138.86 19.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.11 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 96.1 t -123.06 130.8 74.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.107 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . 0.542 ' HG3' ' CE1' ' A' ' 214' ' ' PHE . 25.6 ttm180 -88.34 113.08 23.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.857 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' MET . . . . . 0.453 ' HE3' ' CD2' ' A' ' 173' ' ' LEU . 97.8 mtp -98.15 126.51 43.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.873 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 24.2 mtt180 -123.51 157.5 33.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.877 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 73.79 21.93 78.75 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.479 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.453 ' CD2' ' HE3' ' A' ' 170' ' ' MET . 19.8 mt -74.39 127.5 87.5 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.616 0.722 . . . . 0.0 110.913 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_exo -47.96 149.32 5.73 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.666 2.244 . . . . 0.0 112.349 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 10.8 m-30 -62.49 -26.1 68.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.899 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 63.5 p -90.47 -25.62 20.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.152 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -44.91 126.52 5.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.076 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 5.9 p -125.17 176.49 6.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.15 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -57.12 -36.18 70.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.113 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -68.71 -15.83 63.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.922 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -88.53 -22.43 23.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.86 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.456 ' O ' ' N ' ' A' ' 185' ' ' PHE . 22.4 t -83.94 -52.79 12.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.16 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . 0.425 ' C ' ' O ' ' A' ' 182' ' ' VAL . 47.7 t -36.04 -47.51 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.138 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -74.71 -36.6 62.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.101 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . 0.572 ' CE1' ' CE1' ' A' ' 186' ' ' PHE . 15.5 t80 -48.51 -59.27 3.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.877 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' PHE . . . . . 0.572 ' CE1' ' CE1' ' A' ' 185' ' ' PHE . 57.2 m-85 -92.18 -21.31 20.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.898 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -49.13 -19.16 1.47 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.481 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 12.4 mm100 -56.35 -75.19 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.866 0.365 . . . . 0.0 110.949 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 2.5 t-160 -117.49 -6.28 11.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.869 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 87.0 m -126.86 86.31 59.03 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.552 0.692 . . . . 0.0 110.9 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 133.62 26.1 Favored 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.689 2.259 . . . . 0.0 112.357 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . 0.4 ' CD1' HG11 ' A' ' 182' ' ' VAL . 57.9 mt -85.26 145.58 7.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.129 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 90.9 m -73.66 107.43 5.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.105 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 93.16 -21.85 37.91 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.459 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 78.72 -122.89 6.0 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.476 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.77 -20.71 9.09 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.719 0.295 . . . . 0.0 110.89 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -85.22 -24.87 27.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.895 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -93.4 40.27 2.82 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.46 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 35.2 mt -142.75 153.0 17.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.896 0.379 . . . . 0.0 111.104 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 13.3 tp -146.34 110.96 5.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.925 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -92.89 109.81 21.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.871 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 11.0 t -70.99 128.05 33.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.121 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -133.04 142.66 48.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.134 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -51.4 159.12 1.22 Allowed Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.708 0.766 . . . . 0.0 110.943 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 3.4 2.78 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.648 2.232 . . . . 0.0 112.38 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -112.55 -21.32 11.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.867 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 118.03 9.69 9.59 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.489 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -92.48 141.45 24.75 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.581 0.705 . . . . 0.0 110.887 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 106.49 1.67 Allowed 'Trans proline' 0 C--O 1.233 0.225 0 C-N-CA 122.69 2.26 . . . . 0.0 112.333 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' THR . . . . . 0.522 ' HB ' ' CE1' ' A' ' 256' ' ' PHE . 71.0 p -66.11 -23.4 66.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.131 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 95.49 -22.59 38.07 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.501 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' ASP . . . . . 0.428 ' OD1' ' CZ ' ' A' ' 256' ' ' PHE . 1.0 OUTLIER -90.16 157.03 17.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.776 0.322 . . . . 0.0 110.899 -179.988 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -159.37 178.73 9.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.107 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . 0.542 ' CE1' ' HG3' ' A' ' 169' ' ' ARG . 55.4 m-85 -143.64 145.65 32.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.909 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 4.0 t -131.9 162.02 40.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.137 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 45.3 mt -111.8 137.45 49.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.903 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -130.12 142.39 50.6 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.881 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -50.32 -61.66 2.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.093 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' CYS . . . . . . . . . . . . . 1.9 t -153.11 175.3 13.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.833 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -49.2 -31.31 8.32 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.891 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -51.57 -36.07 43.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.918 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 222' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -92.02 -41.51 10.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.926 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -56.81 -54.41 46.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.114 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 10.2 mm-40 -50.37 -52.11 40.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.893 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 22.4 m-20 -58.6 -23.84 59.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.858 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -79.48 -45.88 18.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.112 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 57.3 mt -52.13 -35.67 49.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.898 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 65.5 mtp180 -56.77 -29.56 62.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.912 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . 0.465 ' O ' ' C ' ' A' ' 230' ' ' HIS . 16.3 mtpp -74.7 -0.69 18.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.896 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 230' ' ' HIS . . . . . 0.51 ' CD2' ' HG2' ' A' ' 231' ' ' LYS . 86.3 t60 -33.35 141.39 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.842 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . 0.51 ' HG2' ' CD2' ' A' ' 230' ' ' HIS . 13.1 mmtp 59.78 26.62 15.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.9 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -53.42 177.96 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.853 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.554 HD23 ' CE1' ' A' ' 238' ' ' TYR . 32.9 mt -136.58 105.03 5.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.97 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 7.0 tt -113.94 115.53 27.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.9 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 59.17 37.18 91.39 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.484 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 62.9 mttt 69.08 52.57 0.49 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.809 0.338 . . . . 0.0 110.877 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 23.2 mmt180 -155.99 117.26 3.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.879 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 238' ' ' TYR . . . . . 0.554 ' CE1' HD23 ' A' ' 233' ' ' LEU . 96.1 m-85 -69.17 133.99 48.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.95 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 76.2 mt -132.59 135.96 56.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.136 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 240' ' ' GLU . . . . . 0.552 ' HB3' ' CZ ' ' A' ' 242' ' ' PHE . 6.8 mt-10 -87.38 179.38 6.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.878 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . 0.59 ' O ' ' CD1' ' A' ' 242' ' ' PHE . 54.8 mt -158.29 132.62 8.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.889 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 242' ' ' PHE . . . . . 0.59 ' CD1' ' O ' ' A' ' 241' ' ' LEU . 6.7 m-85 -154.03 123.05 6.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.861 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . 0.486 ' CG ' ' O ' ' A' ' 243' ' ' ARG . 20.5 ptt180 -59.72 116.46 4.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.893 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 1.9 t -103.89 175.37 5.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.814 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 52.9 p -127.98 150.06 50.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.107 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -40.44 -59.35 1.34 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.056 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -52.36 -51.27 59.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.127 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . 0.408 ' O ' ' N ' ' A' ' 251' ' ' GLN . 13.3 tp10 -52.21 -57.29 10.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.942 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 86.9 t -36.85 -60.13 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.122 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -49.89 -40.37 42.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.896 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 251' ' ' GLN . . . . . 0.499 ' O ' ' ND2' ' A' ' 254' ' ' ASN . 41.9 mt-30 -69.7 -19.88 63.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.943 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 69.0 t -88.64 -26.82 5.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.111 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 10.5 mt -81.46 -39.17 25.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.91 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 254' ' ' ASN . . . . . 0.499 ' ND2' ' O ' ' A' ' 251' ' ' GLN . 0.7 OUTLIER -66.41 -45.43 79.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.885 179.918 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . 0.507 ' CG ' ' N ' ' A' ' 256' ' ' PHE . 6.0 ptm180 -48.07 -48.72 33.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.87 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 256' ' ' PHE . . . . . 0.522 ' CE1' ' HB ' ' A' ' 210' ' ' THR . 12.9 m-85 -64.58 -41.83 96.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.891 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 57.8 m . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.893 -179.834 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.883 0.373 . . . . 0.0 110.884 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 74.4 t -63.41 -36.51 76.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.11 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -38.9 -63.89 0.49 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.098 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 89.7 mm-40 -57.58 -48.09 80.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.903 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 28.0 t80 -47.68 -41.81 23.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.857 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 33.0 mt -83.98 -31.95 25.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.91 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 18.1 t -47.3 -41.24 18.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.85 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . 0.424 ' HG3' ' CD1' ' A' ' 216' ' ' LEU . 0.7 OUTLIER -38.39 129.57 1.35 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.904 179.908 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -110.63 133.63 53.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.862 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 74.24 43.33 0.29 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.884 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 10.4 mm100 -128.38 168.02 16.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.939 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 55.6 t -118.71 141.33 38.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.111 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' ILE . . . . . 0.454 HD13 ' N ' ' A' ' 246' ' ' ALA . 8.6 mt -111.61 143.92 20.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.103 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.416 HG13 ' N ' ' A' ' 169' ' ' ARG . 97.9 t -127.14 133.72 67.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.087 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . 0.416 ' N ' HG13 ' A' ' 168' ' ' VAL . 70.2 ttt180 -91.14 112.83 24.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.868 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' MET . . . . . 0.46 ' HE3' ' CD2' ' A' ' 173' ' ' LEU . 91.0 mtp -100.43 149.56 23.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.89 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 35.0 mtp180 -146.75 133.87 20.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.909 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 96.51 19.28 28.02 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.513 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.46 ' CD2' ' HE3' ' A' ' 170' ' ' MET . 24.3 mt -71.18 121.12 83.29 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.639 0.733 . . . . 0.0 110.907 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . 0.411 ' O ' ' C ' ' A' ' 175' ' ' PHE . 64.9 Cg_exo -47.97 131.66 21.43 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.703 2.269 . . . . 0.0 112.326 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . 0.565 ' CD1' ' HG3' ' A' ' 209' ' ' PRO . 11.6 t80 -37.52 -49.42 1.06 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.885 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' THR . . . . . 0.424 ' O ' ' C ' ' A' ' 177' ' ' ALA . 14.4 p -68.39 -44.98 73.91 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.141 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' A' ' 176' ' ' THR . . . -35.72 111.25 0.13 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.104 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -115.48 -177.16 3.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.161 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -50.01 -47.87 52.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.12 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . 0.407 ' CG ' ' OE2' ' A' ' 181' ' ' GLU . 5.7 pt-20 -51.67 -40.01 59.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.923 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . 0.407 ' OE2' ' CG ' ' A' ' 180' ' ' GLU . 0.1 OUTLIER -65.94 -36.99 84.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.876 -179.95 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.418 ' O ' ' C ' ' A' ' 183' ' ' VAL . 89.9 t -69.47 -50.36 51.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.155 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . 0.418 ' C ' ' O ' ' A' ' 182' ' ' VAL . 34.4 t -35.55 -50.89 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.161 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -75.4 -42.28 54.17 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.127 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . 0.57 ' CE1' ' HE3' ' A' ' 229' ' ' LYS . 10.2 t80 -40.2 -62.03 0.8 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.906 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' PHE . . . . . 0.527 ' CE1' ' CE1' ' A' ' 185' ' ' PHE . 72.8 m-85 -92.81 -21.08 20.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.908 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -49.28 -17.26 1.04 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.535 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -57.95 -72.4 0.09 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.829 0.347 . . . . 0.0 110.931 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 29.5 m170 -118.22 -10.88 10.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.889 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 74.2 m -125.27 85.34 58.43 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.584 0.707 . . . . 0.0 110.89 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 146.54 60.67 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.694 2.263 . . . . 0.0 112.362 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . 0.436 HG23 ' N ' ' A' ' 193' ' ' THR . 56.0 mt -98.43 143.52 12.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.156 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' THR . . . . . 0.436 ' N ' HG23 ' A' ' 192' ' ' ILE . 89.1 m -67.99 101.21 1.08 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.182 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 92.23 -12.18 70.26 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.485 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 68.22 -123.48 17.6 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.461 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 13.9 pttp -49.23 -29.46 5.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.766 0.317 . . . . 0.0 110.921 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -75.6 -31.35 59.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.879 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -94.29 41.83 2.54 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.464 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 87.0 mt -140.35 147.84 22.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.887 0.375 . . . . 0.0 111.117 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 13.4 tp -141.57 127.09 18.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.89 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -105.43 120.71 42.27 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.889 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 20.1 t -78.69 134.19 28.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.088 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' THR . . . . . 0.456 ' CA ' HG21 ' A' ' 210' ' ' THR . 0.8 OUTLIER -138.55 136.61 36.24 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.09 -179.974 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . 0.488 ' N ' ' CG2' ' A' ' 210' ' ' THR . 33.4 m-85 -46.8 158.71 0.4 Allowed Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.618 0.723 . . . . 0.0 110.955 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 3.49 2.75 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.669 2.246 . . . . 0.0 112.354 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -112.9 -19.13 12.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.817 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 120.43 -3.74 12.31 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.492 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.0 140.45 62.2 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.574 0.702 . . . . 0.0 110.895 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' PRO . . . . . 0.565 ' HG3' ' CD1' ' A' ' 175' ' ' PHE . 54.4 Cg_endo -69.72 102.67 1.05 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.672 2.248 . . . . 0.0 112.37 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' THR . . . . . 0.556 HG23 ' CD1' ' A' ' 256' ' ' PHE . 37.6 p -61.39 -13.29 18.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.173 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 82.63 -39.62 2.7 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.525 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -71.05 161.6 30.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.834 0.349 . . . . 0.0 110.848 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . 0.415 ' HB3' ' CD1' ' A' ' 173' ' ' LEU . . . -160.41 -177.6 6.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.115 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -148.06 137.49 22.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.852 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' VAL . . . . . 0.427 HG11 ' CD1' ' A' ' 192' ' ' ILE . 3.3 t -124.09 165.68 20.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.084 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . 0.424 ' CD1' ' HG3' ' A' ' 162' ' ' LYS . 47.7 mt -116.96 145.62 43.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.935 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -134.31 151.5 51.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.84 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -60.0 -59.22 5.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.135 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' CYS . . . . . . . . . . . . . 1.8 t -144.48 177.71 8.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.854 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 13.7 mp0 -58.71 -35.36 72.53 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.865 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -43.55 -38.5 2.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.924 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 222' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -92.98 -34.69 13.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.933 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.6 -59.67 4.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.135 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' GLN . . . . . 0.435 ' HA ' ' CD1' ' A' ' 227' ' ' LEU . 3.1 pt20 -60.41 -37.17 79.99 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.957 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 14.4 m-20 -68.03 -24.03 65.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.874 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -79.89 -32.52 40.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.087 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . 0.435 ' CD1' ' HA ' ' A' ' 224' ' ' GLN . 20.2 mt -56.18 -31.52 63.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.947 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 9.1 mtp-105 -59.8 -18.37 43.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.866 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . 0.57 ' HE3' ' CE1' ' A' ' 185' ' ' PHE . 24.8 mtpp -82.06 -1.16 47.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.873 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 230' ' ' HIS . . . . . 0.454 ' C ' ' O ' ' A' ' 229' ' ' LYS . 75.6 t60 -34.3 136.98 0.12 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.897 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . 0.425 ' HG2' ' CD2' ' A' ' 230' ' ' HIS . 24.1 mmtt 59.35 36.29 23.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.908 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -62.97 -176.99 0.14 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.902 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.563 HD22 ' CE1' ' A' ' 238' ' ' TYR . 30.8 mt -137.83 117.31 12.89 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.896 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 6.6 tt -126.77 112.25 15.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.935 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 59.51 36.2 88.44 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.498 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 30.3 mttp 71.69 52.62 0.22 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.783 0.325 . . . . 0.0 110.861 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 59.5 mmt-85 -156.39 115.35 3.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.876 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 238' ' ' TYR . . . . . 0.563 ' CE1' HD22 ' A' ' 233' ' ' LEU . 96.8 m-85 -68.68 136.66 53.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.908 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 79.5 mt -132.87 131.34 59.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.111 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 240' ' ' GLU . . . . . 0.461 ' HB3' ' CZ ' ' A' ' 242' ' ' PHE . 43.4 mt-10 -92.43 161.78 14.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.874 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . 0.499 ' O ' ' CD1' ' A' ' 242' ' ' PHE . 20.2 mt -136.87 140.15 42.17 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.892 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 242' ' ' PHE . . . . . 0.499 ' CD1' ' O ' ' A' ' 241' ' ' LEU . 22.6 m-85 -153.14 128.22 9.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.82 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 20.3 mtp180 -44.04 153.48 0.14 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.884 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 1.1 t -152.55 160.13 43.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.901 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 41.6 p -138.41 157.67 45.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.088 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 246' ' ' ALA . . . . . 0.454 ' N ' HD13 ' A' ' 167' ' ' ILE . . . -37.45 -59.06 0.8 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.114 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -53.27 -56.59 15.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.151 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -44.59 -51.95 8.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.878 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . 0.418 ' O ' ' N ' ' A' ' 252' ' ' VAL . 98.4 t -47.02 -66.79 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.139 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -43.25 -50.06 6.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.929 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 51.1 mm-40 -59.67 -30.18 68.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.918 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 252' ' ' VAL . . . . . 0.418 ' N ' ' O ' ' A' ' 249' ' ' VAL . 92.7 t -75.92 -36.98 33.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.1 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 8.5 mt -68.47 -37.73 80.41 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.893 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -66.28 -59.53 3.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.868 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . 0.469 ' HG3' ' N ' ' A' ' 256' ' ' PHE . 0.4 OUTLIER -41.21 -38.08 1.05 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.898 -179.94 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 256' ' ' PHE . . . . . 0.556 ' CD1' HG23 ' A' ' 210' ' ' THR . 10.2 m-85 -81.71 -53.1 6.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.868 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 34.7 t . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.83 -179.809 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 . . . . . 0 C--O 1.23 0.066 0 CA-C-O 120.932 0.396 . . . . 0.0 110.894 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 57.5 t -54.73 -43.29 65.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.168 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -43.49 -50.96 6.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.11 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 46.4 mm-40 -65.21 -37.25 86.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.939 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' PHE . . . . . 0.566 ' CE1' ' HG ' ' A' ' 216' ' ' LEU . 64.0 t80 -60.14 -41.32 92.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.886 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 86.3 mt -90.98 -16.59 27.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.893 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 46.5 t -62.62 -35.79 80.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.841 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 12.5 mttp -58.99 120.13 8.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.895 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 37.6 mp0 -94.61 155.83 16.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.852 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 11.1 m-80 63.45 48.89 3.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.866 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 4.9 mm100 -131.87 162.21 31.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.878 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.424 ' CG1' ' CB ' ' A' ' 223' ' ' ALA . 89.5 t -116.73 111.13 33.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.138 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 30.5 mt -85.33 142.09 13.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.082 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.452 HG11 ' N ' ' A' ' 169' ' ' ARG . 40.8 t -127.51 142.52 43.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.155 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . 0.452 ' N ' HG11 ' A' ' 168' ' ' VAL . 30.0 ttp180 -91.75 115.18 27.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.863 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' MET . . . . . 0.44 ' HE3' ' CD2' ' A' ' 173' ' ' LEU . 66.9 mtp -102.63 125.39 49.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.919 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . 0.422 ' HB2' ' NH1' ' A' ' 171' ' ' ARG . 3.3 ttm105 -131.4 139.73 49.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.84 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 90.23 23.09 32.97 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.494 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.44 ' CD2' ' HE3' ' A' ' 170' ' ' MET . 26.3 mt -74.9 128.03 85.88 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.589 0.709 . . . . 0.0 110.924 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . 0.469 ' HG3' ' CB ' ' A' ' 237' ' ' ARG . 64.7 Cg_exo -48.01 130.83 20.56 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.719 2.279 . . . . 0.0 112.36 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -47.93 -22.71 0.62 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.877 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 41.4 p -91.57 -29.39 16.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.118 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -48.77 137.95 11.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.043 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -139.38 171.82 13.71 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.114 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.477 ' N ' ' CZ ' ' A' ' 201' ' ' PHE . . . -47.04 -47.38 22.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.106 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -57.02 -26.66 60.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.882 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . 0.423 ' CD ' HD22 ' A' ' 234' ' ' LEU . 6.7 tt0 -79.71 -35.58 38.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.898 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 48.1 t -74.01 -42.45 52.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.117 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 45.6 t -42.24 -45.81 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.153 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -81.66 -32.49 31.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.102 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . 0.481 ' CE1' ' CE ' ' A' ' 229' ' ' LYS . 41.2 t80 -49.27 -59.44 3.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.863 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -90.51 -24.32 20.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.829 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -48.97 -22.14 2.83 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.516 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 33.1 tp60 -53.08 -70.85 0.08 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.864 0.364 . . . . 0.0 110.884 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 8.9 m80 -118.3 -15.33 9.75 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.862 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 74.7 m -119.88 88.24 39.78 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.592 0.71 . . . . 0.0 110.839 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' PRO . . . . . 0.492 ' HD2' ' CD1' ' A' ' 222' ' ' TYR . 53.7 Cg_endo -69.8 131.62 21.57 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.679 2.253 . . . . 0.0 112.289 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . 0.47 HG23 ' N ' ' A' ' 193' ' ' THR . 55.7 mt -83.25 142.12 13.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.155 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' THR . . . . . 0.47 ' N ' HG23 ' A' ' 192' ' ' ILE . 87.8 m -65.32 102.66 0.7 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.152 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 88.34 -17.43 48.07 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.476 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . 0.424 ' O ' ' N ' ' A' ' 198' ' ' GLY . . . 78.35 -128.2 8.59 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.476 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 17.2 ptmt -44.94 -29.48 0.83 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.748 0.309 . . . . 0.0 110.885 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -74.34 -34.67 63.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.884 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 195' ' ' GLY . . . -86.37 21.24 18.18 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.47 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 76.8 mt -123.56 146.22 29.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.808 0.337 . . . . 0.0 111.133 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 16.3 tp -142.32 123.18 14.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.869 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' PHE . . . . . 0.477 ' CZ ' ' N ' ' A' ' 179' ' ' ALA . 68.1 m-85 -104.24 112.34 25.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.887 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 25.8 t -66.57 122.55 17.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.124 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -131.83 140.34 49.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.155 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -45.79 158.31 0.35 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.685 0.755 . . . . 0.0 110.898 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 3.02 3.04 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.662 2.241 . . . . 0.0 112.339 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -112.15 -16.33 13.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.864 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 106.14 62.82 0.61 Allowed Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.439 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 7.3 mtt85 -148.26 144.26 18.53 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.602 0.715 . . . . 0.0 110.901 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 108.64 2.12 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.692 2.261 . . . . 0.0 112.318 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 74.1 p -74.02 -29.98 62.21 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.117 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 114.63 -37.04 3.68 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.498 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -78.6 169.37 18.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.836 0.35 . . . . 0.0 110.857 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -170.99 174.07 4.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.145 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -139.55 136.78 34.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.865 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 12.6 t -117.61 158.0 18.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.156 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . 0.566 ' HG ' ' CE1' ' A' ' 159' ' ' PHE . 72.2 mt -115.3 139.56 49.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.933 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -132.29 149.47 52.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.86 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -49.87 -65.67 0.52 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.124 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' CYS . . . . . . . . . . . . . 1.8 t -141.57 179.14 6.99 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.876 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . 0.404 ' C ' ' OE1' ' A' ' 220' ' ' GLU . 0.0 OUTLIER -60.21 -16.4 32.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.875 -179.892 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -63.2 -47.48 82.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.87 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 222' ' ' TYR . . . . . 0.492 ' CD1' ' HD2' ' A' ' 191' ' ' PRO . 62.4 m-85 -78.44 -46.35 20.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.92 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . 0.424 ' CB ' ' CG1' ' A' ' 166' ' ' VAL . . . -50.22 -50.35 49.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.066 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 23.6 mm-40 -54.28 -53.09 58.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.93 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 55.0 m-20 -57.6 -25.62 60.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.873 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -74.96 -30.76 61.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.151 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 69.5 mt -62.47 -35.37 79.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.908 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 66.1 mtp85 -56.53 -22.06 30.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.842 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . 0.481 ' CE ' ' CE1' ' A' ' 185' ' ' PHE . 21.2 mtpp -75.03 -2.78 28.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.876 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 230' ' ' HIS . . . . . 0.512 ' CD2' ' HG2' ' A' ' 231' ' ' LYS . 84.9 t60 -34.0 135.8 0.14 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.843 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . 0.512 ' HG2' ' CD2' ' A' ' 230' ' ' HIS . 21.9 mmtt 62.59 29.22 16.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.875 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . 0.425 ' OD2' ' CE2' ' A' ' 185' ' ' PHE . 3.2 t70 -56.01 178.35 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.841 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.515 HD23 ' CE1' ' A' ' 238' ' ' TYR . 30.6 mt -137.71 105.02 5.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.927 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 234' ' ' LEU . . . . . 0.423 HD22 ' CD ' ' A' ' 181' ' ' GLU . 5.8 tt -113.59 108.16 16.77 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.876 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 60.84 44.06 98.49 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.49 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 6.8 mmmm 65.85 54.98 0.99 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.765 0.317 . . . . 0.0 110.932 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 237' ' ' ARG . . . . . 0.469 ' CB ' ' HG3' ' A' ' 174' ' ' PRO . 17.5 mmt85 -156.84 115.11 3.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.863 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 238' ' ' TYR . . . . . 0.515 ' CE1' HD23 ' A' ' 233' ' ' LEU . 97.3 m-85 -70.4 120.81 16.61 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.952 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 19.8 mt -116.27 137.8 48.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.154 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -101.1 171.18 7.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.905 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . 0.401 ' O ' ' CD1' ' A' ' 242' ' ' PHE . 28.8 mt -147.2 145.26 29.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.873 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 242' ' ' PHE . . . . . 0.401 ' CD1' ' O ' ' A' ' 241' ' ' LEU . 28.7 m-85 -155.75 129.43 8.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.878 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 42.4 mtm180 -44.62 140.88 2.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.846 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 9.2 t -140.6 148.4 40.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.857 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 43.0 p -119.88 161.21 21.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.133 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -48.22 -48.68 34.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.104 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -58.87 -53.79 54.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.065 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -49.07 -50.84 34.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.886 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 95.0 t -50.8 -61.92 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.141 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 59.3 mt-30 -44.7 -50.02 10.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.879 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -58.64 -38.63 78.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.932 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 69.4 t -67.92 -44.31 85.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.115 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 9.6 mt -65.77 -45.45 82.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.93 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 42.2 m-20 -68.7 -27.23 65.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.884 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . 0.469 ' HD3' ' N ' ' A' ' 256' ' ' PHE . 0.6 OUTLIER -72.58 -53.32 12.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.866 -179.965 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 256' ' ' PHE . . . . . 0.469 ' N ' ' HD3' ' A' ' 255' ' ' ARG . 11.1 m-85 -59.44 -44.36 92.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.931 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 91.7 p . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.872 -179.809 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.943 0.401 . . . . 0.0 110.927 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.417 ' O ' ' C ' ' A' ' 157' ' ' ALA . 99.3 t -75.09 -47.0 38.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.125 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.417 ' C ' ' O ' ' A' ' 156' ' ' VAL . . . -36.83 -58.19 0.77 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.101 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 27.6 mm-40 -58.02 -50.46 73.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.907 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' PHE . . . . . 0.469 ' CE2' ' HG ' ' A' ' 216' ' ' LEU . 47.3 t80 -50.41 -42.82 54.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.863 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 62.6 mt -85.79 -21.21 28.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.906 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' SER . . . . . 0.417 ' N ' ' O ' ' A' ' 157' ' ' ALA . 15.6 t -58.12 -24.53 59.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.846 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 24.2 mmmt -65.52 131.1 45.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.893 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -109.66 154.99 22.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.923 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 63.19 42.72 6.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.892 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 20.5 mm-40 -127.86 156.57 42.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.914 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 47.1 t -108.63 100.76 11.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.158 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' ILE . . . . . 0.457 HD13 ' N ' ' A' ' 246' ' ' ALA . 49.3 mt -75.27 140.27 17.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.099 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.411 ' N ' HG21 ' A' ' 167' ' ' ILE . 39.0 t -127.92 134.21 65.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.117 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . 0.544 ' HG3' ' CE1' ' A' ' 214' ' ' PHE . 18.1 ttm180 -90.1 125.43 35.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.872 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 59.5 mtp -115.41 111.8 21.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.893 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -114.8 151.66 33.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.884 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 84.23 16.7 66.33 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.502 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.405 ' CD2' HD12 ' A' ' 239' ' ' ILE . 19.7 mt -71.57 133.99 84.5 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.615 0.721 . . . . 0.0 110.886 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . 0.485 ' O ' ' N ' ' A' ' 177' ' ' ALA . 65.3 Cg_exo -47.99 127.57 15.02 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.675 2.25 . . . . 0.0 112.328 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . 0.436 ' C ' ' O ' ' A' ' 174' ' ' PRO . 11.2 m-85 -34.68 -45.37 0.24 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.865 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' THR . . . . . 0.452 ' O ' ' C ' ' A' ' 177' ' ' ALA . 0.0 OUTLIER -74.56 -39.0 62.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.098 -179.894 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . 0.485 ' N ' ' O ' ' A' ' 174' ' ' PRO . . . -33.78 122.54 0.45 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.071 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' THR . . . . . 0.418 ' C ' ' CZ ' ' A' ' 201' ' ' PHE . 25.9 p -132.46 173.04 11.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.113 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.496 ' N ' ' CZ ' ' A' ' 201' ' ' PHE . . . -42.22 -47.52 4.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.044 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -51.26 -37.74 48.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.866 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 56.7 mm-40 -70.52 -34.91 72.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.867 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.444 ' O ' ' C ' ' A' ' 183' ' ' VAL . 92.4 t -71.29 -53.59 20.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.16 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . 0.444 ' C ' ' O ' ' A' ' 182' ' ' VAL . 76.4 t -34.05 -47.36 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.143 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -80.96 -41.47 22.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.106 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . 0.439 ' CD1' ' C ' ' A' ' 185' ' ' PHE . 4.9 t80 -40.03 -59.03 1.3 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.895 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -95.17 -21.94 18.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.901 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -49.33 -19.09 1.64 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.506 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -56.78 -70.82 0.11 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.817 0.341 . . . . 0.0 110.882 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 29.7 m-70 -118.21 -15.46 9.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.877 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 79.4 m -121.15 87.51 44.16 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.57 0.7 . . . . 0.0 110.852 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 140.75 43.53 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.706 2.27 . . . . 0.0 112.34 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . 0.436 ' CD1' HG13 ' A' ' 215' ' ' VAL . 63.1 mt -94.58 140.73 16.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.181 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 57.7 m -62.97 101.8 0.3 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.178 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 89.41 -16.24 56.6 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.483 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . 0.481 ' O ' ' N ' ' A' ' 198' ' ' GLY . . . 67.91 -126.0 23.08 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.462 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 16.8 ptmt -42.31 -27.07 0.13 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.737 0.303 . . . . 0.0 110.906 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -81.74 -36.23 28.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.872 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . 0.481 ' N ' ' O ' ' A' ' 195' ' ' GLY . . . -85.16 34.82 3.19 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.47 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 62.5 mt -135.05 149.26 28.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.901 0.381 . . . . 0.0 111.118 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 13.4 tp -142.51 115.23 8.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.913 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' PHE . . . . . 0.496 ' CZ ' ' N ' ' A' ' 179' ' ' ALA . 46.9 m-85 -96.8 124.42 40.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.862 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 48.0 t -77.21 120.89 28.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.14 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -129.88 137.23 50.3 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.152 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . 0.505 ' CD2' HG21 ' A' ' 210' ' ' THR . 34.9 m-85 -45.39 158.59 0.31 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.689 0.756 . . . . 0.0 110.892 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.81 2.61 3.41 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.63 2.22 . . . . 0.0 112.355 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -111.12 -16.51 13.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.857 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 107.14 53.7 0.69 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.482 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 12.0 mmm180 -138.35 143.7 39.84 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.621 0.724 . . . . 0.0 110.854 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 111.53 2.84 Favored 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.711 2.274 . . . . 0.0 112.357 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' THR . . . . . 0.505 HG21 ' CD2' ' A' ' 204' ' ' TYR . 68.3 p -75.26 -27.84 59.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.175 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 108.41 -27.42 13.85 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.493 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -91.38 154.89 18.88 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.766 0.317 . . . . 0.0 110.894 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -155.78 -177.82 6.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.1 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . 0.544 ' CE1' ' HG3' ' A' ' 169' ' ' ARG . 81.1 m-85 -144.29 151.38 39.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.914 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' VAL . . . . . 0.436 HG13 ' CD1' ' A' ' 192' ' ' ILE . 4.1 t -133.55 157.5 42.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.161 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . 0.469 ' HG ' ' CE2' ' A' ' 159' ' ' PHE . 29.7 mt -109.62 145.95 35.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.957 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -137.11 126.02 24.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.883 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -41.43 -50.34 3.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.115 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' CYS . . . . . . . . . . . . . 72.7 m -152.91 173.15 15.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.84 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -59.56 -35.78 74.91 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.839 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -37.68 -51.45 1.23 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.893 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 222' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -79.46 -42.12 26.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.945 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -48.01 -54.79 11.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.122 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -50.19 -58.79 4.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.883 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 48.8 m-20 -53.32 -22.91 8.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.872 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -88.74 -19.54 25.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.131 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 95.2 mt -72.41 -42.77 64.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.947 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 1.5 ptm180 -55.58 -19.11 9.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.823 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . 0.454 ' O ' ' C ' ' A' ' 230' ' ' HIS . 24.7 mtpp -72.81 -3.4 25.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.89 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 230' ' ' HIS . . . . . 0.454 ' C ' ' O ' ' A' ' 229' ' ' LYS . 83.6 t60 -34.35 138.17 0.1 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.855 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 18.0 mmtp 61.02 29.98 19.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.909 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -57.06 174.97 0.15 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.864 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.459 HD23 ' CG ' ' A' ' 238' ' ' TYR . 31.0 mt -131.07 108.94 10.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.914 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 6.6 tt -118.34 114.65 23.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.894 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 56.4 44.0 90.03 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.479 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . 0.426 ' HA ' ' NZ ' ' A' ' 236' ' ' LYS . 0.0 OUTLIER 63.74 52.75 2.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.802 0.334 . . . . 0.0 110.904 -179.997 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 237' ' ' ARG . . . . . 0.407 ' CB ' ' HG3' ' A' ' 174' ' ' PRO . 19.6 mmt180 -156.44 115.19 3.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.855 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 238' ' ' TYR . . . . . 0.459 ' CG ' HD23 ' A' ' 233' ' ' LEU . 92.2 m-85 -70.51 126.13 28.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.963 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . 0.405 HD12 ' CD2' ' A' ' 173' ' ' LEU . 66.2 mt -122.7 136.76 58.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.123 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 240' ' ' GLU . . . . . 0.494 ' HB3' ' CZ ' ' A' ' 242' ' ' PHE . 24.2 mp0 -96.68 158.94 15.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.883 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . 0.443 ' C ' ' CG ' ' A' ' 242' ' ' PHE . 14.5 mt -136.85 147.77 46.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.961 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 242' ' ' PHE . . . . . 0.494 ' CZ ' ' HB3' ' A' ' 240' ' ' GLU . 7.3 m-85 -158.52 139.47 12.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.84 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 22.8 mtm180 -64.3 128.65 36.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.869 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 1.8 t -128.02 167.21 17.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.854 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 245' ' ' THR . . . . . 0.449 ' O ' ' C ' ' A' ' 246' ' ' ALA . 34.1 p -131.55 148.21 52.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.099 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 246' ' ' ALA . . . . . 0.457 ' N ' HD13 ' A' ' 167' ' ' ILE . . . -34.1 -52.41 0.45 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.101 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -55.7 -54.3 45.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.09 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 -49.2 -56.01 10.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.868 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . 0.512 HG11 ' CD2' ' A' ' 214' ' ' PHE . 59.2 t -44.04 -64.5 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.135 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -39.69 -41.9 1.15 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.898 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 251' ' ' GLN . . . . . 0.461 ' HA ' ' ND2' ' A' ' 254' ' ' ASN . 38.9 mm-40 -68.19 -35.17 77.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.902 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 252' ' ' VAL . . . . . 0.488 ' N ' ' O ' ' A' ' 249' ' ' VAL . 82.6 t -71.22 -19.43 20.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.105 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 7.5 mt -86.57 -40.93 14.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.926 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 254' ' ' ASN . . . . . 0.461 ' ND2' ' HA ' ' A' ' 251' ' ' GLN . 0.4 OUTLIER -75.1 -41.83 57.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.902 179.879 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . 0.569 ' CD ' ' CD1' ' A' ' 256' ' ' PHE . 0.0 OUTLIER -60.09 -25.08 65.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.824 -179.955 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 256' ' ' PHE . . . . . 0.569 ' CD1' ' CD ' ' A' ' 255' ' ' ARG . 6.6 m-85 -90.6 -38.11 13.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.83 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 40.6 t . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.849 -179.775 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.931 0.396 . . . . 0.0 110.9 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.408 ' O ' ' C ' ' A' ' 157' ' ' ALA . 90.9 t -64.36 -42.92 96.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.142 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.408 ' C ' ' O ' ' A' ' 156' ' ' VAL . . . -37.55 -58.69 0.85 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.084 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -60.03 -50.06 75.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.89 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -48.75 -41.72 33.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.862 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 82.0 mt -85.52 -22.52 28.12 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.931 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 44.3 t -53.76 -33.1 54.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.888 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 42.1 mmtt -60.17 103.92 0.27 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.843 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -86.79 157.53 19.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.893 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 63.49 30.69 15.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.882 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . 0.462 ' NE2' ' HA ' ' A' ' 165' ' ' GLN . 8.8 mm100 -121.13 148.21 44.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.881 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 4.6 t -99.17 116.83 43.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.137 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' ILE . . . . . 0.47 HD11 ' N ' ' A' ' 246' ' ' ALA . 73.2 mt -88.55 147.12 5.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.115 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.485 ' CG2' ' CE1' ' A' ' 217' ' ' PHE . 96.1 t -127.65 126.18 66.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.108 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 70.8 ttt180 -88.14 110.19 20.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.888 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' MET . . . . . 0.465 ' HE1' ' CD2' ' A' ' 173' ' ' LEU . 97.4 mtp -97.13 113.01 24.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.892 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 2.1 ttt85 -111.1 141.63 44.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.869 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 89.36 21.08 42.48 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.476 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.465 ' CD2' ' HE1' ' A' ' 170' ' ' MET . 23.0 mt -74.79 123.89 89.28 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.588 0.708 . . . . 0.0 110.958 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_exo -47.97 145.01 10.98 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.683 2.255 . . . . 0.0 112.359 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . 0.565 ' CD1' ' HG3' ' A' ' 209' ' ' PRO . 10.4 t80 -57.0 -30.66 64.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.9 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 6.2 p -86.49 -15.88 38.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.137 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -67.53 117.41 9.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.084 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -124.35 175.24 7.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.119 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.455 ' N ' ' CZ ' ' A' ' 201' ' ' PHE . . . -41.11 -50.34 3.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.103 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -49.68 -40.23 39.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.874 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -69.36 -30.74 68.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.872 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.45 ' O ' ' C ' ' A' ' 183' ' ' VAL . 74.5 t -75.81 -55.52 11.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.1 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . 0.45 ' C ' ' O ' ' A' ' 182' ' ' VAL . 54.5 t -33.98 -44.68 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.1 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . 0.442 ' O ' ' C ' ' A' ' 185' ' ' PHE . . . -79.24 -47.46 15.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.124 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . 0.442 ' C ' ' O ' ' A' ' 184' ' ' ALA . 15.8 t80 -35.32 -60.51 0.48 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.888 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' PHE . . . . . 0.404 ' CE1' ' CE1' ' A' ' 185' ' ' PHE . 50.5 m-85 -94.35 -20.54 19.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.88 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -49.1 -17.36 0.94 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.501 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 8.8 mm100 -59.24 -72.35 0.1 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.824 0.345 . . . . 0.0 110.88 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 28.8 m170 -117.81 -16.47 9.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.88 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 86.7 m -117.38 85.64 20.42 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.647 0.736 . . . . 0.0 110.889 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' PRO . . . . . 0.439 ' HD2' ' CD1' ' A' ' 222' ' ' TYR . 53.9 Cg_endo -69.79 135.78 31.24 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.715 2.277 . . . . 0.0 112.314 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . 0.444 HG23 ' N ' ' A' ' 193' ' ' THR . 61.9 mt -87.47 141.16 14.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.187 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' THR . . . . . 0.444 ' N ' HG23 ' A' ' 192' ' ' ILE . 41.2 m -66.21 103.09 0.92 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.138 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 91.77 -16.97 58.06 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.476 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . 0.401 ' O ' ' N ' ' A' ' 198' ' ' GLY . . . 72.13 -125.19 10.67 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.482 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 14.4 ptmt -47.36 -30.03 2.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.784 0.326 . . . . 0.0 110.943 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -75.49 -30.51 59.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.877 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 195' ' ' GLY . . . -92.82 41.22 2.75 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.498 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 62.6 mt -142.68 144.48 24.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.828 0.347 . . . . 0.0 111.16 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 15.6 tp -139.64 121.66 15.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.9 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' PHE . . . . . 0.455 ' CZ ' ' N ' ' A' ' 179' ' ' ALA . 65.0 m-85 -101.7 112.21 24.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.883 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 39.0 t -70.4 138.15 22.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.129 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -143.66 138.1 28.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.146 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 32.4 m-85 -48.08 159.29 0.5 Allowed Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.699 0.762 . . . . 0.0 110.917 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.81 3.97 2.49 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.644 2.229 . . . . 0.0 112.296 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . 0.413 ' HB3' ' NH1' ' A' ' 208' ' ' ARG . 62.0 m-20 -112.46 -23.71 10.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.895 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 123.65 4.19 8.2 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.508 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' ARG . . . . . 0.413 ' NH1' ' HB3' ' A' ' 206' ' ' ASP . 0.0 OUTLIER -84.75 141.3 38.32 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.576 0.703 . . . . 0.0 110.917 -179.854 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' PRO . . . . . 0.565 ' HG3' ' CD1' ' A' ' 175' ' ' PHE . 53.6 Cg_endo -69.72 110.33 2.52 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.693 2.262 . . . . 0.0 112.367 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' THR . . . . . 0.569 HG23 ' CD1' ' A' ' 256' ' ' PHE . 34.1 p -71.31 -10.85 60.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.175 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 79.89 -40.18 2.27 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.445 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -70.35 154.26 42.1 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.878 0.37 . . . . 0.0 110.874 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -152.06 179.55 8.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.118 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . 0.457 ' CD2' HG11 ' A' ' 249' ' ' VAL . 73.9 m-85 -146.79 130.6 17.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.89 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 19.7 t -118.18 161.03 17.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.15 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 26.9 mt -110.17 139.26 45.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.939 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . 0.485 ' CE1' ' CG2' ' A' ' 168' ' ' VAL . 81.2 m-85 -133.15 130.55 39.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.87 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . 0.46 ' HA ' ' NE2' ' A' ' 165' ' ' GLN . . . -44.78 -57.4 3.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.106 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' CYS . . . . . . . . . . . . . 85.6 m -151.92 161.1 43.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.837 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -45.06 -30.3 1.04 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.877 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -43.45 -41.91 4.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.846 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 222' ' ' TYR . . . . . 0.439 ' CD1' ' HD2' ' A' ' 191' ' ' PRO . 61.1 m-85 -90.25 -47.73 7.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.91 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -49.66 -60.87 2.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.064 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 64.4 mm-40 -45.44 -57.71 3.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.889 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 55.3 m-20 -55.95 -26.65 48.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.868 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -77.46 -39.53 46.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.065 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 29.5 mt -52.88 -31.27 38.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.951 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 75.0 mtt180 -58.91 -26.71 64.57 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.891 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . 0.458 ' O ' ' C ' ' A' ' 230' ' ' HIS . 26.8 mtpp -71.72 -2.58 17.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.897 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 230' ' ' HIS . . . . . 0.518 ' CG ' ' HG2' ' A' ' 231' ' ' LYS . 19.6 t60 -33.96 139.38 0.07 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.894 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . 0.518 ' HG2' ' CG ' ' A' ' 230' ' ' HIS . 0.1 OUTLIER 60.16 35.51 21.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.869 179.966 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -65.8 175.48 1.92 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.865 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.56 HD22 ' CE1' ' A' ' 238' ' ' TYR . 30.4 mt -131.35 101.19 5.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.87 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 234' ' ' LEU . . . . . 0.447 ' C ' ' CD2' ' A' ' 234' ' ' LEU . 5.7 tt -112.1 111.45 22.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.923 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 63.5 37.91 95.51 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.492 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 33.0 mmtm 67.35 54.22 0.72 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.766 0.317 . . . . 0.0 110.88 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 20.4 mmt180 -156.44 116.08 3.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.838 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 238' ' ' TYR . . . . . 0.56 ' CE1' HD22 ' A' ' 233' ' ' LEU . 96.7 m-85 -69.83 116.22 9.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.896 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 41.1 mt -115.9 140.6 36.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.134 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 240' ' ' GLU . . . . . 0.562 ' HB3' ' CZ ' ' A' ' 242' ' ' PHE . 16.7 mt-10 -93.26 -178.51 4.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.888 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . 0.559 ' O ' ' CD1' ' A' ' 242' ' ' PHE . 61.6 mt -158.01 132.82 8.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.909 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 242' ' ' PHE . . . . . 0.562 ' CZ ' ' HB3' ' A' ' 240' ' ' GLU . 4.6 m-85 -152.88 120.44 5.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.856 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 18.0 ptt180 -60.95 126.98 29.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.906 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 5.4 t -119.71 176.68 5.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.868 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 245' ' ' THR . . . . . 0.401 ' O ' ' C ' ' A' ' 246' ' ' ALA . 82.2 p -127.64 151.02 49.46 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.135 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 246' ' ' ALA . . . . . 0.47 ' N ' HD11 ' A' ' 167' ' ' ILE . . . -37.92 -57.2 1.05 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.09 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -53.21 -51.76 61.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.121 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -50.45 -54.81 19.22 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.886 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . 0.457 HG11 ' CD2' ' A' ' 214' ' ' PHE . 78.4 t -43.82 -61.39 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.152 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -44.05 -42.73 6.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.969 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 60.6 mm-40 -65.58 -30.14 70.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.905 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 252' ' ' VAL . . . . . 0.423 ' N ' ' O ' ' A' ' 249' ' ' VAL . 85.9 t -78.93 -20.12 12.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.145 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 10.6 mt -84.38 -41.63 16.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.93 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 254' ' ' ASN . . . . . 0.49 ' C ' ' OD1' ' A' ' 254' ' ' ASN . 0.6 OUTLIER -67.93 -40.86 83.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.89 179.876 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . 0.473 ' N ' ' OD1' ' A' ' 254' ' ' ASN . 8.0 ptm180 -55.35 -42.71 74.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.816 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 256' ' ' PHE . . . . . 0.569 ' CD1' HG23 ' A' ' 210' ' ' THR . 12.8 m-85 -78.9 -51.02 10.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.862 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 41.7 m . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.84 -179.757 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.909 0.385 . . . . 0.0 110.868 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 34.0 t -65.53 -40.19 87.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.119 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -41.45 -60.86 1.17 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.13 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 15.2 mp0 -56.23 -44.44 79.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.873 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -52.34 -41.34 62.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.852 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 75.4 mt -89.29 -19.71 24.99 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.89 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 45.9 t -59.75 -20.94 59.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.833 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 38.8 mmtt -74.95 102.59 4.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.918 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -82.24 158.82 23.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.903 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 66.8 m-20 60.63 47.04 8.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.937 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 10.6 mm-40 -132.2 164.87 25.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.937 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.463 HG12 ' CB ' ' A' ' 223' ' ' ALA . 39.5 t -118.47 115.82 49.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.139 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' ILE . . . . . 0.468 HD12 ' N ' ' A' ' 246' ' ' ALA . 9.5 mt -88.48 141.54 14.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.125 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.424 HG13 ' N ' ' A' ' 169' ' ' ARG . 59.2 t -119.08 140.49 42.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.151 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . 0.444 ' N ' ' HB2' ' A' ' 244' ' ' SER . 27.1 ttp180 -95.78 101.68 13.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.869 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' MET . . . . . 0.415 ' HE2' ' CD2' ' A' ' 173' ' ' LEU . 88.1 mtp -92.58 137.56 32.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.871 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -137.98 129.96 28.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.874 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 98.31 21.97 16.03 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.493 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.415 ' CD2' ' HE2' ' A' ' 170' ' ' MET . 22.1 mt -76.04 120.97 84.04 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.657 0.741 . . . . 0.0 110.946 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . 0.457 ' HG3' ' CB ' ' A' ' 237' ' ' ARG . 65.6 Cg_exo -48.02 139.36 20.51 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.659 2.239 . . . . 0.0 112.336 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . 0.564 ' CD1' ' HG3' ' A' ' 209' ' ' PRO . 9.8 t80 -47.56 -42.53 23.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.859 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 7.3 p -72.21 -20.61 61.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.157 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -60.99 105.99 0.54 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.113 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' THR . . . . . 0.415 ' O ' ' C ' ' A' ' 179' ' ' ALA . 73.7 p -116.74 173.59 6.55 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.158 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.415 ' C ' ' O ' ' A' ' 178' ' ' THR . . . -36.8 -46.46 0.61 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.089 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -55.47 -49.2 73.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.92 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -57.75 -34.24 69.33 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.887 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.428 ' O ' ' C ' ' A' ' 183' ' ' VAL . 89.0 t -74.78 -53.95 15.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.11 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . 0.428 ' C ' ' O ' ' A' ' 182' ' ' VAL . 50.4 t -35.22 -52.06 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.131 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -73.66 -36.96 65.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.112 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . 0.452 ' CE2' ' OD2' ' A' ' 232' ' ' ASP . 21.0 t80 -47.28 -58.03 4.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.88 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' PHE . . . . . 0.444 ' CE1' ' CE1' ' A' ' 185' ' ' PHE . 86.5 m-85 -96.28 -21.36 17.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.926 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -49.05 -24.16 4.34 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.443 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 3.5 tp-100 -49.61 -75.11 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.808 0.337 . . . . 0.0 110.891 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 -118.33 -7.63 10.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.869 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 78.0 m -126.09 84.34 61.66 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.587 0.708 . . . . 0.0 110.918 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' PRO . . . . . 0.487 ' HD2' ' CD1' ' A' ' 222' ' ' TYR . 54.0 Cg_endo -69.79 139.28 39.76 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.655 2.237 . . . . 0.0 112.377 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . 0.4 HG22 ' N ' ' A' ' 193' ' ' THR . 57.8 mt -88.76 144.67 8.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.152 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' THR . . . . . 0.4 ' N ' HG22 ' A' ' 192' ' ' ILE . 17.9 m -70.18 104.7 2.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.173 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 91.72 -15.48 61.52 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.462 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 68.82 -120.22 10.69 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.46 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 43.9 mtmt -48.5 -33.77 10.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.783 0.325 . . . . 0.0 110.901 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -75.07 -27.59 60.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.874 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -94.05 40.4 2.76 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.505 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 55.8 mt -143.0 146.28 21.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.847 0.356 . . . . 0.0 111.14 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 14.5 tp -146.6 122.34 10.55 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.951 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -102.09 121.41 42.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.882 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 60.6 t -72.78 140.17 18.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.149 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -142.9 138.83 30.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.159 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -50.79 159.08 0.99 Allowed Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.614 0.721 . . . . 0.0 110.966 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 3.73 2.62 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.711 2.274 . . . . 0.0 112.334 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -111.92 -18.52 12.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.907 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 110.4 44.18 1.01 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.499 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -126.78 143.72 47.55 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.571 0.701 . . . . 0.0 110.868 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' PRO . . . . . 0.564 ' HG3' ' CD1' ' A' ' 175' ' ' PHE . 53.4 Cg_endo -69.76 95.68 0.56 Allowed 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.686 2.258 . . . . 0.0 112.328 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' THR . . . . . 0.504 ' CG2' ' CD2' ' A' ' 256' ' ' PHE . 33.5 p -60.27 -10.29 4.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.154 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 88.01 -45.73 3.34 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.485 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -66.85 161.67 23.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.768 0.318 . . . . 0.0 110.904 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -161.27 -175.26 4.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.075 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . 0.413 ' CD2' HG11 ' A' ' 249' ' ' VAL . 56.5 m-85 -146.22 151.73 38.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.857 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 4.5 t -138.71 159.91 30.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.162 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 43.0 mt -109.68 145.8 35.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.905 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -140.29 143.0 35.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.899 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -53.85 -66.7 0.35 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.112 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' CYS . . . . . . . . . . . . . 30.1 m -138.31 -175.09 3.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.915 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -62.89 -37.36 86.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.873 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 18.8 tp10 -43.27 -41.2 3.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.9 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 222' ' ' TYR . . . . . 0.487 ' CD1' ' HD2' ' A' ' 191' ' ' PRO . 55.9 m-85 -86.05 -47.58 9.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.934 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . 0.463 ' CB ' HG12 ' A' ' 166' ' ' VAL . . . -56.31 -63.75 1.09 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.107 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 224' ' ' GLN . . . . . 0.461 ' HA ' ' CD1' ' A' ' 227' ' ' LEU . 20.4 mt-30 -46.65 -52.6 13.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.905 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 22.3 m-20 -55.38 -26.34 40.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.872 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -80.78 -34.55 34.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.121 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . 0.461 ' CD1' ' HA ' ' A' ' 224' ' ' GLN . 38.3 mt -54.54 -30.11 52.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.943 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 36.8 mtp180 -63.87 -20.74 66.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.845 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . 0.459 ' O ' ' C ' ' A' ' 230' ' ' HIS . 19.8 mtpp -75.75 -1.92 27.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.926 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 230' ' ' HIS . . . . . 0.506 ' CE1' ' HG2' ' A' ' 231' ' ' LYS . 57.1 t60 -33.9 136.9 0.11 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.874 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . 0.506 ' HG2' ' CE1' ' A' ' 230' ' ' HIS . 0.0 OUTLIER 61.76 30.54 18.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.852 179.96 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . 0.452 ' OD2' ' CE2' ' A' ' 185' ' ' PHE . 8.4 t70 -57.84 173.64 0.3 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.877 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.57 HD22 ' CE1' ' A' ' 238' ' ' TYR . 30.7 mt -132.58 104.33 6.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.899 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 234' ' ' LEU . . . . . 0.435 ' C ' ' CD2' ' A' ' 234' ' ' LEU . 5.8 tt -115.24 114.42 25.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.935 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 60.7 39.56 96.81 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.438 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 31.0 mtmm 65.3 53.0 1.35 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.789 0.328 . . . . 0.0 110.876 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 237' ' ' ARG . . . . . 0.457 ' CB ' ' HG3' ' A' ' 174' ' ' PRO . 12.4 mmt85 -156.09 116.09 3.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.877 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 238' ' ' TYR . . . . . 0.57 ' CE1' HD22 ' A' ' 233' ' ' LEU . 97.2 m-85 -68.6 135.61 51.74 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.918 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 60.2 mt -133.51 134.36 56.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.168 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 240' ' ' GLU . . . . . 0.472 ' CG ' ' CE ' ' A' ' 231' ' ' LYS . 46.8 mt-10 -90.27 175.87 6.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.884 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . 0.497 ' O ' ' CD1' ' A' ' 242' ' ' PHE . 63.6 mt -156.67 138.19 14.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.912 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 242' ' ' PHE . . . . . 0.497 ' CD1' ' O ' ' A' ' 241' ' ' LEU . 20.9 m-85 -155.19 127.85 7.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.852 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 46.5 mtm180 -39.98 136.97 1.03 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.909 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 244' ' ' SER . . . . . 0.444 ' HB2' ' N ' ' A' ' 169' ' ' ARG . 3.6 t -132.57 154.67 49.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.844 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 26.4 p -132.09 156.77 45.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.173 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 246' ' ' ALA . . . . . 0.468 ' N ' HD12 ' A' ' 167' ' ' ILE . . . -42.17 -57.15 2.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.128 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -53.76 -41.13 66.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.115 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -61.15 -49.99 75.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.886 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . 0.413 HG11 ' CD2' ' A' ' 214' ' ' PHE . 95.4 t -53.24 -64.97 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.105 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -42.57 -34.09 0.81 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.929 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 251' ' ' GLN . . . . . 0.436 ' HA ' ' ND2' ' A' ' 254' ' ' ASN . 64.4 mt-30 -73.58 -47.73 38.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.891 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 75.2 t -57.69 -35.13 49.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.11 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 10.9 mt -65.81 -48.83 70.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.872 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 254' ' ' ASN . . . . . 0.485 ' C ' ' OD1' ' A' ' 254' ' ' ASN . 0.6 OUTLIER -67.12 -41.37 86.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.891 179.95 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . 0.47 ' N ' ' OD1' ' A' ' 254' ' ' ASN . 13.7 ttm180 -54.78 -41.39 70.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.868 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 256' ' ' PHE . . . . . 0.504 ' CD2' ' CG2' ' A' ' 210' ' ' THR . 12.8 m-85 -80.49 -47.12 14.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.851 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 51.1 m . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.837 -179.775 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.854 0.359 . . . . 0.0 110.879 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 73.5 t -65.07 -41.61 92.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.123 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -43.24 -60.06 1.83 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.101 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 83.2 mm-40 -62.33 -36.67 82.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.922 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' PHE . . . . . 0.41 ' CD1' ' HB2' ' A' ' 200' ' ' LEU . 76.7 t80 -60.62 -38.74 85.74 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.875 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 86.2 mt -94.59 -15.98 23.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.922 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 10.9 t -55.13 -40.37 70.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.865 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . 0.406 ' HD2' ' CD1' ' A' ' 216' ' ' LEU . 14.5 mttp -52.84 116.0 2.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.891 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 39.4 mp0 -80.9 162.51 23.91 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.856 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 43.74 51.03 6.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.869 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . 0.496 ' OE1' ' CG2' ' A' ' 193' ' ' THR . 0.2 OUTLIER -124.16 156.76 36.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.896 -179.967 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 60.7 t -110.47 133.24 56.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.117 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 56.3 mt -109.53 131.11 61.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.094 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 44.5 t -114.3 133.41 60.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.102 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 61.6 ttt180 -90.03 110.94 21.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.87 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' MET . . . . . 0.403 ' SD ' ' CG2' ' A' ' 215' ' ' VAL . 90.0 mtp -98.16 126.58 43.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.912 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 14.2 ttm180 -127.01 142.31 51.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.873 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 83.46 36.34 14.61 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.498 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 28.0 mt -87.64 130.43 47.11 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.64 0.733 . . . . 0.0 110.894 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . 0.444 ' O ' ' N ' ' A' ' 177' ' ' ALA . 66.2 Cg_exo -47.99 122.5 7.35 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.67 2.247 . . . . 0.0 112.309 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -39.57 -29.81 0.06 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.862 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' THR . . . . . 0.403 ' O ' ' C ' ' A' ' 177' ' ' ALA . 31.6 p -80.67 -41.79 23.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.18 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . 0.444 ' N ' ' O ' ' A' ' 174' ' ' PRO . . . -36.69 126.64 0.86 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.087 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -123.53 -174.91 3.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.116 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.08 -50.53 73.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.066 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -53.39 -34.66 58.58 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.901 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -65.57 -40.76 93.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.929 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.414 ' O ' ' C ' ' A' ' 183' ' ' VAL . 76.1 t -68.33 -51.59 46.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.168 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . 0.414 ' C ' ' O ' ' A' ' 182' ' ' VAL . 41.1 t -36.48 -49.11 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.153 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -76.36 -39.6 53.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.079 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . 0.533 ' CE1' ' CE ' ' A' ' 229' ' ' LYS . 9.0 t80 -42.09 -59.06 1.88 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.909 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' PHE . . . . . 0.453 ' CE1' ' CE1' ' A' ' 185' ' ' PHE . 69.6 m-85 -95.57 -21.95 17.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.867 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -49.24 -22.59 3.51 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.451 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 77.3 mm-40 -52.64 -71.76 0.06 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.838 0.352 . . . . 0.0 110.884 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 33.2 m80 -118.08 -17.2 9.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.829 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 99.7 m -118.27 83.94 21.53 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.608 0.718 . . . . 0.0 110.89 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 130.96 20.2 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.731 2.287 . . . . 0.0 112.311 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . 0.416 HD11 ' CG1' ' A' ' 215' ' ' VAL . 48.4 mt -79.46 146.11 8.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.13 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' THR . . . . . 0.496 ' CG2' ' OE1' ' A' ' 165' ' ' GLN . 53.8 m -67.71 109.08 3.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.098 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 85.11 -22.85 8.86 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.491 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . 0.408 ' O ' ' N ' ' A' ' 198' ' ' GLY . . . 79.64 -125.37 6.93 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.472 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 20.7 mtmm -46.0 -23.72 0.34 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.785 0.326 . . . . 0.0 110.896 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -81.67 -35.22 30.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.887 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 195' ' ' GLY . . . -86.21 26.36 6.3 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.483 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . 0.451 HG23 ' CE1' ' A' ' 201' ' ' PHE . 68.9 mt -125.78 140.13 49.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.854 0.359 . . . . 0.0 111.107 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.419 ' N ' HG21 ' A' ' 199' ' ' ILE . 14.6 tp -136.17 112.26 9.68 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.893 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' PHE . . . . . 0.451 ' CE1' HG23 ' A' ' 199' ' ' ILE . 79.4 m-85 -92.86 112.94 25.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.898 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . 0.498 ' CG1' ' OD2' ' A' ' 212' ' ' ASP . 23.5 t -67.38 114.68 4.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.085 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -126.4 137.19 53.41 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.154 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -43.79 158.67 0.25 Allowed Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.686 0.755 . . . . 0.0 110.929 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 2.84 3.15 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.728 2.285 . . . . 0.0 112.338 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -112.66 -16.98 12.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.915 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 108.38 60.43 0.54 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.535 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 59.7 mtt-85 -147.58 145.98 23.19 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.581 0.705 . . . . 0.0 110.877 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 112.47 3.08 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.71 2.273 . . . . 0.0 112.368 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' THR . . . . . 0.535 ' HB ' ' CE1' ' A' ' 256' ' ' PHE . 80.4 p -79.65 -10.84 59.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.152 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 95.06 -32.56 6.04 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.488 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' ASP . . . . . 0.498 ' OD2' ' CG1' ' A' ' 202' ' ' VAL . 1.2 p-10 -84.6 164.72 18.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.781 0.324 . . . . 0.0 110.893 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -161.72 -179.06 6.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.066 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . 0.418 ' CD2' HG11 ' A' ' 249' ' ' VAL . 59.6 m-85 -146.79 133.01 19.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.896 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' VAL . . . . . 0.416 ' CG1' HD11 ' A' ' 192' ' ' ILE . 14.4 t -118.56 159.75 18.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.105 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . 0.406 ' CD1' ' HD2' ' A' ' 162' ' ' LYS . 51.6 mt -112.18 149.84 31.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.929 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -145.51 139.27 26.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.893 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . 0.462 ' HA ' ' NE2' ' A' ' 165' ' ' GLN . . . -44.79 -57.26 3.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.054 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' CYS . . . . . . . . . . . . . 1.8 t -160.93 -178.38 6.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.925 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 10.6 mp0 -48.3 -34.4 10.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.919 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -54.98 -33.09 62.19 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.903 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 222' ' ' TYR . . . . . 0.43 ' CD1' ' HB3' ' A' ' 218' ' ' ALA . 6.5 m-85 -93.52 -42.88 8.99 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.966 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.29 -62.17 2.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.134 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -45.6 -59.21 2.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.921 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 38.1 m-20 -48.41 -22.15 0.66 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.922 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -92.81 -35.07 13.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.119 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 86.1 mt -54.11 -37.76 64.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.933 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 228' ' ' ARG . . . . . 0.483 ' HB2' ' CZ ' ' A' ' 228' ' ' ARG . 0.2 OUTLIER -58.12 -24.7 59.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.82 179.954 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . 0.533 ' CE ' ' CE1' ' A' ' 185' ' ' PHE . 24.5 mtpp -67.25 -4.08 9.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.889 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 230' ' ' HIS . . . . . 0.508 ' CG ' ' HG2' ' A' ' 231' ' ' LYS . 23.6 t60 -34.33 134.18 0.21 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.878 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . 0.508 ' HG2' ' CG ' ' A' ' 230' ' ' HIS . 0.2 OUTLIER 67.34 27.62 8.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.921 179.999 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -58.19 179.28 0.07 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.845 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.567 HD22 ' CE2' ' A' ' 238' ' ' TYR . 31.3 mt -135.67 110.66 8.84 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.939 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 6.8 tt -119.9 115.46 23.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.936 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 57.04 39.39 89.58 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.492 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 23.3 mmtm 67.39 52.18 0.83 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.814 0.34 . . . . 0.0 110.899 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 237' ' ' ARG . . . . . 0.434 ' CB ' ' HG3' ' A' ' 174' ' ' PRO . 23.3 mmt180 -156.17 115.33 3.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.868 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 238' ' ' TYR . . . . . 0.567 ' CE2' HD22 ' A' ' 233' ' ' LEU . 96.0 m-85 -69.26 128.46 36.69 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.915 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . 0.45 HG23 ' N ' ' A' ' 240' ' ' GLU . 70.7 mt -123.52 138.62 52.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.137 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 240' ' ' GLU . . . . . 0.45 ' N ' HG23 ' A' ' 239' ' ' ILE . 1.3 mp0 -99.95 165.76 11.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.887 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . 0.533 ' O ' ' CD1' ' A' ' 242' ' ' PHE . 18.6 mt -141.67 149.44 40.6 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.914 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 242' ' ' PHE . . . . . 0.533 ' CD1' ' O ' ' A' ' 241' ' ' LEU . 26.8 m-85 -155.65 130.26 9.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.914 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 24.9 mtp180 -52.54 122.85 9.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.889 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 3.5 t -117.84 173.64 6.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.848 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 39.8 p -149.25 161.67 41.56 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.16 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -42.89 -60.24 1.68 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.072 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -53.13 -47.92 68.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.073 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -52.43 -54.74 28.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.817 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . 0.418 HG11 ' CD2' ' A' ' 214' ' ' PHE . 94.0 t -51.79 -63.29 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.145 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -46.87 -31.23 2.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.907 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 60.5 mt-30 -77.89 -28.65 49.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.935 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 55.6 t -82.36 -15.17 12.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.152 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 13.1 mt -86.85 -42.68 13.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.883 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 254' ' ' ASN . . . . . 0.497 ' OD1' ' N ' ' A' ' 255' ' ' ARG . 0.7 OUTLIER -61.0 -43.28 99.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.917 179.944 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . 0.497 ' N ' ' OD1' ' A' ' 254' ' ' ASN . 15.5 ptm180 -58.7 -52.43 65.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.872 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 256' ' ' PHE . . . . . 0.535 ' CE1' ' HB ' ' A' ' 210' ' ' THR . 11.1 m-85 -67.66 -37.47 82.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.89 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 44.2 t . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.865 -179.805 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.877 0.37 . . . . 0.0 110.916 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.403 ' CG1' HD12 ' A' ' 160' ' ' LEU . 48.7 t -51.74 -33.28 15.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.116 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -48.36 -66.96 0.31 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.088 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 12.6 mm-40 -57.23 -28.31 62.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.923 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' PHE . . . . . 0.431 ' CE2' ' HG ' ' A' ' 216' ' ' LEU . 48.0 t80 -68.04 -36.89 80.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.889 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.403 HD12 ' CG1' ' A' ' 156' ' ' VAL . 81.6 mt -92.67 -20.82 20.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.926 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 3.4 t -53.16 -37.18 61.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.844 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 56.9 mmtt -50.97 127.98 20.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.912 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -103.31 137.82 40.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.861 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 4.7 m120 70.55 43.47 0.77 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.859 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 6.2 mp0 -125.75 156.48 39.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.941 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.469 HG12 ' CB ' ' A' ' 223' ' ' ALA . 38.9 t -108.5 136.45 44.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.139 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 52.0 mt -109.19 142.24 22.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.14 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 21.4 t -124.7 140.08 48.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.125 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 30.2 ttt-85 -92.09 108.89 20.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.858 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 80.6 mtp -93.93 129.9 40.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.882 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 17.8 ttm180 -132.9 140.32 47.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.826 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 89.34 24.63 30.74 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.55 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 24.0 mt -77.27 123.73 87.03 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.582 0.706 . . . . 0.0 110.917 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_exo -47.94 125.21 11.17 Favored 'Trans proline' 0 N--CA 1.465 -0.169 0 C-N-CA 122.717 2.278 . . . . 0.0 112.343 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -37.5 -33.51 0.07 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.888 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' THR . . . . . 0.444 ' O ' ' C ' ' A' ' 177' ' ' ALA . 75.0 p -78.07 -50.71 11.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.119 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . 0.444 ' C ' ' O ' ' A' ' 176' ' ' THR . . . -33.7 130.31 0.28 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.103 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 16.9 p -132.06 178.7 6.59 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.119 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.4 ' N ' ' CZ ' ' A' ' 201' ' ' PHE . . . -49.37 -46.14 46.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.1 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -56.51 -28.62 60.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.867 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . 0.424 ' CD ' HD23 ' A' ' 234' ' ' LEU . 4.5 tt0 -76.08 -44.15 40.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.879 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.401 ' O ' ' C ' ' A' ' 183' ' ' VAL . 54.8 t -63.7 -45.37 97.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.127 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . 0.401 ' C ' ' O ' ' A' ' 182' ' ' VAL . 54.6 t -37.19 -46.68 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.135 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -81.06 -37.82 28.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.093 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . 0.547 ' CZ ' ' OD2' ' A' ' 232' ' ' ASP . 68.7 t80 -43.05 -57.03 3.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.882 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -94.6 -21.78 18.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.871 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -49.39 -17.81 1.29 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.713 -0.755 . . . . 0.0 112.514 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 15.9 mm-40 -56.13 -74.81 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.792 0.33 . . . . 0.0 110.89 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -118.27 -5.03 10.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.845 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 72.9 m -129.29 85.0 60.59 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.655 0.741 . . . . 0.0 110.921 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 191' ' ' PRO . . . . . 0.425 ' HD2' ' CD1' ' A' ' 222' ' ' TYR . 53.5 Cg_endo -69.74 130.47 19.43 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.711 2.274 . . . . 0.0 112.336 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 52.7 mt -80.9 144.56 10.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.17 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 91.1 m -67.59 99.68 0.8 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.144 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 95.36 -11.96 68.39 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.481 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 70.31 -126.07 15.51 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.524 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 4.5 ptmm? -48.37 -26.49 2.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.737 0.303 . . . . 0.0 110.909 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -77.92 -30.7 50.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.911 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -89.4 39.5 3.11 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.472 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 72.8 mt -140.76 137.62 35.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.842 0.353 . . . . 0.0 111.146 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 15.3 tp -132.45 114.13 13.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.931 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 201' ' ' PHE . . . . . 0.4 ' CZ ' ' N ' ' A' ' 179' ' ' ALA . 54.4 m-85 -93.27 121.88 35.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.863 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 95.9 t -73.46 118.52 18.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.119 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -126.89 138.03 53.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.189 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . 0.527 ' CD2' HG21 ' A' ' 210' ' ' THR . 35.8 m-85 -45.92 158.45 0.36 Allowed Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.664 0.745 . . . . 0.0 110.943 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.82 2.9 3.14 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.714 2.276 . . . . 0.0 112.318 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -109.42 -21.89 12.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.859 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 112.24 52.82 0.51 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.488 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 5.2 mpt_? -140.18 145.48 41.93 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.586 0.708 . . . . 0.0 110.874 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 107.44 1.85 Allowed 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.708 2.272 . . . . 0.0 112.347 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 210' ' ' THR . . . . . 0.527 HG21 ' CD2' ' A' ' 204' ' ' TYR . 69.5 p -70.82 -29.59 65.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.155 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 115.08 -42.25 1.96 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.496 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -74.39 169.38 17.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.822 0.344 . . . . 0.0 110.867 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -168.95 171.17 8.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.112 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -136.12 143.41 44.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.867 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 4.1 t -124.42 156.95 32.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.092 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . 0.431 ' HG ' ' CE2' ' A' ' 159' ' ' PHE . 28.8 mt -108.22 151.06 26.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.953 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -144.19 135.37 25.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.893 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -49.06 -58.59 4.67 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.102 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 219' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -144.73 170.93 15.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.882 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -55.68 -27.27 49.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.881 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 23.0 tp10 -51.34 -36.27 42.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.907 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 222' ' ' TYR . . . . . 0.425 ' CD1' ' HD2' ' A' ' 191' ' ' PRO . 52.9 m-85 -91.84 -47.49 7.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.911 -179.837 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . 0.469 ' CB ' HG12 ' A' ' 166' ' ' VAL . . . -52.57 -57.39 10.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.101 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 60.0 mt-30 -50.08 -48.56 53.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.916 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 18.8 m-20 -63.15 -23.96 67.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.887 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -77.12 -22.71 52.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.093 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 17.8 mt -70.51 -32.74 70.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.947 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 65.8 mtp180 -58.93 -12.33 4.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.874 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . 0.453 ' O ' ' C ' ' A' ' 230' ' ' HIS . 28.1 mttp -83.46 -1.73 54.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.926 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 230' ' ' HIS . . . . . 0.453 ' C ' ' O ' ' A' ' 229' ' ' LYS . 10.5 t60 -33.65 137.06 0.1 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.887 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . 0.433 ' HG2' ' CG ' ' A' ' 230' ' ' HIS . 0.3 OUTLIER 59.82 34.49 21.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.929 -180.0 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . 0.547 ' OD2' ' CZ ' ' A' ' 185' ' ' PHE . 11.6 t0 -62.3 176.51 0.6 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.845 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.565 HD23 ' CE1' ' A' ' 238' ' ' TYR . 30.9 mt -134.87 107.22 7.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.903 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 234' ' ' LEU . . . . . 0.424 HD23 ' CD ' ' A' ' 181' ' ' GLU . 6.0 tt -114.35 112.45 23.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.935 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 57.75 40.44 92.83 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.477 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 62.3 mttt 68.93 53.21 0.49 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.774 0.321 . . . . 0.0 110.946 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 19.0 mmt180 -156.16 117.3 3.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.926 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 238' ' ' TYR . . . . . 0.565 ' CE1' HD23 ' A' ' 233' ' ' LEU . 98.8 m-85 -69.96 125.85 27.97 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.887 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . 0.452 HG22 ' N ' ' A' ' 240' ' ' GLU . 74.0 mt -121.31 137.39 55.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.138 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 240' ' ' GLU . . . . . 0.452 ' N ' HG22 ' A' ' 239' ' ' ILE . 1.0 OUTLIER -97.79 163.61 12.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.868 179.959 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 41.2 mt -142.91 138.8 30.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.913 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -148.35 138.88 22.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.87 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 64.6 mtm180 -56.81 132.46 52.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.876 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 5.6 t -130.37 163.21 27.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.877 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 68.0 p -134.8 160.06 39.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.152 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -44.69 -49.72 10.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.102 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -60.36 -44.06 95.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.094 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -54.92 -52.27 63.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.917 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 97.3 t -46.7 -62.06 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.141 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 19.7 mt-30 -48.92 -44.06 40.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.908 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 251' ' ' GLN . . . . . 0.469 ' O ' ' ND2' ' A' ' 254' ' ' ASN . 23.8 mt-30 -66.59 -20.04 65.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.931 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 72.8 t -88.91 -24.39 6.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.162 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 10.9 mt -85.2 -39.78 17.43 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.893 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 254' ' ' ASN . . . . . 0.469 ' ND2' ' O ' ' A' ' 251' ' ' GLN . 0.5 OUTLIER -65.47 -38.62 90.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.909 179.922 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 30.2 ptt180 -63.79 -37.89 89.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.898 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -80.57 -40.29 26.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.874 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 41.4 t . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.837 -179.786 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.892 0.377 . . . . 0.0 110.89 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.4 ' O ' ' C ' ' A' ' 157' ' ' ALA . 89.9 t -70.56 -42.26 78.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.146 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' ' 156' ' ' VAL . . . -37.57 -59.22 0.8 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.142 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 11.9 mm100 -56.97 -49.9 74.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.897 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' PHE . . . . . 0.505 ' CE2' ' HG ' ' A' ' 216' ' ' LEU . 58.8 t80 -47.8 -42.71 26.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.838 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 79.9 mt -86.32 -17.25 35.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.883 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 5.6 t -65.14 -30.87 71.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.844 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -53.14 129.38 30.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.943 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -102.93 151.78 22.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.866 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 67.1 m-80 61.85 49.73 4.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.879 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 22.2 mm-40 -131.09 168.08 18.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.887 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 45.5 t -125.06 109.22 21.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.133 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' ILE . . . . . 0.405 ' CD1' ' HA ' ' A' ' 246' ' ' ALA . 96.8 mt -79.37 139.7 17.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.148 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 66.7 t -123.67 130.46 74.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.132 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 52.1 ttp180 -88.26 105.37 17.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.911 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 98.8 mtp -94.36 129.48 41.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.914 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 40.7 mtt180 -128.99 147.08 50.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.872 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 81.26 35.96 22.2 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.475 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 25.9 mt -86.01 125.64 67.86 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.588 0.709 . . . . 0.0 110.915 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_exo -47.99 140.29 18.93 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.691 2.26 . . . . 0.0 112.363 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -53.84 -19.85 4.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.879 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 50.0 p -94.97 -19.43 20.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.14 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -56.87 125.47 22.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.096 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 1.6 p -134.22 171.14 14.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.114 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.431 ' N ' ' CZ ' ' A' ' 201' ' ' PHE . . . -43.24 -55.69 3.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.081 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -48.33 -33.96 9.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.925 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . 0.422 ' CG ' HD22 ' A' ' 234' ' ' LEU . 0.8 OUTLIER -71.59 -44.3 64.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.902 -179.92 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.401 ' O ' ' C ' ' A' ' 183' ' ' VAL . 40.3 t -65.68 -50.19 72.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.102 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . 0.401 ' C ' ' O ' ' A' ' 182' ' ' VAL . 44.7 t -37.52 -42.25 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.109 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -81.54 -39.51 24.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.115 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . 0.538 ' CE2' ' HD3' ' A' ' 229' ' ' LYS . 60.6 t80 -43.86 -58.35 2.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.87 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' PHE . . . . . 0.401 ' CE1' ' CE2' ' A' ' 185' ' ' PHE . 73.6 m-85 -92.81 -23.66 18.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.859 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -50.16 -22.26 4.74 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.495 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 9.6 mm-40 -50.25 -75.9 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.867 0.365 . . . . 0.0 110.913 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . 0.558 ' CE1' ' HB3' ' A' ' 225' ' ' ASN . 0.3 OUTLIER -118.41 -0.29 11.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.899 179.981 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 190' ' ' CYS . . . . . 0.513 ' SG ' ' CD2' ' A' ' 189' ' ' HIS . 94.8 m -128.48 91.9 42.43 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.602 0.715 . . . . 0.0 110.886 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 135.74 31.26 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.73 2.286 . . . . 0.0 112.346 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 62.1 mt -92.6 145.54 7.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.138 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 88.6 m -67.13 104.33 1.41 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.107 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 87.93 -15.32 55.99 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.502 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 73.57 -119.63 6.63 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.504 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.79 -21.32 2.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.748 0.309 . . . . 0.0 110.895 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -87.03 -25.52 24.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.885 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -88.65 33.11 4.27 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.462 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . 0.426 HG23 ' N ' ' A' ' 200' ' ' LEU . 29.0 mt -138.72 153.15 25.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.822 0.344 . . . . 0.0 111.144 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.426 ' N ' HG23 ' A' ' 199' ' ' ILE . 14.0 tp -146.96 113.0 5.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.921 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 201' ' ' PHE . . . . . 0.431 ' CZ ' ' N ' ' A' ' 179' ' ' ALA . 35.9 m-85 -93.72 121.51 35.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.895 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . 0.406 ' CB ' ' OD2' ' A' ' 212' ' ' ASP . 42.1 t -74.39 123.46 29.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.161 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -134.18 137.08 44.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.096 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -46.09 158.42 0.37 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.69 0.757 . . . . 0.0 110.915 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.7 3.04 2.97 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.66 2.24 . . . . 0.0 112.387 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -113.03 -10.05 13.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.882 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 99.92 58.85 0.87 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.459 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 11.2 mmm180 -142.3 143.38 27.01 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.614 0.721 . . . . 0.0 110.86 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.66 109.6 2.33 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.721 2.281 . . . . 0.0 112.371 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 210' ' ' THR . . . . . 0.569 ' HB ' ' CE2' ' A' ' 256' ' ' PHE . 19.8 p -73.43 -32.01 64.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.156 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 112.97 -30.28 7.51 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.487 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 212' ' ' ASP . . . . . 0.406 ' OD2' ' CB ' ' A' ' 202' ' ' VAL . 1.0 OUTLIER -88.45 163.98 15.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.785 0.326 . . . . 0.0 110.876 -179.975 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -162.76 177.37 9.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.091 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . 0.495 ' CD2' HG11 ' A' ' 249' ' ' VAL . 41.2 m-85 -142.35 139.41 31.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.87 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 6.2 t -123.0 156.89 28.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.15 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . 0.505 ' HG ' ' CE2' ' A' ' 159' ' ' PHE . 32.4 mt -109.92 138.8 45.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.922 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -130.12 133.9 46.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.858 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -44.81 -64.53 0.68 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.136 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 219' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -144.23 160.2 41.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.835 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -40.92 -29.51 0.1 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.893 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -47.57 -49.89 25.37 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.9 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 222' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -78.03 -50.99 11.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.893 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -44.85 -57.08 3.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.158 179.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 8.6 mm-40 -48.52 -60.92 2.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.914 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . 0.558 ' HB3' ' CE1' ' A' ' 189' ' ' HIS . 30.3 m-20 -51.86 -21.51 2.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.915 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -83.24 -33.86 25.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.094 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 32.2 mt -60.67 -28.9 68.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.924 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.11 -18.06 55.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.878 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . 0.538 ' HD3' ' CE2' ' A' ' 185' ' ' PHE . 16.2 mttm -80.02 0.19 32.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.891 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 230' ' ' HIS . . . . . 0.464 ' C ' ' O ' ' A' ' 229' ' ' LYS . 8.6 t60 -32.66 126.93 0.29 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.872 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 43.7 mtmt 61.84 37.1 15.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.938 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -60.72 -174.93 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.852 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.556 HD21 ' CE1' ' A' ' 238' ' ' TYR . 33.0 mt -138.8 105.64 5.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.907 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 234' ' ' LEU . . . . . 0.422 HD22 ' CG ' ' A' ' 181' ' ' GLU . 7.1 tt -113.35 114.8 27.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.873 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 59.22 37.67 92.13 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.494 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 33.3 mttt 69.14 52.37 0.49 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.774 0.321 . . . . 0.0 110.898 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 23.3 mmt180 -156.24 115.26 3.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.835 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 238' ' ' TYR . . . . . 0.556 ' CE1' HD21 ' A' ' 233' ' ' LEU . 97.3 m-85 -63.71 128.22 34.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.95 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 97.4 mt -127.04 129.71 71.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.08 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 240' ' ' GLU . . . . . 0.562 ' HB3' ' CE2' ' A' ' 242' ' ' PHE . 3.9 mp0 -85.33 171.92 11.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.85 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . 0.595 ' O ' ' CD1' ' A' ' 242' ' ' PHE . 21.3 mt -154.46 138.75 16.64 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.909 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 242' ' ' PHE . . . . . 0.595 ' CD1' ' O ' ' A' ' 241' ' ' LEU . 6.6 m-85 -158.45 123.43 4.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.878 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . 0.496 ' CG ' ' O ' ' A' ' 243' ' ' ARG . 21.2 ptt180 -60.89 117.33 5.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.85 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 1.7 t -112.49 168.52 9.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.858 -179.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.6 p -109.45 173.83 6.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.168 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 246' ' ' ALA . . . . . 0.405 ' HA ' ' CD1' ' A' ' 167' ' ' ILE . . . -61.63 -63.74 1.17 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.1 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -43.76 -49.67 7.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.074 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -47.27 -57.64 4.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.863 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . 0.495 HG11 ' CD2' ' A' ' 214' ' ' PHE . 97.8 t -44.65 -61.68 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.136 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 53.1 mt-30 -47.59 -29.55 2.98 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.916 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -82.4 -26.43 32.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.933 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 53.3 t -82.63 -15.31 11.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.131 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 13.4 mt -86.82 -43.06 12.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.887 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 254' ' ' ASN . . . . . 0.5 ' OD1' ' N ' ' A' ' 255' ' ' ARG . 0.6 OUTLIER -61.67 -44.49 96.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.85 179.943 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . 0.5 ' N ' ' OD1' ' A' ' 254' ' ' ASN . 11.4 ptm180 -54.17 -31.03 51.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.84 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 256' ' ' PHE . . . . . 0.569 ' CE2' ' HB ' ' A' ' 210' ' ' THR . 16.7 m-85 -91.34 -36.84 13.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.87 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 33.4 t . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.895 -179.805 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.885 0.374 . . . . 0.0 110.846 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 79.0 t -43.34 -39.13 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.154 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -45.46 -48.08 13.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.065 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -69.83 -42.07 74.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.909 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' PHE . . . . . 0.454 ' CD2' ' HB2' ' A' ' 200' ' ' LEU . 41.2 t80 -56.07 -41.77 75.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.899 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 91.0 mt -85.56 -26.05 26.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.903 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 31.6 t -54.62 -26.51 33.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.881 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 18.2 mmmt -61.99 128.77 37.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.873 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -105.99 154.08 21.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.861 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 62.35 49.35 4.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.858 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 24.3 mm-40 -137.21 153.47 50.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.92 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 55.7 t -108.03 119.8 58.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.149 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' ILE . . . . . 0.465 HD13 ' N ' ' A' ' 246' ' ' ALA . 10.8 mt -90.66 147.83 4.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.156 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 95.6 t -128.53 141.43 46.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.127 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 29.0 ttp85 -95.51 107.17 19.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.877 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' MET . . . . . 0.469 ' HE2' ' CD2' ' A' ' 173' ' ' LEU . 89.7 mtp -92.56 127.11 37.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.932 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . 0.411 ' HG3' ' N ' ' A' ' 172' ' ' GLY . 3.8 tpt180 -123.83 144.89 49.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.881 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . 0.411 ' N ' ' HG3' ' A' ' 171' ' ' ARG . . . 79.01 33.63 36.02 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.464 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.503 ' CD1' ' CB ' ' A' ' 213' ' ' ALA . 21.8 mt -81.39 119.33 75.38 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.574 0.702 . . . . 0.0 110.896 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . 0.481 ' O ' ' N ' ' A' ' 177' ' ' ALA . 65.2 Cg_exo -47.94 130.0 18.95 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.695 2.263 . . . . 0.0 112.368 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 34.7 m-85 -41.49 -41.07 1.98 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.889 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 65.3 p -75.52 -29.47 59.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.157 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . 0.481 ' N ' ' O ' ' A' ' 174' ' ' PRO . . . -45.74 112.62 0.49 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.085 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -113.4 170.36 8.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.127 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -46.5 -56.53 5.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.112 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -45.43 -30.18 1.3 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.856 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . 0.443 ' CG ' HD23 ' A' ' 234' ' ' LEU . 2.2 tp10 -71.59 -41.61 68.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.885 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.432 ' O ' ' C ' ' A' ' 183' ' ' VAL . 55.8 t -69.25 -47.41 73.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.107 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . 0.432 ' C ' ' O ' ' A' ' 182' ' ' VAL . 70.8 t -35.26 -54.25 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.08 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -74.78 -39.2 61.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.086 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -41.54 -58.27 1.97 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.87 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' PHE . . . . . 0.481 ' CD1' ' HB3' ' A' ' 226' ' ' ALA . 71.5 m-85 -94.3 -21.32 19.07 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.871 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -49.15 -25.78 5.81 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.463 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -48.3 -72.77 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.836 0.351 . . . . 0.0 110.91 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 14.2 m170 -118.26 -15.52 9.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.894 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 63.8 m -118.41 85.17 25.13 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.638 0.732 . . . . 0.0 110.94 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 191' ' ' PRO . . . . . 0.447 ' HD2' ' CD1' ' A' ' 222' ' ' TYR . 53.3 Cg_endo -69.75 139.9 41.39 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.686 2.257 . . . . 0.0 112.348 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 49.6 mt -91.82 144.69 8.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.135 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 55.0 m -67.3 108.28 2.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.157 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 86.94 -22.18 15.8 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.447 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . 0.409 ' O ' ' N ' ' A' ' 198' ' ' GLY . . . 82.52 -126.56 7.51 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.484 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 8.8 ptpt -46.48 -22.25 0.25 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.767 0.318 . . . . 0.0 110.894 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -82.23 -33.69 29.17 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.912 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 195' ' ' GLY . . . -84.98 35.4 3.11 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.466 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . 0.504 HG21 ' CE1' ' A' ' 201' ' ' PHE . 27.5 mt -138.8 139.92 39.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.828 0.347 . . . . 0.0 111.148 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.454 ' HB2' ' CD2' ' A' ' 159' ' ' PHE . 14.5 tp -137.19 111.83 8.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.939 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 201' ' ' PHE . . . . . 0.504 ' CE1' HG21 ' A' ' 199' ' ' ILE . 84.3 m-85 -90.43 123.43 34.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.901 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 59.0 t -73.51 118.32 18.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.144 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -127.95 137.14 52.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.124 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -45.99 158.75 0.35 Allowed Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.63 0.729 . . . . 0.0 110.918 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.83 3.58 2.72 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.631 2.221 . . . . 0.0 112.327 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -112.4 -21.28 11.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.861 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 113.53 56.41 0.41 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.525 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 7.6 mpt_? -143.53 146.5 35.84 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.554 0.692 . . . . 0.0 110.904 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 111.17 2.74 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.669 2.246 . . . . 0.0 112.363 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 210' ' ' THR . . . . . 0.559 ' HB ' ' CE2' ' A' ' 256' ' ' PHE . 62.0 p -73.09 -14.03 61.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.152 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 97.57 -31.33 7.93 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.523 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -90.38 168.4 11.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.827 0.346 . . . . 0.0 110.832 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . 0.503 ' CB ' ' CD1' ' A' ' 173' ' ' LEU . . . -165.01 174.86 10.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.12 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -137.71 151.37 48.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.899 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 215' ' ' VAL . . . . . 0.402 ' CG2' ' SD ' ' A' ' 170' ' ' MET . 6.9 t -134.76 155.0 37.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.129 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 29.5 mt -108.48 144.05 36.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.915 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -136.41 141.33 43.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.9 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -53.9 -57.17 11.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.156 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 219' ' ' CYS . . . . . . . . . . . . . 95.2 m -136.4 -179.22 5.55 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.887 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -70.14 -28.62 65.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.921 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -48.02 -50.01 29.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.904 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 222' ' ' TYR . . . . . 0.447 ' CD1' ' HD2' ' A' ' 191' ' ' PRO . 29.6 m-85 -74.0 -49.73 23.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.921 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -47.64 -56.75 6.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.107 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -55.87 -52.74 63.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.91 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -49.96 -31.73 13.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.917 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . 0.481 ' HB3' ' CD1' ' A' ' 186' ' ' PHE . . . -75.41 -35.77 60.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.09 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 89.8 mt -52.43 -39.6 61.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.921 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 34.8 mtt85 -54.99 -26.0 33.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.843 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . 0.458 ' O ' ' C ' ' A' ' 230' ' ' HIS . 6.9 mtpm? -69.86 -2.48 12.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.922 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 230' ' ' HIS . . . . . 0.513 ' CE1' ' HD3' ' A' ' 231' ' ' LYS . 12.0 t60 -33.86 136.67 0.11 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.845 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . 0.513 ' HD3' ' CE1' ' A' ' 230' ' ' HIS . 1.2 mmmp? 62.96 29.43 16.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.909 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . 0.423 ' OD1' ' NZ ' ' A' ' 229' ' ' LYS . 2.7 t70 -58.34 -179.69 0.06 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.88 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.571 HD21 ' CE1' ' A' ' 238' ' ' TYR . 30.2 mt -138.19 107.78 6.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.925 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 234' ' ' LEU . . . . . 0.443 HD23 ' CG ' ' A' ' 181' ' ' GLU . 6.1 tt -117.83 111.2 18.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.915 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 60.12 43.23 98.54 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.47 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 64.66 53.8 1.5 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.723 0.297 . . . . 0.0 110.915 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 237' ' ' ARG . . . . . 0.416 ' CB ' ' HG3' ' A' ' 174' ' ' PRO . 14.2 mmt85 -156.65 115.48 3.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.877 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 238' ' ' TYR . . . . . 0.571 ' CE1' HD21 ' A' ' 233' ' ' LEU . 97.2 m-85 -69.69 123.68 22.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.975 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 37.9 mt -119.74 145.9 25.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.132 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 240' ' ' GLU . . . . . 0.445 ' HB3' ' CZ ' ' A' ' 242' ' ' PHE . 38.9 mt-10 -111.35 159.51 17.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.829 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 17.0 mt -136.58 123.87 21.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.98 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 242' ' ' PHE . . . . . 0.445 ' CZ ' ' HB3' ' A' ' 240' ' ' GLU . 4.1 m-85 -131.05 129.57 42.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.855 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 70.2 mtt180 -42.61 150.8 0.14 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.943 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 1.3 t -152.18 156.06 39.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.869 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 50.6 p -131.11 165.92 22.22 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.109 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 246' ' ' ALA . . . . . 0.465 ' N ' HD13 ' A' ' 167' ' ' ILE . . . -48.41 -52.74 20.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.121 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -58.6 -47.92 82.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.098 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -51.64 -55.54 18.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.849 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . 0.402 ' O ' ' C ' ' A' ' 250' ' ' GLN . 91.2 t -42.45 -65.21 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.161 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 250' ' ' GLN . . . . . 0.402 ' C ' ' O ' ' A' ' 249' ' ' VAL . 30.4 mt-30 -38.08 -57.84 1.02 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.93 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -52.33 -44.25 65.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.927 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 91.1 t -59.95 -31.43 47.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.105 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 7.9 mt -79.51 -39.46 31.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.945 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 16.6 m-80 -66.97 -49.0 66.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.904 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . 0.464 ' CZ ' ' HB2' ' A' ' 255' ' ' ARG . 2.7 ptm85 -53.35 -43.5 67.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.826 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 256' ' ' PHE . . . . . 0.559 ' CE2' ' HB ' ' A' ' 210' ' ' THR . 13.1 m-85 -76.34 -37.59 57.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.862 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 24.1 p . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.813 -179.749 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.866 0.365 . . . . 0.0 110.935 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 90.2 t -63.44 -47.4 91.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.156 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -40.01 -61.07 0.92 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.105 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -59.13 -40.69 86.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.909 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' PHE . . . . . 0.521 ' CE2' ' HG ' ' A' ' 216' ' ' LEU . 49.2 t80 -56.41 -40.55 74.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.873 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 86.6 mt -87.94 -24.37 23.61 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.868 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 28.7 t -58.72 -27.38 64.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.843 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 28.6 mmmt -60.75 125.74 24.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.872 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -101.26 150.46 22.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.89 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 34.8 m-20 62.51 49.4 4.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.882 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.9 mm-40 -133.9 143.6 48.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.899 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 48.6 t -100.22 107.23 20.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.188 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 36.7 mt -75.95 134.13 29.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.143 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.466 HG22 ' CD1' ' A' ' 217' ' ' PHE . 57.9 t -116.22 128.46 73.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.127 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 45.8 ttp180 -88.35 108.25 19.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.884 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' MET . . . . . 0.461 ' HE1' ' CD2' ' A' ' 173' ' ' LEU . 97.0 mtp -92.6 113.33 25.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.859 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 8.3 ttp180 -117.21 139.28 50.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.912 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 91.38 25.04 24.81 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.507 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.461 ' CD2' ' HE1' ' A' ' 170' ' ' MET . 19.5 mt -80.27 129.01 71.14 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.612 0.72 . . . . 0.0 110.919 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . 0.414 ' HG3' ' CB ' ' A' ' 237' ' ' ARG . 64.8 Cg_exo -47.92 136.35 22.92 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.75 2.3 . . . . 0.0 112.335 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 8.8 m-30 -50.98 -19.97 1.2 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.86 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 64.1 p -94.98 -28.77 14.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.098 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -41.85 120.64 1.58 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.083 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 40.1 p -116.01 179.56 3.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.164 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -54.12 -48.57 70.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.111 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -52.84 -42.29 65.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.875 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -58.87 -37.14 75.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.895 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 15.5 t -73.21 -47.25 47.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.121 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 42.8 t -39.83 -49.82 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.067 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . 0.428 ' O ' ' C ' ' A' ' 185' ' ' PHE . . . -74.25 -44.71 51.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.106 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . 0.473 ' CD2' ' CZ ' ' A' ' 186' ' ' PHE . 53.9 t80 -36.42 -60.56 0.57 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.864 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' PHE . . . . . 0.473 ' CZ ' ' CD2' ' A' ' 185' ' ' PHE . 42.4 m-85 -95.06 -25.0 16.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.885 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -49.15 -21.31 2.56 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.469 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 42.0 tt0 -55.18 -70.66 0.1 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.816 0.341 . . . . 0.0 110.908 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 20.3 m80 -118.21 -16.72 9.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.853 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 190' ' ' CYS . . . . . 0.406 ' N ' ' O ' ' A' ' 186' ' ' PHE . 70.9 m -120.36 87.26 40.15 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.603 0.716 . . . . 0.0 110.86 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 130.55 19.6 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.692 2.261 . . . . 0.0 112.331 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 54.7 mt -78.1 144.57 11.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.15 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 29.3 m -71.29 104.43 3.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.183 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 91.98 -17.17 57.64 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.497 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . 0.414 ' O ' ' N ' ' A' ' 198' ' ' GLY . . . 70.22 -124.12 13.21 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.516 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 31.4 mtmm -46.09 -30.58 1.94 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.679 0.276 . . . . 0.0 110.859 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -78.13 -32.01 50.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.893 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 195' ' ' GLY . . . -88.46 29.65 5.62 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.492 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . 0.542 HG21 ' CE2' ' A' ' 201' ' ' PHE . 70.2 mt -131.4 142.12 44.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.89 0.376 . . . . 0.0 111.127 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 13.0 tp -139.7 111.74 7.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.919 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 201' ' ' PHE . . . . . 0.542 ' CE2' HG21 ' A' ' 199' ' ' ILE . 97.1 m-85 -96.27 119.26 34.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.909 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 21.7 t -71.51 130.18 35.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.109 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -140.59 137.59 33.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.151 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -48.76 158.88 0.6 Allowed Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.681 0.753 . . . . 0.0 110.903 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 3.05 2.99 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.74 2.293 . . . . 0.0 112.357 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -112.37 -15.29 13.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.864 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 112.25 9.89 18.93 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.501 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -89.64 140.67 28.16 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.603 0.716 . . . . 0.0 110.855 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 115.59 4.16 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.651 2.234 . . . . 0.0 112.339 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 210' ' ' THR . . . . . 0.542 ' HB ' ' CE2' ' A' ' 256' ' ' PHE . 69.8 p -80.24 -21.49 42.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.107 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 95.3 -46.38 2.01 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.515 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -68.64 154.64 41.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.816 0.341 . . . . 0.0 110.875 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . 0.438 ' O ' ' CD1' ' A' ' 214' ' ' PHE . . . -153.53 -175.27 5.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.096 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . 0.438 ' CD1' ' O ' ' A' ' 213' ' ' ALA . 52.8 m-85 -150.63 139.49 20.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.851 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 21.4 t -125.69 162.34 28.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.132 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . 0.521 ' HG ' ' CE2' ' A' ' 159' ' ' PHE . 31.2 mt -112.48 137.23 50.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.919 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . 0.466 ' CD1' HG22 ' A' ' 168' ' ' VAL . 76.4 m-85 -132.5 138.88 47.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.844 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . 0.429 ' HB3' ' CD2' ' A' ' 222' ' ' TYR . . . -48.39 -65.72 0.52 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.147 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 219' ' ' CYS . . . . . . . . . . . . . 2.6 m -154.85 174.81 14.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.845 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -39.81 -42.73 1.33 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.915 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -41.14 -43.31 2.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.896 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 222' ' ' TYR . . . . . 0.429 ' CD2' ' HB3' ' A' ' 218' ' ' ALA . 57.1 m-85 -92.35 -46.27 7.78 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.912 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -52.14 -64.12 0.92 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.104 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 23.0 mm-40 -50.65 -55.93 14.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.945 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . 0.439 ' O ' ' CG ' ' A' ' 228' ' ' ARG . 24.2 m-20 -52.14 -21.24 3.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.903 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -93.83 -34.19 13.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.089 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 63.4 mt -57.65 -32.77 67.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.886 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 228' ' ' ARG . . . . . 0.439 ' CG ' ' O ' ' A' ' 225' ' ' ASN . 3.0 ptm180 -58.52 -13.05 4.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.879 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . 0.456 ' O ' ' C ' ' A' ' 230' ' ' HIS . 16.1 mtpp -86.13 -0.37 55.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.924 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 230' ' ' HIS . . . . . 0.551 ' CE1' ' HG3' ' A' ' 231' ' ' LYS . 48.2 t60 -33.94 131.54 0.27 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.879 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . 0.551 ' HG3' ' CE1' ' A' ' 230' ' ' HIS . 36.8 mttp 62.37 35.36 15.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.879 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -62.01 -176.37 0.09 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.878 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.551 HD23 ' CD1' ' A' ' 238' ' ' TYR . 31.7 mt -133.9 112.42 11.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.893 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 7.3 tt -121.47 117.89 27.98 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.919 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 57.05 36.35 73.74 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.508 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 26.9 mmtm 69.13 50.73 0.56 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.806 0.336 . . . . 0.0 110.889 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 237' ' ' ARG . . . . . 0.414 ' CB ' ' HG3' ' A' ' 174' ' ' PRO . 44.7 mmt-85 -156.06 115.28 3.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.826 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 238' ' ' TYR . . . . . 0.551 ' CD1' HD23 ' A' ' 233' ' ' LEU . 97.5 m-85 -66.58 136.36 55.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.949 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . 0.425 HD11 ' CD2' ' A' ' 173' ' ' LEU . 79.2 mt -135.88 126.21 42.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.154 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 240' ' ' GLU . . . . . 0.572 ' HB3' ' CZ ' ' A' ' 242' ' ' PHE . 6.7 mp0 -84.81 166.33 17.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.908 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . 0.451 ' O ' ' CD1' ' A' ' 242' ' ' PHE . 15.1 mt -148.13 134.03 19.1 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.89 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 242' ' ' PHE . . . . . 0.572 ' CZ ' ' HB3' ' A' ' 240' ' ' GLU . 7.3 m-85 -145.42 120.92 10.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.886 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . 0.486 ' CG ' ' O ' ' A' ' 243' ' ' ARG . 18.4 ptt-85 -57.15 118.25 4.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.883 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 7.5 t -114.4 -174.98 2.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.887 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 245' ' ' THR . . . . . 0.451 ' O ' ' CG2' ' A' ' 249' ' ' VAL . 67.8 p -135.64 179.16 6.51 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.162 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -60.86 -53.62 55.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.091 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -52.95 -58.17 7.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.146 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -49.44 -55.92 11.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.893 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . 0.451 ' CG2' ' O ' ' A' ' 245' ' ' THR . 97.3 t -39.68 -65.58 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.149 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 250' ' ' GLN . . . . . 0.432 ' O ' ' N ' ' A' ' 253' ' ' LEU . 52.2 mt-30 -37.55 -66.72 0.23 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.885 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 28.9 mm-40 -40.97 -39.69 1.23 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.941 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 28.3 t -65.04 -39.44 85.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.125 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 253' ' ' LEU . . . . . 0.432 ' N ' ' O ' ' A' ' 250' ' ' GLN . 7.1 mt -76.89 -36.17 56.87 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.919 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -71.43 -49.77 38.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.89 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . 0.541 ' CG ' ' N ' ' A' ' 256' ' ' PHE . 5.2 ptm180 -49.66 -50.75 42.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.83 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 256' ' ' PHE . . . . . 0.542 ' CE2' ' HB ' ' A' ' 210' ' ' THR . 12.4 m-85 -65.04 -33.6 76.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.877 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 14.2 m . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.849 -179.793 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.884 0.373 . . . . 0.0 110.876 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 76.6 t -60.39 -36.99 72.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.147 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -43.68 -62.25 1.15 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.076 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -60.83 -42.54 97.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.93 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' PHE . . . . . 0.528 ' CE2' ' HG ' ' A' ' 216' ' ' LEU . 59.6 t80 -52.7 -38.85 61.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.853 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 82.9 mt -89.96 -29.03 18.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.946 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 1.7 t -52.04 -33.34 38.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.852 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 27.4 mmmt -45.5 116.68 1.22 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.868 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -84.55 149.96 25.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.869 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 47.71 44.85 17.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.907 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . 0.471 ' NE2' ' HA ' ' A' ' 218' ' ' ALA . 0.4 OUTLIER -117.1 153.13 33.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.907 -179.974 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 46.8 t -106.23 139.06 28.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.157 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' ILE . . . . . 0.448 HD12 ' N ' ' A' ' 246' ' ' ALA . 26.0 mt -113.07 137.22 46.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.113 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.521 HG22 ' CD1' ' A' ' 217' ' ' PHE . 94.1 t -114.2 138.23 44.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.123 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . 0.467 ' N ' HG11 ' A' ' 168' ' ' VAL . 39.9 ttt-85 -93.81 109.25 20.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.893 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' MET . . . . . 0.453 ' HE1' ' CD2' ' A' ' 173' ' ' LEU . 83.6 mtp -99.51 126.39 45.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.908 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 11.0 mtp85 -127.15 145.17 50.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.866 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 81.5 32.63 30.29 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.482 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.456 ' CD1' ' HB2' ' A' ' 213' ' ' ALA . 22.1 mt -82.84 121.28 77.5 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.658 0.742 . . . . 0.0 110.929 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . 0.485 ' O ' ' N ' ' A' ' 176' ' ' THR . 66.6 Cg_exo -48.02 121.44 5.97 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.661 2.24 . . . . 0.0 112.333 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . 0.567 ' CD2' ' HG2' ' A' ' 209' ' ' PRO . 3.4 m-85 -37.21 -29.13 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.859 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' THR . . . . . 0.485 ' N ' ' O ' ' A' ' 174' ' ' PRO . 73.7 p -80.83 -44.01 19.14 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.161 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . 0.476 ' N ' ' O ' ' A' ' 174' ' ' PRO . . . -34.27 125.45 0.49 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.064 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 12.0 p -118.49 177.07 4.96 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.151 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -52.46 -44.91 65.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.113 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -56.18 -41.54 75.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.885 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -57.83 -39.38 77.54 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.882 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.433 ' O ' ' C ' ' A' ' 183' ' ' VAL . 54.7 t -71.99 -52.39 25.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.112 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . 0.433 ' C ' ' O ' ' A' ' 182' ' ' VAL . 89.9 t -35.13 -47.27 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.14 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -79.65 -39.33 31.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.138 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . 0.566 ' CE2' ' HE3' ' A' ' 229' ' ' LYS . 58.2 t80 -41.33 -58.78 1.74 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.903 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' PHE . . . . . 0.491 ' O ' ' N ' ' A' ' 190' ' ' CYS . 63.1 m-85 -96.41 -23.32 16.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.915 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -52.68 -21.15 8.83 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.498 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 188' ' ' GLN . . . . . 0.485 ' NE2' ' O ' ' A' ' 185' ' ' PHE . 1.5 pt20 -59.19 -60.04 4.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.858 0.361 . . . . 0.0 110.91 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . 0.6 ' CE1' ' SG ' ' A' ' 190' ' ' CYS . 0.3 OUTLIER -119.02 -29.11 5.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.843 179.968 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 190' ' ' CYS . . . . . 0.6 ' SG ' ' CE1' ' A' ' 189' ' ' HIS . 93.1 m -116.54 89.78 28.66 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.632 0.729 . . . . 0.0 110.853 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 191' ' ' PRO . . . . . 0.437 ' HD2' ' CD1' ' A' ' 222' ' ' TYR . 53.5 Cg_endo -69.8 132.65 23.73 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.67 2.246 . . . . 0.0 112.305 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 59.4 mt -82.9 145.17 8.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.105 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 98.0 m -63.68 102.14 0.42 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.138 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 88.38 -16.92 51.28 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.476 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . 0.455 ' O ' ' N ' ' A' ' 198' ' ' GLY . . . 75.3 -129.18 10.34 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.502 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 3.9 pttm -41.23 -37.07 0.87 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.762 0.315 . . . . 0.0 110.912 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -70.87 -37.39 73.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.896 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . 0.455 ' N ' ' O ' ' A' ' 195' ' ' GLY . . . -83.06 36.21 2.73 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.534 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 72.1 mt -139.0 148.91 23.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.83 0.348 . . . . 0.0 111.111 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 23.5 tp -137.4 120.94 17.18 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.912 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -101.92 111.37 23.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.883 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 59.7 t -66.09 136.29 26.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.137 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -142.83 141.4 31.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.12 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -47.58 159.42 0.44 Allowed Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.718 0.77 . . . . 0.0 110.886 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 4.18 2.34 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.641 2.227 . . . . 0.0 112.324 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -111.8 -23.42 10.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.839 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 115.05 49.18 0.51 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.516 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 76.4 mtp180 -134.5 147.1 61.98 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.578 0.704 . . . . 0.0 110.886 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 209' ' ' PRO . . . . . 0.567 ' HG2' ' CD2' ' A' ' 175' ' ' PHE . 54.2 Cg_endo -69.72 99.62 0.76 Allowed 'Trans proline' 0 N--CA 1.465 -0.174 0 C-N-CA 122.682 2.255 . . . . 0.0 112.396 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 65.8 p -60.4 -33.3 72.29 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.137 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 115.33 -30.2 6.87 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.486 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -85.65 163.34 18.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.797 0.332 . . . . 0.0 110.876 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . 0.456 ' HB2' ' CD1' ' A' ' 173' ' ' LEU . . . -166.69 159.25 13.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.082 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . 0.501 ' CD2' HG13 ' A' ' 249' ' ' VAL . 71.8 m-85 -124.62 162.78 23.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.903 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 215' ' ' VAL . . . . . 0.423 ' CG1' ' N ' ' A' ' 216' ' ' LEU . 43.3 t -140.34 163.95 22.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.091 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . 0.528 ' HG ' ' CE2' ' A' ' 159' ' ' PHE . 62.3 mt -115.2 145.38 42.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.902 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . 0.521 ' CD1' HG22 ' A' ' 168' ' ' VAL . 80.1 m-85 -141.89 131.58 24.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.869 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . 0.471 ' HA ' ' NE2' ' A' ' 165' ' ' GLN . . . -42.77 -54.14 4.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.116 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 219' ' ' CYS . . . . . . . . . . . . . 5.0 m -157.15 179.99 8.76 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.888 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . 0.422 ' O ' ' C ' ' A' ' 221' ' ' GLU . 0.7 OUTLIER -52.69 -39.48 61.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.915 -179.961 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . 0.422 ' C ' ' O ' ' A' ' 220' ' ' GLU . 29.7 tt0 -36.89 -49.51 0.81 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.897 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 222' ' ' TYR . . . . . 0.437 ' CD1' ' HD2' ' A' ' 191' ' ' PRO . 42.7 m-85 -87.84 -46.98 8.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.933 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -52.99 -62.53 1.59 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.077 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 56.1 mm-40 -47.45 -61.72 1.78 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.934 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 30.6 m-20 -45.44 -31.96 1.94 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.905 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -69.55 -38.05 77.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.089 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 29.0 mt -51.84 -29.34 19.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.934 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 8.9 mpt_? -61.39 -30.03 70.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.851 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . 0.566 ' HE3' ' CE2' ' A' ' 185' ' ' PHE . 20.1 mtpp -71.55 -0.83 11.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.868 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 230' ' ' HIS . . . . . 0.449 ' C ' ' O ' ' A' ' 229' ' ' LYS . 20.9 t60 -34.28 129.71 0.37 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.892 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 39.6 mtmt 62.63 39.67 11.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.879 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -67.09 -175.17 0.42 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.871 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.535 HD21 ' CE2' ' A' ' 238' ' ' TYR . 30.6 mt -135.9 109.8 8.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.927 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 7.1 tt -117.85 117.71 30.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.913 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 54.71 38.69 64.72 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.459 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 38.4 mttp 68.86 50.54 0.62 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.767 0.318 . . . . 0.0 110.929 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 19.6 mmt180 -155.04 115.58 3.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.888 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 238' ' ' TYR . . . . . 0.535 ' CE2' HD21 ' A' ' 233' ' ' LEU . 95.7 m-85 -67.92 131.25 45.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.959 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 75.1 mt -129.76 133.83 64.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.119 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 240' ' ' GLU . . . . . 0.454 ' HB3' ' CZ ' ' A' ' 242' ' ' PHE . 7.4 mp0 -94.18 170.97 9.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.901 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . 0.524 ' O ' ' CG ' ' A' ' 242' ' ' PHE . 14.9 mt -150.78 153.38 35.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.931 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 242' ' ' PHE . . . . . 0.524 ' CG ' ' O ' ' A' ' 241' ' ' LEU . 3.7 m-85 -162.12 151.62 16.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.845 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . 0.471 ' CZ ' ' HB2' ' A' ' 243' ' ' ARG . 12.6 mtm105 -65.76 118.39 9.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.874 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -111.19 160.42 16.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.889 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 40.1 p -132.97 155.8 48.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.146 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 246' ' ' ALA . . . . . 0.448 ' N ' HD12 ' A' ' 167' ' ' ILE . . . -43.17 -53.15 5.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.114 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -56.8 -51.86 67.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.052 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -48.19 -54.73 12.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.939 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . 0.501 HG13 ' CD2' ' A' ' 214' ' ' PHE . 59.9 t -48.81 -65.87 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.133 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 250' ' ' GLN . . . . . 0.409 ' HA ' ' CD1' ' A' ' 253' ' ' LEU . 86.8 mt-30 -38.41 -46.1 1.1 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.954 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -62.67 -51.88 65.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.858 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 73.4 t -54.92 -34.89 32.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.093 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 253' ' ' LEU . . . . . 0.409 ' CD1' ' HA ' ' A' ' 250' ' ' GLN . 14.9 mt -64.62 -49.56 70.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.91 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 254' ' ' ASN . . . . . 0.496 ' OD1' ' N ' ' A' ' 255' ' ' ARG . 0.6 OUTLIER -64.66 -41.55 96.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.911 179.888 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . 0.496 ' N ' ' OD1' ' A' ' 254' ' ' ASN . 25.9 ttt180 -47.67 -46.74 29.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.894 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -83.65 -41.94 17.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.879 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 1.9 t . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.845 -179.808 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.903 0.382 . . . . 0.0 110.867 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 75.3 t -83.24 -36.11 12.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.1 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -43.44 -53.32 5.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.1 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -59.9 -53.25 60.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.915 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' PHE . . . . . 0.5 ' CE1' ' HG ' ' A' ' 216' ' ' LEU . 83.3 t80 -46.12 -39.26 9.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.873 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 95.6 mt -87.9 -27.07 22.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.888 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 29.0 t -49.79 -24.79 2.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.813 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . 0.446 ' CB ' ' HG3' ' A' ' 165' ' ' GLN . 35.4 mmtt -70.3 117.57 12.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.853 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . 0.462 ' HG3' ' ND2' ' A' ' 164' ' ' ASN . 4.7 pt-20 -91.4 153.95 19.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.918 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . 0.462 ' ND2' ' HG3' ' A' ' 163' ' ' GLU . 72.7 m-20 61.16 49.04 5.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.885 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . 0.446 ' HG3' ' CB ' ' A' ' 162' ' ' LYS . 1.8 mm-40 -128.62 151.8 49.08 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.902 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 48.5 t -109.15 109.03 26.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.174 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' ILE . . . . . 0.443 ' CD1' ' HA ' ' A' ' 246' ' ' ALA . 45.4 mt -80.12 143.43 12.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.185 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.478 HG21 ' CE1' ' A' ' 217' ' ' PHE . 86.0 t -123.46 133.66 68.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.15 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 11.0 ttt85 -89.94 106.36 18.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.858 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 91.3 mtp -97.92 125.57 42.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.904 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 47.2 mtp180 -126.57 136.55 52.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.878 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 96.92 17.6 32.11 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.473 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.463 ' CD1' ' HB3' ' A' ' 213' ' ' ALA . 20.7 mt -71.24 116.71 49.8 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.593 0.711 . . . . 0.0 110.912 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . 0.496 ' O ' ' CB ' ' A' ' 177' ' ' ALA . 64.9 Cg_exo -47.99 134.08 23.51 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.672 2.248 . . . . 0.0 112.361 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . 0.453 ' C ' ' O ' ' A' ' 174' ' ' PRO . 19.3 m-85 -34.55 -68.55 0.11 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.893 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -47.63 -40.06 18.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.144 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . 0.496 ' CB ' ' O ' ' A' ' 174' ' ' PRO . . . -38.19 128.07 1.33 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.12 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' THR . . . . . 0.405 ' C ' ' CZ ' ' A' ' 201' ' ' PHE . 1.7 p -141.67 179.85 6.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.179 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -47.21 -46.58 24.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.084 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -53.4 -33.13 52.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.924 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -76.26 -34.04 59.14 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.874 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.441 ' O ' ' N ' ' A' ' 185' ' ' PHE . 85.1 t -74.2 -51.79 22.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.142 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . 0.431 ' C ' ' O ' ' A' ' 182' ' ' VAL . 94.4 t -34.73 -50.55 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.135 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -78.41 -33.5 48.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.127 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . 0.441 ' N ' ' O ' ' A' ' 182' ' ' VAL . 25.1 t80 -47.08 -61.19 2.0 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.863 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -89.9 -21.69 22.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.912 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -49.03 -21.25 2.36 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.451 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -53.24 -75.42 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.86 0.362 . . . . 0.0 110.916 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 11.1 m-70 -118.17 -5.45 10.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.824 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 82.4 m -126.54 87.5 56.27 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-O 121.61 0.719 . . . . 0.0 110.894 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 191' ' ' PRO . . . . . 0.556 ' HD2' ' CD1' ' A' ' 222' ' ' TYR . 52.8 Cg_endo -69.81 131.54 21.38 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.709 2.272 . . . . 0.0 112.279 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 51.3 mt -82.74 142.76 13.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.134 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 47.5 m -67.25 105.92 1.88 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.17 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 87.5 -19.84 30.23 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.493 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . 0.465 ' O ' ' N ' ' A' ' 198' ' ' GLY . . . 78.04 -126.3 7.62 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.507 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 34.4 mtmt -42.9 -33.47 0.78 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.75 0.309 . . . . 0.0 110.873 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -74.27 -34.62 63.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.916 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 195' ' ' GLY . . . -82.98 36.65 2.7 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.495 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 77.5 mt -138.68 151.24 23.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.881 0.372 . . . . 0.0 111.104 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.44 ' HB2' ' CD1' ' A' ' 159' ' ' PHE . 13.4 tp -147.98 111.05 4.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.894 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 201' ' ' PHE . . . . . 0.405 ' CZ ' ' C ' ' A' ' 178' ' ' THR . 53.4 m-85 -93.16 127.65 38.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.902 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 62.0 t -79.73 115.97 23.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.154 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -125.19 137.55 54.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.105 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . 0.421 ' CD1' HG21 ' A' ' 210' ' ' THR . 29.1 m-85 -41.81 159.23 0.19 Allowed Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.694 0.759 . . . . 0.0 110.897 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 2.88 3.14 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.67 2.247 . . . . 0.0 112.379 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -113.43 -18.67 11.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.87 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 110.87 61.51 0.49 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.465 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 37.6 mmt-85 -145.97 145.97 26.82 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.608 0.718 . . . . 0.0 110.886 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 104.02 1.25 Allowed 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.683 2.255 . . . . 0.0 112.38 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 210' ' ' THR . . . . . 0.537 ' HB ' ' CE2' ' A' ' 256' ' ' PHE . 21.0 p -68.42 -31.0 70.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.135 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 114.5 -34.36 4.94 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.504 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -87.61 154.12 20.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.814 0.34 . . . . 0.0 110.872 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . 0.463 ' HB3' ' CD1' ' A' ' 173' ' ' LEU . . . -154.27 175.88 12.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.109 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . 0.548 ' CE2' HG13 ' A' ' 249' ' ' VAL . 60.7 m-85 -138.16 158.32 44.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.876 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 6.6 t -140.64 157.15 23.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.092 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . 0.5 ' HG ' ' CE1' ' A' ' 159' ' ' PHE . 44.7 mt -108.33 141.14 40.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.93 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . 0.478 ' CE1' HG21 ' A' ' 168' ' ' VAL . 88.7 m-85 -135.36 132.5 37.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.904 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -42.65 -66.45 0.36 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.046 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 219' ' ' CYS . . . . . . . . . . . . . 1.9 m -135.01 176.57 8.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.932 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -65.45 -7.37 13.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.855 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -67.85 -37.79 82.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.897 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 222' ' ' TYR . . . . . 0.556 ' CD1' ' HD2' ' A' ' 191' ' ' PRO . 46.5 m-85 -86.52 -39.22 16.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.964 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -59.46 -60.8 3.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.097 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -45.2 -53.98 7.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.934 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 71.1 m-20 -58.69 -25.73 63.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.874 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -75.93 -23.75 55.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.052 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 37.0 mt -68.24 -33.14 73.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.911 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 38.9 mtp180 -60.14 -14.99 19.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.9 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . 0.446 ' O ' ' C ' ' A' ' 230' ' ' HIS . 21.8 mtpp -80.56 -3.42 50.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.854 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 230' ' ' HIS . . . . . 0.466 ' CD2' ' HG2' ' A' ' 231' ' ' LYS . 72.2 t60 -34.16 146.34 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.871 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . 0.466 ' HG2' ' CD2' ' A' ' 230' ' ' HIS . 3.9 mmpt? 53.04 26.84 5.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.892 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -56.47 -177.33 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.86 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.573 HD22 ' CE2' ' A' ' 238' ' ' TYR . 30.8 mt -139.96 105.12 5.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.936 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 6.8 tt -115.53 112.53 22.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.956 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 62.17 34.35 88.83 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.467 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 4.3 mmmm 71.05 52.12 0.27 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.744 0.307 . . . . 0.0 110.893 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 21.2 mmt180 -155.02 115.6 3.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.852 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 238' ' ' TYR . . . . . 0.573 ' CE2' HD22 ' A' ' 233' ' ' LEU . 92.1 m-85 -70.63 117.18 11.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.916 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 57.6 mt -111.73 159.83 11.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.142 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 240' ' ' GLU . . . . . 0.49 ' HB3' ' CZ ' ' A' ' 242' ' ' PHE . 13.7 mt-10 -114.23 167.58 10.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.867 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . 0.546 ' O ' ' CD1' ' A' ' 242' ' ' PHE . 54.0 mt -146.05 143.73 29.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.919 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 242' ' ' PHE . . . . . 0.546 ' CD1' ' O ' ' A' ' 241' ' ' LEU . 9.4 m-85 -159.3 137.13 10.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.865 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 63.0 mtp85 -53.67 141.46 26.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.859 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 8.8 t -138.18 157.41 46.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.85 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 71.7 p -129.3 157.77 40.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.164 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 246' ' ' ALA . . . . . 0.443 ' HA ' ' CD1' ' A' ' 167' ' ' ILE . . . -38.17 -55.78 1.26 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.131 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -54.07 -55.56 26.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.101 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 32.5 tp10 -42.18 -51.49 4.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.929 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . 0.548 HG13 ' CE2' ' A' ' 214' ' ' PHE . 85.9 t -54.69 -63.76 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.172 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -43.01 -33.02 0.73 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.934 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -73.14 -50.54 22.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.914 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 96.9 t -56.9 -37.07 52.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.111 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 16.0 mt -60.75 -50.93 71.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.881 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 254' ' ' ASN . . . . . 0.463 ' C ' ' OD1' ' A' ' 254' ' ' ASN . 0.6 OUTLIER -60.7 -40.47 92.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.882 179.973 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . 0.46 ' N ' ' OD1' ' A' ' 254' ' ' ASN . 21.4 ttt85 -42.92 -55.43 3.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.883 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 256' ' ' PHE . . . . . 0.537 ' CE2' ' HB ' ' A' ' 210' ' ' THR . 67.4 m-85 -74.79 -47.24 31.9 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.896 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 68.7 m . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.897 -179.802 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.858 0.361 . . . . 0.0 110.859 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.402 ' O ' ' C ' ' A' ' 157' ' ' ALA . 72.3 t -60.92 -43.22 95.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.12 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.402 ' C ' ' O ' ' A' ' 156' ' ' VAL . . . -37.46 -61.03 0.63 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.127 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -57.66 -48.62 78.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.907 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' PHE . . . . . 0.495 ' CE1' ' HG ' ' A' ' 216' ' ' LEU . 66.2 t80 -47.68 -38.44 15.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.872 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 85.3 mt -90.57 -27.36 19.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.959 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 30.2 t -50.7 -36.51 36.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.854 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 39.7 mmtt -54.4 124.89 17.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.89 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -99.0 151.74 20.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.881 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 62.35 39.21 12.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.886 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -124.65 147.27 48.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.888 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 48.9 t -100.25 131.68 47.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.116 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' ILE . . . . . 0.448 HD12 ' N ' ' A' ' 246' ' ' ALA . 33.6 mt -101.17 143.8 13.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.176 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 96.8 t -128.26 136.6 59.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.121 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . 0.465 ' N ' ' HB2' ' A' ' 244' ' ' SER . 20.8 ttt85 -90.72 111.92 23.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.891 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' MET . . . . . 0.417 ' SD ' ' CG2' ' A' ' 215' ' ' VAL . 83.2 mtp -98.42 117.08 32.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.857 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 5.7 ttt-85 -120.99 140.66 51.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.833 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 89.91 23.43 32.83 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.512 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 22.9 mt -79.18 129.62 72.01 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.564 0.697 . . . . 0.0 110.917 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . 0.449 ' HG3' ' CB ' ' A' ' 237' ' ' ARG . 65.1 Cg_exo -47.94 154.75 2.0 Allowed 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.661 2.241 . . . . 0.0 112.345 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -60.09 -50.17 74.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.833 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' THR . . . . . 0.457 ' O ' ' C ' ' A' ' 177' ' ' ALA . 0.0 OUTLIER -68.77 -39.07 80.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.135 -179.877 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . 0.457 ' C ' ' O ' ' A' ' 176' ' ' THR . . . -33.53 124.25 0.42 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.072 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' THR . . . . . 0.432 ' O ' ' C ' ' A' ' 179' ' ' ALA . 1.4 p -135.7 176.62 8.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.146 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.501 ' N ' ' CZ ' ' A' ' 201' ' ' PHE . . . -35.14 -44.98 0.27 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.121 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -56.66 -49.33 75.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.926 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . 0.454 ' HG3' ' N ' ' A' ' 182' ' ' VAL . 0.0 OUTLIER -55.07 -33.48 62.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.869 -179.93 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.458 ' O ' ' N ' ' A' ' 185' ' ' PHE . 93.7 t -79.29 -60.03 2.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.156 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . 0.435 ' C ' ' O ' ' A' ' 182' ' ' VAL . 73.4 t -34.34 -39.89 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.134 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -85.77 -39.31 17.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.049 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . 0.458 ' N ' ' O ' ' A' ' 182' ' ' VAL . 63.1 t80 -46.06 -59.58 2.78 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.825 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 186' ' ' PHE . . . . . 0.403 ' CE1' ' HE2' ' A' ' 185' ' ' PHE . 77.2 m-85 -91.79 -22.1 20.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.854 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -50.36 -18.25 2.24 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.511 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -58.49 -70.3 0.15 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.843 0.354 . . . . 0.0 110.882 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -118.15 -15.58 9.82 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.858 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 190' ' ' CYS . . . . . 0.409 ' SG ' ' CB ' ' A' ' 225' ' ' ASN . 70.8 m -120.26 86.69 38.66 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.65 0.738 . . . . 0.0 110.888 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 130.37 19.22 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.663 2.242 . . . . 0.0 112.361 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . 0.422 HD12 ' CG1' ' A' ' 182' ' ' VAL . 50.3 mt -82.14 146.2 7.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.161 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 85.6 m -66.89 105.78 1.71 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.148 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 87.41 -20.14 28.27 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.453 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . 0.401 ' O ' ' N ' ' A' ' 198' ' ' GLY . . . 78.84 -126.66 7.63 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.446 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 16.6 ptmt -45.29 -34.43 2.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.746 0.308 . . . . 0.0 110.874 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -73.72 -32.8 64.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.867 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 195' ' ' GLY . . . -86.69 37.6 3.16 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.5 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 48.0 mt -141.83 146.31 23.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.865 0.364 . . . . 0.0 111.164 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 19.5 tp -134.4 118.14 17.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.91 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 201' ' ' PHE . . . . . 0.501 ' CZ ' ' N ' ' A' ' 179' ' ' ALA . 62.8 m-85 -99.53 114.51 27.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.91 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 22.7 t -70.06 114.23 7.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.179 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -124.86 137.21 54.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.12 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -43.49 158.22 0.25 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.705 0.764 . . . . 0.0 110.882 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 3.01 3.01 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.683 2.256 . . . . 0.0 112.355 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -112.08 -21.05 11.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.829 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 112.5 57.53 0.44 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.462 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 33.2 mmt-85 -141.89 144.61 33.12 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.598 0.713 . . . . 0.0 110.896 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.7 105.67 1.52 Allowed 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.635 2.224 . . . . 0.0 112.381 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 210' ' ' THR . . . . . 0.558 ' HB ' ' CE1' ' A' ' 256' ' ' PHE . 27.2 p -69.07 -32.31 71.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.158 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 114.0 -34.1 5.13 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.442 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -84.68 162.76 19.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.815 0.341 . . . . 0.0 110.862 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -162.89 175.51 11.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.065 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . 0.549 ' CD2' HG12 ' A' ' 249' ' ' VAL . 80.8 m-85 -140.76 136.65 32.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.885 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 215' ' ' VAL . . . . . 0.417 ' CG2' ' SD ' ' A' ' 170' ' ' MET . 5.4 t -115.92 159.33 15.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.096 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . 0.495 ' HG ' ' CE1' ' A' ' 159' ' ' PHE . 29.3 mt -112.37 145.25 40.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.927 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -140.12 137.0 34.13 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.9 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -48.48 -50.06 33.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.123 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 219' ' ' CYS . . . . . . . . . . . . . 2.0 t -154.2 177.48 11.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.913 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -57.84 -23.89 54.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.893 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -50.75 -54.66 21.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.879 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 222' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -71.84 -48.63 44.8 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.936 -179.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -47.36 -52.03 17.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.074 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -51.75 -62.75 1.44 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.908 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . 0.409 ' CB ' ' SG ' ' A' ' 190' ' ' CYS . 38.2 m-20 -48.42 -23.7 1.03 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.898 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -81.31 -40.3 23.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.098 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 95.9 mt -52.28 -39.0 59.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.899 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 37.2 mtt-85 -55.62 -27.85 51.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.861 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . 0.454 ' O ' ' C ' ' A' ' 230' ' ' HIS . 20.7 mtpp -70.62 -2.77 15.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.898 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 230' ' ' HIS . . . . . 0.534 ' CE1' ' HG3' ' A' ' 231' ' ' LYS . 15.7 t60 -33.91 129.19 0.34 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.87 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . 0.534 ' HG3' ' CE1' ' A' ' 230' ' ' HIS . 30.9 mttt 63.07 39.62 9.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.896 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -67.38 -175.1 0.45 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.849 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.573 HD21 ' CE2' ' A' ' 238' ' ' TYR . 29.6 mt -138.08 110.1 7.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.951 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 8.0 tt -121.65 113.94 20.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.894 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 59.13 40.98 96.37 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.456 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . 0.428 ' HA ' ' NZ ' ' A' ' 236' ' ' LYS . 0.0 OUTLIER 65.36 52.4 1.43 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.762 0.315 . . . . 0.0 110.907 -179.967 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 237' ' ' ARG . . . . . 0.449 ' CB ' ' HG3' ' A' ' 174' ' ' PRO . 21.2 mmt180 -156.29 115.13 3.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.815 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 238' ' ' TYR . . . . . 0.573 ' CE2' HD21 ' A' ' 233' ' ' LEU . 93.7 m-85 -69.75 127.3 32.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.91 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 62.1 mt -122.22 134.26 66.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.09 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 240' ' ' GLU . . . . . 0.562 ' HB3' ' CZ ' ' A' ' 242' ' ' PHE . 6.5 mp0 -103.1 149.39 24.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.898 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . 0.517 ' O ' ' CD1' ' A' ' 242' ' ' PHE . 14.3 mt -124.62 149.56 46.95 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.964 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 242' ' ' PHE . . . . . 0.562 ' CZ ' ' HB3' ' A' ' 240' ' ' GLU . 13.6 m-85 -156.84 132.38 9.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.841 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 57.5 mtm180 -48.09 133.04 15.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.901 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 244' ' ' SER . . . . . 0.465 ' HB2' ' N ' ' A' ' 169' ' ' ARG . 3.4 t -130.48 157.59 42.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.825 -179.744 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 245' ' ' THR . . . . . 0.424 ' O ' ' C ' ' A' ' 246' ' ' ALA . 82.1 p -133.45 150.05 51.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.161 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 246' ' ' ALA . . . . . 0.448 ' N ' HD12 ' A' ' 167' ' ' ILE . . . -35.67 -51.94 0.67 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.096 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -59.41 -50.97 71.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.096 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 18.1 tp10 -47.31 -50.28 22.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.903 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . 0.549 HG12 ' CD2' ' A' ' 214' ' ' PHE . 98.5 t -53.48 -64.58 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.148 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 68.4 mt-30 -43.22 -34.96 1.26 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.934 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 251' ' ' GLN . . . . . 0.5 ' O ' ' ND2' ' A' ' 254' ' ' ASN . 27.5 mt-30 -74.34 -33.31 63.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.879 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 252' ' ' VAL . . . . . 0.459 ' HA ' ' NE ' ' A' ' 255' ' ' ARG . 79.1 t -79.67 -19.06 12.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.133 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 17.0 mt -80.81 -46.39 15.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.879 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 254' ' ' ASN . . . . . 0.5 ' ND2' ' O ' ' A' ' 251' ' ' GLN . 1.3 p30 -58.16 -50.06 74.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.857 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . 0.474 ' N ' ' CG ' ' A' ' 254' ' ' ASN . 17.3 ptp180 -49.31 -47.18 47.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.856 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 256' ' ' PHE . . . . . 0.558 ' CE1' ' HB ' ' A' ' 210' ' ' THR . 10.3 m-85 -73.8 -37.45 64.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.855 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 1.4 t . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.822 -179.759 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 . . . . . 0 C--O 1.23 0.065 0 CA-C-O 120.935 0.397 . . . . 0.0 110.907 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.441 ' O ' ' C ' ' A' ' 157' ' ' ALA . 75.5 t -77.29 -50.42 20.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.117 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.441 ' C ' ' O ' ' A' ' 156' ' ' VAL . . . -34.75 -57.32 0.53 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.101 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 76.1 mm-40 -62.13 -45.87 91.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.889 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' PHE . . . . . 0.43 ' CE2' ' HG ' ' A' ' 216' ' ' LEU . 20.1 t80 -52.89 -42.4 65.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.883 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 56.3 mt -82.06 -29.27 31.96 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.916 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 22.9 t -48.28 -43.33 32.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.902 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -38.6 130.26 1.38 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.942 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -106.61 145.54 31.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.883 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . 0.448 ' O ' ' NE2' ' A' ' 165' ' ' GLN . 49.1 m-80 63.28 37.71 10.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.891 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . 0.448 ' NE2' ' O ' ' A' ' 164' ' ' ASN . 2.2 mp0 -122.54 153.81 38.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.904 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 83.9 t -108.36 137.56 39.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.135 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' ILE . . . . . 0.422 HG21 ' CG2' ' A' ' 249' ' ' VAL . 28.6 mt -104.84 139.23 26.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.07 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.409 HG11 ' N ' ' A' ' 169' ' ' ARG . 82.6 t -120.49 133.35 67.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.154 179.787 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . 0.409 ' N ' HG11 ' A' ' 168' ' ' VAL . 39.3 ttp180 -88.51 104.72 17.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.839 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' MET . . . . . 0.446 ' HE1' ' CD2' ' A' ' 173' ' ' LEU . 83.3 mtp -97.39 131.57 43.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.884 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 2.1 ttt85 -135.65 140.48 44.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.852 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 93.23 16.59 46.42 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.504 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.446 ' CD2' ' HE1' ' A' ' 170' ' ' MET . 25.5 mt -72.09 128.95 88.47 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.606 0.717 . . . . 0.0 110.925 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . 0.443 ' HG3' ' CB ' ' A' ' 237' ' ' ARG . 64.3 Cg_exo -47.91 144.61 11.44 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.682 2.255 . . . . 0.0 112.357 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . 0.564 ' CD1' ' HG3' ' A' ' 209' ' ' PRO . 6.7 t80 -49.35 -41.69 39.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.88 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' THR . . . . . 0.45 ' O ' ' C ' ' A' ' 177' ' ' ALA . 7.6 p -76.25 -45.41 32.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.158 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . 0.45 ' C ' ' O ' ' A' ' 176' ' ' THR . . . -33.41 104.55 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.117 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -111.66 177.7 4.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.118 -179.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.447 ' N ' ' CE1' ' A' ' 201' ' ' PHE . . . -45.42 -51.08 11.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.14 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -50.22 -38.87 42.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.916 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . 0.473 ' CG ' HD23 ' A' ' 234' ' ' LEU . 2.6 tp10 -64.65 -41.85 95.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.898 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.481 ' O ' ' N ' ' A' ' 185' ' ' PHE . 94.5 t -64.96 -54.22 32.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.133 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . 0.453 ' C ' ' O ' ' A' ' 182' ' ' VAL . 43.2 t -33.86 -55.72 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.112 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -70.72 -34.33 71.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.095 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . 0.527 ' CE2' ' HD3' ' A' ' 229' ' ' LYS . 63.6 t80 -51.13 -61.11 2.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.904 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -89.58 -20.4 23.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.913 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -49.16 -18.5 1.29 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.474 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 38.4 mm-40 -55.9 -75.17 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.796 0.332 . . . . 0.0 110.921 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -118.34 -3.78 10.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.845 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 71.4 m -128.7 87.09 55.82 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.579 0.704 . . . . 0.0 110.851 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 191' ' ' PRO . . . . . 0.566 ' HD2' ' CD1' ' A' ' 222' ' ' TYR . 54.1 Cg_endo -69.74 143.3 50.5 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.719 2.279 . . . . 0.0 112.38 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . 0.469 HD11 ' CG1' ' A' ' 215' ' ' VAL . 63.1 mt -97.71 143.07 13.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.102 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 88.6 m -66.72 101.41 0.8 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.134 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 89.64 -15.8 58.02 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.428 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 73.01 -118.21 6.28 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.483 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 39.4 mtmt -51.16 -32.71 24.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.73 0.3 . . . . 0.0 110.864 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -75.22 -22.54 57.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.904 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -99.25 35.25 4.82 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.442 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 60.5 mt -137.45 139.22 43.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.88 0.371 . . . . 0.0 111.132 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 12.9 tp -133.44 123.08 24.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.946 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 201' ' ' PHE . . . . . 0.447 ' CE1' ' N ' ' A' ' 179' ' ' ALA . 75.8 m-85 -104.26 124.77 49.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.854 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 55.6 t -79.9 136.31 23.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.082 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -143.21 136.59 28.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.138 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . 0.576 ' CD1' ' HB3' ' A' ' 208' ' ' ARG . 16.7 m-85 -40.31 160.65 0.12 Allowed Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.68 0.752 . . . . 0.0 110.901 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.74 3.22 2.89 Favored 'Trans proline' 0 N--CA 1.465 -0.176 0 C-N-CA 122.724 2.283 . . . . 0.0 112.32 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -117.31 -28.45 6.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.878 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 127.69 42.93 0.25 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.485 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 208' ' ' ARG . . . . . 0.576 ' HB3' ' CD1' ' A' ' 204' ' ' TYR . 10.8 ttm180 -117.3 142.01 29.53 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.639 0.733 . . . . 0.0 110.876 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 209' ' ' PRO . . . . . 0.564 ' HG3' ' CD1' ' A' ' 175' ' ' PHE . 54.0 Cg_endo -69.74 93.27 0.52 Allowed 'Trans proline' 0 C--O 1.232 0.22 0 C-N-CA 122.734 2.29 . . . . 0.0 112.342 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 210' ' ' THR . . . . . 0.564 ' HB ' ' CE2' ' A' ' 256' ' ' PHE . 69.6 p -60.12 -9.45 3.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.097 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 81.36 -42.42 2.76 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.48 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -69.1 165.32 20.55 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.8 0.333 . . . . 0.0 110.892 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -165.34 -177.82 4.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.088 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . 0.539 ' CD2' HG12 ' A' ' 249' ' ' VAL . 51.2 m-85 -145.97 138.68 25.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.9 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 215' ' ' VAL . . . . . 0.469 ' CG1' HD11 ' A' ' 192' ' ' ILE . 10.0 t -121.63 156.71 25.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.168 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . 0.43 ' HG ' ' CE2' ' A' ' 159' ' ' PHE . 49.5 mt -110.85 138.58 47.07 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.936 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -129.91 137.15 50.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.879 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -49.81 -46.66 51.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.084 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 219' ' ' CYS . . . . . . . . . . . . . 10.2 m -154.14 171.57 18.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.893 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . 0.41 ' O ' ' C ' ' A' ' 221' ' ' GLU . 6.8 tp10 -57.6 -40.75 79.77 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.873 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . 0.41 ' C ' ' O ' ' A' ' 220' ' ' GLU . 26.6 tt0 -36.79 -49.54 0.79 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.885 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 222' ' ' TYR . . . . . 0.566 ' CD1' ' HD2' ' A' ' 191' ' ' PRO . 20.9 m-85 -74.54 -50.07 19.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.892 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -44.82 -54.52 6.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.117 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -48.41 -62.42 1.5 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.954 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 41.3 m-20 -49.54 -28.96 6.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.871 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -70.42 -43.21 70.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.038 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 29.0 mt -54.35 -30.28 51.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.934 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 60.8 mtp85 -58.65 -22.22 56.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.841 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . 0.527 ' HD3' ' CE2' ' A' ' 185' ' ' PHE . 16.7 mttm -78.93 -1.71 36.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.9 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 230' ' ' HIS . . . . . 0.544 ' CE1' ' HD3' ' A' ' 231' ' ' LYS . 21.6 t60 -33.86 127.0 0.41 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.886 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . 0.544 ' HD3' ' CE1' ' A' ' 230' ' ' HIS . 0.3 OUTLIER 68.75 32.56 4.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.877 179.978 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -61.91 178.69 0.33 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.881 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.561 HD21 ' CE1' ' A' ' 238' ' ' TYR . 31.1 mt -135.18 109.74 8.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.943 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 234' ' ' LEU . . . . . 0.473 HD23 ' CG ' ' A' ' 181' ' ' GLU . 6.5 tt -117.68 114.15 22.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.905 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 58.4 37.59 88.25 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.482 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 9.6 mmpt? 70.56 52.73 0.32 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.78 0.324 . . . . 0.0 110.889 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 237' ' ' ARG . . . . . 0.443 ' CB ' ' HG3' ' A' ' 174' ' ' PRO . 50.4 mmt-85 -155.47 116.06 3.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.85 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 238' ' ' TYR . . . . . 0.561 ' CE1' HD21 ' A' ' 233' ' ' LEU . 89.6 m-85 -68.61 125.39 26.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.904 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 64.1 mt -120.94 134.53 64.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.116 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 240' ' ' GLU . . . . . 0.482 ' HB3' ' CZ ' ' A' ' 242' ' ' PHE . 38.8 mp0 -96.24 170.21 9.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.85 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 75.1 mt -145.71 139.96 26.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.946 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 242' ' ' PHE . . . . . 0.482 ' CZ ' ' HB3' ' A' ' 240' ' ' GLU . 8.6 m-85 -152.14 130.87 12.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.877 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 57.4 mtm180 -52.25 136.17 31.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.846 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 1.1 t -136.9 166.37 23.79 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.869 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 74.1 p -135.91 165.05 26.54 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.142 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -49.02 -53.55 19.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.076 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -55.6 -50.89 68.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.09 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -50.06 -50.98 46.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.931 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . 0.539 HG12 ' CD2' ' A' ' 214' ' ' PHE . 92.2 t -47.36 -61.97 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.101 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -48.19 -33.03 7.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.902 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 251' ' ' GLN . . . . . 0.414 ' HA ' ' ND2' ' A' ' 254' ' ' ASN . 53.0 mt-30 -76.82 -25.94 53.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.92 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 95.0 t -82.25 -21.71 9.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.135 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 10.7 mt -84.19 -43.54 14.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.905 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 254' ' ' ASN . . . . . 0.494 ' OD1' ' N ' ' A' ' 255' ' ' ARG . 0.5 OUTLIER -65.11 -42.08 94.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.846 179.973 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . 0.494 ' N ' ' OD1' ' A' ' 254' ' ' ASN . 1.8 ptm85 -58.38 -41.86 85.76 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.855 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 256' ' ' PHE . . . . . 0.564 ' CE2' ' HB ' ' A' ' 210' ' ' THR . 11.7 m-85 -75.65 -46.0 33.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.921 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 66.5 m . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.835 -179.81 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.856 0.36 . . . . 0.0 110.905 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.439 ' O ' ' C ' ' A' ' 157' ' ' ALA . 26.7 t -68.55 -41.46 83.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.077 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.439 ' C ' ' O ' ' A' ' 156' ' ' VAL . . . -33.73 -69.94 0.08 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.108 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . 0.498 ' O ' ' N ' ' A' ' 161' ' ' SER . 3.8 pt20 -48.82 -60.17 2.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.947 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 21.4 t80 -39.4 -40.67 0.84 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.921 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 98.6 mt -89.07 -22.92 22.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.934 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' SER . . . . . 0.498 ' N ' ' O ' ' A' ' 158' ' ' GLN . 7.7 t -59.95 -20.93 60.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.853 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . 0.456 ' HG3' ' CD1' ' A' ' 216' ' ' LEU . 25.3 mmmt -69.83 118.27 12.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.926 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 50.3 mm-40 -96.98 158.02 15.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.916 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 62.43 42.18 9.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.868 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 36.1 mm-40 -126.7 172.6 10.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.911 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 86.6 t -128.54 106.45 14.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.11 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' ILE . . . . . 0.461 HG22 ' CG2' ' A' ' 249' ' ' VAL . 70.0 mt -77.67 141.63 15.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.169 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 43.7 t -122.77 133.94 67.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.103 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . 0.429 ' N ' ' HB2' ' A' ' 244' ' ' SER . 29.6 ttp180 -91.43 101.44 14.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.876 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' MET . . . . . 0.43 ' HE2' ' CD2' ' A' ' 173' ' ' LEU . 99.3 mtp -94.9 127.25 40.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.895 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 13.5 ttm180 -126.07 141.49 51.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.884 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 89.91 24.92 28.56 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.501 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.43 ' CD2' ' HE2' ' A' ' 170' ' ' MET . 19.9 mt -78.45 123.29 85.7 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.638 0.732 . . . . 0.0 110.907 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_exo -48.0 141.77 16.63 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.67 2.246 . . . . 0.0 112.341 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . 0.565 ' CD1' ' HG3' ' A' ' 209' ' ' PRO . 9.1 t80 -53.97 -26.18 24.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.892 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 7.2 p -89.69 -14.3 35.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.095 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -65.15 110.16 2.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.125 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' THR . . . . . 0.437 ' O ' ' N ' ' A' ' 181' ' ' GLU . 0.8 OUTLIER -118.96 167.16 12.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.134 -179.925 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 178' ' ' THR . . . -35.42 -42.43 0.21 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.122 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -57.07 -47.69 80.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.89 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . 0.437 ' N ' ' O ' ' A' ' 178' ' ' THR . 3.9 mp0 -61.0 -37.49 82.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.879 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.448 ' O ' ' C ' ' A' ' 183' ' ' VAL . 76.1 t -69.85 -54.23 20.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.119 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . 0.448 ' C ' ' O ' ' A' ' 182' ' ' VAL . 28.1 t -33.78 -50.66 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.125 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -73.54 -44.22 58.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.086 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -39.13 -61.31 0.78 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.903 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -92.27 -21.42 20.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.873 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -49.11 -18.9 1.35 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.495 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -56.25 -75.21 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.803 0.335 . . . . 0.0 110.923 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -118.25 -7.57 10.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.851 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 79.4 m -124.41 86.4 55.0 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.557 0.694 . . . . 0.0 110.876 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 191' ' ' PRO . . . . . 0.557 ' HD2' ' CD1' ' A' ' 222' ' ' TYR . 53.5 Cg_endo -69.78 140.32 42.3 Favored 'Trans proline' 0 C--O 1.231 0.148 0 C-N-CA 122.715 2.276 . . . . 0.0 112.308 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . 0.418 HG23 ' N ' ' A' ' 193' ' ' THR . 57.2 mt -91.5 144.29 9.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.149 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 193' ' ' THR . . . . . 0.418 ' N ' HG23 ' A' ' 192' ' ' ILE . 35.9 m -73.24 105.72 4.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.139 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 91.33 -17.78 54.53 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.478 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 72.09 -121.09 8.22 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.472 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 24.0 mtmm -49.74 -28.46 6.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.731 0.301 . . . . 0.0 110.87 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -77.74 -27.66 50.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.886 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -93.62 40.4 2.79 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.524 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 56.9 mt -144.04 149.77 17.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.885 0.374 . . . . 0.0 111.087 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 14.1 tp -148.46 119.63 7.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.897 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -98.71 117.62 33.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.89 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 42.7 t -73.49 133.63 31.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.124 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -138.39 137.9 37.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.159 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -47.24 158.63 0.45 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.663 0.744 . . . . 0.0 110.916 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 3.14 2.98 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.651 2.234 . . . . 0.0 112.343 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -110.29 -20.51 12.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.825 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 113.72 38.02 1.23 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.506 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 77.6 mtt180 -121.63 146.86 46.53 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.612 0.72 . . . . 0.0 110.854 -179.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 209' ' ' PRO . . . . . 0.565 ' HG3' ' CD1' ' A' ' 175' ' ' PHE . 53.6 Cg_endo -69.79 112.02 2.97 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.672 2.248 . . . . 0.0 112.348 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 210' ' ' THR . . . . . 0.565 HG22 ' CD2' ' A' ' 256' ' ' PHE . 53.7 p -76.59 -6.8 53.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.173 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 80.73 -37.14 2.29 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.467 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -75.85 159.01 31.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.844 0.354 . . . . 0.0 110.861 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -159.31 -177.91 6.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.075 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -145.59 143.85 30.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.885 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 4.4 t -131.9 155.47 41.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.142 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . 0.456 ' CD1' ' HG3' ' A' ' 162' ' ' LYS . 37.5 mt -106.1 135.09 48.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.916 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -127.19 147.26 50.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.88 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -54.31 -63.76 1.05 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.127 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 219' ' ' CYS . . . . . . . . . . . . . 2.2 t -153.58 172.63 16.91 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.87 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -44.89 -35.71 2.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.891 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . 0.566 ' OE2' ' CD1' ' A' ' 222' ' ' TYR . 6.0 tm-20 -45.27 -44.73 11.54 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.915 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 222' ' ' TYR . . . . . 0.566 ' CD1' ' OE2' ' A' ' 221' ' ' GLU . 35.1 m-85 -88.71 -47.48 8.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.872 -179.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -52.15 -60.0 3.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.113 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 43.9 mm-40 -47.22 -50.68 20.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.914 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 20.4 m-20 -60.48 -23.66 64.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.925 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -76.15 -40.32 52.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.132 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 29.2 mt -54.41 -30.74 53.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.94 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 6.7 mtp-105 -58.84 -25.28 63.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.881 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . 0.462 ' O ' ' C ' ' A' ' 230' ' ' HIS . 19.1 mtpp -76.37 -0.92 24.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.887 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 230' ' ' HIS . . . . . 0.467 ' CE1' ' HG3' ' A' ' 231' ' ' LYS . 13.7 t60 -33.54 133.37 0.17 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.833 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . 0.467 ' HG3' ' CE1' ' A' ' 230' ' ' HIS . 47.0 mtmt 59.13 40.35 21.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.904 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -66.64 -177.01 0.53 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.834 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.553 HD21 ' CE1' ' A' ' 238' ' ' TYR . 31.3 mt -136.48 105.03 5.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.909 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 6.6 tt -116.35 113.67 23.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.921 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 60.55 39.42 96.42 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.514 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 4.4 mmmm 66.69 53.39 0.91 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.76 0.314 . . . . 0.0 110.882 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 20.4 mmt180 -156.21 115.47 3.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.877 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 238' ' ' TYR . . . . . 0.553 ' CE1' HD21 ' A' ' 233' ' ' LEU . 95.7 m-85 -68.64 117.36 10.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.916 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . 0.423 HD12 ' CD2' ' A' ' 173' ' ' LEU . 17.7 mt -113.81 129.9 68.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.178 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 240' ' ' GLU . . . . . 0.422 ' O ' ' CD2' ' A' ' 241' ' ' LEU . 0.5 OUTLIER -89.99 175.27 7.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.869 -179.998 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . 0.48 ' O ' ' CD1' ' A' ' 242' ' ' PHE . 38.5 mt -151.57 144.65 24.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.907 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 242' ' ' PHE . . . . . 0.48 ' CD1' ' O ' ' A' ' 241' ' ' LEU . 15.0 m-85 -156.89 129.17 7.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.885 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . 0.47 ' CZ ' ' HB2' ' A' ' 243' ' ' ARG . 17.0 mtm105 -48.25 138.74 9.36 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.876 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 244' ' ' SER . . . . . 0.429 ' HB2' ' N ' ' A' ' 169' ' ' ARG . 1.0 OUTLIER -136.25 160.46 38.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.861 -179.778 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 53.5 p -132.83 155.83 48.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.173 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 246' ' ' ALA . . . . . 0.443 ' HA ' ' CD1' ' A' ' 167' ' ' ILE . . . -40.51 -58.65 1.52 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.058 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -53.44 -55.69 23.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.114 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -46.02 -46.06 16.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.885 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . 0.461 ' CG2' HG22 ' A' ' 167' ' ' ILE . 98.2 t -51.62 -62.54 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.126 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -47.66 -33.38 6.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.898 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 251' ' ' GLN . . . . . 0.499 ' O ' ' ND2' ' A' ' 254' ' ' ASN . 29.4 mm-40 -76.76 -26.3 54.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.921 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 43.1 t -82.38 -21.64 9.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.114 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 10.5 mt -85.41 -43.24 13.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.875 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 254' ' ' ASN . . . . . 0.499 ' ND2' ' O ' ' A' ' 251' ' ' GLN . 0.4 OUTLIER -65.22 -46.0 82.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.876 179.962 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . 0.401 ' N ' ' CG ' ' A' ' 254' ' ' ASN . 7.5 ptm180 -48.68 -30.72 5.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.896 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 256' ' ' PHE . . . . . 0.565 ' CD2' HG22 ' A' ' 210' ' ' THR . 17.0 m-85 -88.42 -32.39 18.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.886 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 32.3 t . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.845 -179.767 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.9 0.381 . . . . 0.0 110.897 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.498 ' O ' ' N ' ' A' ' 159' ' ' PHE . 20.5 t -73.55 -58.03 5.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.141 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.443 ' C ' ' O ' ' A' ' 156' ' ' VAL . . . -34.07 -57.17 0.48 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.087 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 82.3 mt-30 -67.28 -33.79 76.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.931 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' PHE . . . . . 0.498 ' N ' ' O ' ' A' ' 156' ' ' VAL . 71.4 t80 -62.76 -39.49 94.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.867 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 82.8 mt -90.21 -17.13 28.09 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.884 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 13.1 t -55.45 -31.84 62.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.845 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 25.6 mmtt -60.98 118.12 6.33 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.95 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -97.33 136.88 37.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.88 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 74.53 43.99 0.24 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.891 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . 0.469 ' NE2' ' HA ' ' A' ' 165' ' ' GLN . 8.5 mm100 -122.87 176.16 6.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.92 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 15.8 t -129.14 119.68 49.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.112 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 14.6 mt -93.21 149.57 4.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.084 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.475 HG21 ' CE1' ' A' ' 217' ' ' PHE . 57.5 t -130.93 137.01 56.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.123 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 50.7 ttt-85 -92.27 109.4 20.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.854 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 96.6 mtp -102.05 120.63 40.73 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.846 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 3.3 ttt85 -122.76 139.38 54.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.884 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 90.53 28.24 17.35 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.502 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 30.4 mt -82.52 127.37 70.88 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.607 0.718 . . . . 0.0 110.836 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . 0.469 ' HG3' ' CB ' ' A' ' 237' ' ' ARG . 65.9 Cg_exo -48.06 126.2 12.92 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.665 2.243 . . . . 0.0 112.32 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . 0.559 ' CE2' ' HG2' ' A' ' 209' ' ' PRO . 3.8 m-85 -44.06 -24.19 0.14 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.882 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 67.3 p -86.37 -37.16 18.7 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.133 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . 0.401 ' N ' ' O ' ' A' ' 174' ' ' PRO . . . -49.21 124.68 9.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.093 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.76 -173.67 2.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.127 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -51.35 -48.05 62.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.085 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -56.76 -33.44 66.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.878 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -72.41 -22.91 61.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.9 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 93.9 t -87.21 -48.5 15.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.182 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 44.7 t -39.95 -42.53 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.098 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -81.34 -44.19 17.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.064 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . 0.505 ' CE1' ' HD2' ' A' ' 229' ' ' LYS . 18.3 t80 -40.01 -58.14 1.48 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.862 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 186' ' ' PHE . . . . . 0.449 ' CE1' ' CE1' ' A' ' 185' ' ' PHE . 79.3 m-85 -94.34 -22.99 17.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.874 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -49.29 -21.63 2.97 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.505 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 -54.3 -70.88 0.09 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.834 0.349 . . . . 0.0 110.968 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 6.6 m-70 -118.02 -15.49 9.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.881 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 190' ' ' CYS . . . . . 0.405 ' N ' ' O ' ' A' ' 186' ' ' PHE . 82.8 m -120.35 86.4 38.58 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.612 0.72 . . . . 0.0 110.909 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 134.35 27.73 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.685 2.256 . . . . 0.0 112.374 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 48.2 mt -84.12 143.31 12.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.176 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 93.5 m -68.06 106.24 2.31 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.135 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 89.72 -20.55 34.62 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.475 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 78.62 -125.65 7.19 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.498 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 4.7 ptpt -49.49 -21.72 1.02 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.742 0.306 . . . . 0.0 110.845 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -83.54 -30.88 26.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.903 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -89.77 39.64 3.1 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.491 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 42.6 mt -139.94 149.36 22.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.894 0.378 . . . . 0.0 111.139 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 13.4 tp -143.24 113.16 7.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.937 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -95.22 112.38 24.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.854 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 22.9 t -64.12 118.98 7.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.096 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -127.66 138.29 52.78 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.132 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -45.9 158.49 0.35 Allowed Pre-proline 0 C--N 1.328 -0.369 0 CA-C-O 121.719 0.771 . . . . 0.0 110.925 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 2.88 3.12 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.694 2.263 . . . . 0.0 112.379 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -111.45 -15.34 13.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.866 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 105.9 61.94 0.62 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.518 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 41.7 mtt180 -150.9 149.58 25.65 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.587 0.708 . . . . 0.0 110.861 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 209' ' ' PRO . . . . . 0.559 ' HG2' ' CE2' ' A' ' 175' ' ' PHE . 53.3 Cg_endo -69.84 121.0 7.67 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.655 2.237 . . . . 0.0 112.347 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 210' ' ' THR . . . . . 0.525 ' HB ' ' CE2' ' A' ' 256' ' ' PHE . 72.0 p -90.21 -3.95 57.52 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.157 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 89.27 -41.18 3.02 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.473 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -77.24 158.29 30.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.816 0.341 . . . . 0.0 110.881 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -162.03 177.07 10.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.103 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . 0.564 ' CD2' HG11 ' A' ' 249' ' ' VAL . 47.7 m-85 -140.17 153.6 46.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.908 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 14.8 t -136.41 151.88 28.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.128 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . 0.417 ' HG ' ' CE1' ' A' ' 159' ' ' PHE . 33.2 mt -105.68 150.55 25.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.881 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . 0.475 ' CE1' HG21 ' A' ' 168' ' ' VAL . 84.4 m-85 -142.66 147.31 35.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.941 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -54.71 -66.96 0.31 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.112 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 219' ' ' CYS . . . . . . . . . . . . . 6.4 p -133.22 175.31 9.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.928 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -61.49 -24.41 66.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.869 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -58.83 -29.91 67.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.922 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 222' ' ' TYR . . . . . . . . . . . . . 34.9 m-85 -91.99 -40.16 11.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.932 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -64.18 -51.38 64.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.087 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 12.7 mm-40 -55.81 -53.95 50.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.92 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 -54.52 -26.3 30.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.917 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -74.84 -28.58 60.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.086 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 26.1 mt -59.92 -29.17 68.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.852 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 30.2 mtp85 -59.55 -28.82 67.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.837 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . 0.505 ' HD2' ' CE1' ' A' ' 185' ' ' PHE . 20.0 mtmt -74.91 -1.03 20.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.889 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 230' ' ' HIS . . . . . 0.534 ' CE1' ' HG3' ' A' ' 231' ' ' LYS . 34.7 t60 -33.3 129.85 0.25 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.856 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . 0.534 ' HG3' ' CE1' ' A' ' 230' ' ' HIS . 49.9 mtmt 62.04 37.17 14.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.926 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -63.37 179.59 0.42 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.838 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 33.6 mt -131.61 106.33 8.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.932 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 7.7 tt -116.2 114.53 24.55 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.932 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 60.68 34.35 86.06 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.506 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 32.4 mtpt 71.19 52.15 0.26 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.795 0.331 . . . . 0.0 110.908 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 237' ' ' ARG . . . . . 0.469 ' CB ' ' HG3' ' A' ' 174' ' ' PRO . 18.5 mmt180 -155.77 115.36 3.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.884 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -67.44 119.23 11.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.921 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 80.0 mt -115.61 126.93 73.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.105 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 240' ' ' GLU . . . . . 0.46 ' HB3' ' CE2' ' A' ' 242' ' ' PHE . 37.2 mt-10 -86.13 171.61 11.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.903 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 18.8 mt -152.21 139.41 19.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.915 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 242' ' ' PHE . . . . . 0.46 ' CE2' ' HB3' ' A' ' 240' ' ' GLU . 16.5 m-85 -153.35 126.78 8.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.915 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 61.2 mtm180 -39.85 155.02 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.912 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 19.0 t -156.66 160.7 39.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.827 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 18.0 p -135.86 167.36 21.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.153 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -42.46 -58.52 2.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.091 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -54.0 -56.33 18.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.109 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . 0.456 ' O ' ' CG2' ' A' ' 252' ' ' VAL . 22.5 tp10 -40.66 -46.26 2.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.877 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . 0.564 HG11 ' CD2' ' A' ' 214' ' ' PHE . 99.1 t -61.57 -60.72 2.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.16 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 250' ' ' GLN . . . . . 0.403 ' C ' ' O ' ' A' ' 249' ' ' VAL . 59.9 mt-30 -38.27 -61.18 0.7 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.876 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 251' ' ' GLN . . . . . 0.454 ' CG ' ' O ' ' A' ' 248' ' ' GLU . 7.8 pt20 -53.47 -44.26 68.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.906 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 252' ' ' VAL . . . . . 0.456 ' CG2' ' O ' ' A' ' 248' ' ' GLU . 92.5 t -59.96 -40.57 83.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.136 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 34.6 mt -59.43 -50.84 72.39 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.901 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 254' ' ' ASN . . . . . 0.5 ' OD1' ' N ' ' A' ' 255' ' ' ARG . 0.6 OUTLIER -61.92 -40.18 94.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.89 179.924 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . 0.5 ' N ' ' OD1' ' A' ' 254' ' ' ASN . 43.2 ttt180 -40.59 -58.47 1.59 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.847 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 256' ' ' PHE . . . . . 0.525 ' CE2' ' HB ' ' A' ' 210' ' ' THR . 55.9 m-85 -74.14 -53.94 8.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.871 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 257' ' ' SER . . . . . 0.425 ' C ' ' O ' ' A' ' 256' ' ' PHE . 29.5 t . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.88 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.329 0 N-CA-C 112.497 -0.241 . . . . 0.0 112.497 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 57.9 m -111.35 129.72 55.91 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.886 0.374 . . . . 0.0 110.904 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 1.3 t -80.17 156.03 27.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.882 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -163.69 -49.15 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.462 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 87.4 p -62.16 -49.64 75.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.827 0.346 . . . . 0.0 110.799 -179.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 66.7 m -113.97 108.75 17.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.86 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 140.96 61.23 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.505 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 93.88 103.8 1.73 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.509 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -78.38 80.46 1.41 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.483 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 3.6 m -151.95 116.74 5.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.804 0.335 . . . . 0.0 111.13 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 4.2 m -82.2 170.6 15.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.839 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 54.7 m-80 -60.73 -42.94 98.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.876 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -63.76 -44.87 92.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.903 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.412 ' CG1' HD11 ' A' ' 160' ' ' LEU . 94.1 t -59.32 -47.43 90.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.145 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -37.52 -56.79 0.99 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.072 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -61.59 -40.23 94.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.914 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -59.71 -41.17 90.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.849 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.412 HD11 ' CG1' ' A' ' 156' ' ' VAL . 88.1 mt -87.95 -19.17 27.61 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.915 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 29.5 t -61.62 -22.28 65.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.844 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 39.5 mmtm -72.37 118.55 15.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.931 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -97.46 155.67 16.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.92 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 2.8 m120 63.34 45.64 4.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.884 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 24.0 mm-40 -132.05 149.22 52.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.9 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 55.9 t -103.27 108.04 23.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.129 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 86.8 mt -78.04 141.79 15.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.135 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.541 HG21 ' CE1' ' A' ' 217' ' ' PHE . 92.9 t -122.23 129.28 75.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.113 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 32.5 ttp180 -88.33 106.94 18.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.888 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 96.9 mtp -94.9 126.35 40.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.858 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 26.1 mtt180 -128.03 142.79 51.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.882 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 79.36 45.19 8.94 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.436 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 21.1 mt -93.42 133.68 27.96 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.553 0.692 . . . . 0.0 110.953 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . 0.446 ' HG3' ' CB ' ' A' ' 237' ' ' ARG . 64.9 Cg_exo -47.98 133.57 23.26 Favored 'Trans proline' 0 N--CA 1.465 -0.168 0 C-N-CA 122.737 2.291 . . . . 0.0 112.318 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -53.99 -19.26 4.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.836 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 74.7 p -96.29 -22.41 17.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.16 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -60.7 125.97 25.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.078 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -125.89 178.26 5.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.127 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -45.87 -42.69 12.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.069 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -58.21 -41.8 84.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.926 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -61.82 -42.28 98.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.886 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.449 ' O ' ' C ' ' A' ' 183' ' ' VAL . 47.1 t -65.06 -54.4 29.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.099 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . 0.449 ' C ' ' O ' ' A' ' 182' ' ' VAL . 91.4 t -33.99 -52.02 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.131 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . 0.419 ' O ' ' C ' ' A' ' 185' ' ' PHE . . . -72.89 -45.74 56.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.093 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.511 ' CE1' ' CE1' ' A' ' 186' ' ' PHE . 35.2 t80 -36.89 -62.46 0.48 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.875 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' PHE . . . . . 0.511 ' CE1' ' CE1' ' A' ' 185' ' ' PHE . 55.3 m-85 -91.38 -20.81 21.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.869 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -49.01 -23.32 3.62 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.54 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 30.2 mm-40 -50.64 -74.03 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.827 0.346 . . . . 0.0 110.952 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 29.4 m170 -118.19 -18.17 9.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.877 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 58.6 m -115.05 84.24 10.65 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.635 0.731 . . . . 0.0 110.867 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' PRO . . . . . 0.426 ' HD2' ' CD1' ' A' ' 222' ' ' TYR . 53.3 Cg_endo -69.77 142.89 49.12 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.705 2.27 . . . . 0.0 112.31 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 62.6 mt -94.11 144.99 8.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.113 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 87.1 m -70.38 96.5 1.15 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.183 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 95.85 -2.74 64.48 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.508 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 52.8 -120.01 11.14 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.499 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.27 -27.43 2.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.765 0.316 . . . . 0.0 110.893 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 43.9 mm-40 -80.02 -29.98 39.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.85 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -95.23 41.29 2.52 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.497 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 61.9 mt -141.88 140.54 30.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.828 0.347 . . . . 0.0 111.112 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 13.2 tp -135.91 117.49 14.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.972 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -97.15 115.65 27.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.917 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 14.2 t -70.01 121.92 20.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.151 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -131.45 137.99 48.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.151 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -46.45 158.57 0.39 Allowed Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.673 0.749 . . . . 0.0 110.932 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 2.87 3.13 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.689 2.259 . . . . 0.0 112.372 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -109.37 -21.3 12.58 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.875 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 112.01 49.27 0.63 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.466 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -133.7 144.02 50.18 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.645 0.736 . . . . 0.0 110.862 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 101.79 0.96 Allowed 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.664 2.243 . . . . 0.0 112.354 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 46.0 p -66.45 -25.18 66.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.128 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 104.74 -37.71 3.65 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.471 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -78.09 155.7 30.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.771 0.32 . . . . 0.0 110.929 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -157.5 -179.1 7.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.119 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . 0.453 ' CD2' HG13 ' A' ' 249' ' ' VAL . 77.6 m-85 -144.5 140.36 28.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.819 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 4.6 t -124.28 158.99 30.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.133 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 30.4 mt -111.3 142.54 43.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.958 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . 0.541 ' CE1' HG21 ' A' ' 168' ' ' VAL . 77.3 m-85 -135.44 129.52 33.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.916 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -39.64 -64.48 0.48 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.075 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' CYS . . . . . . . . . . . . . 85.3 m -138.93 -175.34 4.11 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.89 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -71.2 -8.74 55.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.917 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -68.28 -34.62 76.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.922 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' TYR . . . . . 0.426 ' CD1' ' HD2' ' A' ' 191' ' ' PRO . 19.6 m-85 -92.42 -48.88 6.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.92 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -49.76 -53.59 24.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.075 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -52.76 -60.16 3.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.897 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -49.76 -28.57 6.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.915 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -76.23 -36.04 58.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.078 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 43.8 mt -55.35 -36.51 66.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.93 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 3.9 mtp-105 -58.23 -18.98 30.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.883 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . 0.459 ' O ' ' C ' ' A' ' 230' ' ' HIS . 23.7 mtpp -78.78 -2.54 40.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.872 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' HIS . . . . . 0.519 ' CD2' ' HG2' ' A' ' 231' ' ' LYS . 78.5 t60 -33.89 136.88 0.11 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.857 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.519 ' HG2' ' CD2' ' A' ' 230' ' ' HIS . 23.1 mmtm 62.16 31.08 17.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.857 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -59.69 -176.24 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.823 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.526 HD21 ' CD1' ' A' ' 238' ' ' TYR . 31.6 mt -140.06 110.42 6.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.93 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 6.8 tt -119.64 114.16 21.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.91 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 58.26 36.1 81.36 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.497 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 38.7 mttp 71.21 52.13 0.26 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.744 0.306 . . . . 0.0 110.912 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' ARG . . . . . 0.446 ' CB ' ' HG3' ' A' ' 174' ' ' PRO . 19.6 mmt180 -155.79 115.46 3.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.901 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' TYR . . . . . 0.526 ' CD1' HD21 ' A' ' 233' ' ' LEU . 83.5 m-85 -69.72 133.0 47.0 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.955 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 70.7 mt -131.69 141.04 46.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.134 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . 0.564 ' HB3' ' CZ ' ' A' ' 242' ' ' PHE . 24.6 mt-10 -92.89 178.33 5.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.906 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . 0.593 ' O ' ' CD1' ' A' ' 242' ' ' PHE . 51.0 mt -157.64 137.35 12.21 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.893 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' PHE . . . . . 0.593 ' CD1' ' O ' ' A' ' 241' ' ' LEU . 5.2 m-85 -157.53 122.8 4.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.871 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . 0.492 ' CG ' ' O ' ' A' ' 243' ' ' ARG . 19.9 ptt180 -59.57 112.58 1.84 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.873 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 1.7 t -106.98 164.32 12.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.866 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 33.7 p -110.19 166.51 10.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.166 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -54.38 -61.53 2.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.079 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -45.44 -56.26 5.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.083 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -45.7 -55.78 6.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.89 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . 0.453 HG13 ' CD2' ' A' ' 214' ' ' PHE . 99.8 t -41.72 -59.88 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.138 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -47.83 -42.56 26.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.882 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' GLN . . . . . 0.494 ' O ' ' ND2' ' A' ' 254' ' ' ASN . 35.4 mm-40 -68.46 -22.6 64.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.952 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 76.7 t -85.1 -21.1 8.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.11 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 10.9 mt -87.38 -42.18 13.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.945 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . 0.494 ' ND2' ' O ' ' A' ' 251' ' ' GLN . 0.5 OUTLIER -64.47 -43.41 94.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.898 179.906 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -53.76 -42.36 68.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.888 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -80.87 -34.02 33.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.848 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 257' ' ' SER . . . . . 0.405 ' O ' ' C ' ' A' ' 258' ' ' SER . 20.6 m -73.32 138.88 45.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.875 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 258' ' ' SER . . . . . 0.432 ' O ' ' C ' ' A' ' 259' ' ' ALA . 88.4 p 37.63 39.18 0.18 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.903 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 259' ' ' ALA . . . . . 0.432 ' C ' ' O ' ' A' ' 258' ' ' SER . . . -35.12 130.56 0.45 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.103 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 9.6 t -103.88 39.18 1.67 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.877 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . 0.428 ' HA3' ' C ' ' A' ' 262' ' ' PRO . . . -153.19 -70.64 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.524 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 262' ' ' PRO . . . . . 0.428 ' C ' ' HA3' ' A' ' 261' ' ' GLY . 54.2 Cg_endo -69.7 -11.96 11.93 Favored 'Cis proline' 0 C--N 1.341 0.18 0 C-N-CA 122.691 -1.795 . . . . 0.0 112.338 0.002 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 32.4 t -55.63 147.01 19.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.872 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 60.6 p -93.93 42.05 1.09 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.898 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.349 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.508 -179.967 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.345 0 N-CA-C 112.466 -0.254 . . . . 0.0 112.466 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 88.7 p -169.81 148.24 3.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.883 0.373 . . . . 0.0 110.885 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 5.6 t -57.39 143.87 38.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.885 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -163.52 -59.41 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.454 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.8 m -87.73 125.65 34.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.867 0.365 . . . . 0.0 110.812 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 9.8 t -120.98 138.32 54.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.886 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -123.2 164.58 16.15 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.477 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 138.44 -69.39 0.49 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.467 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -116.17 161.39 12.96 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.474 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' THR . . . . . 0.424 ' O ' ' C ' ' A' ' 153' ' ' SER . 0.7 OUTLIER -117.2 -25.56 7.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.773 0.32 . . . . 0.0 111.115 -179.862 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' SER . . . . . 0.424 ' C ' ' O ' ' A' ' 152' ' ' THR . 77.4 p -36.27 -42.2 0.3 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.862 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -67.26 -57.57 6.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.865 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -51.07 -47.89 61.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.9 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 76.8 t -66.43 -36.75 78.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.151 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -44.32 -51.37 8.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.079 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -61.37 -51.11 70.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.929 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' PHE . . . . . 0.499 ' CE1' ' HG ' ' A' ' 216' ' ' LEU . 85.3 t80 -46.24 -46.1 17.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.875 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 92.0 mt -84.5 -18.55 35.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.918 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 17.6 t -56.82 -25.38 55.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.845 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . 0.456 ' HG3' ' CD1' ' A' ' 216' ' ' LEU . 28.3 mmtt -71.04 131.78 44.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.886 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -110.01 156.97 19.79 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.847 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 3.5 m120 65.03 36.17 7.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.882 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 22.2 mm-40 -124.95 160.08 29.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.91 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.469 HG11 ' CB ' ' A' ' 223' ' ' ALA . 25.3 t -111.6 115.71 50.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.174 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 19.3 mt -86.99 140.27 16.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.14 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 30.0 t -122.17 137.26 56.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.157 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 51.4 ttp180 -92.29 112.51 24.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.84 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 98.9 mtp -107.29 111.64 24.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.917 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 10.3 ptm180 -118.92 133.96 55.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.835 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 100.6 18.21 21.58 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.47 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.423 HD23 ' CD1' ' A' ' 239' ' ' ILE . 31.0 mt -73.85 133.16 79.47 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.633 0.73 . . . . 0.0 110.91 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . 0.429 ' HG3' ' CB ' ' A' ' 237' ' ' ARG . 65.8 Cg_exo -48.0 135.08 23.92 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.642 2.228 . . . . 0.0 112.369 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 3.3 m-30 -49.71 -35.11 20.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.884 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' THR . . . . . 0.421 ' O ' ' C ' ' A' ' 177' ' ' ALA . 22.8 p -77.68 -43.96 29.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.153 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . 0.422 ' HA ' ' CD ' ' A' ' 181' ' ' GLU . . . -35.55 128.97 0.59 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.087 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 3.9 p -124.54 -178.7 4.21 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.132 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -56.75 -41.78 78.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.098 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -58.84 -34.97 72.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.904 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . 0.422 ' CD ' ' HA ' ' A' ' 177' ' ' ALA . 36.4 mt-10 -69.52 -37.37 77.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.885 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.465 HG12 ' CD1' ' A' ' 192' ' ' ILE . 26.1 t -68.93 -47.01 78.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.176 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 37.7 t -37.95 -49.4 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.096 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . 0.423 ' O ' ' C ' ' A' ' 185' ' ' PHE . . . -74.28 -44.84 51.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.105 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.619 ' CE1' ' CE1' ' A' ' 186' ' ' PHE . 5.7 t80 -36.89 -64.07 0.38 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.829 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' PHE . . . . . 0.619 ' CE1' ' CE1' ' A' ' 185' ' ' PHE . 59.9 m-85 -89.19 -21.64 23.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.899 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -49.62 -26.15 7.36 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.514 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 16.5 tt0 -48.98 -70.91 0.08 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.863 0.363 . . . . 0.0 110.971 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 65.9 m80 -118.27 -16.6 9.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.869 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' CYS . . . . . 0.438 ' N ' ' O ' ' A' ' 186' ' ' PHE . 74.4 m -120.11 85.36 35.35 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.569 0.699 . . . . 0.0 110.818 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' PRO . . . . . 0.445 ' HD2' ' CD1' ' A' ' 222' ' ' TYR . 53.8 Cg_endo -69.78 130.04 18.62 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.701 2.268 . . . . 0.0 112.338 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . 0.465 ' CD1' HG12 ' A' ' 182' ' ' VAL . 53.2 mt -79.03 142.92 13.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.122 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 21.9 m -66.74 98.66 0.54 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.164 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 89.22 -3.92 84.3 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.465 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . 0.412 ' O ' ' N ' ' A' ' 198' ' ' GLY . . . 58.24 -117.46 10.56 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.497 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 4.3 ptpp? -47.38 -28.67 2.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.779 0.323 . . . . 0.0 110.924 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -78.48 -29.85 46.99 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.932 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 195' ' ' GLY . . . -95.69 41.43 2.46 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.469 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . 0.54 HG22 ' CE2' ' A' ' 201' ' ' PHE . 75.9 mt -140.7 138.3 35.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.833 0.349 . . . . 0.0 111.128 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 14.3 tp -132.99 113.03 12.34 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.915 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' PHE . . . . . 0.54 ' CE2' HG22 ' A' ' 199' ' ' ILE . 81.3 m-85 -96.58 110.81 23.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.855 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 22.0 t -67.41 127.36 28.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.128 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -132.48 141.57 48.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.168 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . 0.471 ' CD2' HG21 ' A' ' 210' ' ' THR . 35.6 m-85 -45.78 158.12 0.36 Allowed Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.686 0.755 . . . . 0.0 110.964 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 3.21 2.92 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.707 2.271 . . . . 0.0 112.355 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -112.68 -16.07 12.87 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.891 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 106.94 62.98 0.58 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.501 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 35.2 mtt180 -151.77 151.15 27.85 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.646 0.736 . . . . 0.0 110.861 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 122.42 9.09 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.701 2.268 . . . . 0.0 112.352 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' THR . . . . . 0.471 HG21 ' CD2' ' A' ' 204' ' ' TYR . 42.9 p -90.84 -21.42 21.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.123 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 104.35 -35.49 5.01 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.494 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -80.68 156.54 26.26 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.838 0.351 . . . . 0.0 110.829 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -160.74 172.87 16.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.099 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -140.23 149.13 42.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.869 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . 0.4 ' CG1' HG23 ' A' ' 192' ' ' ILE . 8.1 t -131.49 159.34 43.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.179 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . 0.499 ' HG ' ' CE1' ' A' ' 159' ' ' PHE . 36.9 mt -108.79 143.2 38.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.918 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -136.4 145.24 45.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.895 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -59.03 -62.35 1.95 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.072 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' CYS . . . . . . . . . . . . . 66.7 m -141.14 179.34 6.81 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.918 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -57.83 -36.48 72.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.877 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -40.07 -45.76 2.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.897 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' TYR . . . . . 0.445 ' CD1' ' HD2' ' A' ' 191' ' ' PRO . 24.0 m-85 -84.44 -49.9 8.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.919 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . 0.469 ' CB ' HG11 ' A' ' 166' ' ' VAL . . . -53.49 -63.29 1.2 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.098 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 85.9 mm-40 -49.28 -52.65 26.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.882 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 61.8 m-20 -59.18 -26.33 64.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.92 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -75.27 -28.51 59.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.117 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 26.8 mt -62.37 -29.41 70.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.897 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 65.0 mtp180 -60.87 -19.5 60.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.871 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . 0.539 ' HD2' ' CE1' ' A' ' 185' ' ' PHE . 20.3 mtmm -83.02 0.69 43.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.881 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' HIS . . . . . 0.466 ' C ' ' O ' ' A' ' 229' ' ' LYS . 67.9 t60 -33.4 135.13 0.12 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.866 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.406 ' HG3' ' NE2' ' A' ' 230' ' ' HIS . 13.2 mttm 60.8 32.2 20.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.897 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . 0.475 ' OD2' ' CE2' ' A' ' 185' ' ' PHE . 15.3 t0 -55.64 175.47 0.08 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.838 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.563 HD23 ' CE1' ' A' ' 238' ' ' TYR . 30.5 mt -130.88 106.57 8.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.909 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 6.5 tt -114.38 114.31 25.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.903 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 56.49 42.72 90.23 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.526 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 22.8 mmtp 65.54 52.55 1.34 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.767 0.318 . . . . 0.0 110.877 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' ARG . . . . . 0.429 ' CB ' ' HG3' ' A' ' 174' ' ' PRO . 19.1 mmt180 -156.27 115.38 3.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.876 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' TYR . . . . . 0.563 ' CE1' HD23 ' A' ' 233' ' ' LEU . 97.6 m-85 -68.49 131.48 45.34 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.916 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . 0.423 ' CD1' HD23 ' A' ' 173' ' ' LEU . 56.5 mt -129.1 128.28 66.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.13 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . 0.479 ' HB3' ' CZ ' ' A' ' 242' ' ' PHE . 36.7 mt-10 -88.22 159.71 18.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.9 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . 0.511 ' O ' ' CD1' ' A' ' 242' ' ' PHE . 15.2 mt -141.7 146.3 35.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.899 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' PHE . . . . . 0.511 ' CD1' ' O ' ' A' ' 241' ' ' LEU . 9.7 m-85 -158.49 155.33 28.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.825 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 72.9 mtm180 -69.29 135.61 50.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.873 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 11.2 t -134.89 163.64 29.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.834 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' THR . . . . . 0.413 ' O ' ' C ' ' A' ' 246' ' ' ALA . 72.6 p -139.77 156.57 46.69 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.136 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' ALA . . . . . 0.413 ' C ' ' O ' ' A' ' 245' ' ' THR . . . -36.24 -52.23 0.8 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.07 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -56.87 -52.39 65.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.081 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -49.78 -49.91 46.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.959 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 97.0 t -49.47 -66.48 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.129 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -40.69 -42.98 1.85 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.91 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -63.87 -48.12 77.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.92 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 96.0 t -57.83 -46.05 87.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.148 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 16.5 mt -57.32 -49.59 75.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.942 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 14.4 m-20 -60.11 -51.17 70.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.861 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 30.6 ttt180 -38.91 -52.11 1.77 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.905 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -69.63 -50.4 44.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.912 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 8.6 m -50.54 161.21 0.34 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.828 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 5.6 t 40.11 49.02 2.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.887 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 259' ' ' ALA . . . . . . . . . . . . . . . -99.47 92.35 5.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.102 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 12.5 t -60.17 117.95 5.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.878 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -174.74 -165.17 30.72 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.455 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 262' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 115.19 2.31 Favored 'Cis proline' 0 C--O 1.231 0.153 0 C-N-CA 122.72 -1.783 . . . . 0.0 112.327 0.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 12.7 m -152.43 146.03 24.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.828 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 1.2 t -102.18 175.28 5.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.831 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.275 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.435 179.959 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.344 0 N-CA-C 112.506 -0.237 . . . . 0.0 112.506 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 64.6 m -131.37 -46.24 0.99 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.862 0.363 . . . . 0.0 110.9 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 2.5 m -91.45 120.92 32.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.881 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -102.79 -53.37 0.91 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.481 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.4 t -44.49 130.12 6.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.908 0.385 . . . . 0.0 110.875 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 59.0 m -121.01 128.5 52.75 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.851 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -101.46 177.27 27.06 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.492 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -46.64 105.76 0.11 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.481 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 130.39 89.33 0.52 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.482 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -95.69 111.05 23.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.781 0.324 . . . . 0.0 111.12 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 20.2 m -128.35 -45.61 1.36 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.859 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . 0.475 ' OD1' ' N ' ' A' ' 155' ' ' GLU . 11.3 p30 -68.55 -52.19 34.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.901 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.475 ' N ' ' OD1' ' A' ' 154' ' ' ASN . 18.5 tt0 -53.28 -47.07 69.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.836 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.425 ' O ' ' C ' ' A' ' 157' ' ' ALA . 69.0 t -68.12 -44.51 84.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.15 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.425 ' C ' ' O ' ' A' ' 156' ' ' VAL . . . -36.11 -59.71 0.6 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.073 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 41.7 mm-40 -57.27 -49.88 74.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.891 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -46.33 -39.96 11.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.878 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 83.6 mt -91.33 -18.0 25.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.929 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 28.4 t -58.5 -22.65 55.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.839 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 19.8 mmtp -73.22 120.77 19.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.877 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -96.15 158.32 15.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.871 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 59.93 47.67 9.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.856 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 25.3 mm-40 -131.74 156.28 46.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.921 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 29.9 t -111.14 105.66 19.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.101 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . 0.417 HG23 ' N ' ' A' ' 168' ' ' VAL . 66.4 mt -77.71 135.18 26.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.141 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.417 ' N ' HG23 ' A' ' 167' ' ' ILE . 91.1 t -114.15 128.79 70.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.08 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 7.7 ttp-105 -88.35 106.09 18.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.857 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' MET . . . . . 0.437 ' HE1' ' CD2' ' A' ' 173' ' ' LEU . 99.3 mtp -95.57 138.32 33.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.88 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 73.7 mtt-85 -134.4 139.89 45.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.869 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 83.91 39.39 9.46 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.493 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.437 ' CD2' ' HE1' ' A' ' 170' ' ' MET . 24.1 mt -89.34 126.25 59.14 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.665 0.745 . . . . 0.0 110.889 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . 0.416 ' HG3' ' CB ' ' A' ' 237' ' ' ARG . 65.7 Cg_exo -47.99 132.78 22.84 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.684 2.256 . . . . 0.0 112.326 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . 0.567 ' CD1' ' HG3' ' A' ' 209' ' ' PRO . 10.3 t80 -45.19 -34.78 2.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.899 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 9.2 p -82.46 -30.34 30.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.14 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -52.84 107.0 0.19 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.116 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 5.7 p -113.02 178.16 4.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.155 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -46.48 -39.63 11.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.071 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -60.2 -34.63 73.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.875 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 38.5 mm-40 -75.38 -23.74 57.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.883 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 74.8 t -83.23 -47.2 18.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.17 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 54.8 t -41.47 -44.12 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.125 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -81.47 -37.06 28.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.08 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.507 ' CE1' ' CE1' ' A' ' 186' ' ' PHE . 19.9 t80 -45.69 -62.96 1.08 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.858 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' PHE . . . . . 0.507 ' CE1' ' CE1' ' A' ' 185' ' ' PHE . 68.7 m-85 -89.41 -20.9 23.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.911 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -49.67 -16.9 1.19 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.461 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 25.1 tp60 -58.94 -72.85 0.09 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.825 0.345 . . . . 0.0 110.878 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 23.3 m80 -118.28 -9.31 10.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.878 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 71.3 m -125.46 86.94 56.47 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.543 0.687 . . . . 0.0 110.9 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 141.35 45.04 Favored 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.708 2.272 . . . . 0.0 112.381 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . 0.439 HG23 ' N ' ' A' ' 193' ' ' THR . 61.4 mt -95.78 141.99 14.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.116 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' THR . . . . . 0.439 ' N ' HG23 ' A' ' 192' ' ' ILE . 14.8 m -65.38 102.98 0.74 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.168 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 89.15 -16.96 54.41 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.485 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . 0.4 ' O ' ' N ' ' A' ' 198' ' ' GLY . . . 72.85 -122.43 8.25 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.456 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 15.4 ptmt -46.38 -36.15 6.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.746 0.308 . . . . 0.0 110.903 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -69.85 -31.01 68.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.871 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 195' ' ' GLY . . . -91.99 39.55 3.01 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.52 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 48.5 mt -139.99 145.49 26.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.824 0.345 . . . . 0.0 111.116 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 15.2 tp -143.33 124.32 14.38 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.926 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -103.5 123.66 47.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.875 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . 0.441 HG11 ' N ' ' A' ' 203' ' ' THR . 44.6 t -78.96 140.09 17.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.142 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' THR . . . . . 0.441 ' N ' HG11 ' A' ' 202' ' ' VAL . 0.8 OUTLIER -144.79 139.15 27.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.155 -179.986 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -49.48 159.13 0.7 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.657 0.741 . . . . 0.0 110.914 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 3.24 2.88 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.673 2.248 . . . . 0.0 112.346 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -110.51 -20.83 12.43 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.863 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 114.15 34.27 1.67 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.427 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -116.16 143.62 31.34 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.621 0.724 . . . . 0.0 110.848 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . 0.567 ' HG3' ' CD1' ' A' ' 175' ' ' PHE . 53.9 Cg_endo -69.77 107.79 1.94 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.699 2.266 . . . . 0.0 112.348 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' THR . . . . . 0.43 ' HB ' ' CE1' ' A' ' 256' ' ' PHE . 44.9 p -73.18 -5.65 40.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.117 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 79.42 -40.56 2.21 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.48 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -69.42 161.5 29.29 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.787 0.327 . . . . 0.0 110.852 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . 0.406 ' HB3' ' CD1' ' A' ' 173' ' ' LEU . . . -164.28 -179.15 5.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.105 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . 0.408 ' CD2' HG11 ' A' ' 249' ' ' VAL . 65.0 m-85 -144.88 144.95 31.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.886 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 6.1 t -131.69 160.14 42.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.147 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 37.6 mt -108.8 140.92 41.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.924 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -135.81 125.19 24.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.884 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -38.1 -73.44 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.081 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' CYS . . . . . . . . . . . . . 69.5 m -123.63 174.05 7.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.873 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -64.56 -32.91 74.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.932 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -41.28 -44.65 2.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.896 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -77.7 -43.92 29.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.906 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -50.8 -54.96 19.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.063 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 -50.55 -54.57 21.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.894 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . 0.423 ' HA ' ' NE ' ' A' ' 228' ' ' ARG . 55.0 m-20 -54.98 -27.62 45.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.912 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -76.68 -39.83 50.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.073 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 86.4 mt -55.18 -38.32 68.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.9 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . 0.423 ' NE ' ' HA ' ' A' ' 225' ' ' ASN . 50.4 mtm180 -57.99 -24.26 57.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.883 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . 0.463 ' O ' ' C ' ' A' ' 230' ' ' HIS . 28.1 mtpt -77.01 -1.52 29.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.907 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' HIS . . . . . 0.463 ' C ' ' O ' ' A' ' 229' ' ' LYS . 85.9 t60 -33.6 138.15 0.08 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.856 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.442 ' HG2' ' CD2' ' A' ' 230' ' ' HIS . 37.4 mmtt 62.37 25.67 15.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.937 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -52.25 -179.02 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.876 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.552 HD21 ' CE1' ' A' ' 238' ' ' TYR . 31.2 mt -139.5 107.34 5.66 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.951 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . 0.449 ' C ' ' CD2' ' A' ' 234' ' ' LEU . 5.4 tt -117.64 114.63 23.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.895 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 59.77 37.0 91.8 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.466 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 28.0 mmtt 68.47 52.24 0.62 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.742 0.306 . . . . 0.0 110.893 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' ARG . . . . . 0.416 ' CB ' ' HG3' ' A' ' 174' ' ' PRO . 43.6 mmt-85 -156.19 115.36 3.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.883 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' TYR . . . . . 0.552 ' CE1' HD21 ' A' ' 233' ' ' LEU . 93.8 m-85 -67.84 134.81 51.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.933 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 60.2 mt -132.98 136.32 55.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.133 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . 0.545 ' HB3' ' CE2' ' A' ' 242' ' ' PHE . 66.3 mt-10 -89.33 172.6 8.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.921 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . 0.599 ' O ' ' CD1' ' A' ' 242' ' ' PHE . 18.4 mt -153.99 139.24 17.51 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.905 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' PHE . . . . . 0.599 ' CD1' ' O ' ' A' ' 241' ' ' LEU . 5.7 m-85 -159.13 122.87 3.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.865 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . 0.493 ' CG ' ' O ' ' A' ' 243' ' ' ARG . 19.0 ptt-85 -61.05 118.06 6.29 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.861 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 16.3 t -114.08 -179.22 3.57 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.86 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 71.3 p -127.83 162.2 27.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.137 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -50.58 -56.13 13.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.058 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -50.2 -52.31 36.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.145 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -49.79 -57.77 6.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.879 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . 0.408 HG11 ' CD2' ' A' ' 214' ' ' PHE . 95.1 t -38.78 -66.81 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.135 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -38.64 -48.79 1.5 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.948 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -60.32 -44.56 95.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.93 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 98.7 t -60.76 -44.93 98.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.146 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 17.3 mt -58.39 -49.43 77.28 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.915 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -61.07 -47.02 88.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.89 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 57.2 ttt180 -41.93 -44.04 3.3 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.883 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 256' ' ' PHE . . . . . 0.43 ' CE1' ' HB ' ' A' ' 210' ' ' THR . 49.9 m-85 -73.44 -40.08 64.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.911 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 5.4 m -60.3 -54.44 45.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.896 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 13.6 t -72.54 -50.6 24.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.863 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 259' ' ' ALA . . . . . . . . . . . . . . . 44.15 41.16 4.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.091 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 25.3 m -121.5 84.69 2.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.814 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 45.76 -171.13 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.477 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 262' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.79 179.39 22.5 Favored 'Cis proline' 0 C--N 1.342 0.202 0 C-N-CA 122.635 -1.819 . . . . 0.0 112.335 0.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 46.0 p -78.04 -47.81 17.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.871 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 17.3 m 50.4 42.29 25.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.895 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.293 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.478 -179.996 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.309 0 N-CA-C 112.487 -0.245 . . . . 0.0 112.487 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 78.7 p -44.29 110.83 0.24 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.886 0.374 . . . . 0.0 110.853 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 45.0 m -121.95 144.84 48.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.846 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -161.71 162.54 34.07 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.48 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 36.1 t -94.81 101.33 13.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.895 0.378 . . . . 0.0 110.905 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 78.4 p -90.8 159.81 16.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.857 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -152.13 -90.39 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.494 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -174.62 114.76 0.52 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.454 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -134.1 -85.96 0.25 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.486 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.9 m -97.58 25.09 6.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.79 0.328 . . . . 0.0 111.123 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 10.5 t -82.06 -4.72 57.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.858 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 69.8 m-20 -95.97 -44.72 7.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.911 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -73.91 -28.53 61.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.916 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 73.7 t -79.55 -43.07 23.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.156 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -41.07 -58.05 1.86 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.112 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -59.66 -44.42 93.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.94 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 28.1 t80 -53.49 -42.61 67.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.897 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 86.6 mt -88.97 -16.44 31.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.93 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 8.5 t -61.38 -32.29 72.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.843 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 43.3 mmtt -61.05 126.45 27.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.872 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -102.33 152.87 20.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.858 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 11.3 m-20 68.92 38.82 1.97 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.888 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 5.4 mm-40 -128.8 146.08 51.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.923 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 60.8 t -100.31 106.48 19.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.125 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 36.0 mt -77.19 138.86 19.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.11 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 96.1 t -123.06 130.8 74.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.107 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . 0.542 ' HG3' ' CE1' ' A' ' 214' ' ' PHE . 25.6 ttm180 -88.34 113.08 23.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.857 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' MET . . . . . 0.453 ' HE3' ' CD2' ' A' ' 173' ' ' LEU . 97.8 mtp -98.15 126.51 43.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.873 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 24.2 mtt180 -123.51 157.5 33.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.877 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 73.79 21.93 78.75 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.479 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.453 ' CD2' ' HE3' ' A' ' 170' ' ' MET . 19.8 mt -74.39 127.5 87.5 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.616 0.722 . . . . 0.0 110.913 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_exo -47.96 149.32 5.73 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.666 2.244 . . . . 0.0 112.349 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 10.8 m-30 -62.49 -26.1 68.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.899 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 63.5 p -90.47 -25.62 20.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.152 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -44.91 126.52 5.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.076 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 5.9 p -125.17 176.49 6.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.15 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -57.12 -36.18 70.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.113 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -68.71 -15.83 63.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.922 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -88.53 -22.43 23.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.86 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.456 ' O ' ' N ' ' A' ' 185' ' ' PHE . 22.4 t -83.94 -52.79 12.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.16 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . 0.425 ' C ' ' O ' ' A' ' 182' ' ' VAL . 47.7 t -36.04 -47.51 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.138 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -74.71 -36.6 62.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.101 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.572 ' CE1' ' CE1' ' A' ' 186' ' ' PHE . 15.5 t80 -48.51 -59.27 3.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.877 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' PHE . . . . . 0.572 ' CE1' ' CE1' ' A' ' 185' ' ' PHE . 57.2 m-85 -92.18 -21.31 20.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.898 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -49.13 -19.16 1.47 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.481 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 12.4 mm100 -56.35 -75.19 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.866 0.365 . . . . 0.0 110.949 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 2.5 t-160 -117.49 -6.28 11.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.869 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 87.0 m -126.86 86.31 59.03 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.552 0.692 . . . . 0.0 110.9 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 133.62 26.1 Favored 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.689 2.259 . . . . 0.0 112.357 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . 0.4 ' CD1' HG11 ' A' ' 182' ' ' VAL . 57.9 mt -85.26 145.58 7.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.129 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 90.9 m -73.66 107.43 5.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.105 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 93.16 -21.85 37.91 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.459 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 78.72 -122.89 6.0 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.476 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.77 -20.71 9.09 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.719 0.295 . . . . 0.0 110.89 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -85.22 -24.87 27.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.895 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -93.4 40.27 2.82 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.46 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 35.2 mt -142.75 153.0 17.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.896 0.379 . . . . 0.0 111.104 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 13.3 tp -146.34 110.96 5.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.925 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -92.89 109.81 21.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.871 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 11.0 t -70.99 128.05 33.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.121 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -133.04 142.66 48.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.134 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -51.4 159.12 1.22 Allowed Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.708 0.766 . . . . 0.0 110.943 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 3.4 2.78 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.648 2.232 . . . . 0.0 112.38 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -112.55 -21.32 11.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.867 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 118.03 9.69 9.59 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.489 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -92.48 141.45 24.75 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.581 0.705 . . . . 0.0 110.887 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 106.49 1.67 Allowed 'Trans proline' 0 C--O 1.233 0.225 0 C-N-CA 122.69 2.26 . . . . 0.0 112.333 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' THR . . . . . 0.522 ' HB ' ' CE1' ' A' ' 256' ' ' PHE . 71.0 p -66.11 -23.4 66.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.131 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 95.49 -22.59 38.07 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.501 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' ASP . . . . . 0.428 ' OD1' ' CZ ' ' A' ' 256' ' ' PHE . 1.0 OUTLIER -90.16 157.03 17.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.776 0.322 . . . . 0.0 110.899 -179.988 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -159.37 178.73 9.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.107 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . 0.542 ' CE1' ' HG3' ' A' ' 169' ' ' ARG . 55.4 m-85 -143.64 145.65 32.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.909 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 4.0 t -131.9 162.02 40.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.137 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 45.3 mt -111.8 137.45 49.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.903 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -130.12 142.39 50.6 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.881 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -50.32 -61.66 2.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.093 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' CYS . . . . . . . . . . . . . 1.9 t -153.11 175.3 13.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.833 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -49.2 -31.31 8.32 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.891 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -51.57 -36.07 43.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.918 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -92.02 -41.51 10.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.926 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -56.81 -54.41 46.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.114 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 10.2 mm-40 -50.37 -52.11 40.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.893 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 22.4 m-20 -58.6 -23.84 59.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.858 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -79.48 -45.88 18.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.112 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 57.3 mt -52.13 -35.67 49.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.898 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 65.5 mtp180 -56.77 -29.56 62.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.912 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . 0.465 ' O ' ' C ' ' A' ' 230' ' ' HIS . 16.3 mtpp -74.7 -0.69 18.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.896 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' HIS . . . . . 0.51 ' CD2' ' HG2' ' A' ' 231' ' ' LYS . 86.3 t60 -33.35 141.39 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.842 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.51 ' HG2' ' CD2' ' A' ' 230' ' ' HIS . 13.1 mmtp 59.78 26.62 15.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.9 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -53.42 177.96 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.853 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.554 HD23 ' CE1' ' A' ' 238' ' ' TYR . 32.9 mt -136.58 105.03 5.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.97 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 7.0 tt -113.94 115.53 27.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.9 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 59.17 37.18 91.39 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.484 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 62.9 mttt 69.08 52.57 0.49 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.809 0.338 . . . . 0.0 110.877 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 23.2 mmt180 -155.99 117.26 3.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.879 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' TYR . . . . . 0.554 ' CE1' HD23 ' A' ' 233' ' ' LEU . 96.1 m-85 -69.17 133.99 48.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.95 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 76.2 mt -132.59 135.96 56.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.136 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . 0.552 ' HB3' ' CZ ' ' A' ' 242' ' ' PHE . 6.8 mt-10 -87.38 179.38 6.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.878 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . 0.59 ' O ' ' CD1' ' A' ' 242' ' ' PHE . 54.8 mt -158.29 132.62 8.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.889 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' PHE . . . . . 0.59 ' CD1' ' O ' ' A' ' 241' ' ' LEU . 6.7 m-85 -154.03 123.05 6.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.861 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . 0.486 ' CG ' ' O ' ' A' ' 243' ' ' ARG . 20.5 ptt180 -59.72 116.46 4.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.893 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 1.9 t -103.89 175.37 5.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.814 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 52.9 p -127.98 150.06 50.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.107 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -40.44 -59.35 1.34 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.056 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -52.36 -51.27 59.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.127 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . 0.408 ' O ' ' N ' ' A' ' 251' ' ' GLN . 13.3 tp10 -52.21 -57.29 10.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.942 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 86.9 t -36.85 -60.13 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.122 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -49.89 -40.37 42.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.896 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 251' ' ' GLN . . . . . 0.499 ' O ' ' ND2' ' A' ' 254' ' ' ASN . 41.9 mt-30 -69.7 -19.88 63.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.943 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 69.0 t -88.64 -26.82 5.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.111 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 10.5 mt -81.46 -39.17 25.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.91 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . 0.499 ' ND2' ' O ' ' A' ' 251' ' ' GLN . 0.7 OUTLIER -66.41 -45.43 79.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.885 179.918 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . 0.507 ' CG ' ' N ' ' A' ' 256' ' ' PHE . 6.0 ptm180 -48.07 -48.72 33.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.87 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 256' ' ' PHE . . . . . 0.522 ' CE1' ' HB ' ' A' ' 210' ' ' THR . 12.9 m-85 -64.58 -41.83 96.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.891 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 57.8 m -71.39 152.07 43.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.893 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 1.9 m 38.43 32.98 0.06 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.823 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 259' ' ' ALA . . . . . . . . . . . . . . . -64.95 138.47 58.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.077 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 67.9 m -113.49 -53.29 2.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.885 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 72.71 -168.57 53.05 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.513 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 262' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.75 -40.62 1.07 Allowed 'Cis proline' 0 C--N 1.342 0.203 0 C-N-CA 122.698 -1.793 . . . . 0.0 112.349 0.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 22.1 t -97.82 -55.2 2.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.886 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 58.8 m -89.31 126.63 35.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.843 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.341 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.504 179.989 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 N-CA-C 112.478 -0.249 . . . . 0.0 112.478 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 99.9 p -54.53 130.13 38.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.89 0.376 . . . . 0.0 110.895 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 27.4 p -98.47 111.44 23.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.863 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -85.23 -45.98 5.72 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.46 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 38.3 p -149.53 146.38 27.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.856 0.36 . . . . 0.0 110.839 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 89.3 p -45.24 -43.9 10.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.837 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -83.64 -76.07 1.17 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.524 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 41.61 -105.57 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.539 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . 0.471 ' O ' ' ND2' ' A' ' 154' ' ' ASN . . . -111.66 162.62 12.38 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.504 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' THR . . . . . 0.45 ' O ' ' N ' ' A' ' 154' ' ' ASN . 2.8 m -91.46 -38.45 12.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.811 0.339 . . . . 0.0 111.165 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' SER . . . . . 0.426 ' C ' ' O ' ' A' ' 152' ' ' THR . 64.5 p -35.13 -34.56 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.853 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . 0.471 ' ND2' ' O ' ' A' ' 151' ' ' GLY . 3.3 m-80 -61.52 -56.8 16.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.896 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -69.6 -35.57 75.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.884 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 74.4 t -63.41 -36.51 76.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.11 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -38.9 -63.89 0.49 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.098 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 89.7 mm-40 -57.58 -48.09 80.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.903 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 28.0 t80 -47.68 -41.81 23.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.857 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 33.0 mt -83.98 -31.95 25.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.91 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 18.1 t -47.3 -41.24 18.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.85 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . 0.424 ' HG3' ' CD1' ' A' ' 216' ' ' LEU . 0.7 OUTLIER -38.39 129.57 1.35 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.904 179.908 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -110.63 133.63 53.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.862 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 74.24 43.33 0.29 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.884 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 10.4 mm100 -128.38 168.02 16.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.939 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 55.6 t -118.71 141.33 38.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.111 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . 0.454 HD13 ' N ' ' A' ' 246' ' ' ALA . 8.6 mt -111.61 143.92 20.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.103 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.416 HG13 ' N ' ' A' ' 169' ' ' ARG . 97.9 t -127.14 133.72 67.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.087 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . 0.416 ' N ' HG13 ' A' ' 168' ' ' VAL . 70.2 ttt180 -91.14 112.83 24.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.868 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' MET . . . . . 0.46 ' HE3' ' CD2' ' A' ' 173' ' ' LEU . 91.0 mtp -100.43 149.56 23.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.89 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 35.0 mtp180 -146.75 133.87 20.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.909 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 96.51 19.28 28.02 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.513 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.46 ' CD2' ' HE3' ' A' ' 170' ' ' MET . 24.3 mt -71.18 121.12 83.29 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.639 0.733 . . . . 0.0 110.907 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . 0.411 ' O ' ' C ' ' A' ' 175' ' ' PHE . 64.9 Cg_exo -47.97 131.66 21.43 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.703 2.269 . . . . 0.0 112.326 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . 0.565 ' CD1' ' HG3' ' A' ' 209' ' ' PRO . 11.6 t80 -37.52 -49.42 1.06 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.885 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' THR . . . . . 0.424 ' O ' ' C ' ' A' ' 177' ' ' ALA . 14.4 p -68.39 -44.98 73.91 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.141 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' A' ' 176' ' ' THR . . . -35.72 111.25 0.13 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.104 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -115.48 -177.16 3.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.161 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -50.01 -47.87 52.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.12 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . 0.407 ' CG ' ' OE2' ' A' ' 181' ' ' GLU . 5.7 pt-20 -51.67 -40.01 59.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.923 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . 0.407 ' OE2' ' CG ' ' A' ' 180' ' ' GLU . 0.1 OUTLIER -65.94 -36.99 84.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.876 -179.95 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.418 ' O ' ' C ' ' A' ' 183' ' ' VAL . 89.9 t -69.47 -50.36 51.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.155 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . 0.418 ' C ' ' O ' ' A' ' 182' ' ' VAL . 34.4 t -35.55 -50.89 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.161 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -75.4 -42.28 54.17 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.127 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.57 ' CE1' ' HE3' ' A' ' 229' ' ' LYS . 10.2 t80 -40.2 -62.03 0.8 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.906 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' PHE . . . . . 0.527 ' CE1' ' CE1' ' A' ' 185' ' ' PHE . 72.8 m-85 -92.81 -21.08 20.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.908 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -49.28 -17.26 1.04 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.535 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -57.95 -72.4 0.09 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.829 0.347 . . . . 0.0 110.931 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 29.5 m170 -118.22 -10.88 10.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.889 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 74.2 m -125.27 85.34 58.43 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.584 0.707 . . . . 0.0 110.89 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 146.54 60.67 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.694 2.263 . . . . 0.0 112.362 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . 0.436 HG23 ' N ' ' A' ' 193' ' ' THR . 56.0 mt -98.43 143.52 12.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.156 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' THR . . . . . 0.436 ' N ' HG23 ' A' ' 192' ' ' ILE . 89.1 m -67.99 101.21 1.08 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.182 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 92.23 -12.18 70.26 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.485 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 68.22 -123.48 17.6 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.461 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 13.9 pttp -49.23 -29.46 5.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.766 0.317 . . . . 0.0 110.921 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -75.6 -31.35 59.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.879 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -94.29 41.83 2.54 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.464 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 87.0 mt -140.35 147.84 22.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.887 0.375 . . . . 0.0 111.117 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 13.4 tp -141.57 127.09 18.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.89 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -105.43 120.71 42.27 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.889 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 20.1 t -78.69 134.19 28.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.088 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' THR . . . . . 0.456 ' CA ' HG21 ' A' ' 210' ' ' THR . 0.8 OUTLIER -138.55 136.61 36.24 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.09 -179.974 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . 0.488 ' N ' ' CG2' ' A' ' 210' ' ' THR . 33.4 m-85 -46.8 158.71 0.4 Allowed Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.618 0.723 . . . . 0.0 110.955 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 3.49 2.75 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.669 2.246 . . . . 0.0 112.354 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -112.9 -19.13 12.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.817 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 120.43 -3.74 12.31 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.492 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.0 140.45 62.2 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.574 0.702 . . . . 0.0 110.895 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . 0.565 ' HG3' ' CD1' ' A' ' 175' ' ' PHE . 54.4 Cg_endo -69.72 102.67 1.05 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.672 2.248 . . . . 0.0 112.37 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' THR . . . . . 0.556 HG23 ' CD1' ' A' ' 256' ' ' PHE . 37.6 p -61.39 -13.29 18.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.173 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 82.63 -39.62 2.7 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.525 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -71.05 161.6 30.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.834 0.349 . . . . 0.0 110.848 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . 0.415 ' HB3' ' CD1' ' A' ' 173' ' ' LEU . . . -160.41 -177.6 6.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.115 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -148.06 137.49 22.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.852 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . 0.427 HG11 ' CD1' ' A' ' 192' ' ' ILE . 3.3 t -124.09 165.68 20.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.084 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . 0.424 ' CD1' ' HG3' ' A' ' 162' ' ' LYS . 47.7 mt -116.96 145.62 43.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.935 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -134.31 151.5 51.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.84 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -60.0 -59.22 5.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.135 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' CYS . . . . . . . . . . . . . 1.8 t -144.48 177.71 8.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.854 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 13.7 mp0 -58.71 -35.36 72.53 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.865 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -43.55 -38.5 2.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.924 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -92.98 -34.69 13.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.933 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.6 -59.67 4.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.135 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' GLN . . . . . 0.435 ' HA ' ' CD1' ' A' ' 227' ' ' LEU . 3.1 pt20 -60.41 -37.17 79.99 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.957 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 14.4 m-20 -68.03 -24.03 65.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.874 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -79.89 -32.52 40.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.087 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . 0.435 ' CD1' ' HA ' ' A' ' 224' ' ' GLN . 20.2 mt -56.18 -31.52 63.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.947 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 9.1 mtp-105 -59.8 -18.37 43.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.866 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . 0.57 ' HE3' ' CE1' ' A' ' 185' ' ' PHE . 24.8 mtpp -82.06 -1.16 47.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.873 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' HIS . . . . . 0.454 ' C ' ' O ' ' A' ' 229' ' ' LYS . 75.6 t60 -34.3 136.98 0.12 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.897 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.425 ' HG2' ' CD2' ' A' ' 230' ' ' HIS . 24.1 mmtt 59.35 36.29 23.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.908 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -62.97 -176.99 0.14 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.902 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.563 HD22 ' CE1' ' A' ' 238' ' ' TYR . 30.8 mt -137.83 117.31 12.89 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.896 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 6.6 tt -126.77 112.25 15.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.935 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 59.51 36.2 88.44 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.498 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 30.3 mttp 71.69 52.62 0.22 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.783 0.325 . . . . 0.0 110.861 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 59.5 mmt-85 -156.39 115.35 3.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.876 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' TYR . . . . . 0.563 ' CE1' HD22 ' A' ' 233' ' ' LEU . 96.8 m-85 -68.68 136.66 53.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.908 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 79.5 mt -132.87 131.34 59.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.111 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . 0.461 ' HB3' ' CZ ' ' A' ' 242' ' ' PHE . 43.4 mt-10 -92.43 161.78 14.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.874 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . 0.499 ' O ' ' CD1' ' A' ' 242' ' ' PHE . 20.2 mt -136.87 140.15 42.17 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.892 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' PHE . . . . . 0.499 ' CD1' ' O ' ' A' ' 241' ' ' LEU . 22.6 m-85 -153.14 128.22 9.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.82 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 20.3 mtp180 -44.04 153.48 0.14 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.884 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 1.1 t -152.55 160.13 43.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.901 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 41.6 p -138.41 157.67 45.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.088 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' ALA . . . . . 0.454 ' N ' HD13 ' A' ' 167' ' ' ILE . . . -37.45 -59.06 0.8 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.114 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -53.27 -56.59 15.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.151 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -44.59 -51.95 8.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.878 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . 0.418 ' O ' ' N ' ' A' ' 252' ' ' VAL . 98.4 t -47.02 -66.79 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.139 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -43.25 -50.06 6.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.929 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 51.1 mm-40 -59.67 -30.18 68.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.918 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 252' ' ' VAL . . . . . 0.418 ' N ' ' O ' ' A' ' 249' ' ' VAL . 92.7 t -75.92 -36.98 33.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.1 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 8.5 mt -68.47 -37.73 80.41 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.893 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -66.28 -59.53 3.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.868 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . 0.469 ' HG3' ' N ' ' A' ' 256' ' ' PHE . 0.4 OUTLIER -41.21 -38.08 1.05 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.898 -179.94 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 256' ' ' PHE . . . . . 0.556 ' CD1' HG23 ' A' ' 210' ' ' THR . 10.2 m-85 -81.71 -53.1 6.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.868 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 34.7 t -52.86 -58.5 6.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.83 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 37.4 m -89.78 89.05 7.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.828 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 259' ' ' ALA . . . . . . . . . . . . . . . -114.13 -41.96 3.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.134 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 27.0 p -130.71 130.03 43.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.872 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 262' ' ' PRO . . . 81.99 82.53 0.85 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.514 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 262' ' ' PRO . . . . . 0.499 ' O ' ' N ' ' A' ' 261' ' ' GLY . 53.5 Cg_endo -69.76 173.51 44.3 Favored 'Cis proline' 0 C--N 1.342 0.189 0 C-N-CA 122.677 -1.801 . . . . 0.0 112.355 0.059 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 69.8 p -128.96 156.93 42.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.845 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 43.8 p -60.05 129.98 44.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.827 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.492 179.971 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.258 0 N-CA-C 112.471 -0.252 . . . . 0.0 112.471 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 93.6 p -118.77 142.93 47.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.872 0.368 . . . . 0.0 110.834 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 12.9 t -107.67 141.56 38.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.866 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 131.1 -151.53 19.69 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.537 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 19.0 m -72.66 -43.87 62.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.931 0.396 . . . . 0.0 110.885 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 85.5 p -91.91 147.01 23.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.846 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 96.0 -107.09 3.47 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.448 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -143.48 -148.52 4.93 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.495 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 64.84 102.08 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.473 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' THR . . . . . 0.417 ' CG2' HG22 ' A' ' 156' ' ' VAL . 2.3 m -90.77 107.18 19.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.754 0.311 . . . . 0.0 111.14 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 62.3 p -126.79 -36.94 2.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.848 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -72.58 -52.41 15.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.902 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -64.53 -46.03 84.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.894 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.417 HG22 ' CG2' ' A' ' 152' ' ' THR . 57.5 t -54.73 -43.29 65.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.168 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -43.49 -50.96 6.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.11 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 46.4 mm-40 -65.21 -37.25 86.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.939 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' PHE . . . . . 0.566 ' CE1' ' HG ' ' A' ' 216' ' ' LEU . 64.0 t80 -60.14 -41.32 92.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.886 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 86.3 mt -90.98 -16.59 27.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.893 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 46.5 t -62.62 -35.79 80.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.841 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 12.5 mttp -58.99 120.13 8.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.895 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 37.6 mp0 -94.61 155.83 16.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.852 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 11.1 m-80 63.45 48.89 3.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.866 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 4.9 mm100 -131.87 162.21 31.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.878 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.424 ' CG1' ' CB ' ' A' ' 223' ' ' ALA . 89.5 t -116.73 111.13 33.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.138 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 30.5 mt -85.33 142.09 13.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.082 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.452 HG11 ' N ' ' A' ' 169' ' ' ARG . 40.8 t -127.51 142.52 43.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.155 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . 0.452 ' N ' HG11 ' A' ' 168' ' ' VAL . 30.0 ttp180 -91.75 115.18 27.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.863 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' MET . . . . . 0.44 ' HE3' ' CD2' ' A' ' 173' ' ' LEU . 66.9 mtp -102.63 125.39 49.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.919 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . 0.422 ' HB2' ' NH1' ' A' ' 171' ' ' ARG . 3.3 ttm105 -131.4 139.73 49.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.84 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 90.23 23.09 32.97 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.494 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.44 ' CD2' ' HE3' ' A' ' 170' ' ' MET . 26.3 mt -74.9 128.03 85.88 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.589 0.709 . . . . 0.0 110.924 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . 0.469 ' HG3' ' CB ' ' A' ' 237' ' ' ARG . 64.7 Cg_exo -48.01 130.83 20.56 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.719 2.279 . . . . 0.0 112.36 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -47.93 -22.71 0.62 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.877 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 41.4 p -91.57 -29.39 16.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.118 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -48.77 137.95 11.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.043 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -139.38 171.82 13.71 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.114 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.477 ' N ' ' CZ ' ' A' ' 201' ' ' PHE . . . -47.04 -47.38 22.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.106 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -57.02 -26.66 60.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.882 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . 0.423 ' CD ' HD22 ' A' ' 234' ' ' LEU . 6.7 tt0 -79.71 -35.58 38.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.898 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 48.1 t -74.01 -42.45 52.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.117 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 45.6 t -42.24 -45.81 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.153 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -81.66 -32.49 31.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.102 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.481 ' CE1' ' CE ' ' A' ' 229' ' ' LYS . 41.2 t80 -49.27 -59.44 3.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.863 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -90.51 -24.32 20.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.829 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -48.97 -22.14 2.83 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.516 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 33.1 tp60 -53.08 -70.85 0.08 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.864 0.364 . . . . 0.0 110.884 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 8.9 m80 -118.3 -15.33 9.75 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.862 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 74.7 m -119.88 88.24 39.78 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.592 0.71 . . . . 0.0 110.839 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' PRO . . . . . 0.492 ' HD2' ' CD1' ' A' ' 222' ' ' TYR . 53.7 Cg_endo -69.8 131.62 21.57 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.679 2.253 . . . . 0.0 112.289 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . 0.47 HG23 ' N ' ' A' ' 193' ' ' THR . 55.7 mt -83.25 142.12 13.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.155 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' THR . . . . . 0.47 ' N ' HG23 ' A' ' 192' ' ' ILE . 87.8 m -65.32 102.66 0.7 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.152 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 88.34 -17.43 48.07 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.476 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . 0.424 ' O ' ' N ' ' A' ' 198' ' ' GLY . . . 78.35 -128.2 8.59 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.476 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 17.2 ptmt -44.94 -29.48 0.83 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.748 0.309 . . . . 0.0 110.885 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -74.34 -34.67 63.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.884 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 195' ' ' GLY . . . -86.37 21.24 18.18 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.47 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 76.8 mt -123.56 146.22 29.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.808 0.337 . . . . 0.0 111.133 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 16.3 tp -142.32 123.18 14.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.869 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' PHE . . . . . 0.477 ' CZ ' ' N ' ' A' ' 179' ' ' ALA . 68.1 m-85 -104.24 112.34 25.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.887 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 25.8 t -66.57 122.55 17.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.124 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -131.83 140.34 49.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.155 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -45.79 158.31 0.35 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.685 0.755 . . . . 0.0 110.898 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 3.02 3.04 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.662 2.241 . . . . 0.0 112.339 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -112.15 -16.33 13.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.864 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 106.14 62.82 0.61 Allowed Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.439 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 7.3 mtt85 -148.26 144.26 18.53 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.602 0.715 . . . . 0.0 110.901 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 108.64 2.12 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.692 2.261 . . . . 0.0 112.318 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 74.1 p -74.02 -29.98 62.21 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.117 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 114.63 -37.04 3.68 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.498 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -78.6 169.37 18.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.836 0.35 . . . . 0.0 110.857 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -170.99 174.07 4.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.145 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -139.55 136.78 34.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.865 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 12.6 t -117.61 158.0 18.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.156 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . 0.566 ' HG ' ' CE1' ' A' ' 159' ' ' PHE . 72.2 mt -115.3 139.56 49.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.933 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -132.29 149.47 52.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.86 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -49.87 -65.67 0.52 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.124 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' CYS . . . . . . . . . . . . . 1.8 t -141.57 179.14 6.99 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.876 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . 0.404 ' C ' ' OE1' ' A' ' 220' ' ' GLU . 0.0 OUTLIER -60.21 -16.4 32.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.875 -179.892 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -63.2 -47.48 82.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.87 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' TYR . . . . . 0.492 ' CD1' ' HD2' ' A' ' 191' ' ' PRO . 62.4 m-85 -78.44 -46.35 20.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.92 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . 0.424 ' CB ' ' CG1' ' A' ' 166' ' ' VAL . . . -50.22 -50.35 49.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.066 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 23.6 mm-40 -54.28 -53.09 58.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.93 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 55.0 m-20 -57.6 -25.62 60.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.873 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -74.96 -30.76 61.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.151 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 69.5 mt -62.47 -35.37 79.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.908 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 66.1 mtp85 -56.53 -22.06 30.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.842 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . 0.481 ' CE ' ' CE1' ' A' ' 185' ' ' PHE . 21.2 mtpp -75.03 -2.78 28.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.876 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' HIS . . . . . 0.512 ' CD2' ' HG2' ' A' ' 231' ' ' LYS . 84.9 t60 -34.0 135.8 0.14 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.843 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.512 ' HG2' ' CD2' ' A' ' 230' ' ' HIS . 21.9 mmtt 62.59 29.22 16.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.875 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . 0.425 ' OD2' ' CE2' ' A' ' 185' ' ' PHE . 3.2 t70 -56.01 178.35 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.841 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.515 HD23 ' CE1' ' A' ' 238' ' ' TYR . 30.6 mt -137.71 105.02 5.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.927 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . 0.423 HD22 ' CD ' ' A' ' 181' ' ' GLU . 5.8 tt -113.59 108.16 16.77 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.876 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 60.84 44.06 98.49 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.49 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 6.8 mmmm 65.85 54.98 0.99 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.765 0.317 . . . . 0.0 110.932 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' ARG . . . . . 0.469 ' CB ' ' HG3' ' A' ' 174' ' ' PRO . 17.5 mmt85 -156.84 115.11 3.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.863 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' TYR . . . . . 0.515 ' CE1' HD23 ' A' ' 233' ' ' LEU . 97.3 m-85 -70.4 120.81 16.61 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.952 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 19.8 mt -116.27 137.8 48.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.154 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -101.1 171.18 7.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.905 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . 0.401 ' O ' ' CD1' ' A' ' 242' ' ' PHE . 28.8 mt -147.2 145.26 29.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.873 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' PHE . . . . . 0.401 ' CD1' ' O ' ' A' ' 241' ' ' LEU . 28.7 m-85 -155.75 129.43 8.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.878 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 42.4 mtm180 -44.62 140.88 2.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.846 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 9.2 t -140.6 148.4 40.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.857 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 43.0 p -119.88 161.21 21.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.133 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -48.22 -48.68 34.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.104 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -58.87 -53.79 54.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.065 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -49.07 -50.84 34.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.886 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 95.0 t -50.8 -61.92 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.141 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 59.3 mt-30 -44.7 -50.02 10.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.879 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -58.64 -38.63 78.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.932 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 69.4 t -67.92 -44.31 85.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.115 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 9.6 mt -65.77 -45.45 82.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.93 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 42.2 m-20 -68.7 -27.23 65.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.884 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . 0.469 ' HD3' ' N ' ' A' ' 256' ' ' PHE . 0.6 OUTLIER -72.58 -53.32 12.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.866 -179.965 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 256' ' ' PHE . . . . . 0.469 ' N ' ' HD3' ' A' ' 255' ' ' ARG . 11.1 m-85 -59.44 -44.36 92.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.931 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 91.7 p -58.62 -39.2 79.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.872 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 9.0 t -114.05 71.49 0.75 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.862 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 259' ' ' ALA . . . . . . . . . . . . . . . -102.8 148.04 26.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.113 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 2.0 t -63.38 120.91 12.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.888 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -148.72 -167.98 14.2 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.533 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 262' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.73 116.18 2.64 Favored 'Cis proline' 0 C--N 1.341 0.141 0 C-N-CA 122.695 -1.794 . . . . 0.0 112.345 0.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 5.7 t -169.33 143.5 2.9 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.818 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 83.2 p -104.94 167.85 9.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.902 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.347 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.483 -179.976 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.249 0 N-CA-C 112.46 -0.256 . . . . 0.0 112.46 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 3.1 m -53.65 -52.81 58.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.847 0.356 . . . . 0.0 110.794 -179.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 4.0 m -109.97 -56.51 2.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.874 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -54.21 150.54 15.11 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.483 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 26.5 m -147.91 121.98 9.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.906 0.384 . . . . 0.0 110.826 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 35.9 m -147.8 143.32 27.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.888 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 117.57 179.94 17.37 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.505 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 155.1 159.26 9.19 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.472 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 51.18 -115.0 3.23 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.526 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 17.8 m -134.28 142.65 47.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.794 0.33 . . . . 0.0 111.14 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 1.1 t -73.48 137.55 44.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.89 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -40.72 -58.97 1.5 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.869 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -44.41 -39.76 4.95 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.927 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.417 ' O ' ' C ' ' A' ' 157' ' ' ALA . 99.3 t -75.09 -47.0 38.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.125 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.417 ' C ' ' O ' ' A' ' 156' ' ' VAL . . . -36.83 -58.19 0.77 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.101 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 27.6 mm-40 -58.02 -50.46 73.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.907 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' PHE . . . . . 0.469 ' CE2' ' HG ' ' A' ' 216' ' ' LEU . 47.3 t80 -50.41 -42.82 54.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.863 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 62.6 mt -85.79 -21.21 28.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.906 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' SER . . . . . 0.417 ' N ' ' O ' ' A' ' 157' ' ' ALA . 15.6 t -58.12 -24.53 59.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.846 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 24.2 mmmt -65.52 131.1 45.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.893 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -109.66 154.99 22.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.923 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 63.19 42.72 6.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.892 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 20.5 mm-40 -127.86 156.57 42.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.914 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 47.1 t -108.63 100.76 11.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.158 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . 0.457 HD13 ' N ' ' A' ' 246' ' ' ALA . 49.3 mt -75.27 140.27 17.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.099 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.411 ' N ' HG21 ' A' ' 167' ' ' ILE . 39.0 t -127.92 134.21 65.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.117 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . 0.544 ' HG3' ' CE1' ' A' ' 214' ' ' PHE . 18.1 ttm180 -90.1 125.43 35.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.872 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 59.5 mtp -115.41 111.8 21.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.893 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -114.8 151.66 33.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.884 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 84.23 16.7 66.33 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.502 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.405 ' CD2' HD12 ' A' ' 239' ' ' ILE . 19.7 mt -71.57 133.99 84.5 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.615 0.721 . . . . 0.0 110.886 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . 0.485 ' O ' ' N ' ' A' ' 177' ' ' ALA . 65.3 Cg_exo -47.99 127.57 15.02 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.675 2.25 . . . . 0.0 112.328 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . 0.436 ' C ' ' O ' ' A' ' 174' ' ' PRO . 11.2 m-85 -34.68 -45.37 0.24 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.865 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' THR . . . . . 0.452 ' O ' ' C ' ' A' ' 177' ' ' ALA . 0.0 OUTLIER -74.56 -39.0 62.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.098 -179.894 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . 0.485 ' N ' ' O ' ' A' ' 174' ' ' PRO . . . -33.78 122.54 0.45 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.071 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.418 ' C ' ' CZ ' ' A' ' 201' ' ' PHE . 25.9 p -132.46 173.04 11.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.113 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.496 ' N ' ' CZ ' ' A' ' 201' ' ' PHE . . . -42.22 -47.52 4.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.044 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -51.26 -37.74 48.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.866 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 56.7 mm-40 -70.52 -34.91 72.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.867 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.444 ' O ' ' C ' ' A' ' 183' ' ' VAL . 92.4 t -71.29 -53.59 20.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.16 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . 0.444 ' C ' ' O ' ' A' ' 182' ' ' VAL . 76.4 t -34.05 -47.36 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.143 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -80.96 -41.47 22.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.106 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.439 ' CD1' ' C ' ' A' ' 185' ' ' PHE . 4.9 t80 -40.03 -59.03 1.3 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.895 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -95.17 -21.94 18.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.901 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -49.33 -19.09 1.64 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.506 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -56.78 -70.82 0.11 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.817 0.341 . . . . 0.0 110.882 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 29.7 m-70 -118.21 -15.46 9.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.877 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 79.4 m -121.15 87.51 44.16 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.57 0.7 . . . . 0.0 110.852 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 140.75 43.53 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.706 2.27 . . . . 0.0 112.34 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . 0.436 ' CD1' HG13 ' A' ' 215' ' ' VAL . 63.1 mt -94.58 140.73 16.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.181 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 57.7 m -62.97 101.8 0.3 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.178 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 89.41 -16.24 56.6 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.483 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . 0.481 ' O ' ' N ' ' A' ' 198' ' ' GLY . . . 67.91 -126.0 23.08 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.462 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 16.8 ptmt -42.31 -27.07 0.13 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.737 0.303 . . . . 0.0 110.906 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -81.74 -36.23 28.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.872 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . 0.481 ' N ' ' O ' ' A' ' 195' ' ' GLY . . . -85.16 34.82 3.19 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.47 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 62.5 mt -135.05 149.26 28.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.901 0.381 . . . . 0.0 111.118 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 13.4 tp -142.51 115.23 8.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.913 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' PHE . . . . . 0.496 ' CZ ' ' N ' ' A' ' 179' ' ' ALA . 46.9 m-85 -96.8 124.42 40.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.862 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 48.0 t -77.21 120.89 28.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.14 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -129.88 137.23 50.3 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.152 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . 0.505 ' CD2' HG21 ' A' ' 210' ' ' THR . 34.9 m-85 -45.39 158.59 0.31 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.689 0.756 . . . . 0.0 110.892 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.81 2.61 3.41 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.63 2.22 . . . . 0.0 112.355 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -111.12 -16.51 13.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.857 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 107.14 53.7 0.69 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.482 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 12.0 mmm180 -138.35 143.7 39.84 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.621 0.724 . . . . 0.0 110.854 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 111.53 2.84 Favored 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.711 2.274 . . . . 0.0 112.357 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' THR . . . . . 0.505 HG21 ' CD2' ' A' ' 204' ' ' TYR . 68.3 p -75.26 -27.84 59.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.175 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 108.41 -27.42 13.85 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.493 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -91.38 154.89 18.88 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.766 0.317 . . . . 0.0 110.894 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -155.78 -177.82 6.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.1 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . 0.544 ' CE1' ' HG3' ' A' ' 169' ' ' ARG . 81.1 m-85 -144.29 151.38 39.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.914 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . 0.436 HG13 ' CD1' ' A' ' 192' ' ' ILE . 4.1 t -133.55 157.5 42.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.161 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . 0.469 ' HG ' ' CE2' ' A' ' 159' ' ' PHE . 29.7 mt -109.62 145.95 35.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.957 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -137.11 126.02 24.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.883 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -41.43 -50.34 3.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.115 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' CYS . . . . . . . . . . . . . 72.7 m -152.91 173.15 15.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.84 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -59.56 -35.78 74.91 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.839 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -37.68 -51.45 1.23 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.893 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -79.46 -42.12 26.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.945 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -48.01 -54.79 11.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.122 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -50.19 -58.79 4.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.883 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 48.8 m-20 -53.32 -22.91 8.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.872 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -88.74 -19.54 25.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.131 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 95.2 mt -72.41 -42.77 64.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.947 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 1.5 ptm180 -55.58 -19.11 9.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.823 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . 0.454 ' O ' ' C ' ' A' ' 230' ' ' HIS . 24.7 mtpp -72.81 -3.4 25.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.89 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' HIS . . . . . 0.454 ' C ' ' O ' ' A' ' 229' ' ' LYS . 83.6 t60 -34.35 138.17 0.1 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.855 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 18.0 mmtp 61.02 29.98 19.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.909 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -57.06 174.97 0.15 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.864 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.459 HD23 ' CG ' ' A' ' 238' ' ' TYR . 31.0 mt -131.07 108.94 10.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.914 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 6.6 tt -118.34 114.65 23.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.894 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 56.4 44.0 90.03 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.479 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.426 ' HA ' ' NZ ' ' A' ' 236' ' ' LYS . 0.0 OUTLIER 63.74 52.75 2.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.802 0.334 . . . . 0.0 110.904 -179.997 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' ARG . . . . . 0.407 ' CB ' ' HG3' ' A' ' 174' ' ' PRO . 19.6 mmt180 -156.44 115.19 3.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.855 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' TYR . . . . . 0.459 ' CG ' HD23 ' A' ' 233' ' ' LEU . 92.2 m-85 -70.51 126.13 28.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.963 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . 0.405 HD12 ' CD2' ' A' ' 173' ' ' LEU . 66.2 mt -122.7 136.76 58.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.123 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . 0.494 ' HB3' ' CZ ' ' A' ' 242' ' ' PHE . 24.2 mp0 -96.68 158.94 15.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.883 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . 0.443 ' C ' ' CG ' ' A' ' 242' ' ' PHE . 14.5 mt -136.85 147.77 46.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.961 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' PHE . . . . . 0.494 ' CZ ' ' HB3' ' A' ' 240' ' ' GLU . 7.3 m-85 -158.52 139.47 12.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.84 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 22.8 mtm180 -64.3 128.65 36.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.869 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 1.8 t -128.02 167.21 17.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.854 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 245' ' ' THR . . . . . 0.449 ' O ' ' C ' ' A' ' 246' ' ' ALA . 34.1 p -131.55 148.21 52.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.099 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 246' ' ' ALA . . . . . 0.457 ' N ' HD13 ' A' ' 167' ' ' ILE . . . -34.1 -52.41 0.45 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.101 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -55.7 -54.3 45.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.09 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 -49.2 -56.01 10.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.868 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . 0.512 HG11 ' CD2' ' A' ' 214' ' ' PHE . 59.2 t -44.04 -64.5 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.135 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -39.69 -41.9 1.15 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.898 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 251' ' ' GLN . . . . . 0.461 ' HA ' ' ND2' ' A' ' 254' ' ' ASN . 38.9 mm-40 -68.19 -35.17 77.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.902 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 252' ' ' VAL . . . . . 0.488 ' N ' ' O ' ' A' ' 249' ' ' VAL . 82.6 t -71.22 -19.43 20.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.105 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 7.5 mt -86.57 -40.93 14.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.926 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . 0.461 ' ND2' ' HA ' ' A' ' 251' ' ' GLN . 0.4 OUTLIER -75.1 -41.83 57.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.902 179.879 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . 0.569 ' CD ' ' CD1' ' A' ' 256' ' ' PHE . 0.0 OUTLIER -60.09 -25.08 65.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.824 -179.955 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 256' ' ' PHE . . . . . 0.569 ' CD1' ' CD ' ' A' ' 255' ' ' ARG . 6.6 m-85 -90.6 -38.11 13.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.83 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 40.6 t -70.09 157.69 37.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.849 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 96.2 p 38.57 35.92 0.12 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.857 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 259' ' ' ALA . . . . . . . . . . . . . . . -84.27 147.59 27.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.092 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 90.4 p -95.11 -20.24 19.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.859 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . 0.46 ' HA3' ' N ' ' A' ' 263' ' ' SER . . . -151.97 -71.48 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.5 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 262' ' ' PRO . . . . . 0.435 ' C ' ' HA3' ' A' ' 261' ' ' GLY . 53.8 Cg_endo -69.77 -3.91 7.99 Favored 'Cis proline' 0 C--N 1.341 0.169 0 C-N-CA 122.679 -1.801 . . . . 0.0 112.329 0.058 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 263' ' ' SER . . . . . 0.46 ' N ' ' HA3' ' A' ' 261' ' ' GLY . 37.1 m -146.76 158.65 43.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.915 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 47.6 p -136.47 134.59 37.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.825 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.31 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.488 179.993 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.334 0 N-CA-C 112.498 -0.241 . . . . 0.0 112.498 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 68.4 m -98.18 -49.95 4.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.893 0.377 . . . . 0.0 110.868 -179.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 83.4 p -48.75 -45.04 39.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.833 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 73.19 79.41 0.49 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.499 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 20.3 m -76.32 133.4 40.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.872 0.368 . . . . 0.0 110.858 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 28.7 m -158.33 176.14 12.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.875 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -152.95 95.5 0.16 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.492 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 143.24 96.87 0.24 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.526 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 55.78 179.69 0.36 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.502 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 17.1 m -111.56 119.86 40.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.769 0.319 . . . . 0.0 111.141 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 15.8 m -134.68 -42.86 0.75 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.871 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 -65.66 -48.88 70.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.93 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -67.71 -40.55 84.26 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.9 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.408 ' O ' ' C ' ' A' ' 157' ' ' ALA . 90.9 t -64.36 -42.92 96.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.142 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.408 ' C ' ' O ' ' A' ' 156' ' ' VAL . . . -37.55 -58.69 0.85 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.084 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -60.03 -50.06 75.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.89 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -48.75 -41.72 33.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.862 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 82.0 mt -85.52 -22.52 28.12 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.931 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 44.3 t -53.76 -33.1 54.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.888 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 42.1 mmtt -60.17 103.92 0.27 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.843 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -86.79 157.53 19.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.893 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 63.49 30.69 15.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.882 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . 0.462 ' NE2' ' HA ' ' A' ' 165' ' ' GLN . 8.8 mm100 -121.13 148.21 44.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.881 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 4.6 t -99.17 116.83 43.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.137 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . 0.47 HD11 ' N ' ' A' ' 246' ' ' ALA . 73.2 mt -88.55 147.12 5.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.115 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.485 ' CG2' ' CE1' ' A' ' 217' ' ' PHE . 96.1 t -127.65 126.18 66.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.108 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 70.8 ttt180 -88.14 110.19 20.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.888 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' MET . . . . . 0.465 ' HE1' ' CD2' ' A' ' 173' ' ' LEU . 97.4 mtp -97.13 113.01 24.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.892 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 2.1 ttt85 -111.1 141.63 44.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.869 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 89.36 21.08 42.48 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.476 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.465 ' CD2' ' HE1' ' A' ' 170' ' ' MET . 23.0 mt -74.79 123.89 89.28 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.588 0.708 . . . . 0.0 110.958 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_exo -47.97 145.01 10.98 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.683 2.255 . . . . 0.0 112.359 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . 0.565 ' CD1' ' HG3' ' A' ' 209' ' ' PRO . 10.4 t80 -57.0 -30.66 64.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.9 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 6.2 p -86.49 -15.88 38.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.137 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -67.53 117.41 9.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.084 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -124.35 175.24 7.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.119 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.455 ' N ' ' CZ ' ' A' ' 201' ' ' PHE . . . -41.11 -50.34 3.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.103 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -49.68 -40.23 39.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.874 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -69.36 -30.74 68.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.872 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.45 ' O ' ' C ' ' A' ' 183' ' ' VAL . 74.5 t -75.81 -55.52 11.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.1 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . 0.45 ' C ' ' O ' ' A' ' 182' ' ' VAL . 54.5 t -33.98 -44.68 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.1 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . 0.442 ' O ' ' C ' ' A' ' 185' ' ' PHE . . . -79.24 -47.46 15.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.124 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.442 ' C ' ' O ' ' A' ' 184' ' ' ALA . 15.8 t80 -35.32 -60.51 0.48 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.888 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' PHE . . . . . 0.404 ' CE1' ' CE1' ' A' ' 185' ' ' PHE . 50.5 m-85 -94.35 -20.54 19.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.88 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -49.1 -17.36 0.94 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.501 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 8.8 mm100 -59.24 -72.35 0.1 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.824 0.345 . . . . 0.0 110.88 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 28.8 m170 -117.81 -16.47 9.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.88 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 86.7 m -117.38 85.64 20.42 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.647 0.736 . . . . 0.0 110.889 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' PRO . . . . . 0.439 ' HD2' ' CD1' ' A' ' 222' ' ' TYR . 53.9 Cg_endo -69.79 135.78 31.24 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.715 2.277 . . . . 0.0 112.314 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . 0.444 HG23 ' N ' ' A' ' 193' ' ' THR . 61.9 mt -87.47 141.16 14.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.187 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' THR . . . . . 0.444 ' N ' HG23 ' A' ' 192' ' ' ILE . 41.2 m -66.21 103.09 0.92 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.138 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 91.77 -16.97 58.06 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.476 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . 0.401 ' O ' ' N ' ' A' ' 198' ' ' GLY . . . 72.13 -125.19 10.67 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.482 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 14.4 ptmt -47.36 -30.03 2.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.784 0.326 . . . . 0.0 110.943 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -75.49 -30.51 59.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.877 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 195' ' ' GLY . . . -92.82 41.22 2.75 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.498 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 62.6 mt -142.68 144.48 24.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.828 0.347 . . . . 0.0 111.16 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 15.6 tp -139.64 121.66 15.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.9 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' PHE . . . . . 0.455 ' CZ ' ' N ' ' A' ' 179' ' ' ALA . 65.0 m-85 -101.7 112.21 24.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.883 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 39.0 t -70.4 138.15 22.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.129 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -143.66 138.1 28.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.146 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 32.4 m-85 -48.08 159.29 0.5 Allowed Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.699 0.762 . . . . 0.0 110.917 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.81 3.97 2.49 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.644 2.229 . . . . 0.0 112.296 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . 0.413 ' HB3' ' NH1' ' A' ' 208' ' ' ARG . 62.0 m-20 -112.46 -23.71 10.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.895 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 123.65 4.19 8.2 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.508 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' ARG . . . . . 0.413 ' NH1' ' HB3' ' A' ' 206' ' ' ASP . 0.0 OUTLIER -84.75 141.3 38.32 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.576 0.703 . . . . 0.0 110.917 -179.854 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . 0.565 ' HG3' ' CD1' ' A' ' 175' ' ' PHE . 53.6 Cg_endo -69.72 110.33 2.52 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.693 2.262 . . . . 0.0 112.367 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' THR . . . . . 0.569 HG23 ' CD1' ' A' ' 256' ' ' PHE . 34.1 p -71.31 -10.85 60.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.175 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 79.89 -40.18 2.27 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.445 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -70.35 154.26 42.1 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.878 0.37 . . . . 0.0 110.874 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -152.06 179.55 8.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.118 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . 0.457 ' CD2' HG11 ' A' ' 249' ' ' VAL . 73.9 m-85 -146.79 130.6 17.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.89 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 19.7 t -118.18 161.03 17.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.15 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 26.9 mt -110.17 139.26 45.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.939 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . 0.485 ' CE1' ' CG2' ' A' ' 168' ' ' VAL . 81.2 m-85 -133.15 130.55 39.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.87 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . 0.46 ' HA ' ' NE2' ' A' ' 165' ' ' GLN . . . -44.78 -57.4 3.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.106 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' CYS . . . . . . . . . . . . . 85.6 m -151.92 161.1 43.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.837 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -45.06 -30.3 1.04 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.877 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -43.45 -41.91 4.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.846 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' TYR . . . . . 0.439 ' CD1' ' HD2' ' A' ' 191' ' ' PRO . 61.1 m-85 -90.25 -47.73 7.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.91 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -49.66 -60.87 2.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.064 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 64.4 mm-40 -45.44 -57.71 3.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.889 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 55.3 m-20 -55.95 -26.65 48.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.868 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -77.46 -39.53 46.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.065 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 29.5 mt -52.88 -31.27 38.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.951 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 75.0 mtt180 -58.91 -26.71 64.57 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.891 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . 0.458 ' O ' ' C ' ' A' ' 230' ' ' HIS . 26.8 mtpp -71.72 -2.58 17.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.897 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' HIS . . . . . 0.518 ' CG ' ' HG2' ' A' ' 231' ' ' LYS . 19.6 t60 -33.96 139.38 0.07 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.894 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.518 ' HG2' ' CG ' ' A' ' 230' ' ' HIS . 0.1 OUTLIER 60.16 35.51 21.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.869 179.966 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -65.8 175.48 1.92 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.865 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.56 HD22 ' CE1' ' A' ' 238' ' ' TYR . 30.4 mt -131.35 101.19 5.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.87 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . 0.447 ' C ' ' CD2' ' A' ' 234' ' ' LEU . 5.7 tt -112.1 111.45 22.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.923 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 63.5 37.91 95.51 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.492 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 33.0 mmtm 67.35 54.22 0.72 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.766 0.317 . . . . 0.0 110.88 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 20.4 mmt180 -156.44 116.08 3.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.838 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' TYR . . . . . 0.56 ' CE1' HD22 ' A' ' 233' ' ' LEU . 96.7 m-85 -69.83 116.22 9.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.896 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 41.1 mt -115.9 140.6 36.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.134 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . 0.562 ' HB3' ' CZ ' ' A' ' 242' ' ' PHE . 16.7 mt-10 -93.26 -178.51 4.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.888 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . 0.559 ' O ' ' CD1' ' A' ' 242' ' ' PHE . 61.6 mt -158.01 132.82 8.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.909 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' PHE . . . . . 0.562 ' CZ ' ' HB3' ' A' ' 240' ' ' GLU . 4.6 m-85 -152.88 120.44 5.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.856 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 18.0 ptt180 -60.95 126.98 29.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.906 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 5.4 t -119.71 176.68 5.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.868 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 245' ' ' THR . . . . . 0.401 ' O ' ' C ' ' A' ' 246' ' ' ALA . 82.2 p -127.64 151.02 49.46 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.135 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 246' ' ' ALA . . . . . 0.47 ' N ' HD11 ' A' ' 167' ' ' ILE . . . -37.92 -57.2 1.05 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.09 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -53.21 -51.76 61.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.121 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -50.45 -54.81 19.22 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.886 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . 0.457 HG11 ' CD2' ' A' ' 214' ' ' PHE . 78.4 t -43.82 -61.39 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.152 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -44.05 -42.73 6.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.969 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 60.6 mm-40 -65.58 -30.14 70.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.905 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 252' ' ' VAL . . . . . 0.423 ' N ' ' O ' ' A' ' 249' ' ' VAL . 85.9 t -78.93 -20.12 12.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.145 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 10.6 mt -84.38 -41.63 16.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.93 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . 0.49 ' C ' ' OD1' ' A' ' 254' ' ' ASN . 0.6 OUTLIER -67.93 -40.86 83.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.89 179.876 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . 0.473 ' N ' ' OD1' ' A' ' 254' ' ' ASN . 8.0 ptm180 -55.35 -42.71 74.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.816 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 256' ' ' PHE . . . . . 0.569 ' CD1' HG23 ' A' ' 210' ' ' THR . 12.8 m-85 -78.9 -51.02 10.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.862 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 41.7 m -52.16 -68.43 0.17 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.84 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 29.5 m -77.47 59.18 1.85 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.848 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 259' ' ' ALA . . . . . . . . . . . . . . . -110.18 76.5 0.99 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.105 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 87.3 p -109.91 -47.67 3.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.835 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . 0.432 ' HA2' ' C ' ' A' ' 262' ' ' PRO . . . 128.82 169.98 12.69 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.489 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 262' ' ' PRO . . . . . 0.432 ' C ' ' HA2' ' A' ' 261' ' ' GLY . 53.1 Cg_endo -69.75 134.42 29.4 Favored 'Cis proline' 0 C--N 1.342 0.197 0 C-N-CA 122.665 -1.806 . . . . 0.0 112.37 0.057 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 3.7 m -123.88 175.69 6.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.855 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 1.5 t 51.56 41.31 28.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.91 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.299 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.476 -179.985 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.325 0 N-CA-C 112.456 -0.258 . . . . 0.0 112.456 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 2.6 t -76.91 138.69 39.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.818 0.342 . . . . 0.0 110.857 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 19.7 m -81.16 122.27 27.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.842 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 179.83 -79.75 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.515 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 2.2 m -67.38 137.31 55.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.887 0.375 . . . . 0.0 110.868 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 18.9 t -119.69 173.61 6.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.883 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 99.32 -129.0 9.75 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.502 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -168.95 -73.44 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.486 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -138.33 -131.7 2.91 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.466 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' THR . . . . . 0.468 ' O ' ' CG2' ' A' ' 156' ' ' VAL . 1.6 m -122.92 46.89 2.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.771 0.32 . . . . 0.0 111.121 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 93.2 p -98.03 -36.86 9.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.899 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . 0.47 ' O ' ' NE2' ' A' ' 158' ' ' GLN . 20.8 m120 -66.83 -45.71 77.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.919 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -70.69 -39.84 73.25 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.868 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.468 ' CG2' ' O ' ' A' ' 152' ' ' THR . 34.0 t -65.53 -40.19 87.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.119 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -41.45 -60.86 1.17 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.13 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . 0.47 ' NE2' ' O ' ' A' ' 154' ' ' ASN . 15.2 mp0 -56.23 -44.44 79.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.873 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -52.34 -41.34 62.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.852 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 75.4 mt -89.29 -19.71 24.99 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.89 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 45.9 t -59.75 -20.94 59.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.833 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 38.8 mmtt -74.95 102.59 4.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.918 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -82.24 158.82 23.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.903 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 66.8 m-20 60.63 47.04 8.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.937 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 10.6 mm-40 -132.2 164.87 25.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.937 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.463 HG12 ' CB ' ' A' ' 223' ' ' ALA . 39.5 t -118.47 115.82 49.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.139 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . 0.468 HD12 ' N ' ' A' ' 246' ' ' ALA . 9.5 mt -88.48 141.54 14.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.125 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.424 HG13 ' N ' ' A' ' 169' ' ' ARG . 59.2 t -119.08 140.49 42.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.151 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . 0.444 ' N ' ' HB2' ' A' ' 244' ' ' SER . 27.1 ttp180 -95.78 101.68 13.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.869 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' MET . . . . . 0.415 ' HE2' ' CD2' ' A' ' 173' ' ' LEU . 88.1 mtp -92.58 137.56 32.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.871 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -137.98 129.96 28.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.874 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 98.31 21.97 16.03 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.493 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.415 ' CD2' ' HE2' ' A' ' 170' ' ' MET . 22.1 mt -76.04 120.97 84.04 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.657 0.741 . . . . 0.0 110.946 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . 0.457 ' HG3' ' CB ' ' A' ' 237' ' ' ARG . 65.6 Cg_exo -48.02 139.36 20.51 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.659 2.239 . . . . 0.0 112.336 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . 0.564 ' CD1' ' HG3' ' A' ' 209' ' ' PRO . 9.8 t80 -47.56 -42.53 23.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.859 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 7.3 p -72.21 -20.61 61.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.157 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -60.99 105.99 0.54 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.113 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.415 ' O ' ' C ' ' A' ' 179' ' ' ALA . 73.7 p -116.74 173.59 6.55 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.158 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.415 ' C ' ' O ' ' A' ' 178' ' ' THR . . . -36.8 -46.46 0.61 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.089 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -55.47 -49.2 73.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.92 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -57.75 -34.24 69.33 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.887 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.428 ' O ' ' C ' ' A' ' 183' ' ' VAL . 89.0 t -74.78 -53.95 15.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.11 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . 0.428 ' C ' ' O ' ' A' ' 182' ' ' VAL . 50.4 t -35.22 -52.06 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.131 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -73.66 -36.96 65.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.112 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.452 ' CE2' ' OD2' ' A' ' 232' ' ' ASP . 21.0 t80 -47.28 -58.03 4.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.88 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' PHE . . . . . 0.444 ' CE1' ' CE1' ' A' ' 185' ' ' PHE . 86.5 m-85 -96.28 -21.36 17.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.926 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -49.05 -24.16 4.34 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.443 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 3.5 tp-100 -49.61 -75.11 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.808 0.337 . . . . 0.0 110.891 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 -118.33 -7.63 10.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.869 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 78.0 m -126.09 84.34 61.66 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.587 0.708 . . . . 0.0 110.918 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' PRO . . . . . 0.487 ' HD2' ' CD1' ' A' ' 222' ' ' TYR . 54.0 Cg_endo -69.79 139.28 39.76 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.655 2.237 . . . . 0.0 112.377 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . 0.4 HG22 ' N ' ' A' ' 193' ' ' THR . 57.8 mt -88.76 144.67 8.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.152 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' THR . . . . . 0.4 ' N ' HG22 ' A' ' 192' ' ' ILE . 17.9 m -70.18 104.7 2.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.173 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 91.72 -15.48 61.52 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.462 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 68.82 -120.22 10.69 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.46 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 43.9 mtmt -48.5 -33.77 10.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.783 0.325 . . . . 0.0 110.901 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -75.07 -27.59 60.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.874 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -94.05 40.4 2.76 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.505 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 55.8 mt -143.0 146.28 21.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.847 0.356 . . . . 0.0 111.14 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 14.5 tp -146.6 122.34 10.55 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.951 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -102.09 121.41 42.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.882 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 60.6 t -72.78 140.17 18.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.149 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -142.9 138.83 30.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.159 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -50.79 159.08 0.99 Allowed Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.614 0.721 . . . . 0.0 110.966 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 3.73 2.62 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.711 2.274 . . . . 0.0 112.334 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -111.92 -18.52 12.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.907 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 110.4 44.18 1.01 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.499 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -126.78 143.72 47.55 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.571 0.701 . . . . 0.0 110.868 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . 0.564 ' HG3' ' CD1' ' A' ' 175' ' ' PHE . 53.4 Cg_endo -69.76 95.68 0.56 Allowed 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.686 2.258 . . . . 0.0 112.328 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' THR . . . . . 0.504 ' CG2' ' CD2' ' A' ' 256' ' ' PHE . 33.5 p -60.27 -10.29 4.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.154 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 88.01 -45.73 3.34 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.485 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -66.85 161.67 23.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.768 0.318 . . . . 0.0 110.904 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -161.27 -175.26 4.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.075 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . 0.413 ' CD2' HG11 ' A' ' 249' ' ' VAL . 56.5 m-85 -146.22 151.73 38.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.857 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 4.5 t -138.71 159.91 30.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.162 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 43.0 mt -109.68 145.8 35.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.905 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -140.29 143.0 35.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.899 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -53.85 -66.7 0.35 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.112 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' CYS . . . . . . . . . . . . . 30.1 m -138.31 -175.09 3.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.915 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -62.89 -37.36 86.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.873 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 18.8 tp10 -43.27 -41.2 3.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.9 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' TYR . . . . . 0.487 ' CD1' ' HD2' ' A' ' 191' ' ' PRO . 55.9 m-85 -86.05 -47.58 9.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.934 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . 0.463 ' CB ' HG12 ' A' ' 166' ' ' VAL . . . -56.31 -63.75 1.09 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.107 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' GLN . . . . . 0.461 ' HA ' ' CD1' ' A' ' 227' ' ' LEU . 20.4 mt-30 -46.65 -52.6 13.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.905 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 22.3 m-20 -55.38 -26.34 40.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.872 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -80.78 -34.55 34.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.121 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . 0.461 ' CD1' ' HA ' ' A' ' 224' ' ' GLN . 38.3 mt -54.54 -30.11 52.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.943 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 36.8 mtp180 -63.87 -20.74 66.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.845 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . 0.459 ' O ' ' C ' ' A' ' 230' ' ' HIS . 19.8 mtpp -75.75 -1.92 27.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.926 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' HIS . . . . . 0.506 ' CE1' ' HG2' ' A' ' 231' ' ' LYS . 57.1 t60 -33.9 136.9 0.11 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.874 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.506 ' HG2' ' CE1' ' A' ' 230' ' ' HIS . 0.0 OUTLIER 61.76 30.54 18.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.852 179.96 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . 0.452 ' OD2' ' CE2' ' A' ' 185' ' ' PHE . 8.4 t70 -57.84 173.64 0.3 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.877 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.57 HD22 ' CE1' ' A' ' 238' ' ' TYR . 30.7 mt -132.58 104.33 6.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.899 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . 0.435 ' C ' ' CD2' ' A' ' 234' ' ' LEU . 5.8 tt -115.24 114.42 25.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.935 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 60.7 39.56 96.81 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.438 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 31.0 mtmm 65.3 53.0 1.35 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.789 0.328 . . . . 0.0 110.876 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' ARG . . . . . 0.457 ' CB ' ' HG3' ' A' ' 174' ' ' PRO . 12.4 mmt85 -156.09 116.09 3.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.877 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' TYR . . . . . 0.57 ' CE1' HD22 ' A' ' 233' ' ' LEU . 97.2 m-85 -68.6 135.61 51.74 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.918 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 60.2 mt -133.51 134.36 56.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.168 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . 0.472 ' CG ' ' CE ' ' A' ' 231' ' ' LYS . 46.8 mt-10 -90.27 175.87 6.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.884 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . 0.497 ' O ' ' CD1' ' A' ' 242' ' ' PHE . 63.6 mt -156.67 138.19 14.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.912 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' PHE . . . . . 0.497 ' CD1' ' O ' ' A' ' 241' ' ' LEU . 20.9 m-85 -155.19 127.85 7.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.852 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 46.5 mtm180 -39.98 136.97 1.03 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.909 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 244' ' ' SER . . . . . 0.444 ' HB2' ' N ' ' A' ' 169' ' ' ARG . 3.6 t -132.57 154.67 49.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.844 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 26.4 p -132.09 156.77 45.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.173 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 246' ' ' ALA . . . . . 0.468 ' N ' HD12 ' A' ' 167' ' ' ILE . . . -42.17 -57.15 2.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.128 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -53.76 -41.13 66.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.115 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -61.15 -49.99 75.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.886 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . 0.413 HG11 ' CD2' ' A' ' 214' ' ' PHE . 95.4 t -53.24 -64.97 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.105 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -42.57 -34.09 0.81 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.929 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 251' ' ' GLN . . . . . 0.436 ' HA ' ' ND2' ' A' ' 254' ' ' ASN . 64.4 mt-30 -73.58 -47.73 38.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.891 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 75.2 t -57.69 -35.13 49.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.11 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 10.9 mt -65.81 -48.83 70.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.872 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . 0.485 ' C ' ' OD1' ' A' ' 254' ' ' ASN . 0.6 OUTLIER -67.12 -41.37 86.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.891 179.95 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . 0.47 ' N ' ' OD1' ' A' ' 254' ' ' ASN . 13.7 ttm180 -54.78 -41.39 70.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.868 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 256' ' ' PHE . . . . . 0.504 ' CD2' ' CG2' ' A' ' 210' ' ' THR . 12.8 m-85 -80.49 -47.12 14.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.851 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 51.1 m -61.91 -20.5 63.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.837 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 42.3 m -109.87 61.34 0.6 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.837 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 259' ' ' ALA . . . . . . . . . . . . . . . -111.44 76.34 0.97 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.115 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 33.9 t -40.12 -44.62 1.84 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.85 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . 0.408 ' HA2' ' C ' ' A' ' 262' ' ' PRO . . . -57.5 172.49 2.77 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.487 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 262' ' ' PRO . . . . . 0.408 ' C ' ' HA2' ' A' ' 261' ' ' GLY . 53.9 Cg_endo -69.74 171.82 51.83 Favored 'Cis proline' 0 C--N 1.341 0.179 0 C-N-CA 122.659 -1.809 . . . . 0.0 112.355 -0.027 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 28.5 m 48.79 45.51 21.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.889 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 56.1 p -44.81 152.98 0.19 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.85 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.515 179.984 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.28 0 N-CA-C 112.479 -0.248 . . . . 0.0 112.479 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' SER . . . . . 0.441 ' O ' ' C ' ' A' ' 145' ' ' SER . 41.6 t -49.37 131.26 20.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.876 0.37 . . . . 0.0 110.805 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.441 ' C ' ' O ' ' A' ' 144' ' ' SER . 23.0 t -35.28 -55.55 0.63 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.868 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 144.9 150.71 5.28 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.439 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 12.9 m -130.5 149.88 51.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.899 0.38 . . . . 0.0 110.827 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 31.2 t -79.15 97.03 6.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.818 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -177.92 -173.25 43.19 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.482 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -171.24 -156.67 11.97 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.418 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -85.21 -167.36 43.19 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.472 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 5.3 t -69.73 -23.4 63.4 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.768 0.318 . . . . 0.0 111.161 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 70.5 m -156.66 151.68 26.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.827 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -38.5 -48.47 1.4 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.947 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -54.63 -49.78 69.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.879 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 73.5 t -65.07 -41.61 92.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.123 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -43.24 -60.06 1.83 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.101 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 83.2 mm-40 -62.33 -36.67 82.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.922 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' PHE . . . . . 0.41 ' CD1' ' HB2' ' A' ' 200' ' ' LEU . 76.7 t80 -60.62 -38.74 85.74 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.875 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 86.2 mt -94.59 -15.98 23.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.922 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 10.9 t -55.13 -40.37 70.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.865 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . 0.406 ' HD2' ' CD1' ' A' ' 216' ' ' LEU . 14.5 mttp -52.84 116.0 2.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.891 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 39.4 mp0 -80.9 162.51 23.91 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.856 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 43.74 51.03 6.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.869 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . 0.496 ' OE1' ' CG2' ' A' ' 193' ' ' THR . 0.2 OUTLIER -124.16 156.76 36.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.896 -179.967 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 60.7 t -110.47 133.24 56.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.117 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 56.3 mt -109.53 131.11 61.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.094 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 44.5 t -114.3 133.41 60.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.102 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 61.6 ttt180 -90.03 110.94 21.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.87 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' MET . . . . . 0.403 ' SD ' ' CG2' ' A' ' 215' ' ' VAL . 90.0 mtp -98.16 126.58 43.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.912 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 14.2 ttm180 -127.01 142.31 51.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.873 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 83.46 36.34 14.61 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.498 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 28.0 mt -87.64 130.43 47.11 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.64 0.733 . . . . 0.0 110.894 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . 0.444 ' O ' ' N ' ' A' ' 177' ' ' ALA . 66.2 Cg_exo -47.99 122.5 7.35 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.67 2.247 . . . . 0.0 112.309 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -39.57 -29.81 0.06 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.862 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' THR . . . . . 0.403 ' O ' ' C ' ' A' ' 177' ' ' ALA . 31.6 p -80.67 -41.79 23.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.18 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . 0.444 ' N ' ' O ' ' A' ' 174' ' ' PRO . . . -36.69 126.64 0.86 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.087 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -123.53 -174.91 3.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.116 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.08 -50.53 73.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.066 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -53.39 -34.66 58.58 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.901 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -65.57 -40.76 93.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.929 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.414 ' O ' ' C ' ' A' ' 183' ' ' VAL . 76.1 t -68.33 -51.59 46.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.168 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . 0.414 ' C ' ' O ' ' A' ' 182' ' ' VAL . 41.1 t -36.48 -49.11 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.153 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -76.36 -39.6 53.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.079 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.533 ' CE1' ' CE ' ' A' ' 229' ' ' LYS . 9.0 t80 -42.09 -59.06 1.88 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.909 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' PHE . . . . . 0.453 ' CE1' ' CE1' ' A' ' 185' ' ' PHE . 69.6 m-85 -95.57 -21.95 17.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.867 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -49.24 -22.59 3.51 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.451 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 77.3 mm-40 -52.64 -71.76 0.06 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.838 0.352 . . . . 0.0 110.884 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 33.2 m80 -118.08 -17.2 9.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.829 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 99.7 m -118.27 83.94 21.53 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.608 0.718 . . . . 0.0 110.89 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 130.96 20.2 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.731 2.287 . . . . 0.0 112.311 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . 0.416 HD11 ' CG1' ' A' ' 215' ' ' VAL . 48.4 mt -79.46 146.11 8.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.13 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' THR . . . . . 0.496 ' CG2' ' OE1' ' A' ' 165' ' ' GLN . 53.8 m -67.71 109.08 3.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.098 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 85.11 -22.85 8.86 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.491 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . 0.408 ' O ' ' N ' ' A' ' 198' ' ' GLY . . . 79.64 -125.37 6.93 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.472 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 20.7 mtmm -46.0 -23.72 0.34 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.785 0.326 . . . . 0.0 110.896 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -81.67 -35.22 30.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.887 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 195' ' ' GLY . . . -86.21 26.36 6.3 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.483 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . 0.451 HG23 ' CE1' ' A' ' 201' ' ' PHE . 68.9 mt -125.78 140.13 49.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.854 0.359 . . . . 0.0 111.107 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.419 ' N ' HG21 ' A' ' 199' ' ' ILE . 14.6 tp -136.17 112.26 9.68 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.893 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' PHE . . . . . 0.451 ' CE1' HG23 ' A' ' 199' ' ' ILE . 79.4 m-85 -92.86 112.94 25.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.898 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . 0.498 ' CG1' ' OD2' ' A' ' 212' ' ' ASP . 23.5 t -67.38 114.68 4.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.085 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -126.4 137.19 53.41 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.154 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -43.79 158.67 0.25 Allowed Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.686 0.755 . . . . 0.0 110.929 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 2.84 3.15 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.728 2.285 . . . . 0.0 112.338 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -112.66 -16.98 12.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.915 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 108.38 60.43 0.54 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.535 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 59.7 mtt-85 -147.58 145.98 23.19 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.581 0.705 . . . . 0.0 110.877 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 112.47 3.08 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.71 2.273 . . . . 0.0 112.368 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' THR . . . . . 0.535 ' HB ' ' CE1' ' A' ' 256' ' ' PHE . 80.4 p -79.65 -10.84 59.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.152 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 95.06 -32.56 6.04 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.488 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' ASP . . . . . 0.498 ' OD2' ' CG1' ' A' ' 202' ' ' VAL . 1.2 p-10 -84.6 164.72 18.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.781 0.324 . . . . 0.0 110.893 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -161.72 -179.06 6.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.066 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . 0.418 ' CD2' HG11 ' A' ' 249' ' ' VAL . 59.6 m-85 -146.79 133.01 19.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.896 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . 0.416 ' CG1' HD11 ' A' ' 192' ' ' ILE . 14.4 t -118.56 159.75 18.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.105 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . 0.406 ' CD1' ' HD2' ' A' ' 162' ' ' LYS . 51.6 mt -112.18 149.84 31.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.929 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -145.51 139.27 26.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.893 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . 0.462 ' HA ' ' NE2' ' A' ' 165' ' ' GLN . . . -44.79 -57.26 3.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.054 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' CYS . . . . . . . . . . . . . 1.8 t -160.93 -178.38 6.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.925 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 10.6 mp0 -48.3 -34.4 10.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.919 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -54.98 -33.09 62.19 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.903 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' TYR . . . . . 0.43 ' CD1' ' HB3' ' A' ' 218' ' ' ALA . 6.5 m-85 -93.52 -42.88 8.99 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.966 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.29 -62.17 2.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.134 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -45.6 -59.21 2.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.921 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 38.1 m-20 -48.41 -22.15 0.66 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.922 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -92.81 -35.07 13.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.119 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 86.1 mt -54.11 -37.76 64.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.933 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . 0.483 ' HB2' ' CZ ' ' A' ' 228' ' ' ARG . 0.2 OUTLIER -58.12 -24.7 59.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.82 179.954 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . 0.533 ' CE ' ' CE1' ' A' ' 185' ' ' PHE . 24.5 mtpp -67.25 -4.08 9.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.889 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' HIS . . . . . 0.508 ' CG ' ' HG2' ' A' ' 231' ' ' LYS . 23.6 t60 -34.33 134.18 0.21 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.878 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.508 ' HG2' ' CG ' ' A' ' 230' ' ' HIS . 0.2 OUTLIER 67.34 27.62 8.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.921 179.999 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -58.19 179.28 0.07 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.845 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.567 HD22 ' CE2' ' A' ' 238' ' ' TYR . 31.3 mt -135.67 110.66 8.84 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.939 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 6.8 tt -119.9 115.46 23.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.936 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 57.04 39.39 89.58 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.492 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 23.3 mmtm 67.39 52.18 0.83 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.814 0.34 . . . . 0.0 110.899 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' ARG . . . . . 0.434 ' CB ' ' HG3' ' A' ' 174' ' ' PRO . 23.3 mmt180 -156.17 115.33 3.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.868 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' TYR . . . . . 0.567 ' CE2' HD22 ' A' ' 233' ' ' LEU . 96.0 m-85 -69.26 128.46 36.69 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.915 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . 0.45 HG23 ' N ' ' A' ' 240' ' ' GLU . 70.7 mt -123.52 138.62 52.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.137 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . 0.45 ' N ' HG23 ' A' ' 239' ' ' ILE . 1.3 mp0 -99.95 165.76 11.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.887 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . 0.533 ' O ' ' CD1' ' A' ' 242' ' ' PHE . 18.6 mt -141.67 149.44 40.6 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.914 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 242' ' ' PHE . . . . . 0.533 ' CD1' ' O ' ' A' ' 241' ' ' LEU . 26.8 m-85 -155.65 130.26 9.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.914 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 24.9 mtp180 -52.54 122.85 9.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.889 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 3.5 t -117.84 173.64 6.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.848 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 39.8 p -149.25 161.67 41.56 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.16 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -42.89 -60.24 1.68 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.072 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -53.13 -47.92 68.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.073 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -52.43 -54.74 28.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.817 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . 0.418 HG11 ' CD2' ' A' ' 214' ' ' PHE . 94.0 t -51.79 -63.29 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.145 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -46.87 -31.23 2.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.907 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 60.5 mt-30 -77.89 -28.65 49.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.935 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 55.6 t -82.36 -15.17 12.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.152 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 13.1 mt -86.85 -42.68 13.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.883 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . 0.497 ' OD1' ' N ' ' A' ' 255' ' ' ARG . 0.7 OUTLIER -61.0 -43.28 99.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.917 179.944 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . 0.497 ' N ' ' OD1' ' A' ' 254' ' ' ASN . 15.5 ptm180 -58.7 -52.43 65.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.872 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 256' ' ' PHE . . . . . 0.535 ' CE1' ' HB ' ' A' ' 210' ' ' THR . 11.1 m-85 -67.66 -37.47 82.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.89 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 44.2 t -64.71 -34.82 79.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.865 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 22.9 t -123.59 86.58 2.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.845 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 259' ' ' ALA . . . . . . . . . . . . . . . -115.26 -37.04 4.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.1 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 1.6 t -49.67 134.38 20.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.877 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . 0.512 ' HA3' ' C ' ' A' ' 262' ' ' PRO . . . 143.48 -81.95 0.22 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.515 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 262' ' ' PRO . . . . . 0.512 ' C ' ' HA3' ' A' ' 261' ' ' GLY . 53.6 Cg_endo -69.75 177.92 27.18 Favored 'Cis proline' 0 C--N 1.341 0.17 0 C-N-CA 122.749 -1.771 . . . . 0.0 112.361 0.019 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 93.7 p -122.33 103.44 8.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.828 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 94.5 p -145.93 170.93 15.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.867 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.335 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.485 -179.964 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.285 0 N-CA-C 112.439 -0.264 . . . . 0.0 112.439 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 4.3 m -96.29 -60.53 1.6 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.892 0.377 . . . . 0.0 110.829 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 8.1 t -91.89 127.91 37.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.886 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -142.05 177.86 21.15 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.492 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' SER . . . . . 0.485 ' O ' ' N ' ' A' ' 149' ' ' GLY . 3.9 t -130.38 121.89 26.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.846 0.355 . . . . 0.0 110.845 -179.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 17.8 t -40.08 92.89 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.847 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . 0.485 ' N ' ' O ' ' A' ' 147' ' ' SER . . . -97.52 -119.35 3.88 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.489 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -96.88 97.32 1.99 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.492 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 115.61 162.83 13.56 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.459 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 4.6 m -44.82 141.92 1.96 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.813 0.339 . . . . 0.0 111.126 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 3.3 t -45.95 145.79 1.41 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.814 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -61.34 -32.09 71.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.854 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -75.95 -50.25 15.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.916 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.403 ' CG1' HD12 ' A' ' 160' ' ' LEU . 48.7 t -51.74 -33.28 15.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.116 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -48.36 -66.96 0.31 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.088 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 12.6 mm-40 -57.23 -28.31 62.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.923 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' PHE . . . . . 0.431 ' CE2' ' HG ' ' A' ' 216' ' ' LEU . 48.0 t80 -68.04 -36.89 80.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.889 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.403 HD12 ' CG1' ' A' ' 156' ' ' VAL . 81.6 mt -92.67 -20.82 20.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.926 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 3.4 t -53.16 -37.18 61.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.844 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 56.9 mmtt -50.97 127.98 20.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.912 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -103.31 137.82 40.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.861 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 4.7 m120 70.55 43.47 0.77 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.859 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 6.2 mp0 -125.75 156.48 39.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.941 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.469 HG12 ' CB ' ' A' ' 223' ' ' ALA . 38.9 t -108.5 136.45 44.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.139 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 52.0 mt -109.19 142.24 22.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.14 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 21.4 t -124.7 140.08 48.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.125 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 30.2 ttt-85 -92.09 108.89 20.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.858 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 80.6 mtp -93.93 129.9 40.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.882 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 17.8 ttm180 -132.9 140.32 47.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.826 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 89.34 24.63 30.74 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.55 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 24.0 mt -77.27 123.73 87.03 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.582 0.706 . . . . 0.0 110.917 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_exo -47.94 125.21 11.17 Favored 'Trans proline' 0 N--CA 1.465 -0.169 0 C-N-CA 122.717 2.278 . . . . 0.0 112.343 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -37.5 -33.51 0.07 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.888 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' THR . . . . . 0.444 ' O ' ' C ' ' A' ' 177' ' ' ALA . 75.0 p -78.07 -50.71 11.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.119 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . 0.444 ' C ' ' O ' ' A' ' 176' ' ' THR . . . -33.7 130.31 0.28 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.103 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 16.9 p -132.06 178.7 6.59 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.119 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.4 ' N ' ' CZ ' ' A' ' 201' ' ' PHE . . . -49.37 -46.14 46.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.1 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -56.51 -28.62 60.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.867 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . 0.424 ' CD ' HD23 ' A' ' 234' ' ' LEU . 4.5 tt0 -76.08 -44.15 40.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.879 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.401 ' O ' ' C ' ' A' ' 183' ' ' VAL . 54.8 t -63.7 -45.37 97.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.127 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . 0.401 ' C ' ' O ' ' A' ' 182' ' ' VAL . 54.6 t -37.19 -46.68 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.135 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -81.06 -37.82 28.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.093 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.547 ' CZ ' ' OD2' ' A' ' 232' ' ' ASP . 68.7 t80 -43.05 -57.03 3.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.882 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -94.6 -21.78 18.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.871 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -49.39 -17.81 1.29 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.713 -0.755 . . . . 0.0 112.514 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 15.9 mm-40 -56.13 -74.81 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.792 0.33 . . . . 0.0 110.89 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -118.27 -5.03 10.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.845 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 72.9 m -129.29 85.0 60.59 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.655 0.741 . . . . 0.0 110.921 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' PRO . . . . . 0.425 ' HD2' ' CD1' ' A' ' 222' ' ' TYR . 53.5 Cg_endo -69.74 130.47 19.43 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.711 2.274 . . . . 0.0 112.336 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 52.7 mt -80.9 144.56 10.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.17 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 91.1 m -67.59 99.68 0.8 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.144 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 95.36 -11.96 68.39 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.481 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 70.31 -126.07 15.51 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.524 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 4.5 ptmm? -48.37 -26.49 2.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.737 0.303 . . . . 0.0 110.909 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -77.92 -30.7 50.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.911 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -89.4 39.5 3.11 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.472 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 72.8 mt -140.76 137.62 35.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.842 0.353 . . . . 0.0 111.146 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 15.3 tp -132.45 114.13 13.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.931 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' PHE . . . . . 0.4 ' CZ ' ' N ' ' A' ' 179' ' ' ALA . 54.4 m-85 -93.27 121.88 35.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.863 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 95.9 t -73.46 118.52 18.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.119 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -126.89 138.03 53.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.189 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . 0.527 ' CD2' HG21 ' A' ' 210' ' ' THR . 35.8 m-85 -45.92 158.45 0.36 Allowed Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.664 0.745 . . . . 0.0 110.943 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.82 2.9 3.14 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.714 2.276 . . . . 0.0 112.318 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -109.42 -21.89 12.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.859 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 112.24 52.82 0.51 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.488 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 5.2 mpt_? -140.18 145.48 41.93 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.586 0.708 . . . . 0.0 110.874 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 107.44 1.85 Allowed 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.708 2.272 . . . . 0.0 112.347 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' THR . . . . . 0.527 HG21 ' CD2' ' A' ' 204' ' ' TYR . 69.5 p -70.82 -29.59 65.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.155 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 115.08 -42.25 1.96 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.496 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -74.39 169.38 17.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.822 0.344 . . . . 0.0 110.867 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -168.95 171.17 8.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.112 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -136.12 143.41 44.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.867 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 4.1 t -124.42 156.95 32.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.092 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . 0.431 ' HG ' ' CE2' ' A' ' 159' ' ' PHE . 28.8 mt -108.22 151.06 26.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.953 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -144.19 135.37 25.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.893 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -49.06 -58.59 4.67 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.102 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 219' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -144.73 170.93 15.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.882 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -55.68 -27.27 49.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.881 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 23.0 tp10 -51.34 -36.27 42.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.907 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 222' ' ' TYR . . . . . 0.425 ' CD1' ' HD2' ' A' ' 191' ' ' PRO . 52.9 m-85 -91.84 -47.49 7.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.911 -179.837 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . 0.469 ' CB ' HG12 ' A' ' 166' ' ' VAL . . . -52.57 -57.39 10.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.101 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 60.0 mt-30 -50.08 -48.56 53.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.916 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 18.8 m-20 -63.15 -23.96 67.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.887 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -77.12 -22.71 52.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.093 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 17.8 mt -70.51 -32.74 70.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.947 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 65.8 mtp180 -58.93 -12.33 4.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.874 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . 0.453 ' O ' ' C ' ' A' ' 230' ' ' HIS . 28.1 mttp -83.46 -1.73 54.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.926 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 230' ' ' HIS . . . . . 0.453 ' C ' ' O ' ' A' ' 229' ' ' LYS . 10.5 t60 -33.65 137.06 0.1 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.887 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.433 ' HG2' ' CG ' ' A' ' 230' ' ' HIS . 0.3 OUTLIER 59.82 34.49 21.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.929 -180.0 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . 0.547 ' OD2' ' CZ ' ' A' ' 185' ' ' PHE . 11.6 t0 -62.3 176.51 0.6 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.845 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.565 HD23 ' CE1' ' A' ' 238' ' ' TYR . 30.9 mt -134.87 107.22 7.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.903 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . 0.424 HD23 ' CD ' ' A' ' 181' ' ' GLU . 6.0 tt -114.35 112.45 23.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.935 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 57.75 40.44 92.83 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.477 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 62.3 mttt 68.93 53.21 0.49 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.774 0.321 . . . . 0.0 110.946 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 19.0 mmt180 -156.16 117.3 3.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.926 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 238' ' ' TYR . . . . . 0.565 ' CE1' HD23 ' A' ' 233' ' ' LEU . 98.8 m-85 -69.96 125.85 27.97 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.887 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . 0.452 HG22 ' N ' ' A' ' 240' ' ' GLU . 74.0 mt -121.31 137.39 55.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.138 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . 0.452 ' N ' HG22 ' A' ' 239' ' ' ILE . 1.0 OUTLIER -97.79 163.61 12.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.868 179.959 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 41.2 mt -142.91 138.8 30.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.913 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -148.35 138.88 22.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.87 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 64.6 mtm180 -56.81 132.46 52.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.876 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 5.6 t -130.37 163.21 27.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.877 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 68.0 p -134.8 160.06 39.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.152 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -44.69 -49.72 10.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.102 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -60.36 -44.06 95.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.094 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -54.92 -52.27 63.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.917 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 97.3 t -46.7 -62.06 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.141 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 19.7 mt-30 -48.92 -44.06 40.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.908 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 251' ' ' GLN . . . . . 0.469 ' O ' ' ND2' ' A' ' 254' ' ' ASN . 23.8 mt-30 -66.59 -20.04 65.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.931 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 72.8 t -88.91 -24.39 6.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.162 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 10.9 mt -85.2 -39.78 17.43 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.893 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . 0.469 ' ND2' ' O ' ' A' ' 251' ' ' GLN . 0.5 OUTLIER -65.47 -38.62 90.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.909 179.922 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 30.2 ptt180 -63.79 -37.89 89.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.898 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -80.57 -40.29 26.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.874 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 41.4 t -62.69 -44.67 95.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.837 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 63.5 m -101.15 40.22 1.31 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.878 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 259' ' ' ALA . . . . . . . . . . . . . . . -67.41 -37.55 83.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.115 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 58.1 p -102.05 163.44 12.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.899 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . 0.411 ' HA3' ' C ' ' A' ' 262' ' ' PRO . . . -159.69 -69.17 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.456 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 262' ' ' PRO . . . . . 0.411 ' C ' ' HA3' ' A' ' 261' ' ' GLY . 53.8 Cg_endo -69.76 160.95 87.17 Favored 'Cis proline' 0 C--N 1.341 0.17 0 C-N-CA 122.654 -1.811 . . . . 0.0 112.332 0.074 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 2.7 p -163.42 151.92 13.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.862 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 60.6 p -102.34 133.21 47.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.846 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.299 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.478 -179.993 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.361 0 N-CA-C 112.441 -0.263 . . . . 0.0 112.441 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 88.4 p -109.43 105.19 14.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.881 0.372 . . . . 0.0 110.89 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 87.5 p -147.12 140.07 25.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.844 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -88.78 53.57 4.02 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.459 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 65.0 p -132.43 116.6 17.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.906 0.384 . . . . 0.0 110.856 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 66.0 p -97.11 116.13 28.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.8 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -113.39 -64.25 0.45 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.489 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -99.78 -81.52 1.6 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.795 -0.716 . . . . 0.0 112.479 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -92.9 126.97 8.79 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.46 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' THR . . . . . 0.428 ' CG2' ' HB3' ' A' ' 155' ' ' GLU . 23.9 m -71.26 120.54 16.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.821 0.343 . . . . 0.0 111.147 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 28.9 p -129.24 -45.98 1.23 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.799 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -68.55 -54.03 19.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.92 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.428 ' HB3' ' CG2' ' A' ' 152' ' ' THR . 21.9 tt0 -50.65 -47.07 58.67 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.89 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.4 ' O ' ' C ' ' A' ' 157' ' ' ALA . 89.9 t -70.56 -42.26 78.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.146 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' ' 156' ' ' VAL . . . -37.57 -59.22 0.8 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.142 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 11.9 mm100 -56.97 -49.9 74.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.897 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' PHE . . . . . 0.505 ' CE2' ' HG ' ' A' ' 216' ' ' LEU . 58.8 t80 -47.8 -42.71 26.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.838 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 79.9 mt -86.32 -17.25 35.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.883 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 5.6 t -65.14 -30.87 71.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.844 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -53.14 129.38 30.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.943 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -102.93 151.78 22.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.866 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 67.1 m-80 61.85 49.73 4.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.879 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 22.2 mm-40 -131.09 168.08 18.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.887 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 45.5 t -125.06 109.22 21.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.133 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . 0.405 ' CD1' ' HA ' ' A' ' 246' ' ' ALA . 96.8 mt -79.37 139.7 17.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.148 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 66.7 t -123.67 130.46 74.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.132 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 52.1 ttp180 -88.26 105.37 17.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.911 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 98.8 mtp -94.36 129.48 41.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.914 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 40.7 mtt180 -128.99 147.08 50.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.872 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 81.26 35.96 22.2 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.475 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 25.9 mt -86.01 125.64 67.86 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.588 0.709 . . . . 0.0 110.915 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_exo -47.99 140.29 18.93 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.691 2.26 . . . . 0.0 112.363 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -53.84 -19.85 4.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.879 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 50.0 p -94.97 -19.43 20.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.14 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -56.87 125.47 22.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.096 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 1.6 p -134.22 171.14 14.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.114 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.431 ' N ' ' CZ ' ' A' ' 201' ' ' PHE . . . -43.24 -55.69 3.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.081 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -48.33 -33.96 9.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.925 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . 0.422 ' CG ' HD22 ' A' ' 234' ' ' LEU . 0.8 OUTLIER -71.59 -44.3 64.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.902 -179.92 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.401 ' O ' ' C ' ' A' ' 183' ' ' VAL . 40.3 t -65.68 -50.19 72.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.102 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . 0.401 ' C ' ' O ' ' A' ' 182' ' ' VAL . 44.7 t -37.52 -42.25 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.109 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -81.54 -39.51 24.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.115 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.538 ' CE2' ' HD3' ' A' ' 229' ' ' LYS . 60.6 t80 -43.86 -58.35 2.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.87 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' PHE . . . . . 0.401 ' CE1' ' CE2' ' A' ' 185' ' ' PHE . 73.6 m-85 -92.81 -23.66 18.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.859 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -50.16 -22.26 4.74 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.495 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 9.6 mm-40 -50.25 -75.9 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.867 0.365 . . . . 0.0 110.913 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . 0.558 ' CE1' ' HB3' ' A' ' 225' ' ' ASN . 0.3 OUTLIER -118.41 -0.29 11.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.899 179.981 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' CYS . . . . . 0.513 ' SG ' ' CD2' ' A' ' 189' ' ' HIS . 94.8 m -128.48 91.9 42.43 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.602 0.715 . . . . 0.0 110.886 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 135.74 31.26 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.73 2.286 . . . . 0.0 112.346 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 62.1 mt -92.6 145.54 7.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.138 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 88.6 m -67.13 104.33 1.41 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.107 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 87.93 -15.32 55.99 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.502 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 73.57 -119.63 6.63 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.504 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.79 -21.32 2.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.748 0.309 . . . . 0.0 110.895 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -87.03 -25.52 24.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.885 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -88.65 33.11 4.27 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.462 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . 0.426 HG23 ' N ' ' A' ' 200' ' ' LEU . 29.0 mt -138.72 153.15 25.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.822 0.344 . . . . 0.0 111.144 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.426 ' N ' HG23 ' A' ' 199' ' ' ILE . 14.0 tp -146.96 113.0 5.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.921 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' PHE . . . . . 0.431 ' CZ ' ' N ' ' A' ' 179' ' ' ALA . 35.9 m-85 -93.72 121.51 35.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.895 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . 0.406 ' CB ' ' OD2' ' A' ' 212' ' ' ASP . 42.1 t -74.39 123.46 29.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.161 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -134.18 137.08 44.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.096 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -46.09 158.42 0.37 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.69 0.757 . . . . 0.0 110.915 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.7 3.04 2.97 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.66 2.24 . . . . 0.0 112.387 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -113.03 -10.05 13.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.882 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 99.92 58.85 0.87 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.459 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 11.2 mmm180 -142.3 143.38 27.01 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.614 0.721 . . . . 0.0 110.86 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.66 109.6 2.33 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.721 2.281 . . . . 0.0 112.371 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' THR . . . . . 0.569 ' HB ' ' CE2' ' A' ' 256' ' ' PHE . 19.8 p -73.43 -32.01 64.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.156 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 112.97 -30.28 7.51 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.487 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 212' ' ' ASP . . . . . 0.406 ' OD2' ' CB ' ' A' ' 202' ' ' VAL . 1.0 OUTLIER -88.45 163.98 15.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.785 0.326 . . . . 0.0 110.876 -179.975 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -162.76 177.37 9.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.091 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . 0.495 ' CD2' HG11 ' A' ' 249' ' ' VAL . 41.2 m-85 -142.35 139.41 31.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.87 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 6.2 t -123.0 156.89 28.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.15 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . 0.505 ' HG ' ' CE2' ' A' ' 159' ' ' PHE . 32.4 mt -109.92 138.8 45.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.922 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -130.12 133.9 46.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.858 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -44.81 -64.53 0.68 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.136 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 219' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -144.23 160.2 41.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.835 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -40.92 -29.51 0.1 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.893 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -47.57 -49.89 25.37 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.9 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 222' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -78.03 -50.99 11.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.893 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -44.85 -57.08 3.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.158 179.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 8.6 mm-40 -48.52 -60.92 2.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.914 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . 0.558 ' HB3' ' CE1' ' A' ' 189' ' ' HIS . 30.3 m-20 -51.86 -21.51 2.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.915 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -83.24 -33.86 25.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.094 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 32.2 mt -60.67 -28.9 68.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.924 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.11 -18.06 55.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.878 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . 0.538 ' HD3' ' CE2' ' A' ' 185' ' ' PHE . 16.2 mttm -80.02 0.19 32.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.891 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 230' ' ' HIS . . . . . 0.464 ' C ' ' O ' ' A' ' 229' ' ' LYS . 8.6 t60 -32.66 126.93 0.29 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.872 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 43.7 mtmt 61.84 37.1 15.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.938 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -60.72 -174.93 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.852 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.556 HD21 ' CE1' ' A' ' 238' ' ' TYR . 33.0 mt -138.8 105.64 5.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.907 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . 0.422 HD22 ' CG ' ' A' ' 181' ' ' GLU . 7.1 tt -113.35 114.8 27.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.873 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 59.22 37.67 92.13 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.494 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 33.3 mttt 69.14 52.37 0.49 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.774 0.321 . . . . 0.0 110.898 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 23.3 mmt180 -156.24 115.26 3.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.835 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 238' ' ' TYR . . . . . 0.556 ' CE1' HD21 ' A' ' 233' ' ' LEU . 97.3 m-85 -63.71 128.22 34.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.95 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 97.4 mt -127.04 129.71 71.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.08 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . 0.562 ' HB3' ' CE2' ' A' ' 242' ' ' PHE . 3.9 mp0 -85.33 171.92 11.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.85 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . 0.595 ' O ' ' CD1' ' A' ' 242' ' ' PHE . 21.3 mt -154.46 138.75 16.64 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.909 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 242' ' ' PHE . . . . . 0.595 ' CD1' ' O ' ' A' ' 241' ' ' LEU . 6.6 m-85 -158.45 123.43 4.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.878 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . 0.496 ' CG ' ' O ' ' A' ' 243' ' ' ARG . 21.2 ptt180 -60.89 117.33 5.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.85 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 1.7 t -112.49 168.52 9.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.858 -179.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.6 p -109.45 173.83 6.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.168 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 246' ' ' ALA . . . . . 0.405 ' HA ' ' CD1' ' A' ' 167' ' ' ILE . . . -61.63 -63.74 1.17 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.1 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -43.76 -49.67 7.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.074 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -47.27 -57.64 4.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.863 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . 0.495 HG11 ' CD2' ' A' ' 214' ' ' PHE . 97.8 t -44.65 -61.68 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.136 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 53.1 mt-30 -47.59 -29.55 2.98 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.916 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -82.4 -26.43 32.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.933 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 53.3 t -82.63 -15.31 11.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.131 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 13.4 mt -86.82 -43.06 12.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.887 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . 0.5 ' OD1' ' N ' ' A' ' 255' ' ' ARG . 0.6 OUTLIER -61.67 -44.49 96.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.85 179.943 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . 0.5 ' N ' ' OD1' ' A' ' 254' ' ' ASN . 11.4 ptm180 -54.17 -31.03 51.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.84 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 256' ' ' PHE . . . . . 0.569 ' CE2' ' HB ' ' A' ' 210' ' ' THR . 16.7 m-85 -91.34 -36.84 13.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.87 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 33.4 t -63.29 -74.22 0.1 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.895 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 46.3 m -92.91 64.83 4.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.879 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 259' ' ' ALA . . . . . . . . . . . . . . . -72.16 114.87 10.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.093 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 30.9 t -109.09 -53.09 2.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.894 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . 0.42 ' HA3' ' C ' ' A' ' 262' ' ' PRO . . . 158.75 -69.48 0.26 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.519 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 262' ' ' PRO . . . . . 0.42 ' C ' ' HA3' ' A' ' 261' ' ' GLY . 53.7 Cg_endo -69.77 -38.64 1.56 Allowed 'Cis proline' 0 C--N 1.342 0.209 0 C-N-CA 122.654 -1.811 . . . . 0.0 112.359 0.021 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 14.2 t -147.97 156.26 42.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.808 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 8.5 t 48.41 46.46 20.51 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.856 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.298 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.457 179.989 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 N-CA-C 112.496 -0.242 . . . . 0.0 112.496 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 70.2 p -44.11 99.91 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.875 0.369 . . . . 0.0 110.866 -179.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 6.4 t -147.65 163.86 35.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.916 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -116.54 83.76 0.35 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.479 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 80.3 p -80.82 149.74 29.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.869 0.366 . . . . 0.0 110.855 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 8.5 t -101.22 -61.05 1.42 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.871 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 144.21 112.45 0.83 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.458 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -168.0 73.99 0.14 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.49 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 107.8 -176.78 20.86 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.449 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' THR . . . . . 0.409 ' HA ' ' CD ' ' A' ' 155' ' ' GLU . 0.3 OUTLIER -110.27 -14.68 14.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.852 0.358 . . . . 0.0 111.17 -179.886 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 24.3 m -62.72 -30.13 71.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.802 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -76.3 -57.53 3.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.935 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.409 ' CD ' ' HA ' ' A' ' 152' ' ' THR . 5.0 pt-20 -55.53 -60.13 3.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.846 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 79.0 t -43.34 -39.13 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.154 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -45.46 -48.08 13.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.065 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -69.83 -42.07 74.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.909 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' PHE . . . . . 0.454 ' CD2' ' HB2' ' A' ' 200' ' ' LEU . 41.2 t80 -56.07 -41.77 75.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.899 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 91.0 mt -85.56 -26.05 26.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.903 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 31.6 t -54.62 -26.51 33.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.881 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 18.2 mmmt -61.99 128.77 37.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.873 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -105.99 154.08 21.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.861 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 62.35 49.35 4.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.858 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 24.3 mm-40 -137.21 153.47 50.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.92 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 55.7 t -108.03 119.8 58.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.149 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . 0.465 HD13 ' N ' ' A' ' 246' ' ' ALA . 10.8 mt -90.66 147.83 4.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.156 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 95.6 t -128.53 141.43 46.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.127 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 29.0 ttp85 -95.51 107.17 19.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.877 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' MET . . . . . 0.469 ' HE2' ' CD2' ' A' ' 173' ' ' LEU . 89.7 mtp -92.56 127.11 37.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.932 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . 0.411 ' HG3' ' N ' ' A' ' 172' ' ' GLY . 3.8 tpt180 -123.83 144.89 49.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.881 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . 0.411 ' N ' ' HG3' ' A' ' 171' ' ' ARG . . . 79.01 33.63 36.02 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.464 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.503 ' CD1' ' CB ' ' A' ' 213' ' ' ALA . 21.8 mt -81.39 119.33 75.38 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.574 0.702 . . . . 0.0 110.896 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . 0.481 ' O ' ' N ' ' A' ' 177' ' ' ALA . 65.2 Cg_exo -47.94 130.0 18.95 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.695 2.263 . . . . 0.0 112.368 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 34.7 m-85 -41.49 -41.07 1.98 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.889 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 65.3 p -75.52 -29.47 59.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.157 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . 0.481 ' N ' ' O ' ' A' ' 174' ' ' PRO . . . -45.74 112.62 0.49 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.085 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -113.4 170.36 8.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.127 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -46.5 -56.53 5.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.112 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -45.43 -30.18 1.3 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.856 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . 0.443 ' CG ' HD23 ' A' ' 234' ' ' LEU . 2.2 tp10 -71.59 -41.61 68.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.885 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.432 ' O ' ' C ' ' A' ' 183' ' ' VAL . 55.8 t -69.25 -47.41 73.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.107 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . 0.432 ' C ' ' O ' ' A' ' 182' ' ' VAL . 70.8 t -35.26 -54.25 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.08 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -74.78 -39.2 61.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.086 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -41.54 -58.27 1.97 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.87 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' PHE . . . . . 0.481 ' CD1' ' HB3' ' A' ' 226' ' ' ALA . 71.5 m-85 -94.3 -21.32 19.07 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.871 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -49.15 -25.78 5.81 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.463 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -48.3 -72.77 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.836 0.351 . . . . 0.0 110.91 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 14.2 m170 -118.26 -15.52 9.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.894 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 63.8 m -118.41 85.17 25.13 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.638 0.732 . . . . 0.0 110.94 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' PRO . . . . . 0.447 ' HD2' ' CD1' ' A' ' 222' ' ' TYR . 53.3 Cg_endo -69.75 139.9 41.39 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.686 2.257 . . . . 0.0 112.348 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 49.6 mt -91.82 144.69 8.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.135 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 55.0 m -67.3 108.28 2.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.157 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 86.94 -22.18 15.8 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.447 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . 0.409 ' O ' ' N ' ' A' ' 198' ' ' GLY . . . 82.52 -126.56 7.51 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.484 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 8.8 ptpt -46.48 -22.25 0.25 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.767 0.318 . . . . 0.0 110.894 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -82.23 -33.69 29.17 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.912 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 195' ' ' GLY . . . -84.98 35.4 3.11 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.466 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . 0.504 HG21 ' CE1' ' A' ' 201' ' ' PHE . 27.5 mt -138.8 139.92 39.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.828 0.347 . . . . 0.0 111.148 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.454 ' HB2' ' CD2' ' A' ' 159' ' ' PHE . 14.5 tp -137.19 111.83 8.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.939 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' PHE . . . . . 0.504 ' CE1' HG21 ' A' ' 199' ' ' ILE . 84.3 m-85 -90.43 123.43 34.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.901 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 59.0 t -73.51 118.32 18.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.144 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -127.95 137.14 52.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.124 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -45.99 158.75 0.35 Allowed Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.63 0.729 . . . . 0.0 110.918 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.83 3.58 2.72 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.631 2.221 . . . . 0.0 112.327 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -112.4 -21.28 11.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.861 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 113.53 56.41 0.41 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.525 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 7.6 mpt_? -143.53 146.5 35.84 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.554 0.692 . . . . 0.0 110.904 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 111.17 2.74 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.669 2.246 . . . . 0.0 112.363 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' THR . . . . . 0.559 ' HB ' ' CE2' ' A' ' 256' ' ' PHE . 62.0 p -73.09 -14.03 61.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.152 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 97.57 -31.33 7.93 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.523 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -90.38 168.4 11.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.827 0.346 . . . . 0.0 110.832 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . 0.503 ' CB ' ' CD1' ' A' ' 173' ' ' LEU . . . -165.01 174.86 10.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.12 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -137.71 151.37 48.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.899 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . 0.402 ' CG2' ' SD ' ' A' ' 170' ' ' MET . 6.9 t -134.76 155.0 37.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.129 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 29.5 mt -108.48 144.05 36.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.915 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -136.41 141.33 43.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.9 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -53.9 -57.17 11.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.156 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 219' ' ' CYS . . . . . . . . . . . . . 95.2 m -136.4 -179.22 5.55 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.887 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -70.14 -28.62 65.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.921 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -48.02 -50.01 29.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.904 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 222' ' ' TYR . . . . . 0.447 ' CD1' ' HD2' ' A' ' 191' ' ' PRO . 29.6 m-85 -74.0 -49.73 23.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.921 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -47.64 -56.75 6.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.107 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -55.87 -52.74 63.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.91 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -49.96 -31.73 13.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.917 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . 0.481 ' HB3' ' CD1' ' A' ' 186' ' ' PHE . . . -75.41 -35.77 60.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.09 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 89.8 mt -52.43 -39.6 61.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.921 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 34.8 mtt85 -54.99 -26.0 33.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.843 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . 0.458 ' O ' ' C ' ' A' ' 230' ' ' HIS . 6.9 mtpm? -69.86 -2.48 12.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.922 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 230' ' ' HIS . . . . . 0.513 ' CE1' ' HD3' ' A' ' 231' ' ' LYS . 12.0 t60 -33.86 136.67 0.11 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.845 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.513 ' HD3' ' CE1' ' A' ' 230' ' ' HIS . 1.2 mmmp? 62.96 29.43 16.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.909 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . 0.423 ' OD1' ' NZ ' ' A' ' 229' ' ' LYS . 2.7 t70 -58.34 -179.69 0.06 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.88 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.571 HD21 ' CE1' ' A' ' 238' ' ' TYR . 30.2 mt -138.19 107.78 6.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.925 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . 0.443 HD23 ' CG ' ' A' ' 181' ' ' GLU . 6.1 tt -117.83 111.2 18.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.915 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 60.12 43.23 98.54 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.47 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 64.66 53.8 1.5 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.723 0.297 . . . . 0.0 110.915 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 237' ' ' ARG . . . . . 0.416 ' CB ' ' HG3' ' A' ' 174' ' ' PRO . 14.2 mmt85 -156.65 115.48 3.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.877 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 238' ' ' TYR . . . . . 0.571 ' CE1' HD21 ' A' ' 233' ' ' LEU . 97.2 m-85 -69.69 123.68 22.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.975 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 37.9 mt -119.74 145.9 25.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.132 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . 0.445 ' HB3' ' CZ ' ' A' ' 242' ' ' PHE . 38.9 mt-10 -111.35 159.51 17.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.829 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 17.0 mt -136.58 123.87 21.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.98 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 242' ' ' PHE . . . . . 0.445 ' CZ ' ' HB3' ' A' ' 240' ' ' GLU . 4.1 m-85 -131.05 129.57 42.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.855 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 70.2 mtt180 -42.61 150.8 0.14 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.943 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 1.3 t -152.18 156.06 39.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.869 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 50.6 p -131.11 165.92 22.22 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.109 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 246' ' ' ALA . . . . . 0.465 ' N ' HD13 ' A' ' 167' ' ' ILE . . . -48.41 -52.74 20.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.121 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -58.6 -47.92 82.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.098 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -51.64 -55.54 18.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.849 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . 0.402 ' O ' ' C ' ' A' ' 250' ' ' GLN . 91.2 t -42.45 -65.21 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.161 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 250' ' ' GLN . . . . . 0.402 ' C ' ' O ' ' A' ' 249' ' ' VAL . 30.4 mt-30 -38.08 -57.84 1.02 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.93 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -52.33 -44.25 65.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.927 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 91.1 t -59.95 -31.43 47.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.105 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 7.9 mt -79.51 -39.46 31.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.945 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 16.6 m-80 -66.97 -49.0 66.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.904 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . 0.464 ' CZ ' ' HB2' ' A' ' 255' ' ' ARG . 2.7 ptm85 -53.35 -43.5 67.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.826 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 256' ' ' PHE . . . . . 0.559 ' CE2' ' HB ' ' A' ' 210' ' ' THR . 13.1 m-85 -76.34 -37.59 57.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.862 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 24.1 p -73.58 160.38 31.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.813 -179.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 62.7 m 63.97 31.05 13.98 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.848 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 259' ' ' ALA . . . . . . . . . . . . . . . -116.22 143.62 45.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.108 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 1.9 t -124.14 173.19 8.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.82 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -106.4 -163.42 22.67 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.482 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 262' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 -35.98 2.5 Favored 'Cis proline' 0 C--N 1.341 0.175 0 C-N-CA 122.671 -1.804 . . . . 0.0 112.369 0.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 2.5 m 63.5 44.09 5.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.867 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 33.5 t -144.35 150.38 37.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.83 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.274 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.488 -179.997 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.31 0 N-CA-C 112.521 -0.231 . . . . 0.0 112.521 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 3.8 m -117.95 139.57 50.97 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.884 0.373 . . . . 0.0 110.848 -179.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 26.0 t -75.33 -61.64 1.83 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.858 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 108.49 -110.75 3.14 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.477 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 36.1 m 44.58 41.52 4.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.937 0.399 . . . . 0.0 110.9 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 22.8 t -150.59 146.32 26.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.834 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 100.54 169.7 28.99 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.47 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -64.19 -97.17 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.484 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -75.53 136.64 20.45 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.47 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 2.1 m -69.38 115.81 9.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.793 0.33 . . . . 0.0 111.125 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 18.5 m -130.04 -50.59 1.12 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.831 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -64.49 -50.94 65.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.903 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -51.99 -51.16 59.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.935 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 90.2 t -63.44 -47.4 91.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.156 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -40.01 -61.07 0.92 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.105 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -59.13 -40.69 86.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.909 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' PHE . . . . . 0.521 ' CE2' ' HG ' ' A' ' 216' ' ' LEU . 49.2 t80 -56.41 -40.55 74.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.873 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 86.6 mt -87.94 -24.37 23.61 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.868 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 28.7 t -58.72 -27.38 64.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.843 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 28.6 mmmt -60.75 125.74 24.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.872 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -101.26 150.46 22.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.89 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 34.8 m-20 62.51 49.4 4.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.882 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.9 mm-40 -133.9 143.6 48.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.899 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 48.6 t -100.22 107.23 20.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.188 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 36.7 mt -75.95 134.13 29.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.143 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.466 HG22 ' CD1' ' A' ' 217' ' ' PHE . 57.9 t -116.22 128.46 73.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.127 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 45.8 ttp180 -88.35 108.25 19.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.884 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' MET . . . . . 0.461 ' HE1' ' CD2' ' A' ' 173' ' ' LEU . 97.0 mtp -92.6 113.33 25.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.859 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 8.3 ttp180 -117.21 139.28 50.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.912 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 91.38 25.04 24.81 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.507 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.461 ' CD2' ' HE1' ' A' ' 170' ' ' MET . 19.5 mt -80.27 129.01 71.14 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.612 0.72 . . . . 0.0 110.919 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . 0.414 ' HG3' ' CB ' ' A' ' 237' ' ' ARG . 64.8 Cg_exo -47.92 136.35 22.92 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.75 2.3 . . . . 0.0 112.335 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 8.8 m-30 -50.98 -19.97 1.2 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.86 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 64.1 p -94.98 -28.77 14.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.098 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -41.85 120.64 1.58 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.083 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 40.1 p -116.01 179.56 3.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.164 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -54.12 -48.57 70.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.111 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -52.84 -42.29 65.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.875 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -58.87 -37.14 75.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.895 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 15.5 t -73.21 -47.25 47.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.121 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 42.8 t -39.83 -49.82 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.067 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . 0.428 ' O ' ' C ' ' A' ' 185' ' ' PHE . . . -74.25 -44.71 51.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.106 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.473 ' CD2' ' CZ ' ' A' ' 186' ' ' PHE . 53.9 t80 -36.42 -60.56 0.57 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.864 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' PHE . . . . . 0.473 ' CZ ' ' CD2' ' A' ' 185' ' ' PHE . 42.4 m-85 -95.06 -25.0 16.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.885 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -49.15 -21.31 2.56 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.469 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 42.0 tt0 -55.18 -70.66 0.1 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.816 0.341 . . . . 0.0 110.908 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 20.3 m80 -118.21 -16.72 9.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.853 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' CYS . . . . . 0.406 ' N ' ' O ' ' A' ' 186' ' ' PHE . 70.9 m -120.36 87.26 40.15 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.603 0.716 . . . . 0.0 110.86 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 130.55 19.6 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.692 2.261 . . . . 0.0 112.331 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 54.7 mt -78.1 144.57 11.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.15 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 29.3 m -71.29 104.43 3.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.183 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 91.98 -17.17 57.64 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.497 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . 0.414 ' O ' ' N ' ' A' ' 198' ' ' GLY . . . 70.22 -124.12 13.21 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.516 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 31.4 mtmm -46.09 -30.58 1.94 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.679 0.276 . . . . 0.0 110.859 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -78.13 -32.01 50.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.893 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 195' ' ' GLY . . . -88.46 29.65 5.62 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.492 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . 0.542 HG21 ' CE2' ' A' ' 201' ' ' PHE . 70.2 mt -131.4 142.12 44.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.89 0.376 . . . . 0.0 111.127 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 13.0 tp -139.7 111.74 7.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.919 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' PHE . . . . . 0.542 ' CE2' HG21 ' A' ' 199' ' ' ILE . 97.1 m-85 -96.27 119.26 34.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.909 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 21.7 t -71.51 130.18 35.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.109 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -140.59 137.59 33.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.151 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -48.76 158.88 0.6 Allowed Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.681 0.753 . . . . 0.0 110.903 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 3.05 2.99 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.74 2.293 . . . . 0.0 112.357 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -112.37 -15.29 13.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.864 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 112.25 9.89 18.93 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.501 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -89.64 140.67 28.16 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.603 0.716 . . . . 0.0 110.855 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 115.59 4.16 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.651 2.234 . . . . 0.0 112.339 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' THR . . . . . 0.542 ' HB ' ' CE2' ' A' ' 256' ' ' PHE . 69.8 p -80.24 -21.49 42.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.107 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 95.3 -46.38 2.01 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.515 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -68.64 154.64 41.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.816 0.341 . . . . 0.0 110.875 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . 0.438 ' O ' ' CD1' ' A' ' 214' ' ' PHE . . . -153.53 -175.27 5.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.096 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . 0.438 ' CD1' ' O ' ' A' ' 213' ' ' ALA . 52.8 m-85 -150.63 139.49 20.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.851 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 21.4 t -125.69 162.34 28.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.132 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . 0.521 ' HG ' ' CE2' ' A' ' 159' ' ' PHE . 31.2 mt -112.48 137.23 50.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.919 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . 0.466 ' CD1' HG22 ' A' ' 168' ' ' VAL . 76.4 m-85 -132.5 138.88 47.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.844 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . 0.429 ' HB3' ' CD2' ' A' ' 222' ' ' TYR . . . -48.39 -65.72 0.52 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.147 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 219' ' ' CYS . . . . . . . . . . . . . 2.6 m -154.85 174.81 14.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.845 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -39.81 -42.73 1.33 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.915 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -41.14 -43.31 2.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.896 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 222' ' ' TYR . . . . . 0.429 ' CD2' ' HB3' ' A' ' 218' ' ' ALA . 57.1 m-85 -92.35 -46.27 7.78 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.912 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -52.14 -64.12 0.92 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.104 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 23.0 mm-40 -50.65 -55.93 14.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.945 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . 0.439 ' O ' ' CG ' ' A' ' 228' ' ' ARG . 24.2 m-20 -52.14 -21.24 3.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.903 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -93.83 -34.19 13.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.089 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 63.4 mt -57.65 -32.77 67.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.886 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . 0.439 ' CG ' ' O ' ' A' ' 225' ' ' ASN . 3.0 ptm180 -58.52 -13.05 4.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.879 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . 0.456 ' O ' ' C ' ' A' ' 230' ' ' HIS . 16.1 mtpp -86.13 -0.37 55.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.924 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 230' ' ' HIS . . . . . 0.551 ' CE1' ' HG3' ' A' ' 231' ' ' LYS . 48.2 t60 -33.94 131.54 0.27 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.879 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.551 ' HG3' ' CE1' ' A' ' 230' ' ' HIS . 36.8 mttp 62.37 35.36 15.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.879 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -62.01 -176.37 0.09 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.878 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.551 HD23 ' CD1' ' A' ' 238' ' ' TYR . 31.7 mt -133.9 112.42 11.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.893 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 7.3 tt -121.47 117.89 27.98 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.919 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 57.05 36.35 73.74 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.508 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 26.9 mmtm 69.13 50.73 0.56 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.806 0.336 . . . . 0.0 110.889 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 237' ' ' ARG . . . . . 0.414 ' CB ' ' HG3' ' A' ' 174' ' ' PRO . 44.7 mmt-85 -156.06 115.28 3.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.826 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 238' ' ' TYR . . . . . 0.551 ' CD1' HD23 ' A' ' 233' ' ' LEU . 97.5 m-85 -66.58 136.36 55.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.949 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . 0.425 HD11 ' CD2' ' A' ' 173' ' ' LEU . 79.2 mt -135.88 126.21 42.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.154 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . 0.572 ' HB3' ' CZ ' ' A' ' 242' ' ' PHE . 6.7 mp0 -84.81 166.33 17.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.908 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . 0.451 ' O ' ' CD1' ' A' ' 242' ' ' PHE . 15.1 mt -148.13 134.03 19.1 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.89 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 242' ' ' PHE . . . . . 0.572 ' CZ ' ' HB3' ' A' ' 240' ' ' GLU . 7.3 m-85 -145.42 120.92 10.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.886 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . 0.486 ' CG ' ' O ' ' A' ' 243' ' ' ARG . 18.4 ptt-85 -57.15 118.25 4.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.883 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 7.5 t -114.4 -174.98 2.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.887 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 245' ' ' THR . . . . . 0.451 ' O ' ' CG2' ' A' ' 249' ' ' VAL . 67.8 p -135.64 179.16 6.51 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.162 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -60.86 -53.62 55.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.091 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -52.95 -58.17 7.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.146 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -49.44 -55.92 11.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.893 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . 0.451 ' CG2' ' O ' ' A' ' 245' ' ' THR . 97.3 t -39.68 -65.58 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.149 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 250' ' ' GLN . . . . . 0.432 ' O ' ' N ' ' A' ' 253' ' ' LEU . 52.2 mt-30 -37.55 -66.72 0.23 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.885 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 28.9 mm-40 -40.97 -39.69 1.23 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.941 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 28.3 t -65.04 -39.44 85.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.125 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . 0.432 ' N ' ' O ' ' A' ' 250' ' ' GLN . 7.1 mt -76.89 -36.17 56.87 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.919 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -71.43 -49.77 38.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.89 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . 0.541 ' CG ' ' N ' ' A' ' 256' ' ' PHE . 5.2 ptm180 -49.66 -50.75 42.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.83 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 256' ' ' PHE . . . . . 0.542 ' CE2' ' HB ' ' A' ' 210' ' ' THR . 12.4 m-85 -65.04 -33.6 76.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.877 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 14.2 m -72.82 136.55 45.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.849 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 23.1 t 61.28 53.22 3.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.9 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 259' ' ' ALA . . . . . . . . . . . . . . . -73.44 111.39 8.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.085 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 6.7 t -58.78 -67.9 0.32 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.863 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 134.54 -162.76 24.67 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.43 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 262' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 173.13 45.88 Favored 'Cis proline' 0 C--N 1.341 0.179 0 C-N-CA 122.705 -1.79 . . . . 0.0 112.341 0.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 47.1 t -64.34 -34.62 78.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.862 -179.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 23.3 t -63.62 140.82 58.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.85 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.313 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.494 -179.973 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.381 0 N-CA-C 112.541 -0.223 . . . . 0.0 112.541 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 7.6 t -121.41 131.89 54.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.849 0.357 . . . . 0.0 110.869 -179.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 16.3 t -147.64 133.23 18.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.868 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 96.69 170.58 34.27 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.501 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 17.4 t -99.27 80.43 2.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.887 0.375 . . . . 0.0 110.852 -179.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 2.2 t 56.34 31.11 18.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.826 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -94.7 97.55 2.17 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.486 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 151.74 -68.6 0.32 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.469 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 168.14 -144.76 9.1 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.463 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' THR . . . . . 0.43 ' O ' ' C ' ' A' ' 153' ' ' SER . 1.5 m -130.77 -41.63 1.16 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.818 0.342 . . . . 0.0 111.108 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' SER . . . . . 0.43 ' C ' ' O ' ' A' ' 152' ' ' THR . 44.3 t -35.31 -36.08 0.06 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.818 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . 0.413 ' N ' ' O ' ' A' ' 152' ' ' THR . 4.4 p-10 -57.98 -58.07 10.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.883 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -68.44 -38.79 81.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.876 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 76.6 t -60.39 -36.99 72.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.147 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -43.68 -62.25 1.15 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.076 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -60.83 -42.54 97.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.93 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' PHE . . . . . 0.528 ' CE2' ' HG ' ' A' ' 216' ' ' LEU . 59.6 t80 -52.7 -38.85 61.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.853 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 82.9 mt -89.96 -29.03 18.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.946 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 1.7 t -52.04 -33.34 38.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.852 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 27.4 mmmt -45.5 116.68 1.22 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.868 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -84.55 149.96 25.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.869 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 47.71 44.85 17.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.907 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . 0.471 ' NE2' ' HA ' ' A' ' 218' ' ' ALA . 0.4 OUTLIER -117.1 153.13 33.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.907 -179.974 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 46.8 t -106.23 139.06 28.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.157 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . 0.448 HD12 ' N ' ' A' ' 246' ' ' ALA . 26.0 mt -113.07 137.22 46.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.113 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.521 HG22 ' CD1' ' A' ' 217' ' ' PHE . 94.1 t -114.2 138.23 44.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.123 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . 0.467 ' N ' HG11 ' A' ' 168' ' ' VAL . 39.9 ttt-85 -93.81 109.25 20.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.893 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' MET . . . . . 0.453 ' HE1' ' CD2' ' A' ' 173' ' ' LEU . 83.6 mtp -99.51 126.39 45.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.908 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 11.0 mtp85 -127.15 145.17 50.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.866 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 81.5 32.63 30.29 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.482 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.456 ' CD1' ' HB2' ' A' ' 213' ' ' ALA . 22.1 mt -82.84 121.28 77.5 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.658 0.742 . . . . 0.0 110.929 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . 0.485 ' O ' ' N ' ' A' ' 176' ' ' THR . 66.6 Cg_exo -48.02 121.44 5.97 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.661 2.24 . . . . 0.0 112.333 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . 0.567 ' CD2' ' HG2' ' A' ' 209' ' ' PRO . 3.4 m-85 -37.21 -29.13 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.859 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' THR . . . . . 0.485 ' N ' ' O ' ' A' ' 174' ' ' PRO . 73.7 p -80.83 -44.01 19.14 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.161 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . 0.476 ' N ' ' O ' ' A' ' 174' ' ' PRO . . . -34.27 125.45 0.49 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.064 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 12.0 p -118.49 177.07 4.96 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.151 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -52.46 -44.91 65.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.113 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -56.18 -41.54 75.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.885 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -57.83 -39.38 77.54 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.882 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.433 ' O ' ' C ' ' A' ' 183' ' ' VAL . 54.7 t -71.99 -52.39 25.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.112 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . 0.433 ' C ' ' O ' ' A' ' 182' ' ' VAL . 89.9 t -35.13 -47.27 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.14 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -79.65 -39.33 31.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.138 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.566 ' CE2' ' HE3' ' A' ' 229' ' ' LYS . 58.2 t80 -41.33 -58.78 1.74 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.903 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' PHE . . . . . 0.491 ' O ' ' N ' ' A' ' 190' ' ' CYS . 63.1 m-85 -96.41 -23.32 16.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.915 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -52.68 -21.15 8.83 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.498 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' GLN . . . . . 0.485 ' NE2' ' O ' ' A' ' 185' ' ' PHE . 1.5 pt20 -59.19 -60.04 4.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.858 0.361 . . . . 0.0 110.91 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . 0.6 ' CE1' ' SG ' ' A' ' 190' ' ' CYS . 0.3 OUTLIER -119.02 -29.11 5.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.843 179.968 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' CYS . . . . . 0.6 ' SG ' ' CE1' ' A' ' 189' ' ' HIS . 93.1 m -116.54 89.78 28.66 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.632 0.729 . . . . 0.0 110.853 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' PRO . . . . . 0.437 ' HD2' ' CD1' ' A' ' 222' ' ' TYR . 53.5 Cg_endo -69.8 132.65 23.73 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.67 2.246 . . . . 0.0 112.305 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 59.4 mt -82.9 145.17 8.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.105 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 98.0 m -63.68 102.14 0.42 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.138 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 88.38 -16.92 51.28 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.476 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . 0.455 ' O ' ' N ' ' A' ' 198' ' ' GLY . . . 75.3 -129.18 10.34 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.502 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 3.9 pttm -41.23 -37.07 0.87 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.762 0.315 . . . . 0.0 110.912 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -70.87 -37.39 73.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.896 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . 0.455 ' N ' ' O ' ' A' ' 195' ' ' GLY . . . -83.06 36.21 2.73 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.534 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 72.1 mt -139.0 148.91 23.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.83 0.348 . . . . 0.0 111.111 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 23.5 tp -137.4 120.94 17.18 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.912 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -101.92 111.37 23.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.883 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 59.7 t -66.09 136.29 26.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.137 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -142.83 141.4 31.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.12 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -47.58 159.42 0.44 Allowed Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.718 0.77 . . . . 0.0 110.886 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 4.18 2.34 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.641 2.227 . . . . 0.0 112.324 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -111.8 -23.42 10.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.839 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 115.05 49.18 0.51 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.516 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 76.4 mtp180 -134.5 147.1 61.98 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.578 0.704 . . . . 0.0 110.886 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . 0.567 ' HG2' ' CD2' ' A' ' 175' ' ' PHE . 54.2 Cg_endo -69.72 99.62 0.76 Allowed 'Trans proline' 0 N--CA 1.465 -0.174 0 C-N-CA 122.682 2.255 . . . . 0.0 112.396 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 65.8 p -60.4 -33.3 72.29 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.137 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 115.33 -30.2 6.87 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.486 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -85.65 163.34 18.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.797 0.332 . . . . 0.0 110.876 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . 0.456 ' HB2' ' CD1' ' A' ' 173' ' ' LEU . . . -166.69 159.25 13.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.082 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . 0.501 ' CD2' HG13 ' A' ' 249' ' ' VAL . 71.8 m-85 -124.62 162.78 23.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.903 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . 0.423 ' CG1' ' N ' ' A' ' 216' ' ' LEU . 43.3 t -140.34 163.95 22.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.091 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . 0.528 ' HG ' ' CE2' ' A' ' 159' ' ' PHE . 62.3 mt -115.2 145.38 42.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.902 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . 0.521 ' CD1' HG22 ' A' ' 168' ' ' VAL . 80.1 m-85 -141.89 131.58 24.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.869 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . 0.471 ' HA ' ' NE2' ' A' ' 165' ' ' GLN . . . -42.77 -54.14 4.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.116 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 219' ' ' CYS . . . . . . . . . . . . . 5.0 m -157.15 179.99 8.76 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.888 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . 0.422 ' O ' ' C ' ' A' ' 221' ' ' GLU . 0.7 OUTLIER -52.69 -39.48 61.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.915 -179.961 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . 0.422 ' C ' ' O ' ' A' ' 220' ' ' GLU . 29.7 tt0 -36.89 -49.51 0.81 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.897 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 222' ' ' TYR . . . . . 0.437 ' CD1' ' HD2' ' A' ' 191' ' ' PRO . 42.7 m-85 -87.84 -46.98 8.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.933 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -52.99 -62.53 1.59 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.077 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 56.1 mm-40 -47.45 -61.72 1.78 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.934 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 30.6 m-20 -45.44 -31.96 1.94 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.905 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -69.55 -38.05 77.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.089 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 29.0 mt -51.84 -29.34 19.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.934 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 8.9 mpt_? -61.39 -30.03 70.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.851 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . 0.566 ' HE3' ' CE2' ' A' ' 185' ' ' PHE . 20.1 mtpp -71.55 -0.83 11.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.868 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 230' ' ' HIS . . . . . 0.449 ' C ' ' O ' ' A' ' 229' ' ' LYS . 20.9 t60 -34.28 129.71 0.37 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.892 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 39.6 mtmt 62.63 39.67 11.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.879 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -67.09 -175.17 0.42 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.871 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.535 HD21 ' CE2' ' A' ' 238' ' ' TYR . 30.6 mt -135.9 109.8 8.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.927 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 7.1 tt -117.85 117.71 30.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.913 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 54.71 38.69 64.72 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.459 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 38.4 mttp 68.86 50.54 0.62 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.767 0.318 . . . . 0.0 110.929 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 19.6 mmt180 -155.04 115.58 3.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.888 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 238' ' ' TYR . . . . . 0.535 ' CE2' HD21 ' A' ' 233' ' ' LEU . 95.7 m-85 -67.92 131.25 45.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.959 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 75.1 mt -129.76 133.83 64.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.119 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . 0.454 ' HB3' ' CZ ' ' A' ' 242' ' ' PHE . 7.4 mp0 -94.18 170.97 9.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.901 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . 0.524 ' O ' ' CG ' ' A' ' 242' ' ' PHE . 14.9 mt -150.78 153.38 35.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.931 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 242' ' ' PHE . . . . . 0.524 ' CG ' ' O ' ' A' ' 241' ' ' LEU . 3.7 m-85 -162.12 151.62 16.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.845 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . 0.471 ' CZ ' ' HB2' ' A' ' 243' ' ' ARG . 12.6 mtm105 -65.76 118.39 9.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.874 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -111.19 160.42 16.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.889 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 40.1 p -132.97 155.8 48.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.146 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 246' ' ' ALA . . . . . 0.448 ' N ' HD12 ' A' ' 167' ' ' ILE . . . -43.17 -53.15 5.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.114 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -56.8 -51.86 67.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.052 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -48.19 -54.73 12.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.939 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . 0.501 HG13 ' CD2' ' A' ' 214' ' ' PHE . 59.9 t -48.81 -65.87 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.133 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 250' ' ' GLN . . . . . 0.409 ' HA ' ' CD1' ' A' ' 253' ' ' LEU . 86.8 mt-30 -38.41 -46.1 1.1 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.954 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -62.67 -51.88 65.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.858 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 73.4 t -54.92 -34.89 32.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.093 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . 0.409 ' CD1' ' HA ' ' A' ' 250' ' ' GLN . 14.9 mt -64.62 -49.56 70.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.91 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . 0.496 ' OD1' ' N ' ' A' ' 255' ' ' ARG . 0.6 OUTLIER -64.66 -41.55 96.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.911 179.888 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . 0.496 ' N ' ' OD1' ' A' ' 254' ' ' ASN . 25.9 ttt180 -47.67 -46.74 29.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.894 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -83.65 -41.94 17.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.879 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 1.9 t -70.29 155.57 40.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.845 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 14.1 t 45.83 41.98 8.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.836 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 259' ' ' ALA . . . . . . . . . . . . . . . -98.9 111.43 23.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.114 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 3.6 m -100.58 -54.81 2.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.858 -179.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 134.5 179.08 16.11 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.492 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 262' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 151.09 90.98 Favored 'Cis proline' 0 C--O 1.231 0.168 0 C-N-CA 122.714 -1.786 . . . . 0.0 112.36 -0.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 5.4 t -66.09 163.42 17.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.864 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 79.6 p -150.12 131.82 14.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.862 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.373 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.502 179.976 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.34 0 N-CA-C 112.516 -0.233 . . . . 0.0 112.516 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 65.7 p -91.03 42.66 1.11 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.88 0.371 . . . . 0.0 110.886 -179.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 6.1 t -172.94 146.33 1.52 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.817 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -156.12 139.5 6.61 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.509 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 11.8 t -122.7 -50.54 1.96 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.881 0.372 . . . . 0.0 110.874 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 12.5 t -64.42 108.03 1.52 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.839 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -105.99 106.35 2.58 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.51 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -79.01 -163.27 24.86 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.515 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -130.88 -146.5 5.88 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.501 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' THR . . . . . 0.435 ' CG2' ' HB3' ' A' ' 155' ' ' GLU . 20.4 m -136.89 125.14 23.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.764 0.316 . . . . 0.0 111.184 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 19.8 m -131.8 -51.04 0.98 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.823 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 10.8 p-10 -65.33 -55.61 17.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.908 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.435 ' HB3' ' CG2' ' A' ' 152' ' ' THR . 28.1 tt0 -48.71 -37.28 18.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.867 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 75.3 t -83.24 -36.11 12.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.1 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -43.44 -53.32 5.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.1 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -59.9 -53.25 60.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.915 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' PHE . . . . . 0.5 ' CE1' ' HG ' ' A' ' 216' ' ' LEU . 83.3 t80 -46.12 -39.26 9.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.873 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 95.6 mt -87.9 -27.07 22.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.888 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 29.0 t -49.79 -24.79 2.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.813 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . 0.446 ' CB ' ' HG3' ' A' ' 165' ' ' GLN . 35.4 mmtt -70.3 117.57 12.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.853 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . 0.462 ' HG3' ' ND2' ' A' ' 164' ' ' ASN . 4.7 pt-20 -91.4 153.95 19.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.918 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . 0.462 ' ND2' ' HG3' ' A' ' 163' ' ' GLU . 72.7 m-20 61.16 49.04 5.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.885 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . 0.446 ' HG3' ' CB ' ' A' ' 162' ' ' LYS . 1.8 mm-40 -128.62 151.8 49.08 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.902 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 48.5 t -109.15 109.03 26.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.174 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . 0.443 ' CD1' ' HA ' ' A' ' 246' ' ' ALA . 45.4 mt -80.12 143.43 12.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.185 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.478 HG21 ' CE1' ' A' ' 217' ' ' PHE . 86.0 t -123.46 133.66 68.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.15 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 11.0 ttt85 -89.94 106.36 18.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.858 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 91.3 mtp -97.92 125.57 42.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.904 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 47.2 mtp180 -126.57 136.55 52.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.878 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 96.92 17.6 32.11 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.473 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.463 ' CD1' ' HB3' ' A' ' 213' ' ' ALA . 20.7 mt -71.24 116.71 49.8 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.593 0.711 . . . . 0.0 110.912 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . 0.496 ' O ' ' CB ' ' A' ' 177' ' ' ALA . 64.9 Cg_exo -47.99 134.08 23.51 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.672 2.248 . . . . 0.0 112.361 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . 0.453 ' C ' ' O ' ' A' ' 174' ' ' PRO . 19.3 m-85 -34.55 -68.55 0.11 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.893 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -47.63 -40.06 18.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.144 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . 0.496 ' CB ' ' O ' ' A' ' 174' ' ' PRO . . . -38.19 128.07 1.33 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.12 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.405 ' C ' ' CZ ' ' A' ' 201' ' ' PHE . 1.7 p -141.67 179.85 6.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.179 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -47.21 -46.58 24.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.084 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -53.4 -33.13 52.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.924 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -76.26 -34.04 59.14 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.874 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.441 ' O ' ' N ' ' A' ' 185' ' ' PHE . 85.1 t -74.2 -51.79 22.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.142 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . 0.431 ' C ' ' O ' ' A' ' 182' ' ' VAL . 94.4 t -34.73 -50.55 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.135 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -78.41 -33.5 48.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.127 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.441 ' N ' ' O ' ' A' ' 182' ' ' VAL . 25.1 t80 -47.08 -61.19 2.0 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.863 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -89.9 -21.69 22.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.912 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -49.03 -21.25 2.36 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.451 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -53.24 -75.42 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.86 0.362 . . . . 0.0 110.916 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 11.1 m-70 -118.17 -5.45 10.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.824 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 82.4 m -126.54 87.5 56.27 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-O 121.61 0.719 . . . . 0.0 110.894 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' PRO . . . . . 0.556 ' HD2' ' CD1' ' A' ' 222' ' ' TYR . 52.8 Cg_endo -69.81 131.54 21.38 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.709 2.272 . . . . 0.0 112.279 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 51.3 mt -82.74 142.76 13.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.134 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 47.5 m -67.25 105.92 1.88 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.17 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 87.5 -19.84 30.23 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.493 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . 0.465 ' O ' ' N ' ' A' ' 198' ' ' GLY . . . 78.04 -126.3 7.62 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.507 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 34.4 mtmt -42.9 -33.47 0.78 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.75 0.309 . . . . 0.0 110.873 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -74.27 -34.62 63.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.916 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 195' ' ' GLY . . . -82.98 36.65 2.7 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.495 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 77.5 mt -138.68 151.24 23.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.881 0.372 . . . . 0.0 111.104 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.44 ' HB2' ' CD1' ' A' ' 159' ' ' PHE . 13.4 tp -147.98 111.05 4.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.894 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' PHE . . . . . 0.405 ' CZ ' ' C ' ' A' ' 178' ' ' THR . 53.4 m-85 -93.16 127.65 38.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.902 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 62.0 t -79.73 115.97 23.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.154 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -125.19 137.55 54.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.105 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . 0.421 ' CD1' HG21 ' A' ' 210' ' ' THR . 29.1 m-85 -41.81 159.23 0.19 Allowed Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.694 0.759 . . . . 0.0 110.897 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 2.88 3.14 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.67 2.247 . . . . 0.0 112.379 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -113.43 -18.67 11.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.87 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 110.87 61.51 0.49 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.465 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 37.6 mmt-85 -145.97 145.97 26.82 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.608 0.718 . . . . 0.0 110.886 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 104.02 1.25 Allowed 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.683 2.255 . . . . 0.0 112.38 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 210' ' ' THR . . . . . 0.537 ' HB ' ' CE2' ' A' ' 256' ' ' PHE . 21.0 p -68.42 -31.0 70.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.135 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 114.5 -34.36 4.94 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.504 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -87.61 154.12 20.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.814 0.34 . . . . 0.0 110.872 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . 0.463 ' HB3' ' CD1' ' A' ' 173' ' ' LEU . . . -154.27 175.88 12.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.109 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . 0.548 ' CE2' HG13 ' A' ' 249' ' ' VAL . 60.7 m-85 -138.16 158.32 44.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.876 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 6.6 t -140.64 157.15 23.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.092 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . 0.5 ' HG ' ' CE1' ' A' ' 159' ' ' PHE . 44.7 mt -108.33 141.14 40.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.93 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . 0.478 ' CE1' HG21 ' A' ' 168' ' ' VAL . 88.7 m-85 -135.36 132.5 37.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.904 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -42.65 -66.45 0.36 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.046 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 219' ' ' CYS . . . . . . . . . . . . . 1.9 m -135.01 176.57 8.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.932 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -65.45 -7.37 13.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.855 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -67.85 -37.79 82.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.897 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 222' ' ' TYR . . . . . 0.556 ' CD1' ' HD2' ' A' ' 191' ' ' PRO . 46.5 m-85 -86.52 -39.22 16.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.964 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -59.46 -60.8 3.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.097 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -45.2 -53.98 7.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.934 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 71.1 m-20 -58.69 -25.73 63.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.874 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -75.93 -23.75 55.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.052 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 37.0 mt -68.24 -33.14 73.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.911 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 38.9 mtp180 -60.14 -14.99 19.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.9 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . 0.446 ' O ' ' C ' ' A' ' 230' ' ' HIS . 21.8 mtpp -80.56 -3.42 50.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.854 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 230' ' ' HIS . . . . . 0.466 ' CD2' ' HG2' ' A' ' 231' ' ' LYS . 72.2 t60 -34.16 146.34 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.871 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.466 ' HG2' ' CD2' ' A' ' 230' ' ' HIS . 3.9 mmpt? 53.04 26.84 5.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.892 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -56.47 -177.33 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.86 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.573 HD22 ' CE2' ' A' ' 238' ' ' TYR . 30.8 mt -139.96 105.12 5.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.936 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 6.8 tt -115.53 112.53 22.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.956 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 62.17 34.35 88.83 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.467 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 4.3 mmmm 71.05 52.12 0.27 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.744 0.307 . . . . 0.0 110.893 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 21.2 mmt180 -155.02 115.6 3.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.852 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 238' ' ' TYR . . . . . 0.573 ' CE2' HD22 ' A' ' 233' ' ' LEU . 92.1 m-85 -70.63 117.18 11.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.916 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 57.6 mt -111.73 159.83 11.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.142 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . 0.49 ' HB3' ' CZ ' ' A' ' 242' ' ' PHE . 13.7 mt-10 -114.23 167.58 10.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.867 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . 0.546 ' O ' ' CD1' ' A' ' 242' ' ' PHE . 54.0 mt -146.05 143.73 29.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.919 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 242' ' ' PHE . . . . . 0.546 ' CD1' ' O ' ' A' ' 241' ' ' LEU . 9.4 m-85 -159.3 137.13 10.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.865 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 63.0 mtp85 -53.67 141.46 26.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.859 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 8.8 t -138.18 157.41 46.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.85 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 71.7 p -129.3 157.77 40.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.164 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 246' ' ' ALA . . . . . 0.443 ' HA ' ' CD1' ' A' ' 167' ' ' ILE . . . -38.17 -55.78 1.26 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.131 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -54.07 -55.56 26.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.101 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 32.5 tp10 -42.18 -51.49 4.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.929 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . 0.548 HG13 ' CE2' ' A' ' 214' ' ' PHE . 85.9 t -54.69 -63.76 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.172 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -43.01 -33.02 0.73 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.934 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -73.14 -50.54 22.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.914 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 96.9 t -56.9 -37.07 52.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.111 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 16.0 mt -60.75 -50.93 71.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.881 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . 0.463 ' C ' ' OD1' ' A' ' 254' ' ' ASN . 0.6 OUTLIER -60.7 -40.47 92.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.882 179.973 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . 0.46 ' N ' ' OD1' ' A' ' 254' ' ' ASN . 21.4 ttt85 -42.92 -55.43 3.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.883 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 256' ' ' PHE . . . . . 0.537 ' CE2' ' HB ' ' A' ' 210' ' ' THR . 67.4 m-85 -74.79 -47.24 31.9 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.896 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 68.7 m -45.65 -59.67 2.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.897 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 40.9 t -62.61 -44.11 97.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.826 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 259' ' ' ALA . . . . . . . . . . . . . . . 48.17 41.0 14.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.098 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 23.2 t -98.25 -52.38 3.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.863 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . 0.447 ' HA3' ' C ' ' A' ' 262' ' ' PRO . . . -145.4 -72.66 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.499 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 262' ' ' PRO . . . . . 0.447 ' C ' ' HA3' ' A' ' 261' ' ' GLY . 53.5 Cg_endo -69.73 -34.65 2.98 Favored 'Cis proline' 0 C--N 1.341 0.174 0 C-N-CA 122.676 -1.802 . . . . 0.0 112.34 0.046 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 77.1 p -99.06 97.95 9.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.853 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 68.5 m -39.55 149.9 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.865 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.318 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.468 -179.965 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.287 0 N-CA-C 112.505 -0.238 . . . . 0.0 112.505 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 88.9 p -150.57 124.11 9.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.913 0.387 . . . . 0.0 110.883 -179.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 46.7 p -168.46 143.56 3.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.836 -179.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -152.98 158.66 28.04 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.506 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 20.7 t -99.92 81.2 2.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.862 0.363 . . . . 0.0 110.855 -179.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 90.8 p -114.61 175.93 5.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.86 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -91.88 -145.74 16.31 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.529 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 84.57 154.0 19.73 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.478 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -54.52 162.73 3.9 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.477 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' THR . . . . . 0.434 ' CG2' HG22 ' A' ' 156' ' ' VAL . 5.5 m -43.5 -36.55 2.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.768 0.318 . . . . 0.0 111.138 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' SER . . . . . 0.434 ' C ' ' O ' ' A' ' 152' ' ' THR . 31.3 p -34.68 -37.12 0.06 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.872 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . 0.407 ' N ' ' O ' ' A' ' 152' ' ' THR . 13.8 m120 -60.17 -58.36 8.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.919 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -66.93 -39.29 87.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.859 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.434 HG22 ' CG2' ' A' ' 152' ' ' THR . 72.3 t -60.92 -43.22 95.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.12 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.402 ' C ' ' O ' ' A' ' 156' ' ' VAL . . . -37.46 -61.03 0.63 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.127 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -57.66 -48.62 78.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.907 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' PHE . . . . . 0.495 ' CE1' ' HG ' ' A' ' 216' ' ' LEU . 66.2 t80 -47.68 -38.44 15.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.872 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 85.3 mt -90.57 -27.36 19.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.959 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 30.2 t -50.7 -36.51 36.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.854 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 39.7 mmtt -54.4 124.89 17.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.89 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -99.0 151.74 20.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.881 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 62.35 39.21 12.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.886 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -124.65 147.27 48.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.888 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 48.9 t -100.25 131.68 47.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.116 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . 0.448 HD12 ' N ' ' A' ' 246' ' ' ALA . 33.6 mt -101.17 143.8 13.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.176 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 96.8 t -128.26 136.6 59.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.121 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . 0.465 ' N ' ' HB2' ' A' ' 244' ' ' SER . 20.8 ttt85 -90.72 111.92 23.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.891 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' MET . . . . . 0.417 ' SD ' ' CG2' ' A' ' 215' ' ' VAL . 83.2 mtp -98.42 117.08 32.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.857 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 5.7 ttt-85 -120.99 140.66 51.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.833 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 89.91 23.43 32.83 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.512 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 22.9 mt -79.18 129.62 72.01 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.564 0.697 . . . . 0.0 110.917 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . 0.449 ' HG3' ' CB ' ' A' ' 237' ' ' ARG . 65.1 Cg_exo -47.94 154.75 2.0 Allowed 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.661 2.241 . . . . 0.0 112.345 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -60.09 -50.17 74.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.833 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' THR . . . . . 0.457 ' O ' ' C ' ' A' ' 177' ' ' ALA . 0.0 OUTLIER -68.77 -39.07 80.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.135 -179.877 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . 0.457 ' C ' ' O ' ' A' ' 176' ' ' THR . . . -33.53 124.25 0.42 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.072 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.432 ' O ' ' C ' ' A' ' 179' ' ' ALA . 1.4 p -135.7 176.62 8.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.146 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.501 ' N ' ' CZ ' ' A' ' 201' ' ' PHE . . . -35.14 -44.98 0.27 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.121 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -56.66 -49.33 75.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.926 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . 0.454 ' HG3' ' N ' ' A' ' 182' ' ' VAL . 0.0 OUTLIER -55.07 -33.48 62.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.869 -179.93 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.458 ' O ' ' N ' ' A' ' 185' ' ' PHE . 93.7 t -79.29 -60.03 2.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.156 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . 0.435 ' C ' ' O ' ' A' ' 182' ' ' VAL . 73.4 t -34.34 -39.89 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.134 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -85.77 -39.31 17.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.049 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.458 ' N ' ' O ' ' A' ' 182' ' ' VAL . 63.1 t80 -46.06 -59.58 2.78 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.825 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' PHE . . . . . 0.403 ' CE1' ' HE2' ' A' ' 185' ' ' PHE . 77.2 m-85 -91.79 -22.1 20.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.854 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -50.36 -18.25 2.24 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.511 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -58.49 -70.3 0.15 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.843 0.354 . . . . 0.0 110.882 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -118.15 -15.58 9.82 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.858 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' CYS . . . . . 0.409 ' SG ' ' CB ' ' A' ' 225' ' ' ASN . 70.8 m -120.26 86.69 38.66 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.65 0.738 . . . . 0.0 110.888 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 130.37 19.22 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.663 2.242 . . . . 0.0 112.361 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . 0.422 HD12 ' CG1' ' A' ' 182' ' ' VAL . 50.3 mt -82.14 146.2 7.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.161 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 85.6 m -66.89 105.78 1.71 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.148 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 87.41 -20.14 28.27 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.453 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . 0.401 ' O ' ' N ' ' A' ' 198' ' ' GLY . . . 78.84 -126.66 7.63 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.446 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 16.6 ptmt -45.29 -34.43 2.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.746 0.308 . . . . 0.0 110.874 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -73.72 -32.8 64.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.867 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 195' ' ' GLY . . . -86.69 37.6 3.16 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.5 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 48.0 mt -141.83 146.31 23.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.865 0.364 . . . . 0.0 111.164 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 19.5 tp -134.4 118.14 17.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.91 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' PHE . . . . . 0.501 ' CZ ' ' N ' ' A' ' 179' ' ' ALA . 62.8 m-85 -99.53 114.51 27.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.91 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 22.7 t -70.06 114.23 7.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.179 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -124.86 137.21 54.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.12 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -43.49 158.22 0.25 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.705 0.764 . . . . 0.0 110.882 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 3.01 3.01 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.683 2.256 . . . . 0.0 112.355 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -112.08 -21.05 11.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.829 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 112.5 57.53 0.44 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.462 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 33.2 mmt-85 -141.89 144.61 33.12 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.598 0.713 . . . . 0.0 110.896 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.7 105.67 1.52 Allowed 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.635 2.224 . . . . 0.0 112.381 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 210' ' ' THR . . . . . 0.558 ' HB ' ' CE1' ' A' ' 256' ' ' PHE . 27.2 p -69.07 -32.31 71.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.158 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 114.0 -34.1 5.13 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.442 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -84.68 162.76 19.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.815 0.341 . . . . 0.0 110.862 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -162.89 175.51 11.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.065 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . 0.549 ' CD2' HG12 ' A' ' 249' ' ' VAL . 80.8 m-85 -140.76 136.65 32.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.885 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . 0.417 ' CG2' ' SD ' ' A' ' 170' ' ' MET . 5.4 t -115.92 159.33 15.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.096 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . 0.495 ' HG ' ' CE1' ' A' ' 159' ' ' PHE . 29.3 mt -112.37 145.25 40.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.927 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -140.12 137.0 34.13 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.9 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -48.48 -50.06 33.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.123 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 219' ' ' CYS . . . . . . . . . . . . . 2.0 t -154.2 177.48 11.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.913 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -57.84 -23.89 54.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.893 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -50.75 -54.66 21.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.879 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 222' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -71.84 -48.63 44.8 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.936 -179.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -47.36 -52.03 17.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.074 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -51.75 -62.75 1.44 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.908 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . 0.409 ' CB ' ' SG ' ' A' ' 190' ' ' CYS . 38.2 m-20 -48.42 -23.7 1.03 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.898 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -81.31 -40.3 23.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.098 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 95.9 mt -52.28 -39.0 59.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.899 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 37.2 mtt-85 -55.62 -27.85 51.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.861 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . 0.454 ' O ' ' C ' ' A' ' 230' ' ' HIS . 20.7 mtpp -70.62 -2.77 15.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.898 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 230' ' ' HIS . . . . . 0.534 ' CE1' ' HG3' ' A' ' 231' ' ' LYS . 15.7 t60 -33.91 129.19 0.34 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.87 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.534 ' HG3' ' CE1' ' A' ' 230' ' ' HIS . 30.9 mttt 63.07 39.62 9.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.896 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -67.38 -175.1 0.45 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.849 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.573 HD21 ' CE2' ' A' ' 238' ' ' TYR . 29.6 mt -138.08 110.1 7.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.951 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 8.0 tt -121.65 113.94 20.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.894 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 59.13 40.98 96.37 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.456 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.428 ' HA ' ' NZ ' ' A' ' 236' ' ' LYS . 0.0 OUTLIER 65.36 52.4 1.43 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.762 0.315 . . . . 0.0 110.907 -179.967 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 237' ' ' ARG . . . . . 0.449 ' CB ' ' HG3' ' A' ' 174' ' ' PRO . 21.2 mmt180 -156.29 115.13 3.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.815 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 238' ' ' TYR . . . . . 0.573 ' CE2' HD21 ' A' ' 233' ' ' LEU . 93.7 m-85 -69.75 127.3 32.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.91 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 62.1 mt -122.22 134.26 66.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.09 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . 0.562 ' HB3' ' CZ ' ' A' ' 242' ' ' PHE . 6.5 mp0 -103.1 149.39 24.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.898 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . 0.517 ' O ' ' CD1' ' A' ' 242' ' ' PHE . 14.3 mt -124.62 149.56 46.95 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.964 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 242' ' ' PHE . . . . . 0.562 ' CZ ' ' HB3' ' A' ' 240' ' ' GLU . 13.6 m-85 -156.84 132.38 9.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.841 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 57.5 mtm180 -48.09 133.04 15.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.901 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 244' ' ' SER . . . . . 0.465 ' HB2' ' N ' ' A' ' 169' ' ' ARG . 3.4 t -130.48 157.59 42.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.825 -179.744 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 245' ' ' THR . . . . . 0.424 ' O ' ' C ' ' A' ' 246' ' ' ALA . 82.1 p -133.45 150.05 51.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.161 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 246' ' ' ALA . . . . . 0.448 ' N ' HD12 ' A' ' 167' ' ' ILE . . . -35.67 -51.94 0.67 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.096 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -59.41 -50.97 71.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.096 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 18.1 tp10 -47.31 -50.28 22.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.903 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . 0.549 HG12 ' CD2' ' A' ' 214' ' ' PHE . 98.5 t -53.48 -64.58 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.148 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 68.4 mt-30 -43.22 -34.96 1.26 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.934 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 251' ' ' GLN . . . . . 0.5 ' O ' ' ND2' ' A' ' 254' ' ' ASN . 27.5 mt-30 -74.34 -33.31 63.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.879 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 252' ' ' VAL . . . . . 0.459 ' HA ' ' NE ' ' A' ' 255' ' ' ARG . 79.1 t -79.67 -19.06 12.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.133 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 17.0 mt -80.81 -46.39 15.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.879 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . 0.5 ' ND2' ' O ' ' A' ' 251' ' ' GLN . 1.3 p30 -58.16 -50.06 74.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.857 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . 0.474 ' N ' ' CG ' ' A' ' 254' ' ' ASN . 17.3 ptp180 -49.31 -47.18 47.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.856 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 256' ' ' PHE . . . . . 0.558 ' CE1' ' HB ' ' A' ' 210' ' ' THR . 10.3 m-85 -73.8 -37.45 64.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.855 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 1.4 t -76.53 138.08 39.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.822 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 1.5 t 64.62 39.92 6.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.859 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 259' ' ' ALA . . . . . . . . . . . . . . . -105.5 125.77 51.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.076 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 260' ' ' SER . . . . . 0.504 ' O ' ' N ' ' A' ' 263' ' ' SER . 49.2 m -127.88 148.77 50.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.837 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . 0.477 ' HA3' ' C ' ' A' ' 262' ' ' PRO . . . 120.75 -76.8 0.32 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.484 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 262' ' ' PRO . . . . . 0.477 ' C ' ' HA3' ' A' ' 261' ' ' GLY . 54.1 Cg_endo -69.78 145.29 79.05 Favored 'Cis proline' 0 C--N 1.342 0.201 0 C-N-CA 122.667 -1.805 . . . . 0.0 112.337 0.059 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 263' ' ' SER . . . . . 0.504 ' N ' ' O ' ' A' ' 260' ' ' SER . 58.4 m -77.39 95.18 4.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.881 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 16.2 t -51.44 -53.92 32.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.836 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.344 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.506 -179.979 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.365 0 N-CA-C 112.512 -0.235 . . . . 0.0 112.512 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 23.3 t 66.84 44.79 2.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.923 0.392 . . . . 0.0 110.871 -179.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 81.5 p -98.06 127.94 44.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.879 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 167.53 145.98 4.73 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.499 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.3 t -91.84 136.42 33.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.817 0.342 . . . . 0.0 110.884 -179.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 56.1 p -51.19 155.31 1.37 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.86 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 126.14 78.27 0.29 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.472 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -122.26 -146.01 7.17 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.521 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -142.65 -168.39 11.82 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.52 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 99.0 m -132.26 124.17 28.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.866 0.365 . . . . 0.0 111.112 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' SER . . . . . 0.457 ' O ' ' N ' ' A' ' 156' ' ' VAL . 52.5 p -86.13 149.17 25.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.888 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . 0.407 ' C ' ' O ' ' A' ' 153' ' ' SER . 16.9 t30 -37.7 -50.69 1.21 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.892 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -51.48 -40.56 59.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.907 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.457 ' N ' ' O ' ' A' ' 153' ' ' SER . 75.5 t -77.29 -50.42 20.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.117 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.441 ' C ' ' O ' ' A' ' 156' ' ' VAL . . . -34.75 -57.32 0.53 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.101 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 76.1 mm-40 -62.13 -45.87 91.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.889 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' PHE . . . . . 0.43 ' CE2' ' HG ' ' A' ' 216' ' ' LEU . 20.1 t80 -52.89 -42.4 65.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.883 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 56.3 mt -82.06 -29.27 31.96 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.916 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 22.9 t -48.28 -43.33 32.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.902 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -38.6 130.26 1.38 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.942 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -106.61 145.54 31.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.883 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . 0.448 ' O ' ' NE2' ' A' ' 165' ' ' GLN . 49.1 m-80 63.28 37.71 10.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.891 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . 0.448 ' NE2' ' O ' ' A' ' 164' ' ' ASN . 2.2 mp0 -122.54 153.81 38.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.904 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 83.9 t -108.36 137.56 39.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.135 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . 0.422 HG21 ' CG2' ' A' ' 249' ' ' VAL . 28.6 mt -104.84 139.23 26.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.07 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.409 HG11 ' N ' ' A' ' 169' ' ' ARG . 82.6 t -120.49 133.35 67.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.154 179.787 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . 0.409 ' N ' HG11 ' A' ' 168' ' ' VAL . 39.3 ttp180 -88.51 104.72 17.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.839 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' MET . . . . . 0.446 ' HE1' ' CD2' ' A' ' 173' ' ' LEU . 83.3 mtp -97.39 131.57 43.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.884 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 2.1 ttt85 -135.65 140.48 44.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.852 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 93.23 16.59 46.42 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.504 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.446 ' CD2' ' HE1' ' A' ' 170' ' ' MET . 25.5 mt -72.09 128.95 88.47 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.606 0.717 . . . . 0.0 110.925 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . 0.443 ' HG3' ' CB ' ' A' ' 237' ' ' ARG . 64.3 Cg_exo -47.91 144.61 11.44 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.682 2.255 . . . . 0.0 112.357 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . 0.564 ' CD1' ' HG3' ' A' ' 209' ' ' PRO . 6.7 t80 -49.35 -41.69 39.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.88 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' THR . . . . . 0.45 ' O ' ' C ' ' A' ' 177' ' ' ALA . 7.6 p -76.25 -45.41 32.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.158 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . 0.45 ' C ' ' O ' ' A' ' 176' ' ' THR . . . -33.41 104.55 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.117 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -111.66 177.7 4.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.118 -179.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.447 ' N ' ' CE1' ' A' ' 201' ' ' PHE . . . -45.42 -51.08 11.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.14 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -50.22 -38.87 42.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.916 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . 0.473 ' CG ' HD23 ' A' ' 234' ' ' LEU . 2.6 tp10 -64.65 -41.85 95.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.898 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.481 ' O ' ' N ' ' A' ' 185' ' ' PHE . 94.5 t -64.96 -54.22 32.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.133 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . 0.453 ' C ' ' O ' ' A' ' 182' ' ' VAL . 43.2 t -33.86 -55.72 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.112 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -70.72 -34.33 71.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.095 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.527 ' CE2' ' HD3' ' A' ' 229' ' ' LYS . 63.6 t80 -51.13 -61.11 2.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.904 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -89.58 -20.4 23.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.913 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -49.16 -18.5 1.29 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.474 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 38.4 mm-40 -55.9 -75.17 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.796 0.332 . . . . 0.0 110.921 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -118.34 -3.78 10.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.845 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 71.4 m -128.7 87.09 55.82 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.579 0.704 . . . . 0.0 110.851 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' PRO . . . . . 0.566 ' HD2' ' CD1' ' A' ' 222' ' ' TYR . 54.1 Cg_endo -69.74 143.3 50.5 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.719 2.279 . . . . 0.0 112.38 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . 0.469 HD11 ' CG1' ' A' ' 215' ' ' VAL . 63.1 mt -97.71 143.07 13.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.102 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 88.6 m -66.72 101.41 0.8 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.134 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 89.64 -15.8 58.02 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.428 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 73.01 -118.21 6.28 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.483 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 39.4 mtmt -51.16 -32.71 24.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.73 0.3 . . . . 0.0 110.864 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -75.22 -22.54 57.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.904 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -99.25 35.25 4.82 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.442 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 60.5 mt -137.45 139.22 43.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.88 0.371 . . . . 0.0 111.132 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 12.9 tp -133.44 123.08 24.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.946 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' PHE . . . . . 0.447 ' CE1' ' N ' ' A' ' 179' ' ' ALA . 75.8 m-85 -104.26 124.77 49.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.854 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 55.6 t -79.9 136.31 23.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.082 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -143.21 136.59 28.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.138 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . 0.576 ' CD1' ' HB3' ' A' ' 208' ' ' ARG . 16.7 m-85 -40.31 160.65 0.12 Allowed Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.68 0.752 . . . . 0.0 110.901 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.74 3.22 2.89 Favored 'Trans proline' 0 N--CA 1.465 -0.176 0 C-N-CA 122.724 2.283 . . . . 0.0 112.32 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -117.31 -28.45 6.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.878 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 127.69 42.93 0.25 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.485 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 208' ' ' ARG . . . . . 0.576 ' HB3' ' CD1' ' A' ' 204' ' ' TYR . 10.8 ttm180 -117.3 142.01 29.53 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.639 0.733 . . . . 0.0 110.876 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . 0.564 ' HG3' ' CD1' ' A' ' 175' ' ' PHE . 54.0 Cg_endo -69.74 93.27 0.52 Allowed 'Trans proline' 0 C--O 1.232 0.22 0 C-N-CA 122.734 2.29 . . . . 0.0 112.342 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 210' ' ' THR . . . . . 0.564 ' HB ' ' CE2' ' A' ' 256' ' ' PHE . 69.6 p -60.12 -9.45 3.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.097 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 81.36 -42.42 2.76 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.48 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -69.1 165.32 20.55 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.8 0.333 . . . . 0.0 110.892 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -165.34 -177.82 4.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.088 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . 0.539 ' CD2' HG12 ' A' ' 249' ' ' VAL . 51.2 m-85 -145.97 138.68 25.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.9 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . 0.469 ' CG1' HD11 ' A' ' 192' ' ' ILE . 10.0 t -121.63 156.71 25.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.168 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . 0.43 ' HG ' ' CE2' ' A' ' 159' ' ' PHE . 49.5 mt -110.85 138.58 47.07 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.936 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -129.91 137.15 50.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.879 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -49.81 -46.66 51.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.084 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 219' ' ' CYS . . . . . . . . . . . . . 10.2 m -154.14 171.57 18.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.893 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . 0.41 ' O ' ' C ' ' A' ' 221' ' ' GLU . 6.8 tp10 -57.6 -40.75 79.77 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.873 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . 0.41 ' C ' ' O ' ' A' ' 220' ' ' GLU . 26.6 tt0 -36.79 -49.54 0.79 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.885 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 222' ' ' TYR . . . . . 0.566 ' CD1' ' HD2' ' A' ' 191' ' ' PRO . 20.9 m-85 -74.54 -50.07 19.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.892 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -44.82 -54.52 6.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.117 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -48.41 -62.42 1.5 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.954 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 41.3 m-20 -49.54 -28.96 6.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.871 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -70.42 -43.21 70.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.038 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 29.0 mt -54.35 -30.28 51.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.934 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 60.8 mtp85 -58.65 -22.22 56.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.841 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . 0.527 ' HD3' ' CE2' ' A' ' 185' ' ' PHE . 16.7 mttm -78.93 -1.71 36.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.9 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 230' ' ' HIS . . . . . 0.544 ' CE1' ' HD3' ' A' ' 231' ' ' LYS . 21.6 t60 -33.86 127.0 0.41 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.886 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.544 ' HD3' ' CE1' ' A' ' 230' ' ' HIS . 0.3 OUTLIER 68.75 32.56 4.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.877 179.978 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -61.91 178.69 0.33 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.881 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.561 HD21 ' CE1' ' A' ' 238' ' ' TYR . 31.1 mt -135.18 109.74 8.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.943 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . 0.473 HD23 ' CG ' ' A' ' 181' ' ' GLU . 6.5 tt -117.68 114.15 22.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.905 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 58.4 37.59 88.25 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.482 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 9.6 mmpt? 70.56 52.73 0.32 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.78 0.324 . . . . 0.0 110.889 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 237' ' ' ARG . . . . . 0.443 ' CB ' ' HG3' ' A' ' 174' ' ' PRO . 50.4 mmt-85 -155.47 116.06 3.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.85 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 238' ' ' TYR . . . . . 0.561 ' CE1' HD21 ' A' ' 233' ' ' LEU . 89.6 m-85 -68.61 125.39 26.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.904 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 64.1 mt -120.94 134.53 64.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.116 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . 0.482 ' HB3' ' CZ ' ' A' ' 242' ' ' PHE . 38.8 mp0 -96.24 170.21 9.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.85 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 75.1 mt -145.71 139.96 26.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.946 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 242' ' ' PHE . . . . . 0.482 ' CZ ' ' HB3' ' A' ' 240' ' ' GLU . 8.6 m-85 -152.14 130.87 12.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.877 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 57.4 mtm180 -52.25 136.17 31.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.846 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 1.1 t -136.9 166.37 23.79 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.869 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 74.1 p -135.91 165.05 26.54 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.142 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -49.02 -53.55 19.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.076 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -55.6 -50.89 68.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.09 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -50.06 -50.98 46.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.931 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . 0.539 HG12 ' CD2' ' A' ' 214' ' ' PHE . 92.2 t -47.36 -61.97 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.101 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -48.19 -33.03 7.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.902 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 251' ' ' GLN . . . . . 0.414 ' HA ' ' ND2' ' A' ' 254' ' ' ASN . 53.0 mt-30 -76.82 -25.94 53.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.92 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 95.0 t -82.25 -21.71 9.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.135 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 10.7 mt -84.19 -43.54 14.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.905 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . 0.494 ' OD1' ' N ' ' A' ' 255' ' ' ARG . 0.5 OUTLIER -65.11 -42.08 94.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.846 179.973 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . 0.494 ' N ' ' OD1' ' A' ' 254' ' ' ASN . 1.8 ptm85 -58.38 -41.86 85.76 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.855 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 256' ' ' PHE . . . . . 0.564 ' CE2' ' HB ' ' A' ' 210' ' ' THR . 11.7 m-85 -75.65 -46.0 33.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.921 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 66.5 m -59.39 -35.31 73.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.835 -179.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 36.0 t -101.37 76.62 1.71 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.85 -179.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 259' ' ' ALA . . . . . . . . . . . . . . . -121.81 32.18 5.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.094 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 59.9 p -125.89 172.56 9.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.858 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -172.64 -178.43 42.72 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.449 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 262' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 128.42 12.53 Favored 'Cis proline' 0 C--N 1.342 0.19 0 C-N-CA 122.671 -1.804 . . . . 0.0 112.386 0.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 4.0 t -108.15 132.97 53.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.846 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 24.8 t -61.77 -51.59 67.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.89 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.364 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.512 179.98 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 N-CA-C 112.541 -0.224 . . . . 0.0 112.541 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 2.3 m -154.53 131.27 10.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.86 0.362 . . . . 0.0 110.834 -179.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 43.2 p -133.93 42.08 2.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.843 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 58.35 -147.4 39.05 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.469 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 70.3 m -122.84 122.05 37.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.903 0.382 . . . . 0.0 110.816 -179.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 24.5 m -109.92 -55.27 2.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.847 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -154.69 -120.25 0.72 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.462 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -113.7 157.31 15.04 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.525 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 164.46 171.09 30.28 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.507 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' THR . . . . . 0.442 ' O ' ' N ' ' A' ' 154' ' ' ASN . 1.5 m -81.56 -27.48 34.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.823 0.344 . . . . 0.0 111.192 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 66.7 m -41.62 -24.81 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.826 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . 0.442 ' N ' ' O ' ' A' ' 152' ' ' THR . 1.7 t-20 -74.6 -52.71 11.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.904 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -68.06 -37.18 80.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.905 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.439 ' O ' ' C ' ' A' ' 157' ' ' ALA . 26.7 t -68.55 -41.46 83.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.077 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.439 ' C ' ' O ' ' A' ' 156' ' ' VAL . . . -33.73 -69.94 0.08 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.108 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . 0.498 ' O ' ' N ' ' A' ' 161' ' ' SER . 3.8 pt20 -48.82 -60.17 2.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.947 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 21.4 t80 -39.4 -40.67 0.84 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.921 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 98.6 mt -89.07 -22.92 22.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.934 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' SER . . . . . 0.498 ' N ' ' O ' ' A' ' 158' ' ' GLN . 7.7 t -59.95 -20.93 60.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.853 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . 0.456 ' HG3' ' CD1' ' A' ' 216' ' ' LEU . 25.3 mmmt -69.83 118.27 12.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.926 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 50.3 mm-40 -96.98 158.02 15.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.916 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 62.43 42.18 9.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.868 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 36.1 mm-40 -126.7 172.6 10.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.911 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 86.6 t -128.54 106.45 14.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.11 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . 0.461 HG22 ' CG2' ' A' ' 249' ' ' VAL . 70.0 mt -77.67 141.63 15.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.169 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 43.7 t -122.77 133.94 67.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.103 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . 0.429 ' N ' ' HB2' ' A' ' 244' ' ' SER . 29.6 ttp180 -91.43 101.44 14.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.876 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' MET . . . . . 0.43 ' HE2' ' CD2' ' A' ' 173' ' ' LEU . 99.3 mtp -94.9 127.25 40.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.895 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 13.5 ttm180 -126.07 141.49 51.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.884 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 89.91 24.92 28.56 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.501 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.43 ' CD2' ' HE2' ' A' ' 170' ' ' MET . 19.9 mt -78.45 123.29 85.7 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.638 0.732 . . . . 0.0 110.907 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_exo -48.0 141.77 16.63 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.67 2.246 . . . . 0.0 112.341 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . 0.565 ' CD1' ' HG3' ' A' ' 209' ' ' PRO . 9.1 t80 -53.97 -26.18 24.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.892 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 7.2 p -89.69 -14.3 35.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.095 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -65.15 110.16 2.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.125 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.437 ' O ' ' N ' ' A' ' 181' ' ' GLU . 0.8 OUTLIER -118.96 167.16 12.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.134 -179.925 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 178' ' ' THR . . . -35.42 -42.43 0.21 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.122 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -57.07 -47.69 80.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.89 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . 0.437 ' N ' ' O ' ' A' ' 178' ' ' THR . 3.9 mp0 -61.0 -37.49 82.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.879 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.448 ' O ' ' C ' ' A' ' 183' ' ' VAL . 76.1 t -69.85 -54.23 20.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.119 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . 0.448 ' C ' ' O ' ' A' ' 182' ' ' VAL . 28.1 t -33.78 -50.66 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.125 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -73.54 -44.22 58.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.086 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -39.13 -61.31 0.78 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.903 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -92.27 -21.42 20.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.873 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -49.11 -18.9 1.35 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.495 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -56.25 -75.21 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.803 0.335 . . . . 0.0 110.923 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -118.25 -7.57 10.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.851 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 79.4 m -124.41 86.4 55.0 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.557 0.694 . . . . 0.0 110.876 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' PRO . . . . . 0.557 ' HD2' ' CD1' ' A' ' 222' ' ' TYR . 53.5 Cg_endo -69.78 140.32 42.3 Favored 'Trans proline' 0 C--O 1.231 0.148 0 C-N-CA 122.715 2.276 . . . . 0.0 112.308 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . 0.418 HG23 ' N ' ' A' ' 193' ' ' THR . 57.2 mt -91.5 144.29 9.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.149 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' THR . . . . . 0.418 ' N ' HG23 ' A' ' 192' ' ' ILE . 35.9 m -73.24 105.72 4.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.139 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 91.33 -17.78 54.53 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.478 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 72.09 -121.09 8.22 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.472 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 24.0 mtmm -49.74 -28.46 6.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.731 0.301 . . . . 0.0 110.87 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -77.74 -27.66 50.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.886 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -93.62 40.4 2.79 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.524 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 56.9 mt -144.04 149.77 17.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.885 0.374 . . . . 0.0 111.087 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 14.1 tp -148.46 119.63 7.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.897 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -98.71 117.62 33.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.89 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 42.7 t -73.49 133.63 31.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.124 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -138.39 137.9 37.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.159 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -47.24 158.63 0.45 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.663 0.744 . . . . 0.0 110.916 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 3.14 2.98 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.651 2.234 . . . . 0.0 112.343 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -110.29 -20.51 12.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.825 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 113.72 38.02 1.23 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.506 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 77.6 mtt180 -121.63 146.86 46.53 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.612 0.72 . . . . 0.0 110.854 -179.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . 0.565 ' HG3' ' CD1' ' A' ' 175' ' ' PHE . 53.6 Cg_endo -69.79 112.02 2.97 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.672 2.248 . . . . 0.0 112.348 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 210' ' ' THR . . . . . 0.565 HG22 ' CD2' ' A' ' 256' ' ' PHE . 53.7 p -76.59 -6.8 53.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.173 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 80.73 -37.14 2.29 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.467 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -75.85 159.01 31.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.844 0.354 . . . . 0.0 110.861 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -159.31 -177.91 6.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.075 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -145.59 143.85 30.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.885 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 4.4 t -131.9 155.47 41.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.142 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . 0.456 ' CD1' ' HG3' ' A' ' 162' ' ' LYS . 37.5 mt -106.1 135.09 48.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.916 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -127.19 147.26 50.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.88 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -54.31 -63.76 1.05 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.127 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 219' ' ' CYS . . . . . . . . . . . . . 2.2 t -153.58 172.63 16.91 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.87 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -44.89 -35.71 2.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.891 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . 0.566 ' OE2' ' CD1' ' A' ' 222' ' ' TYR . 6.0 tm-20 -45.27 -44.73 11.54 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.915 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 222' ' ' TYR . . . . . 0.566 ' CD1' ' OE2' ' A' ' 221' ' ' GLU . 35.1 m-85 -88.71 -47.48 8.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.872 -179.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -52.15 -60.0 3.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.113 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 43.9 mm-40 -47.22 -50.68 20.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.914 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 20.4 m-20 -60.48 -23.66 64.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.925 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -76.15 -40.32 52.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.132 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 29.2 mt -54.41 -30.74 53.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.94 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 6.7 mtp-105 -58.84 -25.28 63.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.881 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . 0.462 ' O ' ' C ' ' A' ' 230' ' ' HIS . 19.1 mtpp -76.37 -0.92 24.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.887 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 230' ' ' HIS . . . . . 0.467 ' CE1' ' HG3' ' A' ' 231' ' ' LYS . 13.7 t60 -33.54 133.37 0.17 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.833 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.467 ' HG3' ' CE1' ' A' ' 230' ' ' HIS . 47.0 mtmt 59.13 40.35 21.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.904 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -66.64 -177.01 0.53 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.834 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.553 HD21 ' CE1' ' A' ' 238' ' ' TYR . 31.3 mt -136.48 105.03 5.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.909 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 6.6 tt -116.35 113.67 23.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.921 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 60.55 39.42 96.42 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.514 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 4.4 mmmm 66.69 53.39 0.91 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.76 0.314 . . . . 0.0 110.882 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 20.4 mmt180 -156.21 115.47 3.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.877 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 238' ' ' TYR . . . . . 0.553 ' CE1' HD21 ' A' ' 233' ' ' LEU . 95.7 m-85 -68.64 117.36 10.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.916 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . 0.423 HD12 ' CD2' ' A' ' 173' ' ' LEU . 17.7 mt -113.81 129.9 68.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.178 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . 0.422 ' O ' ' CD2' ' A' ' 241' ' ' LEU . 0.5 OUTLIER -89.99 175.27 7.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.869 -179.998 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . 0.48 ' O ' ' CD1' ' A' ' 242' ' ' PHE . 38.5 mt -151.57 144.65 24.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.907 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 242' ' ' PHE . . . . . 0.48 ' CD1' ' O ' ' A' ' 241' ' ' LEU . 15.0 m-85 -156.89 129.17 7.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.885 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . 0.47 ' CZ ' ' HB2' ' A' ' 243' ' ' ARG . 17.0 mtm105 -48.25 138.74 9.36 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.876 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 244' ' ' SER . . . . . 0.429 ' HB2' ' N ' ' A' ' 169' ' ' ARG . 1.0 OUTLIER -136.25 160.46 38.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.861 -179.778 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 53.5 p -132.83 155.83 48.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.173 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 246' ' ' ALA . . . . . 0.443 ' HA ' ' CD1' ' A' ' 167' ' ' ILE . . . -40.51 -58.65 1.52 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.058 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -53.44 -55.69 23.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.114 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -46.02 -46.06 16.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.885 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . 0.461 ' CG2' HG22 ' A' ' 167' ' ' ILE . 98.2 t -51.62 -62.54 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.126 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -47.66 -33.38 6.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.898 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 251' ' ' GLN . . . . . 0.499 ' O ' ' ND2' ' A' ' 254' ' ' ASN . 29.4 mm-40 -76.76 -26.3 54.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.921 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 43.1 t -82.38 -21.64 9.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.114 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 10.5 mt -85.41 -43.24 13.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.875 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . 0.499 ' ND2' ' O ' ' A' ' 251' ' ' GLN . 0.4 OUTLIER -65.22 -46.0 82.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.876 179.962 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . 0.401 ' N ' ' CG ' ' A' ' 254' ' ' ASN . 7.5 ptm180 -48.68 -30.72 5.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.896 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 256' ' ' PHE . . . . . 0.565 ' CD2' HG22 ' A' ' 210' ' ' THR . 17.0 m-85 -88.42 -32.39 18.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.886 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 32.3 t -70.99 -32.78 69.7 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.845 -179.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 2.6 m -101.47 49.82 0.86 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.837 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 259' ' ' ALA . . . . . . . . . . . . . . . -93.76 89.79 6.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.105 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 4.7 t -140.05 141.02 36.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.877 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . 0.427 ' HA3' ' C ' ' A' ' 262' ' ' PRO . . . 127.02 -69.87 0.51 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.478 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 262' ' ' PRO . . . . . 0.427 ' C ' ' HA3' ' A' ' 261' ' ' GLY . 53.1 Cg_endo -69.8 -14.31 12.55 Favored 'Cis proline' 0 C--N 1.341 0.183 0 C-N-CA 122.66 -1.808 . . . . 0.0 112.347 0.109 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 1.1 t 37.04 45.26 0.44 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.86 -179.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 19.3 t -70.64 93.6 0.94 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.869 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.343 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.501 -179.937 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.306 0 N-CA-C 112.45 -0.26 . . . . 0.0 112.45 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 3.2 m -107.17 -50.96 2.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.881 0.372 . . . . 0.0 110.821 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 84.3 p -137.75 144.25 41.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.814 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 58.92 64.75 4.01 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.488 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 55.8 p -103.74 42.06 1.22 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.891 0.377 . . . . 0.0 110.887 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 7.1 t -95.72 -63.24 1.18 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.9 -179.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 80.0 -76.7 2.0 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.487 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 154.3 -146.53 14.75 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.505 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -41.65 -56.8 3.51 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.466 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' THR . . . . . 0.403 ' CG2' ' HB ' ' A' ' 156' ' ' VAL . 27.9 m -39.9 128.66 2.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.82 0.343 . . . . 0.0 111.11 -179.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' SER . . . . . 0.45 ' O ' ' C ' ' A' ' 154' ' ' ASN . 48.1 m -78.85 142.29 36.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.913 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . 0.45 ' C ' ' O ' ' A' ' 153' ' ' SER . 4.5 m120 -34.41 -62.6 0.33 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.917 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -42.83 -42.16 3.52 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.897 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.498 ' O ' ' N ' ' A' ' 159' ' ' PHE . 20.5 t -73.55 -58.03 5.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.141 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.443 ' C ' ' O ' ' A' ' 156' ' ' VAL . . . -34.07 -57.17 0.48 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.087 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 82.3 mt-30 -67.28 -33.79 76.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.931 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' PHE . . . . . 0.498 ' N ' ' O ' ' A' ' 156' ' ' VAL . 71.4 t80 -62.76 -39.49 94.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.867 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 82.8 mt -90.21 -17.13 28.09 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.884 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 13.1 t -55.45 -31.84 62.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.845 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 25.6 mmtt -60.98 118.12 6.33 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.95 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -97.33 136.88 37.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.88 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 74.53 43.99 0.24 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.891 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . 0.469 ' NE2' ' HA ' ' A' ' 165' ' ' GLN . 8.5 mm100 -122.87 176.16 6.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.92 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 15.8 t -129.14 119.68 49.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.112 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 14.6 mt -93.21 149.57 4.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.084 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.475 HG21 ' CE1' ' A' ' 217' ' ' PHE . 57.5 t -130.93 137.01 56.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.123 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 50.7 ttt-85 -92.27 109.4 20.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.854 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 96.6 mtp -102.05 120.63 40.73 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.846 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 3.3 ttt85 -122.76 139.38 54.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.884 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 90.53 28.24 17.35 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.502 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 30.4 mt -82.52 127.37 70.88 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.607 0.718 . . . . 0.0 110.836 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . 0.469 ' HG3' ' CB ' ' A' ' 237' ' ' ARG . 65.9 Cg_exo -48.06 126.2 12.92 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.665 2.243 . . . . 0.0 112.32 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . 0.559 ' CE2' ' HG2' ' A' ' 209' ' ' PRO . 3.8 m-85 -44.06 -24.19 0.14 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.882 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 67.3 p -86.37 -37.16 18.7 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.133 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . 0.401 ' N ' ' O ' ' A' ' 174' ' ' PRO . . . -49.21 124.68 9.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.093 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.76 -173.67 2.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.127 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -51.35 -48.05 62.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.085 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -56.76 -33.44 66.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.878 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -72.41 -22.91 61.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.9 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 93.9 t -87.21 -48.5 15.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.182 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 44.7 t -39.95 -42.53 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.098 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -81.34 -44.19 17.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.064 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.505 ' CE1' ' HD2' ' A' ' 229' ' ' LYS . 18.3 t80 -40.01 -58.14 1.48 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.862 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' PHE . . . . . 0.449 ' CE1' ' CE1' ' A' ' 185' ' ' PHE . 79.3 m-85 -94.34 -22.99 17.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.874 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -49.29 -21.63 2.97 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.505 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 -54.3 -70.88 0.09 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.834 0.349 . . . . 0.0 110.968 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 6.6 m-70 -118.02 -15.49 9.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.881 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' CYS . . . . . 0.405 ' N ' ' O ' ' A' ' 186' ' ' PHE . 82.8 m -120.35 86.4 38.58 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.612 0.72 . . . . 0.0 110.909 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 134.35 27.73 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.685 2.256 . . . . 0.0 112.374 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 48.2 mt -84.12 143.31 12.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.176 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 93.5 m -68.06 106.24 2.31 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.135 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 89.72 -20.55 34.62 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.475 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 78.62 -125.65 7.19 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.498 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 4.7 ptpt -49.49 -21.72 1.02 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.742 0.306 . . . . 0.0 110.845 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -83.54 -30.88 26.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.903 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -89.77 39.64 3.1 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.491 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 42.6 mt -139.94 149.36 22.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.894 0.378 . . . . 0.0 111.139 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 13.4 tp -143.24 113.16 7.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.937 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -95.22 112.38 24.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.854 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 22.9 t -64.12 118.98 7.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.096 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -127.66 138.29 52.78 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.132 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -45.9 158.49 0.35 Allowed Pre-proline 0 C--N 1.328 -0.369 0 CA-C-O 121.719 0.771 . . . . 0.0 110.925 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 2.88 3.12 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.694 2.263 . . . . 0.0 112.379 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -111.45 -15.34 13.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.866 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 105.9 61.94 0.62 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.518 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 41.7 mtt180 -150.9 149.58 25.65 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.587 0.708 . . . . 0.0 110.861 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . 0.559 ' HG2' ' CE2' ' A' ' 175' ' ' PHE . 53.3 Cg_endo -69.84 121.0 7.67 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.655 2.237 . . . . 0.0 112.347 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 210' ' ' THR . . . . . 0.525 ' HB ' ' CE2' ' A' ' 256' ' ' PHE . 72.0 p -90.21 -3.95 57.52 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.157 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 89.27 -41.18 3.02 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.473 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -77.24 158.29 30.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.816 0.341 . . . . 0.0 110.881 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -162.03 177.07 10.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.103 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . 0.564 ' CD2' HG11 ' A' ' 249' ' ' VAL . 47.7 m-85 -140.17 153.6 46.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.908 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 14.8 t -136.41 151.88 28.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.128 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . 0.417 ' HG ' ' CE1' ' A' ' 159' ' ' PHE . 33.2 mt -105.68 150.55 25.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.881 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . 0.475 ' CE1' HG21 ' A' ' 168' ' ' VAL . 84.4 m-85 -142.66 147.31 35.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.941 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -54.71 -66.96 0.31 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.112 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 219' ' ' CYS . . . . . . . . . . . . . 6.4 p -133.22 175.31 9.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.928 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -61.49 -24.41 66.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.869 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -58.83 -29.91 67.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.922 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 222' ' ' TYR . . . . . . . . . . . . . 34.9 m-85 -91.99 -40.16 11.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.932 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -64.18 -51.38 64.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.087 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 12.7 mm-40 -55.81 -53.95 50.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.92 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 -54.52 -26.3 30.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.917 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -74.84 -28.58 60.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.086 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 26.1 mt -59.92 -29.17 68.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.852 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 30.2 mtp85 -59.55 -28.82 67.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.837 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . 0.505 ' HD2' ' CE1' ' A' ' 185' ' ' PHE . 20.0 mtmt -74.91 -1.03 20.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.889 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 230' ' ' HIS . . . . . 0.534 ' CE1' ' HG3' ' A' ' 231' ' ' LYS . 34.7 t60 -33.3 129.85 0.25 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.856 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.534 ' HG3' ' CE1' ' A' ' 230' ' ' HIS . 49.9 mtmt 62.04 37.17 14.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.926 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -63.37 179.59 0.42 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.838 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 33.6 mt -131.61 106.33 8.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.932 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 7.7 tt -116.2 114.53 24.55 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.932 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 60.68 34.35 86.06 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.506 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 32.4 mtpt 71.19 52.15 0.26 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.795 0.331 . . . . 0.0 110.908 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 237' ' ' ARG . . . . . 0.469 ' CB ' ' HG3' ' A' ' 174' ' ' PRO . 18.5 mmt180 -155.77 115.36 3.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.884 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 238' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -67.44 119.23 11.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.921 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 80.0 mt -115.61 126.93 73.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.105 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . 0.46 ' HB3' ' CE2' ' A' ' 242' ' ' PHE . 37.2 mt-10 -86.13 171.61 11.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.903 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 18.8 mt -152.21 139.41 19.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.915 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 242' ' ' PHE . . . . . 0.46 ' CE2' ' HB3' ' A' ' 240' ' ' GLU . 16.5 m-85 -153.35 126.78 8.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.915 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 61.2 mtm180 -39.85 155.02 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.912 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 19.0 t -156.66 160.7 39.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.827 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 18.0 p -135.86 167.36 21.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.153 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -42.46 -58.52 2.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.091 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -54.0 -56.33 18.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.109 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . 0.456 ' O ' ' CG2' ' A' ' 252' ' ' VAL . 22.5 tp10 -40.66 -46.26 2.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.877 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . 0.564 HG11 ' CD2' ' A' ' 214' ' ' PHE . 99.1 t -61.57 -60.72 2.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.16 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 250' ' ' GLN . . . . . 0.403 ' C ' ' O ' ' A' ' 249' ' ' VAL . 59.9 mt-30 -38.27 -61.18 0.7 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.876 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 251' ' ' GLN . . . . . 0.454 ' CG ' ' O ' ' A' ' 248' ' ' GLU . 7.8 pt20 -53.47 -44.26 68.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.906 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 252' ' ' VAL . . . . . 0.456 ' CG2' ' O ' ' A' ' 248' ' ' GLU . 92.5 t -59.96 -40.57 83.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.136 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 34.6 mt -59.43 -50.84 72.39 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.901 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . 0.5 ' OD1' ' N ' ' A' ' 255' ' ' ARG . 0.6 OUTLIER -61.92 -40.18 94.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.89 179.924 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . 0.5 ' N ' ' OD1' ' A' ' 254' ' ' ASN . 43.2 ttt180 -40.59 -58.47 1.59 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.847 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 256' ' ' PHE . . . . . 0.525 ' CE2' ' HB ' ' A' ' 210' ' ' THR . 55.9 m-85 -74.14 -53.94 8.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.871 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 257' ' ' SER . . . . . 0.425 ' C ' ' O ' ' A' ' 256' ' ' PHE . 29.5 t -36.18 -44.86 0.42 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.88 -179.817 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 16.5 t -121.17 80.37 1.64 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.853 -179.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 259' ' ' ALA . . . . . . . . . . . . . . . -103.46 -54.56 2.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.138 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 2.5 t -78.37 87.43 4.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.867 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . 0.464 ' HA3' ' C ' ' A' ' 262' ' ' PRO . . . -97.22 -74.11 1.17 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.504 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 262' ' ' PRO . . . . . 0.464 ' C ' ' HA3' ' A' ' 261' ' ' GLY . 53.3 Cg_endo -69.76 178.63 24.8 Favored 'Cis proline' 0 C--N 1.341 0.156 0 C-N-CA 122.676 -1.802 . . . . 0.0 112.367 0.016 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 5.6 t -107.54 -58.46 1.96 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.832 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 7.6 t -82.5 125.06 30.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.87 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.363 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.491 -179.954 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.852 0.358 . . . . 0.0 110.903 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 94.1 t -59.32 -47.43 90.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.145 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -37.52 -56.79 0.99 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.072 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -61.59 -40.23 94.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.914 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -59.71 -41.17 90.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.849 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 88.1 mt -87.95 -19.17 27.61 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.915 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 29.5 t -61.62 -22.28 65.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.844 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 39.5 mmtm -72.37 118.55 15.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.931 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -97.46 155.67 16.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.92 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 2.8 m120 63.34 45.64 4.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.884 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 24.0 mm-40 -132.05 149.22 52.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.9 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 55.9 t -103.27 108.04 23.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.129 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' ILE . . . . . 0.458 HD13 HG21 ' A' ' 249' ' ' VAL . 86.8 mt -78.04 141.79 15.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.135 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 92.9 t -122.23 129.28 75.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.113 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 32.5 ttp180 -88.33 106.94 18.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.888 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' MET . . . . . 0.69 ' CE ' HD21 ' A' ' 173' ' ' LEU . 96.9 mtp -94.9 126.35 40.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.858 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 26.1 mtt180 -128.03 142.79 51.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.882 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 79.36 45.19 8.94 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.436 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.744 HD23 HD13 ' A' ' 239' ' ' ILE . 21.1 mt -93.42 133.68 27.96 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.553 0.692 . . . . 0.0 110.953 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 174' ' ' PRO . . . . . 0.462 ' HG3' ' CB ' ' A' ' 237' ' ' ARG . 64.9 Cg_exo -47.98 133.57 23.26 Favored 'Trans proline' 0 N--CA 1.465 -0.168 0 C-N-CA 122.737 2.291 . . . . 0.0 112.318 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -53.99 -19.26 4.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.836 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 74.7 p -96.29 -22.41 17.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.16 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -60.7 125.97 25.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.078 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -125.89 178.26 5.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.127 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.608 ' O ' HG23 ' A' ' 183' ' ' VAL . . . -45.87 -42.69 12.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.069 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -58.21 -41.8 84.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.926 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -61.82 -42.28 98.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.886 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.449 ' O ' ' C ' ' A' ' 183' ' ' VAL . 47.1 t -65.06 -54.4 29.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.099 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.608 HG23 ' O ' ' A' ' 179' ' ' ALA . 91.4 t -33.99 -52.02 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.131 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.419 ' O ' ' C ' ' A' ' 185' ' ' PHE . . . -72.89 -45.74 56.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.093 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.768 ' HD2' HD12 ' A' ' 234' ' ' LEU . 35.2 t80 -36.89 -62.46 0.48 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.875 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 186' ' ' PHE . . . . . 0.511 ' CE1' ' CE1' ' A' ' 185' ' ' PHE . 55.3 m-85 -91.38 -20.81 21.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.869 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -49.01 -23.32 3.62 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.54 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 30.2 mm-40 -50.64 -74.03 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.827 0.346 . . . . 0.0 110.952 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 29.4 m170 -118.19 -18.17 9.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.877 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 58.6 m -115.05 84.24 10.65 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.635 0.731 . . . . 0.0 110.867 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 191' ' ' PRO . . . . . 0.435 ' HD2' ' CD1' ' A' ' 222' ' ' TYR . 53.3 Cg_endo -69.77 142.89 49.12 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.705 2.27 . . . . 0.0 112.31 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 192' ' ' ILE . . . . . 0.563 HG23 ' O ' ' A' ' 216' ' ' LEU . 62.6 mt -94.11 144.99 8.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.113 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 87.1 m -70.38 96.5 1.15 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.183 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 95.85 -2.74 64.48 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.508 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 52.8 -120.01 11.14 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.499 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.27 -27.43 2.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.765 0.316 . . . . 0.0 110.893 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 43.9 mm-40 -80.02 -29.98 39.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.85 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -95.23 41.29 2.52 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.497 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 61.9 mt -141.88 140.54 30.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.828 0.347 . . . . 0.0 111.112 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 13.2 tp -135.91 117.49 14.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.972 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -97.15 115.65 27.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.917 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.557 HG23 ' HA ' ' A' ' 213' ' ' ALA . 14.2 t -70.01 121.92 20.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.151 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 203' ' ' THR . . . . . 0.436 ' HA ' HG23 ' A' ' 210' ' ' THR . 0.8 OUTLIER -131.45 137.99 48.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.151 -179.969 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 204' ' ' TYR . . . . . 0.428 ' CD2' HG22 ' A' ' 210' ' ' THR . 28.0 m-85 -46.45 158.57 0.39 Allowed Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.673 0.749 . . . . 0.0 110.932 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 2.87 3.13 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.689 2.259 . . . . 0.0 112.372 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -109.37 -21.3 12.58 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.875 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 112.01 49.27 0.63 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.466 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -133.7 144.02 50.18 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.645 0.736 . . . . 0.0 110.862 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 101.79 0.96 Allowed 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.664 2.243 . . . . 0.0 112.354 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 210' ' ' THR . . . . . 0.436 HG23 ' HA ' ' A' ' 203' ' ' THR . 46.0 p -66.45 -25.18 66.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.128 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 104.74 -37.71 3.65 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.471 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 212' ' ' ASP . . . . . 0.472 ' OD2' HG11 ' A' ' 202' ' ' VAL . 1.6 p-10 -78.09 155.7 30.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.771 0.32 . . . . 0.0 110.929 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 213' ' ' ALA . . . . . 0.557 ' HA ' HG23 ' A' ' 202' ' ' VAL . . . -157.5 -179.1 7.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.119 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 214' ' ' PHE . . . . . 0.452 ' CE2' HG13 ' A' ' 249' ' ' VAL . 77.6 m-85 -144.5 140.36 28.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.819 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 215' ' ' VAL . . . . . 0.407 HG12 ' N ' ' A' ' 216' ' ' LEU . 4.6 t -124.28 158.99 30.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.133 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 0.563 ' O ' HG23 ' A' ' 192' ' ' ILE . 30.4 mt -111.3 142.54 43.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.958 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -135.44 129.52 33.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.916 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -39.64 -64.48 0.48 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.075 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 219' ' ' CYS . . . . . . . . . . . . . 85.3 m -138.93 -175.34 4.11 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.89 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -71.2 -8.74 55.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.917 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -68.28 -34.62 76.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.922 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 222' ' ' TYR . . . . . 0.435 ' CD1' ' HD2' ' A' ' 191' ' ' PRO . 19.6 m-85 -92.42 -48.88 6.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.92 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -49.76 -53.59 24.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.075 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 224' ' ' GLN . . . . . 0.56 ' HA ' HD12 ' A' ' 227' ' ' LEU . 29.5 mt-30 -52.76 -60.16 3.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.897 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -49.76 -28.57 6.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.915 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -76.23 -36.04 58.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.078 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 227' ' ' LEU . . . . . 0.56 HD12 ' HA ' ' A' ' 224' ' ' GLN . 43.8 mt -55.35 -36.51 66.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.93 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 3.9 mtp-105 -58.23 -18.98 30.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.883 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 229' ' ' LYS . . . . . 0.459 ' O ' ' C ' ' A' ' 230' ' ' HIS . 23.7 mtpp -78.78 -2.54 40.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.872 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 230' ' ' HIS . . . . . 0.542 ' CD2' ' HG2' ' A' ' 231' ' ' LYS . 78.5 t60 -33.89 136.88 0.11 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.857 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.542 ' HG2' ' CD2' ' A' ' 230' ' ' HIS . 23.1 mmtm 62.16 31.08 17.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.857 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -59.69 -176.24 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.823 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.874 HD21 ' CE1' ' A' ' 238' ' ' TYR . 31.6 mt -140.06 110.42 6.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.93 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 234' ' ' LEU . . . . . 0.768 HD12 ' HD2' ' A' ' 185' ' ' PHE . 6.8 tt -119.64 114.16 21.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.91 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 58.26 36.1 81.36 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.497 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 38.7 mttp 71.21 52.13 0.26 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.744 0.306 . . . . 0.0 110.912 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 237' ' ' ARG . . . . . 0.462 ' CB ' ' HG3' ' A' ' 174' ' ' PRO . 19.6 mmt180 -155.79 115.46 3.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.901 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 238' ' ' TYR . . . . . 0.874 ' CE1' HD21 ' A' ' 233' ' ' LEU . 83.5 m-85 -69.72 133.0 47.0 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.955 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 0.744 HD13 HD23 ' A' ' 173' ' ' LEU . 70.7 mt -131.69 141.04 46.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.134 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 240' ' ' GLU . . . . . 0.578 ' HB3' ' CZ ' ' A' ' 242' ' ' PHE . 24.6 mt-10 -92.89 178.33 5.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.906 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 241' ' ' LEU . . . . . 0.593 ' O ' ' CD1' ' A' ' 242' ' ' PHE . 51.0 mt -157.64 137.35 12.21 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.893 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 242' ' ' PHE . . . . . 0.593 ' CD1' ' O ' ' A' ' 241' ' ' LEU . 5.2 m-85 -157.53 122.8 4.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.871 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 243' ' ' ARG . . . . . 0.492 ' CG ' ' O ' ' A' ' 243' ' ' ARG . 19.9 ptt180 -59.57 112.58 1.84 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.873 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 1.7 t -106.98 164.32 12.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.866 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 245' ' ' THR . . . . . 0.594 ' O ' HG23 ' A' ' 249' ' ' VAL . 33.7 p -110.19 166.51 10.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.166 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -54.38 -61.53 2.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.079 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -45.44 -56.26 5.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.083 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -45.7 -55.78 6.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.89 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 0.594 HG23 ' O ' ' A' ' 245' ' ' THR . 99.8 t -41.72 -59.88 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.138 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 250' ' ' GLN . . . . . 0.479 ' HA ' HD12 ' A' ' 253' ' ' LEU . 33.8 mt-30 -47.83 -42.56 26.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.882 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 35.4 mm-40 -68.46 -22.6 64.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.952 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 76.7 t -85.1 -21.1 8.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.11 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 253' ' ' LEU . . . . . 0.479 HD12 ' HA ' ' A' ' 250' ' ' GLN . 10.9 mt -87.38 -42.18 13.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.945 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -64.47 -43.41 94.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.898 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -53.76 -42.36 68.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.888 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -80.87 -34.02 33.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.848 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 20.6 m . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.875 -179.774 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.898 0.38 . . . . 0.0 110.9 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 76.8 t -66.43 -36.75 78.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.151 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -44.32 -51.37 8.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.079 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -61.37 -51.11 70.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.929 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' PHE . . . . . 0.502 ' CE1' ' HG ' ' A' ' 216' ' ' LEU . 85.3 t80 -46.24 -46.1 17.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.875 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 92.0 mt -84.5 -18.55 35.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.918 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 17.6 t -56.82 -25.38 55.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.845 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' LYS . . . . . 0.557 ' HG3' HD13 ' A' ' 216' ' ' LEU . 28.3 mmtt -71.04 131.78 44.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.886 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -110.01 156.97 19.79 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.847 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 3.5 m120 65.03 36.17 7.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.882 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 22.2 mm-40 -124.95 160.08 29.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.91 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 25.3 t -111.6 115.71 50.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.174 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 19.3 mt -86.99 140.27 16.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.14 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.404 HG21 ' CE2' ' A' ' 217' ' ' PHE . 30.0 t -122.17 137.26 56.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.157 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 51.4 ttp180 -92.29 112.51 24.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.84 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' MET . . . . . 0.48 ' CE ' HD21 ' A' ' 173' ' ' LEU . 98.9 mtp -107.29 111.64 24.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.917 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 10.3 ptm180 -118.92 133.96 55.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.835 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 100.6 18.21 21.58 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.47 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.752 HD23 HD13 ' A' ' 239' ' ' ILE . 31.0 mt -73.85 133.16 79.47 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.633 0.73 . . . . 0.0 110.91 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 174' ' ' PRO . . . . . 0.448 ' HG3' ' CB ' ' A' ' 237' ' ' ARG . 65.8 Cg_exo -48.0 135.08 23.92 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.642 2.228 . . . . 0.0 112.369 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 3.3 m-30 -49.71 -35.11 20.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.884 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 176' ' ' THR . . . . . 0.421 ' O ' ' C ' ' A' ' 177' ' ' ALA . 22.8 p -77.68 -43.96 29.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.153 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 177' ' ' ALA . . . . . 0.429 ' HA ' ' CD ' ' A' ' 181' ' ' GLU . . . -35.55 128.97 0.59 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.087 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 3.9 p -124.54 -178.7 4.21 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.132 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -56.75 -41.78 78.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.098 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -58.84 -34.97 72.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.904 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 181' ' ' GLU . . . . . 0.429 ' CD ' ' HA ' ' A' ' 177' ' ' ALA . 36.4 mt-10 -69.52 -37.37 77.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.885 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.588 HG12 ' CD1' ' A' ' 192' ' ' ILE . 26.1 t -68.93 -47.01 78.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.176 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 37.7 t -37.95 -49.4 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.096 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.423 ' O ' ' C ' ' A' ' 185' ' ' PHE . . . -74.28 -44.84 51.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.105 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.619 ' CE1' ' CE1' ' A' ' 186' ' ' PHE . 5.7 t80 -36.89 -64.07 0.38 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.829 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 186' ' ' PHE . . . . . 0.619 ' CE1' ' CE1' ' A' ' 185' ' ' PHE . 59.9 m-85 -89.19 -21.64 23.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.899 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -49.62 -26.15 7.36 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.514 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 16.5 tt0 -48.98 -70.91 0.08 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.863 0.363 . . . . 0.0 110.971 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 65.9 m80 -118.27 -16.6 9.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.869 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 190' ' ' CYS . . . . . 0.438 ' N ' ' O ' ' A' ' 186' ' ' PHE . 74.4 m -120.11 85.36 35.35 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.569 0.699 . . . . 0.0 110.818 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 191' ' ' PRO . . . . . 0.458 ' HD2' ' CD1' ' A' ' 222' ' ' TYR . 53.8 Cg_endo -69.78 130.04 18.62 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.701 2.268 . . . . 0.0 112.338 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 192' ' ' ILE . . . . . 0.588 ' CD1' HG12 ' A' ' 182' ' ' VAL . 53.2 mt -79.03 142.92 13.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.122 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 21.9 m -66.74 98.66 0.54 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.164 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 89.22 -3.92 84.3 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.465 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.412 ' O ' ' N ' ' A' ' 198' ' ' GLY . . . 58.24 -117.46 10.56 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.497 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 4.3 ptpp? -47.38 -28.67 2.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.779 0.323 . . . . 0.0 110.924 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -78.48 -29.85 46.99 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.932 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 198' ' ' GLY . . . . . 0.419 ' HA2' HD12 ' A' ' 216' ' ' LEU . . . -95.69 41.43 2.46 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.469 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.411 HG21 ' CE2' ' A' ' 201' ' ' PHE . 75.9 mt -140.7 138.3 35.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.833 0.349 . . . . 0.0 111.128 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 14.3 tp -132.99 113.03 12.34 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.915 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 201' ' ' PHE . . . . . 0.411 ' CE2' HG21 ' A' ' 199' ' ' ILE . 81.3 m-85 -96.58 110.81 23.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.855 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 22.0 t -67.41 127.36 28.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.128 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -132.48 141.57 48.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.168 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 -45.78 158.12 0.36 Allowed Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.686 0.755 . . . . 0.0 110.964 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 3.21 2.92 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.707 2.271 . . . . 0.0 112.355 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -112.68 -16.07 12.87 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.891 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 106.94 62.98 0.58 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.501 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 35.2 mtt180 -151.77 151.15 27.85 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.646 0.736 . . . . 0.0 110.861 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 122.42 9.09 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.701 2.268 . . . . 0.0 112.352 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 42.9 p -90.84 -21.42 21.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.123 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 104.35 -35.49 5.01 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.494 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -80.68 156.54 26.26 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.838 0.351 . . . . 0.0 110.829 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -160.74 172.87 16.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.099 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -140.23 149.13 42.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.869 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 215' ' ' VAL . . . . . 0.437 HG12 ' N ' ' A' ' 216' ' ' LEU . 8.1 t -131.49 159.34 43.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.179 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 0.557 HD13 ' HG3' ' A' ' 162' ' ' LYS . 36.9 mt -108.79 143.2 38.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.918 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 217' ' ' PHE . . . . . 0.404 ' CE2' HG21 ' A' ' 168' ' ' VAL . 76.9 m-85 -136.4 145.24 45.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.895 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -59.03 -62.35 1.95 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.072 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 219' ' ' CYS . . . . . . . . . . . . . 66.7 m -141.14 179.34 6.81 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.918 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -57.83 -36.48 72.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.877 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -40.07 -45.76 2.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.897 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 222' ' ' TYR . . . . . 0.458 ' CD1' ' HD2' ' A' ' 191' ' ' PRO . 24.0 m-85 -84.44 -49.9 8.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.919 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -53.49 -63.29 1.2 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.098 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 85.9 mm-40 -49.28 -52.65 26.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.882 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 61.8 m-20 -59.18 -26.33 64.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.92 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -75.27 -28.51 59.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.117 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 26.8 mt -62.37 -29.41 70.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.897 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 65.0 mtp180 -60.87 -19.5 60.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.871 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 229' ' ' LYS . . . . . 0.544 ' HD2' ' CE1' ' A' ' 185' ' ' PHE . 20.3 mtmm -83.02 0.69 43.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.881 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 230' ' ' HIS . . . . . 0.466 ' C ' ' O ' ' A' ' 229' ' ' LYS . 67.9 t60 -33.4 135.13 0.12 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.866 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.411 ' HG3' ' NE2' ' A' ' 230' ' ' HIS . 13.2 mttm 60.8 32.2 20.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.897 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 232' ' ' ASP . . . . . 0.475 ' OD2' ' CE2' ' A' ' 185' ' ' PHE . 15.3 t0 -55.64 175.47 0.08 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.838 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.68 HD21 ' CE1' ' A' ' 238' ' ' TYR . 30.5 mt -130.88 106.57 8.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.909 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 234' ' ' LEU . . . . . 0.523 ' C ' HD23 ' A' ' 234' ' ' LEU . 6.5 tt -114.38 114.31 25.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.903 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 56.49 42.72 90.23 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.526 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 22.8 mmtp 65.54 52.55 1.34 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.767 0.318 . . . . 0.0 110.877 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 237' ' ' ARG . . . . . 0.448 ' CB ' ' HG3' ' A' ' 174' ' ' PRO . 19.1 mmt180 -156.27 115.38 3.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.876 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 238' ' ' TYR . . . . . 0.68 ' CE1' HD21 ' A' ' 233' ' ' LEU . 97.6 m-85 -68.49 131.48 45.34 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.916 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 0.752 HD13 HD23 ' A' ' 173' ' ' LEU . 56.5 mt -129.1 128.28 66.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.13 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 240' ' ' GLU . . . . . 0.491 ' HB3' ' CZ ' ' A' ' 242' ' ' PHE . 36.7 mt-10 -88.22 159.71 18.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.9 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 241' ' ' LEU . . . . . 0.511 ' O ' ' CD1' ' A' ' 242' ' ' PHE . 15.2 mt -141.7 146.3 35.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.899 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 242' ' ' PHE . . . . . 0.511 ' CD1' ' O ' ' A' ' 241' ' ' LEU . 9.7 m-85 -158.49 155.33 28.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.825 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 72.9 mtm180 -69.29 135.61 50.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.873 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 11.2 t -134.89 163.64 29.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.834 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 245' ' ' THR . . . . . 0.413 ' O ' ' C ' ' A' ' 246' ' ' ALA . 72.6 p -139.77 156.57 46.69 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.136 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 246' ' ' ALA . . . . . 0.413 ' C ' ' O ' ' A' ' 245' ' ' THR . . . -36.24 -52.23 0.8 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.07 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -56.87 -52.39 65.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.081 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 248' ' ' GLU . . . . . 0.426 ' O ' HG23 ' A' ' 252' ' ' VAL . 6.4 tp10 -49.78 -49.91 46.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.959 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 97.0 t -49.47 -66.48 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.129 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 250' ' ' GLN . . . . . 0.477 ' HA ' HD12 ' A' ' 253' ' ' LEU . 55.9 mt-30 -40.69 -42.98 1.85 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.91 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -63.87 -48.12 77.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.92 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 252' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 248' ' ' GLU . 96.0 t -57.83 -46.05 87.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.148 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 253' ' ' LEU . . . . . 0.477 HD12 ' HA ' ' A' ' 250' ' ' GLN . 16.5 mt -57.32 -49.59 75.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.942 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 14.4 m-20 -60.11 -51.17 70.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.861 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 30.6 ttt180 -38.91 -52.11 1.77 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.905 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -69.63 -50.4 44.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.912 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 8.6 m . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.828 -179.797 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.905 0.383 . . . . 0.0 110.836 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.484 HG22 HD21 ' A' ' 200' ' ' LEU . 69.0 t -68.12 -44.51 84.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.15 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.425 ' C ' ' O ' ' A' ' 156' ' ' VAL . . . -36.11 -59.71 0.6 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.073 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 41.7 mm-40 -57.27 -49.88 74.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.891 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -46.33 -39.96 11.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.878 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 83.6 mt -91.33 -18.0 25.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.929 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 28.4 t -58.5 -22.65 55.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.839 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 19.8 mmtp -73.22 120.77 19.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.877 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -96.15 158.32 15.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.871 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 59.93 47.67 9.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.856 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 25.3 mm-40 -131.74 156.28 46.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.921 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 29.9 t -111.14 105.66 19.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.101 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' ILE . . . . . 0.633 HD13 HG21 ' A' ' 249' ' ' VAL . 66.4 mt -77.71 135.18 26.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.141 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 91.1 t -114.15 128.79 70.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.08 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 7.7 ttp-105 -88.35 106.09 18.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.857 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' MET . . . . . 0.694 ' CE ' HD21 ' A' ' 173' ' ' LEU . 99.3 mtp -95.57 138.32 33.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.88 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 73.7 mtt-85 -134.4 139.89 45.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.869 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 83.91 39.39 9.46 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.493 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.694 HD21 ' CE ' ' A' ' 170' ' ' MET . 24.1 mt -89.34 126.25 59.14 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.665 0.745 . . . . 0.0 110.889 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 174' ' ' PRO . . . . . 0.439 ' HG3' ' CB ' ' A' ' 237' ' ' ARG . 65.7 Cg_exo -47.99 132.78 22.84 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.684 2.256 . . . . 0.0 112.326 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 175' ' ' PHE . . . . . 0.561 ' CD1' ' HG3' ' A' ' 209' ' ' PRO . 10.3 t80 -45.19 -34.78 2.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.899 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 9.2 p -82.46 -30.34 30.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.14 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -52.84 107.0 0.19 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.116 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 5.7 p -113.02 178.16 4.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.155 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -46.48 -39.63 11.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.071 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -60.2 -34.63 73.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.875 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 38.5 mm-40 -75.38 -23.74 57.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.883 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.483 HG12 ' CD1' ' A' ' 192' ' ' ILE . 74.8 t -83.23 -47.2 18.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.17 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 54.8 t -41.47 -44.12 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.125 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -81.47 -37.06 28.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.08 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.696 ' HD2' HD12 ' A' ' 234' ' ' LEU . 19.9 t80 -45.69 -62.96 1.08 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.858 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 186' ' ' PHE . . . . . 0.507 ' CE1' ' CE1' ' A' ' 185' ' ' PHE . 68.7 m-85 -89.41 -20.9 23.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.911 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -49.67 -16.9 1.19 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.461 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 25.1 tp60 -58.94 -72.85 0.09 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.825 0.345 . . . . 0.0 110.878 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 23.3 m80 -118.28 -9.31 10.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.878 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 71.3 m -125.46 86.94 56.47 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.543 0.687 . . . . 0.0 110.9 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 141.35 45.04 Favored 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.708 2.272 . . . . 0.0 112.381 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 192' ' ' ILE . . . . . 0.698 HG23 ' O ' ' A' ' 216' ' ' LEU . 61.4 mt -95.78 141.99 14.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.116 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 14.8 m -65.38 102.98 0.74 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.168 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 89.15 -16.96 54.41 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.485 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.4 ' O ' ' N ' ' A' ' 198' ' ' GLY . . . 72.85 -122.43 8.25 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.456 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 196' ' ' LYS . . . . . 0.607 ' HA ' HD12 ' A' ' 199' ' ' ILE . 15.4 ptmt -46.38 -36.15 6.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.746 0.308 . . . . 0.0 110.903 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -69.85 -31.01 68.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.871 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 198' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 195' ' ' GLY . . . -91.99 39.55 3.01 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.52 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.607 HD12 ' HA ' ' A' ' 196' ' ' LYS . 48.5 mt -139.99 145.49 26.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.824 0.345 . . . . 0.0 111.116 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.484 HD21 HG22 ' A' ' 156' ' ' VAL . 15.2 tp -143.33 124.32 14.38 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.926 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -103.5 123.66 47.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.875 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 44.6 t -78.96 140.09 17.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.142 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 203' ' ' THR . . . . . 0.497 ' HA ' HG23 ' A' ' 210' ' ' THR . 0.8 OUTLIER -144.79 139.15 27.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.155 -179.986 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -49.48 159.13 0.7 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.657 0.741 . . . . 0.0 110.914 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 3.24 2.88 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.673 2.248 . . . . 0.0 112.346 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -110.51 -20.83 12.43 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.863 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 114.15 34.27 1.67 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.427 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -116.16 143.62 31.34 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.621 0.724 . . . . 0.0 110.848 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 209' ' ' PRO . . . . . 0.561 ' HG3' ' CD1' ' A' ' 175' ' ' PHE . 53.9 Cg_endo -69.77 107.79 1.94 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.699 2.266 . . . . 0.0 112.348 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 210' ' ' THR . . . . . 0.497 HG23 ' HA ' ' A' ' 203' ' ' THR . 44.9 p -73.18 -5.65 40.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.117 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 79.42 -40.56 2.21 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.48 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -69.42 161.5 29.29 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.787 0.327 . . . . 0.0 110.852 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 213' ' ' ALA . . . . . 0.514 ' HB3' ' CD1' ' A' ' 173' ' ' LEU . . . -164.28 -179.15 5.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.105 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -144.88 144.95 31.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.886 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 215' ' ' VAL . . . . . 0.445 HG12 ' N ' ' A' ' 216' ' ' LEU . 6.1 t -131.69 160.14 42.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.147 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 0.698 ' O ' HG23 ' A' ' 192' ' ' ILE . 37.6 mt -108.8 140.92 41.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.924 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -135.81 125.19 24.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.884 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -38.1 -73.44 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.081 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 219' ' ' CYS . . . . . . . . . . . . . 69.5 m -123.63 174.05 7.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.873 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -64.56 -32.91 74.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.932 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -41.28 -44.65 2.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.896 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 222' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -77.7 -43.92 29.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.906 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -50.8 -54.96 19.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.063 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 -50.55 -54.57 21.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.894 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 225' ' ' ASN . . . . . 0.433 ' HA ' ' NE ' ' A' ' 228' ' ' ARG . 55.0 m-20 -54.98 -27.62 45.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.912 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -76.68 -39.83 50.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.073 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 86.4 mt -55.18 -38.32 68.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.9 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 228' ' ' ARG . . . . . 0.433 ' NE ' ' HA ' ' A' ' 225' ' ' ASN . 50.4 mtm180 -57.99 -24.26 57.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.883 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 229' ' ' LYS . . . . . 0.463 ' O ' ' C ' ' A' ' 230' ' ' HIS . 28.1 mtpt -77.01 -1.52 29.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.907 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 230' ' ' HIS . . . . . 0.466 ' CD2' ' HG2' ' A' ' 231' ' ' LYS . 85.9 t60 -33.6 138.15 0.08 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.856 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.466 ' HG2' ' CD2' ' A' ' 230' ' ' HIS . 37.4 mmtt 62.37 25.67 15.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.937 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -52.25 -179.02 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.876 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.7 HD21 ' CE1' ' A' ' 238' ' ' TYR . 31.2 mt -139.5 107.34 5.66 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.951 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 234' ' ' LEU . . . . . 0.708 ' C ' HD23 ' A' ' 234' ' ' LEU . 5.4 tt -117.64 114.63 23.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.895 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 59.77 37.0 91.8 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.466 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 28.0 mmtt 68.47 52.24 0.62 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.742 0.306 . . . . 0.0 110.893 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 237' ' ' ARG . . . . . 0.439 ' CB ' ' HG3' ' A' ' 174' ' ' PRO . 43.6 mmt-85 -156.19 115.36 3.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.883 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 238' ' ' TYR . . . . . 0.7 ' CE1' HD21 ' A' ' 233' ' ' LEU . 93.8 m-85 -67.84 134.81 51.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.933 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 0.429 HD13 HD23 ' A' ' 173' ' ' LEU . 60.2 mt -132.98 136.32 55.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.133 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 240' ' ' GLU . . . . . 0.641 ' O ' HD23 ' A' ' 241' ' ' LEU . 66.3 mt-10 -89.33 172.6 8.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.921 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 241' ' ' LEU . . . . . 0.641 HD23 ' O ' ' A' ' 240' ' ' GLU . 18.4 mt -153.99 139.24 17.51 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.905 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 242' ' ' PHE . . . . . 0.599 ' CD1' ' O ' ' A' ' 241' ' ' LEU . 5.7 m-85 -159.13 122.87 3.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.865 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 243' ' ' ARG . . . . . 0.493 ' CG ' ' O ' ' A' ' 243' ' ' ARG . 19.0 ptt-85 -61.05 118.06 6.29 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.861 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 16.3 t -114.08 -179.22 3.57 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.86 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 71.3 p -127.83 162.2 27.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.137 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -50.58 -56.13 13.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.058 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -50.2 -52.31 36.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.145 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -49.79 -57.77 6.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.879 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 0.633 HG21 HD13 ' A' ' 167' ' ' ILE . 95.1 t -38.78 -66.81 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.135 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 250' ' ' GLN . . . . . 0.424 ' HA ' HD12 ' A' ' 253' ' ' LEU . 15.0 mt-30 -38.64 -48.79 1.5 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.948 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -60.32 -44.56 95.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.93 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 98.7 t -60.76 -44.93 98.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.146 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 253' ' ' LEU . . . . . 0.424 HD12 ' HA ' ' A' ' 250' ' ' GLN . 17.3 mt -58.39 -49.43 77.28 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.915 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 28.3 m120 -61.07 -47.02 88.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.89 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 57.2 ttt180 -41.93 -44.04 3.3 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.883 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 256' ' ' PHE . . . . . 0.435 ' CE1' ' HB ' ' A' ' 210' ' ' THR . 49.9 m-85 -73.44 -40.08 64.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.911 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 5.4 m . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.896 -179.827 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.94 0.4 . . . . 0.0 110.916 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.594 HG22 HD21 ' A' ' 200' ' ' LEU . 73.7 t -79.55 -43.07 23.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.156 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -41.07 -58.05 1.86 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.112 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -59.66 -44.42 93.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.94 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 28.1 t80 -53.49 -42.61 67.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.897 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 86.6 mt -88.97 -16.44 31.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.93 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 8.5 t -61.38 -32.29 72.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.843 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 43.3 mmtt -61.05 126.45 27.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.872 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -102.33 152.87 20.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.858 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 11.3 m-20 68.92 38.82 1.97 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.888 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.6 ' OE1' HG21 ' A' ' 193' ' ' THR . 5.4 mm-40 -128.8 146.08 51.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.923 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 60.8 t -100.31 106.48 19.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.125 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 36.0 mt -77.19 138.86 19.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.11 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 96.1 t -123.06 130.8 74.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.107 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' ARG . . . . . 0.537 ' HG3' ' CE1' ' A' ' 214' ' ' PHE . 25.6 ttm180 -88.34 113.08 23.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.857 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 170' ' ' MET . . . . . 0.518 ' CE ' HD21 ' A' ' 173' ' ' LEU . 97.8 mtp -98.15 126.51 43.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.873 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 171' ' ' ARG . . . . . 0.62 ' O ' HG23 ' A' ' 239' ' ' ILE . 24.2 mtt180 -123.51 157.5 33.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.877 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 73.79 21.93 78.75 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.479 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.527 HD23 HD13 ' A' ' 239' ' ' ILE . 19.8 mt -74.39 127.5 87.5 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.616 0.722 . . . . 0.0 110.913 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_exo -47.96 149.32 5.73 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.666 2.244 . . . . 0.0 112.349 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 10.8 m-30 -62.49 -26.1 68.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.899 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 63.5 p -90.47 -25.62 20.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.152 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -44.91 126.52 5.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.076 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 5.9 p -125.17 176.49 6.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.15 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -57.12 -36.18 70.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.113 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -68.71 -15.83 63.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.922 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -88.53 -22.43 23.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.86 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.487 HG12 ' CD1' ' A' ' 192' ' ' ILE . 22.4 t -83.94 -52.79 12.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.16 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.425 ' C ' ' O ' ' A' ' 182' ' ' VAL . 47.7 t -36.04 -47.51 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.138 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -74.71 -36.6 62.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.101 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.605 ' HD2' HD12 ' A' ' 234' ' ' LEU . 15.5 t80 -48.51 -59.27 3.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.877 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 186' ' ' PHE . . . . . 0.572 ' CE1' ' CE1' ' A' ' 185' ' ' PHE . 57.2 m-85 -92.18 -21.31 20.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.898 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -49.13 -19.16 1.47 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.481 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 12.4 mm100 -56.35 -75.19 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.866 0.365 . . . . 0.0 110.949 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 2.5 t-160 -117.49 -6.28 11.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.869 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 87.0 m -126.86 86.31 59.03 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.552 0.692 . . . . 0.0 110.9 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 133.62 26.1 Favored 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.689 2.259 . . . . 0.0 112.357 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 192' ' ' ILE . . . . . 0.553 HG23 ' O ' ' A' ' 216' ' ' LEU . 57.9 mt -85.26 145.58 7.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.129 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 193' ' ' THR . . . . . 0.6 HG21 ' OE1' ' A' ' 165' ' ' GLN . 90.9 m -73.66 107.43 5.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.105 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 93.16 -21.85 37.91 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.459 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 78.72 -122.89 6.0 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.476 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.77 -20.71 9.09 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.719 0.295 . . . . 0.0 110.89 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -85.22 -24.87 27.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.895 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 198' ' ' GLY . . . . . 0.443 ' HA2' HD12 ' A' ' 216' ' ' LEU . . . -93.4 40.27 2.82 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.46 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.41 HG22 ' N ' ' A' ' 200' ' ' LEU . 35.2 mt -142.75 153.0 17.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.896 0.379 . . . . 0.0 111.104 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.594 HD21 HG22 ' A' ' 156' ' ' VAL . 13.3 tp -146.34 110.96 5.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.925 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -92.89 109.81 21.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.871 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.486 HG23 ' HA ' ' A' ' 213' ' ' ALA . 11.0 t -70.99 128.05 33.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.121 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -133.04 142.66 48.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.134 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 204' ' ' TYR . . . . . 0.448 ' N ' HG23 ' A' ' 210' ' ' THR . 27.1 m-85 -51.4 159.12 1.22 Allowed Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.708 0.766 . . . . 0.0 110.943 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 3.4 2.78 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.648 2.232 . . . . 0.0 112.38 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -112.55 -21.32 11.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.867 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 118.03 9.69 9.59 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.489 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -92.48 141.45 24.75 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.581 0.705 . . . . 0.0 110.887 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 106.49 1.67 Allowed 'Trans proline' 0 C--O 1.233 0.225 0 C-N-CA 122.69 2.26 . . . . 0.0 112.333 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 210' ' ' THR . . . . . 0.527 ' HB ' ' CE1' ' A' ' 256' ' ' PHE . 71.0 p -66.11 -23.4 66.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.131 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 95.49 -22.59 38.07 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.501 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 212' ' ' ASP . . . . . 0.428 ' OD1' ' CZ ' ' A' ' 256' ' ' PHE . 1.0 OUTLIER -90.16 157.03 17.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.776 0.322 . . . . 0.0 110.899 -179.988 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 213' ' ' ALA . . . . . 0.486 ' HA ' HG23 ' A' ' 202' ' ' VAL . . . -159.37 178.73 9.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.107 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 214' ' ' PHE . . . . . 0.537 ' CE1' ' HG3' ' A' ' 169' ' ' ARG . 55.4 m-85 -143.64 145.65 32.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.909 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 215' ' ' VAL . . . . . 0.45 HG12 ' N ' ' A' ' 216' ' ' LEU . 4.0 t -131.9 162.02 40.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.137 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 0.553 ' O ' HG23 ' A' ' 192' ' ' ILE . 45.3 mt -111.8 137.45 49.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.903 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -130.12 142.39 50.6 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.881 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 218' ' ' ALA . . . . . 0.853 ' HB3' ' CD2' ' A' ' 222' ' ' TYR . . . -50.32 -61.66 2.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.093 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 219' ' ' CYS . . . . . . . . . . . . . 1.9 t -153.11 175.3 13.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.833 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -49.2 -31.31 8.32 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.891 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -51.57 -36.07 43.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.918 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 222' ' ' TYR . . . . . 0.853 ' CD2' ' HB3' ' A' ' 218' ' ' ALA . 33.3 m-85 -92.02 -41.51 10.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.926 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -56.81 -54.41 46.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.114 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 10.2 mm-40 -50.37 -52.11 40.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.893 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 22.4 m-20 -58.6 -23.84 59.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.858 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -79.48 -45.88 18.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.112 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 57.3 mt -52.13 -35.67 49.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.898 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 65.5 mtp180 -56.77 -29.56 62.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.912 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 229' ' ' LYS . . . . . 0.465 ' O ' ' C ' ' A' ' 230' ' ' HIS . 16.3 mtpp -74.7 -0.69 18.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.896 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 230' ' ' HIS . . . . . 0.504 ' CE1' ' HG2' ' A' ' 231' ' ' LYS . 48.5 t-80 -33.35 141.39 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.842 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.504 ' HG2' ' CE1' ' A' ' 230' ' ' HIS . 13.1 mmtp 59.78 26.62 15.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.9 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -53.42 177.96 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.853 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.582 HD21 ' CD1' ' A' ' 238' ' ' TYR . 32.9 mt -136.58 105.03 5.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.97 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 234' ' ' LEU . . . . . 0.605 HD12 ' HD2' ' A' ' 185' ' ' PHE . 7.0 tt -113.94 115.53 27.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.9 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 59.17 37.18 91.39 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.484 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 62.9 mttt 69.08 52.57 0.49 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.809 0.338 . . . . 0.0 110.877 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 23.2 mmt180 -155.99 117.26 3.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.879 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 238' ' ' TYR . . . . . 0.582 ' CD1' HD21 ' A' ' 233' ' ' LEU . 96.1 m-85 -69.17 133.99 48.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.95 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 0.62 HG23 ' O ' ' A' ' 171' ' ' ARG . 76.2 mt -132.59 135.96 56.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.136 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 240' ' ' GLU . . . . . 0.558 ' HB3' ' CZ ' ' A' ' 242' ' ' PHE . 6.8 mt-10 -87.38 179.38 6.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.878 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 241' ' ' LEU . . . . . 0.59 ' O ' ' CD1' ' A' ' 242' ' ' PHE . 54.8 mt -158.29 132.62 8.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.889 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 242' ' ' PHE . . . . . 0.59 ' CD1' ' O ' ' A' ' 241' ' ' LEU . 6.7 m-85 -154.03 123.05 6.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.861 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 243' ' ' ARG . . . . . 0.486 ' CG ' ' O ' ' A' ' 243' ' ' ARG . 20.5 ptt180 -59.72 116.46 4.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.893 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 1.9 t -103.89 175.37 5.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.814 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 52.9 p -127.98 150.06 50.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.107 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -40.44 -59.35 1.34 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.056 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -52.36 -51.27 59.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.127 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 248' ' ' GLU . . . . . 0.408 ' O ' ' N ' ' A' ' 251' ' ' GLN . 13.3 tp10 -52.21 -57.29 10.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.942 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 0.526 HG13 ' CE2' ' A' ' 214' ' ' PHE . 86.9 t -36.85 -60.13 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.122 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 250' ' ' GLN . . . . . 0.412 ' HA ' HD12 ' A' ' 253' ' ' LEU . 41.7 mt-30 -49.89 -40.37 42.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.896 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 251' ' ' GLN . . . . . 0.408 ' N ' ' O ' ' A' ' 248' ' ' GLU . 60.9 mt-30 -69.7 -19.88 63.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.943 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 69.0 t -88.64 -26.82 5.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.111 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 253' ' ' LEU . . . . . 0.412 HD12 ' HA ' ' A' ' 250' ' ' GLN . 10.5 mt -81.46 -39.17 25.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.91 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -66.41 -45.43 79.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.885 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 255' ' ' ARG . . . . . 0.507 ' CG ' ' N ' ' A' ' 256' ' ' PHE . 6.0 ptm180 -48.07 -48.72 33.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.87 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 256' ' ' PHE . . . . . 0.527 ' CE1' ' HB ' ' A' ' 210' ' ' THR . 12.9 m-85 -64.58 -41.83 96.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.891 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 57.8 m . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.893 -179.834 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.883 0.373 . . . . 0.0 110.884 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 74.4 t -63.41 -36.51 76.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.11 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -38.9 -63.89 0.49 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.098 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 89.7 mm-40 -57.58 -48.09 80.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.903 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 28.0 t80 -47.68 -41.81 23.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.857 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 33.0 mt -83.98 -31.95 25.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.91 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 18.1 t -47.3 -41.24 18.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.85 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' LYS . . . . . 0.687 ' HG3' HD13 ' A' ' 216' ' ' LEU . 0.7 OUTLIER -38.39 129.57 1.35 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.904 179.908 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -110.63 133.63 53.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.862 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' ASN . . . . . 0.407 ' O ' ' NE2' ' A' ' 165' ' ' GLN . 2.0 m-20 74.24 43.33 0.29 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.884 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.407 ' NE2' ' O ' ' A' ' 164' ' ' ASN . 39.8 mm-40 -128.38 168.02 16.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.939 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.414 HG11 ' CB ' ' A' ' 223' ' ' ALA . 55.6 t -118.71 141.33 38.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.111 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 167' ' ' ILE . . . . . 0.583 HD12 ' N ' ' A' ' 246' ' ' ALA . 8.6 mt -111.61 143.92 20.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.103 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 97.9 t -127.14 133.72 67.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.087 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 70.2 ttt180 -91.14 112.83 24.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.868 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' MET . . . . . 0.46 ' CE ' HD21 ' A' ' 173' ' ' LEU . 91.0 mtp -100.43 149.56 23.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.89 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 35.0 mtp180 -146.75 133.87 20.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.909 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 96.51 19.28 28.02 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.513 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.523 ' CD1' ' HB3' ' A' ' 213' ' ' ALA . 24.3 mt -71.18 121.12 83.29 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.639 0.733 . . . . 0.0 110.907 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 174' ' ' PRO . . . . . 0.413 ' HG3' ' CB ' ' A' ' 237' ' ' ARG . 64.9 Cg_exo -47.97 131.66 21.43 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.703 2.269 . . . . 0.0 112.326 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 175' ' ' PHE . . . . . 0.554 ' CD1' ' HG3' ' A' ' 209' ' ' PRO . 11.6 t80 -37.52 -49.42 1.06 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.885 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 176' ' ' THR . . . . . 0.424 ' O ' ' C ' ' A' ' 177' ' ' ALA . 14.4 p -68.39 -44.98 73.91 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.141 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 177' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' A' ' 176' ' ' THR . . . -35.72 111.25 0.13 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.104 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -115.48 -177.16 3.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.161 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.409 ' HB1' ' HA ' ' A' ' 196' ' ' LYS . . . -50.01 -47.87 52.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.12 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 180' ' ' GLU . . . . . 0.407 ' CG ' ' OE2' ' A' ' 181' ' ' GLU . 5.7 pt-20 -51.67 -40.01 59.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.923 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 181' ' ' GLU . . . . . 0.407 ' OE2' ' CG ' ' A' ' 180' ' ' GLU . 0.1 OUTLIER -65.94 -36.99 84.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.876 -179.95 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.505 HG12 HD11 ' A' ' 192' ' ' ILE . 89.9 t -69.47 -50.36 51.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.155 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.418 ' C ' ' O ' ' A' ' 182' ' ' VAL . 34.4 t -35.55 -50.89 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.161 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -75.4 -42.28 54.17 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.127 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.715 ' HD2' HD12 ' A' ' 234' ' ' LEU . 10.2 t80 -40.2 -62.03 0.8 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.906 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 186' ' ' PHE . . . . . 0.527 ' CE1' ' CE1' ' A' ' 185' ' ' PHE . 72.8 m-85 -92.81 -21.08 20.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.908 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -49.28 -17.26 1.04 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.535 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -57.95 -72.4 0.09 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.829 0.347 . . . . 0.0 110.931 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 29.5 m170 -118.22 -10.88 10.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.889 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 74.2 m -125.27 85.34 58.43 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.584 0.707 . . . . 0.0 110.89 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 146.54 60.67 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.694 2.263 . . . . 0.0 112.362 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 192' ' ' ILE . . . . . 0.762 HG23 ' O ' ' A' ' 216' ' ' LEU . 56.0 mt -98.43 143.52 12.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.156 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 89.1 m -67.99 101.21 1.08 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.182 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 92.23 -12.18 70.26 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.485 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 68.22 -123.48 17.6 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.461 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 196' ' ' LYS . . . . . 0.409 ' HA ' ' HB1' ' A' ' 179' ' ' ALA . 13.9 pttp -49.23 -29.46 5.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.766 0.317 . . . . 0.0 110.921 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -75.6 -31.35 59.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.879 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -94.29 41.83 2.54 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.464 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.557 HG12 HG13 ' A' ' 215' ' ' VAL . 87.0 mt -140.35 147.84 22.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.887 0.375 . . . . 0.0 111.117 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 13.4 tp -141.57 127.09 18.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.89 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -105.43 120.71 42.27 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.889 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.443 HG23 ' HA ' ' A' ' 213' ' ' ALA . 20.1 t -78.69 134.19 28.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.088 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 203' ' ' THR . . . . . 0.501 ' HA ' HG23 ' A' ' 210' ' ' THR . 0.8 OUTLIER -138.55 136.61 36.24 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.09 -179.974 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 204' ' ' TYR . . . . . 0.646 ' N ' HG23 ' A' ' 210' ' ' THR . 33.4 m-85 -46.8 158.71 0.4 Allowed Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.618 0.723 . . . . 0.0 110.955 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 3.49 2.75 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.669 2.246 . . . . 0.0 112.354 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -112.9 -19.13 12.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.817 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 120.43 -3.74 12.31 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.492 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.0 140.45 62.2 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.574 0.702 . . . . 0.0 110.895 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 209' ' ' PRO . . . . . 0.554 ' HG3' ' CD1' ' A' ' 175' ' ' PHE . 54.4 Cg_endo -69.72 102.67 1.05 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.672 2.248 . . . . 0.0 112.37 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 210' ' ' THR . . . . . 0.646 HG23 ' N ' ' A' ' 204' ' ' TYR . 37.6 p -61.39 -13.29 18.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.173 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 82.63 -39.62 2.7 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.525 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -71.05 161.6 30.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.834 0.349 . . . . 0.0 110.848 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 213' ' ' ALA . . . . . 0.523 ' HB3' ' CD1' ' A' ' 173' ' ' LEU . . . -160.41 -177.6 6.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.115 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -148.06 137.49 22.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.852 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 215' ' ' VAL . . . . . 0.557 HG13 HG12 ' A' ' 199' ' ' ILE . 3.3 t -124.09 165.68 20.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.084 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 0.762 ' O ' HG23 ' A' ' 192' ' ' ILE . 47.7 mt -116.96 145.62 43.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.935 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -134.31 151.5 51.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.84 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -60.0 -59.22 5.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.135 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 219' ' ' CYS . . . . . . . . . . . . . 1.8 t -144.48 177.71 8.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.854 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 220' ' ' GLU . . . . . 0.487 ' HA ' ' HB3' ' A' ' 223' ' ' ALA . 13.7 mp0 -58.71 -35.36 72.53 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.865 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -43.55 -38.5 2.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.924 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 222' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -92.98 -34.69 13.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.933 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 223' ' ' ALA . . . . . 0.487 ' HB3' ' HA ' ' A' ' 220' ' ' GLU . . . -61.6 -59.67 4.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.135 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 224' ' ' GLN . . . . . 0.455 ' HA ' HD12 ' A' ' 227' ' ' LEU . 3.1 pt20 -60.41 -37.17 79.99 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.957 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 14.4 m-20 -68.03 -24.03 65.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.874 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -79.89 -32.52 40.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.087 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 227' ' ' LEU . . . . . 0.455 HD12 ' HA ' ' A' ' 224' ' ' GLN . 20.2 mt -56.18 -31.52 63.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.947 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 9.1 mtp-105 -59.8 -18.37 43.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.866 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 229' ' ' LYS . . . . . 0.595 ' HE3' ' CE1' ' A' ' 185' ' ' PHE . 24.8 mtpp -82.06 -1.16 47.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.873 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 230' ' ' HIS . . . . . 0.61 ' N ' HD12 ' A' ' 241' ' ' LEU . 75.6 t60 -34.3 136.98 0.12 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.897 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.448 ' HG2' ' CD2' ' A' ' 230' ' ' HIS . 24.1 mmtt 59.35 36.29 23.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.908 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -62.97 -176.99 0.14 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.902 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.661 HD21 ' CE1' ' A' ' 238' ' ' TYR . 30.8 mt -137.83 117.31 12.89 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.896 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 234' ' ' LEU . . . . . 0.715 HD12 ' HD2' ' A' ' 185' ' ' PHE . 6.6 tt -126.77 112.25 15.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.935 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 59.51 36.2 88.44 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.498 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 30.3 mttp 71.69 52.62 0.22 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.783 0.325 . . . . 0.0 110.861 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 237' ' ' ARG . . . . . 0.413 ' CB ' ' HG3' ' A' ' 174' ' ' PRO . 59.5 mmt-85 -156.39 115.35 3.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.876 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 238' ' ' TYR . . . . . 0.661 ' CE1' HD21 ' A' ' 233' ' ' LEU . 96.8 m-85 -68.68 136.66 53.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.908 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 79.5 mt -132.87 131.34 59.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.111 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 240' ' ' GLU . . . . . 0.468 ' HB3' ' CZ ' ' A' ' 242' ' ' PHE . 43.4 mt-10 -92.43 161.78 14.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.874 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 241' ' ' LEU . . . . . 0.61 HD12 ' N ' ' A' ' 230' ' ' HIS . 20.2 mt -136.87 140.15 42.17 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.892 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 242' ' ' PHE . . . . . 0.499 ' CD1' ' O ' ' A' ' 241' ' ' LEU . 22.6 m-85 -153.14 128.22 9.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.82 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 20.3 mtp180 -44.04 153.48 0.14 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.884 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 1.1 t -152.55 160.13 43.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.901 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 41.6 p -138.41 157.67 45.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.088 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 246' ' ' ALA . . . . . 0.583 ' N ' HD12 ' A' ' 167' ' ' ILE . . . -37.45 -59.06 0.8 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.114 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -53.27 -56.59 15.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.151 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 248' ' ' GLU . . . . . 0.741 ' O ' HG23 ' A' ' 252' ' ' VAL . 11.7 tp10 -44.59 -51.95 8.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.878 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 0.418 ' O ' ' N ' ' A' ' 252' ' ' VAL . 98.4 t -47.02 -66.79 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.139 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 250' ' ' GLN . . . . . 0.586 ' HA ' HD12 ' A' ' 253' ' ' LEU . 50.7 mt-30 -43.25 -50.06 6.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.929 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 51.1 mm-40 -59.67 -30.18 68.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.918 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 252' ' ' VAL . . . . . 0.741 HG23 ' O ' ' A' ' 248' ' ' GLU . 92.7 t -75.92 -36.98 33.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.1 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 253' ' ' LEU . . . . . 0.586 HD12 ' HA ' ' A' ' 250' ' ' GLN . 8.5 mt -68.47 -37.73 80.41 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.893 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -66.28 -59.53 3.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.868 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 255' ' ' ARG . . . . . 0.476 ' HG3' ' N ' ' A' ' 256' ' ' PHE . 0.4 OUTLIER -41.21 -38.08 1.05 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.898 -179.94 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 256' ' ' PHE . . . . . 0.476 ' N ' ' HG3' ' A' ' 255' ' ' ARG . 10.2 m-85 -81.71 -53.1 6.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.868 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 34.7 t . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.83 -179.809 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 . . . . . 0 C--O 1.23 0.066 0 CA-C-O 120.932 0.396 . . . . 0.0 110.894 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.416 HG22 HD21 ' A' ' 200' ' ' LEU . 57.5 t -54.73 -43.29 65.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.168 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -43.49 -50.96 6.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.11 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 46.4 mm-40 -65.21 -37.25 86.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.939 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' PHE . . . . . 0.567 ' CE1' ' HG ' ' A' ' 216' ' ' LEU . 64.0 t80 -60.14 -41.32 92.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.886 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 86.3 mt -90.98 -16.59 27.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.893 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 46.5 t -62.62 -35.79 80.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.841 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' LYS . . . . . 0.489 ' HD2' HD13 ' A' ' 216' ' ' LEU . 12.5 mttp -58.99 120.13 8.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.895 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 163' ' ' GLU . . . . . 0.54 ' O ' ' NE2' ' A' ' 165' ' ' GLN . 37.6 mp0 -94.61 155.83 16.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.852 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 11.1 m-80 63.45 48.89 3.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.866 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.54 ' NE2' ' O ' ' A' ' 163' ' ' GLU . 32.0 mm-40 -131.87 162.21 31.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.878 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.725 HG11 ' CB ' ' A' ' 223' ' ' ALA . 89.5 t -116.73 111.13 33.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.138 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 167' ' ' ILE . . . . . 0.71 HG21 HG21 ' A' ' 249' ' ' VAL . 30.5 mt -85.33 142.09 13.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.082 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 40.8 t -127.51 142.52 43.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.155 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 30.0 ttp180 -91.75 115.18 27.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.863 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' MET . . . . . 0.897 ' CE ' HD21 ' A' ' 173' ' ' LEU . 66.9 mtp -102.63 125.39 49.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.919 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 171' ' ' ARG . . . . . 0.432 ' HB2' ' NH1' ' A' ' 171' ' ' ARG . 3.3 ttm105 -131.4 139.73 49.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.84 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 90.23 23.09 32.97 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.494 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.897 HD21 ' CE ' ' A' ' 170' ' ' MET . 26.3 mt -74.9 128.03 85.88 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.589 0.709 . . . . 0.0 110.924 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 174' ' ' PRO . . . . . 0.484 ' HG3' ' CB ' ' A' ' 237' ' ' ARG . 64.7 Cg_exo -48.01 130.83 20.56 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.719 2.279 . . . . 0.0 112.36 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -47.93 -22.71 0.62 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.877 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 41.4 p -91.57 -29.39 16.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.118 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -48.77 137.95 11.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.043 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -139.38 171.82 13.71 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.114 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.477 ' N ' ' CZ ' ' A' ' 201' ' ' PHE . . . -47.04 -47.38 22.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.106 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -57.02 -26.66 60.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.882 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 181' ' ' GLU . . . . . 0.817 ' HG2' HD11 ' A' ' 234' ' ' LEU . 6.7 tt0 -79.71 -35.58 38.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.898 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.405 HG12 HD11 ' A' ' 192' ' ' ILE . 48.1 t -74.01 -42.45 52.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.117 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 45.6 t -42.24 -45.81 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.153 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -81.66 -32.49 31.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.102 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.5 ' HD2' HD12 ' A' ' 234' ' ' LEU . 41.2 t80 -49.27 -59.44 3.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.863 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -90.51 -24.32 20.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.829 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -48.97 -22.14 2.83 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.516 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 33.1 tp60 -53.08 -70.85 0.08 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.864 0.364 . . . . 0.0 110.884 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 8.9 m80 -118.3 -15.33 9.75 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.862 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 74.7 m -119.88 88.24 39.78 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.592 0.71 . . . . 0.0 110.839 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 191' ' ' PRO . . . . . 0.501 ' HD2' ' CD1' ' A' ' 222' ' ' TYR . 53.7 Cg_endo -69.8 131.62 21.57 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.679 2.253 . . . . 0.0 112.289 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 192' ' ' ILE . . . . . 0.748 HG23 ' O ' ' A' ' 216' ' ' LEU . 55.7 mt -83.25 142.12 13.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.155 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 87.8 m -65.32 102.66 0.7 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.152 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 88.34 -17.43 48.07 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.476 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.424 ' O ' ' N ' ' A' ' 198' ' ' GLY . . . 78.35 -128.2 8.59 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.476 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 17.2 ptmt -44.94 -29.48 0.83 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.748 0.309 . . . . 0.0 110.885 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -74.34 -34.67 63.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.884 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 198' ' ' GLY . . . . . 0.923 ' HA2' HD12 ' A' ' 216' ' ' LEU . . . -86.37 21.24 18.18 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.47 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 76.8 mt -123.56 146.22 29.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.808 0.337 . . . . 0.0 111.133 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.416 HD21 HG22 ' A' ' 156' ' ' VAL . 16.3 tp -142.32 123.18 14.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.869 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 201' ' ' PHE . . . . . 0.477 ' CZ ' ' N ' ' A' ' 179' ' ' ALA . 68.1 m-85 -104.24 112.34 25.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.887 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 25.8 t -66.57 122.55 17.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.124 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -131.83 140.34 49.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.155 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -45.79 158.31 0.35 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.685 0.755 . . . . 0.0 110.898 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 3.02 3.04 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.662 2.241 . . . . 0.0 112.339 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -112.15 -16.33 13.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.864 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 106.14 62.82 0.61 Allowed Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.439 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 7.3 mtt85 -148.26 144.26 18.53 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.602 0.715 . . . . 0.0 110.901 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 108.64 2.12 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.692 2.261 . . . . 0.0 112.318 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 74.1 p -74.02 -29.98 62.21 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.117 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 114.63 -37.04 3.68 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.498 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -78.6 169.37 18.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.836 0.35 . . . . 0.0 110.857 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 213' ' ' ALA . . . . . 0.441 ' HB3' ' CD1' ' A' ' 173' ' ' LEU . . . -170.99 174.07 4.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.145 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 214' ' ' PHE . . . . . 0.53 ' CE2' HG13 ' A' ' 249' ' ' VAL . 66.7 m-85 -139.55 136.78 34.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.865 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 215' ' ' VAL . . . . . 0.443 HG12 ' N ' ' A' ' 216' ' ' LEU . 12.6 t -117.61 158.0 18.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.156 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 0.923 HD12 ' HA2' ' A' ' 198' ' ' GLY . 72.2 mt -115.3 139.56 49.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.933 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -132.29 149.47 52.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.86 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 218' ' ' ALA . . . . . 0.679 ' HB3' ' CD2' ' A' ' 222' ' ' TYR . . . -49.87 -65.67 0.52 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.124 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 219' ' ' CYS . . . . . . . . . . . . . 1.8 t -141.57 179.14 6.99 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.876 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 220' ' ' GLU . . . . . 0.404 ' C ' ' OE1' ' A' ' 220' ' ' GLU . 0.0 OUTLIER -60.21 -16.4 32.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.875 -179.892 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -63.2 -47.48 82.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.87 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 222' ' ' TYR . . . . . 0.679 ' CD2' ' HB3' ' A' ' 218' ' ' ALA . 62.4 m-85 -78.44 -46.35 20.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.92 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 223' ' ' ALA . . . . . 0.725 ' CB ' HG11 ' A' ' 166' ' ' VAL . . . -50.22 -50.35 49.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.066 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 23.6 mm-40 -54.28 -53.09 58.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.93 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 55.0 m-20 -57.6 -25.62 60.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.873 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -74.96 -30.76 61.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.151 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 69.5 mt -62.47 -35.37 79.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.908 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 66.1 mtp85 -56.53 -22.06 30.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.842 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 229' ' ' LYS . . . . . 0.481 ' CE ' ' CE1' ' A' ' 185' ' ' PHE . 21.2 mtpp -75.03 -2.78 28.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.876 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 230' ' ' HIS . . . . . 0.536 ' CD2' ' HG2' ' A' ' 231' ' ' LYS . 84.9 t60 -34.0 135.8 0.14 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.843 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.536 ' HG2' ' CD2' ' A' ' 230' ' ' HIS . 21.9 mmtt 62.59 29.22 16.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.875 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 232' ' ' ASP . . . . . 0.425 ' OD2' ' CE2' ' A' ' 185' ' ' PHE . 3.2 t70 -56.01 178.35 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.841 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.64 HD21 ' CE1' ' A' ' 238' ' ' TYR . 30.6 mt -137.71 105.02 5.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.927 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 234' ' ' LEU . . . . . 0.817 HD11 ' HG2' ' A' ' 181' ' ' GLU . 5.8 tt -113.59 108.16 16.77 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.876 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 60.84 44.06 98.49 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.49 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 6.8 mmmm 65.85 54.98 0.99 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.765 0.317 . . . . 0.0 110.932 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 237' ' ' ARG . . . . . 0.484 ' CB ' ' HG3' ' A' ' 174' ' ' PRO . 17.5 mmt85 -156.84 115.11 3.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.863 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 238' ' ' TYR . . . . . 0.64 ' CE1' HD21 ' A' ' 233' ' ' LEU . 97.3 m-85 -70.4 120.81 16.61 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.952 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 0.66 HD13 HD23 ' A' ' 173' ' ' LEU . 19.8 mt -116.27 137.8 48.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.154 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -101.1 171.18 7.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.905 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 241' ' ' LEU . . . . . 0.401 ' O ' ' CD1' ' A' ' 242' ' ' PHE . 28.8 mt -147.2 145.26 29.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.873 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 242' ' ' PHE . . . . . 0.401 ' CD1' ' O ' ' A' ' 241' ' ' LEU . 28.7 m-85 -155.75 129.43 8.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.878 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 42.4 mtm180 -44.62 140.88 2.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.846 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 9.2 t -140.6 148.4 40.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.857 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 245' ' ' THR . . . . . 0.405 ' O ' HG23 ' A' ' 249' ' ' VAL . 43.0 p -119.88 161.21 21.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.133 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -48.22 -48.68 34.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.104 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -58.87 -53.79 54.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.065 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 248' ' ' GLU . . . . . 0.496 ' O ' HG23 ' A' ' 252' ' ' VAL . 8.9 tp10 -49.07 -50.84 34.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.886 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 0.71 HG21 HG21 ' A' ' 167' ' ' ILE . 95.0 t -50.8 -61.92 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.141 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 59.3 mt-30 -44.7 -50.02 10.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.879 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -58.64 -38.63 78.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.932 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 252' ' ' VAL . . . . . 0.496 HG23 ' O ' ' A' ' 248' ' ' GLU . 69.4 t -67.92 -44.31 85.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.115 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 253' ' ' LEU . . . . . 0.559 HD11 HG12 ' A' ' 249' ' ' VAL . 9.6 mt -65.77 -45.45 82.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.93 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 42.2 m-20 -68.7 -27.23 65.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.884 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 255' ' ' ARG . . . . . 0.469 ' HD3' ' N ' ' A' ' 256' ' ' PHE . 0.6 OUTLIER -72.58 -53.32 12.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.866 -179.965 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 256' ' ' PHE . . . . . 0.469 ' N ' ' HD3' ' A' ' 255' ' ' ARG . 11.1 m-85 -59.44 -44.36 92.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.931 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 91.7 p . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.872 -179.809 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.943 0.401 . . . . 0.0 110.927 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.454 HG12 HD12 ' A' ' 160' ' ' LEU . 99.3 t -75.09 -47.0 38.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.125 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.417 ' C ' ' O ' ' A' ' 156' ' ' VAL . . . -36.83 -58.19 0.77 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.101 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 27.6 mm-40 -58.02 -50.46 73.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.907 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' PHE . . . . . 0.474 ' CE2' ' HG ' ' A' ' 216' ' ' LEU . 47.3 t80 -50.41 -42.82 54.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.863 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.454 HD12 HG12 ' A' ' 156' ' ' VAL . 62.6 mt -85.79 -21.21 28.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.906 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' SER . . . . . 0.417 ' N ' ' O ' ' A' ' 157' ' ' ALA . 15.6 t -58.12 -24.53 59.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.846 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 162' ' ' LYS . . . . . 0.451 ' HG3' HD13 ' A' ' 216' ' ' LEU . 24.2 mmmt -65.52 131.1 45.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.893 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -109.66 154.99 22.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.923 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 63.19 42.72 6.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.892 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 20.5 mm-40 -127.86 156.57 42.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.914 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 47.1 t -108.63 100.76 11.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.158 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' ILE . . . . . 0.546 HG21 HG21 ' A' ' 249' ' ' VAL . 49.3 mt -75.27 140.27 17.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.099 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 39.0 t -127.92 134.21 65.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.117 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' ARG . . . . . 0.543 ' HG3' ' CE1' ' A' ' 214' ' ' PHE . 18.1 ttm180 -90.1 125.43 35.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.872 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 170' ' ' MET . . . . . 0.658 ' HE2' HD21 ' A' ' 173' ' ' LEU . 59.5 mtp -115.41 111.8 21.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.893 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -114.8 151.66 33.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.884 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 84.23 16.7 66.33 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.502 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.807 HD23 HD13 ' A' ' 239' ' ' ILE . 19.7 mt -71.57 133.99 84.5 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.615 0.721 . . . . 0.0 110.886 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 174' ' ' PRO . . . . . 0.485 ' O ' ' N ' ' A' ' 177' ' ' ALA . 65.3 Cg_exo -47.99 127.57 15.02 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.675 2.25 . . . . 0.0 112.328 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 175' ' ' PHE . . . . . 0.436 ' C ' ' O ' ' A' ' 174' ' ' PRO . 11.2 m-85 -34.68 -45.37 0.24 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.865 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 176' ' ' THR . . . . . 0.753 ' O ' HG23 ' A' ' 178' ' ' THR . 0.0 OUTLIER -74.56 -39.0 62.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.098 -179.894 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 177' ' ' ALA . . . . . 0.485 ' N ' ' O ' ' A' ' 174' ' ' PRO . . . -33.78 122.54 0.45 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.071 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 178' ' ' THR . . . . . 0.753 HG23 ' O ' ' A' ' 176' ' ' THR . 25.9 p -132.46 173.04 11.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.113 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.496 ' N ' ' CZ ' ' A' ' 201' ' ' PHE . . . -42.22 -47.52 4.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.044 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -51.26 -37.74 48.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.866 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 181' ' ' GLU . . . . . 0.518 ' OE1' HD21 ' A' ' 234' ' ' LEU . 56.7 mm-40 -70.52 -34.91 72.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.867 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.548 HG12 ' CD1' ' A' ' 192' ' ' ILE . 92.4 t -71.29 -53.59 20.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.16 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.444 ' C ' ' O ' ' A' ' 182' ' ' VAL . 76.4 t -34.05 -47.36 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.143 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -80.96 -41.47 22.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.106 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.793 ' HD2' HD12 ' A' ' 234' ' ' LEU . 4.9 t80 -40.03 -59.03 1.3 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.895 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -95.17 -21.94 18.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.901 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -49.33 -19.09 1.64 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.506 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -56.78 -70.82 0.11 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.817 0.341 . . . . 0.0 110.882 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 21.7 m80 -118.21 -15.46 9.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.877 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 79.4 m -121.15 87.51 44.16 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.57 0.7 . . . . 0.0 110.852 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 140.75 43.53 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.706 2.27 . . . . 0.0 112.34 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 192' ' ' ILE . . . . . 0.567 HG23 ' O ' ' A' ' 216' ' ' LEU . 63.1 mt -94.58 140.73 16.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.181 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 57.7 m -62.97 101.8 0.3 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.178 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 89.41 -16.24 56.6 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.483 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.481 ' O ' ' N ' ' A' ' 198' ' ' GLY . . . 67.91 -126.0 23.08 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.462 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 16.8 ptmt -42.31 -27.07 0.13 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.737 0.303 . . . . 0.0 110.906 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -81.74 -36.23 28.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.872 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 198' ' ' GLY . . . . . 0.481 ' N ' ' O ' ' A' ' 195' ' ' GLY . . . -85.16 34.82 3.19 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.47 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.482 HD13 ' HB ' ' A' ' 182' ' ' VAL . 62.5 mt -135.05 149.26 28.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.901 0.381 . . . . 0.0 111.118 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 13.4 tp -142.51 115.23 8.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.913 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 201' ' ' PHE . . . . . 0.496 ' CZ ' ' N ' ' A' ' 179' ' ' ALA . 46.9 m-85 -96.8 124.42 40.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.862 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 48.0 t -77.21 120.89 28.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.14 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -129.88 137.23 50.3 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.152 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 204' ' ' TYR . . . . . 0.695 ' CD2' HG22 ' A' ' 210' ' ' THR . 34.9 m-85 -45.39 158.59 0.31 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.689 0.756 . . . . 0.0 110.892 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.81 2.61 3.41 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.63 2.22 . . . . 0.0 112.355 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -111.12 -16.51 13.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.857 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 107.14 53.7 0.69 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.482 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 12.0 mmm180 -138.35 143.7 39.84 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.621 0.724 . . . . 0.0 110.854 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 111.53 2.84 Favored 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.711 2.274 . . . . 0.0 112.357 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 210' ' ' THR . . . . . 0.695 HG22 ' CD2' ' A' ' 204' ' ' TYR . 68.3 p -75.26 -27.84 59.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.175 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 108.41 -27.42 13.85 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.493 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -91.38 154.89 18.88 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.766 0.317 . . . . 0.0 110.894 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -155.78 -177.82 6.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.1 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 214' ' ' PHE . . . . . 0.603 ' CE2' HG13 ' A' ' 249' ' ' VAL . 81.1 m-85 -144.29 151.38 39.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.914 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 4.1 t -133.55 157.5 42.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.161 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 0.567 ' O ' HG23 ' A' ' 192' ' ' ILE . 29.7 mt -109.62 145.95 35.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.957 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -137.11 126.02 24.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.883 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -41.43 -50.34 3.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.115 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 219' ' ' CYS . . . . . . . . . . . . . 72.7 m -152.91 173.15 15.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.84 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -59.56 -35.78 74.91 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.839 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -37.68 -51.45 1.23 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.893 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 222' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -79.46 -42.12 26.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.945 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -48.01 -54.79 11.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.122 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -50.19 -58.79 4.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.883 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 48.8 m-20 -53.32 -22.91 8.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.872 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -88.74 -19.54 25.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.131 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 95.2 mt -72.41 -42.77 64.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.947 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 1.5 ptm180 -55.58 -19.11 9.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.823 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 229' ' ' LYS . . . . . 0.454 ' O ' ' C ' ' A' ' 230' ' ' HIS . 24.7 mtpp -72.81 -3.4 25.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.89 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 230' ' ' HIS . . . . . 0.454 ' C ' ' O ' ' A' ' 229' ' ' LYS . 83.6 t60 -34.35 138.17 0.1 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.855 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 18.0 mmtp 61.02 29.98 19.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.909 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -57.06 174.97 0.15 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.864 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.683 HD21 ' CE2' ' A' ' 238' ' ' TYR . 31.0 mt -131.07 108.94 10.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.914 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 234' ' ' LEU . . . . . 0.793 HD12 ' HD2' ' A' ' 185' ' ' PHE . 6.6 tt -118.34 114.65 23.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.894 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 56.4 44.0 90.03 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.479 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 236' ' ' LYS . . . . . 0.433 ' HA ' ' NZ ' ' A' ' 236' ' ' LYS . 0.0 OUTLIER 63.74 52.75 2.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.802 0.334 . . . . 0.0 110.904 -179.997 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 237' ' ' ARG . . . . . 0.422 ' CB ' ' HG3' ' A' ' 174' ' ' PRO . 19.6 mmt180 -156.44 115.19 3.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.855 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 238' ' ' TYR . . . . . 0.683 ' CE2' HD21 ' A' ' 233' ' ' LEU . 92.2 m-85 -70.51 126.13 28.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.963 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 0.807 HD13 HD23 ' A' ' 173' ' ' LEU . 66.2 mt -122.7 136.76 58.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.123 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 240' ' ' GLU . . . . . 0.511 ' HB3' ' CZ ' ' A' ' 242' ' ' PHE . 24.2 mp0 -96.68 158.94 15.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.883 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 241' ' ' LEU . . . . . 0.443 ' C ' ' CG ' ' A' ' 242' ' ' PHE . 14.5 mt -136.85 147.77 46.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.961 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 242' ' ' PHE . . . . . 0.511 ' CZ ' ' HB3' ' A' ' 240' ' ' GLU . 7.3 m-85 -158.52 139.47 12.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.84 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 22.8 mtm180 -64.3 128.65 36.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.869 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 1.8 t -128.02 167.21 17.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.854 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 245' ' ' THR . . . . . 0.449 ' O ' ' C ' ' A' ' 246' ' ' ALA . 34.1 p -131.55 148.21 52.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.099 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 246' ' ' ALA . . . . . 0.522 ' N ' HD12 ' A' ' 167' ' ' ILE . . . -34.1 -52.41 0.45 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.101 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -55.7 -54.3 45.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.09 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 -49.2 -56.01 10.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.868 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 0.603 HG13 ' CE2' ' A' ' 214' ' ' PHE . 59.2 t -44.04 -64.5 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.135 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 250' ' ' GLN . . . . . 0.722 ' HA ' HD12 ' A' ' 253' ' ' LEU . 25.2 mt-30 -39.69 -41.9 1.15 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.898 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 251' ' ' GLN . . . . . 0.474 ' HA ' ' ND2' ' A' ' 254' ' ' ASN . 38.9 mm-40 -68.19 -35.17 77.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.902 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 252' ' ' VAL . . . . . 0.486 ' N ' ' O ' ' A' ' 249' ' ' VAL . 82.6 t -71.22 -19.43 20.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.105 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 253' ' ' LEU . . . . . 0.722 HD12 ' HA ' ' A' ' 250' ' ' GLN . 7.5 mt -86.57 -40.93 14.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.926 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 254' ' ' ASN . . . . . 0.474 ' ND2' ' HA ' ' A' ' 251' ' ' GLN . 0.4 OUTLIER -75.1 -41.83 57.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.902 179.879 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 255' ' ' ARG . . . . . 0.569 ' CD ' ' CD1' ' A' ' 256' ' ' PHE . 0.0 OUTLIER -60.09 -25.08 65.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.824 -179.955 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 256' ' ' PHE . . . . . 0.569 ' CD1' ' CD ' ' A' ' 255' ' ' ARG . 6.6 m-85 -90.6 -38.11 13.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.83 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 40.6 t . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.849 -179.775 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.931 0.396 . . . . 0.0 110.9 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.427 HG22 HD21 ' A' ' 200' ' ' LEU . 90.9 t -64.36 -42.92 96.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.142 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.408 ' C ' ' O ' ' A' ' 156' ' ' VAL . . . -37.55 -58.69 0.85 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.084 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -60.03 -50.06 75.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.89 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -48.75 -41.72 33.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.862 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.591 HD13 HE21 ' A' ' 250' ' ' GLN . 82.0 mt -85.52 -22.52 28.12 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.931 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 44.3 t -53.76 -33.1 54.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.888 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' LYS . . . . . 0.519 ' HG3' HD13 ' A' ' 216' ' ' LEU . 42.1 mmtt -60.17 103.92 0.27 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.843 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 163' ' ' GLU . . . . . 0.532 ' O ' ' NE2' ' A' ' 165' ' ' GLN . 13.8 mm-40 -86.79 157.53 19.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.893 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 63.49 30.69 15.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.882 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.532 ' NE2' ' O ' ' A' ' 163' ' ' GLU . 36.9 mm-40 -121.13 148.21 44.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.881 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 4.6 t -99.17 116.83 43.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.137 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' ILE . . . . . 0.471 HD12 ' N ' ' A' ' 246' ' ' ALA . 73.2 mt -88.55 147.12 5.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.115 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.506 HG21 ' CE1' ' A' ' 217' ' ' PHE . 96.1 t -127.65 126.18 66.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.108 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 70.8 ttt180 -88.14 110.19 20.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.888 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' MET . . . . . 0.694 ' CE ' HD21 ' A' ' 173' ' ' LEU . 97.4 mtp -97.13 113.01 24.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.892 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 2.1 ttt85 -111.1 141.63 44.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.869 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 89.36 21.08 42.48 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.476 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.843 HD23 HD13 ' A' ' 239' ' ' ILE . 23.0 mt -74.79 123.89 89.28 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.588 0.708 . . . . 0.0 110.958 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_exo -47.97 145.01 10.98 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.683 2.255 . . . . 0.0 112.359 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' PHE . . . . . 0.554 ' CD1' ' HG3' ' A' ' 209' ' ' PRO . 10.4 t80 -57.0 -30.66 64.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.9 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 6.2 p -86.49 -15.88 38.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.137 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -67.53 117.41 9.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.084 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -124.35 175.24 7.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.119 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.455 ' N ' ' CZ ' ' A' ' 201' ' ' PHE . . . -41.11 -50.34 3.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.103 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -49.68 -40.23 39.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.874 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -69.36 -30.74 68.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.872 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.571 HG12 ' CD1' ' A' ' 192' ' ' ILE . 74.5 t -75.81 -55.52 11.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.1 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.45 ' C ' ' O ' ' A' ' 182' ' ' VAL . 54.5 t -33.98 -44.68 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.1 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.442 ' O ' ' C ' ' A' ' 185' ' ' PHE . . . -79.24 -47.46 15.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.124 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.576 ' HD2' HD12 ' A' ' 234' ' ' LEU . 15.8 t80 -35.32 -60.51 0.48 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.888 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 186' ' ' PHE . . . . . 0.404 ' CE1' ' CE1' ' A' ' 185' ' ' PHE . 50.5 m-85 -94.35 -20.54 19.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.88 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -49.1 -17.36 0.94 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.501 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 8.8 mm100 -59.24 -72.35 0.1 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.824 0.345 . . . . 0.0 110.88 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 28.8 m170 -117.81 -16.47 9.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.88 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 86.7 m -117.38 85.64 20.42 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.647 0.736 . . . . 0.0 110.889 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 191' ' ' PRO . . . . . 0.441 ' HD2' ' CD1' ' A' ' 222' ' ' TYR . 53.9 Cg_endo -69.79 135.78 31.24 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.715 2.277 . . . . 0.0 112.314 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 192' ' ' ILE . . . . . 0.571 ' CD1' HG12 ' A' ' 182' ' ' VAL . 61.9 mt -87.47 141.16 14.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.187 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 41.2 m -66.21 103.09 0.92 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.138 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 91.77 -16.97 58.06 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.476 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.401 ' O ' ' N ' ' A' ' 198' ' ' GLY . . . 72.13 -125.19 10.67 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.482 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 14.4 ptmt -47.36 -30.03 2.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.784 0.326 . . . . 0.0 110.943 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -75.49 -30.51 59.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.877 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 198' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 195' ' ' GLY . . . -92.82 41.22 2.75 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.498 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.473 HD13 ' HB ' ' A' ' 182' ' ' VAL . 62.6 mt -142.68 144.48 24.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.828 0.347 . . . . 0.0 111.16 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.427 HD21 HG22 ' A' ' 156' ' ' VAL . 15.6 tp -139.64 121.66 15.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.9 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 201' ' ' PHE . . . . . 0.455 ' CZ ' ' N ' ' A' ' 179' ' ' ALA . 65.0 m-85 -101.7 112.21 24.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.883 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 39.0 t -70.4 138.15 22.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.129 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 203' ' ' THR . . . . . 0.65 ' HA ' HG23 ' A' ' 210' ' ' THR . 0.8 OUTLIER -143.66 138.1 28.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.146 -179.926 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 204' ' ' TYR . . . . . 0.572 ' CD1' HG22 ' A' ' 210' ' ' THR . 32.4 m-85 -48.08 159.29 0.5 Allowed Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.699 0.762 . . . . 0.0 110.917 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.81 3.97 2.49 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.644 2.229 . . . . 0.0 112.296 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 206' ' ' ASP . . . . . 0.435 ' HB3' ' NH1' ' A' ' 208' ' ' ARG . 62.0 m-20 -112.46 -23.71 10.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.895 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 123.65 4.19 8.2 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.508 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 208' ' ' ARG . . . . . 0.435 ' NH1' ' HB3' ' A' ' 206' ' ' ASP . 0.0 OUTLIER -84.75 141.3 38.32 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.576 0.703 . . . . 0.0 110.917 -179.854 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 209' ' ' PRO . . . . . 0.554 ' HG3' ' CD1' ' A' ' 175' ' ' PHE . 53.6 Cg_endo -69.72 110.33 2.52 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.693 2.262 . . . . 0.0 112.367 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 210' ' ' THR . . . . . 0.65 HG23 ' HA ' ' A' ' 203' ' ' THR . 34.1 p -71.31 -10.85 60.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.175 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 79.89 -40.18 2.27 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.445 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -70.35 154.26 42.1 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.878 0.37 . . . . 0.0 110.874 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 213' ' ' ALA . . . . . 0.461 ' HB3' ' CD1' ' A' ' 173' ' ' LEU . . . -152.06 179.55 8.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.118 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 214' ' ' PHE . . . . . 0.611 ' CE2' HG13 ' A' ' 249' ' ' VAL . 73.9 m-85 -146.79 130.6 17.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.89 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 215' ' ' VAL . . . . . 0.515 HG12 ' N ' ' A' ' 216' ' ' LEU . 19.7 t -118.18 161.03 17.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.15 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 0.528 ' O ' HG23 ' A' ' 192' ' ' ILE . 26.9 mt -110.17 139.26 45.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.939 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 217' ' ' PHE . . . . . 0.506 ' CE1' HG21 ' A' ' 168' ' ' VAL . 81.2 m-85 -133.15 130.55 39.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.87 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -44.78 -57.4 3.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.106 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 219' ' ' CYS . . . . . . . . . . . . . 85.6 m -151.92 161.1 43.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.837 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -45.06 -30.3 1.04 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.877 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -43.45 -41.91 4.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.846 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 222' ' ' TYR . . . . . 0.441 ' CD1' ' HD2' ' A' ' 191' ' ' PRO . 61.1 m-85 -90.25 -47.73 7.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.91 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 223' ' ' ALA . . . . . 0.416 ' O ' ' HB3' ' A' ' 226' ' ' ALA . . . -49.66 -60.87 2.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.064 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 224' ' ' GLN . . . . . 0.666 ' HA ' HD12 ' A' ' 227' ' ' LEU . 64.4 mm-40 -45.44 -57.71 3.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.889 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 55.3 m-20 -55.95 -26.65 48.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.868 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 226' ' ' ALA . . . . . 0.416 ' HB3' ' O ' ' A' ' 223' ' ' ALA . . . -77.46 -39.53 46.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.065 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 227' ' ' LEU . . . . . 0.666 HD12 ' HA ' ' A' ' 224' ' ' GLN . 29.5 mt -52.88 -31.27 38.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.951 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 75.0 mtt180 -58.91 -26.71 64.57 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.891 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 229' ' ' LYS . . . . . 0.458 ' O ' ' C ' ' A' ' 230' ' ' HIS . 26.8 mtpp -71.72 -2.58 17.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.897 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 230' ' ' HIS . . . . . 0.538 ' CG ' ' HG2' ' A' ' 231' ' ' LYS . 19.6 t60 -33.96 139.38 0.07 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.894 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.538 ' HG2' ' CG ' ' A' ' 230' ' ' HIS . 0.1 OUTLIER 60.16 35.51 21.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.869 179.966 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -65.8 175.48 1.92 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.865 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.564 HD21 ' CE1' ' A' ' 238' ' ' TYR . 30.4 mt -131.35 101.19 5.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.87 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 234' ' ' LEU . . . . . 0.689 ' C ' HD23 ' A' ' 234' ' ' LEU . 5.7 tt -112.1 111.45 22.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.923 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 63.5 37.91 95.51 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.492 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 33.0 mmtm 67.35 54.22 0.72 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.766 0.317 . . . . 0.0 110.88 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 20.4 mmt180 -156.44 116.08 3.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.838 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 238' ' ' TYR . . . . . 0.564 ' CE1' HD21 ' A' ' 233' ' ' LEU . 96.7 m-85 -69.83 116.22 9.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.896 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 0.843 HD13 HD23 ' A' ' 173' ' ' LEU . 41.1 mt -115.9 140.6 36.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.134 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 240' ' ' GLU . . . . . 0.575 ' HB3' ' CZ ' ' A' ' 242' ' ' PHE . 16.7 mt-10 -93.26 -178.51 4.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.888 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 241' ' ' LEU . . . . . 0.559 ' O ' ' CD1' ' A' ' 242' ' ' PHE . 61.6 mt -158.01 132.82 8.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.909 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 242' ' ' PHE . . . . . 0.575 ' CZ ' ' HB3' ' A' ' 240' ' ' GLU . 4.6 m-85 -152.88 120.44 5.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.856 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 18.0 ptt180 -60.95 126.98 29.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.906 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 5.4 t -119.71 176.68 5.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.868 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 245' ' ' THR . . . . . 0.401 ' O ' ' C ' ' A' ' 246' ' ' ALA . 82.2 p -127.64 151.02 49.46 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.135 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 246' ' ' ALA . . . . . 0.471 ' N ' HD12 ' A' ' 167' ' ' ILE . . . -37.92 -57.2 1.05 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.09 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -53.21 -51.76 61.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.121 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -50.45 -54.81 19.22 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.886 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 0.611 HG13 ' CE2' ' A' ' 214' ' ' PHE . 78.4 t -43.82 -61.39 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.152 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 250' ' ' GLN . . . . . 0.766 ' HA ' HD12 ' A' ' 253' ' ' LEU . 34.6 mt-30 -44.05 -42.73 6.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.969 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 251' ' ' GLN . . . . . 0.407 ' HA ' ' ND2' ' A' ' 254' ' ' ASN . 60.6 mm-40 -65.58 -30.14 70.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.905 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 252' ' ' VAL . . . . . 0.417 ' N ' ' O ' ' A' ' 249' ' ' VAL . 85.9 t -78.93 -20.12 12.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.145 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 253' ' ' LEU . . . . . 0.766 HD12 ' HA ' ' A' ' 250' ' ' GLN . 10.6 mt -84.38 -41.63 16.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.93 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 254' ' ' ASN . . . . . 0.49 ' C ' ' OD1' ' A' ' 254' ' ' ASN . 0.6 OUTLIER -67.93 -40.86 83.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.89 179.876 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 255' ' ' ARG . . . . . 0.473 ' N ' ' OD1' ' A' ' 254' ' ' ASN . 8.0 ptm180 -55.35 -42.71 74.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.816 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 256' ' ' PHE . . . . . 0.405 ' N ' ' CG ' ' A' ' 255' ' ' ARG . 12.8 m-85 -78.9 -51.02 10.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.862 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 41.7 m . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.84 -179.757 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.909 0.385 . . . . 0.0 110.868 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 34.0 t -65.53 -40.19 87.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.119 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -41.45 -60.86 1.17 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.13 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 15.2 mp0 -56.23 -44.44 79.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.873 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -52.34 -41.34 62.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.852 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 75.4 mt -89.29 -19.71 24.99 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.89 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 45.9 t -59.75 -20.94 59.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.833 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' LYS . . . . . 0.465 ' HG3' HD13 ' A' ' 216' ' ' LEU . 38.8 mmtt -74.95 102.59 4.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.918 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -82.24 158.82 23.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.903 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 66.8 m-20 60.63 47.04 8.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.937 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.602 ' OE1' HG21 ' A' ' 193' ' ' THR . 10.6 mm-40 -132.2 164.87 25.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.937 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 39.5 t -118.47 115.82 49.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.139 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' ILE . . . . . 0.473 HD12 ' N ' ' A' ' 246' ' ' ALA . 9.5 mt -88.48 141.54 14.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.125 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 59.2 t -119.08 140.49 42.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.151 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' ARG . . . . . 0.465 ' N ' ' HB2' ' A' ' 244' ' ' SER . 27.1 ttp180 -95.78 101.68 13.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.869 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 170' ' ' MET . . . . . 0.594 ' HE2' HD21 ' A' ' 173' ' ' LEU . 88.1 mtp -92.58 137.56 32.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.871 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -137.98 129.96 28.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.874 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 98.31 21.97 16.03 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.493 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.866 HD23 HD13 ' A' ' 239' ' ' ILE . 22.1 mt -76.04 120.97 84.04 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.657 0.741 . . . . 0.0 110.946 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 174' ' ' PRO . . . . . 0.482 ' HG3' ' CB ' ' A' ' 237' ' ' ARG . 65.6 Cg_exo -48.02 139.36 20.51 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.659 2.239 . . . . 0.0 112.336 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 175' ' ' PHE . . . . . 0.559 ' CD1' ' HG3' ' A' ' 209' ' ' PRO . 9.8 t80 -47.56 -42.53 23.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.859 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 7.3 p -72.21 -20.61 61.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.157 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 177' ' ' ALA . . . . . 0.482 ' HB3' ' O ' ' A' ' 174' ' ' PRO . . . -60.99 105.99 0.54 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.113 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 178' ' ' THR . . . . . 0.415 ' O ' ' C ' ' A' ' 179' ' ' ALA . 73.7 p -116.74 173.59 6.55 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.158 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.415 ' C ' ' O ' ' A' ' 178' ' ' THR . . . -36.8 -46.46 0.61 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.089 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -55.47 -49.2 73.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.92 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -57.75 -34.24 69.33 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.887 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.54 HG12 HD11 ' A' ' 192' ' ' ILE . 89.0 t -74.78 -53.95 15.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.11 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.428 ' C ' ' O ' ' A' ' 182' ' ' VAL . 50.4 t -35.22 -52.06 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.131 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -73.66 -36.96 65.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.112 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.655 ' HD2' HD12 ' A' ' 234' ' ' LEU . 21.0 t80 -47.28 -58.03 4.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.88 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 186' ' ' PHE . . . . . 0.444 ' CE1' ' CE1' ' A' ' 185' ' ' PHE . 86.5 m-85 -96.28 -21.36 17.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.926 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -49.05 -24.16 4.34 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.443 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 3.5 tp-100 -49.61 -75.11 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.808 0.337 . . . . 0.0 110.891 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 -118.33 -7.63 10.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.869 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 78.0 m -126.09 84.34 61.66 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.587 0.708 . . . . 0.0 110.918 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 191' ' ' PRO . . . . . 0.494 ' HD2' ' CD1' ' A' ' 222' ' ' TYR . 54.0 Cg_endo -69.79 139.28 39.76 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.655 2.237 . . . . 0.0 112.377 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 192' ' ' ILE . . . . . 0.637 HG23 ' O ' ' A' ' 216' ' ' LEU . 57.8 mt -88.76 144.67 8.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.152 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 193' ' ' THR . . . . . 0.602 HG21 ' OE1' ' A' ' 165' ' ' GLN . 17.9 m -70.18 104.7 2.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.173 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 91.72 -15.48 61.52 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.462 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 68.82 -120.22 10.69 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.46 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 43.9 mtmt -48.5 -33.77 10.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.783 0.325 . . . . 0.0 110.901 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -75.07 -27.59 60.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.874 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 198' ' ' GLY . . . . . 0.448 ' HA2' HD12 ' A' ' 216' ' ' LEU . . . -94.05 40.4 2.76 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.505 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 55.8 mt -143.0 146.28 21.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.847 0.356 . . . . 0.0 111.14 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 14.5 tp -146.6 122.34 10.55 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.951 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -102.09 121.41 42.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.882 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 60.6 t -72.78 140.17 18.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.149 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -142.9 138.83 30.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.159 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 204' ' ' TYR . . . . . 0.474 ' N ' HG23 ' A' ' 210' ' ' THR . 30.3 m-85 -50.79 159.08 0.99 Allowed Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.614 0.721 . . . . 0.0 110.966 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 3.73 2.62 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.711 2.274 . . . . 0.0 112.334 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -111.92 -18.52 12.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.907 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 110.4 44.18 1.01 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.499 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -126.78 143.72 47.55 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.571 0.701 . . . . 0.0 110.868 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 209' ' ' PRO . . . . . 0.559 ' HG3' ' CD1' ' A' ' 175' ' ' PHE . 53.4 Cg_endo -69.76 95.68 0.56 Allowed 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.686 2.258 . . . . 0.0 112.328 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 210' ' ' THR . . . . . 0.633 HG21 ' CD2' ' A' ' 256' ' ' PHE . 33.5 p -60.27 -10.29 4.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.154 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 88.01 -45.73 3.34 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.485 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -66.85 161.67 23.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.768 0.318 . . . . 0.0 110.904 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 213' ' ' ALA . . . . . 0.561 ' HB3' ' CD1' ' A' ' 173' ' ' LEU . . . -161.27 -175.26 4.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.075 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 214' ' ' PHE . . . . . 0.451 ' CE2' HG13 ' A' ' 249' ' ' VAL . 56.5 m-85 -146.22 151.73 38.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.857 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 215' ' ' VAL . . . . . 0.427 HG12 ' N ' ' A' ' 216' ' ' LEU . 4.5 t -138.71 159.91 30.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.162 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 0.637 ' O ' HG23 ' A' ' 192' ' ' ILE . 43.0 mt -109.68 145.8 35.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.905 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -140.29 143.0 35.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.899 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 218' ' ' ALA . . . . . 0.418 ' HB3' ' CD2' ' A' ' 222' ' ' TYR . . . -53.85 -66.7 0.35 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.112 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 219' ' ' CYS . . . . . . . . . . . . . 30.1 m -138.31 -175.09 3.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.915 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -62.89 -37.36 86.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.873 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 18.8 tp10 -43.27 -41.2 3.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.9 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 222' ' ' TYR . . . . . 0.494 ' CD1' ' HD2' ' A' ' 191' ' ' PRO . 55.9 m-85 -86.05 -47.58 9.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.934 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -56.31 -63.75 1.09 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.107 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 224' ' ' GLN . . . . . 0.737 ' HA ' HD12 ' A' ' 227' ' ' LEU . 20.4 mt-30 -46.65 -52.6 13.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.905 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 22.3 m-20 -55.38 -26.34 40.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.872 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -80.78 -34.55 34.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.121 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 227' ' ' LEU . . . . . 0.737 HD12 ' HA ' ' A' ' 224' ' ' GLN . 38.3 mt -54.54 -30.11 52.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.943 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 36.8 mtp180 -63.87 -20.74 66.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.845 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 229' ' ' LYS . . . . . 0.459 ' O ' ' C ' ' A' ' 230' ' ' HIS . 19.8 mtpp -75.75 -1.92 27.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.926 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 230' ' ' HIS . . . . . 0.519 ' CE1' ' HG2' ' A' ' 231' ' ' LYS . 57.1 t60 -33.9 136.9 0.11 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.874 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.519 ' HG2' ' CE1' ' A' ' 230' ' ' HIS . 0.0 OUTLIER 61.76 30.54 18.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.852 179.96 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 232' ' ' ASP . . . . . 0.452 ' OD2' ' CE2' ' A' ' 185' ' ' PHE . 8.4 t70 -57.84 173.64 0.3 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.877 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.64 HD21 ' CE1' ' A' ' 238' ' ' TYR . 30.7 mt -132.58 104.33 6.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.899 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 234' ' ' LEU . . . . . 0.679 ' C ' HD23 ' A' ' 234' ' ' LEU . 5.8 tt -115.24 114.42 25.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.935 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 60.7 39.56 96.81 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.438 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 31.0 mtmm 65.3 53.0 1.35 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.789 0.328 . . . . 0.0 110.876 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 237' ' ' ARG . . . . . 0.482 ' CB ' ' HG3' ' A' ' 174' ' ' PRO . 12.4 mmt85 -156.09 116.09 3.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.877 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 238' ' ' TYR . . . . . 0.64 ' CE1' HD21 ' A' ' 233' ' ' LEU . 97.2 m-85 -68.6 135.61 51.74 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.918 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 0.866 HD13 HD23 ' A' ' 173' ' ' LEU . 60.2 mt -133.51 134.36 56.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.168 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 240' ' ' GLU . . . . . 0.54 ' O ' HD23 ' A' ' 241' ' ' LEU . 46.8 mt-10 -90.27 175.87 6.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.884 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 241' ' ' LEU . . . . . 0.54 HD23 ' O ' ' A' ' 240' ' ' GLU . 63.6 mt -156.67 138.19 14.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.912 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 242' ' ' PHE . . . . . 0.497 ' CD1' ' O ' ' A' ' 241' ' ' LEU . 20.9 m-85 -155.19 127.85 7.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.852 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 46.5 mtm180 -39.98 136.97 1.03 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.909 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 244' ' ' SER . . . . . 0.465 ' HB2' ' N ' ' A' ' 169' ' ' ARG . 3.6 t -132.57 154.67 49.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.844 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 26.4 p -132.09 156.77 45.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.173 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 246' ' ' ALA . . . . . 0.473 ' N ' HD12 ' A' ' 167' ' ' ILE . . . -42.17 -57.15 2.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.128 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -53.76 -41.13 66.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.115 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 248' ' ' GLU . . . . . 0.474 ' O ' HG23 ' A' ' 252' ' ' VAL . 2.6 tp10 -61.15 -49.99 75.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.886 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 0.451 HG13 ' CE2' ' A' ' 214' ' ' PHE . 95.4 t -53.24 -64.97 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.105 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 250' ' ' GLN . . . . . 0.773 ' HA ' HD12 ' A' ' 253' ' ' LEU . 28.4 mt-30 -42.57 -34.09 0.81 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.929 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 251' ' ' GLN . . . . . 0.45 ' HA ' ' ND2' ' A' ' 254' ' ' ASN . 64.4 mt-30 -73.58 -47.73 38.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.891 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 252' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 248' ' ' GLU . 75.2 t -57.69 -35.13 49.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.11 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 253' ' ' LEU . . . . . 0.773 HD12 ' HA ' ' A' ' 250' ' ' GLN . 10.9 mt -65.81 -48.83 70.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.872 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 254' ' ' ASN . . . . . 0.485 ' C ' ' OD1' ' A' ' 254' ' ' ASN . 0.6 OUTLIER -67.12 -41.37 86.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.891 179.95 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 255' ' ' ARG . . . . . 0.47 ' N ' ' OD1' ' A' ' 254' ' ' ASN . 13.7 ttm180 -54.78 -41.39 70.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.868 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 256' ' ' PHE . . . . . 0.633 ' CD2' HG21 ' A' ' 210' ' ' THR . 12.8 m-85 -80.49 -47.12 14.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.851 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 51.1 m . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.837 -179.775 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.854 0.359 . . . . 0.0 110.879 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 73.5 t -65.07 -41.61 92.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.123 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -43.24 -60.06 1.83 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.101 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 83.2 mm-40 -62.33 -36.67 82.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.922 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' PHE . . . . . 0.427 ' CD1' ' HB2' ' A' ' 200' ' ' LEU . 76.7 t80 -60.62 -38.74 85.74 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.875 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 86.2 mt -94.59 -15.98 23.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.922 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 10.9 t -55.13 -40.37 70.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.865 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' LYS . . . . . 0.692 ' HD2' HD13 ' A' ' 216' ' ' LEU . 14.5 mttp -52.84 116.0 2.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.891 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 39.4 mp0 -80.9 162.51 23.91 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.856 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 43.74 51.03 6.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.869 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.806 ' OE1' HG21 ' A' ' 193' ' ' THR . 0.2 OUTLIER -124.16 156.76 36.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.896 -179.967 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 60.7 t -110.47 133.24 56.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.117 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' ILE . . . . . 0.618 HG21 HG21 ' A' ' 249' ' ' VAL . 56.3 mt -109.53 131.11 61.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.094 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 44.5 t -114.3 133.41 60.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.102 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' ARG . . . . . 0.413 ' N ' ' HB2' ' A' ' 244' ' ' SER . 61.6 ttt180 -90.03 110.94 21.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.87 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 170' ' ' MET . . . . . 0.61 ' CE ' HD21 ' A' ' 173' ' ' LEU . 90.0 mtp -98.16 126.58 43.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.912 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 14.2 ttm180 -127.01 142.31 51.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.873 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 83.46 36.34 14.61 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.498 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.683 HD23 HD13 ' A' ' 239' ' ' ILE . 28.0 mt -87.64 130.43 47.11 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.64 0.733 . . . . 0.0 110.894 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 174' ' ' PRO . . . . . 0.459 ' HG3' ' CB ' ' A' ' 237' ' ' ARG . 66.2 Cg_exo -47.99 122.5 7.35 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.67 2.247 . . . . 0.0 112.309 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -39.57 -29.81 0.06 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.862 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 176' ' ' THR . . . . . 0.403 ' O ' ' C ' ' A' ' 177' ' ' ALA . 31.6 p -80.67 -41.79 23.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.18 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 177' ' ' ALA . . . . . 0.444 ' N ' ' O ' ' A' ' 174' ' ' PRO . . . -36.69 126.64 0.86 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.087 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -123.53 -174.91 3.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.116 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.08 -50.53 73.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.066 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -53.39 -34.66 58.58 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.901 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -65.57 -40.76 93.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.929 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.485 HG12 HD11 ' A' ' 192' ' ' ILE . 76.1 t -68.33 -51.59 46.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.168 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.414 ' C ' ' O ' ' A' ' 182' ' ' VAL . 41.1 t -36.48 -49.11 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.153 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -76.36 -39.6 53.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.079 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.8 ' HD2' HD12 ' A' ' 234' ' ' LEU . 9.0 t80 -42.09 -59.06 1.88 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.909 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 186' ' ' PHE . . . . . 0.453 ' CE1' ' CE1' ' A' ' 185' ' ' PHE . 69.6 m-85 -95.57 -21.95 17.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.867 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -49.24 -22.59 3.51 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.451 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 77.3 mm-40 -52.64 -71.76 0.06 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.838 0.352 . . . . 0.0 110.884 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 33.2 m80 -118.08 -17.2 9.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.829 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 99.7 m -118.27 83.94 21.53 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.608 0.718 . . . . 0.0 110.89 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 130.96 20.2 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.731 2.287 . . . . 0.0 112.311 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 192' ' ' ILE . . . . . 0.633 HG23 ' O ' ' A' ' 216' ' ' LEU . 48.4 mt -79.46 146.11 8.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.13 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 193' ' ' THR . . . . . 0.806 HG21 ' OE1' ' A' ' 165' ' ' GLN . 53.8 m -67.71 109.08 3.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.098 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 85.11 -22.85 8.86 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.491 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.408 ' O ' ' N ' ' A' ' 198' ' ' GLY . . . 79.64 -125.37 6.93 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.472 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 20.7 mtmm -46.0 -23.72 0.34 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.785 0.326 . . . . 0.0 110.896 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -81.67 -35.22 30.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.887 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 198' ' ' GLY . . . . . 0.817 ' HA2' HD12 ' A' ' 216' ' ' LEU . . . -86.21 26.36 6.3 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.483 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 68.9 mt -125.78 140.13 49.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.854 0.359 . . . . 0.0 111.107 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.427 ' HB2' ' CD1' ' A' ' 159' ' ' PHE . 14.6 tp -136.17 112.26 9.68 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.893 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -92.86 112.94 25.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.898 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.644 HG11 ' OD2' ' A' ' 212' ' ' ASP . 23.5 t -67.38 114.68 4.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.085 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -126.4 137.19 53.41 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.154 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -43.79 158.67 0.25 Allowed Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.686 0.755 . . . . 0.0 110.929 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 2.84 3.15 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.728 2.285 . . . . 0.0 112.338 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -112.66 -16.98 12.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.915 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 108.38 60.43 0.54 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.535 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 59.7 mtt-85 -147.58 145.98 23.19 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.581 0.705 . . . . 0.0 110.877 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 112.47 3.08 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.71 2.273 . . . . 0.0 112.368 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 210' ' ' THR . . . . . 0.541 ' HB ' ' CE1' ' A' ' 256' ' ' PHE . 80.4 p -79.65 -10.84 59.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.152 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 95.06 -32.56 6.04 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.488 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 212' ' ' ASP . . . . . 0.644 ' OD2' HG11 ' A' ' 202' ' ' VAL . 1.2 p-10 -84.6 164.72 18.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.781 0.324 . . . . 0.0 110.893 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 213' ' ' ALA . . . . . 0.521 ' HA ' HG23 ' A' ' 202' ' ' VAL . . . -161.72 -179.06 6.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.066 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 214' ' ' PHE . . . . . 0.699 ' CE2' HG13 ' A' ' 249' ' ' VAL . 59.6 m-85 -146.79 133.01 19.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.896 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 215' ' ' VAL . . . . . 0.478 HG12 ' N ' ' A' ' 216' ' ' LEU . 14.4 t -118.56 159.75 18.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.105 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 0.817 HD12 ' HA2' ' A' ' 198' ' ' GLY . 51.6 mt -112.18 149.84 31.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.929 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -145.51 139.27 26.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.893 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 218' ' ' ALA . . . . . 0.566 ' HB3' ' CD1' ' A' ' 222' ' ' TYR . . . -44.79 -57.26 3.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.054 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 219' ' ' CYS . . . . . . . . . . . . . 1.8 t -160.93 -178.38 6.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.925 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 10.6 mp0 -48.3 -34.4 10.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.919 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -54.98 -33.09 62.19 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.903 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 222' ' ' TYR . . . . . 0.566 ' CD1' ' HB3' ' A' ' 218' ' ' ALA . 6.5 m-85 -93.52 -42.88 8.99 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.966 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.29 -62.17 2.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.134 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 224' ' ' GLN . . . . . 0.624 ' HA ' HD12 ' A' ' 227' ' ' LEU . 33.8 mt-30 -45.6 -59.21 2.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.921 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 38.1 m-20 -48.41 -22.15 0.66 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.922 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -92.81 -35.07 13.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.119 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 227' ' ' LEU . . . . . 0.624 HD12 ' HA ' ' A' ' 224' ' ' GLN . 86.1 mt -54.11 -37.76 64.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.933 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 228' ' ' ARG . . . . . 0.489 ' HB2' ' CZ ' ' A' ' 228' ' ' ARG . 0.2 OUTLIER -58.12 -24.7 59.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.82 179.954 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 229' ' ' LYS . . . . . 0.533 ' CE ' ' CE1' ' A' ' 185' ' ' PHE . 24.5 mtpp -67.25 -4.08 9.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.889 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 230' ' ' HIS . . . . . 0.528 ' CG ' ' HG2' ' A' ' 231' ' ' LYS . 23.6 t60 -34.33 134.18 0.21 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.878 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.528 ' HG2' ' CG ' ' A' ' 230' ' ' HIS . 0.2 OUTLIER 67.34 27.62 8.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.921 179.999 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -58.19 179.28 0.07 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.845 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.711 HD21 ' CE2' ' A' ' 238' ' ' TYR . 31.3 mt -135.67 110.66 8.84 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.939 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 234' ' ' LEU . . . . . 0.8 HD12 ' HD2' ' A' ' 185' ' ' PHE . 6.8 tt -119.9 115.46 23.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.936 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 57.04 39.39 89.58 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.492 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 23.3 mmtm 67.39 52.18 0.83 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.814 0.34 . . . . 0.0 110.899 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 237' ' ' ARG . . . . . 0.459 ' CB ' ' HG3' ' A' ' 174' ' ' PRO . 23.3 mmt180 -156.17 115.33 3.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.868 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 238' ' ' TYR . . . . . 0.711 ' CE2' HD21 ' A' ' 233' ' ' LEU . 96.0 m-85 -69.26 128.46 36.69 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.915 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 0.683 HD13 HD23 ' A' ' 173' ' ' LEU . 70.7 mt -123.52 138.62 52.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.137 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -99.95 165.76 11.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.887 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 241' ' ' LEU . . . . . 0.533 ' O ' ' CD1' ' A' ' 242' ' ' PHE . 18.6 mt -141.67 149.44 40.6 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.914 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 242' ' ' PHE . . . . . 0.533 ' CD1' ' O ' ' A' ' 241' ' ' LEU . 26.8 m-85 -155.65 130.26 9.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.914 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 24.9 mtp180 -52.54 122.85 9.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.889 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 244' ' ' SER . . . . . 0.413 ' HB2' ' N ' ' A' ' 169' ' ' ARG . 3.5 t -117.84 173.64 6.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.848 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 39.8 p -149.25 161.67 41.56 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.16 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -42.89 -60.24 1.68 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.072 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -53.13 -47.92 68.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.073 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -52.43 -54.74 28.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.817 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 0.699 HG13 ' CE2' ' A' ' 214' ' ' PHE . 94.0 t -51.79 -63.29 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.145 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 250' ' ' GLN . . . . . 0.749 ' HA ' HD12 ' A' ' 253' ' ' LEU . 22.9 mt-30 -46.87 -31.23 2.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.907 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 60.5 mt-30 -77.89 -28.65 49.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.935 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 252' ' ' VAL . . . . . 0.419 ' O ' HG12 ' A' ' 252' ' ' VAL . 55.6 t -82.36 -15.17 12.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.152 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 253' ' ' LEU . . . . . 0.749 HD12 ' HA ' ' A' ' 250' ' ' GLN . 13.1 mt -86.85 -42.68 13.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.883 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 254' ' ' ASN . . . . . 0.497 ' OD1' ' N ' ' A' ' 255' ' ' ARG . 0.7 OUTLIER -61.0 -43.28 99.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.917 179.944 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 255' ' ' ARG . . . . . 0.497 ' N ' ' OD1' ' A' ' 254' ' ' ASN . 15.5 ptm180 -58.7 -52.43 65.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.872 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 256' ' ' PHE . . . . . 0.541 ' CE1' ' HB ' ' A' ' 210' ' ' THR . 11.1 m-85 -67.66 -37.47 82.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.89 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 44.2 t . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.865 -179.805 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.877 0.37 . . . . 0.0 110.916 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.807 HG22 HD21 ' A' ' 200' ' ' LEU . 48.7 t -51.74 -33.28 15.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.116 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -48.36 -66.96 0.31 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.088 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 12.6 mm-40 -57.23 -28.31 62.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.923 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' PHE . . . . . 0.434 ' CE2' ' HG ' ' A' ' 216' ' ' LEU . 48.0 t80 -68.04 -36.89 80.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.889 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 81.6 mt -92.67 -20.82 20.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.926 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 3.4 t -53.16 -37.18 61.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.844 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' LYS . . . . . 0.592 ' HG3' HD13 ' A' ' 216' ' ' LEU . 56.9 mmtt -50.97 127.98 20.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.912 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -103.31 137.82 40.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.861 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 4.7 m120 70.55 43.47 0.77 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.859 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 6.2 mp0 -125.75 156.48 39.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.941 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 38.9 t -108.5 136.45 44.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.139 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 167' ' ' ILE . . . . . 0.465 HG21 ' CG2' ' A' ' 249' ' ' VAL . 52.0 mt -109.19 142.24 22.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.14 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 21.4 t -124.7 140.08 48.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.125 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 30.2 ttt-85 -92.09 108.89 20.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.858 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 170' ' ' MET . . . . . 0.646 ' CE ' HD21 ' A' ' 173' ' ' LEU . 80.6 mtp -93.93 129.9 40.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.882 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 17.8 ttm180 -132.9 140.32 47.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.826 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 89.34 24.63 30.74 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.55 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.646 HD21 ' CE ' ' A' ' 170' ' ' MET . 24.0 mt -77.27 123.73 87.03 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.582 0.706 . . . . 0.0 110.917 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_exo -47.94 125.21 11.17 Favored 'Trans proline' 0 N--CA 1.465 -0.169 0 C-N-CA 122.717 2.278 . . . . 0.0 112.343 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -37.5 -33.51 0.07 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.888 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 176' ' ' THR . . . . . 0.562 ' O ' HG23 ' A' ' 178' ' ' THR . 75.0 p -78.07 -50.71 11.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.119 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 177' ' ' ALA . . . . . 0.444 ' C ' ' O ' ' A' ' 176' ' ' THR . . . -33.7 130.31 0.28 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.103 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 178' ' ' THR . . . . . 0.562 HG23 ' O ' ' A' ' 176' ' ' THR . 16.9 p -132.06 178.7 6.59 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.119 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.429 ' O ' HG23 ' A' ' 183' ' ' VAL . . . -49.37 -46.14 46.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.1 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -56.51 -28.62 60.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.867 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 181' ' ' GLU . . . . . 0.84 ' HG2' HD11 ' A' ' 234' ' ' LEU . 4.5 tt0 -76.08 -44.15 40.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.879 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.526 ' HB ' HD13 ' A' ' 199' ' ' ILE . 54.8 t -63.7 -45.37 97.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.127 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 179' ' ' ALA . 54.6 t -37.19 -46.68 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.135 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -81.06 -37.82 28.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.093 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.547 ' CZ ' ' OD2' ' A' ' 232' ' ' ASP . 68.7 t80 -43.05 -57.03 3.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.882 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -94.6 -21.78 18.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.871 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -49.39 -17.81 1.29 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.713 -0.755 . . . . 0.0 112.514 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 15.9 mm-40 -56.13 -74.81 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.792 0.33 . . . . 0.0 110.89 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -118.27 -5.03 10.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.845 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 72.9 m -129.29 85.0 60.59 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.655 0.741 . . . . 0.0 110.921 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 191' ' ' PRO . . . . . 0.429 ' HD2' ' CD1' ' A' ' 222' ' ' TYR . 53.5 Cg_endo -69.74 130.47 19.43 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.711 2.274 . . . . 0.0 112.336 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 192' ' ' ILE . . . . . 0.546 HG23 ' O ' ' A' ' 216' ' ' LEU . 52.7 mt -80.9 144.56 10.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.17 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 91.1 m -67.59 99.68 0.8 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.144 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 95.36 -11.96 68.39 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.481 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 70.31 -126.07 15.51 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.524 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 4.5 ptmm? -48.37 -26.49 2.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.737 0.303 . . . . 0.0 110.909 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -77.92 -30.7 50.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.911 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 198' ' ' GLY . . . . . 0.427 ' HA2' HD12 ' A' ' 216' ' ' LEU . . . -89.4 39.5 3.11 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.472 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.526 HD13 ' HB ' ' A' ' 182' ' ' VAL . 72.8 mt -140.76 137.62 35.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.842 0.353 . . . . 0.0 111.146 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.807 HD21 HG22 ' A' ' 156' ' ' VAL . 15.3 tp -132.45 114.13 13.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.931 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 201' ' ' PHE . . . . . 0.4 ' CZ ' ' N ' ' A' ' 179' ' ' ALA . 54.4 m-85 -93.27 121.88 35.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.863 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.427 HG11 ' OD2' ' A' ' 212' ' ' ASP . 95.9 t -73.46 118.52 18.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.119 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -126.89 138.03 53.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.189 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 204' ' ' TYR . . . . . 0.805 ' CD2' HG22 ' A' ' 210' ' ' THR . 35.8 m-85 -45.92 158.45 0.36 Allowed Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.664 0.745 . . . . 0.0 110.943 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.82 2.9 3.14 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.714 2.276 . . . . 0.0 112.318 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -109.42 -21.89 12.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.859 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 112.24 52.82 0.51 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.488 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 5.2 mpt_? -140.18 145.48 41.93 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.586 0.708 . . . . 0.0 110.874 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 107.44 1.85 Allowed 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.708 2.272 . . . . 0.0 112.347 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 210' ' ' THR . . . . . 0.805 HG22 ' CD2' ' A' ' 204' ' ' TYR . 69.5 p -70.82 -29.59 65.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.155 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 115.08 -42.25 1.96 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.496 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 212' ' ' ASP . . . . . 0.427 ' OD2' HG11 ' A' ' 202' ' ' VAL . 1.7 p-10 -74.39 169.38 17.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.822 0.344 . . . . 0.0 110.867 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 213' ' ' ALA . . . . . 0.503 ' HB3' ' CD1' ' A' ' 173' ' ' LEU . . . -168.95 171.17 8.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.112 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -136.12 143.41 44.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.867 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 4.1 t -124.42 156.95 32.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.092 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 0.592 HD13 ' HG3' ' A' ' 162' ' ' LYS . 28.8 mt -108.22 151.06 26.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.953 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -144.19 135.37 25.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.893 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -49.06 -58.59 4.67 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.102 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 219' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -144.73 170.93 15.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.882 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -55.68 -27.27 49.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.881 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 23.0 tp10 -51.34 -36.27 42.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.907 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 222' ' ' TYR . . . . . 0.429 ' CD1' ' HD2' ' A' ' 191' ' ' PRO . 52.9 m-85 -91.84 -47.49 7.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.911 -179.837 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -52.57 -57.39 10.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.101 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 224' ' ' GLN . . . . . 0.446 ' HA ' HD12 ' A' ' 227' ' ' LEU . 60.0 mt-30 -50.08 -48.56 53.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.916 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 18.8 m-20 -63.15 -23.96 67.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.887 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -77.12 -22.71 52.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.093 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 227' ' ' LEU . . . . . 0.446 HD12 ' HA ' ' A' ' 224' ' ' GLN . 17.8 mt -70.51 -32.74 70.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.947 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 65.8 mtp180 -58.93 -12.33 4.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.874 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 229' ' ' LYS . . . . . 0.453 ' O ' ' C ' ' A' ' 230' ' ' HIS . 28.1 mttp -83.46 -1.73 54.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.926 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 230' ' ' HIS . . . . . 0.453 ' C ' ' O ' ' A' ' 229' ' ' LYS . 10.5 t60 -33.65 137.06 0.1 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.887 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.446 ' HG2' ' CG ' ' A' ' 230' ' ' HIS . 0.3 OUTLIER 59.82 34.49 21.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.929 -180.0 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 232' ' ' ASP . . . . . 0.547 ' OD2' ' CZ ' ' A' ' 185' ' ' PHE . 11.6 t0 -62.3 176.51 0.6 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.845 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.678 HD21 ' CE1' ' A' ' 238' ' ' TYR . 30.9 mt -134.87 107.22 7.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.903 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 234' ' ' LEU . . . . . 0.84 HD11 ' HG2' ' A' ' 181' ' ' GLU . 6.0 tt -114.35 112.45 23.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.935 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 57.75 40.44 92.83 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.477 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 62.3 mttt 68.93 53.21 0.49 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.774 0.321 . . . . 0.0 110.946 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 19.0 mmt180 -156.16 117.3 3.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.926 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 238' ' ' TYR . . . . . 0.678 ' CE1' HD21 ' A' ' 233' ' ' LEU . 98.8 m-85 -69.96 125.85 27.97 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.887 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 74.0 mt -121.31 137.39 55.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.138 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -97.79 163.61 12.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.868 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 41.2 mt -142.91 138.8 30.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.913 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -148.35 138.88 22.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.87 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 64.6 mtm180 -56.81 132.46 52.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.876 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 5.6 t -130.37 163.21 27.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.877 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 68.0 p -134.8 160.06 39.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.152 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -44.69 -49.72 10.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.102 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -60.36 -44.06 95.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.094 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 248' ' ' GLU . . . . . 0.494 ' O ' HG23 ' A' ' 252' ' ' VAL . 10.8 tt0 -54.92 -52.27 63.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.917 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 0.465 ' CG2' HG21 ' A' ' 167' ' ' ILE . 97.3 t -46.7 -62.06 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.141 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 250' ' ' GLN . . . . . 0.403 ' HA ' HD12 ' A' ' 253' ' ' LEU . 19.7 mt-30 -48.92 -44.06 40.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.908 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -66.59 -20.04 65.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.931 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 252' ' ' VAL . . . . . 0.494 HG23 ' O ' ' A' ' 248' ' ' GLU . 72.8 t -88.91 -24.39 6.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.162 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 253' ' ' LEU . . . . . 0.426 HD11 HG12 ' A' ' 249' ' ' VAL . 10.9 mt -85.2 -39.78 17.43 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.893 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -65.47 -38.62 90.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.909 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 255' ' ' ARG . . . . . 0.444 ' NH2' HG13 ' A' ' 252' ' ' VAL . 30.2 ptt180 -63.79 -37.89 89.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.898 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -80.57 -40.29 26.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.874 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 41.4 t . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.837 -179.786 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.892 0.377 . . . . 0.0 110.89 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.401 HG22 HD21 ' A' ' 200' ' ' LEU . 89.9 t -70.56 -42.26 78.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.146 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' ' 156' ' ' VAL . . . -37.57 -59.22 0.8 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.142 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 11.9 mm100 -56.97 -49.9 74.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.897 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' PHE . . . . . 0.51 ' CE2' ' HG ' ' A' ' 216' ' ' LEU . 58.8 t80 -47.8 -42.71 26.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.838 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 79.9 mt -86.32 -17.25 35.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.883 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 5.6 t -65.14 -30.87 71.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.844 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' LYS . . . . . 0.533 ' HG3' HD13 ' A' ' 216' ' ' LEU . 0.4 OUTLIER -53.14 129.38 30.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.943 179.903 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -102.93 151.78 22.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.866 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 67.1 m-80 61.85 49.73 4.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.879 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 22.2 mm-40 -131.09 168.08 18.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.887 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 45.5 t -125.06 109.22 21.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.133 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 167' ' ' ILE . . . . . 0.564 HG21 ' CG2' ' A' ' 249' ' ' VAL . 96.8 mt -79.37 139.7 17.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.148 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 66.7 t -123.67 130.46 74.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.132 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 52.1 ttp180 -88.26 105.37 17.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.911 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 170' ' ' MET . . . . . 0.521 ' CE ' HD21 ' A' ' 173' ' ' LEU . 98.8 mtp -94.36 129.48 41.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.914 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 40.7 mtt180 -128.99 147.08 50.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.872 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 81.26 35.96 22.2 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.475 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.521 HD21 ' CE ' ' A' ' 170' ' ' MET . 25.9 mt -86.01 125.64 67.86 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.588 0.709 . . . . 0.0 110.915 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_exo -47.99 140.29 18.93 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.691 2.26 . . . . 0.0 112.363 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -53.84 -19.85 4.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.879 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 50.0 p -94.97 -19.43 20.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.14 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -56.87 125.47 22.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.096 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 1.6 p -134.22 171.14 14.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.114 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.431 ' N ' ' CZ ' ' A' ' 201' ' ' PHE . . . -43.24 -55.69 3.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.081 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -48.33 -33.96 9.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.925 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 181' ' ' GLU . . . . . 0.49 ' HG3' HD11 ' A' ' 234' ' ' LEU . 0.8 OUTLIER -71.59 -44.3 64.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.902 -179.92 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.401 ' O ' ' C ' ' A' ' 183' ' ' VAL . 40.3 t -65.68 -50.19 72.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.102 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.401 ' C ' ' O ' ' A' ' 182' ' ' VAL . 44.7 t -37.52 -42.25 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.109 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -81.54 -39.51 24.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.115 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.543 ' CE2' ' HD3' ' A' ' 229' ' ' LYS . 60.6 t80 -43.86 -58.35 2.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.87 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 186' ' ' PHE . . . . . 0.401 ' CE1' ' CE2' ' A' ' 185' ' ' PHE . 73.6 m-85 -92.81 -23.66 18.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.859 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -50.16 -22.26 4.74 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.495 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 9.6 mm-40 -50.25 -75.9 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.867 0.365 . . . . 0.0 110.913 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 189' ' ' HIS . . . . . 0.592 ' CE1' ' HG ' ' A' ' 190' ' ' CYS . 0.1 OUTLIER -118.41 -0.29 11.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.899 179.981 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 190' ' ' CYS . . . . . 0.592 ' HG ' ' CE1' ' A' ' 189' ' ' HIS . 94.8 m -128.48 91.9 42.43 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.602 0.715 . . . . 0.0 110.886 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 191' ' ' PRO . . . . . 0.42 ' HD2' ' HA ' ' A' ' 190' ' ' CYS . 53.8 Cg_endo -69.75 135.74 31.26 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.73 2.286 . . . . 0.0 112.346 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 192' ' ' ILE . . . . . 0.544 HG23 ' O ' ' A' ' 216' ' ' LEU . 62.1 mt -92.6 145.54 7.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.138 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 88.6 m -67.13 104.33 1.41 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.107 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 87.93 -15.32 55.99 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.502 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 73.57 -119.63 6.63 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.504 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.79 -21.32 2.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.748 0.309 . . . . 0.0 110.895 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -87.03 -25.52 24.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.885 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 198' ' ' GLY . . . . . 0.445 ' HA2' HD12 ' A' ' 216' ' ' LEU . . . -88.65 33.11 4.27 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.462 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 29.0 mt -138.72 153.15 25.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.822 0.344 . . . . 0.0 111.144 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.401 HD21 HG22 ' A' ' 156' ' ' VAL . 14.0 tp -146.96 113.0 5.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.921 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 201' ' ' PHE . . . . . 0.431 ' CZ ' ' N ' ' A' ' 179' ' ' ALA . 35.9 m-85 -93.72 121.51 35.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.895 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.406 ' CB ' ' OD2' ' A' ' 212' ' ' ASP . 42.1 t -74.39 123.46 29.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.161 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 203' ' ' THR . . . . . 0.573 ' HA ' HG23 ' A' ' 210' ' ' THR . 0.7 OUTLIER -134.18 137.08 44.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.096 -179.947 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -46.09 158.42 0.37 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.69 0.757 . . . . 0.0 110.915 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.7 3.04 2.97 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.66 2.24 . . . . 0.0 112.387 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -113.03 -10.05 13.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.882 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 99.92 58.85 0.87 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.459 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 11.2 mmm180 -142.3 143.38 27.01 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.614 0.721 . . . . 0.0 110.86 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.66 109.6 2.33 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.721 2.281 . . . . 0.0 112.371 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 210' ' ' THR . . . . . 0.576 ' HB ' ' CE2' ' A' ' 256' ' ' PHE . 19.8 p -73.43 -32.01 64.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.156 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 112.97 -30.28 7.51 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.487 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 212' ' ' ASP . . . . . 0.406 ' OD2' ' CB ' ' A' ' 202' ' ' VAL . 1.0 OUTLIER -88.45 163.98 15.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.785 0.326 . . . . 0.0 110.876 -179.975 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -162.76 177.37 9.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.091 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 214' ' ' PHE . . . . . 0.786 ' CE2' HG13 ' A' ' 249' ' ' VAL . 41.2 m-85 -142.35 139.41 31.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.87 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 6.2 t -123.0 156.89 28.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.15 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 0.544 ' O ' HG23 ' A' ' 192' ' ' ILE . 32.4 mt -109.92 138.8 45.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.922 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -130.12 133.9 46.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.858 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 218' ' ' ALA . . . . . 0.66 ' HB3' ' CE2' ' A' ' 222' ' ' TYR . . . -44.81 -64.53 0.68 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.136 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 219' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -144.23 160.2 41.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.835 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -40.92 -29.51 0.1 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.893 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -47.57 -49.89 25.37 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.9 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 222' ' ' TYR . . . . . 0.66 ' CE2' ' HB3' ' A' ' 218' ' ' ALA . 30.1 m-85 -78.03 -50.99 11.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.893 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 223' ' ' ALA . . . . . 0.49 ' O ' ' HB3' ' A' ' 226' ' ' ALA . . . -44.85 -57.08 3.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.158 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 224' ' ' GLN . . . . . 0.542 ' HA ' HD12 ' A' ' 227' ' ' LEU . 8.6 mm-40 -48.52 -60.92 2.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.914 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 30.3 m-20 -51.86 -21.51 2.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.915 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 226' ' ' ALA . . . . . 0.49 ' HB3' ' O ' ' A' ' 223' ' ' ALA . . . -83.24 -33.86 25.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.094 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 227' ' ' LEU . . . . . 0.542 HD12 ' HA ' ' A' ' 224' ' ' GLN . 32.2 mt -60.67 -28.9 68.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.924 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 228' ' ' ARG . . . . . 0.408 HH11 ' CB ' ' A' ' 228' ' ' ARG . 0.0 OUTLIER -61.11 -18.06 55.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.878 179.946 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 229' ' ' LYS . . . . . 0.543 ' HD3' ' CE2' ' A' ' 185' ' ' PHE . 16.2 mttm -80.02 0.19 32.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.891 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 230' ' ' HIS . . . . . 0.482 ' N ' HD12 ' A' ' 241' ' ' LEU . 13.1 t-160 -32.66 126.93 0.29 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.872 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 43.7 mtmt 61.84 37.1 15.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.938 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -60.72 -174.93 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.852 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.612 HD21 ' CD1' ' A' ' 238' ' ' TYR . 33.0 mt -138.8 105.64 5.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.907 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 234' ' ' LEU . . . . . 0.539 ' C ' HD23 ' A' ' 234' ' ' LEU . 7.1 tt -113.35 114.8 27.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.873 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 59.22 37.67 92.13 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.494 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 33.3 mttt 69.14 52.37 0.49 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.774 0.321 . . . . 0.0 110.898 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 23.3 mmt180 -156.24 115.26 3.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.835 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 238' ' ' TYR . . . . . 0.612 ' CD1' HD21 ' A' ' 233' ' ' LEU . 97.3 m-85 -63.71 128.22 34.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.95 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 0.457 HD13 HD23 ' A' ' 173' ' ' LEU . 97.4 mt -127.04 129.71 71.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.08 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 240' ' ' GLU . . . . . 0.576 ' HB3' ' CE2' ' A' ' 242' ' ' PHE . 3.9 mp0 -85.33 171.92 11.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.85 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 241' ' ' LEU . . . . . 0.595 ' O ' ' CD1' ' A' ' 242' ' ' PHE . 21.3 mt -154.46 138.75 16.64 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.909 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 242' ' ' PHE . . . . . 0.595 ' CD1' ' O ' ' A' ' 241' ' ' LEU . 6.6 m-85 -158.45 123.43 4.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.878 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 243' ' ' ARG . . . . . 0.496 ' CG ' ' O ' ' A' ' 243' ' ' ARG . 21.2 ptt180 -60.89 117.33 5.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.85 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 1.7 t -112.49 168.52 9.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.858 -179.775 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.6 p -109.45 173.83 6.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.168 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 246' ' ' ALA . . . . . 0.549 ' HA ' HD12 ' A' ' 167' ' ' ILE . . . -61.63 -63.74 1.17 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.1 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -43.76 -49.67 7.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.074 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -47.27 -57.64 4.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.863 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 0.786 HG13 ' CE2' ' A' ' 214' ' ' PHE . 97.8 t -44.65 -61.68 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.136 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 250' ' ' GLN . . . . . 0.631 ' HA ' HD12 ' A' ' 253' ' ' LEU . 53.1 mt-30 -47.59 -29.55 2.98 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.916 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -82.4 -26.43 32.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.933 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 252' ' ' VAL . . . . . 0.425 ' O ' HG12 ' A' ' 252' ' ' VAL . 53.3 t -82.63 -15.31 11.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.131 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 253' ' ' LEU . . . . . 0.631 HD12 ' HA ' ' A' ' 250' ' ' GLN . 13.4 mt -86.82 -43.06 12.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.887 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 254' ' ' ASN . . . . . 0.5 ' OD1' ' N ' ' A' ' 255' ' ' ARG . 0.6 OUTLIER -61.67 -44.49 96.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.85 179.943 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 255' ' ' ARG . . . . . 0.5 ' N ' ' OD1' ' A' ' 254' ' ' ASN . 11.4 ptm180 -54.17 -31.03 51.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.84 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 256' ' ' PHE . . . . . 0.576 ' CE2' ' HB ' ' A' ' 210' ' ' THR . 16.7 m-85 -91.34 -36.84 13.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.87 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 33.4 t . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.895 -179.805 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.885 0.374 . . . . 0.0 110.846 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.558 HG22 HD21 ' A' ' 200' ' ' LEU . 79.0 t -43.34 -39.13 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.154 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -45.46 -48.08 13.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.065 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -69.83 -42.07 74.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.909 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' PHE . . . . . 0.475 ' CD2' ' HB2' ' A' ' 200' ' ' LEU . 41.2 t80 -56.07 -41.77 75.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.899 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 91.0 mt -85.56 -26.05 26.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.903 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 31.6 t -54.62 -26.51 33.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.881 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 18.2 mmmt -61.99 128.77 37.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.873 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -105.99 154.08 21.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.861 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 62.35 49.35 4.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.858 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 24.3 mm-40 -137.21 153.47 50.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.92 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 55.7 t -108.03 119.8 58.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.149 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 167' ' ' ILE . . . . . 0.462 HD12 ' N ' ' A' ' 246' ' ' ALA . 10.8 mt -90.66 147.83 4.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.156 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 95.6 t -128.53 141.43 46.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.127 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 29.0 ttp85 -95.51 107.17 19.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.877 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 170' ' ' MET . . . . . 0.478 ' CE ' HD21 ' A' ' 173' ' ' LEU . 89.7 mtp -92.56 127.11 37.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.932 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 171' ' ' ARG . . . . . 0.423 ' O ' HG23 ' A' ' 239' ' ' ILE . 3.8 tpt180 -123.83 144.89 49.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.881 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 172' ' ' GLY . . . . . 0.401 ' N ' ' HG3' ' A' ' 171' ' ' ARG . . . 79.01 33.63 36.02 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.464 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.763 ' CD1' ' HB3' ' A' ' 213' ' ' ALA . 21.8 mt -81.39 119.33 75.38 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.574 0.702 . . . . 0.0 110.896 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 174' ' ' PRO . . . . . 0.481 ' O ' ' N ' ' A' ' 177' ' ' ALA . 65.2 Cg_exo -47.94 130.0 18.95 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.695 2.263 . . . . 0.0 112.368 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 34.7 m-85 -41.49 -41.07 1.98 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.889 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 65.3 p -75.52 -29.47 59.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.157 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 177' ' ' ALA . . . . . 0.481 ' N ' ' O ' ' A' ' 174' ' ' PRO . . . -45.74 112.62 0.49 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.085 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -113.4 170.36 8.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.127 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -46.5 -56.53 5.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.112 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -45.43 -30.18 1.3 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.856 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 181' ' ' GLU . . . . . 0.636 ' HG3' HD11 ' A' ' 234' ' ' LEU . 2.2 tp10 -71.59 -41.61 68.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.885 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.45 HG12 HD11 ' A' ' 192' ' ' ILE . 55.8 t -69.25 -47.41 73.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.107 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.432 ' C ' ' O ' ' A' ' 182' ' ' VAL . 70.8 t -35.26 -54.25 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.08 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -74.78 -39.2 61.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.086 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.476 ' CD1' HD12 ' A' ' 234' ' ' LEU . 59.2 t80 -41.54 -58.27 1.97 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.87 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -94.3 -21.32 19.07 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.871 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -49.15 -25.78 5.81 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.463 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -48.3 -72.77 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.836 0.351 . . . . 0.0 110.91 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 14.2 m170 -118.26 -15.52 9.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.894 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 63.8 m -118.41 85.17 25.13 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.638 0.732 . . . . 0.0 110.94 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 191' ' ' PRO . . . . . 0.462 ' HD2' ' CD1' ' A' ' 222' ' ' TYR . 53.3 Cg_endo -69.75 139.9 41.39 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.686 2.257 . . . . 0.0 112.348 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 192' ' ' ILE . . . . . 0.65 HG23 ' O ' ' A' ' 216' ' ' LEU . 49.6 mt -91.82 144.69 8.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.135 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 55.0 m -67.3 108.28 2.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.157 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 86.94 -22.18 15.8 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.447 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.409 ' O ' ' N ' ' A' ' 198' ' ' GLY . . . 82.52 -126.56 7.51 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.484 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 196' ' ' LYS . . . . . 0.423 ' HA ' HD12 ' A' ' 199' ' ' ILE . 8.8 ptpt -46.48 -22.25 0.25 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.767 0.318 . . . . 0.0 110.894 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -82.23 -33.69 29.17 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.912 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 198' ' ' GLY . . . . . 0.465 ' HA2' HD12 ' A' ' 216' ' ' LEU . . . -84.98 35.4 3.11 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.466 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.423 HD12 ' HA ' ' A' ' 196' ' ' LYS . 27.5 mt -138.8 139.92 39.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.828 0.347 . . . . 0.0 111.148 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.558 HD21 HG22 ' A' ' 156' ' ' VAL . 14.5 tp -137.19 111.83 8.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.939 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -90.43 123.43 34.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.901 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 59.0 t -73.51 118.32 18.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.144 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -127.95 137.14 52.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.124 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -45.99 158.75 0.35 Allowed Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.63 0.729 . . . . 0.0 110.918 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.83 3.58 2.72 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.631 2.221 . . . . 0.0 112.327 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -112.4 -21.28 11.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.861 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 113.53 56.41 0.41 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.525 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 7.6 mpt_? -143.53 146.5 35.84 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.554 0.692 . . . . 0.0 110.904 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 111.17 2.74 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.669 2.246 . . . . 0.0 112.363 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 210' ' ' THR . . . . . 0.566 ' HB ' ' CE2' ' A' ' 256' ' ' PHE . 62.0 p -73.09 -14.03 61.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.152 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 97.57 -31.33 7.93 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.523 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -90.38 168.4 11.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.827 0.346 . . . . 0.0 110.832 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 213' ' ' ALA . . . . . 0.763 ' HB3' ' CD1' ' A' ' 173' ' ' LEU . . . -165.01 174.86 10.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.12 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 214' ' ' PHE . . . . . 0.498 ' HZ ' HG21 ' A' ' 252' ' ' VAL . 56.4 m-85 -137.71 151.37 48.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.899 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 215' ' ' VAL . . . . . 0.402 ' CG2' ' SD ' ' A' ' 170' ' ' MET . 6.9 t -134.76 155.0 37.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.129 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 0.65 ' O ' HG23 ' A' ' 192' ' ' ILE . 29.5 mt -108.48 144.05 36.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.915 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -136.41 141.33 43.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.9 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -53.9 -57.17 11.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.156 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 219' ' ' CYS . . . . . . . . . . . . . 95.2 m -136.4 -179.22 5.55 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.887 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -70.14 -28.62 65.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.921 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -48.02 -50.01 29.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.904 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 222' ' ' TYR . . . . . 0.462 ' CD1' ' HD2' ' A' ' 191' ' ' PRO . 29.6 m-85 -74.0 -49.73 23.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.921 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -47.64 -56.75 6.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.107 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -55.87 -52.74 63.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.91 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -49.96 -31.73 13.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.917 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -75.41 -35.77 60.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.09 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 89.8 mt -52.43 -39.6 61.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.921 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 34.8 mtt85 -54.99 -26.0 33.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.843 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 229' ' ' LYS . . . . . 0.458 ' O ' ' C ' ' A' ' 230' ' ' HIS . 6.9 mtpm? -69.86 -2.48 12.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.922 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 230' ' ' HIS . . . . . 0.519 ' CE1' ' HD3' ' A' ' 231' ' ' LYS . 12.0 t60 -33.86 136.67 0.11 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.845 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.519 ' HD3' ' CE1' ' A' ' 230' ' ' HIS . 1.2 mmmp? 62.96 29.43 16.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.909 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 232' ' ' ASP . . . . . 0.423 ' OD1' ' NZ ' ' A' ' 229' ' ' LYS . 2.7 t70 -58.34 -179.69 0.06 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.88 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.617 HD21 ' CD1' ' A' ' 238' ' ' TYR . 30.2 mt -138.19 107.78 6.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.925 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 234' ' ' LEU . . . . . 0.636 HD11 ' HG3' ' A' ' 181' ' ' GLU . 6.1 tt -117.83 111.2 18.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.915 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 60.12 43.23 98.54 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.47 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 64.66 53.8 1.5 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.723 0.297 . . . . 0.0 110.915 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 237' ' ' ARG . . . . . 0.438 ' CB ' ' HG3' ' A' ' 174' ' ' PRO . 14.2 mmt85 -156.65 115.48 3.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.877 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 238' ' ' TYR . . . . . 0.617 ' CD1' HD21 ' A' ' 233' ' ' LEU . 97.2 m-85 -69.69 123.68 22.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.975 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 0.489 HD13 HD23 ' A' ' 173' ' ' LEU . 37.9 mt -119.74 145.9 25.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.132 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 240' ' ' GLU . . . . . 0.464 ' HB3' ' CZ ' ' A' ' 242' ' ' PHE . 38.9 mt-10 -111.35 159.51 17.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.829 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 17.0 mt -136.58 123.87 21.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.98 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 242' ' ' PHE . . . . . 0.464 ' CZ ' ' HB3' ' A' ' 240' ' ' GLU . 4.1 m-85 -131.05 129.57 42.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.855 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 70.2 mtt180 -42.61 150.8 0.14 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.943 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 1.3 t -152.18 156.06 39.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.869 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 50.6 p -131.11 165.92 22.22 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.109 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 246' ' ' ALA . . . . . 0.462 ' N ' HD12 ' A' ' 167' ' ' ILE . . . -48.41 -52.74 20.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.121 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -58.6 -47.92 82.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.098 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -51.64 -55.54 18.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.849 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 0.437 ' CG2' HG21 ' A' ' 167' ' ' ILE . 91.2 t -42.45 -65.21 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.161 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 250' ' ' GLN . . . . . 0.62 ' HA ' HD12 ' A' ' 253' ' ' LEU . 30.4 mt-30 -38.08 -57.84 1.02 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.93 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -52.33 -44.25 65.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.927 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 252' ' ' VAL . . . . . 0.498 HG21 ' HZ ' ' A' ' 214' ' ' PHE . 91.1 t -59.95 -31.43 47.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.105 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 253' ' ' LEU . . . . . 0.62 HD12 ' HA ' ' A' ' 250' ' ' GLN . 7.9 mt -79.51 -39.46 31.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.945 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 16.6 m-80 -66.97 -49.0 66.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.904 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 255' ' ' ARG . . . . . 0.475 ' HG3' ' N ' ' A' ' 256' ' ' PHE . 2.7 ptm85 -53.35 -43.5 67.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.826 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 256' ' ' PHE . . . . . 0.566 ' CE2' ' HB ' ' A' ' 210' ' ' THR . 13.1 m-85 -76.34 -37.59 57.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.862 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 24.1 p . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.813 -179.749 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.866 0.365 . . . . 0.0 110.935 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 90.2 t -63.44 -47.4 91.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.156 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -40.01 -61.07 0.92 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.105 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -59.13 -40.69 86.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.909 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' PHE . . . . . 0.526 ' CE2' ' HG ' ' A' ' 216' ' ' LEU . 49.2 t80 -56.41 -40.55 74.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.873 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 86.6 mt -87.94 -24.37 23.61 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.868 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 28.7 t -58.72 -27.38 64.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.843 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' LYS . . . . . 0.527 ' HG3' HD13 ' A' ' 216' ' ' LEU . 28.6 mmmt -60.75 125.74 24.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.872 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -101.26 150.46 22.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.89 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 34.8 m-20 62.51 49.4 4.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.882 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.9 mm-40 -133.9 143.6 48.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.899 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 48.6 t -100.22 107.23 20.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.188 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 36.7 mt -75.95 134.13 29.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.143 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 57.9 t -116.22 128.46 73.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.127 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 45.8 ttp180 -88.35 108.25 19.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.884 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 170' ' ' MET . . . . . 0.485 ' CE ' HD21 ' A' ' 173' ' ' LEU . 97.0 mtp -92.6 113.33 25.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.859 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 8.3 ttp180 -117.21 139.28 50.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.912 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 91.38 25.04 24.81 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.507 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.894 HD23 HD13 ' A' ' 239' ' ' ILE . 19.5 mt -80.27 129.01 71.14 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.612 0.72 . . . . 0.0 110.919 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 174' ' ' PRO . . . . . 0.434 ' HG3' ' CB ' ' A' ' 237' ' ' ARG . 64.8 Cg_exo -47.92 136.35 22.92 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.75 2.3 . . . . 0.0 112.335 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 8.8 m-30 -50.98 -19.97 1.2 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.86 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 176' ' ' THR . . . . . 0.539 ' O ' HG23 ' A' ' 178' ' ' THR . 64.1 p -94.98 -28.77 14.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.098 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -41.85 120.64 1.58 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.083 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 178' ' ' THR . . . . . 0.539 HG23 ' O ' ' A' ' 176' ' ' THR . 40.1 p -116.01 179.56 3.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.164 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -54.12 -48.57 70.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.111 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -52.84 -42.29 65.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.875 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -58.87 -37.14 75.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.895 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.506 HG12 ' CD1' ' A' ' 192' ' ' ILE . 15.5 t -73.21 -47.25 47.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.121 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 42.8 t -39.83 -49.82 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.067 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.428 ' O ' ' C ' ' A' ' 185' ' ' PHE . . . -74.25 -44.71 51.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.106 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.491 ' HD1' HD12 ' A' ' 234' ' ' LEU . 53.9 t80 -36.42 -60.56 0.57 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.864 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 186' ' ' PHE . . . . . 0.473 ' CZ ' ' CD2' ' A' ' 185' ' ' PHE . 42.4 m-85 -95.06 -25.0 16.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.885 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -49.15 -21.31 2.56 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.469 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 42.0 tt0 -55.18 -70.66 0.1 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.816 0.341 . . . . 0.0 110.908 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 20.3 m80 -118.21 -16.72 9.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.853 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 190' ' ' CYS . . . . . 0.423 ' SG ' ' HB2' ' A' ' 226' ' ' ALA . 70.9 m -120.36 87.26 40.15 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.603 0.716 . . . . 0.0 110.86 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 130.55 19.6 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.692 2.261 . . . . 0.0 112.331 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 192' ' ' ILE . . . . . 0.506 ' CD1' HG12 ' A' ' 182' ' ' VAL . 54.7 mt -78.1 144.57 11.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.15 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 29.3 m -71.29 104.43 3.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.183 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 91.98 -17.17 57.64 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.497 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.414 ' O ' ' N ' ' A' ' 198' ' ' GLY . . . 70.22 -124.12 13.21 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.516 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 31.4 mtmm -46.09 -30.58 1.94 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.679 0.276 . . . . 0.0 110.859 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -78.13 -32.01 50.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.893 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 198' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 195' ' ' GLY . . . -88.46 29.65 5.62 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.492 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 70.2 mt -131.4 142.12 44.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.89 0.376 . . . . 0.0 111.127 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 13.0 tp -139.7 111.74 7.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.919 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -96.27 119.26 34.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.909 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.466 HG23 ' HA ' ' A' ' 213' ' ' ALA . 21.7 t -71.51 130.18 35.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.109 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -140.59 137.59 33.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.151 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -48.76 158.88 0.6 Allowed Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.681 0.753 . . . . 0.0 110.903 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 3.05 2.99 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.74 2.293 . . . . 0.0 112.357 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -112.37 -15.29 13.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.864 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 112.25 9.89 18.93 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.501 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -89.64 140.67 28.16 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.603 0.716 . . . . 0.0 110.855 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 115.59 4.16 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.651 2.234 . . . . 0.0 112.339 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 210' ' ' THR . . . . . 0.549 ' HB ' ' CE2' ' A' ' 256' ' ' PHE . 69.8 p -80.24 -21.49 42.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.107 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 95.3 -46.38 2.01 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.515 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 212' ' ' ASP . . . . . 0.434 ' OD2' HG11 ' A' ' 202' ' ' VAL . 1.1 p-10 -68.64 154.64 41.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.816 0.341 . . . . 0.0 110.875 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 213' ' ' ALA . . . . . 0.466 ' HA ' HG23 ' A' ' 202' ' ' VAL . . . -153.53 -175.27 5.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.096 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 214' ' ' PHE . . . . . 0.447 ' HZ ' HG11 ' A' ' 252' ' ' VAL . 52.8 m-85 -150.63 139.49 20.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.851 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 215' ' ' VAL . . . . . 0.542 HG12 ' N ' ' A' ' 216' ' ' LEU . 21.4 t -125.69 162.34 28.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.132 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 0.542 ' N ' HG12 ' A' ' 215' ' ' VAL . 31.2 mt -112.48 137.23 50.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.919 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -132.5 138.88 47.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.844 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 218' ' ' ALA . . . . . 0.832 ' HB3' ' CD2' ' A' ' 222' ' ' TYR . . . -48.39 -65.72 0.52 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.147 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 219' ' ' CYS . . . . . . . . . . . . . 2.6 m -154.85 174.81 14.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.845 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 220' ' ' GLU . . . . . 0.405 ' HA ' ' HB3' ' A' ' 223' ' ' ALA . 1.7 mp0 -39.81 -42.73 1.33 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.915 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -41.14 -43.31 2.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.896 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 222' ' ' TYR . . . . . 0.832 ' CD2' ' HB3' ' A' ' 218' ' ' ALA . 57.1 m-85 -92.35 -46.27 7.78 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.912 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 223' ' ' ALA . . . . . 0.405 ' HB3' ' HA ' ' A' ' 220' ' ' GLU . . . -52.14 -64.12 0.92 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.104 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 224' ' ' GLN . . . . . 0.692 ' HA ' HD12 ' A' ' 227' ' ' LEU . 23.0 mm-40 -50.65 -55.93 14.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.945 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 225' ' ' ASN . . . . . 0.439 ' O ' ' CG ' ' A' ' 228' ' ' ARG . 24.2 m-20 -52.14 -21.24 3.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.903 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 226' ' ' ALA . . . . . 0.423 ' HB2' ' SG ' ' A' ' 190' ' ' CYS . . . -93.83 -34.19 13.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.089 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 227' ' ' LEU . . . . . 0.692 HD12 ' HA ' ' A' ' 224' ' ' GLN . 63.4 mt -57.65 -32.77 67.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.886 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 228' ' ' ARG . . . . . 0.439 ' CG ' ' O ' ' A' ' 225' ' ' ASN . 3.0 ptm180 -58.52 -13.05 4.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.879 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 229' ' ' LYS . . . . . 0.456 ' O ' ' C ' ' A' ' 230' ' ' HIS . 16.1 mtpp -86.13 -0.37 55.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.924 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 230' ' ' HIS . . . . . 0.556 ' CE1' ' HG3' ' A' ' 231' ' ' LYS . 48.2 t60 -33.94 131.54 0.27 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.879 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.556 ' HG3' ' CE1' ' A' ' 230' ' ' HIS . 36.8 mttp 62.37 35.36 15.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.879 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -62.01 -176.37 0.09 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.878 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.708 HD21 ' CE1' ' A' ' 238' ' ' TYR . 31.7 mt -133.9 112.42 11.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.893 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 234' ' ' LEU . . . . . 0.571 ' C ' HD23 ' A' ' 234' ' ' LEU . 7.3 tt -121.47 117.89 27.98 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.919 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 57.05 36.35 73.74 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.508 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 26.9 mmtm 69.13 50.73 0.56 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.806 0.336 . . . . 0.0 110.889 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 237' ' ' ARG . . . . . 0.434 ' CB ' ' HG3' ' A' ' 174' ' ' PRO . 44.7 mmt-85 -156.06 115.28 3.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.826 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 238' ' ' TYR . . . . . 0.708 ' CE1' HD21 ' A' ' 233' ' ' LEU . 97.5 m-85 -66.58 136.36 55.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.949 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 0.894 HD13 HD23 ' A' ' 173' ' ' LEU . 79.2 mt -135.88 126.21 42.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.154 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 240' ' ' GLU . . . . . 0.584 ' HB3' ' CZ ' ' A' ' 242' ' ' PHE . 6.7 mp0 -84.81 166.33 17.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.908 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 241' ' ' LEU . . . . . 0.451 ' O ' ' CD1' ' A' ' 242' ' ' PHE . 15.1 mt -148.13 134.03 19.1 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.89 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 242' ' ' PHE . . . . . 0.584 ' CZ ' ' HB3' ' A' ' 240' ' ' GLU . 7.3 m-85 -145.42 120.92 10.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.886 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 243' ' ' ARG . . . . . 0.486 ' CG ' ' O ' ' A' ' 243' ' ' ARG . 18.4 ptt-85 -57.15 118.25 4.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.883 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 7.5 t -114.4 -174.98 2.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.887 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 245' ' ' THR . . . . . 0.956 ' O ' HG23 ' A' ' 249' ' ' VAL . 67.8 p -135.64 179.16 6.51 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.162 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -60.86 -53.62 55.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.091 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -52.95 -58.17 7.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.146 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 248' ' ' GLU . . . . . 0.508 ' O ' HG23 ' A' ' 252' ' ' VAL . 1.9 tp10 -49.44 -55.92 11.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.893 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 0.956 HG23 ' O ' ' A' ' 245' ' ' THR . 97.3 t -39.68 -65.58 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.149 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 250' ' ' GLN . . . . . 0.432 ' O ' ' N ' ' A' ' 253' ' ' LEU . 52.2 mt-30 -37.55 -66.72 0.23 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.885 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 28.9 mm-40 -40.97 -39.69 1.23 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.941 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 252' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 248' ' ' GLU . 28.3 t -65.04 -39.44 85.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.125 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 253' ' ' LEU . . . . . 0.432 ' N ' ' O ' ' A' ' 250' ' ' GLN . 7.1 mt -76.89 -36.17 56.87 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.919 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -71.43 -49.77 38.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.89 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 255' ' ' ARG . . . . . 0.541 ' CG ' ' N ' ' A' ' 256' ' ' PHE . 5.2 ptm180 -49.66 -50.75 42.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.83 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 256' ' ' PHE . . . . . 0.549 ' CE2' ' HB ' ' A' ' 210' ' ' THR . 12.4 m-85 -65.04 -33.6 76.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.877 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 14.2 m . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.849 -179.793 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.884 0.373 . . . . 0.0 110.876 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.537 HG22 HD21 ' A' ' 200' ' ' LEU . 76.6 t -60.39 -36.99 72.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.147 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -43.68 -62.25 1.15 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.076 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -60.83 -42.54 97.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.93 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 159' ' ' PHE . . . . . 0.531 ' CE2' ' HG ' ' A' ' 216' ' ' LEU . 59.6 t80 -52.7 -38.85 61.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.853 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 82.9 mt -89.96 -29.03 18.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.946 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 1.7 t -52.04 -33.34 38.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.852 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 162' ' ' LYS . . . . . 0.58 ' HG3' HD13 ' A' ' 216' ' ' LEU . 27.4 mmmt -45.5 116.68 1.22 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.868 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -84.55 149.96 25.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.869 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 47.71 44.85 17.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.907 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.567 ' OE1' HG21 ' A' ' 193' ' ' THR . 0.4 OUTLIER -117.1 153.13 33.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.907 -179.974 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 46.8 t -106.23 139.06 28.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.157 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 167' ' ' ILE . . . . . 0.531 HG21 HG21 ' A' ' 249' ' ' VAL . 26.0 mt -113.07 137.22 46.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.113 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.477 HG21 ' CE1' ' A' ' 217' ' ' PHE . 94.1 t -114.2 138.23 44.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.123 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 39.9 ttt-85 -93.81 109.25 20.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.893 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 170' ' ' MET . . . . . 0.48 ' CE ' HD21 ' A' ' 173' ' ' LEU . 83.6 mtp -99.51 126.39 45.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.908 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 11.0 mtp85 -127.15 145.17 50.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.866 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 81.5 32.63 30.29 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.482 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.827 ' CD1' ' HB3' ' A' ' 213' ' ' ALA . 22.1 mt -82.84 121.28 77.5 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.658 0.742 . . . . 0.0 110.929 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 174' ' ' PRO . . . . . 0.485 ' O ' ' N ' ' A' ' 176' ' ' THR . 66.6 Cg_exo -48.02 121.44 5.97 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.661 2.24 . . . . 0.0 112.333 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 175' ' ' PHE . . . . . 0.591 ' CD2' ' HG2' ' A' ' 209' ' ' PRO . 3.4 m-85 -37.21 -29.13 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.859 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 176' ' ' THR . . . . . 0.485 ' N ' ' O ' ' A' ' 174' ' ' PRO . 73.7 p -80.83 -44.01 19.14 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.161 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 177' ' ' ALA . . . . . 0.476 ' N ' ' O ' ' A' ' 174' ' ' PRO . . . -34.27 125.45 0.49 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.064 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 178' ' ' THR . . . . . 0.404 HG23 ' O ' ' A' ' 176' ' ' THR . 12.0 p -118.49 177.07 4.96 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.151 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.445 ' O ' HG23 ' A' ' 183' ' ' VAL . . . -52.46 -44.91 65.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.113 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -56.18 -41.54 75.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.885 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -57.83 -39.38 77.54 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.882 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.502 HG12 ' CD1' ' A' ' 192' ' ' ILE . 54.7 t -71.99 -52.39 25.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.112 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 179' ' ' ALA . 89.9 t -35.13 -47.27 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.14 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -79.65 -39.33 31.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.138 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.612 ' CD1' HD12 ' A' ' 234' ' ' LEU . 58.2 t80 -41.33 -58.78 1.74 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.903 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 186' ' ' PHE . . . . . 0.491 ' O ' ' N ' ' A' ' 190' ' ' CYS . 63.1 m-85 -96.41 -23.32 16.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.915 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -52.68 -21.15 8.83 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.498 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 188' ' ' GLN . . . . . 0.485 ' NE2' ' O ' ' A' ' 185' ' ' PHE . 1.5 pt20 -59.19 -60.04 4.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.858 0.361 . . . . 0.0 110.91 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 189' ' ' HIS . . . . . 0.624 ' CE1' ' SG ' ' A' ' 190' ' ' CYS . 2.3 p-80 -119.02 -29.11 5.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.843 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 190' ' ' CYS . . . . . 0.624 ' SG ' ' CE1' ' A' ' 189' ' ' HIS . 93.1 m -116.54 89.78 28.66 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.632 0.729 . . . . 0.0 110.853 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 191' ' ' PRO . . . . . 0.444 ' HD2' ' CD1' ' A' ' 222' ' ' TYR . 53.5 Cg_endo -69.8 132.65 23.73 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.67 2.246 . . . . 0.0 112.305 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 192' ' ' ILE . . . . . 0.641 HG23 ' O ' ' A' ' 216' ' ' LEU . 59.4 mt -82.9 145.17 8.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.105 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 193' ' ' THR . . . . . 0.567 HG21 ' OE1' ' A' ' 165' ' ' GLN . 98.0 m -63.68 102.14 0.42 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.138 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 88.38 -16.92 51.28 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.476 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.455 ' O ' ' N ' ' A' ' 198' ' ' GLY . . . 75.3 -129.18 10.34 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.502 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 3.9 pttm -41.23 -37.07 0.87 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.762 0.315 . . . . 0.0 110.912 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -70.87 -37.39 73.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.896 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 198' ' ' GLY . . . . . 0.536 ' HA2' HD12 ' A' ' 216' ' ' LEU . . . -83.06 36.21 2.73 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.534 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 72.1 mt -139.0 148.91 23.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.83 0.348 . . . . 0.0 111.111 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.537 HD21 HG22 ' A' ' 156' ' ' VAL . 23.5 tp -137.4 120.94 17.18 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.912 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -101.92 111.37 23.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.883 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.435 HG11 ' OD2' ' A' ' 212' ' ' ASP . 59.7 t -66.09 136.29 26.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.137 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -142.83 141.4 31.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.12 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 204' ' ' TYR . . . . . 0.453 ' N ' HG23 ' A' ' 210' ' ' THR . 21.0 m-85 -47.58 159.42 0.44 Allowed Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.718 0.77 . . . . 0.0 110.886 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 4.18 2.34 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.641 2.227 . . . . 0.0 112.324 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -111.8 -23.42 10.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.839 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 115.05 49.18 0.51 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.516 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 76.4 mtp180 -134.5 147.1 61.98 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.578 0.704 . . . . 0.0 110.886 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 209' ' ' PRO . . . . . 0.591 ' HG2' ' CD2' ' A' ' 175' ' ' PHE . 54.2 Cg_endo -69.72 99.62 0.76 Allowed 'Trans proline' 0 N--CA 1.465 -0.174 0 C-N-CA 122.682 2.255 . . . . 0.0 112.396 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 210' ' ' THR . . . . . 0.453 HG23 ' N ' ' A' ' 204' ' ' TYR . 65.8 p -60.4 -33.3 72.29 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.137 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 115.33 -30.2 6.87 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.486 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 212' ' ' ASP . . . . . 0.435 ' OD2' HG11 ' A' ' 202' ' ' VAL . 1.3 p-10 -85.65 163.34 18.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.797 0.332 . . . . 0.0 110.876 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 213' ' ' ALA . . . . . 0.827 ' HB3' ' CD1' ' A' ' 173' ' ' LEU . . . -166.69 159.25 13.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.082 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 214' ' ' PHE . . . . . 0.492 ' CD2' HG13 ' A' ' 249' ' ' VAL . 71.8 m-85 -124.62 162.78 23.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.903 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 215' ' ' VAL . . . . . 0.597 HG12 ' N ' ' A' ' 216' ' ' LEU . 43.3 t -140.34 163.95 22.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.091 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 0.641 ' O ' HG23 ' A' ' 192' ' ' ILE . 62.3 mt -115.2 145.38 42.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.902 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 217' ' ' PHE . . . . . 0.477 ' CE1' HG21 ' A' ' 168' ' ' VAL . 80.1 m-85 -141.89 131.58 24.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.869 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 218' ' ' ALA . . . . . 0.486 ' HA ' ' NE2' ' A' ' 165' ' ' GLN . . . -42.77 -54.14 4.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.116 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 219' ' ' CYS . . . . . . . . . . . . . 5.0 m -157.15 179.99 8.76 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.888 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 220' ' ' GLU . . . . . 0.44 ' HA ' ' HB3' ' A' ' 223' ' ' ALA . 0.7 OUTLIER -52.69 -39.48 61.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.915 -179.961 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 221' ' ' GLU . . . . . 0.422 ' C ' ' O ' ' A' ' 220' ' ' GLU . 29.7 tt0 -36.89 -49.51 0.81 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.897 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 222' ' ' TYR . . . . . 0.444 ' CD1' ' HD2' ' A' ' 191' ' ' PRO . 42.7 m-85 -87.84 -46.98 8.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.933 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 223' ' ' ALA . . . . . 0.526 ' O ' ' HB3' ' A' ' 226' ' ' ALA . . . -52.99 -62.53 1.59 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.077 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 56.1 mm-40 -47.45 -61.72 1.78 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.934 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 30.6 m-20 -45.44 -31.96 1.94 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.905 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 226' ' ' ALA . . . . . 0.526 ' HB3' ' O ' ' A' ' 223' ' ' ALA . . . -69.55 -38.05 77.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.089 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 29.0 mt -51.84 -29.34 19.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.934 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 8.9 mpt_? -61.39 -30.03 70.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.851 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 229' ' ' LYS . . . . . 0.589 ' HE3' ' CE2' ' A' ' 185' ' ' PHE . 20.1 mtpp -71.55 -0.83 11.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.868 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 230' ' ' HIS . . . . . 0.449 ' C ' ' O ' ' A' ' 229' ' ' LYS . 20.9 t60 -34.28 129.71 0.37 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.892 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.41 ' HG3' ' CE1' ' A' ' 230' ' ' HIS . 39.6 mtmt 62.63 39.67 11.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.879 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -67.09 -175.17 0.42 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.871 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.67 HD21 ' CE2' ' A' ' 238' ' ' TYR . 30.6 mt -135.9 109.8 8.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.927 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 234' ' ' LEU . . . . . 0.612 HD12 ' CD1' ' A' ' 185' ' ' PHE . 7.1 tt -117.85 117.71 30.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.913 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 54.71 38.69 64.72 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.459 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 38.4 mttp 68.86 50.54 0.62 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.767 0.318 . . . . 0.0 110.929 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 19.6 mmt180 -155.04 115.58 3.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.888 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 238' ' ' TYR . . . . . 0.67 ' CE2' HD21 ' A' ' 233' ' ' LEU . 95.7 m-85 -67.92 131.25 45.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.959 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 0.467 HD13 HD23 ' A' ' 173' ' ' LEU . 75.1 mt -129.76 133.83 64.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.119 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 240' ' ' GLU . . . . . 0.465 ' HB3' ' CZ ' ' A' ' 242' ' ' PHE . 7.4 mp0 -94.18 170.97 9.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.901 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 241' ' ' LEU . . . . . 0.524 ' O ' ' CG ' ' A' ' 242' ' ' PHE . 14.9 mt -150.78 153.38 35.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.931 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 242' ' ' PHE . . . . . 0.524 ' CG ' ' O ' ' A' ' 241' ' ' LEU . 3.7 m-85 -162.12 151.62 16.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.845 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 243' ' ' ARG . . . . . 0.474 ' CZ ' ' HB2' ' A' ' 243' ' ' ARG . 12.6 mtm105 -65.76 118.39 9.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.874 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 244' ' ' SER . . . . . 0.443 ' HB3' HG22 ' A' ' 167' ' ' ILE . 1.0 OUTLIER -111.19 160.42 16.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.889 -179.785 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 40.1 p -132.97 155.8 48.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.146 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 246' ' ' ALA . . . . . 0.503 ' N ' HD12 ' A' ' 167' ' ' ILE . . . -43.17 -53.15 5.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.114 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -56.8 -51.86 67.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.052 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -48.19 -54.73 12.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.939 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 0.531 HG21 HG21 ' A' ' 167' ' ' ILE . 59.9 t -48.81 -65.87 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.133 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 250' ' ' GLN . . . . . 0.905 ' HA ' HD12 ' A' ' 253' ' ' LEU . 86.8 mt-30 -38.41 -46.1 1.1 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.954 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -62.67 -51.88 65.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.858 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 73.4 t -54.92 -34.89 32.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.093 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 253' ' ' LEU . . . . . 0.905 HD12 ' HA ' ' A' ' 250' ' ' GLN . 14.9 mt -64.62 -49.56 70.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.91 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 254' ' ' ASN . . . . . 0.496 ' OD1' ' N ' ' A' ' 255' ' ' ARG . 0.6 OUTLIER -64.66 -41.55 96.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.911 179.888 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 255' ' ' ARG . . . . . 0.496 ' N ' ' OD1' ' A' ' 254' ' ' ASN . 25.9 ttt180 -47.67 -46.74 29.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.894 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -83.65 -41.94 17.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.879 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 1.9 t . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.845 -179.808 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.903 0.382 . . . . 0.0 110.867 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.595 HG22 HD21 ' A' ' 200' ' ' LEU . 75.3 t -83.24 -36.11 12.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.1 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -43.44 -53.32 5.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.1 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -59.9 -53.25 60.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.915 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 159' ' ' PHE . . . . . 0.504 ' CE1' ' HG ' ' A' ' 216' ' ' LEU . 83.3 t80 -46.12 -39.26 9.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.873 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 95.6 mt -87.9 -27.07 22.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.888 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 29.0 t -49.79 -24.79 2.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.813 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 162' ' ' LYS . . . . . 0.457 ' CB ' ' HG3' ' A' ' 165' ' ' GLN . 35.4 mmtt -70.3 117.57 12.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.853 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -91.4 153.95 19.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.918 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 17.6 m120 61.16 49.04 5.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.885 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.457 ' HG3' ' CB ' ' A' ' 162' ' ' LYS . 1.8 mm-40 -128.62 151.8 49.08 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.902 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 48.5 t -109.15 109.03 26.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.174 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 167' ' ' ILE . . . . . 0.581 HG21 ' CG2' ' A' ' 249' ' ' VAL . 45.4 mt -80.12 143.43 12.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.185 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 86.0 t -123.46 133.66 68.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.15 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 11.0 ttt85 -89.94 106.36 18.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.858 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 170' ' ' MET . . . . . 0.593 ' CE ' HD21 ' A' ' 173' ' ' LEU . 91.3 mtp -97.92 125.57 42.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.904 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 47.2 mtp180 -126.57 136.55 52.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.878 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 96.92 17.6 32.11 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.473 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.593 HD21 ' CE ' ' A' ' 170' ' ' MET . 20.7 mt -71.24 116.71 49.8 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.593 0.711 . . . . 0.0 110.912 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 174' ' ' PRO . . . . . 0.681 ' O ' ' HB3' ' A' ' 177' ' ' ALA . 64.9 Cg_exo -47.99 134.08 23.51 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.672 2.248 . . . . 0.0 112.361 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 175' ' ' PHE . . . . . 0.453 ' C ' ' O ' ' A' ' 174' ' ' PRO . 19.3 m-85 -34.55 -68.55 0.11 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.893 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -47.63 -40.06 18.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.144 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 177' ' ' ALA . . . . . 0.681 ' HB3' ' O ' ' A' ' 174' ' ' PRO . . . -38.19 128.07 1.33 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.12 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 178' ' ' THR . . . . . 0.405 ' C ' ' CZ ' ' A' ' 201' ' ' PHE . 1.7 p -141.67 179.85 6.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.179 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.522 ' O ' HG23 ' A' ' 183' ' ' VAL . . . -47.21 -46.58 24.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.084 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -53.4 -33.13 52.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.924 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 181' ' ' GLU . . . . . 0.476 ' CD ' HD21 ' A' ' 234' ' ' LEU . 5.5 mm-40 -76.26 -34.04 59.14 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.874 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.477 HG12 HD11 ' A' ' 192' ' ' ILE . 85.1 t -74.2 -51.79 22.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.142 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.522 HG23 ' O ' ' A' ' 179' ' ' ALA . 94.4 t -34.73 -50.55 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.135 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -78.41 -33.5 48.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.127 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.781 ' HD2' HD12 ' A' ' 234' ' ' LEU . 25.1 t80 -47.08 -61.19 2.0 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.863 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -89.9 -21.69 22.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.912 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -49.03 -21.25 2.36 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.451 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -53.24 -75.42 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.86 0.362 . . . . 0.0 110.916 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 11.1 m-70 -118.17 -5.45 10.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.824 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 82.4 m -126.54 87.5 56.27 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-O 121.61 0.719 . . . . 0.0 110.894 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 191' ' ' PRO . . . . . 0.561 ' HD2' ' CD1' ' A' ' 222' ' ' TYR . 52.8 Cg_endo -69.81 131.54 21.38 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.709 2.272 . . . . 0.0 112.279 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 192' ' ' ILE . . . . . 0.481 HG23 ' O ' ' A' ' 216' ' ' LEU . 51.3 mt -82.74 142.76 13.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.134 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 193' ' ' THR . . . . . 0.429 HG21 ' OE1' ' A' ' 165' ' ' GLN . 47.5 m -67.25 105.92 1.88 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.17 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 87.5 -19.84 30.23 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.493 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.465 ' O ' ' N ' ' A' ' 198' ' ' GLY . . . 78.04 -126.3 7.62 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.507 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 34.4 mtmt -42.9 -33.47 0.78 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.75 0.309 . . . . 0.0 110.873 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -74.27 -34.62 63.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.916 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 198' ' ' GLY . . . . . 0.57 ' HA2' HD12 ' A' ' 216' ' ' LEU . . . -82.98 36.65 2.7 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.495 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 77.5 mt -138.68 151.24 23.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.881 0.372 . . . . 0.0 111.104 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.595 HD21 HG22 ' A' ' 156' ' ' VAL . 13.4 tp -147.98 111.05 4.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.894 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 201' ' ' PHE . . . . . 0.405 ' CZ ' ' C ' ' A' ' 178' ' ' THR . 53.4 m-85 -93.16 127.65 38.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.902 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 62.0 t -79.73 115.97 23.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.154 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 203' ' ' THR . . . . . 0.576 ' HA ' HG23 ' A' ' 210' ' ' THR . 0.7 OUTLIER -125.19 137.55 54.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.105 -179.914 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 204' ' ' TYR . . . . . 0.636 ' CD1' HG22 ' A' ' 210' ' ' THR . 29.1 m-85 -41.81 159.23 0.19 Allowed Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.694 0.759 . . . . 0.0 110.897 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 2.88 3.14 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.67 2.247 . . . . 0.0 112.379 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -113.43 -18.67 11.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.87 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 110.87 61.51 0.49 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.465 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 37.6 mmt-85 -145.97 145.97 26.82 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.608 0.718 . . . . 0.0 110.886 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 104.02 1.25 Allowed 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.683 2.255 . . . . 0.0 112.38 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 210' ' ' THR . . . . . 0.636 HG22 ' CD1' ' A' ' 204' ' ' TYR . 21.0 p -68.42 -31.0 70.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.135 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 114.5 -34.36 4.94 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.504 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -87.61 154.12 20.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.814 0.34 . . . . 0.0 110.872 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 213' ' ' ALA . . . . . 0.55 ' HB3' ' CD1' ' A' ' 173' ' ' LEU . . . -154.27 175.88 12.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.109 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 214' ' ' PHE . . . . . 0.663 ' CE2' HG13 ' A' ' 249' ' ' VAL . 60.7 m-85 -138.16 158.32 44.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.876 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 6.6 t -140.64 157.15 23.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.092 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 0.57 HD12 ' HA2' ' A' ' 198' ' ' GLY . 44.7 mt -108.33 141.14 40.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.93 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -135.36 132.5 37.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.904 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -42.65 -66.45 0.36 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.046 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 219' ' ' CYS . . . . . . . . . . . . . 1.9 m -135.01 176.57 8.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.932 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -65.45 -7.37 13.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.855 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -67.85 -37.79 82.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.897 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 222' ' ' TYR . . . . . 0.561 ' CD1' ' HD2' ' A' ' 191' ' ' PRO . 46.5 m-85 -86.52 -39.22 16.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.964 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 223' ' ' ALA . . . . . 0.434 ' O ' ' HB3' ' A' ' 226' ' ' ALA . . . -59.46 -60.8 3.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.097 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 224' ' ' GLN . . . . . 0.403 ' HA ' HD12 ' A' ' 227' ' ' LEU . 83.4 mt-30 -45.2 -53.98 7.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.934 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 71.1 m-20 -58.69 -25.73 63.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.874 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 226' ' ' ALA . . . . . 0.434 ' HB3' ' O ' ' A' ' 223' ' ' ALA . . . -75.93 -23.75 55.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.052 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 227' ' ' LEU . . . . . 0.403 HD12 ' HA ' ' A' ' 224' ' ' GLN . 37.0 mt -68.24 -33.14 73.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.911 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 38.9 mtp180 -60.14 -14.99 19.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.9 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 229' ' ' LYS . . . . . 0.446 ' O ' ' C ' ' A' ' 230' ' ' HIS . 21.8 mtpp -80.56 -3.42 50.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.854 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 230' ' ' HIS . . . . . 0.491 ' CD2' ' HG2' ' A' ' 231' ' ' LYS . 72.2 t60 -34.16 146.34 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.871 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.491 ' HG2' ' CD2' ' A' ' 230' ' ' HIS . 3.9 mmpt? 53.04 26.84 5.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.892 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -56.47 -177.33 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.86 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.633 HD21 ' CE2' ' A' ' 238' ' ' TYR . 30.8 mt -139.96 105.12 5.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.936 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 234' ' ' LEU . . . . . 0.781 HD12 ' HD2' ' A' ' 185' ' ' PHE . 6.8 tt -115.53 112.53 22.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.956 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 62.17 34.35 88.83 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.467 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 4.3 mmmm 71.05 52.12 0.27 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.744 0.307 . . . . 0.0 110.893 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 21.2 mmt180 -155.02 115.6 3.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.852 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 238' ' ' TYR . . . . . 0.633 ' CE2' HD21 ' A' ' 233' ' ' LEU . 92.1 m-85 -70.63 117.18 11.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.916 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 0.531 HG22 ' N ' ' A' ' 240' ' ' GLU . 57.6 mt -111.73 159.83 11.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.142 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 240' ' ' GLU . . . . . 0.531 ' N ' HG22 ' A' ' 239' ' ' ILE . 13.7 mt-10 -114.23 167.58 10.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.867 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 241' ' ' LEU . . . . . 0.546 ' O ' ' CD1' ' A' ' 242' ' ' PHE . 54.0 mt -146.05 143.73 29.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.919 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 242' ' ' PHE . . . . . 0.546 ' CD1' ' O ' ' A' ' 241' ' ' LEU . 9.4 m-85 -159.3 137.13 10.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.865 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 63.0 mtp85 -53.67 141.46 26.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.859 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 8.8 t -138.18 157.41 46.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.85 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 71.7 p -129.3 157.77 40.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.164 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 246' ' ' ALA . . . . . 0.561 ' N ' HD12 ' A' ' 167' ' ' ILE . . . -38.17 -55.78 1.26 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.131 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -54.07 -55.56 26.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.101 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 32.5 tp10 -42.18 -51.49 4.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.929 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 0.663 HG13 ' CE2' ' A' ' 214' ' ' PHE . 85.9 t -54.69 -63.76 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.172 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 250' ' ' GLN . . . . . 0.788 ' HA ' HD12 ' A' ' 253' ' ' LEU . 32.4 mt-30 -43.01 -33.02 0.73 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.934 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -73.14 -50.54 22.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.914 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 96.9 t -56.9 -37.07 52.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.111 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 253' ' ' LEU . . . . . 0.788 HD12 ' HA ' ' A' ' 250' ' ' GLN . 16.0 mt -60.75 -50.93 71.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.881 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 254' ' ' ASN . . . . . 0.463 ' C ' ' OD1' ' A' ' 254' ' ' ASN . 0.6 OUTLIER -60.7 -40.47 92.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.882 179.973 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 255' ' ' ARG . . . . . 0.46 ' N ' ' OD1' ' A' ' 254' ' ' ASN . 21.4 ttt85 -42.92 -55.43 3.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.883 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 256' ' ' PHE . . . . . 0.547 ' CE2' ' HB ' ' A' ' 210' ' ' THR . 67.4 m-85 -74.79 -47.24 31.9 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.896 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 68.7 m . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.897 -179.802 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.858 0.361 . . . . 0.0 110.859 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.651 HG22 HD21 ' A' ' 200' ' ' LEU . 72.3 t -60.92 -43.22 95.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.12 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.402 ' C ' ' O ' ' A' ' 156' ' ' VAL . . . -37.46 -61.03 0.63 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.127 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -57.66 -48.62 78.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.907 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 159' ' ' PHE . . . . . 0.497 ' CE1' ' HG ' ' A' ' 216' ' ' LEU . 66.2 t80 -47.68 -38.44 15.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.872 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 85.3 mt -90.57 -27.36 19.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.959 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 30.2 t -50.7 -36.51 36.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.854 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 39.7 mmtt -54.4 124.89 17.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.89 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -99.0 151.74 20.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.881 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 62.35 39.21 12.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.886 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -124.65 147.27 48.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.888 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 48.9 t -100.25 131.68 47.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.116 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 167' ' ' ILE . . . . . 0.773 HD12 ' N ' ' A' ' 246' ' ' ALA . 33.6 mt -101.17 143.8 13.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.176 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 96.8 t -128.26 136.6 59.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.121 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 169' ' ' ARG . . . . . 0.485 ' N ' ' HB2' ' A' ' 244' ' ' SER . 20.8 ttt85 -90.72 111.92 23.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.891 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 170' ' ' MET . . . . . 0.708 ' CE ' HD21 ' A' ' 173' ' ' LEU . 83.2 mtp -98.42 117.08 32.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.857 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 5.7 ttt-85 -120.99 140.66 51.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.833 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 89.91 23.43 32.83 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.512 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.708 HD21 ' CE ' ' A' ' 170' ' ' MET . 22.9 mt -79.18 129.62 72.01 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.564 0.697 . . . . 0.0 110.917 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 174' ' ' PRO . . . . . 0.467 ' HG3' ' CB ' ' A' ' 237' ' ' ARG . 65.1 Cg_exo -47.94 154.75 2.0 Allowed 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.661 2.241 . . . . 0.0 112.345 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -60.09 -50.17 74.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.833 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 176' ' ' THR . . . . . 0.457 ' O ' ' C ' ' A' ' 177' ' ' ALA . 0.0 OUTLIER -68.77 -39.07 80.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.135 -179.877 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 177' ' ' ALA . . . . . 0.691 ' HB1' ' HG2' ' A' ' 181' ' ' GLU . . . -33.53 124.25 0.42 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.072 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 178' ' ' THR . . . . . 0.432 ' O ' ' C ' ' A' ' 179' ' ' ALA . 1.4 p -135.7 176.62 8.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.146 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.501 ' N ' ' CZ ' ' A' ' 201' ' ' PHE . . . -35.14 -44.98 0.27 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.121 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -56.66 -49.33 75.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.926 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 181' ' ' GLU . . . . . 0.691 ' HG2' ' HB1' ' A' ' 177' ' ' ALA . 0.0 OUTLIER -55.07 -33.48 62.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.869 -179.93 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.655 HG12 ' CD1' ' A' ' 192' ' ' ILE . 93.7 t -79.29 -60.03 2.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.156 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 179' ' ' ALA . 73.4 t -34.34 -39.89 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.134 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -85.77 -39.31 17.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.049 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.575 ' HD1' HD12 ' A' ' 234' ' ' LEU . 63.1 t80 -46.06 -59.58 2.78 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.825 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 186' ' ' PHE . . . . . 0.403 ' CE1' ' HE2' ' A' ' 185' ' ' PHE . 77.2 m-85 -91.79 -22.1 20.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.854 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -50.36 -18.25 2.24 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.511 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -58.49 -70.3 0.15 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.843 0.354 . . . . 0.0 110.882 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -118.15 -15.58 9.82 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.858 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 190' ' ' CYS . . . . . 0.409 ' SG ' ' CB ' ' A' ' 225' ' ' ASN . 70.8 m -120.26 86.69 38.66 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.65 0.738 . . . . 0.0 110.888 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 130.37 19.22 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.663 2.242 . . . . 0.0 112.361 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 192' ' ' ILE . . . . . 0.655 ' CD1' HG12 ' A' ' 182' ' ' VAL . 50.3 mt -82.14 146.2 7.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.161 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 85.6 m -66.89 105.78 1.71 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.148 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 87.41 -20.14 28.27 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.453 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.401 ' O ' ' N ' ' A' ' 198' ' ' GLY . . . 78.84 -126.66 7.63 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.446 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 16.6 ptmt -45.29 -34.43 2.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.746 0.308 . . . . 0.0 110.874 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -73.72 -32.8 64.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.867 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 198' ' ' GLY . . . . . 0.433 ' HA2' HD12 ' A' ' 216' ' ' LEU . . . -86.69 37.6 3.16 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.5 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.466 HD13 ' HB ' ' A' ' 182' ' ' VAL . 48.0 mt -141.83 146.31 23.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.865 0.364 . . . . 0.0 111.164 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.651 HD21 HG22 ' A' ' 156' ' ' VAL . 19.5 tp -134.4 118.14 17.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.91 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 201' ' ' PHE . . . . . 0.501 ' CZ ' ' N ' ' A' ' 179' ' ' ALA . 62.8 m-85 -99.53 114.51 27.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.91 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 22.7 t -70.06 114.23 7.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.179 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 203' ' ' THR . . . . . 0.511 ' HA ' HG23 ' A' ' 210' ' ' THR . 0.7 OUTLIER -124.86 137.21 54.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.12 -179.922 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -43.49 158.22 0.25 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.705 0.764 . . . . 0.0 110.882 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 3.01 3.01 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.683 2.256 . . . . 0.0 112.355 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -112.08 -21.05 11.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.829 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 112.5 57.53 0.44 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.462 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 33.2 mmt-85 -141.89 144.61 33.12 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.598 0.713 . . . . 0.0 110.896 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.7 105.67 1.52 Allowed 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.635 2.224 . . . . 0.0 112.381 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 210' ' ' THR . . . . . 0.565 ' HB ' ' CE1' ' A' ' 256' ' ' PHE . 27.2 p -69.07 -32.31 71.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.158 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 114.0 -34.1 5.13 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.442 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -84.68 162.76 19.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.815 0.341 . . . . 0.0 110.862 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -162.89 175.51 11.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.065 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 214' ' ' PHE . . . . . 0.659 ' CE2' HG13 ' A' ' 249' ' ' VAL . 80.8 m-85 -140.76 136.65 32.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.885 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 215' ' ' VAL . . . . . 0.432 HG12 ' N ' ' A' ' 216' ' ' LEU . 5.4 t -115.92 159.33 15.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.096 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 0.53 ' O ' HG23 ' A' ' 192' ' ' ILE . 29.3 mt -112.37 145.25 40.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.927 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -140.12 137.0 34.13 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.9 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 218' ' ' ALA . . . . . 0.641 ' HB3' ' CE2' ' A' ' 222' ' ' TYR . . . -48.48 -50.06 33.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.123 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 219' ' ' CYS . . . . . . . . . . . . . 2.0 t -154.2 177.48 11.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.913 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -57.84 -23.89 54.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.893 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -50.75 -54.66 21.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.879 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 222' ' ' TYR . . . . . 0.641 ' CE2' ' HB3' ' A' ' 218' ' ' ALA . 61.3 m-85 -71.84 -48.63 44.8 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.936 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 223' ' ' ALA . . . . . 0.456 ' O ' ' HB3' ' A' ' 226' ' ' ALA . . . -47.36 -52.03 17.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.074 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -51.75 -62.75 1.44 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.908 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 225' ' ' ASN . . . . . 0.409 ' CB ' ' SG ' ' A' ' 190' ' ' CYS . 38.2 m-20 -48.42 -23.7 1.03 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.898 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 226' ' ' ALA . . . . . 0.456 ' HB3' ' O ' ' A' ' 223' ' ' ALA . . . -81.31 -40.3 23.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.098 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 95.9 mt -52.28 -39.0 59.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.899 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 37.2 mtt-85 -55.62 -27.85 51.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.861 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 229' ' ' LYS . . . . . 0.454 ' O ' ' C ' ' A' ' 230' ' ' HIS . 20.7 mtpp -70.62 -2.77 15.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.898 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 230' ' ' HIS . . . . . 0.559 ' CE1' ' HG3' ' A' ' 231' ' ' LYS . 15.7 t60 -33.91 129.19 0.34 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.87 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.559 ' HG3' ' CE1' ' A' ' 230' ' ' HIS . 30.9 mttt 63.07 39.62 9.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.896 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -67.38 -175.1 0.45 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.849 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.638 HD21 ' CE2' ' A' ' 238' ' ' TYR . 29.6 mt -138.08 110.1 7.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.951 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 234' ' ' LEU . . . . . 0.575 HD12 ' HD1' ' A' ' 185' ' ' PHE . 8.0 tt -121.65 113.94 20.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.894 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 59.13 40.98 96.37 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.456 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 236' ' ' LYS . . . . . 0.436 ' HA ' ' NZ ' ' A' ' 236' ' ' LYS . 0.0 OUTLIER 65.36 52.4 1.43 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.762 0.315 . . . . 0.0 110.907 -179.967 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 237' ' ' ARG . . . . . 0.467 ' CB ' ' HG3' ' A' ' 174' ' ' PRO . 21.2 mmt180 -156.29 115.13 3.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.815 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 238' ' ' TYR . . . . . 0.638 ' CE2' HD21 ' A' ' 233' ' ' LEU . 93.7 m-85 -69.75 127.3 32.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.91 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 0.498 HD13 HD23 ' A' ' 173' ' ' LEU . 62.1 mt -122.22 134.26 66.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.09 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 240' ' ' GLU . . . . . 0.58 ' HB3' ' CZ ' ' A' ' 242' ' ' PHE . 6.5 mp0 -103.1 149.39 24.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.898 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 241' ' ' LEU . . . . . 0.517 ' O ' ' CD1' ' A' ' 242' ' ' PHE . 14.3 mt -124.62 149.56 46.95 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.964 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 242' ' ' PHE . . . . . 0.58 ' CZ ' ' HB3' ' A' ' 240' ' ' GLU . 13.6 m-85 -156.84 132.38 9.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.841 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 57.5 mtm180 -48.09 133.04 15.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.901 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 244' ' ' SER . . . . . 0.485 ' HB2' ' N ' ' A' ' 169' ' ' ARG . 3.4 t -130.48 157.59 42.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.825 -179.744 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 245' ' ' THR . . . . . 0.424 ' O ' ' C ' ' A' ' 246' ' ' ALA . 82.1 p -133.45 150.05 51.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.161 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 246' ' ' ALA . . . . . 0.773 ' N ' HD12 ' A' ' 167' ' ' ILE . . . -35.67 -51.94 0.67 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.096 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -59.41 -50.97 71.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.096 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 18.1 tp10 -47.31 -50.28 22.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.903 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 0.659 HG13 ' CE2' ' A' ' 214' ' ' PHE . 98.5 t -53.48 -64.58 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.148 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 250' ' ' GLN . . . . . 0.749 ' HA ' HD12 ' A' ' 253' ' ' LEU . 68.4 mt-30 -43.22 -34.96 1.26 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.934 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -74.34 -33.31 63.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.879 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 252' ' ' VAL . . . . . 0.471 ' HA ' ' NE ' ' A' ' 255' ' ' ARG . 79.1 t -79.67 -19.06 12.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.133 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 253' ' ' LEU . . . . . 0.749 HD12 ' HA ' ' A' ' 250' ' ' GLN . 17.0 mt -80.81 -46.39 15.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.879 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 254' ' ' ASN . . . . . 0.474 ' CG ' ' N ' ' A' ' 255' ' ' ARG . 0.2 OUTLIER -58.16 -50.06 74.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.857 179.924 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 255' ' ' ARG . . . . . 0.474 ' N ' ' CG ' ' A' ' 254' ' ' ASN . 17.3 ptp180 -49.31 -47.18 47.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.856 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 256' ' ' PHE . . . . . 0.565 ' CE1' ' HB ' ' A' ' 210' ' ' THR . 10.3 m-85 -73.8 -37.45 64.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.855 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 1.4 t . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.822 -179.759 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 . . . . . 0 C--O 1.23 0.065 0 CA-C-O 120.935 0.397 . . . . 0.0 110.907 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.441 ' O ' ' C ' ' A' ' 157' ' ' ALA . 75.5 t -77.29 -50.42 20.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.117 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.441 ' C ' ' O ' ' A' ' 156' ' ' VAL . . . -34.75 -57.32 0.53 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.101 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 76.1 mm-40 -62.13 -45.87 91.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.889 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 159' ' ' PHE . . . . . 0.431 ' CE2' ' HG ' ' A' ' 216' ' ' LEU . 20.1 t80 -52.89 -42.4 65.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.883 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 56.3 mt -82.06 -29.27 31.96 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.916 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 22.9 t -48.28 -43.33 32.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.902 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 162' ' ' LYS . . . . . 0.706 ' HG3' HD13 ' A' ' 216' ' ' LEU . 0.2 OUTLIER -38.6 130.26 1.38 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.942 179.897 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -106.61 145.54 31.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.883 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 164' ' ' ASN . . . . . 0.448 ' O ' ' NE2' ' A' ' 165' ' ' GLN . 49.1 m-80 63.28 37.71 10.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.891 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.448 ' NE2' ' O ' ' A' ' 164' ' ' ASN . 2.2 mp0 -122.54 153.81 38.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.904 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 83.9 t -108.36 137.56 39.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.135 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 167' ' ' ILE . . . . . 0.475 HD12 ' N ' ' A' ' 246' ' ' ALA . 28.6 mt -104.84 139.23 26.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.07 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 82.6 t -120.49 133.35 67.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.154 179.787 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 39.3 ttp180 -88.51 104.72 17.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.839 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 170' ' ' MET . . . . . 0.855 ' CE ' HD21 ' A' ' 173' ' ' LEU . 83.3 mtp -97.39 131.57 43.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.884 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 2.1 ttt85 -135.65 140.48 44.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.852 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 93.23 16.59 46.42 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.504 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.855 HD21 ' CE ' ' A' ' 170' ' ' MET . 25.5 mt -72.09 128.95 88.47 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.606 0.717 . . . . 0.0 110.925 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 174' ' ' PRO . . . . . 0.464 ' HG3' ' CB ' ' A' ' 237' ' ' ARG . 64.3 Cg_exo -47.91 144.61 11.44 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.682 2.255 . . . . 0.0 112.357 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 175' ' ' PHE . . . . . 0.558 ' CD1' ' HG3' ' A' ' 209' ' ' PRO . 6.7 t80 -49.35 -41.69 39.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.88 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 176' ' ' THR . . . . . 0.45 ' O ' ' C ' ' A' ' 177' ' ' ALA . 7.6 p -76.25 -45.41 32.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.158 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 177' ' ' ALA . . . . . 0.45 ' C ' ' O ' ' A' ' 176' ' ' THR . . . -33.41 104.55 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.117 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -111.66 177.7 4.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.118 -179.878 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.447 ' N ' ' CE1' ' A' ' 201' ' ' PHE . . . -45.42 -51.08 11.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.14 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -50.22 -38.87 42.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.916 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 181' ' ' GLU . . . . . 0.735 ' HG3' HD11 ' A' ' 234' ' ' LEU . 2.6 tp10 -64.65 -41.85 95.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.898 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.481 ' O ' ' N ' ' A' ' 185' ' ' PHE . 94.5 t -64.96 -54.22 32.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.133 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.453 ' C ' ' O ' ' A' ' 182' ' ' VAL . 43.2 t -33.86 -55.72 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.112 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -70.72 -34.33 71.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.095 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.532 ' CE2' ' HD3' ' A' ' 229' ' ' LYS . 63.6 t80 -51.13 -61.11 2.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.904 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -89.58 -20.4 23.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.913 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -49.16 -18.5 1.29 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.474 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 38.4 mm-40 -55.9 -75.17 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.796 0.332 . . . . 0.0 110.921 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -118.34 -3.78 10.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.845 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 71.4 m -128.7 87.09 55.82 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.579 0.704 . . . . 0.0 110.851 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 191' ' ' PRO . . . . . 0.577 ' HD2' ' CD1' ' A' ' 222' ' ' TYR . 54.1 Cg_endo -69.74 143.3 50.5 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.719 2.279 . . . . 0.0 112.38 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 192' ' ' ILE . . . . . 0.591 HG23 ' O ' ' A' ' 216' ' ' LEU . 63.1 mt -97.71 143.07 13.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.102 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 88.6 m -66.72 101.41 0.8 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.134 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 89.64 -15.8 58.02 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.428 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 73.01 -118.21 6.28 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.483 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 39.4 mtmt -51.16 -32.71 24.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.73 0.3 . . . . 0.0 110.864 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -75.22 -22.54 57.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.904 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 198' ' ' GLY . . . . . 0.67 ' HA2' HD12 ' A' ' 216' ' ' LEU . . . -99.25 35.25 4.82 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.442 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 60.5 mt -137.45 139.22 43.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.88 0.371 . . . . 0.0 111.132 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 12.9 tp -133.44 123.08 24.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.946 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 201' ' ' PHE . . . . . 0.447 ' CE1' ' N ' ' A' ' 179' ' ' ALA . 75.8 m-85 -104.26 124.77 49.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.854 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 55.6 t -79.9 136.31 23.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.082 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 203' ' ' THR . . . . . 0.429 ' HA ' HG23 ' A' ' 210' ' ' THR . 0.8 OUTLIER -143.21 136.59 28.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.138 179.99 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 204' ' ' TYR . . . . . 0.59 ' CD1' ' HB3' ' A' ' 208' ' ' ARG . 16.7 m-85 -40.31 160.65 0.12 Allowed Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.68 0.752 . . . . 0.0 110.901 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.74 3.22 2.89 Favored 'Trans proline' 0 N--CA 1.465 -0.176 0 C-N-CA 122.724 2.283 . . . . 0.0 112.32 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -117.31 -28.45 6.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.878 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 127.69 42.93 0.25 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.485 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 208' ' ' ARG . . . . . 0.59 ' HB3' ' CD1' ' A' ' 204' ' ' TYR . 10.8 ttm180 -117.3 142.01 29.53 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.639 0.733 . . . . 0.0 110.876 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 209' ' ' PRO . . . . . 0.558 ' HG3' ' CD1' ' A' ' 175' ' ' PHE . 54.0 Cg_endo -69.74 93.27 0.52 Allowed 'Trans proline' 0 C--O 1.232 0.22 0 C-N-CA 122.734 2.29 . . . . 0.0 112.342 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 210' ' ' THR . . . . . 0.572 ' HB ' ' CE2' ' A' ' 256' ' ' PHE . 69.6 p -60.12 -9.45 3.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.097 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 81.36 -42.42 2.76 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.48 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -69.1 165.32 20.55 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.8 0.333 . . . . 0.0 110.892 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -165.34 -177.82 4.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.088 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 214' ' ' PHE . . . . . 0.562 ' CE2' HG13 ' A' ' 249' ' ' VAL . 51.2 m-85 -145.97 138.68 25.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.9 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 215' ' ' VAL . . . . . 0.411 HG12 ' N ' ' A' ' 216' ' ' LEU . 10.0 t -121.63 156.71 25.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.168 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 0.706 HD13 ' HG3' ' A' ' 162' ' ' LYS . 49.5 mt -110.85 138.58 47.07 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.936 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -129.91 137.15 50.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.879 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -49.81 -46.66 51.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.084 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 219' ' ' CYS . . . . . . . . . . . . . 10.2 m -154.14 171.57 18.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.893 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 220' ' ' GLU . . . . . 0.41 ' O ' ' C ' ' A' ' 221' ' ' GLU . 6.8 tp10 -57.6 -40.75 79.77 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.873 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 221' ' ' GLU . . . . . 0.41 ' C ' ' O ' ' A' ' 220' ' ' GLU . 26.6 tt0 -36.79 -49.54 0.79 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.885 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 222' ' ' TYR . . . . . 0.577 ' CD1' ' HD2' ' A' ' 191' ' ' PRO . 20.9 m-85 -74.54 -50.07 19.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.892 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 223' ' ' ALA . . . . . 0.518 ' O ' ' HB3' ' A' ' 226' ' ' ALA . . . -44.82 -54.52 6.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.117 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -48.41 -62.42 1.5 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.954 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 41.3 m-20 -49.54 -28.96 6.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.871 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 226' ' ' ALA . . . . . 0.518 ' HB3' ' O ' ' A' ' 223' ' ' ALA . . . -70.42 -43.21 70.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.038 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 29.0 mt -54.35 -30.28 51.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.934 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 60.8 mtp85 -58.65 -22.22 56.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.841 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 229' ' ' LYS . . . . . 0.532 ' HD3' ' CE2' ' A' ' 185' ' ' PHE . 16.7 mttm -78.93 -1.71 36.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.9 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 230' ' ' HIS . . . . . 0.546 ' CE1' ' HD3' ' A' ' 231' ' ' LYS . 21.6 t60 -33.86 127.0 0.41 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.886 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.546 ' HD3' ' CE1' ' A' ' 230' ' ' HIS . 0.3 OUTLIER 68.75 32.56 4.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.877 179.978 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -61.91 178.69 0.33 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.881 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.621 HD21 ' CD1' ' A' ' 238' ' ' TYR . 31.1 mt -135.18 109.74 8.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.943 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 234' ' ' LEU . . . . . 0.735 HD11 ' HG3' ' A' ' 181' ' ' GLU . 6.5 tt -117.68 114.15 22.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.905 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 58.4 37.59 88.25 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.482 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 9.6 mmpt? 70.56 52.73 0.32 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.78 0.324 . . . . 0.0 110.889 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 237' ' ' ARG . . . . . 0.464 ' CB ' ' HG3' ' A' ' 174' ' ' PRO . 50.4 mmt-85 -155.47 116.06 3.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.85 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 238' ' ' TYR . . . . . 0.621 ' CD1' HD21 ' A' ' 233' ' ' LEU . 89.6 m-85 -68.61 125.39 26.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.904 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 0.776 HD13 HD23 ' A' ' 173' ' ' LEU . 64.1 mt -120.94 134.53 64.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.116 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 240' ' ' GLU . . . . . 0.496 ' HB3' ' CZ ' ' A' ' 242' ' ' PHE . 38.8 mp0 -96.24 170.21 9.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.85 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 75.1 mt -145.71 139.96 26.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.946 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 242' ' ' PHE . . . . . 0.496 ' CZ ' ' HB3' ' A' ' 240' ' ' GLU . 8.6 m-85 -152.14 130.87 12.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.877 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 57.4 mtm180 -52.25 136.17 31.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.846 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 1.1 t -136.9 166.37 23.79 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.869 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 245' ' ' THR . . . . . 0.444 ' O ' HG23 ' A' ' 249' ' ' VAL . 74.1 p -135.91 165.05 26.54 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.142 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 246' ' ' ALA . . . . . 0.475 ' N ' HD12 ' A' ' 167' ' ' ILE . . . -49.02 -53.55 19.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.076 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -55.6 -50.89 68.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.09 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -50.06 -50.98 46.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.931 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 0.562 HG13 ' CE2' ' A' ' 214' ' ' PHE . 92.2 t -47.36 -61.97 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.101 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 250' ' ' GLN . . . . . 0.549 ' HA ' HD12 ' A' ' 253' ' ' LEU . 34.4 mt-30 -48.19 -33.03 7.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.902 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 251' ' ' GLN . . . . . 0.427 ' HA ' ' ND2' ' A' ' 254' ' ' ASN . 53.0 mt-30 -76.82 -25.94 53.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.92 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 95.0 t -82.25 -21.71 9.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.135 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 253' ' ' LEU . . . . . 0.549 HD12 ' HA ' ' A' ' 250' ' ' GLN . 10.7 mt -84.19 -43.54 14.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.905 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 254' ' ' ASN . . . . . 0.494 ' OD1' ' N ' ' A' ' 255' ' ' ARG . 0.5 OUTLIER -65.11 -42.08 94.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.846 179.973 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 255' ' ' ARG . . . . . 0.494 ' N ' ' OD1' ' A' ' 254' ' ' ASN . 1.8 ptm85 -58.38 -41.86 85.76 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.855 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 256' ' ' PHE . . . . . 0.572 ' CE2' ' HB ' ' A' ' 210' ' ' THR . 11.7 m-85 -75.65 -46.0 33.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.921 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 66.5 m . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.835 -179.81 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.856 0.36 . . . . 0.0 110.905 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.445 HG22 HD21 ' A' ' 200' ' ' LEU . 26.7 t -68.55 -41.46 83.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.077 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.439 ' C ' ' O ' ' A' ' 156' ' ' VAL . . . -33.73 -69.94 0.08 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.108 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 158' ' ' GLN . . . . . 0.498 ' O ' ' N ' ' A' ' 161' ' ' SER . 3.8 pt20 -48.82 -60.17 2.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.947 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 21.4 t80 -39.4 -40.67 0.84 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.921 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 98.6 mt -89.07 -22.92 22.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.934 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 161' ' ' SER . . . . . 0.498 ' N ' ' O ' ' A' ' 158' ' ' GLN . 7.7 t -59.95 -20.93 60.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.853 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 162' ' ' LYS . . . . . 0.476 ' HG3' HD13 ' A' ' 216' ' ' LEU . 25.3 mmmt -69.83 118.27 12.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.926 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 50.3 mm-40 -96.98 158.02 15.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.916 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 62.43 42.18 9.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.868 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 36.1 mm-40 -126.7 172.6 10.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.911 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.462 HG11 ' CB ' ' A' ' 223' ' ' ALA . 86.6 t -128.54 106.45 14.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.11 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 167' ' ' ILE . . . . . 0.548 HD12 ' N ' ' A' ' 246' ' ' ALA . 70.0 mt -77.67 141.63 15.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.169 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 43.7 t -122.77 133.94 67.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.103 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 169' ' ' ARG . . . . . 0.449 ' N ' ' HB2' ' A' ' 244' ' ' SER . 29.6 ttp180 -91.43 101.44 14.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.876 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 170' ' ' MET . . . . . 0.547 ' CE ' HD21 ' A' ' 173' ' ' LEU . 99.3 mtp -94.9 127.25 40.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.895 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 13.5 ttm180 -126.07 141.49 51.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.884 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 89.91 24.92 28.56 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.501 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.929 HD23 HD13 ' A' ' 239' ' ' ILE . 19.9 mt -78.45 123.29 85.7 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.638 0.732 . . . . 0.0 110.907 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_exo -48.0 141.77 16.63 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.67 2.246 . . . . 0.0 112.341 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 175' ' ' PHE . . . . . 0.558 ' CD1' ' HG3' ' A' ' 209' ' ' PRO . 9.1 t80 -53.97 -26.18 24.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.892 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 7.2 p -89.69 -14.3 35.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.095 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -65.15 110.16 2.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.125 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 178' ' ' THR . . . . . 0.437 ' O ' ' N ' ' A' ' 181' ' ' GLU . 0.8 OUTLIER -118.96 167.16 12.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.134 -179.925 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 178' ' ' THR . . . -35.42 -42.43 0.21 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.122 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -57.07 -47.69 80.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.89 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 181' ' ' GLU . . . . . 0.437 ' N ' ' O ' ' A' ' 178' ' ' THR . 3.9 mp0 -61.0 -37.49 82.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.879 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.477 HG12 HD11 ' A' ' 192' ' ' ILE . 76.1 t -69.85 -54.23 20.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.119 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.448 ' C ' ' O ' ' A' ' 182' ' ' VAL . 28.1 t -33.78 -50.66 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.125 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -73.54 -44.22 58.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.086 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -39.13 -61.31 0.78 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.903 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -92.27 -21.42 20.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.873 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -49.11 -18.9 1.35 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.495 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -56.25 -75.21 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.803 0.335 . . . . 0.0 110.923 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -118.25 -7.57 10.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.851 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 79.4 m -124.41 86.4 55.0 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.557 0.694 . . . . 0.0 110.876 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 191' ' ' PRO . . . . . 0.571 ' HD2' ' CD1' ' A' ' 222' ' ' TYR . 53.5 Cg_endo -69.78 140.32 42.3 Favored 'Trans proline' 0 C--O 1.231 0.148 0 C-N-CA 122.715 2.276 . . . . 0.0 112.308 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 192' ' ' ILE . . . . . 0.591 HG23 ' O ' ' A' ' 216' ' ' LEU . 57.2 mt -91.5 144.29 9.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.149 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 35.9 m -73.24 105.72 4.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.139 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 91.33 -17.78 54.53 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.478 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 72.09 -121.09 8.22 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.472 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 24.0 mtmm -49.74 -28.46 6.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.731 0.301 . . . . 0.0 110.87 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -77.74 -27.66 50.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.886 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 198' ' ' GLY . . . . . 0.449 ' HA2' HD12 ' A' ' 216' ' ' LEU . . . -93.62 40.4 2.79 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.524 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 56.9 mt -144.04 149.77 17.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.885 0.374 . . . . 0.0 111.087 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.445 HD21 HG22 ' A' ' 156' ' ' VAL . 14.1 tp -148.46 119.63 7.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.897 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -98.71 117.62 33.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.89 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 42.7 t -73.49 133.63 31.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.124 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 203' ' ' THR . . . . . 0.539 ' HA ' HG23 ' A' ' 210' ' ' THR . 0.8 OUTLIER -138.39 137.9 37.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.159 -179.971 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 204' ' ' TYR . . . . . 0.502 ' CD2' HG22 ' A' ' 210' ' ' THR . 35.1 m-85 -47.24 158.63 0.45 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.663 0.744 . . . . 0.0 110.916 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 3.14 2.98 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.651 2.234 . . . . 0.0 112.343 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -110.29 -20.51 12.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.825 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 113.72 38.02 1.23 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.506 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 77.6 mtt180 -121.63 146.86 46.53 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.612 0.72 . . . . 0.0 110.854 -179.837 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 209' ' ' PRO . . . . . 0.558 ' HG3' ' CD1' ' A' ' 175' ' ' PHE . 53.6 Cg_endo -69.79 112.02 2.97 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.672 2.248 . . . . 0.0 112.348 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 210' ' ' THR . . . . . 0.539 HG23 ' HA ' ' A' ' 203' ' ' THR . 53.7 p -76.59 -6.8 53.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.173 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 80.73 -37.14 2.29 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.467 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -75.85 159.01 31.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.844 0.354 . . . . 0.0 110.861 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 213' ' ' ALA . . . . . 0.554 ' HB3' ' CD1' ' A' ' 173' ' ' LEU . . . -159.31 -177.91 6.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.075 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 214' ' ' PHE . . . . . 0.459 ' CE2' HG13 ' A' ' 249' ' ' VAL . 58.0 m-85 -145.59 143.85 30.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.885 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 4.4 t -131.9 155.47 41.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.142 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 0.591 ' O ' HG23 ' A' ' 192' ' ' ILE . 37.5 mt -106.1 135.09 48.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.916 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -127.19 147.26 50.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.88 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 218' ' ' ALA . . . . . 0.63 ' HB3' ' HD2' ' A' ' 222' ' ' TYR . . . -54.31 -63.76 1.05 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.127 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 219' ' ' CYS . . . . . . . . . . . . . 2.2 t -153.58 172.63 16.91 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.87 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -44.89 -35.71 2.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.891 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 221' ' ' GLU . . . . . 0.566 ' OE2' ' CD1' ' A' ' 222' ' ' TYR . 6.0 tm-20 -45.27 -44.73 11.54 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.915 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 222' ' ' TYR . . . . . 0.63 ' HD2' ' HB3' ' A' ' 218' ' ' ALA . 35.1 m-85 -88.71 -47.48 8.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.872 -179.857 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 223' ' ' ALA . . . . . 0.462 ' CB ' HG11 ' A' ' 166' ' ' VAL . . . -52.15 -60.0 3.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.113 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 43.9 mm-40 -47.22 -50.68 20.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.914 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 20.4 m-20 -60.48 -23.66 64.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.925 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 226' ' ' ALA . . . . . 0.446 ' HB3' ' O ' ' A' ' 223' ' ' ALA . . . -76.15 -40.32 52.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.132 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 29.2 mt -54.41 -30.74 53.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.94 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 6.7 mtp-105 -58.84 -25.28 63.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.881 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 229' ' ' LYS . . . . . 0.462 ' O ' ' C ' ' A' ' 230' ' ' HIS . 19.1 mtpp -76.37 -0.92 24.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.887 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 230' ' ' HIS . . . . . 0.488 ' CE1' ' HG3' ' A' ' 231' ' ' LYS . 13.7 t60 -33.54 133.37 0.17 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.833 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.488 ' HG3' ' CE1' ' A' ' 230' ' ' HIS . 47.0 mtmt 59.13 40.35 21.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.904 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -66.64 -177.01 0.53 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.834 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.576 HD21 ' CD1' ' A' ' 238' ' ' TYR . 31.3 mt -136.48 105.03 5.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.909 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 234' ' ' LEU . . . . . 0.623 ' C ' HD23 ' A' ' 234' ' ' LEU . 6.6 tt -116.35 113.67 23.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.921 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 60.55 39.42 96.42 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.514 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 4.4 mmmm 66.69 53.39 0.91 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.76 0.314 . . . . 0.0 110.882 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 20.4 mmt180 -156.21 115.47 3.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.877 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 238' ' ' TYR . . . . . 0.576 ' CD1' HD21 ' A' ' 233' ' ' LEU . 95.7 m-85 -68.64 117.36 10.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.916 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 0.929 HD13 HD23 ' A' ' 173' ' ' LEU . 17.7 mt -113.81 129.9 68.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.178 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 240' ' ' GLU . . . . . 0.725 ' O ' HD23 ' A' ' 241' ' ' LEU . 0.5 OUTLIER -89.99 175.27 7.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.869 -179.998 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 241' ' ' LEU . . . . . 0.725 HD23 ' O ' ' A' ' 240' ' ' GLU . 38.5 mt -151.57 144.65 24.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.907 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 242' ' ' PHE . . . . . 0.48 ' CD1' ' O ' ' A' ' 241' ' ' LEU . 15.0 m-85 -156.89 129.17 7.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.885 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 243' ' ' ARG . . . . . 0.475 ' CZ ' ' HB2' ' A' ' 243' ' ' ARG . 17.0 mtm105 -48.25 138.74 9.36 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.876 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 244' ' ' SER . . . . . 0.449 ' HB2' ' N ' ' A' ' 169' ' ' ARG . 1.0 OUTLIER -136.25 160.46 38.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.861 -179.778 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 53.5 p -132.83 155.83 48.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.173 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 246' ' ' ALA . . . . . 0.548 ' N ' HD12 ' A' ' 167' ' ' ILE . . . -40.51 -58.65 1.52 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.058 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -53.44 -55.69 23.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.114 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -46.02 -46.06 16.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.885 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 0.486 HG21 HD13 ' A' ' 167' ' ' ILE . 98.2 t -51.62 -62.54 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.126 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 250' ' ' GLN . . . . . 0.497 ' HA ' HD12 ' A' ' 253' ' ' LEU . 49.5 mt-30 -47.66 -33.38 6.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.898 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 -76.76 -26.3 54.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.921 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 43.1 t -82.38 -21.64 9.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.114 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 253' ' ' LEU . . . . . 0.497 HD12 ' HA ' ' A' ' 250' ' ' GLN . 10.5 mt -85.41 -43.24 13.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.875 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 254' ' ' ASN . . . . . 0.401 ' CG ' ' N ' ' A' ' 255' ' ' ARG . 0.6 OUTLIER -65.22 -46.0 82.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.876 179.962 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 255' ' ' ARG . . . . . 0.401 ' N ' ' CG ' ' A' ' 254' ' ' ASN . 7.5 ptm180 -48.68 -30.72 5.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.896 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -88.42 -32.39 18.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.886 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 32.3 t . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.845 -179.767 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.9 0.381 . . . . 0.0 110.897 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.498 ' O ' ' N ' ' A' ' 159' ' ' PHE . 20.5 t -73.55 -58.03 5.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.141 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.443 ' C ' ' O ' ' A' ' 156' ' ' VAL . . . -34.07 -57.17 0.48 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.087 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 82.3 mt-30 -67.28 -33.79 76.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.931 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 159' ' ' PHE . . . . . 0.498 ' N ' ' O ' ' A' ' 156' ' ' VAL . 71.4 t80 -62.76 -39.49 94.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.867 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.443 HD22 ' HB1' ' A' ' 246' ' ' ALA . 82.8 mt -90.21 -17.13 28.09 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.884 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 13.1 t -55.45 -31.84 62.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.845 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 162' ' ' LYS . . . . . 0.544 ' HG3' HD13 ' A' ' 216' ' ' LEU . 25.6 mmtt -60.98 118.12 6.33 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.95 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 163' ' ' GLU . . . . . 0.455 ' O ' ' NE2' ' A' ' 165' ' ' GLN . 17.6 mt-10 -97.33 136.88 37.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.88 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 74.53 43.99 0.24 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.891 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.455 ' NE2' ' O ' ' A' ' 163' ' ' GLU . 31.6 mm-40 -122.87 176.16 6.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.92 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.407 HG11 ' CB ' ' A' ' 223' ' ' ALA . 15.8 t -129.14 119.68 49.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.112 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 167' ' ' ILE . . . . . 0.479 HD12 ' N ' ' A' ' 246' ' ' ALA . 14.6 mt -93.21 149.57 4.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.084 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 57.5 t -130.93 137.01 56.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.123 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 50.7 ttt-85 -92.27 109.4 20.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.854 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 170' ' ' MET . . . . . 0.641 ' CE ' HD21 ' A' ' 173' ' ' LEU . 96.6 mtp -102.05 120.63 40.73 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.846 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 3.3 ttt85 -122.76 139.38 54.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.884 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 90.53 28.24 17.35 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.502 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.675 HD23 HD13 ' A' ' 239' ' ' ILE . 30.4 mt -82.52 127.37 70.88 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.607 0.718 . . . . 0.0 110.836 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 174' ' ' PRO . . . . . 0.493 ' HG3' ' CB ' ' A' ' 237' ' ' ARG . 65.9 Cg_exo -48.06 126.2 12.92 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.665 2.243 . . . . 0.0 112.32 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 175' ' ' PHE . . . . . 0.58 ' CE2' ' HG2' ' A' ' 209' ' ' PRO . 3.8 m-85 -44.06 -24.19 0.14 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.882 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 67.3 p -86.37 -37.16 18.7 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.133 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 177' ' ' ALA . . . . . 0.401 ' N ' ' O ' ' A' ' 174' ' ' PRO . . . -49.21 124.68 9.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.093 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 178' ' ' THR . . . . . 0.651 HG22 ' H ' ' A' ' 179' ' ' ALA . 0.2 OUTLIER -123.76 -173.67 2.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.127 -179.925 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.651 ' H ' HG22 ' A' ' 178' ' ' THR . . . -51.35 -48.05 62.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.085 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -56.76 -33.44 66.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.878 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 181' ' ' GLU . . . . . 0.715 ' OE2' HD21 ' A' ' 234' ' ' LEU . 4.0 mm-40 -72.41 -22.91 61.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.9 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.651 HG12 HD11 ' A' ' 192' ' ' ILE . 93.9 t -87.21 -48.5 15.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.182 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 44.7 t -39.95 -42.53 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.098 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -81.34 -44.19 17.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.064 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.616 ' HD2' HD12 ' A' ' 234' ' ' LEU . 18.3 t80 -40.01 -58.14 1.48 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.862 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 186' ' ' PHE . . . . . 0.449 ' CE1' ' CE1' ' A' ' 185' ' ' PHE . 79.3 m-85 -94.34 -22.99 17.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.874 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -49.29 -21.63 2.97 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.505 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 -54.3 -70.88 0.09 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.834 0.349 . . . . 0.0 110.968 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 6.6 m-70 -118.02 -15.49 9.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.881 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 82.8 m -120.35 86.4 38.58 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.612 0.72 . . . . 0.0 110.909 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 191' ' ' PRO . . . . . 0.406 ' HD2' ' CD1' ' A' ' 222' ' ' TYR . 53.8 Cg_endo -69.78 134.35 27.73 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.685 2.256 . . . . 0.0 112.374 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 192' ' ' ILE . . . . . 0.666 HG23 ' O ' ' A' ' 216' ' ' LEU . 48.2 mt -84.12 143.31 12.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.176 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 93.5 m -68.06 106.24 2.31 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.135 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 89.72 -20.55 34.62 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.475 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 78.62 -125.65 7.19 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.498 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 196' ' ' LYS . . . . . 0.438 ' HA ' HD12 ' A' ' 199' ' ' ILE . 4.7 ptpt -49.49 -21.72 1.02 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.742 0.306 . . . . 0.0 110.845 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -83.54 -30.88 26.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.903 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 198' ' ' GLY . . . . . 0.503 ' HA2' HD12 ' A' ' 216' ' ' LEU . . . -89.77 39.64 3.1 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.491 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.438 HD12 ' HA ' ' A' ' 196' ' ' LYS . 42.6 mt -139.94 149.36 22.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.894 0.378 . . . . 0.0 111.139 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 13.4 tp -143.24 113.16 7.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.937 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 201' ' ' PHE . . . . . 0.426 ' CE1' HG21 ' A' ' 199' ' ' ILE . 49.2 m-85 -95.22 112.38 24.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.854 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.454 HG11 ' OD2' ' A' ' 212' ' ' ASP . 22.9 t -64.12 118.98 7.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.096 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -127.66 138.29 52.78 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.132 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -45.9 158.49 0.35 Allowed Pre-proline 0 C--N 1.328 -0.369 0 CA-C-O 121.719 0.771 . . . . 0.0 110.925 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 2.88 3.12 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.694 2.263 . . . . 0.0 112.379 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -111.45 -15.34 13.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.866 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 105.9 61.94 0.62 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.518 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 41.7 mtt180 -150.9 149.58 25.65 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.587 0.708 . . . . 0.0 110.861 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 209' ' ' PRO . . . . . 0.58 ' HG2' ' CE2' ' A' ' 175' ' ' PHE . 53.3 Cg_endo -69.84 121.0 7.67 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.655 2.237 . . . . 0.0 112.347 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 210' ' ' THR . . . . . 0.531 ' HB ' ' CE2' ' A' ' 256' ' ' PHE . 72.0 p -90.21 -3.95 57.52 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.157 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 89.27 -41.18 3.02 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.473 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 212' ' ' ASP . . . . . 0.454 ' OD2' HG11 ' A' ' 202' ' ' VAL . 1.2 p-10 -77.24 158.29 30.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.816 0.341 . . . . 0.0 110.881 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 213' ' ' ALA . . . . . 0.448 ' HB3' HD12 ' A' ' 173' ' ' LEU . . . -162.03 177.07 10.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.103 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 214' ' ' PHE . . . . . 0.59 ' CE2' HG13 ' A' ' 249' ' ' VAL . 47.7 m-85 -140.17 153.6 46.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.908 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 14.8 t -136.41 151.88 28.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.128 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 0.666 ' O ' HG23 ' A' ' 192' ' ' ILE . 33.2 mt -105.68 150.55 25.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.881 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -142.66 147.31 35.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.941 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 218' ' ' ALA . . . . . 0.454 ' HB3' ' CD2' ' A' ' 222' ' ' TYR . . . -54.71 -66.96 0.31 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.112 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 219' ' ' CYS . . . . . . . . . . . . . 6.4 p -133.22 175.31 9.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.928 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -61.49 -24.41 66.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.869 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -58.83 -29.91 67.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.922 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 222' ' ' TYR . . . . . 0.454 ' CD2' ' HB3' ' A' ' 218' ' ' ALA . 34.9 m-85 -91.99 -40.16 11.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.932 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 223' ' ' ALA . . . . . 0.407 ' CB ' HG11 ' A' ' 166' ' ' VAL . . . -64.18 -51.38 64.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.087 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 224' ' ' GLN . . . . . 0.4 ' HA ' ' CD1' ' A' ' 227' ' ' LEU . 12.7 mm-40 -55.81 -53.95 50.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.92 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 -54.52 -26.3 30.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.917 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -74.84 -28.58 60.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.086 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 227' ' ' LEU . . . . . 0.4 ' CD1' ' HA ' ' A' ' 224' ' ' GLN . 26.1 mt -59.92 -29.17 68.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.852 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 30.2 mtp85 -59.55 -28.82 67.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.837 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 229' ' ' LYS . . . . . 0.513 ' HD2' ' CE1' ' A' ' 185' ' ' PHE . 20.0 mtmt -74.91 -1.03 20.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.889 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 230' ' ' HIS . . . . . 0.555 ' CE1' ' HG3' ' A' ' 231' ' ' LYS . 34.7 t60 -33.3 129.85 0.25 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.856 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.555 ' HG3' ' CE1' ' A' ' 230' ' ' HIS . 49.9 mtmt 62.04 37.17 14.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.926 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -63.37 179.59 0.42 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.838 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.663 HD21 ' CE1' ' A' ' 238' ' ' TYR . 33.6 mt -131.61 106.33 8.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.932 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 234' ' ' LEU . . . . . 0.715 HD21 ' OE2' ' A' ' 181' ' ' GLU . 7.7 tt -116.2 114.53 24.55 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.932 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 60.68 34.35 86.06 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.506 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 32.4 mtpt 71.19 52.15 0.26 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.795 0.331 . . . . 0.0 110.908 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 237' ' ' ARG . . . . . 0.493 ' CB ' ' HG3' ' A' ' 174' ' ' PRO . 18.5 mmt180 -155.77 115.36 3.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.884 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 238' ' ' TYR . . . . . 0.663 ' CE1' HD21 ' A' ' 233' ' ' LEU . 97.6 m-85 -67.44 119.23 11.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.921 -179.848 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 0.675 HD13 HD23 ' A' ' 173' ' ' LEU . 80.0 mt -115.61 126.93 73.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.105 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 240' ' ' GLU . . . . . 0.476 ' HB3' ' CE2' ' A' ' 242' ' ' PHE . 37.2 mt-10 -86.13 171.61 11.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.903 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 18.8 mt -152.21 139.41 19.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.915 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 242' ' ' PHE . . . . . 0.476 ' CE2' ' HB3' ' A' ' 240' ' ' GLU . 16.5 m-85 -153.35 126.78 8.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.915 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 61.2 mtm180 -39.85 155.02 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.912 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 19.0 t -156.66 160.7 39.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.827 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 18.0 p -135.86 167.36 21.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.153 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 246' ' ' ALA . . . . . 0.479 ' N ' HD12 ' A' ' 167' ' ' ILE . . . -42.46 -58.52 2.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.091 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -54.0 -56.33 18.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.109 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 248' ' ' GLU . . . . . 0.952 ' O ' HG23 ' A' ' 252' ' ' VAL . 22.5 tp10 -40.66 -46.26 2.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.877 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 0.59 HG13 ' CE2' ' A' ' 214' ' ' PHE . 99.1 t -61.57 -60.72 2.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.16 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 250' ' ' GLN . . . . . 0.544 ' HA ' HD12 ' A' ' 253' ' ' LEU . 59.9 mt-30 -38.27 -61.18 0.7 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.876 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 251' ' ' GLN . . . . . 0.454 ' CG ' ' O ' ' A' ' 248' ' ' GLU . 7.8 pt20 -53.47 -44.26 68.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.906 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 252' ' ' VAL . . . . . 0.952 HG23 ' O ' ' A' ' 248' ' ' GLU . 92.5 t -59.96 -40.57 83.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.136 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 253' ' ' LEU . . . . . 0.544 HD12 ' HA ' ' A' ' 250' ' ' GLN . 34.6 mt -59.43 -50.84 72.39 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.901 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 254' ' ' ASN . . . . . 0.5 ' OD1' ' N ' ' A' ' 255' ' ' ARG . 0.6 OUTLIER -61.92 -40.18 94.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.89 179.924 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 255' ' ' ARG . . . . . 0.5 ' N ' ' OD1' ' A' ' 254' ' ' ASN . 43.2 ttt180 -40.59 -58.47 1.59 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.847 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 256' ' ' PHE . . . . . 0.531 ' CE2' ' HB ' ' A' ' 210' ' ' THR . 55.9 m-85 -74.14 -53.94 8.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.871 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 257' ' ' SER . . . . . 0.425 ' C ' ' O ' ' A' ' 256' ' ' PHE . 29.5 t . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.88 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.329 0 N-CA-C 112.497 -0.241 . . . . 0.0 112.497 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 57.9 m -111.35 129.72 55.91 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.886 0.374 . . . . 0.0 110.904 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 1.3 t -80.17 156.03 27.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.882 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -163.69 -49.15 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.462 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 87.4 p -62.16 -49.64 75.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.827 0.346 . . . . 0.0 110.799 -179.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 66.7 m -113.97 108.75 17.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.86 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 140.96 61.23 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.505 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 93.88 103.8 1.73 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.509 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -78.38 80.46 1.41 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.483 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 3.6 m -151.95 116.74 5.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.804 0.335 . . . . 0.0 111.13 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 4.2 m -82.2 170.6 15.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.839 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 54.7 m-80 -60.73 -42.94 98.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.876 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -63.76 -44.87 92.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.903 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 94.1 t -59.32 -47.43 90.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.145 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -37.52 -56.79 0.99 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.072 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -61.59 -40.23 94.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.914 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -59.71 -41.17 90.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.849 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 88.1 mt -87.95 -19.17 27.61 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.915 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 29.5 t -61.62 -22.28 65.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.844 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 39.5 mmtm -72.37 118.55 15.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.931 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -97.46 155.67 16.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.92 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 2.8 m120 63.34 45.64 4.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.884 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 24.0 mm-40 -132.05 149.22 52.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.9 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 55.9 t -103.27 108.04 23.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.129 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' ILE . . . . . 0.458 HD13 HG21 ' A' ' 249' ' ' VAL . 86.8 mt -78.04 141.79 15.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.135 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 92.9 t -122.23 129.28 75.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.113 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 32.5 ttp180 -88.33 106.94 18.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.888 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' MET . . . . . 0.69 ' CE ' HD21 ' A' ' 173' ' ' LEU . 96.9 mtp -94.9 126.35 40.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.858 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 26.1 mtt180 -128.03 142.79 51.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.882 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 79.36 45.19 8.94 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.436 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.744 HD23 HD13 ' A' ' 239' ' ' ILE . 21.1 mt -93.42 133.68 27.96 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.553 0.692 . . . . 0.0 110.953 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 174' ' ' PRO . . . . . 0.462 ' HG3' ' CB ' ' A' ' 237' ' ' ARG . 64.9 Cg_exo -47.98 133.57 23.26 Favored 'Trans proline' 0 N--CA 1.465 -0.168 0 C-N-CA 122.737 2.291 . . . . 0.0 112.318 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -53.99 -19.26 4.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.836 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 74.7 p -96.29 -22.41 17.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.16 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -60.7 125.97 25.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.078 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -125.89 178.26 5.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.127 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.608 ' O ' HG23 ' A' ' 183' ' ' VAL . . . -45.87 -42.69 12.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.069 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -58.21 -41.8 84.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.926 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -61.82 -42.28 98.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.886 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.449 ' O ' ' C ' ' A' ' 183' ' ' VAL . 47.1 t -65.06 -54.4 29.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.099 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.608 HG23 ' O ' ' A' ' 179' ' ' ALA . 91.4 t -33.99 -52.02 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.131 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.419 ' O ' ' C ' ' A' ' 185' ' ' PHE . . . -72.89 -45.74 56.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.093 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.768 ' HD2' HD12 ' A' ' 234' ' ' LEU . 35.2 t80 -36.89 -62.46 0.48 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.875 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 186' ' ' PHE . . . . . 0.511 ' CE1' ' CE1' ' A' ' 185' ' ' PHE . 55.3 m-85 -91.38 -20.81 21.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.869 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -49.01 -23.32 3.62 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.54 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 30.2 mm-40 -50.64 -74.03 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.827 0.346 . . . . 0.0 110.952 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 29.4 m170 -118.19 -18.17 9.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.877 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 58.6 m -115.05 84.24 10.65 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.635 0.731 . . . . 0.0 110.867 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' PRO . . . . . 0.435 ' HD2' ' CD1' ' A' ' 222' ' ' TYR . 53.3 Cg_endo -69.77 142.89 49.12 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.705 2.27 . . . . 0.0 112.31 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 192' ' ' ILE . . . . . 0.563 HG23 ' O ' ' A' ' 216' ' ' LEU . 62.6 mt -94.11 144.99 8.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.113 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 87.1 m -70.38 96.5 1.15 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.183 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 95.85 -2.74 64.48 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.508 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 52.8 -120.01 11.14 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.499 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.27 -27.43 2.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.765 0.316 . . . . 0.0 110.893 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 43.9 mm-40 -80.02 -29.98 39.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.85 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -95.23 41.29 2.52 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.497 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 61.9 mt -141.88 140.54 30.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.828 0.347 . . . . 0.0 111.112 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 13.2 tp -135.91 117.49 14.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.972 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -97.15 115.65 27.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.917 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.557 HG23 ' HA ' ' A' ' 213' ' ' ALA . 14.2 t -70.01 121.92 20.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.151 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 203' ' ' THR . . . . . 0.436 ' HA ' HG23 ' A' ' 210' ' ' THR . 0.8 OUTLIER -131.45 137.99 48.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.151 -179.969 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 204' ' ' TYR . . . . . 0.428 ' CD2' HG22 ' A' ' 210' ' ' THR . 28.0 m-85 -46.45 158.57 0.39 Allowed Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.673 0.749 . . . . 0.0 110.932 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 2.87 3.13 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.689 2.259 . . . . 0.0 112.372 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -109.37 -21.3 12.58 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.875 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 112.01 49.27 0.63 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.466 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -133.7 144.02 50.18 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.645 0.736 . . . . 0.0 110.862 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 101.79 0.96 Allowed 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.664 2.243 . . . . 0.0 112.354 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 210' ' ' THR . . . . . 0.436 HG23 ' HA ' ' A' ' 203' ' ' THR . 46.0 p -66.45 -25.18 66.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.128 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 104.74 -37.71 3.65 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.471 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 212' ' ' ASP . . . . . 0.472 ' OD2' HG11 ' A' ' 202' ' ' VAL . 1.6 p-10 -78.09 155.7 30.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.771 0.32 . . . . 0.0 110.929 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 213' ' ' ALA . . . . . 0.557 ' HA ' HG23 ' A' ' 202' ' ' VAL . . . -157.5 -179.1 7.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.119 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 214' ' ' PHE . . . . . 0.452 ' CE2' HG13 ' A' ' 249' ' ' VAL . 77.6 m-85 -144.5 140.36 28.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.819 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 215' ' ' VAL . . . . . 0.407 HG12 ' N ' ' A' ' 216' ' ' LEU . 4.6 t -124.28 158.99 30.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.133 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.563 ' O ' HG23 ' A' ' 192' ' ' ILE . 30.4 mt -111.3 142.54 43.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.958 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -135.44 129.52 33.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.916 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -39.64 -64.48 0.48 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.075 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 219' ' ' CYS . . . . . . . . . . . . . 85.3 m -138.93 -175.34 4.11 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.89 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -71.2 -8.74 55.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.917 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -68.28 -34.62 76.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.922 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 222' ' ' TYR . . . . . 0.435 ' CD1' ' HD2' ' A' ' 191' ' ' PRO . 19.6 m-85 -92.42 -48.88 6.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.92 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -49.76 -53.59 24.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.075 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 224' ' ' GLN . . . . . 0.56 ' HA ' HD12 ' A' ' 227' ' ' LEU . 29.5 mt-30 -52.76 -60.16 3.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.897 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -49.76 -28.57 6.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.915 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -76.23 -36.04 58.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.078 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 227' ' ' LEU . . . . . 0.56 HD12 ' HA ' ' A' ' 224' ' ' GLN . 43.8 mt -55.35 -36.51 66.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.93 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 3.9 mtp-105 -58.23 -18.98 30.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.883 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 229' ' ' LYS . . . . . 0.459 ' O ' ' C ' ' A' ' 230' ' ' HIS . 23.7 mtpp -78.78 -2.54 40.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.872 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 230' ' ' HIS . . . . . 0.542 ' CD2' ' HG2' ' A' ' 231' ' ' LYS . 78.5 t60 -33.89 136.88 0.11 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.857 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.542 ' HG2' ' CD2' ' A' ' 230' ' ' HIS . 23.1 mmtm 62.16 31.08 17.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.857 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -59.69 -176.24 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.823 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.874 HD21 ' CE1' ' A' ' 238' ' ' TYR . 31.6 mt -140.06 110.42 6.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.93 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 234' ' ' LEU . . . . . 0.768 HD12 ' HD2' ' A' ' 185' ' ' PHE . 6.8 tt -119.64 114.16 21.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.91 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 58.26 36.1 81.36 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.497 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 38.7 mttp 71.21 52.13 0.26 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.744 0.306 . . . . 0.0 110.912 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 237' ' ' ARG . . . . . 0.462 ' CB ' ' HG3' ' A' ' 174' ' ' PRO . 19.6 mmt180 -155.79 115.46 3.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.901 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 238' ' ' TYR . . . . . 0.874 ' CE1' HD21 ' A' ' 233' ' ' LEU . 83.5 m-85 -69.72 133.0 47.0 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.955 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 0.744 HD13 HD23 ' A' ' 173' ' ' LEU . 70.7 mt -131.69 141.04 46.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.134 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 240' ' ' GLU . . . . . 0.578 ' HB3' ' CZ ' ' A' ' 242' ' ' PHE . 24.6 mt-10 -92.89 178.33 5.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.906 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 241' ' ' LEU . . . . . 0.593 ' O ' ' CD1' ' A' ' 242' ' ' PHE . 51.0 mt -157.64 137.35 12.21 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.893 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 242' ' ' PHE . . . . . 0.593 ' CD1' ' O ' ' A' ' 241' ' ' LEU . 5.2 m-85 -157.53 122.8 4.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.871 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 243' ' ' ARG . . . . . 0.492 ' CG ' ' O ' ' A' ' 243' ' ' ARG . 19.9 ptt180 -59.57 112.58 1.84 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.873 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 1.7 t -106.98 164.32 12.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.866 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 245' ' ' THR . . . . . 0.594 ' O ' HG23 ' A' ' 249' ' ' VAL . 33.7 p -110.19 166.51 10.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.166 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -54.38 -61.53 2.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.079 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -45.44 -56.26 5.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.083 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -45.7 -55.78 6.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.89 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.594 HG23 ' O ' ' A' ' 245' ' ' THR . 99.8 t -41.72 -59.88 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.138 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 250' ' ' GLN . . . . . 0.479 ' HA ' HD12 ' A' ' 253' ' ' LEU . 33.8 mt-30 -47.83 -42.56 26.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.882 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 35.4 mm-40 -68.46 -22.6 64.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.952 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 76.7 t -85.1 -21.1 8.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.11 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.479 HD12 ' HA ' ' A' ' 250' ' ' GLN . 10.9 mt -87.38 -42.18 13.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.945 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -64.47 -43.41 94.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.898 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -53.76 -42.36 68.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.888 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -80.87 -34.02 33.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.848 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 257' ' ' SER . . . . . 0.405 ' O ' ' C ' ' A' ' 258' ' ' SER . 20.6 m -73.32 138.88 45.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.875 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 258' ' ' SER . . . . . 0.432 ' O ' ' C ' ' A' ' 259' ' ' ALA . 88.4 p 37.63 39.18 0.18 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.903 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 259' ' ' ALA . . . . . 0.432 ' C ' ' O ' ' A' ' 258' ' ' SER . . . -35.12 130.56 0.45 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.103 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 9.6 t -103.88 39.18 1.67 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.877 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 261' ' ' GLY . . . . . 0.42 ' HA3' ' C ' ' A' ' 262' ' ' PRO . . . -153.19 -70.64 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.524 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 262' ' ' PRO . . . . . 0.42 ' C ' ' HA3' ' A' ' 261' ' ' GLY . 54.2 Cg_endo -69.7 -11.96 11.93 Favored 'Cis proline' 0 C--N 1.341 0.18 0 C-N-CA 122.691 -1.795 . . . . 0.0 112.338 0.002 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 32.4 t -55.63 147.01 19.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.872 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 60.6 p -93.93 42.05 1.09 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.898 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.349 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.508 -179.967 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.345 0 N-CA-C 112.466 -0.254 . . . . 0.0 112.466 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 88.7 p -169.81 148.24 3.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.883 0.373 . . . . 0.0 110.885 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 5.6 t -57.39 143.87 38.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.885 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -163.52 -59.41 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.454 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.8 m -87.73 125.65 34.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.867 0.365 . . . . 0.0 110.812 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 9.8 t -120.98 138.32 54.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.886 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -123.2 164.58 16.15 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.477 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 138.44 -69.39 0.49 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.467 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -116.17 161.39 12.96 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.474 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.54 HG22 HG23 ' A' ' 156' ' ' VAL . 0.7 OUTLIER -117.2 -25.56 7.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.773 0.32 . . . . 0.0 111.115 -179.862 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 153' ' ' SER . . . . . 0.424 ' C ' ' O ' ' A' ' 152' ' ' THR . 77.4 p -36.27 -42.2 0.3 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.862 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' ASN . . . . . 0.416 ' O ' ' HB3' ' A' ' 157' ' ' ALA . 14.3 t-20 -67.26 -57.57 6.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.865 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -51.07 -47.89 61.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.9 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.54 HG23 HG22 ' A' ' 152' ' ' THR . 76.8 t -66.43 -36.75 78.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.151 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.416 ' HB3' ' O ' ' A' ' 154' ' ' ASN . . . -44.32 -51.37 8.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.079 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -61.37 -51.11 70.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.929 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' PHE . . . . . 0.502 ' CE1' ' HG ' ' A' ' 216' ' ' LEU . 85.3 t80 -46.24 -46.1 17.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.875 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 92.0 mt -84.5 -18.55 35.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.918 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 17.6 t -56.82 -25.38 55.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.845 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' LYS . . . . . 0.557 ' HG3' HD13 ' A' ' 216' ' ' LEU . 28.3 mmtt -71.04 131.78 44.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.886 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -110.01 156.97 19.79 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.847 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 3.5 m120 65.03 36.17 7.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.882 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 22.2 mm-40 -124.95 160.08 29.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.91 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 25.3 t -111.6 115.71 50.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.174 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 19.3 mt -86.99 140.27 16.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.14 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.404 HG21 ' CE2' ' A' ' 217' ' ' PHE . 30.0 t -122.17 137.26 56.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.157 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 51.4 ttp180 -92.29 112.51 24.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.84 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' MET . . . . . 0.48 ' CE ' HD21 ' A' ' 173' ' ' LEU . 98.9 mtp -107.29 111.64 24.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.917 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 10.3 ptm180 -118.92 133.96 55.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.835 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 100.6 18.21 21.58 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.47 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.752 HD23 HD13 ' A' ' 239' ' ' ILE . 31.0 mt -73.85 133.16 79.47 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.633 0.73 . . . . 0.0 110.91 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 174' ' ' PRO . . . . . 0.448 ' HG3' ' CB ' ' A' ' 237' ' ' ARG . 65.8 Cg_exo -48.0 135.08 23.92 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.642 2.228 . . . . 0.0 112.369 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 3.3 m-30 -49.71 -35.11 20.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.884 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.421 ' O ' ' C ' ' A' ' 177' ' ' ALA . 22.8 p -77.68 -43.96 29.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.153 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.429 ' HA ' ' CD ' ' A' ' 181' ' ' GLU . . . -35.55 128.97 0.59 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.087 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 3.9 p -124.54 -178.7 4.21 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.132 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -56.75 -41.78 78.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.098 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -58.84 -34.97 72.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.904 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' GLU . . . . . 0.429 ' CD ' ' HA ' ' A' ' 177' ' ' ALA . 36.4 mt-10 -69.52 -37.37 77.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.885 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.588 HG12 ' CD1' ' A' ' 192' ' ' ILE . 26.1 t -68.93 -47.01 78.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.176 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 37.7 t -37.95 -49.4 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.096 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.423 ' O ' ' C ' ' A' ' 185' ' ' PHE . . . -74.28 -44.84 51.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.105 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.619 ' CE1' ' CE1' ' A' ' 186' ' ' PHE . 5.7 t80 -36.89 -64.07 0.38 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.829 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 186' ' ' PHE . . . . . 0.619 ' CE1' ' CE1' ' A' ' 185' ' ' PHE . 59.9 m-85 -89.19 -21.64 23.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.899 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -49.62 -26.15 7.36 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.514 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 16.5 tt0 -48.98 -70.91 0.08 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.863 0.363 . . . . 0.0 110.971 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 65.9 m80 -118.27 -16.6 9.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.869 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' CYS . . . . . 0.438 ' N ' ' O ' ' A' ' 186' ' ' PHE . 74.4 m -120.11 85.36 35.35 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.569 0.699 . . . . 0.0 110.818 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 191' ' ' PRO . . . . . 0.458 ' HD2' ' CD1' ' A' ' 222' ' ' TYR . 53.8 Cg_endo -69.78 130.04 18.62 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.701 2.268 . . . . 0.0 112.338 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 192' ' ' ILE . . . . . 0.588 ' CD1' HG12 ' A' ' 182' ' ' VAL . 53.2 mt -79.03 142.92 13.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.122 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 21.9 m -66.74 98.66 0.54 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.164 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 89.22 -3.92 84.3 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.465 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.412 ' O ' ' N ' ' A' ' 198' ' ' GLY . . . 58.24 -117.46 10.56 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.497 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 4.3 ptpp? -47.38 -28.67 2.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.779 0.323 . . . . 0.0 110.924 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -78.48 -29.85 46.99 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.932 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 198' ' ' GLY . . . . . 0.419 ' HA2' HD12 ' A' ' 216' ' ' LEU . . . -95.69 41.43 2.46 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.469 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.411 HG21 ' CE2' ' A' ' 201' ' ' PHE . 75.9 mt -140.7 138.3 35.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.833 0.349 . . . . 0.0 111.128 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 14.3 tp -132.99 113.03 12.34 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.915 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 201' ' ' PHE . . . . . 0.411 ' CE2' HG21 ' A' ' 199' ' ' ILE . 81.3 m-85 -96.58 110.81 23.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.855 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 22.0 t -67.41 127.36 28.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.128 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -132.48 141.57 48.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.168 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 -45.78 158.12 0.36 Allowed Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.686 0.755 . . . . 0.0 110.964 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 3.21 2.92 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.707 2.271 . . . . 0.0 112.355 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -112.68 -16.07 12.87 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.891 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 106.94 62.98 0.58 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.501 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 35.2 mtt180 -151.77 151.15 27.85 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.646 0.736 . . . . 0.0 110.861 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 122.42 9.09 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.701 2.268 . . . . 0.0 112.352 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 42.9 p -90.84 -21.42 21.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.123 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 104.35 -35.49 5.01 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.494 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -80.68 156.54 26.26 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.838 0.351 . . . . 0.0 110.829 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -160.74 172.87 16.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.099 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -140.23 149.13 42.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.869 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 215' ' ' VAL . . . . . 0.437 HG12 ' N ' ' A' ' 216' ' ' LEU . 8.1 t -131.49 159.34 43.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.179 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.557 HD13 ' HG3' ' A' ' 162' ' ' LYS . 36.9 mt -108.79 143.2 38.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.918 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 217' ' ' PHE . . . . . 0.404 ' CE2' HG21 ' A' ' 168' ' ' VAL . 76.9 m-85 -136.4 145.24 45.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.895 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -59.03 -62.35 1.95 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.072 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 219' ' ' CYS . . . . . . . . . . . . . 66.7 m -141.14 179.34 6.81 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.918 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -57.83 -36.48 72.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.877 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -40.07 -45.76 2.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.897 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 222' ' ' TYR . . . . . 0.458 ' CD1' ' HD2' ' A' ' 191' ' ' PRO . 24.0 m-85 -84.44 -49.9 8.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.919 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -53.49 -63.29 1.2 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.098 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 85.9 mm-40 -49.28 -52.65 26.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.882 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 61.8 m-20 -59.18 -26.33 64.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.92 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -75.27 -28.51 59.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.117 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 26.8 mt -62.37 -29.41 70.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.897 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 65.0 mtp180 -60.87 -19.5 60.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.871 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 229' ' ' LYS . . . . . 0.544 ' HD2' ' CE1' ' A' ' 185' ' ' PHE . 20.3 mtmm -83.02 0.69 43.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.881 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 230' ' ' HIS . . . . . 0.466 ' C ' ' O ' ' A' ' 229' ' ' LYS . 67.9 t60 -33.4 135.13 0.12 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.866 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.411 ' HG3' ' NE2' ' A' ' 230' ' ' HIS . 13.2 mttm 60.8 32.2 20.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.897 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 232' ' ' ASP . . . . . 0.475 ' OD2' ' CE2' ' A' ' 185' ' ' PHE . 15.3 t0 -55.64 175.47 0.08 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.838 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.68 HD21 ' CE1' ' A' ' 238' ' ' TYR . 30.5 mt -130.88 106.57 8.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.909 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 234' ' ' LEU . . . . . 0.523 ' C ' HD23 ' A' ' 234' ' ' LEU . 6.5 tt -114.38 114.31 25.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.903 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 56.49 42.72 90.23 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.526 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 22.8 mmtp 65.54 52.55 1.34 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.767 0.318 . . . . 0.0 110.877 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 237' ' ' ARG . . . . . 0.448 ' CB ' ' HG3' ' A' ' 174' ' ' PRO . 19.1 mmt180 -156.27 115.38 3.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.876 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 238' ' ' TYR . . . . . 0.68 ' CE1' HD21 ' A' ' 233' ' ' LEU . 97.6 m-85 -68.49 131.48 45.34 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.916 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 0.752 HD13 HD23 ' A' ' 173' ' ' LEU . 56.5 mt -129.1 128.28 66.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.13 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 240' ' ' GLU . . . . . 0.491 ' HB3' ' CZ ' ' A' ' 242' ' ' PHE . 36.7 mt-10 -88.22 159.71 18.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.9 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 241' ' ' LEU . . . . . 0.511 ' O ' ' CD1' ' A' ' 242' ' ' PHE . 15.2 mt -141.7 146.3 35.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.899 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 242' ' ' PHE . . . . . 0.511 ' CD1' ' O ' ' A' ' 241' ' ' LEU . 9.7 m-85 -158.49 155.33 28.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.825 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 72.9 mtm180 -69.29 135.61 50.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.873 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 11.2 t -134.89 163.64 29.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.834 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 245' ' ' THR . . . . . 0.413 ' O ' ' C ' ' A' ' 246' ' ' ALA . 72.6 p -139.77 156.57 46.69 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.136 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 246' ' ' ALA . . . . . 0.413 ' C ' ' O ' ' A' ' 245' ' ' THR . . . -36.24 -52.23 0.8 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.07 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -56.87 -52.39 65.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.081 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 248' ' ' GLU . . . . . 0.426 ' O ' HG23 ' A' ' 252' ' ' VAL . 6.4 tp10 -49.78 -49.91 46.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.959 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 97.0 t -49.47 -66.48 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.129 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 250' ' ' GLN . . . . . 0.477 ' HA ' HD12 ' A' ' 253' ' ' LEU . 55.9 mt-30 -40.69 -42.98 1.85 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.91 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -63.87 -48.12 77.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.92 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 252' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 248' ' ' GLU . 96.0 t -57.83 -46.05 87.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.148 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.477 HD12 ' HA ' ' A' ' 250' ' ' GLN . 16.5 mt -57.32 -49.59 75.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.942 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 14.4 m-20 -60.11 -51.17 70.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.861 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 30.6 ttt180 -38.91 -52.11 1.77 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.905 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 256' ' ' PHE . . . . . 0.585 ' O ' ' HB2' ' A' ' 259' ' ' ALA . 56.3 m-85 -69.63 -50.4 44.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.912 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 8.6 m -50.54 161.21 0.34 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.828 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 5.6 t 40.11 49.02 2.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.887 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 259' ' ' ALA . . . . . 0.585 ' HB2' ' O ' ' A' ' 256' ' ' PHE . . . -99.47 92.35 5.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.102 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 12.5 t -60.17 117.95 5.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.878 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -174.74 -165.17 30.72 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.455 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 262' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 115.19 2.31 Favored 'Cis proline' 0 C--O 1.231 0.153 0 C-N-CA 122.72 -1.783 . . . . 0.0 112.327 0.103 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 12.7 m -152.43 146.03 24.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.828 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 1.2 t -102.18 175.28 5.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.831 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.275 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.435 179.959 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.344 0 N-CA-C 112.506 -0.237 . . . . 0.0 112.506 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 64.6 m -131.37 -46.24 0.99 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.862 0.363 . . . . 0.0 110.9 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 2.5 m -91.45 120.92 32.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.881 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -102.79 -53.37 0.91 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.481 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.4 t -44.49 130.12 6.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.908 0.385 . . . . 0.0 110.875 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 59.0 m -121.01 128.5 52.75 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.851 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -101.46 177.27 27.06 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.492 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -46.64 105.76 0.11 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.481 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 130.39 89.33 0.52 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.482 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -95.69 111.05 23.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.781 0.324 . . . . 0.0 111.12 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 20.2 m -128.35 -45.61 1.36 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.859 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' ASN . . . . . 0.475 ' OD1' ' N ' ' A' ' 155' ' ' GLU . 11.3 p30 -68.55 -52.19 34.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.901 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.475 ' N ' ' OD1' ' A' ' 154' ' ' ASN . 18.5 tt0 -53.28 -47.07 69.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.836 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.484 HG22 HD21 ' A' ' 200' ' ' LEU . 69.0 t -68.12 -44.51 84.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.15 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.425 ' C ' ' O ' ' A' ' 156' ' ' VAL . . . -36.11 -59.71 0.6 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.073 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 41.7 mm-40 -57.27 -49.88 74.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.891 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -46.33 -39.96 11.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.878 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 83.6 mt -91.33 -18.0 25.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.929 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 28.4 t -58.5 -22.65 55.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.839 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 19.8 mmtp -73.22 120.77 19.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.877 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -96.15 158.32 15.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.871 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 59.93 47.67 9.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.856 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 25.3 mm-40 -131.74 156.28 46.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.921 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 29.9 t -111.14 105.66 19.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.101 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' ILE . . . . . 0.633 HD13 HG21 ' A' ' 249' ' ' VAL . 66.4 mt -77.71 135.18 26.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.141 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 91.1 t -114.15 128.79 70.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.08 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 7.7 ttp-105 -88.35 106.09 18.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.857 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' MET . . . . . 0.694 ' CE ' HD21 ' A' ' 173' ' ' LEU . 99.3 mtp -95.57 138.32 33.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.88 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 73.7 mtt-85 -134.4 139.89 45.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.869 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 83.91 39.39 9.46 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.493 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.694 HD21 ' CE ' ' A' ' 170' ' ' MET . 24.1 mt -89.34 126.25 59.14 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.665 0.745 . . . . 0.0 110.889 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 174' ' ' PRO . . . . . 0.439 ' HG3' ' CB ' ' A' ' 237' ' ' ARG . 65.7 Cg_exo -47.99 132.78 22.84 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.684 2.256 . . . . 0.0 112.326 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 175' ' ' PHE . . . . . 0.561 ' CD1' ' HG3' ' A' ' 209' ' ' PRO . 10.3 t80 -45.19 -34.78 2.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.899 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 9.2 p -82.46 -30.34 30.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.14 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -52.84 107.0 0.19 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.116 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 5.7 p -113.02 178.16 4.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.155 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -46.48 -39.63 11.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.071 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -60.2 -34.63 73.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.875 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 38.5 mm-40 -75.38 -23.74 57.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.883 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.483 HG12 ' CD1' ' A' ' 192' ' ' ILE . 74.8 t -83.23 -47.2 18.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.17 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 54.8 t -41.47 -44.12 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.125 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -81.47 -37.06 28.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.08 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.696 ' HD2' HD12 ' A' ' 234' ' ' LEU . 19.9 t80 -45.69 -62.96 1.08 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.858 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 186' ' ' PHE . . . . . 0.507 ' CE1' ' CE1' ' A' ' 185' ' ' PHE . 68.7 m-85 -89.41 -20.9 23.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.911 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -49.67 -16.9 1.19 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.461 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 25.1 tp60 -58.94 -72.85 0.09 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.825 0.345 . . . . 0.0 110.878 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 23.3 m80 -118.28 -9.31 10.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.878 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 71.3 m -125.46 86.94 56.47 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.543 0.687 . . . . 0.0 110.9 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 141.35 45.04 Favored 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.708 2.272 . . . . 0.0 112.381 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 192' ' ' ILE . . . . . 0.698 HG23 ' O ' ' A' ' 216' ' ' LEU . 61.4 mt -95.78 141.99 14.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.116 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 14.8 m -65.38 102.98 0.74 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.168 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 89.15 -16.96 54.41 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.485 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.4 ' O ' ' N ' ' A' ' 198' ' ' GLY . . . 72.85 -122.43 8.25 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.456 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 196' ' ' LYS . . . . . 0.607 ' HA ' HD12 ' A' ' 199' ' ' ILE . 15.4 ptmt -46.38 -36.15 6.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.746 0.308 . . . . 0.0 110.903 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -69.85 -31.01 68.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.871 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 198' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 195' ' ' GLY . . . -91.99 39.55 3.01 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.52 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.607 HD12 ' HA ' ' A' ' 196' ' ' LYS . 48.5 mt -139.99 145.49 26.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.824 0.345 . . . . 0.0 111.116 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.484 HD21 HG22 ' A' ' 156' ' ' VAL . 15.2 tp -143.33 124.32 14.38 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.926 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -103.5 123.66 47.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.875 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 44.6 t -78.96 140.09 17.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.142 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 203' ' ' THR . . . . . 0.497 ' HA ' HG23 ' A' ' 210' ' ' THR . 0.8 OUTLIER -144.79 139.15 27.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.155 -179.986 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -49.48 159.13 0.7 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.657 0.741 . . . . 0.0 110.914 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 3.24 2.88 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.673 2.248 . . . . 0.0 112.346 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -110.51 -20.83 12.43 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.863 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 114.15 34.27 1.67 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.427 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -116.16 143.62 31.34 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.621 0.724 . . . . 0.0 110.848 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 209' ' ' PRO . . . . . 0.561 ' HG3' ' CD1' ' A' ' 175' ' ' PHE . 53.9 Cg_endo -69.77 107.79 1.94 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.699 2.266 . . . . 0.0 112.348 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 210' ' ' THR . . . . . 0.497 HG23 ' HA ' ' A' ' 203' ' ' THR . 44.9 p -73.18 -5.65 40.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.117 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 79.42 -40.56 2.21 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.48 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -69.42 161.5 29.29 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.787 0.327 . . . . 0.0 110.852 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 213' ' ' ALA . . . . . 0.514 ' HB3' ' CD1' ' A' ' 173' ' ' LEU . . . -164.28 -179.15 5.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.105 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -144.88 144.95 31.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.886 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 215' ' ' VAL . . . . . 0.445 HG12 ' N ' ' A' ' 216' ' ' LEU . 6.1 t -131.69 160.14 42.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.147 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.698 ' O ' HG23 ' A' ' 192' ' ' ILE . 37.6 mt -108.8 140.92 41.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.924 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -135.81 125.19 24.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.884 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -38.1 -73.44 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.081 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 219' ' ' CYS . . . . . . . . . . . . . 69.5 m -123.63 174.05 7.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.873 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -64.56 -32.91 74.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.932 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -41.28 -44.65 2.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.896 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 222' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -77.7 -43.92 29.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.906 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -50.8 -54.96 19.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.063 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 -50.55 -54.57 21.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.894 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 225' ' ' ASN . . . . . 0.433 ' HA ' ' NE ' ' A' ' 228' ' ' ARG . 55.0 m-20 -54.98 -27.62 45.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.912 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -76.68 -39.83 50.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.073 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 86.4 mt -55.18 -38.32 68.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.9 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 228' ' ' ARG . . . . . 0.433 ' NE ' ' HA ' ' A' ' 225' ' ' ASN . 50.4 mtm180 -57.99 -24.26 57.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.883 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 229' ' ' LYS . . . . . 0.463 ' O ' ' C ' ' A' ' 230' ' ' HIS . 28.1 mtpt -77.01 -1.52 29.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.907 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 230' ' ' HIS . . . . . 0.466 ' CD2' ' HG2' ' A' ' 231' ' ' LYS . 85.9 t60 -33.6 138.15 0.08 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.856 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.466 ' HG2' ' CD2' ' A' ' 230' ' ' HIS . 37.4 mmtt 62.37 25.67 15.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.937 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -52.25 -179.02 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.876 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.7 HD21 ' CE1' ' A' ' 238' ' ' TYR . 31.2 mt -139.5 107.34 5.66 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.951 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 234' ' ' LEU . . . . . 0.708 ' C ' HD23 ' A' ' 234' ' ' LEU . 5.4 tt -117.64 114.63 23.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.895 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 59.77 37.0 91.8 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.466 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 28.0 mmtt 68.47 52.24 0.62 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.742 0.306 . . . . 0.0 110.893 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 237' ' ' ARG . . . . . 0.439 ' CB ' ' HG3' ' A' ' 174' ' ' PRO . 43.6 mmt-85 -156.19 115.36 3.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.883 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 238' ' ' TYR . . . . . 0.7 ' CE1' HD21 ' A' ' 233' ' ' LEU . 93.8 m-85 -67.84 134.81 51.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.933 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 0.429 HD13 HD23 ' A' ' 173' ' ' LEU . 60.2 mt -132.98 136.32 55.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.133 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 240' ' ' GLU . . . . . 0.641 ' O ' HD23 ' A' ' 241' ' ' LEU . 66.3 mt-10 -89.33 172.6 8.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.921 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 241' ' ' LEU . . . . . 0.641 HD23 ' O ' ' A' ' 240' ' ' GLU . 18.4 mt -153.99 139.24 17.51 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.905 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 242' ' ' PHE . . . . . 0.599 ' CD1' ' O ' ' A' ' 241' ' ' LEU . 5.7 m-85 -159.13 122.87 3.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.865 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 243' ' ' ARG . . . . . 0.493 ' CG ' ' O ' ' A' ' 243' ' ' ARG . 19.0 ptt-85 -61.05 118.06 6.29 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.861 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 16.3 t -114.08 -179.22 3.57 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.86 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 71.3 p -127.83 162.2 27.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.137 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -50.58 -56.13 13.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.058 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -50.2 -52.31 36.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.145 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -49.79 -57.77 6.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.879 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.633 HG21 HD13 ' A' ' 167' ' ' ILE . 95.1 t -38.78 -66.81 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.135 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 250' ' ' GLN . . . . . 0.424 ' HA ' HD12 ' A' ' 253' ' ' LEU . 15.0 mt-30 -38.64 -48.79 1.5 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.948 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -60.32 -44.56 95.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.93 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 98.7 t -60.76 -44.93 98.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.146 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.424 HD12 ' HA ' ' A' ' 250' ' ' GLN . 17.3 mt -58.39 -49.43 77.28 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.915 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 28.3 m120 -61.07 -47.02 88.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.89 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 57.2 ttt180 -41.93 -44.04 3.3 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.883 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 256' ' ' PHE . . . . . 0.435 ' CE1' ' HB ' ' A' ' 210' ' ' THR . 49.9 m-85 -73.44 -40.08 64.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.911 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 5.4 m -60.3 -54.44 45.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.896 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 13.6 t -72.54 -50.6 24.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.863 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 259' ' ' ALA . . . . . . . . . . . . . . . 44.15 41.16 4.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.091 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 25.3 m -121.5 84.69 2.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.814 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 45.76 -171.13 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.477 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 262' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.79 179.39 22.5 Favored 'Cis proline' 0 C--N 1.342 0.202 0 C-N-CA 122.635 -1.819 . . . . 0.0 112.335 0.088 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 46.0 p -78.04 -47.81 17.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.871 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 17.3 m 50.4 42.29 25.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.895 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.293 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.478 -179.996 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.309 0 N-CA-C 112.487 -0.245 . . . . 0.0 112.487 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 78.7 p -44.29 110.83 0.24 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.886 0.374 . . . . 0.0 110.853 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 45.0 m -121.95 144.84 48.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.846 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -161.71 162.54 34.07 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.48 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 36.1 t -94.81 101.33 13.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.895 0.378 . . . . 0.0 110.905 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 78.4 p -90.8 159.81 16.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.857 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -152.13 -90.39 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.494 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -174.62 114.76 0.52 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.454 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -134.1 -85.96 0.25 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.486 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.453 HG22 HG23 ' A' ' 156' ' ' VAL . 1.9 m -97.58 25.09 6.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.79 0.328 . . . . 0.0 111.123 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 10.5 t -82.06 -4.72 57.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.858 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 69.8 m-20 -95.97 -44.72 7.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.911 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -73.91 -28.53 61.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.916 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.594 HG22 HD21 ' A' ' 200' ' ' LEU . 73.7 t -79.55 -43.07 23.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.156 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -41.07 -58.05 1.86 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.112 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -59.66 -44.42 93.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.94 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 28.1 t80 -53.49 -42.61 67.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.897 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 86.6 mt -88.97 -16.44 31.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.93 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 8.5 t -61.38 -32.29 72.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.843 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 43.3 mmtt -61.05 126.45 27.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.872 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -102.33 152.87 20.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.858 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 11.3 m-20 68.92 38.82 1.97 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.888 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.6 ' OE1' HG21 ' A' ' 193' ' ' THR . 5.4 mm-40 -128.8 146.08 51.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.923 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 60.8 t -100.31 106.48 19.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.125 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 36.0 mt -77.19 138.86 19.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.11 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 96.1 t -123.06 130.8 74.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.107 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' ARG . . . . . 0.537 ' HG3' ' CE1' ' A' ' 214' ' ' PHE . 25.6 ttm180 -88.34 113.08 23.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.857 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 170' ' ' MET . . . . . 0.518 ' CE ' HD21 ' A' ' 173' ' ' LEU . 97.8 mtp -98.15 126.51 43.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.873 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.62 ' O ' HG23 ' A' ' 239' ' ' ILE . 24.2 mtt180 -123.51 157.5 33.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.877 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 73.79 21.93 78.75 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.479 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.527 HD23 HD13 ' A' ' 239' ' ' ILE . 19.8 mt -74.39 127.5 87.5 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.616 0.722 . . . . 0.0 110.913 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_exo -47.96 149.32 5.73 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.666 2.244 . . . . 0.0 112.349 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 10.8 m-30 -62.49 -26.1 68.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.899 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 63.5 p -90.47 -25.62 20.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.152 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -44.91 126.52 5.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.076 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 5.9 p -125.17 176.49 6.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.15 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -57.12 -36.18 70.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.113 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -68.71 -15.83 63.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.922 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -88.53 -22.43 23.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.86 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.487 HG12 ' CD1' ' A' ' 192' ' ' ILE . 22.4 t -83.94 -52.79 12.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.16 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.425 ' C ' ' O ' ' A' ' 182' ' ' VAL . 47.7 t -36.04 -47.51 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.138 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -74.71 -36.6 62.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.101 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.605 ' HD2' HD12 ' A' ' 234' ' ' LEU . 15.5 t80 -48.51 -59.27 3.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.877 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 186' ' ' PHE . . . . . 0.572 ' CE1' ' CE1' ' A' ' 185' ' ' PHE . 57.2 m-85 -92.18 -21.31 20.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.898 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -49.13 -19.16 1.47 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.481 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 12.4 mm100 -56.35 -75.19 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.866 0.365 . . . . 0.0 110.949 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 2.5 t-160 -117.49 -6.28 11.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.869 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 87.0 m -126.86 86.31 59.03 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.552 0.692 . . . . 0.0 110.9 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 133.62 26.1 Favored 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.689 2.259 . . . . 0.0 112.357 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 192' ' ' ILE . . . . . 0.553 HG23 ' O ' ' A' ' 216' ' ' LEU . 57.9 mt -85.26 145.58 7.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.129 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 193' ' ' THR . . . . . 0.6 HG21 ' OE1' ' A' ' 165' ' ' GLN . 90.9 m -73.66 107.43 5.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.105 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 93.16 -21.85 37.91 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.459 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 78.72 -122.89 6.0 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.476 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.77 -20.71 9.09 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.719 0.295 . . . . 0.0 110.89 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -85.22 -24.87 27.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.895 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 198' ' ' GLY . . . . . 0.443 ' HA2' HD12 ' A' ' 216' ' ' LEU . . . -93.4 40.27 2.82 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.46 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.41 HG22 ' N ' ' A' ' 200' ' ' LEU . 35.2 mt -142.75 153.0 17.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.896 0.379 . . . . 0.0 111.104 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.594 HD21 HG22 ' A' ' 156' ' ' VAL . 13.3 tp -146.34 110.96 5.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.925 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -92.89 109.81 21.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.871 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.486 HG23 ' HA ' ' A' ' 213' ' ' ALA . 11.0 t -70.99 128.05 33.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.121 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -133.04 142.66 48.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.134 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 204' ' ' TYR . . . . . 0.448 ' N ' HG23 ' A' ' 210' ' ' THR . 27.1 m-85 -51.4 159.12 1.22 Allowed Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.708 0.766 . . . . 0.0 110.943 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 3.4 2.78 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.648 2.232 . . . . 0.0 112.38 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -112.55 -21.32 11.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.867 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 118.03 9.69 9.59 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.489 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -92.48 141.45 24.75 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.581 0.705 . . . . 0.0 110.887 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 106.49 1.67 Allowed 'Trans proline' 0 C--O 1.233 0.225 0 C-N-CA 122.69 2.26 . . . . 0.0 112.333 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 210' ' ' THR . . . . . 0.527 ' HB ' ' CE1' ' A' ' 256' ' ' PHE . 71.0 p -66.11 -23.4 66.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.131 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 95.49 -22.59 38.07 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.501 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 212' ' ' ASP . . . . . 0.428 ' OD1' ' CZ ' ' A' ' 256' ' ' PHE . 1.0 OUTLIER -90.16 157.03 17.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.776 0.322 . . . . 0.0 110.899 -179.988 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 213' ' ' ALA . . . . . 0.486 ' HA ' HG23 ' A' ' 202' ' ' VAL . . . -159.37 178.73 9.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.107 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 214' ' ' PHE . . . . . 0.537 ' CE1' ' HG3' ' A' ' 169' ' ' ARG . 55.4 m-85 -143.64 145.65 32.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.909 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 215' ' ' VAL . . . . . 0.45 HG12 ' N ' ' A' ' 216' ' ' LEU . 4.0 t -131.9 162.02 40.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.137 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.553 ' O ' HG23 ' A' ' 192' ' ' ILE . 45.3 mt -111.8 137.45 49.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.903 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -130.12 142.39 50.6 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.881 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 218' ' ' ALA . . . . . 0.853 ' HB3' ' CD2' ' A' ' 222' ' ' TYR . . . -50.32 -61.66 2.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.093 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 219' ' ' CYS . . . . . . . . . . . . . 1.9 t -153.11 175.3 13.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.833 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -49.2 -31.31 8.32 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.891 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -51.57 -36.07 43.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.918 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 222' ' ' TYR . . . . . 0.853 ' CD2' ' HB3' ' A' ' 218' ' ' ALA . 33.3 m-85 -92.02 -41.51 10.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.926 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -56.81 -54.41 46.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.114 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 10.2 mm-40 -50.37 -52.11 40.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.893 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 22.4 m-20 -58.6 -23.84 59.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.858 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -79.48 -45.88 18.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.112 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 57.3 mt -52.13 -35.67 49.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.898 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 65.5 mtp180 -56.77 -29.56 62.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.912 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 229' ' ' LYS . . . . . 0.465 ' O ' ' C ' ' A' ' 230' ' ' HIS . 16.3 mtpp -74.7 -0.69 18.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.896 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 230' ' ' HIS . . . . . 0.504 ' CE1' ' HG2' ' A' ' 231' ' ' LYS . 48.5 t-80 -33.35 141.39 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.842 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.504 ' HG2' ' CE1' ' A' ' 230' ' ' HIS . 13.1 mmtp 59.78 26.62 15.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.9 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -53.42 177.96 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.853 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.582 HD21 ' CD1' ' A' ' 238' ' ' TYR . 32.9 mt -136.58 105.03 5.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.97 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 234' ' ' LEU . . . . . 0.605 HD12 ' HD2' ' A' ' 185' ' ' PHE . 7.0 tt -113.94 115.53 27.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.9 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 59.17 37.18 91.39 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.484 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 62.9 mttt 69.08 52.57 0.49 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.809 0.338 . . . . 0.0 110.877 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 23.2 mmt180 -155.99 117.26 3.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.879 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 238' ' ' TYR . . . . . 0.582 ' CD1' HD21 ' A' ' 233' ' ' LEU . 96.1 m-85 -69.17 133.99 48.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.95 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 0.62 HG23 ' O ' ' A' ' 171' ' ' ARG . 76.2 mt -132.59 135.96 56.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.136 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 240' ' ' GLU . . . . . 0.558 ' HB3' ' CZ ' ' A' ' 242' ' ' PHE . 6.8 mt-10 -87.38 179.38 6.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.878 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 241' ' ' LEU . . . . . 0.59 ' O ' ' CD1' ' A' ' 242' ' ' PHE . 54.8 mt -158.29 132.62 8.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.889 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 242' ' ' PHE . . . . . 0.59 ' CD1' ' O ' ' A' ' 241' ' ' LEU . 6.7 m-85 -154.03 123.05 6.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.861 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 243' ' ' ARG . . . . . 0.486 ' CG ' ' O ' ' A' ' 243' ' ' ARG . 20.5 ptt180 -59.72 116.46 4.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.893 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 1.9 t -103.89 175.37 5.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.814 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 52.9 p -127.98 150.06 50.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.107 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -40.44 -59.35 1.34 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.056 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -52.36 -51.27 59.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.127 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 248' ' ' GLU . . . . . 0.408 ' O ' ' N ' ' A' ' 251' ' ' GLN . 13.3 tp10 -52.21 -57.29 10.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.942 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.526 HG13 ' CE2' ' A' ' 214' ' ' PHE . 86.9 t -36.85 -60.13 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.122 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 250' ' ' GLN . . . . . 0.412 ' HA ' HD12 ' A' ' 253' ' ' LEU . 41.7 mt-30 -49.89 -40.37 42.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.896 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 251' ' ' GLN . . . . . 0.408 ' N ' ' O ' ' A' ' 248' ' ' GLU . 60.9 mt-30 -69.7 -19.88 63.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.943 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 69.0 t -88.64 -26.82 5.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.111 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.412 HD12 ' HA ' ' A' ' 250' ' ' GLN . 10.5 mt -81.46 -39.17 25.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.91 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -66.41 -45.43 79.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.885 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 255' ' ' ARG . . . . . 0.507 ' CG ' ' N ' ' A' ' 256' ' ' PHE . 6.0 ptm180 -48.07 -48.72 33.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.87 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 256' ' ' PHE . . . . . 0.527 ' CE1' ' HB ' ' A' ' 210' ' ' THR . 12.9 m-85 -64.58 -41.83 96.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.891 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 57.8 m -71.39 152.07 43.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.893 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 1.9 m 38.43 32.98 0.06 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.823 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 259' ' ' ALA . . . . . . . . . . . . . . . -64.95 138.47 58.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.077 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 67.9 m -113.49 -53.29 2.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.885 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 72.71 -168.57 53.05 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.513 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 262' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.75 -40.62 1.07 Allowed 'Cis proline' 0 C--N 1.342 0.203 0 C-N-CA 122.698 -1.793 . . . . 0.0 112.349 0.051 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 22.1 t -97.82 -55.2 2.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.886 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 58.8 m -89.31 126.63 35.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.843 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.341 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.504 179.989 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 N-CA-C 112.478 -0.249 . . . . 0.0 112.478 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 99.9 p -54.53 130.13 38.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.89 0.376 . . . . 0.0 110.895 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 27.4 p -98.47 111.44 23.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.863 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -85.23 -45.98 5.72 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.46 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 38.3 p -149.53 146.38 27.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.856 0.36 . . . . 0.0 110.839 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 89.3 p -45.24 -43.9 10.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.837 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -83.64 -76.07 1.17 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.524 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 41.61 -105.57 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.539 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.471 ' O ' ' ND2' ' A' ' 154' ' ' ASN . . . -111.66 162.62 12.38 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.504 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.89 HG22 HG23 ' A' ' 156' ' ' VAL . 2.8 m -91.46 -38.45 12.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.811 0.339 . . . . 0.0 111.165 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' SER . . . . . 0.426 ' C ' ' O ' ' A' ' 152' ' ' THR . 64.5 p -35.13 -34.56 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.853 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' ASN . . . . . 0.471 ' ND2' ' O ' ' A' ' 151' ' ' GLY . 3.3 m-80 -61.52 -56.8 16.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.896 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -69.6 -35.57 75.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.884 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.89 HG23 HG22 ' A' ' 152' ' ' THR . 74.4 t -63.41 -36.51 76.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.11 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -38.9 -63.89 0.49 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.098 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 89.7 mm-40 -57.58 -48.09 80.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.903 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 28.0 t80 -47.68 -41.81 23.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.857 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 33.0 mt -83.98 -31.95 25.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.91 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 18.1 t -47.3 -41.24 18.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.85 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' LYS . . . . . 0.687 ' HG3' HD13 ' A' ' 216' ' ' LEU . 0.7 OUTLIER -38.39 129.57 1.35 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.904 179.908 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -110.63 133.63 53.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.862 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' ASN . . . . . 0.407 ' O ' ' NE2' ' A' ' 165' ' ' GLN . 2.0 m-20 74.24 43.33 0.29 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.884 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.407 ' NE2' ' O ' ' A' ' 164' ' ' ASN . 39.8 mm-40 -128.38 168.02 16.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.939 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.414 HG11 ' CB ' ' A' ' 223' ' ' ALA . 55.6 t -118.71 141.33 38.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.111 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' ILE . . . . . 0.583 HD12 ' N ' ' A' ' 246' ' ' ALA . 8.6 mt -111.61 143.92 20.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.103 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 97.9 t -127.14 133.72 67.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.087 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 70.2 ttt180 -91.14 112.83 24.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.868 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' MET . . . . . 0.46 ' CE ' HD21 ' A' ' 173' ' ' LEU . 91.0 mtp -100.43 149.56 23.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.89 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 35.0 mtp180 -146.75 133.87 20.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.909 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 96.51 19.28 28.02 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.513 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.523 ' CD1' ' HB3' ' A' ' 213' ' ' ALA . 24.3 mt -71.18 121.12 83.29 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.639 0.733 . . . . 0.0 110.907 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 174' ' ' PRO . . . . . 0.413 ' HG3' ' CB ' ' A' ' 237' ' ' ARG . 64.9 Cg_exo -47.97 131.66 21.43 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.703 2.269 . . . . 0.0 112.326 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 175' ' ' PHE . . . . . 0.554 ' CD1' ' HG3' ' A' ' 209' ' ' PRO . 11.6 t80 -37.52 -49.42 1.06 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.885 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.424 ' O ' ' C ' ' A' ' 177' ' ' ALA . 14.4 p -68.39 -44.98 73.91 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.141 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' A' ' 176' ' ' THR . . . -35.72 111.25 0.13 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.104 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -115.48 -177.16 3.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.161 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.409 ' HB1' ' HA ' ' A' ' 196' ' ' LYS . . . -50.01 -47.87 52.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.12 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 180' ' ' GLU . . . . . 0.407 ' CG ' ' OE2' ' A' ' 181' ' ' GLU . 5.7 pt-20 -51.67 -40.01 59.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.923 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 181' ' ' GLU . . . . . 0.407 ' OE2' ' CG ' ' A' ' 180' ' ' GLU . 0.1 OUTLIER -65.94 -36.99 84.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.876 -179.95 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.505 HG12 HD11 ' A' ' 192' ' ' ILE . 89.9 t -69.47 -50.36 51.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.155 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.418 ' C ' ' O ' ' A' ' 182' ' ' VAL . 34.4 t -35.55 -50.89 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.161 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -75.4 -42.28 54.17 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.127 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.715 ' HD2' HD12 ' A' ' 234' ' ' LEU . 10.2 t80 -40.2 -62.03 0.8 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.906 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 186' ' ' PHE . . . . . 0.527 ' CE1' ' CE1' ' A' ' 185' ' ' PHE . 72.8 m-85 -92.81 -21.08 20.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.908 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -49.28 -17.26 1.04 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.535 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -57.95 -72.4 0.09 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.829 0.347 . . . . 0.0 110.931 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 29.5 m170 -118.22 -10.88 10.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.889 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 74.2 m -125.27 85.34 58.43 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.584 0.707 . . . . 0.0 110.89 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 146.54 60.67 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.694 2.263 . . . . 0.0 112.362 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 192' ' ' ILE . . . . . 0.762 HG23 ' O ' ' A' ' 216' ' ' LEU . 56.0 mt -98.43 143.52 12.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.156 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 89.1 m -67.99 101.21 1.08 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.182 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 92.23 -12.18 70.26 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.485 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 68.22 -123.48 17.6 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.461 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 196' ' ' LYS . . . . . 0.409 ' HA ' ' HB1' ' A' ' 179' ' ' ALA . 13.9 pttp -49.23 -29.46 5.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.766 0.317 . . . . 0.0 110.921 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -75.6 -31.35 59.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.879 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -94.29 41.83 2.54 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.464 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.557 HG12 HG13 ' A' ' 215' ' ' VAL . 87.0 mt -140.35 147.84 22.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.887 0.375 . . . . 0.0 111.117 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 13.4 tp -141.57 127.09 18.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.89 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -105.43 120.71 42.27 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.889 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.443 HG23 ' HA ' ' A' ' 213' ' ' ALA . 20.1 t -78.69 134.19 28.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.088 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 203' ' ' THR . . . . . 0.501 ' HA ' HG23 ' A' ' 210' ' ' THR . 0.8 OUTLIER -138.55 136.61 36.24 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.09 -179.974 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 204' ' ' TYR . . . . . 0.646 ' N ' HG23 ' A' ' 210' ' ' THR . 33.4 m-85 -46.8 158.71 0.4 Allowed Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.618 0.723 . . . . 0.0 110.955 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 3.49 2.75 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.669 2.246 . . . . 0.0 112.354 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -112.9 -19.13 12.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.817 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 120.43 -3.74 12.31 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.492 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.0 140.45 62.2 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.574 0.702 . . . . 0.0 110.895 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 209' ' ' PRO . . . . . 0.554 ' HG3' ' CD1' ' A' ' 175' ' ' PHE . 54.4 Cg_endo -69.72 102.67 1.05 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.672 2.248 . . . . 0.0 112.37 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 210' ' ' THR . . . . . 0.646 HG23 ' N ' ' A' ' 204' ' ' TYR . 37.6 p -61.39 -13.29 18.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.173 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 82.63 -39.62 2.7 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.525 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -71.05 161.6 30.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.834 0.349 . . . . 0.0 110.848 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 213' ' ' ALA . . . . . 0.523 ' HB3' ' CD1' ' A' ' 173' ' ' LEU . . . -160.41 -177.6 6.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.115 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -148.06 137.49 22.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.852 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 215' ' ' VAL . . . . . 0.557 HG13 HG12 ' A' ' 199' ' ' ILE . 3.3 t -124.09 165.68 20.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.084 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.762 ' O ' HG23 ' A' ' 192' ' ' ILE . 47.7 mt -116.96 145.62 43.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.935 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -134.31 151.5 51.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.84 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -60.0 -59.22 5.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.135 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 219' ' ' CYS . . . . . . . . . . . . . 1.8 t -144.48 177.71 8.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.854 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.487 ' HA ' ' HB3' ' A' ' 223' ' ' ALA . 13.7 mp0 -58.71 -35.36 72.53 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.865 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -43.55 -38.5 2.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.924 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 222' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -92.98 -34.69 13.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.933 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.487 ' HB3' ' HA ' ' A' ' 220' ' ' GLU . . . -61.6 -59.67 4.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.135 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 224' ' ' GLN . . . . . 0.455 ' HA ' HD12 ' A' ' 227' ' ' LEU . 3.1 pt20 -60.41 -37.17 79.99 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.957 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 14.4 m-20 -68.03 -24.03 65.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.874 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -79.89 -32.52 40.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.087 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 227' ' ' LEU . . . . . 0.455 HD12 ' HA ' ' A' ' 224' ' ' GLN . 20.2 mt -56.18 -31.52 63.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.947 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 9.1 mtp-105 -59.8 -18.37 43.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.866 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 229' ' ' LYS . . . . . 0.595 ' HE3' ' CE1' ' A' ' 185' ' ' PHE . 24.8 mtpp -82.06 -1.16 47.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.873 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 230' ' ' HIS . . . . . 0.61 ' N ' HD12 ' A' ' 241' ' ' LEU . 75.6 t60 -34.3 136.98 0.12 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.897 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.448 ' HG2' ' CD2' ' A' ' 230' ' ' HIS . 24.1 mmtt 59.35 36.29 23.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.908 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -62.97 -176.99 0.14 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.902 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.661 HD21 ' CE1' ' A' ' 238' ' ' TYR . 30.8 mt -137.83 117.31 12.89 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.896 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 234' ' ' LEU . . . . . 0.715 HD12 ' HD2' ' A' ' 185' ' ' PHE . 6.6 tt -126.77 112.25 15.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.935 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 59.51 36.2 88.44 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.498 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 30.3 mttp 71.69 52.62 0.22 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.783 0.325 . . . . 0.0 110.861 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 237' ' ' ARG . . . . . 0.413 ' CB ' ' HG3' ' A' ' 174' ' ' PRO . 59.5 mmt-85 -156.39 115.35 3.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.876 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 238' ' ' TYR . . . . . 0.661 ' CE1' HD21 ' A' ' 233' ' ' LEU . 96.8 m-85 -68.68 136.66 53.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.908 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 79.5 mt -132.87 131.34 59.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.111 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 240' ' ' GLU . . . . . 0.468 ' HB3' ' CZ ' ' A' ' 242' ' ' PHE . 43.4 mt-10 -92.43 161.78 14.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.874 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 241' ' ' LEU . . . . . 0.61 HD12 ' N ' ' A' ' 230' ' ' HIS . 20.2 mt -136.87 140.15 42.17 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.892 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 242' ' ' PHE . . . . . 0.499 ' CD1' ' O ' ' A' ' 241' ' ' LEU . 22.6 m-85 -153.14 128.22 9.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.82 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 20.3 mtp180 -44.04 153.48 0.14 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.884 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 1.1 t -152.55 160.13 43.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.901 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 41.6 p -138.41 157.67 45.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.088 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 246' ' ' ALA . . . . . 0.583 ' N ' HD12 ' A' ' 167' ' ' ILE . . . -37.45 -59.06 0.8 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.114 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -53.27 -56.59 15.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.151 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 248' ' ' GLU . . . . . 0.741 ' O ' HG23 ' A' ' 252' ' ' VAL . 11.7 tp10 -44.59 -51.95 8.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.878 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.418 ' O ' ' N ' ' A' ' 252' ' ' VAL . 98.4 t -47.02 -66.79 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.139 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 250' ' ' GLN . . . . . 0.586 ' HA ' HD12 ' A' ' 253' ' ' LEU . 50.7 mt-30 -43.25 -50.06 6.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.929 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 51.1 mm-40 -59.67 -30.18 68.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.918 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 252' ' ' VAL . . . . . 0.741 HG23 ' O ' ' A' ' 248' ' ' GLU . 92.7 t -75.92 -36.98 33.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.1 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.586 HD12 ' HA ' ' A' ' 250' ' ' GLN . 8.5 mt -68.47 -37.73 80.41 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.893 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -66.28 -59.53 3.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.868 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 255' ' ' ARG . . . . . 0.476 ' HG3' ' N ' ' A' ' 256' ' ' PHE . 0.4 OUTLIER -41.21 -38.08 1.05 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.898 -179.94 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 256' ' ' PHE . . . . . 0.476 ' N ' ' HG3' ' A' ' 255' ' ' ARG . 10.2 m-85 -81.71 -53.1 6.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.868 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 34.7 t -52.86 -58.5 6.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.83 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 37.4 m -89.78 89.05 7.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.828 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 259' ' ' ALA . . . . . . . . . . . . . . . -114.13 -41.96 3.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.134 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 27.0 p -130.71 130.03 43.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.872 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 261' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 262' ' ' PRO . . . 81.99 82.53 0.85 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.514 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 262' ' ' PRO . . . . . 0.499 ' O ' ' N ' ' A' ' 261' ' ' GLY . 53.5 Cg_endo -69.76 173.51 44.3 Favored 'Cis proline' 0 C--N 1.342 0.189 0 C-N-CA 122.677 -1.801 . . . . 0.0 112.355 0.059 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 69.8 p -128.96 156.93 42.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.845 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 43.8 p -60.05 129.98 44.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.827 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.492 179.971 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.258 0 N-CA-C 112.471 -0.252 . . . . 0.0 112.471 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 93.6 p -118.77 142.93 47.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.872 0.368 . . . . 0.0 110.834 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 12.9 t -107.67 141.56 38.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.866 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 131.1 -151.53 19.69 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.537 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 19.0 m -72.66 -43.87 62.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.931 0.396 . . . . 0.0 110.885 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 85.5 p -91.91 147.01 23.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.846 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 96.0 -107.09 3.47 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.448 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -143.48 -148.52 4.93 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.495 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 64.84 102.08 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.473 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.829 HG22 HG23 ' A' ' 156' ' ' VAL . 2.3 m -90.77 107.18 19.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.754 0.311 . . . . 0.0 111.14 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 62.3 p -126.79 -36.94 2.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.848 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -72.58 -52.41 15.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.902 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -64.53 -46.03 84.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.894 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.829 HG23 HG22 ' A' ' 152' ' ' THR . 57.5 t -54.73 -43.29 65.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.168 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -43.49 -50.96 6.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.11 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 46.4 mm-40 -65.21 -37.25 86.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.939 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' PHE . . . . . 0.567 ' CE1' ' HG ' ' A' ' 216' ' ' LEU . 64.0 t80 -60.14 -41.32 92.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.886 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 86.3 mt -90.98 -16.59 27.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.893 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 46.5 t -62.62 -35.79 80.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.841 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' LYS . . . . . 0.489 ' HD2' HD13 ' A' ' 216' ' ' LEU . 12.5 mttp -58.99 120.13 8.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.895 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' GLU . . . . . 0.54 ' O ' ' NE2' ' A' ' 165' ' ' GLN . 37.6 mp0 -94.61 155.83 16.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.852 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 11.1 m-80 63.45 48.89 3.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.866 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.54 ' NE2' ' O ' ' A' ' 163' ' ' GLU . 32.0 mm-40 -131.87 162.21 31.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.878 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.725 HG11 ' CB ' ' A' ' 223' ' ' ALA . 89.5 t -116.73 111.13 33.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.138 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' ILE . . . . . 0.71 HG21 HG21 ' A' ' 249' ' ' VAL . 30.5 mt -85.33 142.09 13.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.082 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 40.8 t -127.51 142.52 43.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.155 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 30.0 ttp180 -91.75 115.18 27.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.863 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' MET . . . . . 0.897 ' CE ' HD21 ' A' ' 173' ' ' LEU . 66.9 mtp -102.63 125.39 49.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.919 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.432 ' HB2' ' NH1' ' A' ' 171' ' ' ARG . 3.3 ttm105 -131.4 139.73 49.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.84 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 90.23 23.09 32.97 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.494 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.897 HD21 ' CE ' ' A' ' 170' ' ' MET . 26.3 mt -74.9 128.03 85.88 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.589 0.709 . . . . 0.0 110.924 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 174' ' ' PRO . . . . . 0.484 ' HG3' ' CB ' ' A' ' 237' ' ' ARG . 64.7 Cg_exo -48.01 130.83 20.56 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.719 2.279 . . . . 0.0 112.36 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -47.93 -22.71 0.62 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.877 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 41.4 p -91.57 -29.39 16.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.118 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -48.77 137.95 11.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.043 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -139.38 171.82 13.71 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.114 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.477 ' N ' ' CZ ' ' A' ' 201' ' ' PHE . . . -47.04 -47.38 22.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.106 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -57.02 -26.66 60.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.882 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' GLU . . . . . 0.817 ' HG2' HD11 ' A' ' 234' ' ' LEU . 6.7 tt0 -79.71 -35.58 38.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.898 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.405 HG12 HD11 ' A' ' 192' ' ' ILE . 48.1 t -74.01 -42.45 52.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.117 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 45.6 t -42.24 -45.81 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.153 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -81.66 -32.49 31.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.102 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.5 ' HD2' HD12 ' A' ' 234' ' ' LEU . 41.2 t80 -49.27 -59.44 3.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.863 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -90.51 -24.32 20.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.829 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -48.97 -22.14 2.83 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.516 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 33.1 tp60 -53.08 -70.85 0.08 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.864 0.364 . . . . 0.0 110.884 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 8.9 m80 -118.3 -15.33 9.75 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.862 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 74.7 m -119.88 88.24 39.78 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.592 0.71 . . . . 0.0 110.839 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' PRO . . . . . 0.501 ' HD2' ' CD1' ' A' ' 222' ' ' TYR . 53.7 Cg_endo -69.8 131.62 21.57 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.679 2.253 . . . . 0.0 112.289 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 192' ' ' ILE . . . . . 0.748 HG23 ' O ' ' A' ' 216' ' ' LEU . 55.7 mt -83.25 142.12 13.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.155 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 87.8 m -65.32 102.66 0.7 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.152 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 88.34 -17.43 48.07 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.476 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.424 ' O ' ' N ' ' A' ' 198' ' ' GLY . . . 78.35 -128.2 8.59 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.476 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 17.2 ptmt -44.94 -29.48 0.83 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.748 0.309 . . . . 0.0 110.885 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -74.34 -34.67 63.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.884 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 198' ' ' GLY . . . . . 0.923 ' HA2' HD12 ' A' ' 216' ' ' LEU . . . -86.37 21.24 18.18 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.47 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 76.8 mt -123.56 146.22 29.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.808 0.337 . . . . 0.0 111.133 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.416 HD21 HG22 ' A' ' 156' ' ' VAL . 16.3 tp -142.32 123.18 14.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.869 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 201' ' ' PHE . . . . . 0.477 ' CZ ' ' N ' ' A' ' 179' ' ' ALA . 68.1 m-85 -104.24 112.34 25.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.887 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 25.8 t -66.57 122.55 17.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.124 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -131.83 140.34 49.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.155 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -45.79 158.31 0.35 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.685 0.755 . . . . 0.0 110.898 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 3.02 3.04 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.662 2.241 . . . . 0.0 112.339 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -112.15 -16.33 13.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.864 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 106.14 62.82 0.61 Allowed Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.439 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 7.3 mtt85 -148.26 144.26 18.53 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.602 0.715 . . . . 0.0 110.901 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 108.64 2.12 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.692 2.261 . . . . 0.0 112.318 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 74.1 p -74.02 -29.98 62.21 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.117 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 114.63 -37.04 3.68 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.498 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -78.6 169.37 18.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.836 0.35 . . . . 0.0 110.857 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 213' ' ' ALA . . . . . 0.441 ' HB3' ' CD1' ' A' ' 173' ' ' LEU . . . -170.99 174.07 4.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.145 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 214' ' ' PHE . . . . . 0.53 ' CE2' HG13 ' A' ' 249' ' ' VAL . 66.7 m-85 -139.55 136.78 34.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.865 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 215' ' ' VAL . . . . . 0.443 HG12 ' N ' ' A' ' 216' ' ' LEU . 12.6 t -117.61 158.0 18.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.156 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.923 HD12 ' HA2' ' A' ' 198' ' ' GLY . 72.2 mt -115.3 139.56 49.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.933 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -132.29 149.47 52.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.86 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 218' ' ' ALA . . . . . 0.679 ' HB3' ' CD2' ' A' ' 222' ' ' TYR . . . -49.87 -65.67 0.52 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.124 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 219' ' ' CYS . . . . . . . . . . . . . 1.8 t -141.57 179.14 6.99 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.876 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.404 ' C ' ' OE1' ' A' ' 220' ' ' GLU . 0.0 OUTLIER -60.21 -16.4 32.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.875 -179.892 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -63.2 -47.48 82.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.87 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 222' ' ' TYR . . . . . 0.679 ' CD2' ' HB3' ' A' ' 218' ' ' ALA . 62.4 m-85 -78.44 -46.35 20.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.92 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.725 ' CB ' HG11 ' A' ' 166' ' ' VAL . . . -50.22 -50.35 49.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.066 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 23.6 mm-40 -54.28 -53.09 58.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.93 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 55.0 m-20 -57.6 -25.62 60.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.873 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -74.96 -30.76 61.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.151 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 69.5 mt -62.47 -35.37 79.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.908 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 66.1 mtp85 -56.53 -22.06 30.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.842 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 229' ' ' LYS . . . . . 0.481 ' CE ' ' CE1' ' A' ' 185' ' ' PHE . 21.2 mtpp -75.03 -2.78 28.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.876 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 230' ' ' HIS . . . . . 0.536 ' CD2' ' HG2' ' A' ' 231' ' ' LYS . 84.9 t60 -34.0 135.8 0.14 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.843 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.536 ' HG2' ' CD2' ' A' ' 230' ' ' HIS . 21.9 mmtt 62.59 29.22 16.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.875 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 232' ' ' ASP . . . . . 0.425 ' OD2' ' CE2' ' A' ' 185' ' ' PHE . 3.2 t70 -56.01 178.35 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.841 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.64 HD21 ' CE1' ' A' ' 238' ' ' TYR . 30.6 mt -137.71 105.02 5.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.927 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 234' ' ' LEU . . . . . 0.817 HD11 ' HG2' ' A' ' 181' ' ' GLU . 5.8 tt -113.59 108.16 16.77 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.876 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 60.84 44.06 98.49 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.49 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 6.8 mmmm 65.85 54.98 0.99 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.765 0.317 . . . . 0.0 110.932 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 237' ' ' ARG . . . . . 0.484 ' CB ' ' HG3' ' A' ' 174' ' ' PRO . 17.5 mmt85 -156.84 115.11 3.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.863 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 238' ' ' TYR . . . . . 0.64 ' CE1' HD21 ' A' ' 233' ' ' LEU . 97.3 m-85 -70.4 120.81 16.61 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.952 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 0.66 HD13 HD23 ' A' ' 173' ' ' LEU . 19.8 mt -116.27 137.8 48.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.154 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -101.1 171.18 7.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.905 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 241' ' ' LEU . . . . . 0.401 ' O ' ' CD1' ' A' ' 242' ' ' PHE . 28.8 mt -147.2 145.26 29.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.873 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 242' ' ' PHE . . . . . 0.401 ' CD1' ' O ' ' A' ' 241' ' ' LEU . 28.7 m-85 -155.75 129.43 8.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.878 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 42.4 mtm180 -44.62 140.88 2.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.846 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 9.2 t -140.6 148.4 40.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.857 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 245' ' ' THR . . . . . 0.405 ' O ' HG23 ' A' ' 249' ' ' VAL . 43.0 p -119.88 161.21 21.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.133 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -48.22 -48.68 34.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.104 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -58.87 -53.79 54.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.065 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 248' ' ' GLU . . . . . 0.496 ' O ' HG23 ' A' ' 252' ' ' VAL . 8.9 tp10 -49.07 -50.84 34.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.886 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.71 HG21 HG21 ' A' ' 167' ' ' ILE . 95.0 t -50.8 -61.92 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.141 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 59.3 mt-30 -44.7 -50.02 10.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.879 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -58.64 -38.63 78.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.932 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 252' ' ' VAL . . . . . 0.496 HG23 ' O ' ' A' ' 248' ' ' GLU . 69.4 t -67.92 -44.31 85.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.115 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.559 HD11 HG12 ' A' ' 249' ' ' VAL . 9.6 mt -65.77 -45.45 82.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.93 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 42.2 m-20 -68.7 -27.23 65.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.884 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 255' ' ' ARG . . . . . 0.469 ' HD3' ' N ' ' A' ' 256' ' ' PHE . 0.6 OUTLIER -72.58 -53.32 12.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.866 -179.965 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 256' ' ' PHE . . . . . 0.469 ' N ' ' HD3' ' A' ' 255' ' ' ARG . 11.1 m-85 -59.44 -44.36 92.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.931 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 91.7 p -58.62 -39.2 79.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.872 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 9.0 t -114.05 71.49 0.75 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.862 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 259' ' ' ALA . . . . . . . . . . . . . . . -102.8 148.04 26.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.113 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 2.0 t -63.38 120.91 12.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.888 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -148.72 -167.98 14.2 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.533 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 262' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.73 116.18 2.64 Favored 'Cis proline' 0 C--N 1.341 0.141 0 C-N-CA 122.695 -1.794 . . . . 0.0 112.345 0.009 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 5.7 t -169.33 143.5 2.9 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.818 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 83.2 p -104.94 167.85 9.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.902 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.347 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.483 -179.976 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.249 0 N-CA-C 112.46 -0.256 . . . . 0.0 112.46 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 3.1 m -53.65 -52.81 58.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.847 0.356 . . . . 0.0 110.794 -179.66 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 4.0 m -109.97 -56.51 2.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.874 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -54.21 150.54 15.11 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.483 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 26.5 m -147.91 121.98 9.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.906 0.384 . . . . 0.0 110.826 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 35.9 m -147.8 143.32 27.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.888 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 117.57 179.94 17.37 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.505 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 155.1 159.26 9.19 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.472 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 51.18 -115.0 3.23 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.526 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.477 HG22 ' HB ' ' A' ' 156' ' ' VAL . 17.8 m -134.28 142.65 47.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.794 0.33 . . . . 0.0 111.14 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 1.1 t -73.48 137.55 44.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.89 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -40.72 -58.97 1.5 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.869 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -44.41 -39.76 4.95 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.927 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.477 ' HB ' HG22 ' A' ' 152' ' ' THR . 99.3 t -75.09 -47.0 38.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.125 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.417 ' C ' ' O ' ' A' ' 156' ' ' VAL . . . -36.83 -58.19 0.77 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.101 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 27.6 mm-40 -58.02 -50.46 73.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.907 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' PHE . . . . . 0.474 ' CE2' ' HG ' ' A' ' 216' ' ' LEU . 47.3 t80 -50.41 -42.82 54.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.863 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.454 HD12 HG12 ' A' ' 156' ' ' VAL . 62.6 mt -85.79 -21.21 28.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.906 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' SER . . . . . 0.417 ' N ' ' O ' ' A' ' 157' ' ' ALA . 15.6 t -58.12 -24.53 59.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.846 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' LYS . . . . . 0.451 ' HG3' HD13 ' A' ' 216' ' ' LEU . 24.2 mmmt -65.52 131.1 45.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.893 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -109.66 154.99 22.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.923 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 63.19 42.72 6.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.892 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 20.5 mm-40 -127.86 156.57 42.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.914 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 47.1 t -108.63 100.76 11.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.158 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' ILE . . . . . 0.546 HG21 HG21 ' A' ' 249' ' ' VAL . 49.3 mt -75.27 140.27 17.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.099 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 39.0 t -127.92 134.21 65.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.117 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' ARG . . . . . 0.543 ' HG3' ' CE1' ' A' ' 214' ' ' PHE . 18.1 ttm180 -90.1 125.43 35.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.872 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' MET . . . . . 0.658 ' HE2' HD21 ' A' ' 173' ' ' LEU . 59.5 mtp -115.41 111.8 21.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.893 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -114.8 151.66 33.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.884 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 84.23 16.7 66.33 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.502 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.807 HD23 HD13 ' A' ' 239' ' ' ILE . 19.7 mt -71.57 133.99 84.5 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.615 0.721 . . . . 0.0 110.886 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 174' ' ' PRO . . . . . 0.485 ' O ' ' N ' ' A' ' 177' ' ' ALA . 65.3 Cg_exo -47.99 127.57 15.02 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.675 2.25 . . . . 0.0 112.328 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 175' ' ' PHE . . . . . 0.436 ' C ' ' O ' ' A' ' 174' ' ' PRO . 11.2 m-85 -34.68 -45.37 0.24 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.865 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.753 ' O ' HG23 ' A' ' 178' ' ' THR . 0.0 OUTLIER -74.56 -39.0 62.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.098 -179.894 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.485 ' N ' ' O ' ' A' ' 174' ' ' PRO . . . -33.78 122.54 0.45 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.071 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.753 HG23 ' O ' ' A' ' 176' ' ' THR . 25.9 p -132.46 173.04 11.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.113 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.496 ' N ' ' CZ ' ' A' ' 201' ' ' PHE . . . -42.22 -47.52 4.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.044 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -51.26 -37.74 48.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.866 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' GLU . . . . . 0.518 ' OE1' HD21 ' A' ' 234' ' ' LEU . 56.7 mm-40 -70.52 -34.91 72.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.867 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.548 HG12 ' CD1' ' A' ' 192' ' ' ILE . 92.4 t -71.29 -53.59 20.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.16 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.444 ' C ' ' O ' ' A' ' 182' ' ' VAL . 76.4 t -34.05 -47.36 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.143 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -80.96 -41.47 22.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.106 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.793 ' HD2' HD12 ' A' ' 234' ' ' LEU . 4.9 t80 -40.03 -59.03 1.3 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.895 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -95.17 -21.94 18.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.901 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -49.33 -19.09 1.64 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.506 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -56.78 -70.82 0.11 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.817 0.341 . . . . 0.0 110.882 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 21.7 m80 -118.21 -15.46 9.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.877 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 79.4 m -121.15 87.51 44.16 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.57 0.7 . . . . 0.0 110.852 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 140.75 43.53 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.706 2.27 . . . . 0.0 112.34 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 192' ' ' ILE . . . . . 0.567 HG23 ' O ' ' A' ' 216' ' ' LEU . 63.1 mt -94.58 140.73 16.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.181 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 57.7 m -62.97 101.8 0.3 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.178 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 89.41 -16.24 56.6 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.483 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.481 ' O ' ' N ' ' A' ' 198' ' ' GLY . . . 67.91 -126.0 23.08 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.462 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 16.8 ptmt -42.31 -27.07 0.13 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.737 0.303 . . . . 0.0 110.906 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -81.74 -36.23 28.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.872 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 198' ' ' GLY . . . . . 0.481 ' N ' ' O ' ' A' ' 195' ' ' GLY . . . -85.16 34.82 3.19 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.47 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.482 HD13 ' HB ' ' A' ' 182' ' ' VAL . 62.5 mt -135.05 149.26 28.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.901 0.381 . . . . 0.0 111.118 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 13.4 tp -142.51 115.23 8.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.913 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 201' ' ' PHE . . . . . 0.496 ' CZ ' ' N ' ' A' ' 179' ' ' ALA . 46.9 m-85 -96.8 124.42 40.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.862 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 48.0 t -77.21 120.89 28.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.14 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -129.88 137.23 50.3 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.152 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 204' ' ' TYR . . . . . 0.695 ' CD2' HG22 ' A' ' 210' ' ' THR . 34.9 m-85 -45.39 158.59 0.31 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.689 0.756 . . . . 0.0 110.892 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.81 2.61 3.41 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.63 2.22 . . . . 0.0 112.355 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -111.12 -16.51 13.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.857 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 107.14 53.7 0.69 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.482 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 12.0 mmm180 -138.35 143.7 39.84 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.621 0.724 . . . . 0.0 110.854 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 111.53 2.84 Favored 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.711 2.274 . . . . 0.0 112.357 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 210' ' ' THR . . . . . 0.695 HG22 ' CD2' ' A' ' 204' ' ' TYR . 68.3 p -75.26 -27.84 59.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.175 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 108.41 -27.42 13.85 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.493 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -91.38 154.89 18.88 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.766 0.317 . . . . 0.0 110.894 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -155.78 -177.82 6.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.1 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 214' ' ' PHE . . . . . 0.603 ' CE2' HG13 ' A' ' 249' ' ' VAL . 81.1 m-85 -144.29 151.38 39.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.914 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 4.1 t -133.55 157.5 42.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.161 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.567 ' O ' HG23 ' A' ' 192' ' ' ILE . 29.7 mt -109.62 145.95 35.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.957 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -137.11 126.02 24.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.883 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -41.43 -50.34 3.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.115 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 219' ' ' CYS . . . . . . . . . . . . . 72.7 m -152.91 173.15 15.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.84 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -59.56 -35.78 74.91 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.839 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -37.68 -51.45 1.23 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.893 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 222' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -79.46 -42.12 26.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.945 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -48.01 -54.79 11.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.122 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -50.19 -58.79 4.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.883 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 48.8 m-20 -53.32 -22.91 8.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.872 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -88.74 -19.54 25.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.131 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 95.2 mt -72.41 -42.77 64.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.947 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 1.5 ptm180 -55.58 -19.11 9.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.823 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 229' ' ' LYS . . . . . 0.454 ' O ' ' C ' ' A' ' 230' ' ' HIS . 24.7 mtpp -72.81 -3.4 25.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.89 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 230' ' ' HIS . . . . . 0.454 ' C ' ' O ' ' A' ' 229' ' ' LYS . 83.6 t60 -34.35 138.17 0.1 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.855 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 18.0 mmtp 61.02 29.98 19.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.909 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -57.06 174.97 0.15 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.864 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.683 HD21 ' CE2' ' A' ' 238' ' ' TYR . 31.0 mt -131.07 108.94 10.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.914 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 234' ' ' LEU . . . . . 0.793 HD12 ' HD2' ' A' ' 185' ' ' PHE . 6.6 tt -118.34 114.65 23.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.894 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 56.4 44.0 90.03 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.479 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.433 ' HA ' ' NZ ' ' A' ' 236' ' ' LYS . 0.0 OUTLIER 63.74 52.75 2.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.802 0.334 . . . . 0.0 110.904 -179.997 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 237' ' ' ARG . . . . . 0.422 ' CB ' ' HG3' ' A' ' 174' ' ' PRO . 19.6 mmt180 -156.44 115.19 3.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.855 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 238' ' ' TYR . . . . . 0.683 ' CE2' HD21 ' A' ' 233' ' ' LEU . 92.2 m-85 -70.51 126.13 28.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.963 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 0.807 HD13 HD23 ' A' ' 173' ' ' LEU . 66.2 mt -122.7 136.76 58.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.123 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 240' ' ' GLU . . . . . 0.511 ' HB3' ' CZ ' ' A' ' 242' ' ' PHE . 24.2 mp0 -96.68 158.94 15.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.883 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 241' ' ' LEU . . . . . 0.443 ' C ' ' CG ' ' A' ' 242' ' ' PHE . 14.5 mt -136.85 147.77 46.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.961 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 242' ' ' PHE . . . . . 0.511 ' CZ ' ' HB3' ' A' ' 240' ' ' GLU . 7.3 m-85 -158.52 139.47 12.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.84 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 22.8 mtm180 -64.3 128.65 36.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.869 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 1.8 t -128.02 167.21 17.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.854 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 245' ' ' THR . . . . . 0.449 ' O ' ' C ' ' A' ' 246' ' ' ALA . 34.1 p -131.55 148.21 52.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.099 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 246' ' ' ALA . . . . . 0.522 ' N ' HD12 ' A' ' 167' ' ' ILE . . . -34.1 -52.41 0.45 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.101 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -55.7 -54.3 45.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.09 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 -49.2 -56.01 10.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.868 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.603 HG13 ' CE2' ' A' ' 214' ' ' PHE . 59.2 t -44.04 -64.5 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.135 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 250' ' ' GLN . . . . . 0.722 ' HA ' HD12 ' A' ' 253' ' ' LEU . 25.2 mt-30 -39.69 -41.9 1.15 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.898 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 251' ' ' GLN . . . . . 0.474 ' HA ' ' ND2' ' A' ' 254' ' ' ASN . 38.9 mm-40 -68.19 -35.17 77.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.902 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 252' ' ' VAL . . . . . 0.486 ' N ' ' O ' ' A' ' 249' ' ' VAL . 82.6 t -71.22 -19.43 20.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.105 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.722 HD12 ' HA ' ' A' ' 250' ' ' GLN . 7.5 mt -86.57 -40.93 14.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.926 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 254' ' ' ASN . . . . . 0.474 ' ND2' ' HA ' ' A' ' 251' ' ' GLN . 0.4 OUTLIER -75.1 -41.83 57.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.902 179.879 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 255' ' ' ARG . . . . . 0.569 ' CD ' ' CD1' ' A' ' 256' ' ' PHE . 0.0 OUTLIER -60.09 -25.08 65.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.824 -179.955 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 256' ' ' PHE . . . . . 0.569 ' CD1' ' CD ' ' A' ' 255' ' ' ARG . 6.6 m-85 -90.6 -38.11 13.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.83 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 40.6 t -70.09 157.69 37.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.849 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 96.2 p 38.57 35.92 0.12 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.857 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 259' ' ' ALA . . . . . . . . . . . . . . . -84.27 147.59 27.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.092 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 90.4 p -95.11 -20.24 19.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.859 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 261' ' ' GLY . . . . . 0.462 ' HA3' ' N ' ' A' ' 263' ' ' SER . . . -151.97 -71.48 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.5 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 262' ' ' PRO . . . . . 0.426 ' C ' ' HA3' ' A' ' 261' ' ' GLY . 53.8 Cg_endo -69.77 -3.91 7.99 Favored 'Cis proline' 0 C--N 1.341 0.169 0 C-N-CA 122.679 -1.801 . . . . 0.0 112.329 0.058 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 263' ' ' SER . . . . . 0.462 ' N ' ' HA3' ' A' ' 261' ' ' GLY . 37.1 m -146.76 158.65 43.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.915 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 47.6 p -136.47 134.59 37.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.825 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.31 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.488 179.993 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.334 0 N-CA-C 112.498 -0.241 . . . . 0.0 112.498 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 68.4 m -98.18 -49.95 4.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.893 0.377 . . . . 0.0 110.868 -179.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 83.4 p -48.75 -45.04 39.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.833 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 73.19 79.41 0.49 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.499 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 20.3 m -76.32 133.4 40.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.872 0.368 . . . . 0.0 110.858 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 28.7 m -158.33 176.14 12.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.875 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -152.95 95.5 0.16 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.492 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 143.24 96.87 0.24 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.526 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 55.78 179.69 0.36 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.502 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.852 HG22 HG23 ' A' ' 156' ' ' VAL . 17.1 m -111.56 119.86 40.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.769 0.319 . . . . 0.0 111.141 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 15.8 m -134.68 -42.86 0.75 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.871 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 -65.66 -48.88 70.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.93 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -67.71 -40.55 84.26 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.9 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.852 HG23 HG22 ' A' ' 152' ' ' THR . 90.9 t -64.36 -42.92 96.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.142 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.408 ' C ' ' O ' ' A' ' 156' ' ' VAL . . . -37.55 -58.69 0.85 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.084 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -60.03 -50.06 75.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.89 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -48.75 -41.72 33.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.862 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.591 HD13 HE21 ' A' ' 250' ' ' GLN . 82.0 mt -85.52 -22.52 28.12 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.931 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 44.3 t -53.76 -33.1 54.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.888 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' LYS . . . . . 0.519 ' HG3' HD13 ' A' ' 216' ' ' LEU . 42.1 mmtt -60.17 103.92 0.27 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.843 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' GLU . . . . . 0.532 ' O ' ' NE2' ' A' ' 165' ' ' GLN . 13.8 mm-40 -86.79 157.53 19.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.893 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 63.49 30.69 15.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.882 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.532 ' NE2' ' O ' ' A' ' 163' ' ' GLU . 36.9 mm-40 -121.13 148.21 44.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.881 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 4.6 t -99.17 116.83 43.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.137 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' ILE . . . . . 0.471 HD12 ' N ' ' A' ' 246' ' ' ALA . 73.2 mt -88.55 147.12 5.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.115 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.506 HG21 ' CE1' ' A' ' 217' ' ' PHE . 96.1 t -127.65 126.18 66.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.108 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 70.8 ttt180 -88.14 110.19 20.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.888 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' MET . . . . . 0.694 ' CE ' HD21 ' A' ' 173' ' ' LEU . 97.4 mtp -97.13 113.01 24.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.892 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 2.1 ttt85 -111.1 141.63 44.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.869 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 89.36 21.08 42.48 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.476 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.843 HD23 HD13 ' A' ' 239' ' ' ILE . 23.0 mt -74.79 123.89 89.28 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.588 0.708 . . . . 0.0 110.958 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_exo -47.97 145.01 10.98 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.683 2.255 . . . . 0.0 112.359 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' PHE . . . . . 0.554 ' CD1' ' HG3' ' A' ' 209' ' ' PRO . 10.4 t80 -57.0 -30.66 64.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.9 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 6.2 p -86.49 -15.88 38.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.137 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -67.53 117.41 9.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.084 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -124.35 175.24 7.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.119 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.455 ' N ' ' CZ ' ' A' ' 201' ' ' PHE . . . -41.11 -50.34 3.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.103 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -49.68 -40.23 39.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.874 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -69.36 -30.74 68.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.872 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.571 HG12 ' CD1' ' A' ' 192' ' ' ILE . 74.5 t -75.81 -55.52 11.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.1 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.45 ' C ' ' O ' ' A' ' 182' ' ' VAL . 54.5 t -33.98 -44.68 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.1 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.442 ' O ' ' C ' ' A' ' 185' ' ' PHE . . . -79.24 -47.46 15.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.124 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.576 ' HD2' HD12 ' A' ' 234' ' ' LEU . 15.8 t80 -35.32 -60.51 0.48 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.888 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 186' ' ' PHE . . . . . 0.404 ' CE1' ' CE1' ' A' ' 185' ' ' PHE . 50.5 m-85 -94.35 -20.54 19.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.88 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -49.1 -17.36 0.94 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.501 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 8.8 mm100 -59.24 -72.35 0.1 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.824 0.345 . . . . 0.0 110.88 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 28.8 m170 -117.81 -16.47 9.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.88 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 86.7 m -117.38 85.64 20.42 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.647 0.736 . . . . 0.0 110.889 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 191' ' ' PRO . . . . . 0.441 ' HD2' ' CD1' ' A' ' 222' ' ' TYR . 53.9 Cg_endo -69.79 135.78 31.24 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.715 2.277 . . . . 0.0 112.314 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 192' ' ' ILE . . . . . 0.571 ' CD1' HG12 ' A' ' 182' ' ' VAL . 61.9 mt -87.47 141.16 14.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.187 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 41.2 m -66.21 103.09 0.92 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.138 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 91.77 -16.97 58.06 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.476 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.401 ' O ' ' N ' ' A' ' 198' ' ' GLY . . . 72.13 -125.19 10.67 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.482 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 14.4 ptmt -47.36 -30.03 2.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.784 0.326 . . . . 0.0 110.943 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -75.49 -30.51 59.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.877 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 198' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 195' ' ' GLY . . . -92.82 41.22 2.75 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.498 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.473 HD13 ' HB ' ' A' ' 182' ' ' VAL . 62.6 mt -142.68 144.48 24.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.828 0.347 . . . . 0.0 111.16 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.427 HD21 HG22 ' A' ' 156' ' ' VAL . 15.6 tp -139.64 121.66 15.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.9 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 201' ' ' PHE . . . . . 0.455 ' CZ ' ' N ' ' A' ' 179' ' ' ALA . 65.0 m-85 -101.7 112.21 24.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.883 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 39.0 t -70.4 138.15 22.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.129 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 203' ' ' THR . . . . . 0.65 ' HA ' HG23 ' A' ' 210' ' ' THR . 0.8 OUTLIER -143.66 138.1 28.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.146 -179.926 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 204' ' ' TYR . . . . . 0.572 ' CD1' HG22 ' A' ' 210' ' ' THR . 32.4 m-85 -48.08 159.29 0.5 Allowed Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.699 0.762 . . . . 0.0 110.917 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.81 3.97 2.49 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.644 2.229 . . . . 0.0 112.296 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 206' ' ' ASP . . . . . 0.435 ' HB3' ' NH1' ' A' ' 208' ' ' ARG . 62.0 m-20 -112.46 -23.71 10.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.895 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 123.65 4.19 8.2 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.508 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 208' ' ' ARG . . . . . 0.435 ' NH1' ' HB3' ' A' ' 206' ' ' ASP . 0.0 OUTLIER -84.75 141.3 38.32 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.576 0.703 . . . . 0.0 110.917 -179.854 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 209' ' ' PRO . . . . . 0.554 ' HG3' ' CD1' ' A' ' 175' ' ' PHE . 53.6 Cg_endo -69.72 110.33 2.52 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.693 2.262 . . . . 0.0 112.367 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 210' ' ' THR . . . . . 0.65 HG23 ' HA ' ' A' ' 203' ' ' THR . 34.1 p -71.31 -10.85 60.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.175 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 79.89 -40.18 2.27 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.445 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -70.35 154.26 42.1 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.878 0.37 . . . . 0.0 110.874 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 213' ' ' ALA . . . . . 0.461 ' HB3' ' CD1' ' A' ' 173' ' ' LEU . . . -152.06 179.55 8.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.118 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 214' ' ' PHE . . . . . 0.611 ' CE2' HG13 ' A' ' 249' ' ' VAL . 73.9 m-85 -146.79 130.6 17.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.89 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 215' ' ' VAL . . . . . 0.515 HG12 ' N ' ' A' ' 216' ' ' LEU . 19.7 t -118.18 161.03 17.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.15 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.528 ' O ' HG23 ' A' ' 192' ' ' ILE . 26.9 mt -110.17 139.26 45.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.939 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 217' ' ' PHE . . . . . 0.506 ' CE1' HG21 ' A' ' 168' ' ' VAL . 81.2 m-85 -133.15 130.55 39.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.87 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -44.78 -57.4 3.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.106 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 219' ' ' CYS . . . . . . . . . . . . . 85.6 m -151.92 161.1 43.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.837 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -45.06 -30.3 1.04 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.877 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -43.45 -41.91 4.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.846 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 222' ' ' TYR . . . . . 0.441 ' CD1' ' HD2' ' A' ' 191' ' ' PRO . 61.1 m-85 -90.25 -47.73 7.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.91 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.416 ' O ' ' HB3' ' A' ' 226' ' ' ALA . . . -49.66 -60.87 2.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.064 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 224' ' ' GLN . . . . . 0.666 ' HA ' HD12 ' A' ' 227' ' ' LEU . 64.4 mm-40 -45.44 -57.71 3.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.889 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 55.3 m-20 -55.95 -26.65 48.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.868 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 226' ' ' ALA . . . . . 0.416 ' HB3' ' O ' ' A' ' 223' ' ' ALA . . . -77.46 -39.53 46.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.065 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 227' ' ' LEU . . . . . 0.666 HD12 ' HA ' ' A' ' 224' ' ' GLN . 29.5 mt -52.88 -31.27 38.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.951 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 75.0 mtt180 -58.91 -26.71 64.57 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.891 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 229' ' ' LYS . . . . . 0.458 ' O ' ' C ' ' A' ' 230' ' ' HIS . 26.8 mtpp -71.72 -2.58 17.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.897 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 230' ' ' HIS . . . . . 0.538 ' CG ' ' HG2' ' A' ' 231' ' ' LYS . 19.6 t60 -33.96 139.38 0.07 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.894 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.538 ' HG2' ' CG ' ' A' ' 230' ' ' HIS . 0.1 OUTLIER 60.16 35.51 21.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.869 179.966 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -65.8 175.48 1.92 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.865 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.564 HD21 ' CE1' ' A' ' 238' ' ' TYR . 30.4 mt -131.35 101.19 5.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.87 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 234' ' ' LEU . . . . . 0.689 ' C ' HD23 ' A' ' 234' ' ' LEU . 5.7 tt -112.1 111.45 22.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.923 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 63.5 37.91 95.51 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.492 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 33.0 mmtm 67.35 54.22 0.72 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.766 0.317 . . . . 0.0 110.88 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 20.4 mmt180 -156.44 116.08 3.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.838 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 238' ' ' TYR . . . . . 0.564 ' CE1' HD21 ' A' ' 233' ' ' LEU . 96.7 m-85 -69.83 116.22 9.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.896 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 0.843 HD13 HD23 ' A' ' 173' ' ' LEU . 41.1 mt -115.9 140.6 36.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.134 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 240' ' ' GLU . . . . . 0.575 ' HB3' ' CZ ' ' A' ' 242' ' ' PHE . 16.7 mt-10 -93.26 -178.51 4.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.888 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 241' ' ' LEU . . . . . 0.559 ' O ' ' CD1' ' A' ' 242' ' ' PHE . 61.6 mt -158.01 132.82 8.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.909 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 242' ' ' PHE . . . . . 0.575 ' CZ ' ' HB3' ' A' ' 240' ' ' GLU . 4.6 m-85 -152.88 120.44 5.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.856 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 18.0 ptt180 -60.95 126.98 29.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.906 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 5.4 t -119.71 176.68 5.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.868 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 245' ' ' THR . . . . . 0.401 ' O ' ' C ' ' A' ' 246' ' ' ALA . 82.2 p -127.64 151.02 49.46 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.135 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 246' ' ' ALA . . . . . 0.471 ' N ' HD12 ' A' ' 167' ' ' ILE . . . -37.92 -57.2 1.05 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.09 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -53.21 -51.76 61.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.121 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -50.45 -54.81 19.22 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.886 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.611 HG13 ' CE2' ' A' ' 214' ' ' PHE . 78.4 t -43.82 -61.39 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.152 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 250' ' ' GLN . . . . . 0.766 ' HA ' HD12 ' A' ' 253' ' ' LEU . 34.6 mt-30 -44.05 -42.73 6.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.969 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 251' ' ' GLN . . . . . 0.407 ' HA ' ' ND2' ' A' ' 254' ' ' ASN . 60.6 mm-40 -65.58 -30.14 70.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.905 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 252' ' ' VAL . . . . . 0.417 ' N ' ' O ' ' A' ' 249' ' ' VAL . 85.9 t -78.93 -20.12 12.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.145 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.766 HD12 ' HA ' ' A' ' 250' ' ' GLN . 10.6 mt -84.38 -41.63 16.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.93 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 254' ' ' ASN . . . . . 0.49 ' C ' ' OD1' ' A' ' 254' ' ' ASN . 0.6 OUTLIER -67.93 -40.86 83.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.89 179.876 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 255' ' ' ARG . . . . . 0.473 ' N ' ' OD1' ' A' ' 254' ' ' ASN . 8.0 ptm180 -55.35 -42.71 74.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.816 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 256' ' ' PHE . . . . . 0.405 ' N ' ' CG ' ' A' ' 255' ' ' ARG . 12.8 m-85 -78.9 -51.02 10.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.862 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 41.7 m -52.16 -68.43 0.17 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.84 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 29.5 m -77.47 59.18 1.85 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.848 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 259' ' ' ALA . . . . . . . . . . . . . . . -110.18 76.5 0.99 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.105 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 87.3 p -109.91 -47.67 3.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.835 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 261' ' ' GLY . . . . . 0.439 ' HA2' ' C ' ' A' ' 262' ' ' PRO . . . 128.82 169.98 12.69 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.489 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 262' ' ' PRO . . . . . 0.439 ' C ' ' HA2' ' A' ' 261' ' ' GLY . 53.1 Cg_endo -69.75 134.42 29.4 Favored 'Cis proline' 0 C--N 1.342 0.197 0 C-N-CA 122.665 -1.806 . . . . 0.0 112.37 0.057 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 3.7 m -123.88 175.69 6.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.855 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 1.5 t 51.56 41.31 28.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.91 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.299 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.476 -179.985 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.325 0 N-CA-C 112.456 -0.258 . . . . 0.0 112.456 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 2.6 t -76.91 138.69 39.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.818 0.342 . . . . 0.0 110.857 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 19.7 m -81.16 122.27 27.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.842 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 179.83 -79.75 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.515 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 2.2 m -67.38 137.31 55.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.887 0.375 . . . . 0.0 110.868 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 18.9 t -119.69 173.61 6.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.883 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 99.32 -129.0 9.75 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.502 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -168.95 -73.44 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.486 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -138.33 -131.7 2.91 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.466 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.539 HG22 HG23 ' A' ' 156' ' ' VAL . 1.6 m -122.92 46.89 2.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.771 0.32 . . . . 0.0 111.121 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 93.2 p -98.03 -36.86 9.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.899 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' ASN . . . . . 0.47 ' O ' ' NE2' ' A' ' 158' ' ' GLN . 20.8 m120 -66.83 -45.71 77.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.919 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -70.69 -39.84 73.25 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.868 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.539 HG23 HG22 ' A' ' 152' ' ' THR . 34.0 t -65.53 -40.19 87.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.119 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -41.45 -60.86 1.17 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.13 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' GLN . . . . . 0.47 ' NE2' ' O ' ' A' ' 154' ' ' ASN . 15.2 mp0 -56.23 -44.44 79.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.873 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -52.34 -41.34 62.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.852 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 75.4 mt -89.29 -19.71 24.99 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.89 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 45.9 t -59.75 -20.94 59.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.833 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' LYS . . . . . 0.465 ' HG3' HD13 ' A' ' 216' ' ' LEU . 38.8 mmtt -74.95 102.59 4.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.918 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -82.24 158.82 23.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.903 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 66.8 m-20 60.63 47.04 8.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.937 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.602 ' OE1' HG21 ' A' ' 193' ' ' THR . 10.6 mm-40 -132.2 164.87 25.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.937 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 39.5 t -118.47 115.82 49.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.139 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' ILE . . . . . 0.473 HD12 ' N ' ' A' ' 246' ' ' ALA . 9.5 mt -88.48 141.54 14.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.125 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 59.2 t -119.08 140.49 42.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.151 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' ARG . . . . . 0.465 ' N ' ' HB2' ' A' ' 244' ' ' SER . 27.1 ttp180 -95.78 101.68 13.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.869 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 170' ' ' MET . . . . . 0.594 ' HE2' HD21 ' A' ' 173' ' ' LEU . 88.1 mtp -92.58 137.56 32.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.871 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -137.98 129.96 28.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.874 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 98.31 21.97 16.03 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.493 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.866 HD23 HD13 ' A' ' 239' ' ' ILE . 22.1 mt -76.04 120.97 84.04 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.657 0.741 . . . . 0.0 110.946 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 174' ' ' PRO . . . . . 0.482 ' HG3' ' CB ' ' A' ' 237' ' ' ARG . 65.6 Cg_exo -48.02 139.36 20.51 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.659 2.239 . . . . 0.0 112.336 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 175' ' ' PHE . . . . . 0.559 ' CD1' ' HG3' ' A' ' 209' ' ' PRO . 9.8 t80 -47.56 -42.53 23.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.859 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 7.3 p -72.21 -20.61 61.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.157 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.482 ' HB3' ' O ' ' A' ' 174' ' ' PRO . . . -60.99 105.99 0.54 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.113 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.415 ' O ' ' C ' ' A' ' 179' ' ' ALA . 73.7 p -116.74 173.59 6.55 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.158 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.415 ' C ' ' O ' ' A' ' 178' ' ' THR . . . -36.8 -46.46 0.61 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.089 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -55.47 -49.2 73.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.92 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -57.75 -34.24 69.33 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.887 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.54 HG12 HD11 ' A' ' 192' ' ' ILE . 89.0 t -74.78 -53.95 15.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.11 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.428 ' C ' ' O ' ' A' ' 182' ' ' VAL . 50.4 t -35.22 -52.06 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.131 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -73.66 -36.96 65.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.112 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.655 ' HD2' HD12 ' A' ' 234' ' ' LEU . 21.0 t80 -47.28 -58.03 4.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.88 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 186' ' ' PHE . . . . . 0.444 ' CE1' ' CE1' ' A' ' 185' ' ' PHE . 86.5 m-85 -96.28 -21.36 17.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.926 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -49.05 -24.16 4.34 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.443 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 3.5 tp-100 -49.61 -75.11 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.808 0.337 . . . . 0.0 110.891 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 -118.33 -7.63 10.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.869 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 78.0 m -126.09 84.34 61.66 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.587 0.708 . . . . 0.0 110.918 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 191' ' ' PRO . . . . . 0.494 ' HD2' ' CD1' ' A' ' 222' ' ' TYR . 54.0 Cg_endo -69.79 139.28 39.76 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.655 2.237 . . . . 0.0 112.377 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 192' ' ' ILE . . . . . 0.637 HG23 ' O ' ' A' ' 216' ' ' LEU . 57.8 mt -88.76 144.67 8.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.152 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 193' ' ' THR . . . . . 0.602 HG21 ' OE1' ' A' ' 165' ' ' GLN . 17.9 m -70.18 104.7 2.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.173 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 91.72 -15.48 61.52 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.462 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 68.82 -120.22 10.69 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.46 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 43.9 mtmt -48.5 -33.77 10.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.783 0.325 . . . . 0.0 110.901 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -75.07 -27.59 60.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.874 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 198' ' ' GLY . . . . . 0.448 ' HA2' HD12 ' A' ' 216' ' ' LEU . . . -94.05 40.4 2.76 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.505 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 55.8 mt -143.0 146.28 21.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.847 0.356 . . . . 0.0 111.14 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 14.5 tp -146.6 122.34 10.55 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.951 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -102.09 121.41 42.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.882 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 60.6 t -72.78 140.17 18.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.149 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -142.9 138.83 30.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.159 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 204' ' ' TYR . . . . . 0.474 ' N ' HG23 ' A' ' 210' ' ' THR . 30.3 m-85 -50.79 159.08 0.99 Allowed Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.614 0.721 . . . . 0.0 110.966 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 3.73 2.62 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.711 2.274 . . . . 0.0 112.334 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -111.92 -18.52 12.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.907 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 110.4 44.18 1.01 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.499 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -126.78 143.72 47.55 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.571 0.701 . . . . 0.0 110.868 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 209' ' ' PRO . . . . . 0.559 ' HG3' ' CD1' ' A' ' 175' ' ' PHE . 53.4 Cg_endo -69.76 95.68 0.56 Allowed 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.686 2.258 . . . . 0.0 112.328 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 210' ' ' THR . . . . . 0.633 HG21 ' CD2' ' A' ' 256' ' ' PHE . 33.5 p -60.27 -10.29 4.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.154 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 88.01 -45.73 3.34 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.485 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -66.85 161.67 23.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.768 0.318 . . . . 0.0 110.904 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 213' ' ' ALA . . . . . 0.561 ' HB3' ' CD1' ' A' ' 173' ' ' LEU . . . -161.27 -175.26 4.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.075 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 214' ' ' PHE . . . . . 0.451 ' CE2' HG13 ' A' ' 249' ' ' VAL . 56.5 m-85 -146.22 151.73 38.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.857 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 215' ' ' VAL . . . . . 0.427 HG12 ' N ' ' A' ' 216' ' ' LEU . 4.5 t -138.71 159.91 30.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.162 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.637 ' O ' HG23 ' A' ' 192' ' ' ILE . 43.0 mt -109.68 145.8 35.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.905 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -140.29 143.0 35.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.899 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 218' ' ' ALA . . . . . 0.418 ' HB3' ' CD2' ' A' ' 222' ' ' TYR . . . -53.85 -66.7 0.35 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.112 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 219' ' ' CYS . . . . . . . . . . . . . 30.1 m -138.31 -175.09 3.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.915 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -62.89 -37.36 86.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.873 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 18.8 tp10 -43.27 -41.2 3.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.9 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 222' ' ' TYR . . . . . 0.494 ' CD1' ' HD2' ' A' ' 191' ' ' PRO . 55.9 m-85 -86.05 -47.58 9.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.934 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -56.31 -63.75 1.09 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.107 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 224' ' ' GLN . . . . . 0.737 ' HA ' HD12 ' A' ' 227' ' ' LEU . 20.4 mt-30 -46.65 -52.6 13.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.905 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 22.3 m-20 -55.38 -26.34 40.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.872 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -80.78 -34.55 34.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.121 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 227' ' ' LEU . . . . . 0.737 HD12 ' HA ' ' A' ' 224' ' ' GLN . 38.3 mt -54.54 -30.11 52.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.943 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 36.8 mtp180 -63.87 -20.74 66.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.845 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 229' ' ' LYS . . . . . 0.459 ' O ' ' C ' ' A' ' 230' ' ' HIS . 19.8 mtpp -75.75 -1.92 27.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.926 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 230' ' ' HIS . . . . . 0.519 ' CE1' ' HG2' ' A' ' 231' ' ' LYS . 57.1 t60 -33.9 136.9 0.11 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.874 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.519 ' HG2' ' CE1' ' A' ' 230' ' ' HIS . 0.0 OUTLIER 61.76 30.54 18.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.852 179.96 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 232' ' ' ASP . . . . . 0.452 ' OD2' ' CE2' ' A' ' 185' ' ' PHE . 8.4 t70 -57.84 173.64 0.3 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.877 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.64 HD21 ' CE1' ' A' ' 238' ' ' TYR . 30.7 mt -132.58 104.33 6.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.899 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 234' ' ' LEU . . . . . 0.679 ' C ' HD23 ' A' ' 234' ' ' LEU . 5.8 tt -115.24 114.42 25.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.935 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 60.7 39.56 96.81 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.438 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 31.0 mtmm 65.3 53.0 1.35 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.789 0.328 . . . . 0.0 110.876 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 237' ' ' ARG . . . . . 0.482 ' CB ' ' HG3' ' A' ' 174' ' ' PRO . 12.4 mmt85 -156.09 116.09 3.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.877 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 238' ' ' TYR . . . . . 0.64 ' CE1' HD21 ' A' ' 233' ' ' LEU . 97.2 m-85 -68.6 135.61 51.74 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.918 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 0.866 HD13 HD23 ' A' ' 173' ' ' LEU . 60.2 mt -133.51 134.36 56.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.168 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 240' ' ' GLU . . . . . 0.54 ' O ' HD23 ' A' ' 241' ' ' LEU . 46.8 mt-10 -90.27 175.87 6.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.884 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 241' ' ' LEU . . . . . 0.54 HD23 ' O ' ' A' ' 240' ' ' GLU . 63.6 mt -156.67 138.19 14.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.912 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 242' ' ' PHE . . . . . 0.497 ' CD1' ' O ' ' A' ' 241' ' ' LEU . 20.9 m-85 -155.19 127.85 7.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.852 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 46.5 mtm180 -39.98 136.97 1.03 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.909 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 244' ' ' SER . . . . . 0.465 ' HB2' ' N ' ' A' ' 169' ' ' ARG . 3.6 t -132.57 154.67 49.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.844 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 26.4 p -132.09 156.77 45.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.173 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 246' ' ' ALA . . . . . 0.473 ' N ' HD12 ' A' ' 167' ' ' ILE . . . -42.17 -57.15 2.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.128 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -53.76 -41.13 66.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.115 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 248' ' ' GLU . . . . . 0.474 ' O ' HG23 ' A' ' 252' ' ' VAL . 2.6 tp10 -61.15 -49.99 75.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.886 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.451 HG13 ' CE2' ' A' ' 214' ' ' PHE . 95.4 t -53.24 -64.97 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.105 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 250' ' ' GLN . . . . . 0.773 ' HA ' HD12 ' A' ' 253' ' ' LEU . 28.4 mt-30 -42.57 -34.09 0.81 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.929 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 251' ' ' GLN . . . . . 0.45 ' HA ' ' ND2' ' A' ' 254' ' ' ASN . 64.4 mt-30 -73.58 -47.73 38.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.891 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 252' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 248' ' ' GLU . 75.2 t -57.69 -35.13 49.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.11 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.773 HD12 ' HA ' ' A' ' 250' ' ' GLN . 10.9 mt -65.81 -48.83 70.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.872 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 254' ' ' ASN . . . . . 0.485 ' C ' ' OD1' ' A' ' 254' ' ' ASN . 0.6 OUTLIER -67.12 -41.37 86.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.891 179.95 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 255' ' ' ARG . . . . . 0.47 ' N ' ' OD1' ' A' ' 254' ' ' ASN . 13.7 ttm180 -54.78 -41.39 70.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.868 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 256' ' ' PHE . . . . . 0.633 ' CD2' HG21 ' A' ' 210' ' ' THR . 12.8 m-85 -80.49 -47.12 14.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.851 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 51.1 m -61.91 -20.5 63.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.837 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 42.3 m -109.87 61.34 0.6 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.837 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 259' ' ' ALA . . . . . . . . . . . . . . . -111.44 76.34 0.97 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.115 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 33.9 t -40.12 -44.62 1.84 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.85 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 261' ' ' GLY . . . . . 0.417 ' HA2' ' C ' ' A' ' 262' ' ' PRO . . . -57.5 172.49 2.77 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.487 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 262' ' ' PRO . . . . . 0.417 ' C ' ' HA2' ' A' ' 261' ' ' GLY . 53.9 Cg_endo -69.74 171.82 51.83 Favored 'Cis proline' 0 C--N 1.341 0.179 0 C-N-CA 122.659 -1.809 . . . . 0.0 112.355 -0.027 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 28.5 m 48.79 45.51 21.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.889 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 56.1 p -44.81 152.98 0.19 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.85 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.515 179.984 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.28 0 N-CA-C 112.479 -0.248 . . . . 0.0 112.479 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 144' ' ' SER . . . . . 0.441 ' O ' ' C ' ' A' ' 145' ' ' SER . 41.6 t -49.37 131.26 20.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.876 0.37 . . . . 0.0 110.805 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.441 ' C ' ' O ' ' A' ' 144' ' ' SER . 23.0 t -35.28 -55.55 0.63 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.868 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 144.9 150.71 5.28 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.439 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 12.9 m -130.5 149.88 51.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.899 0.38 . . . . 0.0 110.827 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 31.2 t -79.15 97.03 6.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.818 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -177.92 -173.25 43.19 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.482 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -171.24 -156.67 11.97 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.418 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -85.21 -167.36 43.19 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.472 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.692 HG22 HG21 ' A' ' 156' ' ' VAL . 5.3 t -69.73 -23.4 63.4 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.768 0.318 . . . . 0.0 111.161 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 70.5 m -156.66 151.68 26.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.827 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -38.5 -48.47 1.4 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.947 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -54.63 -49.78 69.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.879 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.692 HG21 HG22 ' A' ' 152' ' ' THR . 73.5 t -65.07 -41.61 92.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.123 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -43.24 -60.06 1.83 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.101 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 83.2 mm-40 -62.33 -36.67 82.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.922 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' PHE . . . . . 0.427 ' CD1' ' HB2' ' A' ' 200' ' ' LEU . 76.7 t80 -60.62 -38.74 85.74 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.875 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 86.2 mt -94.59 -15.98 23.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.922 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 10.9 t -55.13 -40.37 70.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.865 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' LYS . . . . . 0.692 ' HD2' HD13 ' A' ' 216' ' ' LEU . 14.5 mttp -52.84 116.0 2.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.891 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 39.4 mp0 -80.9 162.51 23.91 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.856 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 43.74 51.03 6.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.869 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.806 ' OE1' HG21 ' A' ' 193' ' ' THR . 0.2 OUTLIER -124.16 156.76 36.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.896 -179.967 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 60.7 t -110.47 133.24 56.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.117 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' ILE . . . . . 0.618 HG21 HG21 ' A' ' 249' ' ' VAL . 56.3 mt -109.53 131.11 61.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.094 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 44.5 t -114.3 133.41 60.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.102 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' ARG . . . . . 0.413 ' N ' ' HB2' ' A' ' 244' ' ' SER . 61.6 ttt180 -90.03 110.94 21.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.87 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 170' ' ' MET . . . . . 0.61 ' CE ' HD21 ' A' ' 173' ' ' LEU . 90.0 mtp -98.16 126.58 43.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.912 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 14.2 ttm180 -127.01 142.31 51.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.873 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 83.46 36.34 14.61 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.498 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.683 HD23 HD13 ' A' ' 239' ' ' ILE . 28.0 mt -87.64 130.43 47.11 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.64 0.733 . . . . 0.0 110.894 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 174' ' ' PRO . . . . . 0.459 ' HG3' ' CB ' ' A' ' 237' ' ' ARG . 66.2 Cg_exo -47.99 122.5 7.35 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.67 2.247 . . . . 0.0 112.309 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -39.57 -29.81 0.06 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.862 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.403 ' O ' ' C ' ' A' ' 177' ' ' ALA . 31.6 p -80.67 -41.79 23.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.18 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.444 ' N ' ' O ' ' A' ' 174' ' ' PRO . . . -36.69 126.64 0.86 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.087 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -123.53 -174.91 3.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.116 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.08 -50.53 73.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.066 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -53.39 -34.66 58.58 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.901 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -65.57 -40.76 93.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.929 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.485 HG12 HD11 ' A' ' 192' ' ' ILE . 76.1 t -68.33 -51.59 46.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.168 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.414 ' C ' ' O ' ' A' ' 182' ' ' VAL . 41.1 t -36.48 -49.11 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.153 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -76.36 -39.6 53.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.079 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.8 ' HD2' HD12 ' A' ' 234' ' ' LEU . 9.0 t80 -42.09 -59.06 1.88 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.909 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 186' ' ' PHE . . . . . 0.453 ' CE1' ' CE1' ' A' ' 185' ' ' PHE . 69.6 m-85 -95.57 -21.95 17.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.867 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -49.24 -22.59 3.51 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.451 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 77.3 mm-40 -52.64 -71.76 0.06 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.838 0.352 . . . . 0.0 110.884 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 33.2 m80 -118.08 -17.2 9.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.829 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 99.7 m -118.27 83.94 21.53 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.608 0.718 . . . . 0.0 110.89 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 130.96 20.2 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.731 2.287 . . . . 0.0 112.311 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 192' ' ' ILE . . . . . 0.633 HG23 ' O ' ' A' ' 216' ' ' LEU . 48.4 mt -79.46 146.11 8.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.13 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 193' ' ' THR . . . . . 0.806 HG21 ' OE1' ' A' ' 165' ' ' GLN . 53.8 m -67.71 109.08 3.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.098 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 85.11 -22.85 8.86 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.491 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.408 ' O ' ' N ' ' A' ' 198' ' ' GLY . . . 79.64 -125.37 6.93 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.472 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 20.7 mtmm -46.0 -23.72 0.34 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.785 0.326 . . . . 0.0 110.896 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -81.67 -35.22 30.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.887 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 198' ' ' GLY . . . . . 0.817 ' HA2' HD12 ' A' ' 216' ' ' LEU . . . -86.21 26.36 6.3 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.483 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 68.9 mt -125.78 140.13 49.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.854 0.359 . . . . 0.0 111.107 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.427 ' HB2' ' CD1' ' A' ' 159' ' ' PHE . 14.6 tp -136.17 112.26 9.68 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.893 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -92.86 112.94 25.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.898 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.644 HG11 ' OD2' ' A' ' 212' ' ' ASP . 23.5 t -67.38 114.68 4.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.085 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -126.4 137.19 53.41 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.154 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -43.79 158.67 0.25 Allowed Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.686 0.755 . . . . 0.0 110.929 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 2.84 3.15 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.728 2.285 . . . . 0.0 112.338 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -112.66 -16.98 12.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.915 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 108.38 60.43 0.54 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.535 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 59.7 mtt-85 -147.58 145.98 23.19 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.581 0.705 . . . . 0.0 110.877 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 112.47 3.08 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.71 2.273 . . . . 0.0 112.368 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 210' ' ' THR . . . . . 0.541 ' HB ' ' CE1' ' A' ' 256' ' ' PHE . 80.4 p -79.65 -10.84 59.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.152 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 95.06 -32.56 6.04 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.488 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 212' ' ' ASP . . . . . 0.644 ' OD2' HG11 ' A' ' 202' ' ' VAL . 1.2 p-10 -84.6 164.72 18.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.781 0.324 . . . . 0.0 110.893 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 213' ' ' ALA . . . . . 0.521 ' HA ' HG23 ' A' ' 202' ' ' VAL . . . -161.72 -179.06 6.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.066 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 214' ' ' PHE . . . . . 0.699 ' CE2' HG13 ' A' ' 249' ' ' VAL . 59.6 m-85 -146.79 133.01 19.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.896 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 215' ' ' VAL . . . . . 0.478 HG12 ' N ' ' A' ' 216' ' ' LEU . 14.4 t -118.56 159.75 18.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.105 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.817 HD12 ' HA2' ' A' ' 198' ' ' GLY . 51.6 mt -112.18 149.84 31.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.929 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -145.51 139.27 26.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.893 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 218' ' ' ALA . . . . . 0.566 ' HB3' ' CD1' ' A' ' 222' ' ' TYR . . . -44.79 -57.26 3.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.054 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 219' ' ' CYS . . . . . . . . . . . . . 1.8 t -160.93 -178.38 6.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.925 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 10.6 mp0 -48.3 -34.4 10.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.919 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -54.98 -33.09 62.19 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.903 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 222' ' ' TYR . . . . . 0.566 ' CD1' ' HB3' ' A' ' 218' ' ' ALA . 6.5 m-85 -93.52 -42.88 8.99 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.966 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.29 -62.17 2.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.134 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 224' ' ' GLN . . . . . 0.624 ' HA ' HD12 ' A' ' 227' ' ' LEU . 33.8 mt-30 -45.6 -59.21 2.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.921 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 38.1 m-20 -48.41 -22.15 0.66 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.922 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -92.81 -35.07 13.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.119 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 227' ' ' LEU . . . . . 0.624 HD12 ' HA ' ' A' ' 224' ' ' GLN . 86.1 mt -54.11 -37.76 64.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.933 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 228' ' ' ARG . . . . . 0.489 ' HB2' ' CZ ' ' A' ' 228' ' ' ARG . 0.2 OUTLIER -58.12 -24.7 59.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.82 179.954 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 229' ' ' LYS . . . . . 0.533 ' CE ' ' CE1' ' A' ' 185' ' ' PHE . 24.5 mtpp -67.25 -4.08 9.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.889 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 230' ' ' HIS . . . . . 0.528 ' CG ' ' HG2' ' A' ' 231' ' ' LYS . 23.6 t60 -34.33 134.18 0.21 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.878 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.528 ' HG2' ' CG ' ' A' ' 230' ' ' HIS . 0.2 OUTLIER 67.34 27.62 8.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.921 179.999 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -58.19 179.28 0.07 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.845 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.711 HD21 ' CE2' ' A' ' 238' ' ' TYR . 31.3 mt -135.67 110.66 8.84 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.939 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 234' ' ' LEU . . . . . 0.8 HD12 ' HD2' ' A' ' 185' ' ' PHE . 6.8 tt -119.9 115.46 23.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.936 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 57.04 39.39 89.58 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.492 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 23.3 mmtm 67.39 52.18 0.83 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.814 0.34 . . . . 0.0 110.899 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 237' ' ' ARG . . . . . 0.459 ' CB ' ' HG3' ' A' ' 174' ' ' PRO . 23.3 mmt180 -156.17 115.33 3.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.868 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 238' ' ' TYR . . . . . 0.711 ' CE2' HD21 ' A' ' 233' ' ' LEU . 96.0 m-85 -69.26 128.46 36.69 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.915 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 0.683 HD13 HD23 ' A' ' 173' ' ' LEU . 70.7 mt -123.52 138.62 52.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.137 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -99.95 165.76 11.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.887 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 241' ' ' LEU . . . . . 0.533 ' O ' ' CD1' ' A' ' 242' ' ' PHE . 18.6 mt -141.67 149.44 40.6 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.914 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 242' ' ' PHE . . . . . 0.533 ' CD1' ' O ' ' A' ' 241' ' ' LEU . 26.8 m-85 -155.65 130.26 9.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.914 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 24.9 mtp180 -52.54 122.85 9.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.889 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 244' ' ' SER . . . . . 0.413 ' HB2' ' N ' ' A' ' 169' ' ' ARG . 3.5 t -117.84 173.64 6.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.848 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 39.8 p -149.25 161.67 41.56 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.16 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -42.89 -60.24 1.68 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.072 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -53.13 -47.92 68.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.073 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -52.43 -54.74 28.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.817 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.699 HG13 ' CE2' ' A' ' 214' ' ' PHE . 94.0 t -51.79 -63.29 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.145 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 250' ' ' GLN . . . . . 0.749 ' HA ' HD12 ' A' ' 253' ' ' LEU . 22.9 mt-30 -46.87 -31.23 2.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.907 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 60.5 mt-30 -77.89 -28.65 49.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.935 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 252' ' ' VAL . . . . . 0.419 ' O ' HG12 ' A' ' 252' ' ' VAL . 55.6 t -82.36 -15.17 12.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.152 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.749 HD12 ' HA ' ' A' ' 250' ' ' GLN . 13.1 mt -86.85 -42.68 13.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.883 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 254' ' ' ASN . . . . . 0.497 ' OD1' ' N ' ' A' ' 255' ' ' ARG . 0.7 OUTLIER -61.0 -43.28 99.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.917 179.944 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 255' ' ' ARG . . . . . 0.497 ' N ' ' OD1' ' A' ' 254' ' ' ASN . 15.5 ptm180 -58.7 -52.43 65.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.872 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 256' ' ' PHE . . . . . 0.541 ' CE1' ' HB ' ' A' ' 210' ' ' THR . 11.1 m-85 -67.66 -37.47 82.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.89 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 44.2 t -64.71 -34.82 79.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.865 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 22.9 t -123.59 86.58 2.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.845 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 259' ' ' ALA . . . . . . . . . . . . . . . -115.26 -37.04 4.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.1 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 1.6 t -49.67 134.38 20.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.877 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 261' ' ' GLY . . . . . 0.506 ' HA3' ' C ' ' A' ' 262' ' ' PRO . . . 143.48 -81.95 0.22 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.515 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 262' ' ' PRO . . . . . 0.506 ' C ' ' HA3' ' A' ' 261' ' ' GLY . 53.6 Cg_endo -69.75 177.92 27.18 Favored 'Cis proline' 0 C--N 1.341 0.17 0 C-N-CA 122.749 -1.771 . . . . 0.0 112.361 0.019 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 93.7 p -122.33 103.44 8.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.828 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 94.5 p -145.93 170.93 15.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.867 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.335 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.485 -179.964 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.285 0 N-CA-C 112.439 -0.264 . . . . 0.0 112.439 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 4.3 m -96.29 -60.53 1.6 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.892 0.377 . . . . 0.0 110.829 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 8.1 t -91.89 127.91 37.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.886 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -142.05 177.86 21.15 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.492 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' SER . . . . . 0.485 ' O ' ' N ' ' A' ' 149' ' ' GLY . 3.9 t -130.38 121.89 26.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.846 0.355 . . . . 0.0 110.845 -179.72 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 17.8 t -40.08 92.89 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.847 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' GLY . . . . . 0.485 ' N ' ' O ' ' A' ' 147' ' ' SER . . . -97.52 -119.35 3.88 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.489 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -96.88 97.32 1.99 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.492 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 115.61 162.83 13.56 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.459 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 4.6 m -44.82 141.92 1.96 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.813 0.339 . . . . 0.0 111.126 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 3.3 t -45.95 145.79 1.41 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.814 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -61.34 -32.09 71.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.854 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -75.95 -50.25 15.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.916 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.807 HG22 HD21 ' A' ' 200' ' ' LEU . 48.7 t -51.74 -33.28 15.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.116 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -48.36 -66.96 0.31 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.088 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 12.6 mm-40 -57.23 -28.31 62.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.923 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' PHE . . . . . 0.434 ' CE2' ' HG ' ' A' ' 216' ' ' LEU . 48.0 t80 -68.04 -36.89 80.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.889 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 81.6 mt -92.67 -20.82 20.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.926 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 3.4 t -53.16 -37.18 61.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.844 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' LYS . . . . . 0.592 ' HG3' HD13 ' A' ' 216' ' ' LEU . 56.9 mmtt -50.97 127.98 20.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.912 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -103.31 137.82 40.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.861 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 4.7 m120 70.55 43.47 0.77 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.859 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 6.2 mp0 -125.75 156.48 39.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.941 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 38.9 t -108.5 136.45 44.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.139 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' ILE . . . . . 0.465 HG21 ' CG2' ' A' ' 249' ' ' VAL . 52.0 mt -109.19 142.24 22.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.14 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 21.4 t -124.7 140.08 48.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.125 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 30.2 ttt-85 -92.09 108.89 20.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.858 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' MET . . . . . 0.646 ' CE ' HD21 ' A' ' 173' ' ' LEU . 80.6 mtp -93.93 129.9 40.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.882 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 17.8 ttm180 -132.9 140.32 47.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.826 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 89.34 24.63 30.74 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.55 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.646 HD21 ' CE ' ' A' ' 170' ' ' MET . 24.0 mt -77.27 123.73 87.03 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.582 0.706 . . . . 0.0 110.917 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_exo -47.94 125.21 11.17 Favored 'Trans proline' 0 N--CA 1.465 -0.169 0 C-N-CA 122.717 2.278 . . . . 0.0 112.343 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -37.5 -33.51 0.07 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.888 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.562 ' O ' HG23 ' A' ' 178' ' ' THR . 75.0 p -78.07 -50.71 11.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.119 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.444 ' C ' ' O ' ' A' ' 176' ' ' THR . . . -33.7 130.31 0.28 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.103 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.562 HG23 ' O ' ' A' ' 176' ' ' THR . 16.9 p -132.06 178.7 6.59 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.119 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.429 ' O ' HG23 ' A' ' 183' ' ' VAL . . . -49.37 -46.14 46.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.1 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -56.51 -28.62 60.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.867 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' GLU . . . . . 0.84 ' HG2' HD11 ' A' ' 234' ' ' LEU . 4.5 tt0 -76.08 -44.15 40.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.879 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.526 ' HB ' HD13 ' A' ' 199' ' ' ILE . 54.8 t -63.7 -45.37 97.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.127 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 179' ' ' ALA . 54.6 t -37.19 -46.68 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.135 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -81.06 -37.82 28.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.093 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.547 ' CZ ' ' OD2' ' A' ' 232' ' ' ASP . 68.7 t80 -43.05 -57.03 3.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.882 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -94.6 -21.78 18.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.871 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -49.39 -17.81 1.29 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.713 -0.755 . . . . 0.0 112.514 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 15.9 mm-40 -56.13 -74.81 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.792 0.33 . . . . 0.0 110.89 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -118.27 -5.03 10.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.845 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 72.9 m -129.29 85.0 60.59 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.655 0.741 . . . . 0.0 110.921 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 191' ' ' PRO . . . . . 0.429 ' HD2' ' CD1' ' A' ' 222' ' ' TYR . 53.5 Cg_endo -69.74 130.47 19.43 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.711 2.274 . . . . 0.0 112.336 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 192' ' ' ILE . . . . . 0.546 HG23 ' O ' ' A' ' 216' ' ' LEU . 52.7 mt -80.9 144.56 10.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.17 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 91.1 m -67.59 99.68 0.8 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.144 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 95.36 -11.96 68.39 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.481 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 70.31 -126.07 15.51 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.524 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 4.5 ptmm? -48.37 -26.49 2.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.737 0.303 . . . . 0.0 110.909 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -77.92 -30.7 50.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.911 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 198' ' ' GLY . . . . . 0.427 ' HA2' HD12 ' A' ' 216' ' ' LEU . . . -89.4 39.5 3.11 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.472 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.526 HD13 ' HB ' ' A' ' 182' ' ' VAL . 72.8 mt -140.76 137.62 35.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.842 0.353 . . . . 0.0 111.146 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.807 HD21 HG22 ' A' ' 156' ' ' VAL . 15.3 tp -132.45 114.13 13.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.931 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 201' ' ' PHE . . . . . 0.4 ' CZ ' ' N ' ' A' ' 179' ' ' ALA . 54.4 m-85 -93.27 121.88 35.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.863 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.427 HG11 ' OD2' ' A' ' 212' ' ' ASP . 95.9 t -73.46 118.52 18.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.119 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -126.89 138.03 53.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.189 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 204' ' ' TYR . . . . . 0.805 ' CD2' HG22 ' A' ' 210' ' ' THR . 35.8 m-85 -45.92 158.45 0.36 Allowed Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.664 0.745 . . . . 0.0 110.943 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.82 2.9 3.14 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.714 2.276 . . . . 0.0 112.318 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -109.42 -21.89 12.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.859 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 112.24 52.82 0.51 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.488 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 5.2 mpt_? -140.18 145.48 41.93 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.586 0.708 . . . . 0.0 110.874 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 107.44 1.85 Allowed 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.708 2.272 . . . . 0.0 112.347 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 210' ' ' THR . . . . . 0.805 HG22 ' CD2' ' A' ' 204' ' ' TYR . 69.5 p -70.82 -29.59 65.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.155 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 115.08 -42.25 1.96 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.496 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 212' ' ' ASP . . . . . 0.427 ' OD2' HG11 ' A' ' 202' ' ' VAL . 1.7 p-10 -74.39 169.38 17.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.822 0.344 . . . . 0.0 110.867 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 213' ' ' ALA . . . . . 0.503 ' HB3' ' CD1' ' A' ' 173' ' ' LEU . . . -168.95 171.17 8.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.112 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -136.12 143.41 44.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.867 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 4.1 t -124.42 156.95 32.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.092 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.592 HD13 ' HG3' ' A' ' 162' ' ' LYS . 28.8 mt -108.22 151.06 26.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.953 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -144.19 135.37 25.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.893 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -49.06 -58.59 4.67 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.102 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 219' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -144.73 170.93 15.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.882 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -55.68 -27.27 49.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.881 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 23.0 tp10 -51.34 -36.27 42.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.907 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 222' ' ' TYR . . . . . 0.429 ' CD1' ' HD2' ' A' ' 191' ' ' PRO . 52.9 m-85 -91.84 -47.49 7.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.911 -179.837 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -52.57 -57.39 10.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.101 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 224' ' ' GLN . . . . . 0.446 ' HA ' HD12 ' A' ' 227' ' ' LEU . 60.0 mt-30 -50.08 -48.56 53.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.916 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 18.8 m-20 -63.15 -23.96 67.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.887 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -77.12 -22.71 52.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.093 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 227' ' ' LEU . . . . . 0.446 HD12 ' HA ' ' A' ' 224' ' ' GLN . 17.8 mt -70.51 -32.74 70.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.947 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 65.8 mtp180 -58.93 -12.33 4.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.874 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 229' ' ' LYS . . . . . 0.453 ' O ' ' C ' ' A' ' 230' ' ' HIS . 28.1 mttp -83.46 -1.73 54.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.926 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 230' ' ' HIS . . . . . 0.453 ' C ' ' O ' ' A' ' 229' ' ' LYS . 10.5 t60 -33.65 137.06 0.1 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.887 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.446 ' HG2' ' CG ' ' A' ' 230' ' ' HIS . 0.3 OUTLIER 59.82 34.49 21.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.929 -180.0 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 232' ' ' ASP . . . . . 0.547 ' OD2' ' CZ ' ' A' ' 185' ' ' PHE . 11.6 t0 -62.3 176.51 0.6 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.845 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.678 HD21 ' CE1' ' A' ' 238' ' ' TYR . 30.9 mt -134.87 107.22 7.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.903 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 234' ' ' LEU . . . . . 0.84 HD11 ' HG2' ' A' ' 181' ' ' GLU . 6.0 tt -114.35 112.45 23.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.935 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 57.75 40.44 92.83 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.477 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 62.3 mttt 68.93 53.21 0.49 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.774 0.321 . . . . 0.0 110.946 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 19.0 mmt180 -156.16 117.3 3.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.926 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 238' ' ' TYR . . . . . 0.678 ' CE1' HD21 ' A' ' 233' ' ' LEU . 98.8 m-85 -69.96 125.85 27.97 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.887 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 74.0 mt -121.31 137.39 55.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.138 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -97.79 163.61 12.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.868 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 41.2 mt -142.91 138.8 30.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.913 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -148.35 138.88 22.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.87 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 64.6 mtm180 -56.81 132.46 52.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.876 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 5.6 t -130.37 163.21 27.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.877 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 68.0 p -134.8 160.06 39.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.152 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -44.69 -49.72 10.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.102 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -60.36 -44.06 95.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.094 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 248' ' ' GLU . . . . . 0.494 ' O ' HG23 ' A' ' 252' ' ' VAL . 10.8 tt0 -54.92 -52.27 63.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.917 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.465 ' CG2' HG21 ' A' ' 167' ' ' ILE . 97.3 t -46.7 -62.06 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.141 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 250' ' ' GLN . . . . . 0.403 ' HA ' HD12 ' A' ' 253' ' ' LEU . 19.7 mt-30 -48.92 -44.06 40.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.908 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -66.59 -20.04 65.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.931 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 252' ' ' VAL . . . . . 0.494 HG23 ' O ' ' A' ' 248' ' ' GLU . 72.8 t -88.91 -24.39 6.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.162 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.426 HD11 HG12 ' A' ' 249' ' ' VAL . 10.9 mt -85.2 -39.78 17.43 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.893 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -65.47 -38.62 90.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.909 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 255' ' ' ARG . . . . . 0.444 ' NH2' HG13 ' A' ' 252' ' ' VAL . 30.2 ptt180 -63.79 -37.89 89.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.898 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -80.57 -40.29 26.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.874 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 41.4 t -62.69 -44.67 95.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.837 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 63.5 m -101.15 40.22 1.31 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.878 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 259' ' ' ALA . . . . . . . . . . . . . . . -67.41 -37.55 83.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.115 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 58.1 p -102.05 163.44 12.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.899 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 261' ' ' GLY . . . . . 0.403 ' HA3' ' C ' ' A' ' 262' ' ' PRO . . . -159.69 -69.17 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.456 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 262' ' ' PRO . . . . . 0.403 ' C ' ' HA3' ' A' ' 261' ' ' GLY . 53.8 Cg_endo -69.76 160.95 87.17 Favored 'Cis proline' 0 C--N 1.341 0.17 0 C-N-CA 122.654 -1.811 . . . . 0.0 112.332 0.074 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 2.7 p -163.42 151.92 13.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.862 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 60.6 p -102.34 133.21 47.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.846 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.299 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.478 -179.993 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.361 0 N-CA-C 112.441 -0.263 . . . . 0.0 112.441 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 88.4 p -109.43 105.19 14.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.881 0.372 . . . . 0.0 110.89 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 87.5 p -147.12 140.07 25.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.844 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -88.78 53.57 4.02 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.459 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 65.0 p -132.43 116.6 17.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.906 0.384 . . . . 0.0 110.856 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 66.0 p -97.11 116.13 28.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.8 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -113.39 -64.25 0.45 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.489 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -99.78 -81.52 1.6 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.795 -0.716 . . . . 0.0 112.479 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -92.9 126.97 8.79 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.46 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.481 HG22 HG23 ' A' ' 156' ' ' VAL . 23.9 m -71.26 120.54 16.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.821 0.343 . . . . 0.0 111.147 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 28.9 p -129.24 -45.98 1.23 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.799 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -68.55 -54.03 19.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.92 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.449 ' HB3' ' CG2' ' A' ' 152' ' ' THR . 21.9 tt0 -50.65 -47.07 58.67 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.89 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.481 HG23 HG22 ' A' ' 152' ' ' THR . 89.9 t -70.56 -42.26 78.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.146 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' ' 156' ' ' VAL . . . -37.57 -59.22 0.8 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.142 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 11.9 mm100 -56.97 -49.9 74.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.897 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' PHE . . . . . 0.51 ' CE2' ' HG ' ' A' ' 216' ' ' LEU . 58.8 t80 -47.8 -42.71 26.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.838 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 79.9 mt -86.32 -17.25 35.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.883 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 5.6 t -65.14 -30.87 71.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.844 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' LYS . . . . . 0.533 ' HG3' HD13 ' A' ' 216' ' ' LEU . 0.4 OUTLIER -53.14 129.38 30.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.943 179.903 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -102.93 151.78 22.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.866 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 67.1 m-80 61.85 49.73 4.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.879 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 22.2 mm-40 -131.09 168.08 18.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.887 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 45.5 t -125.06 109.22 21.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.133 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' ILE . . . . . 0.564 HG21 ' CG2' ' A' ' 249' ' ' VAL . 96.8 mt -79.37 139.7 17.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.148 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 66.7 t -123.67 130.46 74.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.132 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 52.1 ttp180 -88.26 105.37 17.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.911 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' MET . . . . . 0.521 ' CE ' HD21 ' A' ' 173' ' ' LEU . 98.8 mtp -94.36 129.48 41.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.914 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 40.7 mtt180 -128.99 147.08 50.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.872 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 81.26 35.96 22.2 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.475 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.521 HD21 ' CE ' ' A' ' 170' ' ' MET . 25.9 mt -86.01 125.64 67.86 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.588 0.709 . . . . 0.0 110.915 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_exo -47.99 140.29 18.93 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.691 2.26 . . . . 0.0 112.363 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -53.84 -19.85 4.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.879 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 50.0 p -94.97 -19.43 20.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.14 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -56.87 125.47 22.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.096 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 1.6 p -134.22 171.14 14.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.114 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.431 ' N ' ' CZ ' ' A' ' 201' ' ' PHE . . . -43.24 -55.69 3.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.081 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -48.33 -33.96 9.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.925 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' GLU . . . . . 0.49 ' HG3' HD11 ' A' ' 234' ' ' LEU . 0.8 OUTLIER -71.59 -44.3 64.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.902 -179.92 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.401 ' O ' ' C ' ' A' ' 183' ' ' VAL . 40.3 t -65.68 -50.19 72.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.102 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.401 ' C ' ' O ' ' A' ' 182' ' ' VAL . 44.7 t -37.52 -42.25 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.109 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -81.54 -39.51 24.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.115 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.543 ' CE2' ' HD3' ' A' ' 229' ' ' LYS . 60.6 t80 -43.86 -58.35 2.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.87 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 186' ' ' PHE . . . . . 0.401 ' CE1' ' CE2' ' A' ' 185' ' ' PHE . 73.6 m-85 -92.81 -23.66 18.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.859 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -50.16 -22.26 4.74 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.495 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 9.6 mm-40 -50.25 -75.9 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.867 0.365 . . . . 0.0 110.913 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 189' ' ' HIS . . . . . 0.592 ' CE1' ' HG ' ' A' ' 190' ' ' CYS . 0.1 OUTLIER -118.41 -0.29 11.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.899 179.981 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 190' ' ' CYS . . . . . 0.592 ' HG ' ' CE1' ' A' ' 189' ' ' HIS . 94.8 m -128.48 91.9 42.43 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.602 0.715 . . . . 0.0 110.886 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 191' ' ' PRO . . . . . 0.42 ' HD2' ' HA ' ' A' ' 190' ' ' CYS . 53.8 Cg_endo -69.75 135.74 31.26 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.73 2.286 . . . . 0.0 112.346 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 192' ' ' ILE . . . . . 0.544 HG23 ' O ' ' A' ' 216' ' ' LEU . 62.1 mt -92.6 145.54 7.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.138 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 88.6 m -67.13 104.33 1.41 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.107 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 87.93 -15.32 55.99 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.502 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 73.57 -119.63 6.63 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.504 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.79 -21.32 2.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.748 0.309 . . . . 0.0 110.895 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -87.03 -25.52 24.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.885 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 198' ' ' GLY . . . . . 0.445 ' HA2' HD12 ' A' ' 216' ' ' LEU . . . -88.65 33.11 4.27 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.462 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 29.0 mt -138.72 153.15 25.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.822 0.344 . . . . 0.0 111.144 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.401 HD21 HG22 ' A' ' 156' ' ' VAL . 14.0 tp -146.96 113.0 5.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.921 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 201' ' ' PHE . . . . . 0.431 ' CZ ' ' N ' ' A' ' 179' ' ' ALA . 35.9 m-85 -93.72 121.51 35.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.895 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.406 ' CB ' ' OD2' ' A' ' 212' ' ' ASP . 42.1 t -74.39 123.46 29.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.161 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 203' ' ' THR . . . . . 0.573 ' HA ' HG23 ' A' ' 210' ' ' THR . 0.7 OUTLIER -134.18 137.08 44.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.096 -179.947 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -46.09 158.42 0.37 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.69 0.757 . . . . 0.0 110.915 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.7 3.04 2.97 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.66 2.24 . . . . 0.0 112.387 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -113.03 -10.05 13.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.882 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 99.92 58.85 0.87 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.459 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 11.2 mmm180 -142.3 143.38 27.01 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.614 0.721 . . . . 0.0 110.86 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.66 109.6 2.33 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.721 2.281 . . . . 0.0 112.371 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 210' ' ' THR . . . . . 0.576 ' HB ' ' CE2' ' A' ' 256' ' ' PHE . 19.8 p -73.43 -32.01 64.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.156 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 112.97 -30.28 7.51 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.487 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 212' ' ' ASP . . . . . 0.406 ' OD2' ' CB ' ' A' ' 202' ' ' VAL . 1.0 OUTLIER -88.45 163.98 15.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.785 0.326 . . . . 0.0 110.876 -179.975 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -162.76 177.37 9.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.091 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 214' ' ' PHE . . . . . 0.786 ' CE2' HG13 ' A' ' 249' ' ' VAL . 41.2 m-85 -142.35 139.41 31.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.87 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 6.2 t -123.0 156.89 28.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.15 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.544 ' O ' HG23 ' A' ' 192' ' ' ILE . 32.4 mt -109.92 138.8 45.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.922 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -130.12 133.9 46.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.858 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 218' ' ' ALA . . . . . 0.66 ' HB3' ' CE2' ' A' ' 222' ' ' TYR . . . -44.81 -64.53 0.68 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.136 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 219' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -144.23 160.2 41.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.835 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -40.92 -29.51 0.1 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.893 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -47.57 -49.89 25.37 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.9 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 222' ' ' TYR . . . . . 0.66 ' CE2' ' HB3' ' A' ' 218' ' ' ALA . 30.1 m-85 -78.03 -50.99 11.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.893 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.49 ' O ' ' HB3' ' A' ' 226' ' ' ALA . . . -44.85 -57.08 3.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.158 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 224' ' ' GLN . . . . . 0.542 ' HA ' HD12 ' A' ' 227' ' ' LEU . 8.6 mm-40 -48.52 -60.92 2.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.914 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 30.3 m-20 -51.86 -21.51 2.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.915 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 226' ' ' ALA . . . . . 0.49 ' HB3' ' O ' ' A' ' 223' ' ' ALA . . . -83.24 -33.86 25.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.094 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 227' ' ' LEU . . . . . 0.542 HD12 ' HA ' ' A' ' 224' ' ' GLN . 32.2 mt -60.67 -28.9 68.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.924 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 228' ' ' ARG . . . . . 0.408 HH11 ' CB ' ' A' ' 228' ' ' ARG . 0.0 OUTLIER -61.11 -18.06 55.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.878 179.946 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 229' ' ' LYS . . . . . 0.543 ' HD3' ' CE2' ' A' ' 185' ' ' PHE . 16.2 mttm -80.02 0.19 32.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.891 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 230' ' ' HIS . . . . . 0.482 ' N ' HD12 ' A' ' 241' ' ' LEU . 13.1 t-160 -32.66 126.93 0.29 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.872 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 43.7 mtmt 61.84 37.1 15.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.938 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -60.72 -174.93 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.852 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.612 HD21 ' CD1' ' A' ' 238' ' ' TYR . 33.0 mt -138.8 105.64 5.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.907 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 234' ' ' LEU . . . . . 0.539 ' C ' HD23 ' A' ' 234' ' ' LEU . 7.1 tt -113.35 114.8 27.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.873 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 59.22 37.67 92.13 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.494 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 33.3 mttt 69.14 52.37 0.49 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.774 0.321 . . . . 0.0 110.898 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 23.3 mmt180 -156.24 115.26 3.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.835 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 238' ' ' TYR . . . . . 0.612 ' CD1' HD21 ' A' ' 233' ' ' LEU . 97.3 m-85 -63.71 128.22 34.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.95 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 0.457 HD13 HD23 ' A' ' 173' ' ' LEU . 97.4 mt -127.04 129.71 71.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.08 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 240' ' ' GLU . . . . . 0.576 ' HB3' ' CE2' ' A' ' 242' ' ' PHE . 3.9 mp0 -85.33 171.92 11.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.85 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 241' ' ' LEU . . . . . 0.595 ' O ' ' CD1' ' A' ' 242' ' ' PHE . 21.3 mt -154.46 138.75 16.64 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.909 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 242' ' ' PHE . . . . . 0.595 ' CD1' ' O ' ' A' ' 241' ' ' LEU . 6.6 m-85 -158.45 123.43 4.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.878 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 243' ' ' ARG . . . . . 0.496 ' CG ' ' O ' ' A' ' 243' ' ' ARG . 21.2 ptt180 -60.89 117.33 5.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.85 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 1.7 t -112.49 168.52 9.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.858 -179.775 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.6 p -109.45 173.83 6.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.168 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 246' ' ' ALA . . . . . 0.549 ' HA ' HD12 ' A' ' 167' ' ' ILE . . . -61.63 -63.74 1.17 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.1 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -43.76 -49.67 7.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.074 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -47.27 -57.64 4.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.863 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.786 HG13 ' CE2' ' A' ' 214' ' ' PHE . 97.8 t -44.65 -61.68 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.136 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 250' ' ' GLN . . . . . 0.631 ' HA ' HD12 ' A' ' 253' ' ' LEU . 53.1 mt-30 -47.59 -29.55 2.98 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.916 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -82.4 -26.43 32.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.933 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 252' ' ' VAL . . . . . 0.425 ' O ' HG12 ' A' ' 252' ' ' VAL . 53.3 t -82.63 -15.31 11.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.131 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.631 HD12 ' HA ' ' A' ' 250' ' ' GLN . 13.4 mt -86.82 -43.06 12.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.887 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 254' ' ' ASN . . . . . 0.5 ' OD1' ' N ' ' A' ' 255' ' ' ARG . 0.6 OUTLIER -61.67 -44.49 96.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.85 179.943 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 255' ' ' ARG . . . . . 0.5 ' N ' ' OD1' ' A' ' 254' ' ' ASN . 11.4 ptm180 -54.17 -31.03 51.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.84 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 256' ' ' PHE . . . . . 0.576 ' CE2' ' HB ' ' A' ' 210' ' ' THR . 16.7 m-85 -91.34 -36.84 13.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.87 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 33.4 t -63.29 -74.22 0.1 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.895 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 46.3 m -92.91 64.83 4.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.879 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 259' ' ' ALA . . . . . . . . . . . . . . . -72.16 114.87 10.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.093 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 30.9 t -109.09 -53.09 2.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.894 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 261' ' ' GLY . . . . . 0.411 ' HA3' ' C ' ' A' ' 262' ' ' PRO . . . 158.75 -69.48 0.26 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.519 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 262' ' ' PRO . . . . . 0.411 ' C ' ' HA3' ' A' ' 261' ' ' GLY . 53.7 Cg_endo -69.77 -38.64 1.56 Allowed 'Cis proline' 0 C--N 1.342 0.209 0 C-N-CA 122.654 -1.811 . . . . 0.0 112.359 0.021 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 14.2 t -147.97 156.26 42.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.808 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 8.5 t 48.41 46.46 20.51 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.856 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.298 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.457 179.989 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 N-CA-C 112.496 -0.242 . . . . 0.0 112.496 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 70.2 p -44.11 99.91 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.875 0.369 . . . . 0.0 110.866 -179.746 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 6.4 t -147.65 163.86 35.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.916 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -116.54 83.76 0.35 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.479 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 80.3 p -80.82 149.74 29.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.869 0.366 . . . . 0.0 110.855 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 8.5 t -101.22 -61.05 1.42 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.871 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 144.21 112.45 0.83 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.458 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -168.0 73.99 0.14 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.49 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 107.8 -176.78 20.86 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.449 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.738 HG22 HG23 ' A' ' 156' ' ' VAL . 0.3 OUTLIER -110.27 -14.68 14.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.852 0.358 . . . . 0.0 111.17 -179.886 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 24.3 m -62.72 -30.13 71.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.802 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' ASN . . . . . 0.498 ' O ' ' HB3' ' A' ' 157' ' ' ALA . 2.7 t30 -76.3 -57.53 3.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.935 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.606 ' OE2' HG23 ' A' ' 152' ' ' THR . 5.0 pt-20 -55.53 -60.13 3.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.846 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.738 HG23 HG22 ' A' ' 152' ' ' THR . 79.0 t -43.34 -39.13 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.154 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.498 ' HB3' ' O ' ' A' ' 154' ' ' ASN . . . -45.46 -48.08 13.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.065 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -69.83 -42.07 74.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.909 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' PHE . . . . . 0.475 ' CD2' ' HB2' ' A' ' 200' ' ' LEU . 41.2 t80 -56.07 -41.77 75.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.899 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 91.0 mt -85.56 -26.05 26.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.903 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 31.6 t -54.62 -26.51 33.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.881 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 18.2 mmmt -61.99 128.77 37.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.873 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -105.99 154.08 21.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.861 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 62.35 49.35 4.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.858 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 24.3 mm-40 -137.21 153.47 50.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.92 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 55.7 t -108.03 119.8 58.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.149 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' ILE . . . . . 0.462 HD12 ' N ' ' A' ' 246' ' ' ALA . 10.8 mt -90.66 147.83 4.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.156 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 95.6 t -128.53 141.43 46.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.127 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 29.0 ttp85 -95.51 107.17 19.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.877 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' MET . . . . . 0.478 ' CE ' HD21 ' A' ' 173' ' ' LEU . 89.7 mtp -92.56 127.11 37.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.932 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.423 ' O ' HG23 ' A' ' 239' ' ' ILE . 3.8 tpt180 -123.83 144.89 49.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.881 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 172' ' ' GLY . . . . . 0.401 ' N ' ' HG3' ' A' ' 171' ' ' ARG . . . 79.01 33.63 36.02 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.464 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.763 ' CD1' ' HB3' ' A' ' 213' ' ' ALA . 21.8 mt -81.39 119.33 75.38 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.574 0.702 . . . . 0.0 110.896 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 174' ' ' PRO . . . . . 0.481 ' O ' ' N ' ' A' ' 177' ' ' ALA . 65.2 Cg_exo -47.94 130.0 18.95 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.695 2.263 . . . . 0.0 112.368 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 34.7 m-85 -41.49 -41.07 1.98 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.889 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 65.3 p -75.52 -29.47 59.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.157 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.481 ' N ' ' O ' ' A' ' 174' ' ' PRO . . . -45.74 112.62 0.49 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.085 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -113.4 170.36 8.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.127 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -46.5 -56.53 5.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.112 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -45.43 -30.18 1.3 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.856 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 181' ' ' GLU . . . . . 0.636 ' HG3' HD11 ' A' ' 234' ' ' LEU . 2.2 tp10 -71.59 -41.61 68.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.885 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.45 HG12 HD11 ' A' ' 192' ' ' ILE . 55.8 t -69.25 -47.41 73.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.107 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.432 ' C ' ' O ' ' A' ' 182' ' ' VAL . 70.8 t -35.26 -54.25 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.08 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -74.78 -39.2 61.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.086 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.476 ' CD1' HD12 ' A' ' 234' ' ' LEU . 59.2 t80 -41.54 -58.27 1.97 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.87 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -94.3 -21.32 19.07 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.871 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -49.15 -25.78 5.81 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.463 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -48.3 -72.77 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.836 0.351 . . . . 0.0 110.91 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 14.2 m170 -118.26 -15.52 9.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.894 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 63.8 m -118.41 85.17 25.13 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.638 0.732 . . . . 0.0 110.94 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 191' ' ' PRO . . . . . 0.462 ' HD2' ' CD1' ' A' ' 222' ' ' TYR . 53.3 Cg_endo -69.75 139.9 41.39 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.686 2.257 . . . . 0.0 112.348 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 192' ' ' ILE . . . . . 0.65 HG23 ' O ' ' A' ' 216' ' ' LEU . 49.6 mt -91.82 144.69 8.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.135 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 55.0 m -67.3 108.28 2.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.157 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 86.94 -22.18 15.8 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.447 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.409 ' O ' ' N ' ' A' ' 198' ' ' GLY . . . 82.52 -126.56 7.51 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.484 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 196' ' ' LYS . . . . . 0.423 ' HA ' HD12 ' A' ' 199' ' ' ILE . 8.8 ptpt -46.48 -22.25 0.25 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.767 0.318 . . . . 0.0 110.894 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -82.23 -33.69 29.17 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.912 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 198' ' ' GLY . . . . . 0.465 ' HA2' HD12 ' A' ' 216' ' ' LEU . . . -84.98 35.4 3.11 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.466 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.423 HD12 ' HA ' ' A' ' 196' ' ' LYS . 27.5 mt -138.8 139.92 39.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.828 0.347 . . . . 0.0 111.148 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.558 HD21 HG22 ' A' ' 156' ' ' VAL . 14.5 tp -137.19 111.83 8.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.939 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -90.43 123.43 34.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.901 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 59.0 t -73.51 118.32 18.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.144 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -127.95 137.14 52.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.124 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -45.99 158.75 0.35 Allowed Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.63 0.729 . . . . 0.0 110.918 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.83 3.58 2.72 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.631 2.221 . . . . 0.0 112.327 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -112.4 -21.28 11.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.861 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 113.53 56.41 0.41 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.525 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 7.6 mpt_? -143.53 146.5 35.84 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.554 0.692 . . . . 0.0 110.904 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 111.17 2.74 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.669 2.246 . . . . 0.0 112.363 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 210' ' ' THR . . . . . 0.566 ' HB ' ' CE2' ' A' ' 256' ' ' PHE . 62.0 p -73.09 -14.03 61.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.152 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 97.57 -31.33 7.93 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.523 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -90.38 168.4 11.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.827 0.346 . . . . 0.0 110.832 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 213' ' ' ALA . . . . . 0.763 ' HB3' ' CD1' ' A' ' 173' ' ' LEU . . . -165.01 174.86 10.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.12 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 214' ' ' PHE . . . . . 0.498 ' HZ ' HG21 ' A' ' 252' ' ' VAL . 56.4 m-85 -137.71 151.37 48.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.899 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 215' ' ' VAL . . . . . 0.402 ' CG2' ' SD ' ' A' ' 170' ' ' MET . 6.9 t -134.76 155.0 37.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.129 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.65 ' O ' HG23 ' A' ' 192' ' ' ILE . 29.5 mt -108.48 144.05 36.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.915 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -136.41 141.33 43.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.9 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -53.9 -57.17 11.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.156 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 219' ' ' CYS . . . . . . . . . . . . . 95.2 m -136.4 -179.22 5.55 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.887 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -70.14 -28.62 65.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.921 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -48.02 -50.01 29.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.904 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 222' ' ' TYR . . . . . 0.462 ' CD1' ' HD2' ' A' ' 191' ' ' PRO . 29.6 m-85 -74.0 -49.73 23.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.921 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -47.64 -56.75 6.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.107 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -55.87 -52.74 63.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.91 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -49.96 -31.73 13.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.917 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -75.41 -35.77 60.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.09 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 89.8 mt -52.43 -39.6 61.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.921 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 34.8 mtt85 -54.99 -26.0 33.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.843 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 229' ' ' LYS . . . . . 0.458 ' O ' ' C ' ' A' ' 230' ' ' HIS . 6.9 mtpm? -69.86 -2.48 12.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.922 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 230' ' ' HIS . . . . . 0.519 ' CE1' ' HD3' ' A' ' 231' ' ' LYS . 12.0 t60 -33.86 136.67 0.11 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.845 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.519 ' HD3' ' CE1' ' A' ' 230' ' ' HIS . 1.2 mmmp? 62.96 29.43 16.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.909 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 232' ' ' ASP . . . . . 0.423 ' OD1' ' NZ ' ' A' ' 229' ' ' LYS . 2.7 t70 -58.34 -179.69 0.06 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.88 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.617 HD21 ' CD1' ' A' ' 238' ' ' TYR . 30.2 mt -138.19 107.78 6.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.925 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 234' ' ' LEU . . . . . 0.636 HD11 ' HG3' ' A' ' 181' ' ' GLU . 6.1 tt -117.83 111.2 18.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.915 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 60.12 43.23 98.54 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.47 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 64.66 53.8 1.5 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.723 0.297 . . . . 0.0 110.915 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 237' ' ' ARG . . . . . 0.438 ' CB ' ' HG3' ' A' ' 174' ' ' PRO . 14.2 mmt85 -156.65 115.48 3.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.877 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 238' ' ' TYR . . . . . 0.617 ' CD1' HD21 ' A' ' 233' ' ' LEU . 97.2 m-85 -69.69 123.68 22.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.975 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 0.489 HD13 HD23 ' A' ' 173' ' ' LEU . 37.9 mt -119.74 145.9 25.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.132 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 240' ' ' GLU . . . . . 0.464 ' HB3' ' CZ ' ' A' ' 242' ' ' PHE . 38.9 mt-10 -111.35 159.51 17.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.829 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 17.0 mt -136.58 123.87 21.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.98 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 242' ' ' PHE . . . . . 0.464 ' CZ ' ' HB3' ' A' ' 240' ' ' GLU . 4.1 m-85 -131.05 129.57 42.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.855 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 70.2 mtt180 -42.61 150.8 0.14 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.943 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 1.3 t -152.18 156.06 39.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.869 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 50.6 p -131.11 165.92 22.22 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.109 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 246' ' ' ALA . . . . . 0.462 ' N ' HD12 ' A' ' 167' ' ' ILE . . . -48.41 -52.74 20.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.121 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -58.6 -47.92 82.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.098 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -51.64 -55.54 18.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.849 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.437 ' CG2' HG21 ' A' ' 167' ' ' ILE . 91.2 t -42.45 -65.21 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.161 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 250' ' ' GLN . . . . . 0.62 ' HA ' HD12 ' A' ' 253' ' ' LEU . 30.4 mt-30 -38.08 -57.84 1.02 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.93 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -52.33 -44.25 65.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.927 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 252' ' ' VAL . . . . . 0.498 HG21 ' HZ ' ' A' ' 214' ' ' PHE . 91.1 t -59.95 -31.43 47.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.105 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.62 HD12 ' HA ' ' A' ' 250' ' ' GLN . 7.9 mt -79.51 -39.46 31.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.945 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 16.6 m-80 -66.97 -49.0 66.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.904 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 255' ' ' ARG . . . . . 0.475 ' HG3' ' N ' ' A' ' 256' ' ' PHE . 2.7 ptm85 -53.35 -43.5 67.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.826 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 256' ' ' PHE . . . . . 0.566 ' CE2' ' HB ' ' A' ' 210' ' ' THR . 13.1 m-85 -76.34 -37.59 57.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.862 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 24.1 p -73.58 160.38 31.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.813 -179.749 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 62.7 m 63.97 31.05 13.98 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.848 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 259' ' ' ALA . . . . . . . . . . . . . . . -116.22 143.62 45.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.108 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 1.9 t -124.14 173.19 8.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.82 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -106.4 -163.42 22.67 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.482 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 262' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 -35.98 2.5 Favored 'Cis proline' 0 C--N 1.341 0.175 0 C-N-CA 122.671 -1.804 . . . . 0.0 112.369 0.063 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 2.5 m 63.5 44.09 5.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.867 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 33.5 t -144.35 150.38 37.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.83 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.274 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.488 -179.997 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.31 0 N-CA-C 112.521 -0.231 . . . . 0.0 112.521 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 3.8 m -117.95 139.57 50.97 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.884 0.373 . . . . 0.0 110.848 -179.716 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 26.0 t -75.33 -61.64 1.83 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.858 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 108.49 -110.75 3.14 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.477 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 36.1 m 44.58 41.52 4.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.937 0.399 . . . . 0.0 110.9 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 22.8 t -150.59 146.32 26.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.834 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 100.54 169.7 28.99 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.47 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -64.19 -97.17 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.484 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -75.53 136.64 20.45 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.47 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 2.1 m -69.38 115.81 9.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.793 0.33 . . . . 0.0 111.125 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 18.5 m -130.04 -50.59 1.12 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.831 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -64.49 -50.94 65.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.903 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -51.99 -51.16 59.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.935 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 90.2 t -63.44 -47.4 91.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.156 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -40.01 -61.07 0.92 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.105 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -59.13 -40.69 86.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.909 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' PHE . . . . . 0.526 ' CE2' ' HG ' ' A' ' 216' ' ' LEU . 49.2 t80 -56.41 -40.55 74.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.873 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 86.6 mt -87.94 -24.37 23.61 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.868 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 28.7 t -58.72 -27.38 64.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.843 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' LYS . . . . . 0.527 ' HG3' HD13 ' A' ' 216' ' ' LEU . 28.6 mmmt -60.75 125.74 24.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.872 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -101.26 150.46 22.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.89 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 34.8 m-20 62.51 49.4 4.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.882 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.9 mm-40 -133.9 143.6 48.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.899 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 48.6 t -100.22 107.23 20.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.188 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 36.7 mt -75.95 134.13 29.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.143 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 57.9 t -116.22 128.46 73.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.127 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 45.8 ttp180 -88.35 108.25 19.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.884 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' MET . . . . . 0.485 ' CE ' HD21 ' A' ' 173' ' ' LEU . 97.0 mtp -92.6 113.33 25.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.859 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 8.3 ttp180 -117.21 139.28 50.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.912 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 91.38 25.04 24.81 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.507 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.894 HD23 HD13 ' A' ' 239' ' ' ILE . 19.5 mt -80.27 129.01 71.14 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.612 0.72 . . . . 0.0 110.919 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 174' ' ' PRO . . . . . 0.434 ' HG3' ' CB ' ' A' ' 237' ' ' ARG . 64.8 Cg_exo -47.92 136.35 22.92 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.75 2.3 . . . . 0.0 112.335 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 8.8 m-30 -50.98 -19.97 1.2 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.86 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.539 ' O ' HG23 ' A' ' 178' ' ' THR . 64.1 p -94.98 -28.77 14.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.098 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -41.85 120.64 1.58 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.083 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.539 HG23 ' O ' ' A' ' 176' ' ' THR . 40.1 p -116.01 179.56 3.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.164 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -54.12 -48.57 70.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.111 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -52.84 -42.29 65.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.875 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -58.87 -37.14 75.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.895 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.506 HG12 ' CD1' ' A' ' 192' ' ' ILE . 15.5 t -73.21 -47.25 47.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.121 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 42.8 t -39.83 -49.82 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.067 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.428 ' O ' ' C ' ' A' ' 185' ' ' PHE . . . -74.25 -44.71 51.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.106 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.491 ' HD1' HD12 ' A' ' 234' ' ' LEU . 53.9 t80 -36.42 -60.56 0.57 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.864 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 186' ' ' PHE . . . . . 0.473 ' CZ ' ' CD2' ' A' ' 185' ' ' PHE . 42.4 m-85 -95.06 -25.0 16.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.885 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -49.15 -21.31 2.56 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.469 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 42.0 tt0 -55.18 -70.66 0.1 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.816 0.341 . . . . 0.0 110.908 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 20.3 m80 -118.21 -16.72 9.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.853 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 190' ' ' CYS . . . . . 0.423 ' SG ' ' HB2' ' A' ' 226' ' ' ALA . 70.9 m -120.36 87.26 40.15 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.603 0.716 . . . . 0.0 110.86 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 130.55 19.6 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.692 2.261 . . . . 0.0 112.331 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 192' ' ' ILE . . . . . 0.506 ' CD1' HG12 ' A' ' 182' ' ' VAL . 54.7 mt -78.1 144.57 11.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.15 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 29.3 m -71.29 104.43 3.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.183 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 91.98 -17.17 57.64 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.497 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.414 ' O ' ' N ' ' A' ' 198' ' ' GLY . . . 70.22 -124.12 13.21 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.516 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 31.4 mtmm -46.09 -30.58 1.94 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.679 0.276 . . . . 0.0 110.859 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -78.13 -32.01 50.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.893 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 198' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 195' ' ' GLY . . . -88.46 29.65 5.62 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.492 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 70.2 mt -131.4 142.12 44.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.89 0.376 . . . . 0.0 111.127 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 13.0 tp -139.7 111.74 7.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.919 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -96.27 119.26 34.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.909 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.466 HG23 ' HA ' ' A' ' 213' ' ' ALA . 21.7 t -71.51 130.18 35.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.109 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -140.59 137.59 33.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.151 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -48.76 158.88 0.6 Allowed Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.681 0.753 . . . . 0.0 110.903 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 3.05 2.99 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.74 2.293 . . . . 0.0 112.357 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -112.37 -15.29 13.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.864 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 112.25 9.89 18.93 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.501 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -89.64 140.67 28.16 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.603 0.716 . . . . 0.0 110.855 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 115.59 4.16 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.651 2.234 . . . . 0.0 112.339 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 210' ' ' THR . . . . . 0.549 ' HB ' ' CE2' ' A' ' 256' ' ' PHE . 69.8 p -80.24 -21.49 42.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.107 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 95.3 -46.38 2.01 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.515 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 212' ' ' ASP . . . . . 0.434 ' OD2' HG11 ' A' ' 202' ' ' VAL . 1.1 p-10 -68.64 154.64 41.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.816 0.341 . . . . 0.0 110.875 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 213' ' ' ALA . . . . . 0.466 ' HA ' HG23 ' A' ' 202' ' ' VAL . . . -153.53 -175.27 5.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.096 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 214' ' ' PHE . . . . . 0.447 ' HZ ' HG11 ' A' ' 252' ' ' VAL . 52.8 m-85 -150.63 139.49 20.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.851 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 215' ' ' VAL . . . . . 0.542 HG12 ' N ' ' A' ' 216' ' ' LEU . 21.4 t -125.69 162.34 28.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.132 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.542 ' N ' HG12 ' A' ' 215' ' ' VAL . 31.2 mt -112.48 137.23 50.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.919 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -132.5 138.88 47.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.844 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 218' ' ' ALA . . . . . 0.832 ' HB3' ' CD2' ' A' ' 222' ' ' TYR . . . -48.39 -65.72 0.52 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.147 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 219' ' ' CYS . . . . . . . . . . . . . 2.6 m -154.85 174.81 14.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.845 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.405 ' HA ' ' HB3' ' A' ' 223' ' ' ALA . 1.7 mp0 -39.81 -42.73 1.33 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.915 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -41.14 -43.31 2.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.896 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 222' ' ' TYR . . . . . 0.832 ' CD2' ' HB3' ' A' ' 218' ' ' ALA . 57.1 m-85 -92.35 -46.27 7.78 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.912 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.405 ' HB3' ' HA ' ' A' ' 220' ' ' GLU . . . -52.14 -64.12 0.92 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.104 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 224' ' ' GLN . . . . . 0.692 ' HA ' HD12 ' A' ' 227' ' ' LEU . 23.0 mm-40 -50.65 -55.93 14.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.945 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 225' ' ' ASN . . . . . 0.439 ' O ' ' CG ' ' A' ' 228' ' ' ARG . 24.2 m-20 -52.14 -21.24 3.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.903 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 226' ' ' ALA . . . . . 0.423 ' HB2' ' SG ' ' A' ' 190' ' ' CYS . . . -93.83 -34.19 13.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.089 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 227' ' ' LEU . . . . . 0.692 HD12 ' HA ' ' A' ' 224' ' ' GLN . 63.4 mt -57.65 -32.77 67.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.886 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 228' ' ' ARG . . . . . 0.439 ' CG ' ' O ' ' A' ' 225' ' ' ASN . 3.0 ptm180 -58.52 -13.05 4.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.879 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 229' ' ' LYS . . . . . 0.456 ' O ' ' C ' ' A' ' 230' ' ' HIS . 16.1 mtpp -86.13 -0.37 55.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.924 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 230' ' ' HIS . . . . . 0.556 ' CE1' ' HG3' ' A' ' 231' ' ' LYS . 48.2 t60 -33.94 131.54 0.27 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.879 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.556 ' HG3' ' CE1' ' A' ' 230' ' ' HIS . 36.8 mttp 62.37 35.36 15.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.879 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -62.01 -176.37 0.09 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.878 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.708 HD21 ' CE1' ' A' ' 238' ' ' TYR . 31.7 mt -133.9 112.42 11.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.893 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 234' ' ' LEU . . . . . 0.571 ' C ' HD23 ' A' ' 234' ' ' LEU . 7.3 tt -121.47 117.89 27.98 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.919 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 57.05 36.35 73.74 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.508 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 26.9 mmtm 69.13 50.73 0.56 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.806 0.336 . . . . 0.0 110.889 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 237' ' ' ARG . . . . . 0.434 ' CB ' ' HG3' ' A' ' 174' ' ' PRO . 44.7 mmt-85 -156.06 115.28 3.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.826 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 238' ' ' TYR . . . . . 0.708 ' CE1' HD21 ' A' ' 233' ' ' LEU . 97.5 m-85 -66.58 136.36 55.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.949 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 0.894 HD13 HD23 ' A' ' 173' ' ' LEU . 79.2 mt -135.88 126.21 42.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.154 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 240' ' ' GLU . . . . . 0.584 ' HB3' ' CZ ' ' A' ' 242' ' ' PHE . 6.7 mp0 -84.81 166.33 17.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.908 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 241' ' ' LEU . . . . . 0.451 ' O ' ' CD1' ' A' ' 242' ' ' PHE . 15.1 mt -148.13 134.03 19.1 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.89 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 242' ' ' PHE . . . . . 0.584 ' CZ ' ' HB3' ' A' ' 240' ' ' GLU . 7.3 m-85 -145.42 120.92 10.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.886 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 243' ' ' ARG . . . . . 0.486 ' CG ' ' O ' ' A' ' 243' ' ' ARG . 18.4 ptt-85 -57.15 118.25 4.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.883 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 7.5 t -114.4 -174.98 2.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.887 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 245' ' ' THR . . . . . 0.956 ' O ' HG23 ' A' ' 249' ' ' VAL . 67.8 p -135.64 179.16 6.51 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.162 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -60.86 -53.62 55.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.091 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -52.95 -58.17 7.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.146 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 248' ' ' GLU . . . . . 0.508 ' O ' HG23 ' A' ' 252' ' ' VAL . 1.9 tp10 -49.44 -55.92 11.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.893 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.956 HG23 ' O ' ' A' ' 245' ' ' THR . 97.3 t -39.68 -65.58 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.149 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 250' ' ' GLN . . . . . 0.432 ' O ' ' N ' ' A' ' 253' ' ' LEU . 52.2 mt-30 -37.55 -66.72 0.23 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.885 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 28.9 mm-40 -40.97 -39.69 1.23 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.941 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 252' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 248' ' ' GLU . 28.3 t -65.04 -39.44 85.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.125 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.432 ' N ' ' O ' ' A' ' 250' ' ' GLN . 7.1 mt -76.89 -36.17 56.87 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.919 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -71.43 -49.77 38.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.89 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 255' ' ' ARG . . . . . 0.541 ' CG ' ' N ' ' A' ' 256' ' ' PHE . 5.2 ptm180 -49.66 -50.75 42.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.83 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 256' ' ' PHE . . . . . 0.549 ' CE2' ' HB ' ' A' ' 210' ' ' THR . 12.4 m-85 -65.04 -33.6 76.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.877 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 14.2 m -72.82 136.55 45.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.849 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 23.1 t 61.28 53.22 3.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.9 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 259' ' ' ALA . . . . . . . . . . . . . . . -73.44 111.39 8.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.085 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 6.7 t -58.78 -67.9 0.32 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.863 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 134.54 -162.76 24.67 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.43 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 262' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 173.13 45.88 Favored 'Cis proline' 0 C--N 1.341 0.179 0 C-N-CA 122.705 -1.79 . . . . 0.0 112.341 0.061 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 47.1 t -64.34 -34.62 78.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.862 -179.825 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 23.3 t -63.62 140.82 58.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.85 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.313 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.494 -179.973 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.381 0 N-CA-C 112.541 -0.223 . . . . 0.0 112.541 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 7.6 t -121.41 131.89 54.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.849 0.357 . . . . 0.0 110.869 -179.731 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 16.3 t -147.64 133.23 18.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.868 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 96.69 170.58 34.27 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.501 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 17.4 t -99.27 80.43 2.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.887 0.375 . . . . 0.0 110.852 -179.728 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 2.2 t 56.34 31.11 18.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.826 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -94.7 97.55 2.17 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.486 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 151.74 -68.6 0.32 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.469 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 168.14 -144.76 9.1 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.463 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.698 HG22 HG23 ' A' ' 156' ' ' VAL . 1.5 m -130.77 -41.63 1.16 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.818 0.342 . . . . 0.0 111.108 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' SER . . . . . 0.43 ' C ' ' O ' ' A' ' 152' ' ' THR . 44.3 t -35.31 -36.08 0.06 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.818 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' ASN . . . . . 0.413 ' N ' ' O ' ' A' ' 152' ' ' THR . 4.4 p-10 -57.98 -58.07 10.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.883 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -68.44 -38.79 81.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.876 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.698 HG23 HG22 ' A' ' 152' ' ' THR . 76.6 t -60.39 -36.99 72.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.147 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -43.68 -62.25 1.15 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.076 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -60.83 -42.54 97.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.93 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' PHE . . . . . 0.531 ' CE2' ' HG ' ' A' ' 216' ' ' LEU . 59.6 t80 -52.7 -38.85 61.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.853 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 82.9 mt -89.96 -29.03 18.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.946 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 1.7 t -52.04 -33.34 38.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.852 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' LYS . . . . . 0.58 ' HG3' HD13 ' A' ' 216' ' ' LEU . 27.4 mmmt -45.5 116.68 1.22 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.868 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -84.55 149.96 25.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.869 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 47.71 44.85 17.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.907 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.567 ' OE1' HG21 ' A' ' 193' ' ' THR . 0.4 OUTLIER -117.1 153.13 33.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.907 -179.974 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 46.8 t -106.23 139.06 28.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.157 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' ILE . . . . . 0.531 HG21 HG21 ' A' ' 249' ' ' VAL . 26.0 mt -113.07 137.22 46.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.113 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.477 HG21 ' CE1' ' A' ' 217' ' ' PHE . 94.1 t -114.2 138.23 44.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.123 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 39.9 ttt-85 -93.81 109.25 20.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.893 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' MET . . . . . 0.48 ' CE ' HD21 ' A' ' 173' ' ' LEU . 83.6 mtp -99.51 126.39 45.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.908 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 11.0 mtp85 -127.15 145.17 50.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.866 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 81.5 32.63 30.29 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.482 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.827 ' CD1' ' HB3' ' A' ' 213' ' ' ALA . 22.1 mt -82.84 121.28 77.5 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.658 0.742 . . . . 0.0 110.929 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 174' ' ' PRO . . . . . 0.485 ' O ' ' N ' ' A' ' 176' ' ' THR . 66.6 Cg_exo -48.02 121.44 5.97 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.661 2.24 . . . . 0.0 112.333 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 175' ' ' PHE . . . . . 0.591 ' CD2' ' HG2' ' A' ' 209' ' ' PRO . 3.4 m-85 -37.21 -29.13 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.859 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.485 ' N ' ' O ' ' A' ' 174' ' ' PRO . 73.7 p -80.83 -44.01 19.14 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.161 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.476 ' N ' ' O ' ' A' ' 174' ' ' PRO . . . -34.27 125.45 0.49 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.064 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.404 HG23 ' O ' ' A' ' 176' ' ' THR . 12.0 p -118.49 177.07 4.96 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.151 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.445 ' O ' HG23 ' A' ' 183' ' ' VAL . . . -52.46 -44.91 65.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.113 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -56.18 -41.54 75.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.885 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -57.83 -39.38 77.54 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.882 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.502 HG12 ' CD1' ' A' ' 192' ' ' ILE . 54.7 t -71.99 -52.39 25.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.112 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 179' ' ' ALA . 89.9 t -35.13 -47.27 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.14 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -79.65 -39.33 31.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.138 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.612 ' CD1' HD12 ' A' ' 234' ' ' LEU . 58.2 t80 -41.33 -58.78 1.74 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.903 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 186' ' ' PHE . . . . . 0.491 ' O ' ' N ' ' A' ' 190' ' ' CYS . 63.1 m-85 -96.41 -23.32 16.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.915 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -52.68 -21.15 8.83 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.498 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 188' ' ' GLN . . . . . 0.485 ' NE2' ' O ' ' A' ' 185' ' ' PHE . 1.5 pt20 -59.19 -60.04 4.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.858 0.361 . . . . 0.0 110.91 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 189' ' ' HIS . . . . . 0.624 ' CE1' ' SG ' ' A' ' 190' ' ' CYS . 2.3 p-80 -119.02 -29.11 5.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.843 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 190' ' ' CYS . . . . . 0.624 ' SG ' ' CE1' ' A' ' 189' ' ' HIS . 93.1 m -116.54 89.78 28.66 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.632 0.729 . . . . 0.0 110.853 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 191' ' ' PRO . . . . . 0.444 ' HD2' ' CD1' ' A' ' 222' ' ' TYR . 53.5 Cg_endo -69.8 132.65 23.73 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.67 2.246 . . . . 0.0 112.305 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 192' ' ' ILE . . . . . 0.641 HG23 ' O ' ' A' ' 216' ' ' LEU . 59.4 mt -82.9 145.17 8.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.105 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 193' ' ' THR . . . . . 0.567 HG21 ' OE1' ' A' ' 165' ' ' GLN . 98.0 m -63.68 102.14 0.42 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.138 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 88.38 -16.92 51.28 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.476 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.455 ' O ' ' N ' ' A' ' 198' ' ' GLY . . . 75.3 -129.18 10.34 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.502 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 3.9 pttm -41.23 -37.07 0.87 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.762 0.315 . . . . 0.0 110.912 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -70.87 -37.39 73.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.896 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 198' ' ' GLY . . . . . 0.536 ' HA2' HD12 ' A' ' 216' ' ' LEU . . . -83.06 36.21 2.73 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.534 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 72.1 mt -139.0 148.91 23.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.83 0.348 . . . . 0.0 111.111 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.537 HD21 HG22 ' A' ' 156' ' ' VAL . 23.5 tp -137.4 120.94 17.18 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.912 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -101.92 111.37 23.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.883 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.435 HG11 ' OD2' ' A' ' 212' ' ' ASP . 59.7 t -66.09 136.29 26.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.137 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -142.83 141.4 31.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.12 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 204' ' ' TYR . . . . . 0.453 ' N ' HG23 ' A' ' 210' ' ' THR . 21.0 m-85 -47.58 159.42 0.44 Allowed Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.718 0.77 . . . . 0.0 110.886 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 4.18 2.34 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.641 2.227 . . . . 0.0 112.324 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -111.8 -23.42 10.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.839 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 115.05 49.18 0.51 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.516 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 76.4 mtp180 -134.5 147.1 61.98 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.578 0.704 . . . . 0.0 110.886 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 209' ' ' PRO . . . . . 0.591 ' HG2' ' CD2' ' A' ' 175' ' ' PHE . 54.2 Cg_endo -69.72 99.62 0.76 Allowed 'Trans proline' 0 N--CA 1.465 -0.174 0 C-N-CA 122.682 2.255 . . . . 0.0 112.396 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 210' ' ' THR . . . . . 0.453 HG23 ' N ' ' A' ' 204' ' ' TYR . 65.8 p -60.4 -33.3 72.29 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.137 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 115.33 -30.2 6.87 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.486 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 212' ' ' ASP . . . . . 0.435 ' OD2' HG11 ' A' ' 202' ' ' VAL . 1.3 p-10 -85.65 163.34 18.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.797 0.332 . . . . 0.0 110.876 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 213' ' ' ALA . . . . . 0.827 ' HB3' ' CD1' ' A' ' 173' ' ' LEU . . . -166.69 159.25 13.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.082 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 214' ' ' PHE . . . . . 0.492 ' CD2' HG13 ' A' ' 249' ' ' VAL . 71.8 m-85 -124.62 162.78 23.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.903 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 215' ' ' VAL . . . . . 0.597 HG12 ' N ' ' A' ' 216' ' ' LEU . 43.3 t -140.34 163.95 22.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.091 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.641 ' O ' HG23 ' A' ' 192' ' ' ILE . 62.3 mt -115.2 145.38 42.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.902 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 217' ' ' PHE . . . . . 0.477 ' CE1' HG21 ' A' ' 168' ' ' VAL . 80.1 m-85 -141.89 131.58 24.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.869 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 218' ' ' ALA . . . . . 0.486 ' HA ' ' NE2' ' A' ' 165' ' ' GLN . . . -42.77 -54.14 4.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.116 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 219' ' ' CYS . . . . . . . . . . . . . 5.0 m -157.15 179.99 8.76 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.888 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.44 ' HA ' ' HB3' ' A' ' 223' ' ' ALA . 0.7 OUTLIER -52.69 -39.48 61.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.915 -179.961 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 221' ' ' GLU . . . . . 0.422 ' C ' ' O ' ' A' ' 220' ' ' GLU . 29.7 tt0 -36.89 -49.51 0.81 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.897 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 222' ' ' TYR . . . . . 0.444 ' CD1' ' HD2' ' A' ' 191' ' ' PRO . 42.7 m-85 -87.84 -46.98 8.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.933 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.526 ' O ' ' HB3' ' A' ' 226' ' ' ALA . . . -52.99 -62.53 1.59 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.077 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 56.1 mm-40 -47.45 -61.72 1.78 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.934 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 30.6 m-20 -45.44 -31.96 1.94 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.905 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 226' ' ' ALA . . . . . 0.526 ' HB3' ' O ' ' A' ' 223' ' ' ALA . . . -69.55 -38.05 77.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.089 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 29.0 mt -51.84 -29.34 19.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.934 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 8.9 mpt_? -61.39 -30.03 70.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.851 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 229' ' ' LYS . . . . . 0.589 ' HE3' ' CE2' ' A' ' 185' ' ' PHE . 20.1 mtpp -71.55 -0.83 11.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.868 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 230' ' ' HIS . . . . . 0.449 ' C ' ' O ' ' A' ' 229' ' ' LYS . 20.9 t60 -34.28 129.71 0.37 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.892 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.41 ' HG3' ' CE1' ' A' ' 230' ' ' HIS . 39.6 mtmt 62.63 39.67 11.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.879 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -67.09 -175.17 0.42 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.871 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.67 HD21 ' CE2' ' A' ' 238' ' ' TYR . 30.6 mt -135.9 109.8 8.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.927 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 234' ' ' LEU . . . . . 0.612 HD12 ' CD1' ' A' ' 185' ' ' PHE . 7.1 tt -117.85 117.71 30.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.913 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 54.71 38.69 64.72 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.459 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 38.4 mttp 68.86 50.54 0.62 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.767 0.318 . . . . 0.0 110.929 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 19.6 mmt180 -155.04 115.58 3.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.888 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 238' ' ' TYR . . . . . 0.67 ' CE2' HD21 ' A' ' 233' ' ' LEU . 95.7 m-85 -67.92 131.25 45.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.959 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 0.467 HD13 HD23 ' A' ' 173' ' ' LEU . 75.1 mt -129.76 133.83 64.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.119 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 240' ' ' GLU . . . . . 0.465 ' HB3' ' CZ ' ' A' ' 242' ' ' PHE . 7.4 mp0 -94.18 170.97 9.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.901 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 241' ' ' LEU . . . . . 0.524 ' O ' ' CG ' ' A' ' 242' ' ' PHE . 14.9 mt -150.78 153.38 35.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.931 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 242' ' ' PHE . . . . . 0.524 ' CG ' ' O ' ' A' ' 241' ' ' LEU . 3.7 m-85 -162.12 151.62 16.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.845 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 243' ' ' ARG . . . . . 0.474 ' CZ ' ' HB2' ' A' ' 243' ' ' ARG . 12.6 mtm105 -65.76 118.39 9.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.874 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 244' ' ' SER . . . . . 0.443 ' HB3' HG22 ' A' ' 167' ' ' ILE . 1.0 OUTLIER -111.19 160.42 16.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.889 -179.785 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 40.1 p -132.97 155.8 48.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.146 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 246' ' ' ALA . . . . . 0.503 ' N ' HD12 ' A' ' 167' ' ' ILE . . . -43.17 -53.15 5.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.114 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -56.8 -51.86 67.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.052 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -48.19 -54.73 12.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.939 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.531 HG21 HG21 ' A' ' 167' ' ' ILE . 59.9 t -48.81 -65.87 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.133 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 250' ' ' GLN . . . . . 0.905 ' HA ' HD12 ' A' ' 253' ' ' LEU . 86.8 mt-30 -38.41 -46.1 1.1 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.954 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -62.67 -51.88 65.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.858 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 73.4 t -54.92 -34.89 32.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.093 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.905 HD12 ' HA ' ' A' ' 250' ' ' GLN . 14.9 mt -64.62 -49.56 70.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.91 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 254' ' ' ASN . . . . . 0.496 ' OD1' ' N ' ' A' ' 255' ' ' ARG . 0.6 OUTLIER -64.66 -41.55 96.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.911 179.888 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 255' ' ' ARG . . . . . 0.496 ' N ' ' OD1' ' A' ' 254' ' ' ASN . 25.9 ttt180 -47.67 -46.74 29.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.894 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -83.65 -41.94 17.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.879 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 1.9 t -70.29 155.57 40.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.845 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 14.1 t 45.83 41.98 8.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.836 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 259' ' ' ALA . . . . . . . . . . . . . . . -98.9 111.43 23.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.114 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 3.6 m -100.58 -54.81 2.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.858 -179.766 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 134.5 179.08 16.11 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.492 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 262' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 151.09 90.98 Favored 'Cis proline' 0 C--O 1.231 0.168 0 C-N-CA 122.714 -1.786 . . . . 0.0 112.36 -0.001 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 5.4 t -66.09 163.42 17.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.864 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 79.6 p -150.12 131.82 14.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.862 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.373 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.502 179.976 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.34 0 N-CA-C 112.516 -0.233 . . . . 0.0 112.516 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 65.7 p -91.03 42.66 1.11 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.88 0.371 . . . . 0.0 110.886 -179.723 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 6.1 t -172.94 146.33 1.52 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.817 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -156.12 139.5 6.61 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.509 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 11.8 t -122.7 -50.54 1.96 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.881 0.372 . . . . 0.0 110.874 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 12.5 t -64.42 108.03 1.52 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.839 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -105.99 106.35 2.58 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.51 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -79.01 -163.27 24.86 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.515 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -130.88 -146.5 5.88 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.501 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.455 ' CG2' ' HB3' ' A' ' 155' ' ' GLU . 20.4 m -136.89 125.14 23.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.764 0.316 . . . . 0.0 111.184 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 19.8 m -131.8 -51.04 0.98 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.823 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 10.8 p-10 -65.33 -55.61 17.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.908 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.455 ' HB3' ' CG2' ' A' ' 152' ' ' THR . 28.1 tt0 -48.71 -37.28 18.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.867 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.595 HG22 HD21 ' A' ' 200' ' ' LEU . 75.3 t -83.24 -36.11 12.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.1 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -43.44 -53.32 5.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.1 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -59.9 -53.25 60.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.915 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 159' ' ' PHE . . . . . 0.504 ' CE1' ' HG ' ' A' ' 216' ' ' LEU . 83.3 t80 -46.12 -39.26 9.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.873 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 95.6 mt -87.9 -27.07 22.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.888 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 29.0 t -49.79 -24.79 2.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.813 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' LYS . . . . . 0.457 ' CB ' ' HG3' ' A' ' 165' ' ' GLN . 35.4 mmtt -70.3 117.57 12.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.853 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -91.4 153.95 19.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.918 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 17.6 m120 61.16 49.04 5.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.885 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.457 ' HG3' ' CB ' ' A' ' 162' ' ' LYS . 1.8 mm-40 -128.62 151.8 49.08 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.902 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 48.5 t -109.15 109.03 26.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.174 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' ILE . . . . . 0.581 HG21 ' CG2' ' A' ' 249' ' ' VAL . 45.4 mt -80.12 143.43 12.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.185 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 86.0 t -123.46 133.66 68.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.15 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 11.0 ttt85 -89.94 106.36 18.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.858 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' MET . . . . . 0.593 ' CE ' HD21 ' A' ' 173' ' ' LEU . 91.3 mtp -97.92 125.57 42.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.904 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 47.2 mtp180 -126.57 136.55 52.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.878 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 96.92 17.6 32.11 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.473 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.593 HD21 ' CE ' ' A' ' 170' ' ' MET . 20.7 mt -71.24 116.71 49.8 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.593 0.711 . . . . 0.0 110.912 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 174' ' ' PRO . . . . . 0.681 ' O ' ' HB3' ' A' ' 177' ' ' ALA . 64.9 Cg_exo -47.99 134.08 23.51 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.672 2.248 . . . . 0.0 112.361 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 175' ' ' PHE . . . . . 0.453 ' C ' ' O ' ' A' ' 174' ' ' PRO . 19.3 m-85 -34.55 -68.55 0.11 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.893 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -47.63 -40.06 18.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.144 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.681 ' HB3' ' O ' ' A' ' 174' ' ' PRO . . . -38.19 128.07 1.33 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.12 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.405 ' C ' ' CZ ' ' A' ' 201' ' ' PHE . 1.7 p -141.67 179.85 6.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.179 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.522 ' O ' HG23 ' A' ' 183' ' ' VAL . . . -47.21 -46.58 24.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.084 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -53.4 -33.13 52.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.924 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 181' ' ' GLU . . . . . 0.476 ' CD ' HD21 ' A' ' 234' ' ' LEU . 5.5 mm-40 -76.26 -34.04 59.14 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.874 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.477 HG12 HD11 ' A' ' 192' ' ' ILE . 85.1 t -74.2 -51.79 22.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.142 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.522 HG23 ' O ' ' A' ' 179' ' ' ALA . 94.4 t -34.73 -50.55 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.135 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -78.41 -33.5 48.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.127 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.781 ' HD2' HD12 ' A' ' 234' ' ' LEU . 25.1 t80 -47.08 -61.19 2.0 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.863 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -89.9 -21.69 22.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.912 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -49.03 -21.25 2.36 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.451 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -53.24 -75.42 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.86 0.362 . . . . 0.0 110.916 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 11.1 m-70 -118.17 -5.45 10.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.824 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 82.4 m -126.54 87.5 56.27 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-O 121.61 0.719 . . . . 0.0 110.894 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 191' ' ' PRO . . . . . 0.561 ' HD2' ' CD1' ' A' ' 222' ' ' TYR . 52.8 Cg_endo -69.81 131.54 21.38 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.709 2.272 . . . . 0.0 112.279 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 192' ' ' ILE . . . . . 0.481 HG23 ' O ' ' A' ' 216' ' ' LEU . 51.3 mt -82.74 142.76 13.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.134 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 193' ' ' THR . . . . . 0.429 HG21 ' OE1' ' A' ' 165' ' ' GLN . 47.5 m -67.25 105.92 1.88 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.17 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 87.5 -19.84 30.23 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.493 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.465 ' O ' ' N ' ' A' ' 198' ' ' GLY . . . 78.04 -126.3 7.62 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.507 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 34.4 mtmt -42.9 -33.47 0.78 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.75 0.309 . . . . 0.0 110.873 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -74.27 -34.62 63.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.916 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 198' ' ' GLY . . . . . 0.57 ' HA2' HD12 ' A' ' 216' ' ' LEU . . . -82.98 36.65 2.7 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.495 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 77.5 mt -138.68 151.24 23.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.881 0.372 . . . . 0.0 111.104 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.595 HD21 HG22 ' A' ' 156' ' ' VAL . 13.4 tp -147.98 111.05 4.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.894 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 201' ' ' PHE . . . . . 0.405 ' CZ ' ' C ' ' A' ' 178' ' ' THR . 53.4 m-85 -93.16 127.65 38.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.902 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 62.0 t -79.73 115.97 23.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.154 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 203' ' ' THR . . . . . 0.576 ' HA ' HG23 ' A' ' 210' ' ' THR . 0.7 OUTLIER -125.19 137.55 54.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.105 -179.914 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 204' ' ' TYR . . . . . 0.636 ' CD1' HG22 ' A' ' 210' ' ' THR . 29.1 m-85 -41.81 159.23 0.19 Allowed Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.694 0.759 . . . . 0.0 110.897 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 2.88 3.14 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.67 2.247 . . . . 0.0 112.379 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -113.43 -18.67 11.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.87 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 110.87 61.51 0.49 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.465 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 37.6 mmt-85 -145.97 145.97 26.82 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.608 0.718 . . . . 0.0 110.886 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 104.02 1.25 Allowed 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.683 2.255 . . . . 0.0 112.38 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 210' ' ' THR . . . . . 0.636 HG22 ' CD1' ' A' ' 204' ' ' TYR . 21.0 p -68.42 -31.0 70.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.135 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 114.5 -34.36 4.94 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.504 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -87.61 154.12 20.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.814 0.34 . . . . 0.0 110.872 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 213' ' ' ALA . . . . . 0.55 ' HB3' ' CD1' ' A' ' 173' ' ' LEU . . . -154.27 175.88 12.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.109 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 214' ' ' PHE . . . . . 0.663 ' CE2' HG13 ' A' ' 249' ' ' VAL . 60.7 m-85 -138.16 158.32 44.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.876 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 6.6 t -140.64 157.15 23.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.092 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.57 HD12 ' HA2' ' A' ' 198' ' ' GLY . 44.7 mt -108.33 141.14 40.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.93 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -135.36 132.5 37.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.904 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -42.65 -66.45 0.36 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.046 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 219' ' ' CYS . . . . . . . . . . . . . 1.9 m -135.01 176.57 8.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.932 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -65.45 -7.37 13.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.855 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -67.85 -37.79 82.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.897 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 222' ' ' TYR . . . . . 0.561 ' CD1' ' HD2' ' A' ' 191' ' ' PRO . 46.5 m-85 -86.52 -39.22 16.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.964 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.434 ' O ' ' HB3' ' A' ' 226' ' ' ALA . . . -59.46 -60.8 3.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.097 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 224' ' ' GLN . . . . . 0.403 ' HA ' HD12 ' A' ' 227' ' ' LEU . 83.4 mt-30 -45.2 -53.98 7.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.934 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 71.1 m-20 -58.69 -25.73 63.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.874 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 226' ' ' ALA . . . . . 0.434 ' HB3' ' O ' ' A' ' 223' ' ' ALA . . . -75.93 -23.75 55.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.052 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 227' ' ' LEU . . . . . 0.403 HD12 ' HA ' ' A' ' 224' ' ' GLN . 37.0 mt -68.24 -33.14 73.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.911 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 38.9 mtp180 -60.14 -14.99 19.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.9 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 229' ' ' LYS . . . . . 0.446 ' O ' ' C ' ' A' ' 230' ' ' HIS . 21.8 mtpp -80.56 -3.42 50.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.854 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 230' ' ' HIS . . . . . 0.491 ' CD2' ' HG2' ' A' ' 231' ' ' LYS . 72.2 t60 -34.16 146.34 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.871 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.491 ' HG2' ' CD2' ' A' ' 230' ' ' HIS . 3.9 mmpt? 53.04 26.84 5.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.892 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -56.47 -177.33 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.86 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.633 HD21 ' CE2' ' A' ' 238' ' ' TYR . 30.8 mt -139.96 105.12 5.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.936 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 234' ' ' LEU . . . . . 0.781 HD12 ' HD2' ' A' ' 185' ' ' PHE . 6.8 tt -115.53 112.53 22.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.956 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 62.17 34.35 88.83 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.467 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 4.3 mmmm 71.05 52.12 0.27 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.744 0.307 . . . . 0.0 110.893 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 21.2 mmt180 -155.02 115.6 3.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.852 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 238' ' ' TYR . . . . . 0.633 ' CE2' HD21 ' A' ' 233' ' ' LEU . 92.1 m-85 -70.63 117.18 11.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.916 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 0.531 HG22 ' N ' ' A' ' 240' ' ' GLU . 57.6 mt -111.73 159.83 11.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.142 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 240' ' ' GLU . . . . . 0.531 ' N ' HG22 ' A' ' 239' ' ' ILE . 13.7 mt-10 -114.23 167.58 10.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.867 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 241' ' ' LEU . . . . . 0.546 ' O ' ' CD1' ' A' ' 242' ' ' PHE . 54.0 mt -146.05 143.73 29.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.919 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 242' ' ' PHE . . . . . 0.546 ' CD1' ' O ' ' A' ' 241' ' ' LEU . 9.4 m-85 -159.3 137.13 10.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.865 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 63.0 mtp85 -53.67 141.46 26.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.859 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 8.8 t -138.18 157.41 46.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.85 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 71.7 p -129.3 157.77 40.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.164 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 246' ' ' ALA . . . . . 0.561 ' N ' HD12 ' A' ' 167' ' ' ILE . . . -38.17 -55.78 1.26 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.131 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -54.07 -55.56 26.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.101 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 32.5 tp10 -42.18 -51.49 4.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.929 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.663 HG13 ' CE2' ' A' ' 214' ' ' PHE . 85.9 t -54.69 -63.76 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.172 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 250' ' ' GLN . . . . . 0.788 ' HA ' HD12 ' A' ' 253' ' ' LEU . 32.4 mt-30 -43.01 -33.02 0.73 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.934 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -73.14 -50.54 22.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.914 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 96.9 t -56.9 -37.07 52.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.111 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.788 HD12 ' HA ' ' A' ' 250' ' ' GLN . 16.0 mt -60.75 -50.93 71.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.881 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 254' ' ' ASN . . . . . 0.463 ' C ' ' OD1' ' A' ' 254' ' ' ASN . 0.6 OUTLIER -60.7 -40.47 92.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.882 179.973 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 255' ' ' ARG . . . . . 0.46 ' N ' ' OD1' ' A' ' 254' ' ' ASN . 21.4 ttt85 -42.92 -55.43 3.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.883 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 256' ' ' PHE . . . . . 0.547 ' CE2' ' HB ' ' A' ' 210' ' ' THR . 67.4 m-85 -74.79 -47.24 31.9 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.896 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 68.7 m -45.65 -59.67 2.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.897 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 40.9 t -62.61 -44.11 97.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.826 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 259' ' ' ALA . . . . . . . . . . . . . . . 48.17 41.0 14.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.098 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 23.2 t -98.25 -52.38 3.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.863 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 261' ' ' GLY . . . . . 0.437 ' HA3' ' C ' ' A' ' 262' ' ' PRO . . . -145.4 -72.66 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.499 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 262' ' ' PRO . . . . . 0.437 ' C ' ' HA3' ' A' ' 261' ' ' GLY . 53.5 Cg_endo -69.73 -34.65 2.98 Favored 'Cis proline' 0 C--N 1.341 0.174 0 C-N-CA 122.676 -1.802 . . . . 0.0 112.34 0.046 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 77.1 p -99.06 97.95 9.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.853 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 68.5 m -39.55 149.9 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.865 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.318 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.468 -179.965 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.287 0 N-CA-C 112.505 -0.238 . . . . 0.0 112.505 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 88.9 p -150.57 124.11 9.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.913 0.387 . . . . 0.0 110.883 -179.766 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 46.7 p -168.46 143.56 3.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.836 -179.823 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -152.98 158.66 28.04 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.506 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 20.7 t -99.92 81.2 2.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.862 0.363 . . . . 0.0 110.855 -179.724 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 90.8 p -114.61 175.93 5.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.86 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -91.88 -145.74 16.31 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.529 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 84.57 154.0 19.73 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.478 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -54.52 162.73 3.9 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.477 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' THR . . . . . 1.011 HG22 HG23 ' A' ' 156' ' ' VAL . 5.5 m -43.5 -36.55 2.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.768 0.318 . . . . 0.0 111.138 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' SER . . . . . 0.434 ' C ' ' O ' ' A' ' 152' ' ' THR . 31.3 p -34.68 -37.12 0.06 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.872 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' ASN . . . . . 0.407 ' N ' ' O ' ' A' ' 152' ' ' THR . 13.8 m120 -60.17 -58.36 8.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.919 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -66.93 -39.29 87.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.859 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 1.011 HG23 HG22 ' A' ' 152' ' ' THR . 72.3 t -60.92 -43.22 95.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.12 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.402 ' C ' ' O ' ' A' ' 156' ' ' VAL . . . -37.46 -61.03 0.63 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.127 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -57.66 -48.62 78.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.907 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' PHE . . . . . 0.497 ' CE1' ' HG ' ' A' ' 216' ' ' LEU . 66.2 t80 -47.68 -38.44 15.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.872 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 85.3 mt -90.57 -27.36 19.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.959 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 30.2 t -50.7 -36.51 36.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.854 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 39.7 mmtt -54.4 124.89 17.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.89 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -99.0 151.74 20.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.881 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 62.35 39.21 12.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.886 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -124.65 147.27 48.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.888 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 48.9 t -100.25 131.68 47.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.116 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' ILE . . . . . 0.773 HD12 ' N ' ' A' ' 246' ' ' ALA . 33.6 mt -101.17 143.8 13.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.176 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 96.8 t -128.26 136.6 59.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.121 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' ARG . . . . . 0.485 ' N ' ' HB2' ' A' ' 244' ' ' SER . 20.8 ttt85 -90.72 111.92 23.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.891 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 170' ' ' MET . . . . . 0.708 ' CE ' HD21 ' A' ' 173' ' ' LEU . 83.2 mtp -98.42 117.08 32.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.857 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 5.7 ttt-85 -120.99 140.66 51.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.833 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 89.91 23.43 32.83 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.512 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.708 HD21 ' CE ' ' A' ' 170' ' ' MET . 22.9 mt -79.18 129.62 72.01 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.564 0.697 . . . . 0.0 110.917 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 174' ' ' PRO . . . . . 0.467 ' HG3' ' CB ' ' A' ' 237' ' ' ARG . 65.1 Cg_exo -47.94 154.75 2.0 Allowed 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.661 2.241 . . . . 0.0 112.345 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -60.09 -50.17 74.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.833 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.457 ' O ' ' C ' ' A' ' 177' ' ' ALA . 0.0 OUTLIER -68.77 -39.07 80.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.135 -179.877 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.691 ' HB1' ' HG2' ' A' ' 181' ' ' GLU . . . -33.53 124.25 0.42 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.072 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.432 ' O ' ' C ' ' A' ' 179' ' ' ALA . 1.4 p -135.7 176.62 8.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.146 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.501 ' N ' ' CZ ' ' A' ' 201' ' ' PHE . . . -35.14 -44.98 0.27 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.121 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -56.66 -49.33 75.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.926 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 181' ' ' GLU . . . . . 0.691 ' HG2' ' HB1' ' A' ' 177' ' ' ALA . 0.0 OUTLIER -55.07 -33.48 62.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.869 -179.93 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.655 HG12 ' CD1' ' A' ' 192' ' ' ILE . 93.7 t -79.29 -60.03 2.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.156 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 179' ' ' ALA . 73.4 t -34.34 -39.89 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.134 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -85.77 -39.31 17.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.049 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.575 ' HD1' HD12 ' A' ' 234' ' ' LEU . 63.1 t80 -46.06 -59.58 2.78 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.825 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 186' ' ' PHE . . . . . 0.403 ' CE1' ' HE2' ' A' ' 185' ' ' PHE . 77.2 m-85 -91.79 -22.1 20.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.854 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -50.36 -18.25 2.24 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.511 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -58.49 -70.3 0.15 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.843 0.354 . . . . 0.0 110.882 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -118.15 -15.58 9.82 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.858 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 190' ' ' CYS . . . . . 0.409 ' SG ' ' CB ' ' A' ' 225' ' ' ASN . 70.8 m -120.26 86.69 38.66 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.65 0.738 . . . . 0.0 110.888 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 130.37 19.22 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.663 2.242 . . . . 0.0 112.361 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 192' ' ' ILE . . . . . 0.655 ' CD1' HG12 ' A' ' 182' ' ' VAL . 50.3 mt -82.14 146.2 7.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.161 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 85.6 m -66.89 105.78 1.71 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.148 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 87.41 -20.14 28.27 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.453 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.401 ' O ' ' N ' ' A' ' 198' ' ' GLY . . . 78.84 -126.66 7.63 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.446 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 16.6 ptmt -45.29 -34.43 2.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.746 0.308 . . . . 0.0 110.874 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -73.72 -32.8 64.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.867 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 198' ' ' GLY . . . . . 0.433 ' HA2' HD12 ' A' ' 216' ' ' LEU . . . -86.69 37.6 3.16 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.5 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.466 HD13 ' HB ' ' A' ' 182' ' ' VAL . 48.0 mt -141.83 146.31 23.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.865 0.364 . . . . 0.0 111.164 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.651 HD21 HG22 ' A' ' 156' ' ' VAL . 19.5 tp -134.4 118.14 17.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.91 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 201' ' ' PHE . . . . . 0.501 ' CZ ' ' N ' ' A' ' 179' ' ' ALA . 62.8 m-85 -99.53 114.51 27.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.91 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 22.7 t -70.06 114.23 7.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.179 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 203' ' ' THR . . . . . 0.511 ' HA ' HG23 ' A' ' 210' ' ' THR . 0.7 OUTLIER -124.86 137.21 54.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.12 -179.922 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -43.49 158.22 0.25 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.705 0.764 . . . . 0.0 110.882 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 3.01 3.01 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.683 2.256 . . . . 0.0 112.355 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -112.08 -21.05 11.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.829 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 112.5 57.53 0.44 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.462 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 33.2 mmt-85 -141.89 144.61 33.12 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.598 0.713 . . . . 0.0 110.896 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.7 105.67 1.52 Allowed 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.635 2.224 . . . . 0.0 112.381 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 210' ' ' THR . . . . . 0.565 ' HB ' ' CE1' ' A' ' 256' ' ' PHE . 27.2 p -69.07 -32.31 71.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.158 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 114.0 -34.1 5.13 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.442 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -84.68 162.76 19.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.815 0.341 . . . . 0.0 110.862 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -162.89 175.51 11.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.065 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 214' ' ' PHE . . . . . 0.659 ' CE2' HG13 ' A' ' 249' ' ' VAL . 80.8 m-85 -140.76 136.65 32.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.885 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 215' ' ' VAL . . . . . 0.432 HG12 ' N ' ' A' ' 216' ' ' LEU . 5.4 t -115.92 159.33 15.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.096 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.53 ' O ' HG23 ' A' ' 192' ' ' ILE . 29.3 mt -112.37 145.25 40.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.927 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -140.12 137.0 34.13 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.9 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 218' ' ' ALA . . . . . 0.641 ' HB3' ' CE2' ' A' ' 222' ' ' TYR . . . -48.48 -50.06 33.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.123 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 219' ' ' CYS . . . . . . . . . . . . . 2.0 t -154.2 177.48 11.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.913 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -57.84 -23.89 54.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.893 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -50.75 -54.66 21.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.879 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 222' ' ' TYR . . . . . 0.641 ' CE2' ' HB3' ' A' ' 218' ' ' ALA . 61.3 m-85 -71.84 -48.63 44.8 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.936 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.456 ' O ' ' HB3' ' A' ' 226' ' ' ALA . . . -47.36 -52.03 17.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.074 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -51.75 -62.75 1.44 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.908 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 225' ' ' ASN . . . . . 0.409 ' CB ' ' SG ' ' A' ' 190' ' ' CYS . 38.2 m-20 -48.42 -23.7 1.03 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.898 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 226' ' ' ALA . . . . . 0.456 ' HB3' ' O ' ' A' ' 223' ' ' ALA . . . -81.31 -40.3 23.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.098 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 95.9 mt -52.28 -39.0 59.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.899 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 37.2 mtt-85 -55.62 -27.85 51.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.861 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 229' ' ' LYS . . . . . 0.454 ' O ' ' C ' ' A' ' 230' ' ' HIS . 20.7 mtpp -70.62 -2.77 15.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.898 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 230' ' ' HIS . . . . . 0.559 ' CE1' ' HG3' ' A' ' 231' ' ' LYS . 15.7 t60 -33.91 129.19 0.34 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.87 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.559 ' HG3' ' CE1' ' A' ' 230' ' ' HIS . 30.9 mttt 63.07 39.62 9.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.896 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -67.38 -175.1 0.45 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.849 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.638 HD21 ' CE2' ' A' ' 238' ' ' TYR . 29.6 mt -138.08 110.1 7.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.951 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 234' ' ' LEU . . . . . 0.575 HD12 ' HD1' ' A' ' 185' ' ' PHE . 8.0 tt -121.65 113.94 20.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.894 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 59.13 40.98 96.37 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.456 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.436 ' HA ' ' NZ ' ' A' ' 236' ' ' LYS . 0.0 OUTLIER 65.36 52.4 1.43 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.762 0.315 . . . . 0.0 110.907 -179.967 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 237' ' ' ARG . . . . . 0.467 ' CB ' ' HG3' ' A' ' 174' ' ' PRO . 21.2 mmt180 -156.29 115.13 3.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.815 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 238' ' ' TYR . . . . . 0.638 ' CE2' HD21 ' A' ' 233' ' ' LEU . 93.7 m-85 -69.75 127.3 32.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.91 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 0.498 HD13 HD23 ' A' ' 173' ' ' LEU . 62.1 mt -122.22 134.26 66.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.09 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 240' ' ' GLU . . . . . 0.58 ' HB3' ' CZ ' ' A' ' 242' ' ' PHE . 6.5 mp0 -103.1 149.39 24.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.898 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 241' ' ' LEU . . . . . 0.517 ' O ' ' CD1' ' A' ' 242' ' ' PHE . 14.3 mt -124.62 149.56 46.95 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.964 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 242' ' ' PHE . . . . . 0.58 ' CZ ' ' HB3' ' A' ' 240' ' ' GLU . 13.6 m-85 -156.84 132.38 9.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.841 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 57.5 mtm180 -48.09 133.04 15.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.901 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 244' ' ' SER . . . . . 0.485 ' HB2' ' N ' ' A' ' 169' ' ' ARG . 3.4 t -130.48 157.59 42.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.825 -179.744 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 245' ' ' THR . . . . . 0.424 ' O ' ' C ' ' A' ' 246' ' ' ALA . 82.1 p -133.45 150.05 51.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.161 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 246' ' ' ALA . . . . . 0.773 ' N ' HD12 ' A' ' 167' ' ' ILE . . . -35.67 -51.94 0.67 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.096 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -59.41 -50.97 71.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.096 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 18.1 tp10 -47.31 -50.28 22.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.903 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.659 HG13 ' CE2' ' A' ' 214' ' ' PHE . 98.5 t -53.48 -64.58 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.148 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 250' ' ' GLN . . . . . 0.749 ' HA ' HD12 ' A' ' 253' ' ' LEU . 68.4 mt-30 -43.22 -34.96 1.26 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.934 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -74.34 -33.31 63.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.879 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 252' ' ' VAL . . . . . 0.471 ' HA ' ' NE ' ' A' ' 255' ' ' ARG . 79.1 t -79.67 -19.06 12.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.133 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.749 HD12 ' HA ' ' A' ' 250' ' ' GLN . 17.0 mt -80.81 -46.39 15.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.879 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 254' ' ' ASN . . . . . 0.474 ' CG ' ' N ' ' A' ' 255' ' ' ARG . 0.2 OUTLIER -58.16 -50.06 74.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.857 179.924 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 255' ' ' ARG . . . . . 0.474 ' N ' ' CG ' ' A' ' 254' ' ' ASN . 17.3 ptp180 -49.31 -47.18 47.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.856 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 256' ' ' PHE . . . . . 0.565 ' CE1' ' HB ' ' A' ' 210' ' ' THR . 10.3 m-85 -73.8 -37.45 64.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.855 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 1.4 t -76.53 138.08 39.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.822 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 1.5 t 64.62 39.92 6.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.859 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 259' ' ' ALA . . . . . . . . . . . . . . . -105.5 125.77 51.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.076 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 260' ' ' SER . . . . . 0.504 ' O ' ' N ' ' A' ' 263' ' ' SER . 49.2 m -127.88 148.77 50.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.837 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 261' ' ' GLY . . . . . 0.469 ' HA3' ' C ' ' A' ' 262' ' ' PRO . . . 120.75 -76.8 0.32 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.484 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 262' ' ' PRO . . . . . 0.469 ' C ' ' HA3' ' A' ' 261' ' ' GLY . 54.1 Cg_endo -69.78 145.29 79.05 Favored 'Cis proline' 0 C--N 1.342 0.201 0 C-N-CA 122.667 -1.805 . . . . 0.0 112.337 0.059 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 263' ' ' SER . . . . . 0.504 ' N ' ' O ' ' A' ' 260' ' ' SER . 58.4 m -77.39 95.18 4.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.881 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 16.2 t -51.44 -53.92 32.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.836 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.344 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.506 -179.979 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.365 0 N-CA-C 112.512 -0.235 . . . . 0.0 112.512 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 23.3 t 66.84 44.79 2.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.923 0.392 . . . . 0.0 110.871 -179.722 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 81.5 p -98.06 127.94 44.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.879 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 167.53 145.98 4.73 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.499 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.3 t -91.84 136.42 33.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.817 0.342 . . . . 0.0 110.884 -179.744 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 56.1 p -51.19 155.31 1.37 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.86 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 126.14 78.27 0.29 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.472 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -122.26 -146.01 7.17 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.521 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -142.65 -168.39 11.82 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.52 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.468 HG23 ' HB ' ' A' ' 156' ' ' VAL . 99.0 m -132.26 124.17 28.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.866 0.365 . . . . 0.0 111.112 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' SER . . . . . 0.457 ' O ' ' N ' ' A' ' 156' ' ' VAL . 52.5 p -86.13 149.17 25.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.888 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 154' ' ' ASN . . . . . 0.407 ' C ' ' O ' ' A' ' 153' ' ' SER . 16.9 t30 -37.7 -50.69 1.21 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.892 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -51.48 -40.56 59.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.907 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.468 ' HB ' HG23 ' A' ' 152' ' ' THR . 75.5 t -77.29 -50.42 20.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.117 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.441 ' C ' ' O ' ' A' ' 156' ' ' VAL . . . -34.75 -57.32 0.53 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.101 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 76.1 mm-40 -62.13 -45.87 91.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.889 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' PHE . . . . . 0.431 ' CE2' ' HG ' ' A' ' 216' ' ' LEU . 20.1 t80 -52.89 -42.4 65.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.883 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 56.3 mt -82.06 -29.27 31.96 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.916 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 22.9 t -48.28 -43.33 32.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.902 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' LYS . . . . . 0.706 ' HG3' HD13 ' A' ' 216' ' ' LEU . 0.2 OUTLIER -38.6 130.26 1.38 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.942 179.897 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -106.61 145.54 31.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.883 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' ASN . . . . . 0.448 ' O ' ' NE2' ' A' ' 165' ' ' GLN . 49.1 m-80 63.28 37.71 10.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.891 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.448 ' NE2' ' O ' ' A' ' 164' ' ' ASN . 2.2 mp0 -122.54 153.81 38.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.904 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 83.9 t -108.36 137.56 39.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.135 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' ILE . . . . . 0.475 HD12 ' N ' ' A' ' 246' ' ' ALA . 28.6 mt -104.84 139.23 26.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.07 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 82.6 t -120.49 133.35 67.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.154 179.787 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 39.3 ttp180 -88.51 104.72 17.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.839 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' MET . . . . . 0.855 ' CE ' HD21 ' A' ' 173' ' ' LEU . 83.3 mtp -97.39 131.57 43.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.884 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 2.1 ttt85 -135.65 140.48 44.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.852 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 93.23 16.59 46.42 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.504 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.855 HD21 ' CE ' ' A' ' 170' ' ' MET . 25.5 mt -72.09 128.95 88.47 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.606 0.717 . . . . 0.0 110.925 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 174' ' ' PRO . . . . . 0.464 ' HG3' ' CB ' ' A' ' 237' ' ' ARG . 64.3 Cg_exo -47.91 144.61 11.44 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.682 2.255 . . . . 0.0 112.357 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 175' ' ' PHE . . . . . 0.558 ' CD1' ' HG3' ' A' ' 209' ' ' PRO . 6.7 t80 -49.35 -41.69 39.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.88 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.45 ' O ' ' C ' ' A' ' 177' ' ' ALA . 7.6 p -76.25 -45.41 32.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.158 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.45 ' C ' ' O ' ' A' ' 176' ' ' THR . . . -33.41 104.55 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.117 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -111.66 177.7 4.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.118 -179.878 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.447 ' N ' ' CE1' ' A' ' 201' ' ' PHE . . . -45.42 -51.08 11.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.14 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -50.22 -38.87 42.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.916 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 181' ' ' GLU . . . . . 0.735 ' HG3' HD11 ' A' ' 234' ' ' LEU . 2.6 tp10 -64.65 -41.85 95.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.898 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.481 ' O ' ' N ' ' A' ' 185' ' ' PHE . 94.5 t -64.96 -54.22 32.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.133 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.453 ' C ' ' O ' ' A' ' 182' ' ' VAL . 43.2 t -33.86 -55.72 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.112 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -70.72 -34.33 71.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.095 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.532 ' CE2' ' HD3' ' A' ' 229' ' ' LYS . 63.6 t80 -51.13 -61.11 2.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.904 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -89.58 -20.4 23.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.913 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -49.16 -18.5 1.29 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.474 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 38.4 mm-40 -55.9 -75.17 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.796 0.332 . . . . 0.0 110.921 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -118.34 -3.78 10.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.845 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 71.4 m -128.7 87.09 55.82 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.579 0.704 . . . . 0.0 110.851 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 191' ' ' PRO . . . . . 0.577 ' HD2' ' CD1' ' A' ' 222' ' ' TYR . 54.1 Cg_endo -69.74 143.3 50.5 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.719 2.279 . . . . 0.0 112.38 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 192' ' ' ILE . . . . . 0.591 HG23 ' O ' ' A' ' 216' ' ' LEU . 63.1 mt -97.71 143.07 13.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.102 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 88.6 m -66.72 101.41 0.8 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.134 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 89.64 -15.8 58.02 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.428 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 73.01 -118.21 6.28 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.483 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 39.4 mtmt -51.16 -32.71 24.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.73 0.3 . . . . 0.0 110.864 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -75.22 -22.54 57.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.904 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 198' ' ' GLY . . . . . 0.67 ' HA2' HD12 ' A' ' 216' ' ' LEU . . . -99.25 35.25 4.82 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.442 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 60.5 mt -137.45 139.22 43.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.88 0.371 . . . . 0.0 111.132 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 12.9 tp -133.44 123.08 24.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.946 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 201' ' ' PHE . . . . . 0.447 ' CE1' ' N ' ' A' ' 179' ' ' ALA . 75.8 m-85 -104.26 124.77 49.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.854 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 55.6 t -79.9 136.31 23.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.082 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 203' ' ' THR . . . . . 0.429 ' HA ' HG23 ' A' ' 210' ' ' THR . 0.8 OUTLIER -143.21 136.59 28.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.138 179.99 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 204' ' ' TYR . . . . . 0.59 ' CD1' ' HB3' ' A' ' 208' ' ' ARG . 16.7 m-85 -40.31 160.65 0.12 Allowed Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.68 0.752 . . . . 0.0 110.901 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.74 3.22 2.89 Favored 'Trans proline' 0 N--CA 1.465 -0.176 0 C-N-CA 122.724 2.283 . . . . 0.0 112.32 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -117.31 -28.45 6.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.878 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 127.69 42.93 0.25 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.485 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 208' ' ' ARG . . . . . 0.59 ' HB3' ' CD1' ' A' ' 204' ' ' TYR . 10.8 ttm180 -117.3 142.01 29.53 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.639 0.733 . . . . 0.0 110.876 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 209' ' ' PRO . . . . . 0.558 ' HG3' ' CD1' ' A' ' 175' ' ' PHE . 54.0 Cg_endo -69.74 93.27 0.52 Allowed 'Trans proline' 0 C--O 1.232 0.22 0 C-N-CA 122.734 2.29 . . . . 0.0 112.342 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 210' ' ' THR . . . . . 0.572 ' HB ' ' CE2' ' A' ' 256' ' ' PHE . 69.6 p -60.12 -9.45 3.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.097 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 81.36 -42.42 2.76 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.48 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -69.1 165.32 20.55 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.8 0.333 . . . . 0.0 110.892 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -165.34 -177.82 4.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.088 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 214' ' ' PHE . . . . . 0.562 ' CE2' HG13 ' A' ' 249' ' ' VAL . 51.2 m-85 -145.97 138.68 25.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.9 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 215' ' ' VAL . . . . . 0.411 HG12 ' N ' ' A' ' 216' ' ' LEU . 10.0 t -121.63 156.71 25.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.168 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.706 HD13 ' HG3' ' A' ' 162' ' ' LYS . 49.5 mt -110.85 138.58 47.07 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.936 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -129.91 137.15 50.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.879 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -49.81 -46.66 51.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.084 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 219' ' ' CYS . . . . . . . . . . . . . 10.2 m -154.14 171.57 18.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.893 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.41 ' O ' ' C ' ' A' ' 221' ' ' GLU . 6.8 tp10 -57.6 -40.75 79.77 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.873 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 221' ' ' GLU . . . . . 0.41 ' C ' ' O ' ' A' ' 220' ' ' GLU . 26.6 tt0 -36.79 -49.54 0.79 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.885 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 222' ' ' TYR . . . . . 0.577 ' CD1' ' HD2' ' A' ' 191' ' ' PRO . 20.9 m-85 -74.54 -50.07 19.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.892 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.518 ' O ' ' HB3' ' A' ' 226' ' ' ALA . . . -44.82 -54.52 6.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.117 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -48.41 -62.42 1.5 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.954 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 41.3 m-20 -49.54 -28.96 6.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.871 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 226' ' ' ALA . . . . . 0.518 ' HB3' ' O ' ' A' ' 223' ' ' ALA . . . -70.42 -43.21 70.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.038 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 29.0 mt -54.35 -30.28 51.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.934 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 60.8 mtp85 -58.65 -22.22 56.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.841 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 229' ' ' LYS . . . . . 0.532 ' HD3' ' CE2' ' A' ' 185' ' ' PHE . 16.7 mttm -78.93 -1.71 36.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.9 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 230' ' ' HIS . . . . . 0.546 ' CE1' ' HD3' ' A' ' 231' ' ' LYS . 21.6 t60 -33.86 127.0 0.41 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.886 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.546 ' HD3' ' CE1' ' A' ' 230' ' ' HIS . 0.3 OUTLIER 68.75 32.56 4.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.877 179.978 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -61.91 178.69 0.33 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.881 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.621 HD21 ' CD1' ' A' ' 238' ' ' TYR . 31.1 mt -135.18 109.74 8.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.943 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 234' ' ' LEU . . . . . 0.735 HD11 ' HG3' ' A' ' 181' ' ' GLU . 6.5 tt -117.68 114.15 22.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.905 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 58.4 37.59 88.25 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.482 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 9.6 mmpt? 70.56 52.73 0.32 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.78 0.324 . . . . 0.0 110.889 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 237' ' ' ARG . . . . . 0.464 ' CB ' ' HG3' ' A' ' 174' ' ' PRO . 50.4 mmt-85 -155.47 116.06 3.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.85 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 238' ' ' TYR . . . . . 0.621 ' CD1' HD21 ' A' ' 233' ' ' LEU . 89.6 m-85 -68.61 125.39 26.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.904 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 0.776 HD13 HD23 ' A' ' 173' ' ' LEU . 64.1 mt -120.94 134.53 64.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.116 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 240' ' ' GLU . . . . . 0.496 ' HB3' ' CZ ' ' A' ' 242' ' ' PHE . 38.8 mp0 -96.24 170.21 9.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.85 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 75.1 mt -145.71 139.96 26.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.946 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 242' ' ' PHE . . . . . 0.496 ' CZ ' ' HB3' ' A' ' 240' ' ' GLU . 8.6 m-85 -152.14 130.87 12.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.877 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 57.4 mtm180 -52.25 136.17 31.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.846 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 1.1 t -136.9 166.37 23.79 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.869 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 245' ' ' THR . . . . . 0.444 ' O ' HG23 ' A' ' 249' ' ' VAL . 74.1 p -135.91 165.05 26.54 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.142 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 246' ' ' ALA . . . . . 0.475 ' N ' HD12 ' A' ' 167' ' ' ILE . . . -49.02 -53.55 19.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.076 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -55.6 -50.89 68.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.09 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -50.06 -50.98 46.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.931 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.562 HG13 ' CE2' ' A' ' 214' ' ' PHE . 92.2 t -47.36 -61.97 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.101 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 250' ' ' GLN . . . . . 0.549 ' HA ' HD12 ' A' ' 253' ' ' LEU . 34.4 mt-30 -48.19 -33.03 7.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.902 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 251' ' ' GLN . . . . . 0.427 ' HA ' ' ND2' ' A' ' 254' ' ' ASN . 53.0 mt-30 -76.82 -25.94 53.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.92 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 95.0 t -82.25 -21.71 9.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.135 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.549 HD12 ' HA ' ' A' ' 250' ' ' GLN . 10.7 mt -84.19 -43.54 14.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.905 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 254' ' ' ASN . . . . . 0.494 ' OD1' ' N ' ' A' ' 255' ' ' ARG . 0.5 OUTLIER -65.11 -42.08 94.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.846 179.973 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 255' ' ' ARG . . . . . 0.494 ' N ' ' OD1' ' A' ' 254' ' ' ASN . 1.8 ptm85 -58.38 -41.86 85.76 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.855 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 256' ' ' PHE . . . . . 0.572 ' CE2' ' HB ' ' A' ' 210' ' ' THR . 11.7 m-85 -75.65 -46.0 33.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.921 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 66.5 m -59.39 -35.31 73.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.835 -179.81 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 36.0 t -101.37 76.62 1.71 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.85 -179.772 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 259' ' ' ALA . . . . . . . . . . . . . . . -121.81 32.18 5.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.094 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 59.9 p -125.89 172.56 9.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.858 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -172.64 -178.43 42.72 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.449 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 262' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 128.42 12.53 Favored 'Cis proline' 0 C--N 1.342 0.19 0 C-N-CA 122.671 -1.804 . . . . 0.0 112.386 0.066 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 4.0 t -108.15 132.97 53.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.846 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 24.8 t -61.77 -51.59 67.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.89 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.364 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.512 179.98 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 N-CA-C 112.541 -0.224 . . . . 0.0 112.541 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 2.3 m -154.53 131.27 10.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.86 0.362 . . . . 0.0 110.834 -179.746 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 43.2 p -133.93 42.08 2.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.843 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 58.35 -147.4 39.05 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.469 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 70.3 m -122.84 122.05 37.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.903 0.382 . . . . 0.0 110.816 -179.733 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 24.5 m -109.92 -55.27 2.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.847 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -154.69 -120.25 0.72 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.462 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -113.7 157.31 15.04 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.525 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 164.46 171.09 30.28 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.507 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.547 HG22 HG23 ' A' ' 156' ' ' VAL . 1.5 m -81.56 -27.48 34.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.823 0.344 . . . . 0.0 111.192 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 66.7 m -41.62 -24.81 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.826 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' ASN . . . . . 0.442 ' N ' ' O ' ' A' ' 152' ' ' THR . 1.7 t-20 -74.6 -52.71 11.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.904 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -68.06 -37.18 80.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.905 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.547 HG23 HG22 ' A' ' 152' ' ' THR . 26.7 t -68.55 -41.46 83.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.077 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.439 ' C ' ' O ' ' A' ' 156' ' ' VAL . . . -33.73 -69.94 0.08 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.108 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 158' ' ' GLN . . . . . 0.498 ' O ' ' N ' ' A' ' 161' ' ' SER . 3.8 pt20 -48.82 -60.17 2.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.947 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 21.4 t80 -39.4 -40.67 0.84 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.921 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 98.6 mt -89.07 -22.92 22.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.934 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' SER . . . . . 0.498 ' N ' ' O ' ' A' ' 158' ' ' GLN . 7.7 t -59.95 -20.93 60.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.853 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 162' ' ' LYS . . . . . 0.476 ' HG3' HD13 ' A' ' 216' ' ' LEU . 25.3 mmmt -69.83 118.27 12.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.926 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 50.3 mm-40 -96.98 158.02 15.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.916 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 62.43 42.18 9.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.868 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 36.1 mm-40 -126.7 172.6 10.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.911 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.462 HG11 ' CB ' ' A' ' 223' ' ' ALA . 86.6 t -128.54 106.45 14.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.11 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 167' ' ' ILE . . . . . 0.548 HD12 ' N ' ' A' ' 246' ' ' ALA . 70.0 mt -77.67 141.63 15.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.169 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 43.7 t -122.77 133.94 67.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.103 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' ARG . . . . . 0.449 ' N ' ' HB2' ' A' ' 244' ' ' SER . 29.6 ttp180 -91.43 101.44 14.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.876 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 170' ' ' MET . . . . . 0.547 ' CE ' HD21 ' A' ' 173' ' ' LEU . 99.3 mtp -94.9 127.25 40.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.895 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 13.5 ttm180 -126.07 141.49 51.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.884 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 89.91 24.92 28.56 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.501 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.929 HD23 HD13 ' A' ' 239' ' ' ILE . 19.9 mt -78.45 123.29 85.7 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.638 0.732 . . . . 0.0 110.907 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_exo -48.0 141.77 16.63 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.67 2.246 . . . . 0.0 112.341 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 175' ' ' PHE . . . . . 0.558 ' CD1' ' HG3' ' A' ' 209' ' ' PRO . 9.1 t80 -53.97 -26.18 24.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.892 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 7.2 p -89.69 -14.3 35.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.095 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -65.15 110.16 2.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.125 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.437 ' O ' ' N ' ' A' ' 181' ' ' GLU . 0.8 OUTLIER -118.96 167.16 12.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.134 -179.925 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 178' ' ' THR . . . -35.42 -42.43 0.21 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.122 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -57.07 -47.69 80.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.89 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 181' ' ' GLU . . . . . 0.437 ' N ' ' O ' ' A' ' 178' ' ' THR . 3.9 mp0 -61.0 -37.49 82.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.879 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.477 HG12 HD11 ' A' ' 192' ' ' ILE . 76.1 t -69.85 -54.23 20.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.119 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.448 ' C ' ' O ' ' A' ' 182' ' ' VAL . 28.1 t -33.78 -50.66 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.125 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -73.54 -44.22 58.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.086 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -39.13 -61.31 0.78 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.903 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -92.27 -21.42 20.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.873 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -49.11 -18.9 1.35 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.495 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -56.25 -75.21 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.803 0.335 . . . . 0.0 110.923 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -118.25 -7.57 10.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.851 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 79.4 m -124.41 86.4 55.0 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.557 0.694 . . . . 0.0 110.876 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 191' ' ' PRO . . . . . 0.571 ' HD2' ' CD1' ' A' ' 222' ' ' TYR . 53.5 Cg_endo -69.78 140.32 42.3 Favored 'Trans proline' 0 C--O 1.231 0.148 0 C-N-CA 122.715 2.276 . . . . 0.0 112.308 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 192' ' ' ILE . . . . . 0.591 HG23 ' O ' ' A' ' 216' ' ' LEU . 57.2 mt -91.5 144.29 9.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.149 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 35.9 m -73.24 105.72 4.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.139 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 91.33 -17.78 54.53 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.478 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 72.09 -121.09 8.22 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.472 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 24.0 mtmm -49.74 -28.46 6.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.731 0.301 . . . . 0.0 110.87 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -77.74 -27.66 50.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.886 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 198' ' ' GLY . . . . . 0.449 ' HA2' HD12 ' A' ' 216' ' ' LEU . . . -93.62 40.4 2.79 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.524 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 56.9 mt -144.04 149.77 17.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.885 0.374 . . . . 0.0 111.087 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.445 HD21 HG22 ' A' ' 156' ' ' VAL . 14.1 tp -148.46 119.63 7.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.897 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -98.71 117.62 33.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.89 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 42.7 t -73.49 133.63 31.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.124 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 203' ' ' THR . . . . . 0.539 ' HA ' HG23 ' A' ' 210' ' ' THR . 0.8 OUTLIER -138.39 137.9 37.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.159 -179.971 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 204' ' ' TYR . . . . . 0.502 ' CD2' HG22 ' A' ' 210' ' ' THR . 35.1 m-85 -47.24 158.63 0.45 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.663 0.744 . . . . 0.0 110.916 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 3.14 2.98 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.651 2.234 . . . . 0.0 112.343 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -110.29 -20.51 12.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.825 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 113.72 38.02 1.23 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.506 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 77.6 mtt180 -121.63 146.86 46.53 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.612 0.72 . . . . 0.0 110.854 -179.837 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 209' ' ' PRO . . . . . 0.558 ' HG3' ' CD1' ' A' ' 175' ' ' PHE . 53.6 Cg_endo -69.79 112.02 2.97 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.672 2.248 . . . . 0.0 112.348 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 210' ' ' THR . . . . . 0.539 HG23 ' HA ' ' A' ' 203' ' ' THR . 53.7 p -76.59 -6.8 53.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.173 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 80.73 -37.14 2.29 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.467 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -75.85 159.01 31.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.844 0.354 . . . . 0.0 110.861 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 213' ' ' ALA . . . . . 0.554 ' HB3' ' CD1' ' A' ' 173' ' ' LEU . . . -159.31 -177.91 6.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.075 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 214' ' ' PHE . . . . . 0.459 ' CE2' HG13 ' A' ' 249' ' ' VAL . 58.0 m-85 -145.59 143.85 30.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.885 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 4.4 t -131.9 155.47 41.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.142 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.591 ' O ' HG23 ' A' ' 192' ' ' ILE . 37.5 mt -106.1 135.09 48.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.916 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -127.19 147.26 50.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.88 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 218' ' ' ALA . . . . . 0.63 ' HB3' ' HD2' ' A' ' 222' ' ' TYR . . . -54.31 -63.76 1.05 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.127 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 219' ' ' CYS . . . . . . . . . . . . . 2.2 t -153.58 172.63 16.91 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.87 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -44.89 -35.71 2.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.891 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 221' ' ' GLU . . . . . 0.566 ' OE2' ' CD1' ' A' ' 222' ' ' TYR . 6.0 tm-20 -45.27 -44.73 11.54 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.915 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 222' ' ' TYR . . . . . 0.63 ' HD2' ' HB3' ' A' ' 218' ' ' ALA . 35.1 m-85 -88.71 -47.48 8.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.872 -179.857 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.462 ' CB ' HG11 ' A' ' 166' ' ' VAL . . . -52.15 -60.0 3.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.113 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 43.9 mm-40 -47.22 -50.68 20.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.914 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 20.4 m-20 -60.48 -23.66 64.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.925 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 226' ' ' ALA . . . . . 0.446 ' HB3' ' O ' ' A' ' 223' ' ' ALA . . . -76.15 -40.32 52.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.132 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 29.2 mt -54.41 -30.74 53.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.94 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 6.7 mtp-105 -58.84 -25.28 63.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.881 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 229' ' ' LYS . . . . . 0.462 ' O ' ' C ' ' A' ' 230' ' ' HIS . 19.1 mtpp -76.37 -0.92 24.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.887 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 230' ' ' HIS . . . . . 0.488 ' CE1' ' HG3' ' A' ' 231' ' ' LYS . 13.7 t60 -33.54 133.37 0.17 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.833 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.488 ' HG3' ' CE1' ' A' ' 230' ' ' HIS . 47.0 mtmt 59.13 40.35 21.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.904 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -66.64 -177.01 0.53 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.834 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.576 HD21 ' CD1' ' A' ' 238' ' ' TYR . 31.3 mt -136.48 105.03 5.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.909 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 234' ' ' LEU . . . . . 0.623 ' C ' HD23 ' A' ' 234' ' ' LEU . 6.6 tt -116.35 113.67 23.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.921 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 60.55 39.42 96.42 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.514 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 4.4 mmmm 66.69 53.39 0.91 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.76 0.314 . . . . 0.0 110.882 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 20.4 mmt180 -156.21 115.47 3.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.877 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 238' ' ' TYR . . . . . 0.576 ' CD1' HD21 ' A' ' 233' ' ' LEU . 95.7 m-85 -68.64 117.36 10.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.916 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 0.929 HD13 HD23 ' A' ' 173' ' ' LEU . 17.7 mt -113.81 129.9 68.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.178 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 240' ' ' GLU . . . . . 0.725 ' O ' HD23 ' A' ' 241' ' ' LEU . 0.5 OUTLIER -89.99 175.27 7.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.869 -179.998 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 241' ' ' LEU . . . . . 0.725 HD23 ' O ' ' A' ' 240' ' ' GLU . 38.5 mt -151.57 144.65 24.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.907 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 242' ' ' PHE . . . . . 0.48 ' CD1' ' O ' ' A' ' 241' ' ' LEU . 15.0 m-85 -156.89 129.17 7.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.885 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 243' ' ' ARG . . . . . 0.475 ' CZ ' ' HB2' ' A' ' 243' ' ' ARG . 17.0 mtm105 -48.25 138.74 9.36 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.876 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 244' ' ' SER . . . . . 0.449 ' HB2' ' N ' ' A' ' 169' ' ' ARG . 1.0 OUTLIER -136.25 160.46 38.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.861 -179.778 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 53.5 p -132.83 155.83 48.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.173 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 246' ' ' ALA . . . . . 0.548 ' N ' HD12 ' A' ' 167' ' ' ILE . . . -40.51 -58.65 1.52 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.058 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -53.44 -55.69 23.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.114 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -46.02 -46.06 16.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.885 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.486 HG21 HD13 ' A' ' 167' ' ' ILE . 98.2 t -51.62 -62.54 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.126 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 250' ' ' GLN . . . . . 0.497 ' HA ' HD12 ' A' ' 253' ' ' LEU . 49.5 mt-30 -47.66 -33.38 6.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.898 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 -76.76 -26.3 54.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.921 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 43.1 t -82.38 -21.64 9.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.114 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.497 HD12 ' HA ' ' A' ' 250' ' ' GLN . 10.5 mt -85.41 -43.24 13.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.875 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 254' ' ' ASN . . . . . 0.401 ' CG ' ' N ' ' A' ' 255' ' ' ARG . 0.6 OUTLIER -65.22 -46.0 82.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.876 179.962 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 255' ' ' ARG . . . . . 0.401 ' N ' ' CG ' ' A' ' 254' ' ' ASN . 7.5 ptm180 -48.68 -30.72 5.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.896 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -88.42 -32.39 18.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.886 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 32.3 t -70.99 -32.78 69.7 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.845 -179.767 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 2.6 m -101.47 49.82 0.86 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.837 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 259' ' ' ALA . . . . . . . . . . . . . . . -93.76 89.79 6.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.105 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 260' ' ' SER . . . . . 0.44 ' C ' ' HA ' ' A' ' 262' ' ' PRO . 4.7 t -140.05 141.02 36.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.877 -179.82 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 261' ' ' GLY . . . . . 0.417 ' HA3' ' C ' ' A' ' 262' ' ' PRO . . . 127.02 -69.87 0.51 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.478 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 262' ' ' PRO . . . . . 0.44 ' HA ' ' C ' ' A' ' 260' ' ' SER . 53.1 Cg_endo -69.8 -14.31 12.55 Favored 'Cis proline' 0 C--N 1.341 0.183 0 C-N-CA 122.66 -1.808 . . . . 0.0 112.347 0.109 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 1.1 t 37.04 45.26 0.44 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.86 -179.845 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 19.3 t -70.64 93.6 0.94 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.869 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.343 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.501 -179.937 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.306 0 N-CA-C 112.45 -0.26 . . . . 0.0 112.45 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 3.2 m -107.17 -50.96 2.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.881 0.372 . . . . 0.0 110.821 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 84.3 p -137.75 144.25 41.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.814 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 58.92 64.75 4.01 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.488 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 55.8 p -103.74 42.06 1.22 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.891 0.377 . . . . 0.0 110.887 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 7.1 t -95.72 -63.24 1.18 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.9 -179.809 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 80.0 -76.7 2.0 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.487 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 154.3 -146.53 14.75 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.505 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -41.65 -56.8 3.51 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.466 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.41 ' CG2' ' HB ' ' A' ' 156' ' ' VAL . 27.9 m -39.9 128.66 2.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.82 0.343 . . . . 0.0 111.11 -179.826 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' SER . . . . . 0.45 ' O ' ' C ' ' A' ' 154' ' ' ASN . 48.1 m -78.85 142.29 36.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.913 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 154' ' ' ASN . . . . . 0.45 ' C ' ' O ' ' A' ' 153' ' ' SER . 4.5 m120 -34.41 -62.6 0.33 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.917 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -42.83 -42.16 3.52 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.897 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.498 ' O ' ' N ' ' A' ' 159' ' ' PHE . 20.5 t -73.55 -58.03 5.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.141 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.443 ' C ' ' O ' ' A' ' 156' ' ' VAL . . . -34.07 -57.17 0.48 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.087 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 82.3 mt-30 -67.28 -33.79 76.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.931 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' PHE . . . . . 0.498 ' N ' ' O ' ' A' ' 156' ' ' VAL . 71.4 t80 -62.76 -39.49 94.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.867 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.443 HD22 ' HB1' ' A' ' 246' ' ' ALA . 82.8 mt -90.21 -17.13 28.09 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.884 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 13.1 t -55.45 -31.84 62.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.845 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' LYS . . . . . 0.544 ' HG3' HD13 ' A' ' 216' ' ' LEU . 25.6 mmtt -60.98 118.12 6.33 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.95 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 163' ' ' GLU . . . . . 0.455 ' O ' ' NE2' ' A' ' 165' ' ' GLN . 17.6 mt-10 -97.33 136.88 37.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.88 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 74.53 43.99 0.24 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.891 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.455 ' NE2' ' O ' ' A' ' 163' ' ' GLU . 31.6 mm-40 -122.87 176.16 6.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.92 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.407 HG11 ' CB ' ' A' ' 223' ' ' ALA . 15.8 t -129.14 119.68 49.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.112 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 167' ' ' ILE . . . . . 0.479 HD12 ' N ' ' A' ' 246' ' ' ALA . 14.6 mt -93.21 149.57 4.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.084 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 57.5 t -130.93 137.01 56.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.123 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 50.7 ttt-85 -92.27 109.4 20.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.854 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 170' ' ' MET . . . . . 0.641 ' CE ' HD21 ' A' ' 173' ' ' LEU . 96.6 mtp -102.05 120.63 40.73 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.846 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 3.3 ttt85 -122.76 139.38 54.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.884 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 90.53 28.24 17.35 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.502 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.675 HD23 HD13 ' A' ' 239' ' ' ILE . 30.4 mt -82.52 127.37 70.88 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.607 0.718 . . . . 0.0 110.836 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 174' ' ' PRO . . . . . 0.493 ' HG3' ' CB ' ' A' ' 237' ' ' ARG . 65.9 Cg_exo -48.06 126.2 12.92 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.665 2.243 . . . . 0.0 112.32 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 175' ' ' PHE . . . . . 0.58 ' CE2' ' HG2' ' A' ' 209' ' ' PRO . 3.8 m-85 -44.06 -24.19 0.14 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.882 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 67.3 p -86.37 -37.16 18.7 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.133 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.401 ' N ' ' O ' ' A' ' 174' ' ' PRO . . . -49.21 124.68 9.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.093 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.651 HG22 ' H ' ' A' ' 179' ' ' ALA . 0.2 OUTLIER -123.76 -173.67 2.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.127 -179.925 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.651 ' H ' HG22 ' A' ' 178' ' ' THR . . . -51.35 -48.05 62.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.085 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -56.76 -33.44 66.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.878 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 181' ' ' GLU . . . . . 0.715 ' OE2' HD21 ' A' ' 234' ' ' LEU . 4.0 mm-40 -72.41 -22.91 61.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.9 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.651 HG12 HD11 ' A' ' 192' ' ' ILE . 93.9 t -87.21 -48.5 15.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.182 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 44.7 t -39.95 -42.53 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.098 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -81.34 -44.19 17.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.064 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.616 ' HD2' HD12 ' A' ' 234' ' ' LEU . 18.3 t80 -40.01 -58.14 1.48 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.862 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 186' ' ' PHE . . . . . 0.449 ' CE1' ' CE1' ' A' ' 185' ' ' PHE . 79.3 m-85 -94.34 -22.99 17.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.874 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -49.29 -21.63 2.97 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.505 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 -54.3 -70.88 0.09 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.834 0.349 . . . . 0.0 110.968 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 6.6 m-70 -118.02 -15.49 9.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.881 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 82.8 m -120.35 86.4 38.58 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.612 0.72 . . . . 0.0 110.909 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 191' ' ' PRO . . . . . 0.406 ' HD2' ' CD1' ' A' ' 222' ' ' TYR . 53.8 Cg_endo -69.78 134.35 27.73 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.685 2.256 . . . . 0.0 112.374 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 192' ' ' ILE . . . . . 0.666 HG23 ' O ' ' A' ' 216' ' ' LEU . 48.2 mt -84.12 143.31 12.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.176 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 93.5 m -68.06 106.24 2.31 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.135 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 89.72 -20.55 34.62 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.475 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 78.62 -125.65 7.19 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.498 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 196' ' ' LYS . . . . . 0.438 ' HA ' HD12 ' A' ' 199' ' ' ILE . 4.7 ptpt -49.49 -21.72 1.02 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.742 0.306 . . . . 0.0 110.845 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -83.54 -30.88 26.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.903 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 198' ' ' GLY . . . . . 0.503 ' HA2' HD12 ' A' ' 216' ' ' LEU . . . -89.77 39.64 3.1 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.491 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.438 HD12 ' HA ' ' A' ' 196' ' ' LYS . 42.6 mt -139.94 149.36 22.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.894 0.378 . . . . 0.0 111.139 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 13.4 tp -143.24 113.16 7.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.937 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 201' ' ' PHE . . . . . 0.426 ' CE1' HG21 ' A' ' 199' ' ' ILE . 49.2 m-85 -95.22 112.38 24.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.854 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.454 HG11 ' OD2' ' A' ' 212' ' ' ASP . 22.9 t -64.12 118.98 7.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.096 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -127.66 138.29 52.78 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.132 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -45.9 158.49 0.35 Allowed Pre-proline 0 C--N 1.328 -0.369 0 CA-C-O 121.719 0.771 . . . . 0.0 110.925 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 2.88 3.12 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.694 2.263 . . . . 0.0 112.379 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -111.45 -15.34 13.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.866 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 105.9 61.94 0.62 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.518 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 41.7 mtt180 -150.9 149.58 25.65 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.587 0.708 . . . . 0.0 110.861 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 209' ' ' PRO . . . . . 0.58 ' HG2' ' CE2' ' A' ' 175' ' ' PHE . 53.3 Cg_endo -69.84 121.0 7.67 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.655 2.237 . . . . 0.0 112.347 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 210' ' ' THR . . . . . 0.531 ' HB ' ' CE2' ' A' ' 256' ' ' PHE . 72.0 p -90.21 -3.95 57.52 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.157 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 89.27 -41.18 3.02 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.473 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 212' ' ' ASP . . . . . 0.454 ' OD2' HG11 ' A' ' 202' ' ' VAL . 1.2 p-10 -77.24 158.29 30.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.816 0.341 . . . . 0.0 110.881 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 213' ' ' ALA . . . . . 0.448 ' HB3' HD12 ' A' ' 173' ' ' LEU . . . -162.03 177.07 10.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.103 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 214' ' ' PHE . . . . . 0.59 ' CE2' HG13 ' A' ' 249' ' ' VAL . 47.7 m-85 -140.17 153.6 46.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.908 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 14.8 t -136.41 151.88 28.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.128 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.666 ' O ' HG23 ' A' ' 192' ' ' ILE . 33.2 mt -105.68 150.55 25.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.881 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -142.66 147.31 35.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.941 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 218' ' ' ALA . . . . . 0.454 ' HB3' ' CD2' ' A' ' 222' ' ' TYR . . . -54.71 -66.96 0.31 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.112 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 219' ' ' CYS . . . . . . . . . . . . . 6.4 p -133.22 175.31 9.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.928 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -61.49 -24.41 66.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.869 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -58.83 -29.91 67.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.922 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 222' ' ' TYR . . . . . 0.454 ' CD2' ' HB3' ' A' ' 218' ' ' ALA . 34.9 m-85 -91.99 -40.16 11.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.932 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.407 ' CB ' HG11 ' A' ' 166' ' ' VAL . . . -64.18 -51.38 64.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.087 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 224' ' ' GLN . . . . . 0.4 ' HA ' ' CD1' ' A' ' 227' ' ' LEU . 12.7 mm-40 -55.81 -53.95 50.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.92 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 -54.52 -26.3 30.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.917 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -74.84 -28.58 60.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.086 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 227' ' ' LEU . . . . . 0.4 ' CD1' ' HA ' ' A' ' 224' ' ' GLN . 26.1 mt -59.92 -29.17 68.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.852 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 30.2 mtp85 -59.55 -28.82 67.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.837 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 229' ' ' LYS . . . . . 0.513 ' HD2' ' CE1' ' A' ' 185' ' ' PHE . 20.0 mtmt -74.91 -1.03 20.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.889 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 230' ' ' HIS . . . . . 0.555 ' CE1' ' HG3' ' A' ' 231' ' ' LYS . 34.7 t60 -33.3 129.85 0.25 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.856 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.555 ' HG3' ' CE1' ' A' ' 230' ' ' HIS . 49.9 mtmt 62.04 37.17 14.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.926 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -63.37 179.59 0.42 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.838 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.663 HD21 ' CE1' ' A' ' 238' ' ' TYR . 33.6 mt -131.61 106.33 8.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.932 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 234' ' ' LEU . . . . . 0.715 HD21 ' OE2' ' A' ' 181' ' ' GLU . 7.7 tt -116.2 114.53 24.55 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.932 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 60.68 34.35 86.06 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.506 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 32.4 mtpt 71.19 52.15 0.26 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.795 0.331 . . . . 0.0 110.908 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 237' ' ' ARG . . . . . 0.493 ' CB ' ' HG3' ' A' ' 174' ' ' PRO . 18.5 mmt180 -155.77 115.36 3.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.884 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 238' ' ' TYR . . . . . 0.663 ' CE1' HD21 ' A' ' 233' ' ' LEU . 97.6 m-85 -67.44 119.23 11.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.921 -179.848 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 0.675 HD13 HD23 ' A' ' 173' ' ' LEU . 80.0 mt -115.61 126.93 73.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.105 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 240' ' ' GLU . . . . . 0.476 ' HB3' ' CE2' ' A' ' 242' ' ' PHE . 37.2 mt-10 -86.13 171.61 11.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.903 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 18.8 mt -152.21 139.41 19.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.915 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 242' ' ' PHE . . . . . 0.476 ' CE2' ' HB3' ' A' ' 240' ' ' GLU . 16.5 m-85 -153.35 126.78 8.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.915 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 61.2 mtm180 -39.85 155.02 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.912 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 19.0 t -156.66 160.7 39.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.827 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 18.0 p -135.86 167.36 21.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.153 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 246' ' ' ALA . . . . . 0.479 ' N ' HD12 ' A' ' 167' ' ' ILE . . . -42.46 -58.52 2.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.091 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -54.0 -56.33 18.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.109 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 248' ' ' GLU . . . . . 0.952 ' O ' HG23 ' A' ' 252' ' ' VAL . 22.5 tp10 -40.66 -46.26 2.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.877 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.59 HG13 ' CE2' ' A' ' 214' ' ' PHE . 99.1 t -61.57 -60.72 2.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.16 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 250' ' ' GLN . . . . . 0.544 ' HA ' HD12 ' A' ' 253' ' ' LEU . 59.9 mt-30 -38.27 -61.18 0.7 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.876 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 251' ' ' GLN . . . . . 0.454 ' CG ' ' O ' ' A' ' 248' ' ' GLU . 7.8 pt20 -53.47 -44.26 68.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.906 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 252' ' ' VAL . . . . . 0.952 HG23 ' O ' ' A' ' 248' ' ' GLU . 92.5 t -59.96 -40.57 83.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.136 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.544 HD12 ' HA ' ' A' ' 250' ' ' GLN . 34.6 mt -59.43 -50.84 72.39 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.901 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 254' ' ' ASN . . . . . 0.5 ' OD1' ' N ' ' A' ' 255' ' ' ARG . 0.6 OUTLIER -61.92 -40.18 94.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.89 179.924 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 255' ' ' ARG . . . . . 0.5 ' N ' ' OD1' ' A' ' 254' ' ' ASN . 43.2 ttt180 -40.59 -58.47 1.59 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.847 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 256' ' ' PHE . . . . . 0.531 ' CE2' ' HB ' ' A' ' 210' ' ' THR . 55.9 m-85 -74.14 -53.94 8.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.871 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 257' ' ' SER . . . . . 0.425 ' C ' ' O ' ' A' ' 256' ' ' PHE . 29.5 t -36.18 -44.86 0.42 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.88 -179.817 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 16.5 t -121.17 80.37 1.64 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.853 -179.773 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 259' ' ' ALA . . . . . . . . . . . . . . . -103.46 -54.56 2.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.138 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 2.5 t -78.37 87.43 4.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.867 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 261' ' ' GLY . . . . . 0.456 ' HA3' ' C ' ' A' ' 262' ' ' PRO . . . -97.22 -74.11 1.17 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.504 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 262' ' ' PRO . . . . . 0.456 ' C ' ' HA3' ' A' ' 261' ' ' GLY . 53.3 Cg_endo -69.76 178.63 24.8 Favored 'Cis proline' 0 C--N 1.341 0.156 0 C-N-CA 122.676 -1.802 . . . . 0.0 112.367 0.016 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 5.6 t -107.54 -58.46 1.96 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.832 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 7.6 t -82.5 125.06 30.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.87 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.363 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.491 -179.954 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.852 0.358 . . . . 0.0 110.903 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 94.1 t -59.32 -47.43 90.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.145 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -37.52 -56.79 0.99 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.072 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -61.59 -40.23 94.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.914 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -59.71 -41.17 90.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.849 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 88.1 mt -87.95 -19.17 27.61 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.915 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 29.5 t -61.62 -22.28 65.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.844 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 39.5 mmtm -72.37 118.55 15.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.931 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -97.46 155.67 16.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.92 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 2.8 m120 63.34 45.64 4.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.884 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 24.0 mm-40 -132.05 149.22 52.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.9 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 55.9 t -103.27 108.04 23.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.129 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' ILE . . . . . 0.458 HD13 HG21 ' A' ' 249' ' ' VAL . 86.8 mt -78.04 141.79 15.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.135 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 92.9 t -122.23 129.28 75.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.113 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 32.5 ttp180 -88.33 106.94 18.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.888 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' MET . . . . . 0.69 ' CE ' HD21 ' A' ' 173' ' ' LEU . 96.9 mtp -94.9 126.35 40.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.858 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 26.1 mtt180 -128.03 142.79 51.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.882 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 79.36 45.19 8.94 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.436 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.744 HD23 HD13 ' A' ' 239' ' ' ILE . 21.1 mt -93.42 133.68 27.96 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.553 0.692 . . . . 0.0 110.953 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . 0.462 ' HG3' ' CB ' ' A' ' 237' ' ' ARG . 64.9 Cg_exo -47.98 133.57 23.26 Favored 'Trans proline' 0 N--CA 1.465 -0.168 0 C-N-CA 122.737 2.291 . . . . 0.0 112.318 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -53.99 -19.26 4.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.836 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 74.7 p -96.29 -22.41 17.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.16 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -60.7 125.97 25.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.078 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -125.89 178.26 5.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.127 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.608 ' O ' HG23 ' A' ' 183' ' ' VAL . . . -45.87 -42.69 12.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.069 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -58.21 -41.8 84.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.926 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -61.82 -42.28 98.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.886 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.449 ' O ' ' C ' ' A' ' 183' ' ' VAL . 47.1 t -65.06 -54.4 29.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.099 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.608 HG23 ' O ' ' A' ' 179' ' ' ALA . 91.4 t -33.99 -52.02 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.131 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.419 ' O ' ' C ' ' A' ' 185' ' ' PHE . . . -72.89 -45.74 56.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.093 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.768 ' HD2' HD12 ' A' ' 234' ' ' LEU . 35.2 t80 -36.89 -62.46 0.48 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.875 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' PHE . . . . . 0.511 ' CE1' ' CE1' ' A' ' 185' ' ' PHE . 55.3 m-85 -91.38 -20.81 21.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.869 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -49.01 -23.32 3.62 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.54 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 30.2 mm-40 -50.64 -74.03 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.827 0.346 . . . . 0.0 110.952 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 29.4 m170 -118.19 -18.17 9.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.877 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 58.6 m -115.05 84.24 10.65 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.635 0.731 . . . . 0.0 110.867 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' PRO . . . . . 0.435 ' HD2' ' CD1' ' A' ' 222' ' ' TYR . 53.3 Cg_endo -69.77 142.89 49.12 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.705 2.27 . . . . 0.0 112.31 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . 0.563 HG23 ' O ' ' A' ' 216' ' ' LEU . 62.6 mt -94.11 144.99 8.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.113 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 87.1 m -70.38 96.5 1.15 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.183 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 95.85 -2.74 64.48 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.508 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 52.8 -120.01 11.14 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.499 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.27 -27.43 2.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.765 0.316 . . . . 0.0 110.893 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 43.9 mm-40 -80.02 -29.98 39.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.85 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -95.23 41.29 2.52 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.497 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 61.9 mt -141.88 140.54 30.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.828 0.347 . . . . 0.0 111.112 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 13.2 tp -135.91 117.49 14.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.972 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -97.15 115.65 27.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.917 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.557 HG23 ' HA ' ' A' ' 213' ' ' ALA . 14.2 t -70.01 121.92 20.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.151 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . 0.436 ' HA ' HG23 ' A' ' 210' ' ' THR . 0.8 OUTLIER -131.45 137.99 48.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.151 -179.969 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . 0.428 ' CD2' HG22 ' A' ' 210' ' ' THR . 28.0 m-85 -46.45 158.57 0.39 Allowed Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.673 0.749 . . . . 0.0 110.932 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 2.87 3.13 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.689 2.259 . . . . 0.0 112.372 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -109.37 -21.3 12.58 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.875 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 112.01 49.27 0.63 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.466 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -133.7 144.02 50.18 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.645 0.736 . . . . 0.0 110.862 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 101.79 0.96 Allowed 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.664 2.243 . . . . 0.0 112.354 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . 0.436 HG23 ' HA ' ' A' ' 203' ' ' THR . 46.0 p -66.45 -25.18 66.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.128 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 104.74 -37.71 3.65 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.471 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' ASP . . . . . 0.472 ' OD2' HG11 ' A' ' 202' ' ' VAL . 1.6 p-10 -78.09 155.7 30.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.771 0.32 . . . . 0.0 110.929 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . 0.557 ' HA ' HG23 ' A' ' 202' ' ' VAL . . . -157.5 -179.1 7.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.119 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . 0.452 ' CE2' HG13 ' A' ' 249' ' ' VAL . 77.6 m-85 -144.5 140.36 28.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.819 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' VAL . . . . . 0.407 HG12 ' N ' ' A' ' 216' ' ' LEU . 4.6 t -124.28 158.99 30.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.133 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 0.563 ' O ' HG23 ' A' ' 192' ' ' ILE . 30.4 mt -111.3 142.54 43.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.958 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -135.44 129.52 33.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.916 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -39.64 -64.48 0.48 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.075 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' CYS . . . . . . . . . . . . . 85.3 m -138.93 -175.34 4.11 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.89 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -71.2 -8.74 55.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.917 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -68.28 -34.62 76.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.922 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 222' ' ' TYR . . . . . 0.435 ' CD1' ' HD2' ' A' ' 191' ' ' PRO . 19.6 m-85 -92.42 -48.88 6.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.92 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -49.76 -53.59 24.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.075 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' GLN . . . . . 0.56 ' HA ' HD12 ' A' ' 227' ' ' LEU . 29.5 mt-30 -52.76 -60.16 3.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.897 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -49.76 -28.57 6.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.915 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -76.23 -36.04 58.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.078 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . 0.56 HD12 ' HA ' ' A' ' 224' ' ' GLN . 43.8 mt -55.35 -36.51 66.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.93 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 3.9 mtp-105 -58.23 -18.98 30.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.883 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . 0.459 ' O ' ' C ' ' A' ' 230' ' ' HIS . 23.7 mtpp -78.78 -2.54 40.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.872 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 230' ' ' HIS . . . . . 0.542 ' CD2' ' HG2' ' A' ' 231' ' ' LYS . 78.5 t60 -33.89 136.88 0.11 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.857 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.542 ' HG2' ' CD2' ' A' ' 230' ' ' HIS . 23.1 mmtm 62.16 31.08 17.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.857 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -59.69 -176.24 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.823 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.874 HD21 ' CE1' ' A' ' 238' ' ' TYR . 31.6 mt -140.06 110.42 6.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.93 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 234' ' ' LEU . . . . . 0.768 HD12 ' HD2' ' A' ' 185' ' ' PHE . 6.8 tt -119.64 114.16 21.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.91 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 58.26 36.1 81.36 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.497 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 38.7 mttp 71.21 52.13 0.26 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.744 0.306 . . . . 0.0 110.912 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 237' ' ' ARG . . . . . 0.462 ' CB ' ' HG3' ' A' ' 174' ' ' PRO . 19.6 mmt180 -155.79 115.46 3.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.901 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 238' ' ' TYR . . . . . 0.874 ' CE1' HD21 ' A' ' 233' ' ' LEU . 83.5 m-85 -69.72 133.0 47.0 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.955 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 0.744 HD13 HD23 ' A' ' 173' ' ' LEU . 70.7 mt -131.69 141.04 46.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.134 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 240' ' ' GLU . . . . . 0.578 ' HB3' ' CZ ' ' A' ' 242' ' ' PHE . 24.6 mt-10 -92.89 178.33 5.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.906 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . 0.593 ' O ' ' CD1' ' A' ' 242' ' ' PHE . 51.0 mt -157.64 137.35 12.21 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.893 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 242' ' ' PHE . . . . . 0.593 ' CD1' ' O ' ' A' ' 241' ' ' LEU . 5.2 m-85 -157.53 122.8 4.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.871 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . 0.492 ' O ' ' CG ' ' A' ' 243' ' ' ARG . 19.9 ptt180 -59.57 112.58 1.84 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.873 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 1.7 t -106.98 164.32 12.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.866 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . 0.594 ' O ' HG23 ' A' ' 249' ' ' VAL . 33.7 p -110.19 166.51 10.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.166 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -54.38 -61.53 2.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.079 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -45.44 -56.26 5.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.083 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -45.7 -55.78 6.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.89 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 0.594 HG23 ' O ' ' A' ' 245' ' ' THR . 99.8 t -41.72 -59.88 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.138 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 250' ' ' GLN . . . . . 0.479 ' HA ' HD12 ' A' ' 253' ' ' LEU . 33.8 mt-30 -47.83 -42.56 26.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.882 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 251' ' ' GLN . . . . . 0.494 ' O ' ' ND2' ' A' ' 254' ' ' ASN . 35.4 mm-40 -68.46 -22.6 64.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.952 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 76.7 t -85.1 -21.1 8.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.11 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 253' ' ' LEU . . . . . 0.479 HD12 ' HA ' ' A' ' 250' ' ' GLN . 10.9 mt -87.38 -42.18 13.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.945 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 254' ' ' ASN . . . . . 0.494 ' ND2' ' O ' ' A' ' 251' ' ' GLN . 0.5 OUTLIER -64.47 -43.41 94.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.898 179.906 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -53.76 -42.36 68.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.888 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -80.87 -34.02 33.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.848 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 20.6 m . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.875 -179.774 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.898 0.38 . . . . 0.0 110.9 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 76.8 t -66.43 -36.75 78.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.151 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -44.32 -51.37 8.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.079 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -61.37 -51.11 70.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.929 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' PHE . . . . . 0.502 ' CE1' ' HG ' ' A' ' 216' ' ' LEU . 85.3 t80 -46.24 -46.1 17.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.875 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 92.0 mt -84.5 -18.55 35.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.918 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 17.6 t -56.82 -25.38 55.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.845 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . 0.557 ' HG3' HD13 ' A' ' 216' ' ' LEU . 28.3 mmtt -71.04 131.78 44.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.886 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -110.01 156.97 19.79 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.847 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 3.5 m120 65.03 36.17 7.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.882 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 22.2 mm-40 -124.95 160.08 29.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.91 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 25.3 t -111.6 115.71 50.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.174 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 19.3 mt -86.99 140.27 16.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.14 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.404 HG21 ' CE2' ' A' ' 217' ' ' PHE . 30.0 t -122.17 137.26 56.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.157 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 51.4 ttp180 -92.29 112.51 24.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.84 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' MET . . . . . 0.48 ' CE ' HD21 ' A' ' 173' ' ' LEU . 98.9 mtp -107.29 111.64 24.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.917 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 10.3 ptm180 -118.92 133.96 55.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.835 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 100.6 18.21 21.58 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.47 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.752 HD23 HD13 ' A' ' 239' ' ' ILE . 31.0 mt -73.85 133.16 79.47 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.633 0.73 . . . . 0.0 110.91 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . 0.448 ' HG3' ' CB ' ' A' ' 237' ' ' ARG . 65.8 Cg_exo -48.0 135.08 23.92 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.642 2.228 . . . . 0.0 112.369 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 3.3 m-30 -49.71 -35.11 20.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.884 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . 0.421 ' O ' ' C ' ' A' ' 177' ' ' ALA . 22.8 p -77.68 -43.96 29.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.153 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . 0.429 ' HA ' ' CD ' ' A' ' 181' ' ' GLU . . . -35.55 128.97 0.59 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.087 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 3.9 p -124.54 -178.7 4.21 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.132 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -56.75 -41.78 78.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.098 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -58.84 -34.97 72.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.904 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . 0.429 ' CD ' ' HA ' ' A' ' 177' ' ' ALA . 36.4 mt-10 -69.52 -37.37 77.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.885 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.588 HG12 ' CD1' ' A' ' 192' ' ' ILE . 26.1 t -68.93 -47.01 78.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.176 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 37.7 t -37.95 -49.4 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.096 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.423 ' O ' ' C ' ' A' ' 185' ' ' PHE . . . -74.28 -44.84 51.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.105 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.619 ' CE1' ' CE1' ' A' ' 186' ' ' PHE . 5.7 t80 -36.89 -64.07 0.38 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.829 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' PHE . . . . . 0.619 ' CE1' ' CE1' ' A' ' 185' ' ' PHE . 59.9 m-85 -89.19 -21.64 23.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.899 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -49.62 -26.15 7.36 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.514 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 16.5 tt0 -48.98 -70.91 0.08 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.863 0.363 . . . . 0.0 110.971 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 65.9 m80 -118.27 -16.6 9.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.869 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' CYS . . . . . 0.438 ' N ' ' O ' ' A' ' 186' ' ' PHE . 74.4 m -120.11 85.36 35.35 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.569 0.699 . . . . 0.0 110.818 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' PRO . . . . . 0.458 ' HD2' ' CD1' ' A' ' 222' ' ' TYR . 53.8 Cg_endo -69.78 130.04 18.62 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.701 2.268 . . . . 0.0 112.338 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . 0.588 ' CD1' HG12 ' A' ' 182' ' ' VAL . 53.2 mt -79.03 142.92 13.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.122 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 21.9 m -66.74 98.66 0.54 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.164 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 89.22 -3.92 84.3 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.465 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.412 ' O ' ' N ' ' A' ' 198' ' ' GLY . . . 58.24 -117.46 10.56 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.497 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 4.3 ptpp? -47.38 -28.67 2.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.779 0.323 . . . . 0.0 110.924 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -78.48 -29.85 46.99 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.932 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . 0.419 ' HA2' HD12 ' A' ' 216' ' ' LEU . . . -95.69 41.43 2.46 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.469 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.411 HG21 ' CE2' ' A' ' 201' ' ' PHE . 75.9 mt -140.7 138.3 35.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.833 0.349 . . . . 0.0 111.128 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 14.3 tp -132.99 113.03 12.34 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.915 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' PHE . . . . . 0.411 ' CE2' HG21 ' A' ' 199' ' ' ILE . 81.3 m-85 -96.58 110.81 23.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.855 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 22.0 t -67.41 127.36 28.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.128 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -132.48 141.57 48.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.168 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 -45.78 158.12 0.36 Allowed Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.686 0.755 . . . . 0.0 110.964 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 3.21 2.92 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.707 2.271 . . . . 0.0 112.355 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -112.68 -16.07 12.87 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.891 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 106.94 62.98 0.58 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.501 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 35.2 mtt180 -151.77 151.15 27.85 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.646 0.736 . . . . 0.0 110.861 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 122.42 9.09 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.701 2.268 . . . . 0.0 112.352 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 42.9 p -90.84 -21.42 21.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.123 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 104.35 -35.49 5.01 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.494 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -80.68 156.54 26.26 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.838 0.351 . . . . 0.0 110.829 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -160.74 172.87 16.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.099 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -140.23 149.13 42.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.869 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' VAL . . . . . 0.437 HG12 ' N ' ' A' ' 216' ' ' LEU . 8.1 t -131.49 159.34 43.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.179 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 0.557 HD13 ' HG3' ' A' ' 162' ' ' LYS . 36.9 mt -108.79 143.2 38.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.918 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . 0.404 ' CE2' HG21 ' A' ' 168' ' ' VAL . 76.9 m-85 -136.4 145.24 45.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.895 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -59.03 -62.35 1.95 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.072 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' CYS . . . . . . . . . . . . . 66.7 m -141.14 179.34 6.81 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.918 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -57.83 -36.48 72.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.877 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -40.07 -45.76 2.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.897 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 222' ' ' TYR . . . . . 0.458 ' CD1' ' HD2' ' A' ' 191' ' ' PRO . 24.0 m-85 -84.44 -49.9 8.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.919 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -53.49 -63.29 1.2 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.098 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 85.9 mm-40 -49.28 -52.65 26.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.882 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 61.8 m-20 -59.18 -26.33 64.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.92 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -75.27 -28.51 59.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.117 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 26.8 mt -62.37 -29.41 70.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.897 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 65.0 mtp180 -60.87 -19.5 60.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.871 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . 0.544 ' HD2' ' CE1' ' A' ' 185' ' ' PHE . 20.3 mtmm -83.02 0.69 43.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.881 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 230' ' ' HIS . . . . . 0.466 ' C ' ' O ' ' A' ' 229' ' ' LYS . 67.9 t60 -33.4 135.13 0.12 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.866 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.411 ' HG3' ' NE2' ' A' ' 230' ' ' HIS . 13.2 mttm 60.8 32.2 20.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.897 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . 0.475 ' OD2' ' CE2' ' A' ' 185' ' ' PHE . 15.3 t0 -55.64 175.47 0.08 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.838 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.68 HD21 ' CE1' ' A' ' 238' ' ' TYR . 30.5 mt -130.88 106.57 8.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.909 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 234' ' ' LEU . . . . . 0.523 HD23 ' C ' ' A' ' 234' ' ' LEU . 6.5 tt -114.38 114.31 25.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.903 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 56.49 42.72 90.23 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.526 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 22.8 mmtp 65.54 52.55 1.34 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.767 0.318 . . . . 0.0 110.877 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 237' ' ' ARG . . . . . 0.448 ' CB ' ' HG3' ' A' ' 174' ' ' PRO . 19.1 mmt180 -156.27 115.38 3.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.876 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 238' ' ' TYR . . . . . 0.68 ' CE1' HD21 ' A' ' 233' ' ' LEU . 97.6 m-85 -68.49 131.48 45.34 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.916 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 0.752 HD13 HD23 ' A' ' 173' ' ' LEU . 56.5 mt -129.1 128.28 66.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.13 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 240' ' ' GLU . . . . . 0.491 ' HB3' ' CZ ' ' A' ' 242' ' ' PHE . 36.7 mt-10 -88.22 159.71 18.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.9 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . 0.511 ' O ' ' CD1' ' A' ' 242' ' ' PHE . 15.2 mt -141.7 146.3 35.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.899 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 242' ' ' PHE . . . . . 0.511 ' CD1' ' O ' ' A' ' 241' ' ' LEU . 9.7 m-85 -158.49 155.33 28.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.825 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 72.9 mtm180 -69.29 135.61 50.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.873 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 11.2 t -134.89 163.64 29.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.834 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . 0.413 ' O ' ' C ' ' A' ' 246' ' ' ALA . 72.6 p -139.77 156.57 46.69 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.136 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 246' ' ' ALA . . . . . 0.413 ' C ' ' O ' ' A' ' 245' ' ' THR . . . -36.24 -52.23 0.8 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.07 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -56.87 -52.39 65.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.081 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . 0.426 ' O ' HG23 ' A' ' 252' ' ' VAL . 6.4 tp10 -49.78 -49.91 46.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.959 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 97.0 t -49.47 -66.48 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.129 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 250' ' ' GLN . . . . . 0.477 ' HA ' HD12 ' A' ' 253' ' ' LEU . 55.9 mt-30 -40.69 -42.98 1.85 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.91 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -63.87 -48.12 77.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.92 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 252' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 248' ' ' GLU . 96.0 t -57.83 -46.05 87.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.148 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 253' ' ' LEU . . . . . 0.477 HD12 ' HA ' ' A' ' 250' ' ' GLN . 16.5 mt -57.32 -49.59 75.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.942 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 14.4 m-20 -60.11 -51.17 70.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.861 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 30.6 ttt180 -38.91 -52.11 1.77 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.905 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -69.63 -50.4 44.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.912 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 8.6 m . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.828 -179.797 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.905 0.383 . . . . 0.0 110.836 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.484 HG22 HD21 ' A' ' 200' ' ' LEU . 69.0 t -68.12 -44.51 84.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.15 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.425 ' C ' ' O ' ' A' ' 156' ' ' VAL . . . -36.11 -59.71 0.6 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.073 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 41.7 mm-40 -57.27 -49.88 74.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.891 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -46.33 -39.96 11.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.878 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.5 HD13 HE21 ' A' ' 250' ' ' GLN . 83.6 mt -91.33 -18.0 25.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.929 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 28.4 t -58.5 -22.65 55.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.839 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 19.8 mmtp -73.22 120.77 19.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.877 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -96.15 158.32 15.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.871 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 59.93 47.67 9.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.856 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 25.3 mm-40 -131.74 156.28 46.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.921 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 29.9 t -111.14 105.66 19.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.101 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' ILE . . . . . 0.633 HD13 HG21 ' A' ' 249' ' ' VAL . 66.4 mt -77.71 135.18 26.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.141 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 91.1 t -114.15 128.79 70.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.08 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 7.7 ttp-105 -88.35 106.09 18.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.857 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' MET . . . . . 0.694 ' CE ' HD21 ' A' ' 173' ' ' LEU . 99.3 mtp -95.57 138.32 33.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.88 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 73.7 mtt-85 -134.4 139.89 45.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.869 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 83.91 39.39 9.46 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.493 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.694 HD21 ' CE ' ' A' ' 170' ' ' MET . 24.1 mt -89.34 126.25 59.14 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.665 0.745 . . . . 0.0 110.889 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . 0.439 ' HG3' ' CB ' ' A' ' 237' ' ' ARG . 65.7 Cg_exo -47.99 132.78 22.84 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.684 2.256 . . . . 0.0 112.326 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . 0.561 ' CD1' ' HG3' ' A' ' 209' ' ' PRO . 10.3 t80 -45.19 -34.78 2.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.899 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 9.2 p -82.46 -30.34 30.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.14 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -52.84 107.0 0.19 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.116 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 5.7 p -113.02 178.16 4.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.155 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -46.48 -39.63 11.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.071 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -60.2 -34.63 73.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.875 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 38.5 mm-40 -75.38 -23.74 57.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.883 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.483 HG12 ' CD1' ' A' ' 192' ' ' ILE . 74.8 t -83.23 -47.2 18.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.17 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 54.8 t -41.47 -44.12 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.125 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -81.47 -37.06 28.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.08 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.696 ' HD2' HD12 ' A' ' 234' ' ' LEU . 19.9 t80 -45.69 -62.96 1.08 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.858 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' PHE . . . . . 0.507 ' CE1' ' CE1' ' A' ' 185' ' ' PHE . 68.7 m-85 -89.41 -20.9 23.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.911 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -49.67 -16.9 1.19 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.461 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 25.1 tp60 -58.94 -72.85 0.09 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.825 0.345 . . . . 0.0 110.878 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 23.3 m80 -118.28 -9.31 10.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.878 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 71.3 m -125.46 86.94 56.47 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.543 0.687 . . . . 0.0 110.9 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 141.35 45.04 Favored 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.708 2.272 . . . . 0.0 112.381 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . 0.698 HG23 ' O ' ' A' ' 216' ' ' LEU . 61.4 mt -95.78 141.99 14.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.116 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 14.8 m -65.38 102.98 0.74 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.168 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 89.15 -16.96 54.41 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.485 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.4 ' O ' ' N ' ' A' ' 198' ' ' GLY . . . 72.85 -122.43 8.25 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.456 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . 0.607 ' HA ' HD12 ' A' ' 199' ' ' ILE . 15.4 ptmt -46.38 -36.15 6.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.746 0.308 . . . . 0.0 110.903 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -69.85 -31.01 68.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.871 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 195' ' ' GLY . . . -91.99 39.55 3.01 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.52 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.607 HD12 ' HA ' ' A' ' 196' ' ' LYS . 48.5 mt -139.99 145.49 26.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.824 0.345 . . . . 0.0 111.116 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.484 HD21 HG22 ' A' ' 156' ' ' VAL . 15.2 tp -143.33 124.32 14.38 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.926 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -103.5 123.66 47.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.875 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 44.6 t -78.96 140.09 17.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.142 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . 0.497 ' HA ' HG23 ' A' ' 210' ' ' THR . 0.8 OUTLIER -144.79 139.15 27.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.155 -179.986 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -49.48 159.13 0.7 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.657 0.741 . . . . 0.0 110.914 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 3.24 2.88 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.673 2.248 . . . . 0.0 112.346 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -110.51 -20.83 12.43 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.863 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 114.15 34.27 1.67 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.427 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -116.16 143.62 31.34 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.621 0.724 . . . . 0.0 110.848 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' PRO . . . . . 0.561 ' HG3' ' CD1' ' A' ' 175' ' ' PHE . 53.9 Cg_endo -69.77 107.79 1.94 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.699 2.266 . . . . 0.0 112.348 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . 0.497 HG23 ' HA ' ' A' ' 203' ' ' THR . 44.9 p -73.18 -5.65 40.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.117 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 79.42 -40.56 2.21 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.48 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -69.42 161.5 29.29 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.787 0.327 . . . . 0.0 110.852 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . 0.514 ' HB3' ' CD1' ' A' ' 173' ' ' LEU . . . -164.28 -179.15 5.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.105 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -144.88 144.95 31.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.886 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' VAL . . . . . 0.445 HG12 ' N ' ' A' ' 216' ' ' LEU . 6.1 t -131.69 160.14 42.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.147 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 0.698 ' O ' HG23 ' A' ' 192' ' ' ILE . 37.6 mt -108.8 140.92 41.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.924 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -135.81 125.19 24.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.884 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -38.1 -73.44 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.081 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' CYS . . . . . . . . . . . . . 69.5 m -123.63 174.05 7.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.873 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -64.56 -32.91 74.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.932 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -41.28 -44.65 2.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.896 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 222' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -77.7 -43.92 29.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.906 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -50.8 -54.96 19.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.063 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 -50.55 -54.57 21.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.894 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . 0.433 ' HA ' ' NE ' ' A' ' 228' ' ' ARG . 55.0 m-20 -54.98 -27.62 45.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.912 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -76.68 -39.83 50.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.073 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 86.4 mt -55.18 -38.32 68.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.9 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 228' ' ' ARG . . . . . 0.433 ' NE ' ' HA ' ' A' ' 225' ' ' ASN . 50.4 mtm180 -57.99 -24.26 57.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.883 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . 0.463 ' O ' ' C ' ' A' ' 230' ' ' HIS . 28.1 mtpt -77.01 -1.52 29.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.907 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 230' ' ' HIS . . . . . 0.466 ' CD2' ' HG2' ' A' ' 231' ' ' LYS . 85.9 t60 -33.6 138.15 0.08 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.856 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.466 ' HG2' ' CD2' ' A' ' 230' ' ' HIS . 37.4 mmtt 62.37 25.67 15.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.937 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -52.25 -179.02 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.876 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.7 HD21 ' CE1' ' A' ' 238' ' ' TYR . 31.2 mt -139.5 107.34 5.66 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.951 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 234' ' ' LEU . . . . . 0.708 HD23 ' C ' ' A' ' 234' ' ' LEU . 5.4 tt -117.64 114.63 23.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.895 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 59.77 37.0 91.8 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.466 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 28.0 mmtt 68.47 52.24 0.62 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.742 0.306 . . . . 0.0 110.893 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 237' ' ' ARG . . . . . 0.439 ' CB ' ' HG3' ' A' ' 174' ' ' PRO . 43.6 mmt-85 -156.19 115.36 3.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.883 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 238' ' ' TYR . . . . . 0.7 ' CE1' HD21 ' A' ' 233' ' ' LEU . 93.8 m-85 -67.84 134.81 51.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.933 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 0.429 HD13 HD23 ' A' ' 173' ' ' LEU . 60.2 mt -132.98 136.32 55.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.133 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 240' ' ' GLU . . . . . 0.641 ' O ' HD23 ' A' ' 241' ' ' LEU . 66.3 mt-10 -89.33 172.6 8.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.921 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . 0.641 HD23 ' O ' ' A' ' 240' ' ' GLU . 18.4 mt -153.99 139.24 17.51 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.905 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 242' ' ' PHE . . . . . 0.599 ' CD1' ' O ' ' A' ' 241' ' ' LEU . 5.7 m-85 -159.13 122.87 3.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.865 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . 0.493 ' O ' ' CG ' ' A' ' 243' ' ' ARG . 19.0 ptt-85 -61.05 118.06 6.29 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.861 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 16.3 t -114.08 -179.22 3.57 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.86 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 71.3 p -127.83 162.2 27.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.137 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -50.58 -56.13 13.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.058 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -50.2 -52.31 36.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.145 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -49.79 -57.77 6.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.879 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 0.633 HG21 HD13 ' A' ' 167' ' ' ILE . 95.1 t -38.78 -66.81 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.135 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 250' ' ' GLN . . . . . 0.5 HE21 HD13 ' A' ' 160' ' ' LEU . 50.3 mt-30 -38.64 -48.79 1.5 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.948 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -60.32 -44.56 95.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.93 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 98.7 t -60.76 -44.93 98.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.146 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 253' ' ' LEU . . . . . 0.424 HD12 ' HA ' ' A' ' 250' ' ' GLN . 17.3 mt -58.39 -49.43 77.28 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.915 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -61.07 -47.02 88.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.89 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 57.2 ttt180 -41.93 -44.04 3.3 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.883 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 256' ' ' PHE . . . . . 0.435 ' CE1' ' HB ' ' A' ' 210' ' ' THR . 49.9 m-85 -73.44 -40.08 64.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.911 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 5.4 m . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.896 -179.827 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.94 0.4 . . . . 0.0 110.916 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.594 HG22 HD21 ' A' ' 200' ' ' LEU . 73.7 t -79.55 -43.07 23.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.156 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -41.07 -58.05 1.86 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.112 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -59.66 -44.42 93.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.94 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 28.1 t80 -53.49 -42.61 67.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.897 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 86.6 mt -88.97 -16.44 31.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.93 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 8.5 t -61.38 -32.29 72.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.843 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 43.3 mmtt -61.05 126.45 27.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.872 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -102.33 152.87 20.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.858 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 11.3 m-20 68.92 38.82 1.97 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.888 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 0.6 ' OE1' HG21 ' A' ' 193' ' ' THR . 5.4 mm-40 -128.8 146.08 51.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.923 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 60.8 t -100.31 106.48 19.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.125 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 36.0 mt -77.19 138.86 19.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.11 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 96.1 t -123.06 130.8 74.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.107 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . 0.537 ' HG3' ' CE1' ' A' ' 214' ' ' PHE . 25.6 ttm180 -88.34 113.08 23.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.857 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' MET . . . . . 0.518 ' CE ' HD21 ' A' ' 173' ' ' LEU . 97.8 mtp -98.15 126.51 43.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.873 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . 0.62 ' O ' HG23 ' A' ' 239' ' ' ILE . 24.2 mtt180 -123.51 157.5 33.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.877 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 73.79 21.93 78.75 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.479 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.527 HD23 HD13 ' A' ' 239' ' ' ILE . 19.8 mt -74.39 127.5 87.5 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.616 0.722 . . . . 0.0 110.913 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_exo -47.96 149.32 5.73 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.666 2.244 . . . . 0.0 112.349 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 10.8 m-30 -62.49 -26.1 68.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.899 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 63.5 p -90.47 -25.62 20.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.152 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -44.91 126.52 5.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.076 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 5.9 p -125.17 176.49 6.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.15 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -57.12 -36.18 70.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.113 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -68.71 -15.83 63.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.922 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -88.53 -22.43 23.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.86 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.487 HG12 ' CD1' ' A' ' 192' ' ' ILE . 22.4 t -83.94 -52.79 12.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.16 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.425 ' C ' ' O ' ' A' ' 182' ' ' VAL . 47.7 t -36.04 -47.51 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.138 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -74.71 -36.6 62.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.101 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.605 ' HD2' HD12 ' A' ' 234' ' ' LEU . 15.5 t80 -48.51 -59.27 3.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.877 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' PHE . . . . . 0.572 ' CE1' ' CE1' ' A' ' 185' ' ' PHE . 57.2 m-85 -92.18 -21.31 20.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.898 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -49.13 -19.16 1.47 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.481 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 12.4 mm100 -56.35 -75.19 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.866 0.365 . . . . 0.0 110.949 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 2.5 t-160 -117.49 -6.28 11.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.869 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 87.0 m -126.86 86.31 59.03 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.552 0.692 . . . . 0.0 110.9 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 133.62 26.1 Favored 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.689 2.259 . . . . 0.0 112.357 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . 0.553 HG23 ' O ' ' A' ' 216' ' ' LEU . 57.9 mt -85.26 145.58 7.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.129 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . 0.6 HG21 ' OE1' ' A' ' 165' ' ' GLN . 90.9 m -73.66 107.43 5.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.105 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 93.16 -21.85 37.91 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.459 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 78.72 -122.89 6.0 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.476 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.77 -20.71 9.09 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.719 0.295 . . . . 0.0 110.89 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -85.22 -24.87 27.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.895 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . 0.443 ' HA2' HD12 ' A' ' 216' ' ' LEU . . . -93.4 40.27 2.82 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.46 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.41 HG22 ' N ' ' A' ' 200' ' ' LEU . 35.2 mt -142.75 153.0 17.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.896 0.379 . . . . 0.0 111.104 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.594 HD21 HG22 ' A' ' 156' ' ' VAL . 13.3 tp -146.34 110.96 5.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.925 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -92.89 109.81 21.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.871 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.486 HG23 ' HA ' ' A' ' 213' ' ' ALA . 11.0 t -70.99 128.05 33.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.121 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -133.04 142.66 48.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.134 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . 0.448 ' N ' HG23 ' A' ' 210' ' ' THR . 27.1 m-85 -51.4 159.12 1.22 Allowed Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.708 0.766 . . . . 0.0 110.943 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 3.4 2.78 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.648 2.232 . . . . 0.0 112.38 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -112.55 -21.32 11.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.867 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 118.03 9.69 9.59 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.489 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -92.48 141.45 24.75 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.581 0.705 . . . . 0.0 110.887 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 106.49 1.67 Allowed 'Trans proline' 0 C--O 1.233 0.225 0 C-N-CA 122.69 2.26 . . . . 0.0 112.333 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . 0.527 ' HB ' ' CE1' ' A' ' 256' ' ' PHE . 71.0 p -66.11 -23.4 66.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.131 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 95.49 -22.59 38.07 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.501 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' ASP . . . . . 0.428 ' OD1' ' CZ ' ' A' ' 256' ' ' PHE . 1.0 OUTLIER -90.16 157.03 17.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.776 0.322 . . . . 0.0 110.899 -179.988 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . 0.486 ' HA ' HG23 ' A' ' 202' ' ' VAL . . . -159.37 178.73 9.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.107 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . 0.537 ' CE1' ' HG3' ' A' ' 169' ' ' ARG . 55.4 m-85 -143.64 145.65 32.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.909 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' VAL . . . . . 0.45 HG12 ' N ' ' A' ' 216' ' ' LEU . 4.0 t -131.9 162.02 40.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.137 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 0.553 ' O ' HG23 ' A' ' 192' ' ' ILE . 45.3 mt -111.8 137.45 49.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.903 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -130.12 142.39 50.6 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.881 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . 0.853 ' HB3' ' CD2' ' A' ' 222' ' ' TYR . . . -50.32 -61.66 2.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.093 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' CYS . . . . . . . . . . . . . 1.9 t -153.11 175.3 13.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.833 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -49.2 -31.31 8.32 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.891 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -51.57 -36.07 43.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.918 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 222' ' ' TYR . . . . . 0.853 ' CD2' ' HB3' ' A' ' 218' ' ' ALA . 33.3 m-85 -92.02 -41.51 10.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.926 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -56.81 -54.41 46.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.114 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 10.2 mm-40 -50.37 -52.11 40.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.893 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 22.4 m-20 -58.6 -23.84 59.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.858 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -79.48 -45.88 18.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.112 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 57.3 mt -52.13 -35.67 49.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.898 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 65.5 mtp180 -56.77 -29.56 62.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.912 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . 0.465 ' O ' ' C ' ' A' ' 230' ' ' HIS . 16.3 mtpp -74.7 -0.69 18.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.896 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 230' ' ' HIS . . . . . 0.537 ' CD2' ' HG2' ' A' ' 231' ' ' LYS . 86.3 t60 -33.35 141.39 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.842 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.537 ' HG2' ' CD2' ' A' ' 230' ' ' HIS . 13.1 mmtp 59.78 26.62 15.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.9 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -53.42 177.96 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.853 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.582 HD21 ' CD1' ' A' ' 238' ' ' TYR . 32.9 mt -136.58 105.03 5.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.97 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 234' ' ' LEU . . . . . 0.605 HD12 ' HD2' ' A' ' 185' ' ' PHE . 7.0 tt -113.94 115.53 27.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.9 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 59.17 37.18 91.39 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.484 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 62.9 mttt 69.08 52.57 0.49 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.809 0.338 . . . . 0.0 110.877 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 23.2 mmt180 -155.99 117.26 3.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.879 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 238' ' ' TYR . . . . . 0.582 ' CD1' HD21 ' A' ' 233' ' ' LEU . 96.1 m-85 -69.17 133.99 48.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.95 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 0.62 HG23 ' O ' ' A' ' 171' ' ' ARG . 76.2 mt -132.59 135.96 56.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.136 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 240' ' ' GLU . . . . . 0.558 ' HB3' ' CZ ' ' A' ' 242' ' ' PHE . 6.8 mt-10 -87.38 179.38 6.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.878 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . 0.59 ' O ' ' CD1' ' A' ' 242' ' ' PHE . 54.8 mt -158.29 132.62 8.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.889 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 242' ' ' PHE . . . . . 0.59 ' CD1' ' O ' ' A' ' 241' ' ' LEU . 6.7 m-85 -154.03 123.05 6.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.861 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . 0.486 ' O ' ' CG ' ' A' ' 243' ' ' ARG . 20.5 ptt180 -59.72 116.46 4.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.893 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 1.9 t -103.89 175.37 5.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.814 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 52.9 p -127.98 150.06 50.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.107 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -40.44 -59.35 1.34 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.056 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -52.36 -51.27 59.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.127 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . 0.408 ' O ' ' N ' ' A' ' 251' ' ' GLN . 13.3 tp10 -52.21 -57.29 10.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.942 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 0.526 HG13 ' CE2' ' A' ' 214' ' ' PHE . 86.9 t -36.85 -60.13 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.122 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 250' ' ' GLN . . . . . 0.412 ' HA ' HD12 ' A' ' 253' ' ' LEU . 41.7 mt-30 -49.89 -40.37 42.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.896 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 251' ' ' GLN . . . . . 0.499 ' O ' ' ND2' ' A' ' 254' ' ' ASN . 41.9 mt-30 -69.7 -19.88 63.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.943 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 69.0 t -88.64 -26.82 5.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.111 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 253' ' ' LEU . . . . . 0.412 HD12 ' HA ' ' A' ' 250' ' ' GLN . 10.5 mt -81.46 -39.17 25.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.91 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 254' ' ' ASN . . . . . 0.499 ' ND2' ' O ' ' A' ' 251' ' ' GLN . 0.7 OUTLIER -66.41 -45.43 79.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.885 179.918 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . 0.507 ' CG ' ' N ' ' A' ' 256' ' ' PHE . 6.0 ptm180 -48.07 -48.72 33.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.87 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 256' ' ' PHE . . . . . 0.527 ' CE1' ' HB ' ' A' ' 210' ' ' THR . 12.9 m-85 -64.58 -41.83 96.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.891 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 57.8 m . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.893 -179.834 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.883 0.373 . . . . 0.0 110.884 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 74.4 t -63.41 -36.51 76.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.11 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -38.9 -63.89 0.49 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.098 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 89.7 mm-40 -57.58 -48.09 80.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.903 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 28.0 t80 -47.68 -41.81 23.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.857 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 33.0 mt -83.98 -31.95 25.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.91 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 18.1 t -47.3 -41.24 18.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.85 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . 0.687 ' HG3' HD13 ' A' ' 216' ' ' LEU . 0.7 OUTLIER -38.39 129.57 1.35 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.904 179.908 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -110.63 133.63 53.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.862 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 74.24 43.33 0.29 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.884 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 10.4 mm100 -128.38 168.02 16.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.939 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.414 HG11 ' CB ' ' A' ' 223' ' ' ALA . 55.6 t -118.71 141.33 38.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.111 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' ILE . . . . . 0.583 HD12 ' N ' ' A' ' 246' ' ' ALA . 8.6 mt -111.61 143.92 20.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.103 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 97.9 t -127.14 133.72 67.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.087 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 70.2 ttt180 -91.14 112.83 24.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.868 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' MET . . . . . 0.46 ' CE ' HD21 ' A' ' 173' ' ' LEU . 91.0 mtp -100.43 149.56 23.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.89 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 35.0 mtp180 -146.75 133.87 20.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.909 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 96.51 19.28 28.02 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.513 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.523 ' CD1' ' HB3' ' A' ' 213' ' ' ALA . 24.3 mt -71.18 121.12 83.29 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.639 0.733 . . . . 0.0 110.907 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . 0.413 ' HG3' ' CB ' ' A' ' 237' ' ' ARG . 64.9 Cg_exo -47.97 131.66 21.43 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.703 2.269 . . . . 0.0 112.326 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . 0.554 ' CD1' ' HG3' ' A' ' 209' ' ' PRO . 11.6 t80 -37.52 -49.42 1.06 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.885 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . 0.424 ' O ' ' C ' ' A' ' 177' ' ' ALA . 14.4 p -68.39 -44.98 73.91 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.141 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' A' ' 176' ' ' THR . . . -35.72 111.25 0.13 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.104 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -115.48 -177.16 3.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.161 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.409 ' HB1' ' HA ' ' A' ' 196' ' ' LYS . . . -50.01 -47.87 52.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.12 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . 0.407 ' CG ' ' OE2' ' A' ' 181' ' ' GLU . 5.7 pt-20 -51.67 -40.01 59.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.923 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . 0.407 ' OE2' ' CG ' ' A' ' 180' ' ' GLU . 0.1 OUTLIER -65.94 -36.99 84.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.876 -179.95 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.505 HG12 HD11 ' A' ' 192' ' ' ILE . 89.9 t -69.47 -50.36 51.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.155 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.418 ' C ' ' O ' ' A' ' 182' ' ' VAL . 34.4 t -35.55 -50.89 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.161 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -75.4 -42.28 54.17 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.127 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.715 ' HD2' HD12 ' A' ' 234' ' ' LEU . 10.2 t80 -40.2 -62.03 0.8 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.906 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' PHE . . . . . 0.527 ' CE1' ' CE1' ' A' ' 185' ' ' PHE . 72.8 m-85 -92.81 -21.08 20.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.908 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -49.28 -17.26 1.04 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.535 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -57.95 -72.4 0.09 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.829 0.347 . . . . 0.0 110.931 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 29.5 m170 -118.22 -10.88 10.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.889 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 74.2 m -125.27 85.34 58.43 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.584 0.707 . . . . 0.0 110.89 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 146.54 60.67 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.694 2.263 . . . . 0.0 112.362 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . 0.762 HG23 ' O ' ' A' ' 216' ' ' LEU . 56.0 mt -98.43 143.52 12.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.156 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 89.1 m -67.99 101.21 1.08 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.182 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 92.23 -12.18 70.26 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.485 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 68.22 -123.48 17.6 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.461 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . 0.409 ' HA ' ' HB1' ' A' ' 179' ' ' ALA . 13.9 pttp -49.23 -29.46 5.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.766 0.317 . . . . 0.0 110.921 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -75.6 -31.35 59.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.879 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -94.29 41.83 2.54 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.464 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.557 HG12 HG13 ' A' ' 215' ' ' VAL . 87.0 mt -140.35 147.84 22.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.887 0.375 . . . . 0.0 111.117 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 13.4 tp -141.57 127.09 18.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.89 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -105.43 120.71 42.27 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.889 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.443 HG23 ' HA ' ' A' ' 213' ' ' ALA . 20.1 t -78.69 134.19 28.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.088 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . 0.501 ' HA ' HG23 ' A' ' 210' ' ' THR . 0.8 OUTLIER -138.55 136.61 36.24 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.09 -179.974 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . 0.646 ' N ' HG23 ' A' ' 210' ' ' THR . 33.4 m-85 -46.8 158.71 0.4 Allowed Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.618 0.723 . . . . 0.0 110.955 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 3.49 2.75 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.669 2.246 . . . . 0.0 112.354 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -112.9 -19.13 12.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.817 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 120.43 -3.74 12.31 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.492 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.0 140.45 62.2 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.574 0.702 . . . . 0.0 110.895 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' PRO . . . . . 0.554 ' HG3' ' CD1' ' A' ' 175' ' ' PHE . 54.4 Cg_endo -69.72 102.67 1.05 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.672 2.248 . . . . 0.0 112.37 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . 0.646 HG23 ' N ' ' A' ' 204' ' ' TYR . 37.6 p -61.39 -13.29 18.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.173 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 82.63 -39.62 2.7 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.525 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -71.05 161.6 30.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.834 0.349 . . . . 0.0 110.848 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . 0.523 ' HB3' ' CD1' ' A' ' 173' ' ' LEU . . . -160.41 -177.6 6.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.115 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -148.06 137.49 22.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.852 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' VAL . . . . . 0.557 HG13 HG12 ' A' ' 199' ' ' ILE . 3.3 t -124.09 165.68 20.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.084 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 0.762 ' O ' HG23 ' A' ' 192' ' ' ILE . 47.7 mt -116.96 145.62 43.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.935 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -134.31 151.5 51.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.84 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -60.0 -59.22 5.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.135 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' CYS . . . . . . . . . . . . . 1.8 t -144.48 177.71 8.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.854 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . 0.487 ' HA ' ' HB3' ' A' ' 223' ' ' ALA . 13.7 mp0 -58.71 -35.36 72.53 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.865 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -43.55 -38.5 2.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.924 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 222' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -92.98 -34.69 13.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.933 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . 0.487 ' HB3' ' HA ' ' A' ' 220' ' ' GLU . . . -61.6 -59.67 4.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.135 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' GLN . . . . . 0.455 ' HA ' HD12 ' A' ' 227' ' ' LEU . 3.1 pt20 -60.41 -37.17 79.99 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.957 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 14.4 m-20 -68.03 -24.03 65.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.874 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -79.89 -32.52 40.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.087 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . 0.455 HD12 ' HA ' ' A' ' 224' ' ' GLN . 20.2 mt -56.18 -31.52 63.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.947 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 9.1 mtp-105 -59.8 -18.37 43.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.866 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . 0.595 ' HE3' ' CE1' ' A' ' 185' ' ' PHE . 24.8 mtpp -82.06 -1.16 47.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.873 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 230' ' ' HIS . . . . . 0.61 ' N ' HD12 ' A' ' 241' ' ' LEU . 75.6 t60 -34.3 136.98 0.12 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.897 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.448 ' HG2' ' CD2' ' A' ' 230' ' ' HIS . 24.1 mmtt 59.35 36.29 23.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.908 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -62.97 -176.99 0.14 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.902 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.661 HD21 ' CE1' ' A' ' 238' ' ' TYR . 30.8 mt -137.83 117.31 12.89 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.896 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 234' ' ' LEU . . . . . 0.715 HD12 ' HD2' ' A' ' 185' ' ' PHE . 6.6 tt -126.77 112.25 15.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.935 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 59.51 36.2 88.44 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.498 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 30.3 mttp 71.69 52.62 0.22 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.783 0.325 . . . . 0.0 110.861 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 237' ' ' ARG . . . . . 0.413 ' CB ' ' HG3' ' A' ' 174' ' ' PRO . 59.5 mmt-85 -156.39 115.35 3.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.876 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 238' ' ' TYR . . . . . 0.661 ' CE1' HD21 ' A' ' 233' ' ' LEU . 96.8 m-85 -68.68 136.66 53.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.908 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 79.5 mt -132.87 131.34 59.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.111 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 240' ' ' GLU . . . . . 0.468 ' HB3' ' CZ ' ' A' ' 242' ' ' PHE . 43.4 mt-10 -92.43 161.78 14.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.874 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . 0.61 HD12 ' N ' ' A' ' 230' ' ' HIS . 20.2 mt -136.87 140.15 42.17 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.892 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 242' ' ' PHE . . . . . 0.499 ' CD1' ' O ' ' A' ' 241' ' ' LEU . 22.6 m-85 -153.14 128.22 9.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.82 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 20.3 mtp180 -44.04 153.48 0.14 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.884 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 1.1 t -152.55 160.13 43.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.901 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 41.6 p -138.41 157.67 45.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.088 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 246' ' ' ALA . . . . . 0.583 ' N ' HD12 ' A' ' 167' ' ' ILE . . . -37.45 -59.06 0.8 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.114 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -53.27 -56.59 15.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.151 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . 0.741 ' O ' HG23 ' A' ' 252' ' ' VAL . 11.7 tp10 -44.59 -51.95 8.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.878 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 0.418 ' O ' ' N ' ' A' ' 252' ' ' VAL . 98.4 t -47.02 -66.79 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.139 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 250' ' ' GLN . . . . . 0.586 ' HA ' HD12 ' A' ' 253' ' ' LEU . 50.7 mt-30 -43.25 -50.06 6.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.929 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 51.1 mm-40 -59.67 -30.18 68.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.918 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 252' ' ' VAL . . . . . 0.741 HG23 ' O ' ' A' ' 248' ' ' GLU . 92.7 t -75.92 -36.98 33.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.1 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 253' ' ' LEU . . . . . 0.586 HD12 ' HA ' ' A' ' 250' ' ' GLN . 8.5 mt -68.47 -37.73 80.41 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.893 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -66.28 -59.53 3.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.868 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . 0.476 ' HG3' ' N ' ' A' ' 256' ' ' PHE . 0.4 OUTLIER -41.21 -38.08 1.05 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.898 -179.94 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 256' ' ' PHE . . . . . 0.476 ' N ' ' HG3' ' A' ' 255' ' ' ARG . 10.2 m-85 -81.71 -53.1 6.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.868 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 34.7 t . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.83 -179.809 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 . . . . . 0 C--O 1.23 0.066 0 CA-C-O 120.932 0.396 . . . . 0.0 110.894 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.416 HG22 HD21 ' A' ' 200' ' ' LEU . 57.5 t -54.73 -43.29 65.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.168 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -43.49 -50.96 6.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.11 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 46.4 mm-40 -65.21 -37.25 86.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.939 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' PHE . . . . . 0.567 ' CE1' ' HG ' ' A' ' 216' ' ' LEU . 64.0 t80 -60.14 -41.32 92.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.886 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 86.3 mt -90.98 -16.59 27.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.893 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 46.5 t -62.62 -35.79 80.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.841 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . 0.489 ' HD2' HD13 ' A' ' 216' ' ' LEU . 12.5 mttp -58.99 120.13 8.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.895 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 37.6 mp0 -94.61 155.83 16.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.852 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 11.1 m-80 63.45 48.89 3.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.866 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 4.9 mm100 -131.87 162.21 31.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.878 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.725 HG11 ' CB ' ' A' ' 223' ' ' ALA . 89.5 t -116.73 111.13 33.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.138 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' ILE . . . . . 0.71 HG21 HG21 ' A' ' 249' ' ' VAL . 30.5 mt -85.33 142.09 13.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.082 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 40.8 t -127.51 142.52 43.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.155 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 30.0 ttp180 -91.75 115.18 27.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.863 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' MET . . . . . 0.897 ' CE ' HD21 ' A' ' 173' ' ' LEU . 66.9 mtp -102.63 125.39 49.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.919 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . 0.432 ' HB2' ' NH1' ' A' ' 171' ' ' ARG . 3.3 ttm105 -131.4 139.73 49.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.84 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 90.23 23.09 32.97 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.494 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.897 HD21 ' CE ' ' A' ' 170' ' ' MET . 26.3 mt -74.9 128.03 85.88 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.589 0.709 . . . . 0.0 110.924 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . 0.484 ' HG3' ' CB ' ' A' ' 237' ' ' ARG . 64.7 Cg_exo -48.01 130.83 20.56 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.719 2.279 . . . . 0.0 112.36 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -47.93 -22.71 0.62 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.877 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 41.4 p -91.57 -29.39 16.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.118 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -48.77 137.95 11.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.043 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -139.38 171.82 13.71 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.114 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.477 ' N ' ' CZ ' ' A' ' 201' ' ' PHE . . . -47.04 -47.38 22.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.106 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -57.02 -26.66 60.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.882 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . 0.817 ' HG2' HD11 ' A' ' 234' ' ' LEU . 6.7 tt0 -79.71 -35.58 38.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.898 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.405 HG12 HD11 ' A' ' 192' ' ' ILE . 48.1 t -74.01 -42.45 52.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.117 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 45.6 t -42.24 -45.81 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.153 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -81.66 -32.49 31.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.102 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.5 ' HD2' HD12 ' A' ' 234' ' ' LEU . 41.2 t80 -49.27 -59.44 3.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.863 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -90.51 -24.32 20.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.829 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -48.97 -22.14 2.83 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.516 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 33.1 tp60 -53.08 -70.85 0.08 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.864 0.364 . . . . 0.0 110.884 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 8.9 m80 -118.3 -15.33 9.75 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.862 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 74.7 m -119.88 88.24 39.78 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.592 0.71 . . . . 0.0 110.839 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' PRO . . . . . 0.501 ' HD2' ' CD1' ' A' ' 222' ' ' TYR . 53.7 Cg_endo -69.8 131.62 21.57 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.679 2.253 . . . . 0.0 112.289 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . 0.748 HG23 ' O ' ' A' ' 216' ' ' LEU . 55.7 mt -83.25 142.12 13.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.155 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 87.8 m -65.32 102.66 0.7 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.152 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 88.34 -17.43 48.07 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.476 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.424 ' O ' ' N ' ' A' ' 198' ' ' GLY . . . 78.35 -128.2 8.59 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.476 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 17.2 ptmt -44.94 -29.48 0.83 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.748 0.309 . . . . 0.0 110.885 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -74.34 -34.67 63.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.884 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . 0.923 ' HA2' HD12 ' A' ' 216' ' ' LEU . . . -86.37 21.24 18.18 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.47 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 76.8 mt -123.56 146.22 29.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.808 0.337 . . . . 0.0 111.133 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.416 HD21 HG22 ' A' ' 156' ' ' VAL . 16.3 tp -142.32 123.18 14.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.869 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' PHE . . . . . 0.477 ' CZ ' ' N ' ' A' ' 179' ' ' ALA . 68.1 m-85 -104.24 112.34 25.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.887 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 25.8 t -66.57 122.55 17.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.124 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -131.83 140.34 49.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.155 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -45.79 158.31 0.35 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.685 0.755 . . . . 0.0 110.898 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 3.02 3.04 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.662 2.241 . . . . 0.0 112.339 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -112.15 -16.33 13.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.864 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 106.14 62.82 0.61 Allowed Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.439 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 7.3 mtt85 -148.26 144.26 18.53 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.602 0.715 . . . . 0.0 110.901 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 108.64 2.12 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.692 2.261 . . . . 0.0 112.318 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 74.1 p -74.02 -29.98 62.21 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.117 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 114.63 -37.04 3.68 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.498 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -78.6 169.37 18.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.836 0.35 . . . . 0.0 110.857 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . 0.441 ' HB3' ' CD1' ' A' ' 173' ' ' LEU . . . -170.99 174.07 4.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.145 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . 0.53 ' CE2' HG13 ' A' ' 249' ' ' VAL . 66.7 m-85 -139.55 136.78 34.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.865 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' VAL . . . . . 0.443 HG12 ' N ' ' A' ' 216' ' ' LEU . 12.6 t -117.61 158.0 18.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.156 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 0.923 HD12 ' HA2' ' A' ' 198' ' ' GLY . 72.2 mt -115.3 139.56 49.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.933 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -132.29 149.47 52.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.86 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . 0.679 ' HB3' ' CD2' ' A' ' 222' ' ' TYR . . . -49.87 -65.67 0.52 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.124 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' CYS . . . . . . . . . . . . . 1.8 t -141.57 179.14 6.99 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.876 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . 0.404 ' C ' ' OE1' ' A' ' 220' ' ' GLU . 0.0 OUTLIER -60.21 -16.4 32.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.875 -179.892 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -63.2 -47.48 82.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.87 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 222' ' ' TYR . . . . . 0.679 ' CD2' ' HB3' ' A' ' 218' ' ' ALA . 62.4 m-85 -78.44 -46.35 20.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.92 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . 0.725 ' CB ' HG11 ' A' ' 166' ' ' VAL . . . -50.22 -50.35 49.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.066 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 23.6 mm-40 -54.28 -53.09 58.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.93 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 55.0 m-20 -57.6 -25.62 60.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.873 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -74.96 -30.76 61.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.151 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 69.5 mt -62.47 -35.37 79.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.908 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 66.1 mtp85 -56.53 -22.06 30.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.842 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . 0.481 ' CE ' ' CE1' ' A' ' 185' ' ' PHE . 21.2 mtpp -75.03 -2.78 28.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.876 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 230' ' ' HIS . . . . . 0.536 ' CD2' ' HG2' ' A' ' 231' ' ' LYS . 84.9 t60 -34.0 135.8 0.14 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.843 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.536 ' HG2' ' CD2' ' A' ' 230' ' ' HIS . 21.9 mmtt 62.59 29.22 16.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.875 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . 0.425 ' OD2' ' CE2' ' A' ' 185' ' ' PHE . 3.2 t70 -56.01 178.35 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.841 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.64 HD21 ' CE1' ' A' ' 238' ' ' TYR . 30.6 mt -137.71 105.02 5.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.927 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 234' ' ' LEU . . . . . 0.817 HD11 ' HG2' ' A' ' 181' ' ' GLU . 5.8 tt -113.59 108.16 16.77 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.876 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 60.84 44.06 98.49 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.49 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 6.8 mmmm 65.85 54.98 0.99 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.765 0.317 . . . . 0.0 110.932 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 237' ' ' ARG . . . . . 0.484 ' CB ' ' HG3' ' A' ' 174' ' ' PRO . 17.5 mmt85 -156.84 115.11 3.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.863 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 238' ' ' TYR . . . . . 0.64 ' CE1' HD21 ' A' ' 233' ' ' LEU . 97.3 m-85 -70.4 120.81 16.61 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.952 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 0.66 HD13 HD23 ' A' ' 173' ' ' LEU . 19.8 mt -116.27 137.8 48.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.154 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -101.1 171.18 7.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.905 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . 0.401 ' O ' ' CD1' ' A' ' 242' ' ' PHE . 28.8 mt -147.2 145.26 29.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.873 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 242' ' ' PHE . . . . . 0.401 ' CD1' ' O ' ' A' ' 241' ' ' LEU . 28.7 m-85 -155.75 129.43 8.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.878 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 42.4 mtm180 -44.62 140.88 2.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.846 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 9.2 t -140.6 148.4 40.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.857 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . 0.405 ' O ' HG23 ' A' ' 249' ' ' VAL . 43.0 p -119.88 161.21 21.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.133 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -48.22 -48.68 34.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.104 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -58.87 -53.79 54.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.065 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . 0.496 ' O ' HG23 ' A' ' 252' ' ' VAL . 8.9 tp10 -49.07 -50.84 34.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.886 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 0.71 HG21 HG21 ' A' ' 167' ' ' ILE . 95.0 t -50.8 -61.92 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.141 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 59.3 mt-30 -44.7 -50.02 10.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.879 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -58.64 -38.63 78.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.932 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 252' ' ' VAL . . . . . 0.496 HG23 ' O ' ' A' ' 248' ' ' GLU . 69.4 t -67.92 -44.31 85.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.115 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 253' ' ' LEU . . . . . 0.559 HD11 HG12 ' A' ' 249' ' ' VAL . 9.6 mt -65.77 -45.45 82.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.93 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 42.2 m-20 -68.7 -27.23 65.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.884 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . 0.469 ' HD3' ' N ' ' A' ' 256' ' ' PHE . 0.6 OUTLIER -72.58 -53.32 12.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.866 -179.965 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 256' ' ' PHE . . . . . 0.469 ' N ' ' HD3' ' A' ' 255' ' ' ARG . 11.1 m-85 -59.44 -44.36 92.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.931 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 91.7 p . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.872 -179.809 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.943 0.401 . . . . 0.0 110.927 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.454 HG12 HD12 ' A' ' 160' ' ' LEU . 99.3 t -75.09 -47.0 38.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.125 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.417 ' C ' ' O ' ' A' ' 156' ' ' VAL . . . -36.83 -58.19 0.77 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.101 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 27.6 mm-40 -58.02 -50.46 73.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.907 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' PHE . . . . . 0.474 ' CE2' ' HG ' ' A' ' 216' ' ' LEU . 47.3 t80 -50.41 -42.82 54.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.863 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.454 HD12 HG12 ' A' ' 156' ' ' VAL . 62.6 mt -85.79 -21.21 28.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.906 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . 0.417 ' N ' ' O ' ' A' ' 157' ' ' ALA . 15.6 t -58.12 -24.53 59.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.846 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . 0.451 ' HG3' HD13 ' A' ' 216' ' ' LEU . 24.2 mmmt -65.52 131.1 45.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.893 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -109.66 154.99 22.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.923 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 63.19 42.72 6.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.892 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 20.5 mm-40 -127.86 156.57 42.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.914 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 47.1 t -108.63 100.76 11.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.158 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' ILE . . . . . 0.546 HG21 HG21 ' A' ' 249' ' ' VAL . 49.3 mt -75.27 140.27 17.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.099 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 39.0 t -127.92 134.21 65.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.117 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . 0.543 ' HG3' ' CE1' ' A' ' 214' ' ' PHE . 18.1 ttm180 -90.1 125.43 35.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.872 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' MET . . . . . 0.658 ' HE2' HD21 ' A' ' 173' ' ' LEU . 59.5 mtp -115.41 111.8 21.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.893 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -114.8 151.66 33.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.884 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 84.23 16.7 66.33 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.502 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.807 HD23 HD13 ' A' ' 239' ' ' ILE . 19.7 mt -71.57 133.99 84.5 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.615 0.721 . . . . 0.0 110.886 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . 0.485 ' O ' ' N ' ' A' ' 177' ' ' ALA . 65.3 Cg_exo -47.99 127.57 15.02 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.675 2.25 . . . . 0.0 112.328 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . 0.436 ' C ' ' O ' ' A' ' 174' ' ' PRO . 11.2 m-85 -34.68 -45.37 0.24 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.865 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . 0.753 ' O ' HG23 ' A' ' 178' ' ' THR . 0.0 OUTLIER -74.56 -39.0 62.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.098 -179.894 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . 0.485 ' N ' ' O ' ' A' ' 174' ' ' PRO . . . -33.78 122.54 0.45 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.071 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . 0.753 HG23 ' O ' ' A' ' 176' ' ' THR . 25.9 p -132.46 173.04 11.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.113 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.496 ' N ' ' CZ ' ' A' ' 201' ' ' PHE . . . -42.22 -47.52 4.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.044 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -51.26 -37.74 48.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.866 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . 0.518 ' OE1' HD21 ' A' ' 234' ' ' LEU . 56.7 mm-40 -70.52 -34.91 72.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.867 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.548 HG12 ' CD1' ' A' ' 192' ' ' ILE . 92.4 t -71.29 -53.59 20.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.16 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.444 ' C ' ' O ' ' A' ' 182' ' ' VAL . 76.4 t -34.05 -47.36 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.143 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -80.96 -41.47 22.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.106 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.793 ' HD2' HD12 ' A' ' 234' ' ' LEU . 4.9 t80 -40.03 -59.03 1.3 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.895 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -95.17 -21.94 18.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.901 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -49.33 -19.09 1.64 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.506 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -56.78 -70.82 0.11 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.817 0.341 . . . . 0.0 110.882 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 29.7 m-70 -118.21 -15.46 9.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.877 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 79.4 m -121.15 87.51 44.16 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.57 0.7 . . . . 0.0 110.852 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 140.75 43.53 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.706 2.27 . . . . 0.0 112.34 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . 0.567 HG23 ' O ' ' A' ' 216' ' ' LEU . 63.1 mt -94.58 140.73 16.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.181 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 57.7 m -62.97 101.8 0.3 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.178 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 89.41 -16.24 56.6 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.483 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.481 ' O ' ' N ' ' A' ' 198' ' ' GLY . . . 67.91 -126.0 23.08 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.462 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 16.8 ptmt -42.31 -27.07 0.13 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.737 0.303 . . . . 0.0 110.906 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -81.74 -36.23 28.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.872 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . 0.481 ' N ' ' O ' ' A' ' 195' ' ' GLY . . . -85.16 34.82 3.19 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.47 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.482 HD13 ' HB ' ' A' ' 182' ' ' VAL . 62.5 mt -135.05 149.26 28.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.901 0.381 . . . . 0.0 111.118 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 13.4 tp -142.51 115.23 8.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.913 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' PHE . . . . . 0.496 ' CZ ' ' N ' ' A' ' 179' ' ' ALA . 46.9 m-85 -96.8 124.42 40.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.862 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 48.0 t -77.21 120.89 28.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.14 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -129.88 137.23 50.3 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.152 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . 0.695 ' CD2' HG22 ' A' ' 210' ' ' THR . 34.9 m-85 -45.39 158.59 0.31 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.689 0.756 . . . . 0.0 110.892 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.81 2.61 3.41 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.63 2.22 . . . . 0.0 112.355 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -111.12 -16.51 13.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.857 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 107.14 53.7 0.69 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.482 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 12.0 mmm180 -138.35 143.7 39.84 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.621 0.724 . . . . 0.0 110.854 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 111.53 2.84 Favored 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.711 2.274 . . . . 0.0 112.357 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . 0.695 HG22 ' CD2' ' A' ' 204' ' ' TYR . 68.3 p -75.26 -27.84 59.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.175 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 108.41 -27.42 13.85 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.493 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -91.38 154.89 18.88 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.766 0.317 . . . . 0.0 110.894 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -155.78 -177.82 6.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.1 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . 0.603 ' CE2' HG13 ' A' ' 249' ' ' VAL . 81.1 m-85 -144.29 151.38 39.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.914 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 4.1 t -133.55 157.5 42.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.161 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 0.567 ' O ' HG23 ' A' ' 192' ' ' ILE . 29.7 mt -109.62 145.95 35.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.957 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -137.11 126.02 24.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.883 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -41.43 -50.34 3.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.115 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' CYS . . . . . . . . . . . . . 72.7 m -152.91 173.15 15.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.84 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -59.56 -35.78 74.91 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.839 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -37.68 -51.45 1.23 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.893 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 222' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -79.46 -42.12 26.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.945 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -48.01 -54.79 11.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.122 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -50.19 -58.79 4.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.883 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 48.8 m-20 -53.32 -22.91 8.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.872 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -88.74 -19.54 25.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.131 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 95.2 mt -72.41 -42.77 64.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.947 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 1.5 ptm180 -55.58 -19.11 9.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.823 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . 0.454 ' O ' ' C ' ' A' ' 230' ' ' HIS . 24.7 mtpp -72.81 -3.4 25.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.89 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 230' ' ' HIS . . . . . 0.454 ' C ' ' O ' ' A' ' 229' ' ' LYS . 83.6 t60 -34.35 138.17 0.1 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.855 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 18.0 mmtp 61.02 29.98 19.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.909 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -57.06 174.97 0.15 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.864 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.683 HD21 ' CE2' ' A' ' 238' ' ' TYR . 31.0 mt -131.07 108.94 10.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.914 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 234' ' ' LEU . . . . . 0.793 HD12 ' HD2' ' A' ' 185' ' ' PHE . 6.6 tt -118.34 114.65 23.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.894 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 56.4 44.0 90.03 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.479 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . 0.433 ' NZ ' ' HA ' ' A' ' 236' ' ' LYS . 0.0 OUTLIER 63.74 52.75 2.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.802 0.334 . . . . 0.0 110.904 -179.997 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 237' ' ' ARG . . . . . 0.422 ' CB ' ' HG3' ' A' ' 174' ' ' PRO . 19.6 mmt180 -156.44 115.19 3.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.855 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 238' ' ' TYR . . . . . 0.683 ' CE2' HD21 ' A' ' 233' ' ' LEU . 92.2 m-85 -70.51 126.13 28.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.963 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 0.807 HD13 HD23 ' A' ' 173' ' ' LEU . 66.2 mt -122.7 136.76 58.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.123 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 240' ' ' GLU . . . . . 0.511 ' HB3' ' CZ ' ' A' ' 242' ' ' PHE . 24.2 mp0 -96.68 158.94 15.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.883 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . 0.443 ' C ' ' CG ' ' A' ' 242' ' ' PHE . 14.5 mt -136.85 147.77 46.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.961 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 242' ' ' PHE . . . . . 0.511 ' CZ ' ' HB3' ' A' ' 240' ' ' GLU . 7.3 m-85 -158.52 139.47 12.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.84 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 22.8 mtm180 -64.3 128.65 36.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.869 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 1.8 t -128.02 167.21 17.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.854 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . 0.449 ' O ' ' C ' ' A' ' 246' ' ' ALA . 34.1 p -131.55 148.21 52.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.099 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 246' ' ' ALA . . . . . 0.522 ' N ' HD12 ' A' ' 167' ' ' ILE . . . -34.1 -52.41 0.45 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.101 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -55.7 -54.3 45.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.09 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 -49.2 -56.01 10.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.868 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 0.603 HG13 ' CE2' ' A' ' 214' ' ' PHE . 59.2 t -44.04 -64.5 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.135 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 250' ' ' GLN . . . . . 0.722 ' HA ' HD12 ' A' ' 253' ' ' LEU . 25.2 mt-30 -39.69 -41.9 1.15 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.898 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 251' ' ' GLN . . . . . 0.474 ' HA ' ' ND2' ' A' ' 254' ' ' ASN . 38.9 mm-40 -68.19 -35.17 77.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.902 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 252' ' ' VAL . . . . . 0.486 ' N ' ' O ' ' A' ' 249' ' ' VAL . 82.6 t -71.22 -19.43 20.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.105 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 253' ' ' LEU . . . . . 0.722 HD12 ' HA ' ' A' ' 250' ' ' GLN . 7.5 mt -86.57 -40.93 14.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.926 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 254' ' ' ASN . . . . . 0.474 ' ND2' ' HA ' ' A' ' 251' ' ' GLN . 0.4 OUTLIER -75.1 -41.83 57.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.902 179.879 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . 0.569 ' CD ' ' CD1' ' A' ' 256' ' ' PHE . 0.0 OUTLIER -60.09 -25.08 65.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.824 -179.955 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 256' ' ' PHE . . . . . 0.569 ' CD1' ' CD ' ' A' ' 255' ' ' ARG . 6.6 m-85 -90.6 -38.11 13.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.83 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 40.6 t . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.849 -179.775 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.931 0.396 . . . . 0.0 110.9 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.427 HG22 HD21 ' A' ' 200' ' ' LEU . 90.9 t -64.36 -42.92 96.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.142 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.408 ' C ' ' O ' ' A' ' 156' ' ' VAL . . . -37.55 -58.69 0.85 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.084 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -60.03 -50.06 75.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.89 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -48.75 -41.72 33.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.862 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.591 HD13 HE21 ' A' ' 250' ' ' GLN . 82.0 mt -85.52 -22.52 28.12 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.931 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 44.3 t -53.76 -33.1 54.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.888 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . 0.519 ' HG3' HD13 ' A' ' 216' ' ' LEU . 42.1 mmtt -60.17 103.92 0.27 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.843 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -86.79 157.53 19.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.893 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 63.49 30.69 15.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.882 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 0.477 ' NE2' ' HA ' ' A' ' 218' ' ' ALA . 8.8 mm100 -121.13 148.21 44.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.881 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 4.6 t -99.17 116.83 43.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.137 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' ILE . . . . . 0.471 HD12 ' N ' ' A' ' 246' ' ' ALA . 73.2 mt -88.55 147.12 5.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.115 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.506 HG21 ' CE1' ' A' ' 217' ' ' PHE . 96.1 t -127.65 126.18 66.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.108 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 70.8 ttt180 -88.14 110.19 20.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.888 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' MET . . . . . 0.694 ' CE ' HD21 ' A' ' 173' ' ' LEU . 97.4 mtp -97.13 113.01 24.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.892 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 2.1 ttt85 -111.1 141.63 44.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.869 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 89.36 21.08 42.48 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.476 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.843 HD23 HD13 ' A' ' 239' ' ' ILE . 23.0 mt -74.79 123.89 89.28 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.588 0.708 . . . . 0.0 110.958 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_exo -47.97 145.01 10.98 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.683 2.255 . . . . 0.0 112.359 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . 0.554 ' CD1' ' HG3' ' A' ' 209' ' ' PRO . 10.4 t80 -57.0 -30.66 64.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.9 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 6.2 p -86.49 -15.88 38.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.137 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -67.53 117.41 9.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.084 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -124.35 175.24 7.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.119 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.455 ' N ' ' CZ ' ' A' ' 201' ' ' PHE . . . -41.11 -50.34 3.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.103 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -49.68 -40.23 39.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.874 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -69.36 -30.74 68.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.872 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.571 HG12 ' CD1' ' A' ' 192' ' ' ILE . 74.5 t -75.81 -55.52 11.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.1 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.45 ' C ' ' O ' ' A' ' 182' ' ' VAL . 54.5 t -33.98 -44.68 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.1 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.442 ' O ' ' C ' ' A' ' 185' ' ' PHE . . . -79.24 -47.46 15.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.124 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.576 ' HD2' HD12 ' A' ' 234' ' ' LEU . 15.8 t80 -35.32 -60.51 0.48 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.888 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' PHE . . . . . 0.404 ' CE1' ' CE1' ' A' ' 185' ' ' PHE . 50.5 m-85 -94.35 -20.54 19.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.88 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -49.1 -17.36 0.94 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.501 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 8.8 mm100 -59.24 -72.35 0.1 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.824 0.345 . . . . 0.0 110.88 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 28.8 m170 -117.81 -16.47 9.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.88 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 86.7 m -117.38 85.64 20.42 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.647 0.736 . . . . 0.0 110.889 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' PRO . . . . . 0.441 ' HD2' ' CD1' ' A' ' 222' ' ' TYR . 53.9 Cg_endo -69.79 135.78 31.24 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.715 2.277 . . . . 0.0 112.314 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . 0.571 ' CD1' HG12 ' A' ' 182' ' ' VAL . 61.9 mt -87.47 141.16 14.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.187 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 41.2 m -66.21 103.09 0.92 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.138 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 91.77 -16.97 58.06 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.476 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.401 ' O ' ' N ' ' A' ' 198' ' ' GLY . . . 72.13 -125.19 10.67 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.482 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 14.4 ptmt -47.36 -30.03 2.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.784 0.326 . . . . 0.0 110.943 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -75.49 -30.51 59.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.877 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 195' ' ' GLY . . . -92.82 41.22 2.75 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.498 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.473 HD13 ' HB ' ' A' ' 182' ' ' VAL . 62.6 mt -142.68 144.48 24.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.828 0.347 . . . . 0.0 111.16 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.427 HD21 HG22 ' A' ' 156' ' ' VAL . 15.6 tp -139.64 121.66 15.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.9 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' PHE . . . . . 0.455 ' CZ ' ' N ' ' A' ' 179' ' ' ALA . 65.0 m-85 -101.7 112.21 24.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.883 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 39.0 t -70.4 138.15 22.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.129 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . 0.65 ' HA ' HG23 ' A' ' 210' ' ' THR . 0.8 OUTLIER -143.66 138.1 28.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.146 -179.926 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . 0.572 ' CD1' HG22 ' A' ' 210' ' ' THR . 32.4 m-85 -48.08 159.29 0.5 Allowed Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.699 0.762 . . . . 0.0 110.917 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.81 3.97 2.49 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.644 2.229 . . . . 0.0 112.296 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . 0.435 ' HB3' ' NH1' ' A' ' 208' ' ' ARG . 62.0 m-20 -112.46 -23.71 10.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.895 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 123.65 4.19 8.2 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.508 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' ARG . . . . . 0.435 ' NH1' ' HB3' ' A' ' 206' ' ' ASP . 0.0 OUTLIER -84.75 141.3 38.32 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.576 0.703 . . . . 0.0 110.917 -179.854 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' PRO . . . . . 0.554 ' HG3' ' CD1' ' A' ' 175' ' ' PHE . 53.6 Cg_endo -69.72 110.33 2.52 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.693 2.262 . . . . 0.0 112.367 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . 0.65 HG23 ' HA ' ' A' ' 203' ' ' THR . 34.1 p -71.31 -10.85 60.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.175 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 79.89 -40.18 2.27 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.445 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -70.35 154.26 42.1 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.878 0.37 . . . . 0.0 110.874 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . 0.461 ' HB3' ' CD1' ' A' ' 173' ' ' LEU . . . -152.06 179.55 8.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.118 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . 0.611 ' CE2' HG13 ' A' ' 249' ' ' VAL . 73.9 m-85 -146.79 130.6 17.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.89 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' VAL . . . . . 0.515 HG12 ' N ' ' A' ' 216' ' ' LEU . 19.7 t -118.18 161.03 17.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.15 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 0.528 ' O ' HG23 ' A' ' 192' ' ' ILE . 26.9 mt -110.17 139.26 45.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.939 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . 0.506 ' CE1' HG21 ' A' ' 168' ' ' VAL . 81.2 m-85 -133.15 130.55 39.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.87 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . 0.477 ' HA ' ' NE2' ' A' ' 165' ' ' GLN . . . -44.78 -57.4 3.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.106 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' CYS . . . . . . . . . . . . . 85.6 m -151.92 161.1 43.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.837 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -45.06 -30.3 1.04 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.877 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -43.45 -41.91 4.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.846 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 222' ' ' TYR . . . . . 0.441 ' CD1' ' HD2' ' A' ' 191' ' ' PRO . 61.1 m-85 -90.25 -47.73 7.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.91 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . 0.416 ' O ' ' HB3' ' A' ' 226' ' ' ALA . . . -49.66 -60.87 2.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.064 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 224' ' ' GLN . . . . . 0.666 ' HA ' HD12 ' A' ' 227' ' ' LEU . 64.4 mm-40 -45.44 -57.71 3.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.889 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 55.3 m-20 -55.95 -26.65 48.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.868 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . 0.416 ' HB3' ' O ' ' A' ' 223' ' ' ALA . . . -77.46 -39.53 46.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.065 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . 0.666 HD12 ' HA ' ' A' ' 224' ' ' GLN . 29.5 mt -52.88 -31.27 38.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.951 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 75.0 mtt180 -58.91 -26.71 64.57 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.891 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . 0.458 ' O ' ' C ' ' A' ' 230' ' ' HIS . 26.8 mtpp -71.72 -2.58 17.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.897 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 230' ' ' HIS . . . . . 0.538 ' CG ' ' HG2' ' A' ' 231' ' ' LYS . 19.6 t60 -33.96 139.38 0.07 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.894 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.538 ' HG2' ' CG ' ' A' ' 230' ' ' HIS . 0.1 OUTLIER 60.16 35.51 21.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.869 179.966 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -65.8 175.48 1.92 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.865 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.564 HD21 ' CE1' ' A' ' 238' ' ' TYR . 30.4 mt -131.35 101.19 5.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.87 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 234' ' ' LEU . . . . . 0.689 HD23 ' C ' ' A' ' 234' ' ' LEU . 5.7 tt -112.1 111.45 22.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.923 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 63.5 37.91 95.51 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.492 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 33.0 mmtm 67.35 54.22 0.72 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.766 0.317 . . . . 0.0 110.88 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 20.4 mmt180 -156.44 116.08 3.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.838 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 238' ' ' TYR . . . . . 0.564 ' CE1' HD21 ' A' ' 233' ' ' LEU . 96.7 m-85 -69.83 116.22 9.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.896 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 0.843 HD13 HD23 ' A' ' 173' ' ' LEU . 41.1 mt -115.9 140.6 36.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.134 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 240' ' ' GLU . . . . . 0.575 ' HB3' ' CZ ' ' A' ' 242' ' ' PHE . 16.7 mt-10 -93.26 -178.51 4.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.888 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . 0.559 ' O ' ' CD1' ' A' ' 242' ' ' PHE . 61.6 mt -158.01 132.82 8.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.909 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 242' ' ' PHE . . . . . 0.575 ' CZ ' ' HB3' ' A' ' 240' ' ' GLU . 4.6 m-85 -152.88 120.44 5.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.856 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 18.0 ptt180 -60.95 126.98 29.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.906 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 5.4 t -119.71 176.68 5.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.868 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . 0.401 ' O ' ' C ' ' A' ' 246' ' ' ALA . 82.2 p -127.64 151.02 49.46 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.135 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 246' ' ' ALA . . . . . 0.471 ' N ' HD12 ' A' ' 167' ' ' ILE . . . -37.92 -57.2 1.05 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.09 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -53.21 -51.76 61.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.121 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -50.45 -54.81 19.22 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.886 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 0.611 HG13 ' CE2' ' A' ' 214' ' ' PHE . 78.4 t -43.82 -61.39 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.152 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 250' ' ' GLN . . . . . 0.766 ' HA ' HD12 ' A' ' 253' ' ' LEU . 34.6 mt-30 -44.05 -42.73 6.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.969 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 251' ' ' GLN . . . . . 0.407 ' HA ' ' ND2' ' A' ' 254' ' ' ASN . 60.6 mm-40 -65.58 -30.14 70.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.905 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 252' ' ' VAL . . . . . 0.417 ' N ' ' O ' ' A' ' 249' ' ' VAL . 85.9 t -78.93 -20.12 12.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.145 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 253' ' ' LEU . . . . . 0.766 HD12 ' HA ' ' A' ' 250' ' ' GLN . 10.6 mt -84.38 -41.63 16.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.93 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 254' ' ' ASN . . . . . 0.49 ' C ' ' OD1' ' A' ' 254' ' ' ASN . 0.6 OUTLIER -67.93 -40.86 83.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.89 179.876 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . 0.473 ' N ' ' OD1' ' A' ' 254' ' ' ASN . 8.0 ptm180 -55.35 -42.71 74.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.816 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 256' ' ' PHE . . . . . 0.405 ' N ' ' CG ' ' A' ' 255' ' ' ARG . 12.8 m-85 -78.9 -51.02 10.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.862 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 41.7 m . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.84 -179.757 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.909 0.385 . . . . 0.0 110.868 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 34.0 t -65.53 -40.19 87.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.119 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -41.45 -60.86 1.17 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.13 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 15.2 mp0 -56.23 -44.44 79.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.873 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -52.34 -41.34 62.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.852 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 75.4 mt -89.29 -19.71 24.99 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.89 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 45.9 t -59.75 -20.94 59.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.833 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . 0.465 ' HG3' HD13 ' A' ' 216' ' ' LEU . 38.8 mmtt -74.95 102.59 4.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.918 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -82.24 158.82 23.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.903 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 66.8 m-20 60.63 47.04 8.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.937 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 0.602 ' OE1' HG21 ' A' ' 193' ' ' THR . 10.6 mm-40 -132.2 164.87 25.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.937 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 39.5 t -118.47 115.82 49.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.139 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' ILE . . . . . 0.473 HD12 ' N ' ' A' ' 246' ' ' ALA . 9.5 mt -88.48 141.54 14.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.125 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 59.2 t -119.08 140.49 42.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.151 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . 0.465 ' N ' ' HB2' ' A' ' 244' ' ' SER . 27.1 ttp180 -95.78 101.68 13.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.869 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' MET . . . . . 0.594 ' HE2' HD21 ' A' ' 173' ' ' LEU . 88.1 mtp -92.58 137.56 32.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.871 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -137.98 129.96 28.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.874 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 98.31 21.97 16.03 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.493 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.866 HD23 HD13 ' A' ' 239' ' ' ILE . 22.1 mt -76.04 120.97 84.04 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.657 0.741 . . . . 0.0 110.946 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . 0.482 ' O ' ' HB3' ' A' ' 177' ' ' ALA . 65.6 Cg_exo -48.02 139.36 20.51 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.659 2.239 . . . . 0.0 112.336 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . 0.559 ' CD1' ' HG3' ' A' ' 209' ' ' PRO . 9.8 t80 -47.56 -42.53 23.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.859 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 7.3 p -72.21 -20.61 61.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.157 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . 0.482 ' HB3' ' O ' ' A' ' 174' ' ' PRO . . . -60.99 105.99 0.54 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.113 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . 0.415 ' O ' ' C ' ' A' ' 179' ' ' ALA . 73.7 p -116.74 173.59 6.55 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.158 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.415 ' C ' ' O ' ' A' ' 178' ' ' THR . . . -36.8 -46.46 0.61 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.089 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -55.47 -49.2 73.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.92 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -57.75 -34.24 69.33 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.887 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.54 HG12 HD11 ' A' ' 192' ' ' ILE . 89.0 t -74.78 -53.95 15.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.11 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.428 ' C ' ' O ' ' A' ' 182' ' ' VAL . 50.4 t -35.22 -52.06 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.131 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -73.66 -36.96 65.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.112 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.655 ' HD2' HD12 ' A' ' 234' ' ' LEU . 21.0 t80 -47.28 -58.03 4.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.88 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' PHE . . . . . 0.444 ' CE1' ' CE1' ' A' ' 185' ' ' PHE . 86.5 m-85 -96.28 -21.36 17.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.926 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -49.05 -24.16 4.34 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.443 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 3.5 tp-100 -49.61 -75.11 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.808 0.337 . . . . 0.0 110.891 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 -118.33 -7.63 10.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.869 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 78.0 m -126.09 84.34 61.66 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.587 0.708 . . . . 0.0 110.918 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' PRO . . . . . 0.494 ' HD2' ' CD1' ' A' ' 222' ' ' TYR . 54.0 Cg_endo -69.79 139.28 39.76 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.655 2.237 . . . . 0.0 112.377 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . 0.637 HG23 ' O ' ' A' ' 216' ' ' LEU . 57.8 mt -88.76 144.67 8.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.152 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . 0.602 HG21 ' OE1' ' A' ' 165' ' ' GLN . 17.9 m -70.18 104.7 2.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.173 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 91.72 -15.48 61.52 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.462 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 68.82 -120.22 10.69 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.46 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 43.9 mtmt -48.5 -33.77 10.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.783 0.325 . . . . 0.0 110.901 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -75.07 -27.59 60.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.874 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . 0.448 ' HA2' HD12 ' A' ' 216' ' ' LEU . . . -94.05 40.4 2.76 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.505 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 55.8 mt -143.0 146.28 21.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.847 0.356 . . . . 0.0 111.14 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 14.5 tp -146.6 122.34 10.55 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.951 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -102.09 121.41 42.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.882 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 60.6 t -72.78 140.17 18.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.149 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -142.9 138.83 30.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.159 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . 0.474 ' N ' HG23 ' A' ' 210' ' ' THR . 30.3 m-85 -50.79 159.08 0.99 Allowed Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.614 0.721 . . . . 0.0 110.966 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 3.73 2.62 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.711 2.274 . . . . 0.0 112.334 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -111.92 -18.52 12.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.907 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 110.4 44.18 1.01 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.499 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -126.78 143.72 47.55 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.571 0.701 . . . . 0.0 110.868 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' PRO . . . . . 0.559 ' HG3' ' CD1' ' A' ' 175' ' ' PHE . 53.4 Cg_endo -69.76 95.68 0.56 Allowed 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.686 2.258 . . . . 0.0 112.328 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . 0.633 HG21 ' CD2' ' A' ' 256' ' ' PHE . 33.5 p -60.27 -10.29 4.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.154 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 88.01 -45.73 3.34 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.485 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -66.85 161.67 23.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.768 0.318 . . . . 0.0 110.904 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . 0.561 ' HB3' ' CD1' ' A' ' 173' ' ' LEU . . . -161.27 -175.26 4.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.075 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . 0.451 ' CE2' HG13 ' A' ' 249' ' ' VAL . 56.5 m-85 -146.22 151.73 38.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.857 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' VAL . . . . . 0.427 HG12 ' N ' ' A' ' 216' ' ' LEU . 4.5 t -138.71 159.91 30.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.162 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 0.637 ' O ' HG23 ' A' ' 192' ' ' ILE . 43.0 mt -109.68 145.8 35.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.905 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -140.29 143.0 35.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.899 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . 0.418 ' HB3' ' CD2' ' A' ' 222' ' ' TYR . . . -53.85 -66.7 0.35 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.112 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' CYS . . . . . . . . . . . . . 30.1 m -138.31 -175.09 3.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.915 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -62.89 -37.36 86.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.873 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 18.8 tp10 -43.27 -41.2 3.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.9 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 222' ' ' TYR . . . . . 0.494 ' CD1' ' HD2' ' A' ' 191' ' ' PRO . 55.9 m-85 -86.05 -47.58 9.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.934 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -56.31 -63.75 1.09 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.107 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 224' ' ' GLN . . . . . 0.737 ' HA ' HD12 ' A' ' 227' ' ' LEU . 20.4 mt-30 -46.65 -52.6 13.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.905 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 22.3 m-20 -55.38 -26.34 40.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.872 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -80.78 -34.55 34.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.121 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . 0.737 HD12 ' HA ' ' A' ' 224' ' ' GLN . 38.3 mt -54.54 -30.11 52.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.943 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 36.8 mtp180 -63.87 -20.74 66.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.845 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . 0.459 ' O ' ' C ' ' A' ' 230' ' ' HIS . 19.8 mtpp -75.75 -1.92 27.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.926 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 230' ' ' HIS . . . . . 0.519 ' CE1' ' HG2' ' A' ' 231' ' ' LYS . 57.1 t60 -33.9 136.9 0.11 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.874 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.519 ' HG2' ' CE1' ' A' ' 230' ' ' HIS . 0.0 OUTLIER 61.76 30.54 18.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.852 179.96 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . 0.452 ' OD2' ' CE2' ' A' ' 185' ' ' PHE . 8.4 t70 -57.84 173.64 0.3 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.877 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.64 HD21 ' CE1' ' A' ' 238' ' ' TYR . 30.7 mt -132.58 104.33 6.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.899 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 234' ' ' LEU . . . . . 0.679 HD23 ' C ' ' A' ' 234' ' ' LEU . 5.8 tt -115.24 114.42 25.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.935 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 60.7 39.56 96.81 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.438 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 31.0 mtmm 65.3 53.0 1.35 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.789 0.328 . . . . 0.0 110.876 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 237' ' ' ARG . . . . . 0.482 ' CB ' ' HG3' ' A' ' 174' ' ' PRO . 12.4 mmt85 -156.09 116.09 3.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.877 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 238' ' ' TYR . . . . . 0.64 ' CE1' HD21 ' A' ' 233' ' ' LEU . 97.2 m-85 -68.6 135.61 51.74 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.918 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 0.866 HD13 HD23 ' A' ' 173' ' ' LEU . 60.2 mt -133.51 134.36 56.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.168 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 240' ' ' GLU . . . . . 0.54 ' O ' HD23 ' A' ' 241' ' ' LEU . 46.8 mt-10 -90.27 175.87 6.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.884 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . 0.54 HD23 ' O ' ' A' ' 240' ' ' GLU . 63.6 mt -156.67 138.19 14.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.912 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 242' ' ' PHE . . . . . 0.497 ' CD1' ' O ' ' A' ' 241' ' ' LEU . 20.9 m-85 -155.19 127.85 7.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.852 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 46.5 mtm180 -39.98 136.97 1.03 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.909 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . 0.465 ' HB2' ' N ' ' A' ' 169' ' ' ARG . 3.6 t -132.57 154.67 49.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.844 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 26.4 p -132.09 156.77 45.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.173 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 246' ' ' ALA . . . . . 0.473 ' N ' HD12 ' A' ' 167' ' ' ILE . . . -42.17 -57.15 2.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.128 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -53.76 -41.13 66.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.115 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . 0.474 ' O ' HG23 ' A' ' 252' ' ' VAL . 2.6 tp10 -61.15 -49.99 75.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.886 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 0.451 HG13 ' CE2' ' A' ' 214' ' ' PHE . 95.4 t -53.24 -64.97 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.105 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 250' ' ' GLN . . . . . 0.773 ' HA ' HD12 ' A' ' 253' ' ' LEU . 28.4 mt-30 -42.57 -34.09 0.81 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.929 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 251' ' ' GLN . . . . . 0.45 ' HA ' ' ND2' ' A' ' 254' ' ' ASN . 64.4 mt-30 -73.58 -47.73 38.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.891 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 252' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 248' ' ' GLU . 75.2 t -57.69 -35.13 49.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.11 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 253' ' ' LEU . . . . . 0.773 HD12 ' HA ' ' A' ' 250' ' ' GLN . 10.9 mt -65.81 -48.83 70.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.872 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 254' ' ' ASN . . . . . 0.485 ' C ' ' OD1' ' A' ' 254' ' ' ASN . 0.6 OUTLIER -67.12 -41.37 86.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.891 179.95 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . 0.47 ' N ' ' OD1' ' A' ' 254' ' ' ASN . 13.7 ttm180 -54.78 -41.39 70.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.868 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 256' ' ' PHE . . . . . 0.633 ' CD2' HG21 ' A' ' 210' ' ' THR . 12.8 m-85 -80.49 -47.12 14.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.851 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 51.1 m . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.837 -179.775 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.854 0.359 . . . . 0.0 110.879 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 73.5 t -65.07 -41.61 92.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.123 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -43.24 -60.06 1.83 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.101 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 83.2 mm-40 -62.33 -36.67 82.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.922 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' PHE . . . . . 0.427 ' CD1' ' HB2' ' A' ' 200' ' ' LEU . 76.7 t80 -60.62 -38.74 85.74 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.875 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 86.2 mt -94.59 -15.98 23.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.922 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 10.9 t -55.13 -40.37 70.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.865 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . 0.692 ' HD2' HD13 ' A' ' 216' ' ' LEU . 14.5 mttp -52.84 116.0 2.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.891 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 39.4 mp0 -80.9 162.51 23.91 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.856 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 43.74 51.03 6.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.869 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 0.806 ' OE1' HG21 ' A' ' 193' ' ' THR . 0.2 OUTLIER -124.16 156.76 36.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.896 -179.967 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 60.7 t -110.47 133.24 56.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.117 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' ILE . . . . . 0.618 HG21 HG21 ' A' ' 249' ' ' VAL . 56.3 mt -109.53 131.11 61.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.094 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 44.5 t -114.3 133.41 60.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.102 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . 0.413 ' N ' ' HB2' ' A' ' 244' ' ' SER . 61.6 ttt180 -90.03 110.94 21.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.87 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' MET . . . . . 0.61 ' CE ' HD21 ' A' ' 173' ' ' LEU . 90.0 mtp -98.16 126.58 43.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.912 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 14.2 ttm180 -127.01 142.31 51.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.873 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 83.46 36.34 14.61 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.498 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.683 HD23 HD13 ' A' ' 239' ' ' ILE . 28.0 mt -87.64 130.43 47.11 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.64 0.733 . . . . 0.0 110.894 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . 0.459 ' HG3' ' CB ' ' A' ' 237' ' ' ARG . 66.2 Cg_exo -47.99 122.5 7.35 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.67 2.247 . . . . 0.0 112.309 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -39.57 -29.81 0.06 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.862 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . 0.403 ' O ' ' C ' ' A' ' 177' ' ' ALA . 31.6 p -80.67 -41.79 23.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.18 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . 0.444 ' N ' ' O ' ' A' ' 174' ' ' PRO . . . -36.69 126.64 0.86 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.087 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -123.53 -174.91 3.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.116 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.08 -50.53 73.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.066 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -53.39 -34.66 58.58 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.901 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -65.57 -40.76 93.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.929 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.485 HG12 HD11 ' A' ' 192' ' ' ILE . 76.1 t -68.33 -51.59 46.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.168 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.414 ' C ' ' O ' ' A' ' 182' ' ' VAL . 41.1 t -36.48 -49.11 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.153 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -76.36 -39.6 53.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.079 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.8 ' HD2' HD12 ' A' ' 234' ' ' LEU . 9.0 t80 -42.09 -59.06 1.88 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.909 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' PHE . . . . . 0.453 ' CE1' ' CE1' ' A' ' 185' ' ' PHE . 69.6 m-85 -95.57 -21.95 17.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.867 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -49.24 -22.59 3.51 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.451 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 77.3 mm-40 -52.64 -71.76 0.06 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.838 0.352 . . . . 0.0 110.884 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 33.2 m80 -118.08 -17.2 9.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.829 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 99.7 m -118.27 83.94 21.53 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.608 0.718 . . . . 0.0 110.89 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 130.96 20.2 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.731 2.287 . . . . 0.0 112.311 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . 0.633 HG23 ' O ' ' A' ' 216' ' ' LEU . 48.4 mt -79.46 146.11 8.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.13 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . 0.806 HG21 ' OE1' ' A' ' 165' ' ' GLN . 53.8 m -67.71 109.08 3.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.098 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 85.11 -22.85 8.86 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.491 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.408 ' O ' ' N ' ' A' ' 198' ' ' GLY . . . 79.64 -125.37 6.93 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.472 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 20.7 mtmm -46.0 -23.72 0.34 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.785 0.326 . . . . 0.0 110.896 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -81.67 -35.22 30.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.887 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . 0.817 ' HA2' HD12 ' A' ' 216' ' ' LEU . . . -86.21 26.36 6.3 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.483 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 68.9 mt -125.78 140.13 49.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.854 0.359 . . . . 0.0 111.107 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.427 ' HB2' ' CD1' ' A' ' 159' ' ' PHE . 14.6 tp -136.17 112.26 9.68 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.893 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -92.86 112.94 25.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.898 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.644 HG11 ' OD2' ' A' ' 212' ' ' ASP . 23.5 t -67.38 114.68 4.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.085 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -126.4 137.19 53.41 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.154 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -43.79 158.67 0.25 Allowed Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.686 0.755 . . . . 0.0 110.929 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 2.84 3.15 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.728 2.285 . . . . 0.0 112.338 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -112.66 -16.98 12.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.915 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 108.38 60.43 0.54 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.535 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 59.7 mtt-85 -147.58 145.98 23.19 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.581 0.705 . . . . 0.0 110.877 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 112.47 3.08 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.71 2.273 . . . . 0.0 112.368 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . 0.541 ' HB ' ' CE1' ' A' ' 256' ' ' PHE . 80.4 p -79.65 -10.84 59.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.152 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 95.06 -32.56 6.04 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.488 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' ASP . . . . . 0.644 ' OD2' HG11 ' A' ' 202' ' ' VAL . 1.2 p-10 -84.6 164.72 18.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.781 0.324 . . . . 0.0 110.893 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . 0.521 ' HA ' HG23 ' A' ' 202' ' ' VAL . . . -161.72 -179.06 6.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.066 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . 0.699 ' CE2' HG13 ' A' ' 249' ' ' VAL . 59.6 m-85 -146.79 133.01 19.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.896 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' VAL . . . . . 0.478 HG12 ' N ' ' A' ' 216' ' ' LEU . 14.4 t -118.56 159.75 18.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.105 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 0.817 HD12 ' HA2' ' A' ' 198' ' ' GLY . 51.6 mt -112.18 149.84 31.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.929 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -145.51 139.27 26.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.893 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . 0.566 ' HB3' ' CD1' ' A' ' 222' ' ' TYR . . . -44.79 -57.26 3.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.054 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' CYS . . . . . . . . . . . . . 1.8 t -160.93 -178.38 6.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.925 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 10.6 mp0 -48.3 -34.4 10.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.919 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -54.98 -33.09 62.19 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.903 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 222' ' ' TYR . . . . . 0.566 ' CD1' ' HB3' ' A' ' 218' ' ' ALA . 6.5 m-85 -93.52 -42.88 8.99 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.966 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.29 -62.17 2.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.134 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 224' ' ' GLN . . . . . 0.624 ' HA ' HD12 ' A' ' 227' ' ' LEU . 33.8 mt-30 -45.6 -59.21 2.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.921 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 38.1 m-20 -48.41 -22.15 0.66 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.922 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -92.81 -35.07 13.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.119 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . 0.624 HD12 ' HA ' ' A' ' 224' ' ' GLN . 86.1 mt -54.11 -37.76 64.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.933 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 228' ' ' ARG . . . . . 0.489 ' CZ ' ' HB2' ' A' ' 228' ' ' ARG . 0.2 OUTLIER -58.12 -24.7 59.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.82 179.954 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . 0.533 ' CE ' ' CE1' ' A' ' 185' ' ' PHE . 24.5 mtpp -67.25 -4.08 9.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.889 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 230' ' ' HIS . . . . . 0.528 ' CG ' ' HG2' ' A' ' 231' ' ' LYS . 23.6 t60 -34.33 134.18 0.21 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.878 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.528 ' HG2' ' CG ' ' A' ' 230' ' ' HIS . 0.2 OUTLIER 67.34 27.62 8.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.921 179.999 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -58.19 179.28 0.07 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.845 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.711 HD21 ' CE2' ' A' ' 238' ' ' TYR . 31.3 mt -135.67 110.66 8.84 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.939 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 234' ' ' LEU . . . . . 0.8 HD12 ' HD2' ' A' ' 185' ' ' PHE . 6.8 tt -119.9 115.46 23.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.936 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 57.04 39.39 89.58 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.492 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 23.3 mmtm 67.39 52.18 0.83 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.814 0.34 . . . . 0.0 110.899 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 237' ' ' ARG . . . . . 0.459 ' CB ' ' HG3' ' A' ' 174' ' ' PRO . 23.3 mmt180 -156.17 115.33 3.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.868 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 238' ' ' TYR . . . . . 0.711 ' CE2' HD21 ' A' ' 233' ' ' LEU . 96.0 m-85 -69.26 128.46 36.69 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.915 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 0.683 HD13 HD23 ' A' ' 173' ' ' LEU . 70.7 mt -123.52 138.62 52.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.137 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -99.95 165.76 11.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.887 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . 0.533 ' O ' ' CD1' ' A' ' 242' ' ' PHE . 18.6 mt -141.67 149.44 40.6 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.914 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 242' ' ' PHE . . . . . 0.533 ' CD1' ' O ' ' A' ' 241' ' ' LEU . 26.8 m-85 -155.65 130.26 9.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.914 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 24.9 mtp180 -52.54 122.85 9.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.889 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . 0.413 ' HB2' ' N ' ' A' ' 169' ' ' ARG . 3.5 t -117.84 173.64 6.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.848 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 39.8 p -149.25 161.67 41.56 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.16 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -42.89 -60.24 1.68 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.072 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -53.13 -47.92 68.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.073 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -52.43 -54.74 28.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.817 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 0.699 HG13 ' CE2' ' A' ' 214' ' ' PHE . 94.0 t -51.79 -63.29 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.145 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 250' ' ' GLN . . . . . 0.749 ' HA ' HD12 ' A' ' 253' ' ' LEU . 22.9 mt-30 -46.87 -31.23 2.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.907 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 60.5 mt-30 -77.89 -28.65 49.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.935 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 252' ' ' VAL . . . . . 0.419 ' O ' HG12 ' A' ' 252' ' ' VAL . 55.6 t -82.36 -15.17 12.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.152 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 253' ' ' LEU . . . . . 0.749 HD12 ' HA ' ' A' ' 250' ' ' GLN . 13.1 mt -86.85 -42.68 13.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.883 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 254' ' ' ASN . . . . . 0.497 ' OD1' ' N ' ' A' ' 255' ' ' ARG . 0.7 OUTLIER -61.0 -43.28 99.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.917 179.944 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . 0.497 ' N ' ' OD1' ' A' ' 254' ' ' ASN . 15.5 ptm180 -58.7 -52.43 65.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.872 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 256' ' ' PHE . . . . . 0.541 ' CE1' ' HB ' ' A' ' 210' ' ' THR . 11.1 m-85 -67.66 -37.47 82.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.89 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 44.2 t . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.865 -179.805 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.877 0.37 . . . . 0.0 110.916 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.807 HG22 HD21 ' A' ' 200' ' ' LEU . 48.7 t -51.74 -33.28 15.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.116 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -48.36 -66.96 0.31 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.088 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 12.6 mm-40 -57.23 -28.31 62.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.923 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' PHE . . . . . 0.434 ' CE2' ' HG ' ' A' ' 216' ' ' LEU . 48.0 t80 -68.04 -36.89 80.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.889 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 81.6 mt -92.67 -20.82 20.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.926 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 3.4 t -53.16 -37.18 61.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.844 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . 0.592 ' HG3' HD13 ' A' ' 216' ' ' LEU . 56.9 mmtt -50.97 127.98 20.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.912 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -103.31 137.82 40.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.861 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 4.7 m120 70.55 43.47 0.77 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.859 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 6.2 mp0 -125.75 156.48 39.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.941 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 38.9 t -108.5 136.45 44.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.139 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' ILE . . . . . 0.465 HG21 ' CG2' ' A' ' 249' ' ' VAL . 52.0 mt -109.19 142.24 22.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.14 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 21.4 t -124.7 140.08 48.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.125 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 30.2 ttt-85 -92.09 108.89 20.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.858 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' MET . . . . . 0.646 ' CE ' HD21 ' A' ' 173' ' ' LEU . 80.6 mtp -93.93 129.9 40.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.882 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 17.8 ttm180 -132.9 140.32 47.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.826 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 89.34 24.63 30.74 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.55 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.646 HD21 ' CE ' ' A' ' 170' ' ' MET . 24.0 mt -77.27 123.73 87.03 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.582 0.706 . . . . 0.0 110.917 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_exo -47.94 125.21 11.17 Favored 'Trans proline' 0 N--CA 1.465 -0.169 0 C-N-CA 122.717 2.278 . . . . 0.0 112.343 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -37.5 -33.51 0.07 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.888 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . 0.562 ' O ' HG23 ' A' ' 178' ' ' THR . 75.0 p -78.07 -50.71 11.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.119 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . 0.444 ' C ' ' O ' ' A' ' 176' ' ' THR . . . -33.7 130.31 0.28 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.103 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . 0.562 HG23 ' O ' ' A' ' 176' ' ' THR . 16.9 p -132.06 178.7 6.59 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.119 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.429 ' O ' HG23 ' A' ' 183' ' ' VAL . . . -49.37 -46.14 46.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.1 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -56.51 -28.62 60.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.867 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . 0.84 ' HG2' HD11 ' A' ' 234' ' ' LEU . 4.5 tt0 -76.08 -44.15 40.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.879 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.526 ' HB ' HD13 ' A' ' 199' ' ' ILE . 54.8 t -63.7 -45.37 97.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.127 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 179' ' ' ALA . 54.6 t -37.19 -46.68 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.135 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -81.06 -37.82 28.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.093 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.547 ' CZ ' ' OD2' ' A' ' 232' ' ' ASP . 68.7 t80 -43.05 -57.03 3.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.882 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -94.6 -21.78 18.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.871 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -49.39 -17.81 1.29 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.713 -0.755 . . . . 0.0 112.514 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 15.9 mm-40 -56.13 -74.81 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.792 0.33 . . . . 0.0 110.89 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -118.27 -5.03 10.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.845 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 72.9 m -129.29 85.0 60.59 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.655 0.741 . . . . 0.0 110.921 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 191' ' ' PRO . . . . . 0.429 ' HD2' ' CD1' ' A' ' 222' ' ' TYR . 53.5 Cg_endo -69.74 130.47 19.43 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.711 2.274 . . . . 0.0 112.336 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . 0.546 HG23 ' O ' ' A' ' 216' ' ' LEU . 52.7 mt -80.9 144.56 10.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.17 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 91.1 m -67.59 99.68 0.8 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.144 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 95.36 -11.96 68.39 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.481 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 70.31 -126.07 15.51 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.524 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 4.5 ptmm? -48.37 -26.49 2.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.737 0.303 . . . . 0.0 110.909 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -77.92 -30.7 50.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.911 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . 0.427 ' HA2' HD12 ' A' ' 216' ' ' LEU . . . -89.4 39.5 3.11 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.472 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.526 HD13 ' HB ' ' A' ' 182' ' ' VAL . 72.8 mt -140.76 137.62 35.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.842 0.353 . . . . 0.0 111.146 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.807 HD21 HG22 ' A' ' 156' ' ' VAL . 15.3 tp -132.45 114.13 13.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.931 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 201' ' ' PHE . . . . . 0.4 ' CZ ' ' N ' ' A' ' 179' ' ' ALA . 54.4 m-85 -93.27 121.88 35.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.863 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.427 HG11 ' OD2' ' A' ' 212' ' ' ASP . 95.9 t -73.46 118.52 18.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.119 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -126.89 138.03 53.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.189 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . 0.805 ' CD2' HG22 ' A' ' 210' ' ' THR . 35.8 m-85 -45.92 158.45 0.36 Allowed Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.664 0.745 . . . . 0.0 110.943 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.82 2.9 3.14 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.714 2.276 . . . . 0.0 112.318 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -109.42 -21.89 12.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.859 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 112.24 52.82 0.51 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.488 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 5.2 mpt_? -140.18 145.48 41.93 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.586 0.708 . . . . 0.0 110.874 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 107.44 1.85 Allowed 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.708 2.272 . . . . 0.0 112.347 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . 0.805 HG22 ' CD2' ' A' ' 204' ' ' TYR . 69.5 p -70.82 -29.59 65.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.155 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 115.08 -42.25 1.96 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.496 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 212' ' ' ASP . . . . . 0.427 ' OD2' HG11 ' A' ' 202' ' ' VAL . 1.7 p-10 -74.39 169.38 17.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.822 0.344 . . . . 0.0 110.867 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . 0.503 ' HB3' ' CD1' ' A' ' 173' ' ' LEU . . . -168.95 171.17 8.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.112 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -136.12 143.41 44.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.867 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 4.1 t -124.42 156.95 32.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.092 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 0.592 HD13 ' HG3' ' A' ' 162' ' ' LYS . 28.8 mt -108.22 151.06 26.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.953 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -144.19 135.37 25.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.893 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -49.06 -58.59 4.67 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.102 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 219' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -144.73 170.93 15.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.882 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -55.68 -27.27 49.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.881 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 23.0 tp10 -51.34 -36.27 42.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.907 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 222' ' ' TYR . . . . . 0.429 ' CD1' ' HD2' ' A' ' 191' ' ' PRO . 52.9 m-85 -91.84 -47.49 7.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.911 -179.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -52.57 -57.39 10.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.101 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 224' ' ' GLN . . . . . 0.446 ' HA ' HD12 ' A' ' 227' ' ' LEU . 60.0 mt-30 -50.08 -48.56 53.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.916 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 18.8 m-20 -63.15 -23.96 67.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.887 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -77.12 -22.71 52.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.093 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . 0.446 HD12 ' HA ' ' A' ' 224' ' ' GLN . 17.8 mt -70.51 -32.74 70.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.947 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 65.8 mtp180 -58.93 -12.33 4.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.874 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . 0.453 ' O ' ' C ' ' A' ' 230' ' ' HIS . 28.1 mttp -83.46 -1.73 54.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.926 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 230' ' ' HIS . . . . . 0.453 ' C ' ' O ' ' A' ' 229' ' ' LYS . 10.5 t60 -33.65 137.06 0.1 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.887 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.446 ' HG2' ' CG ' ' A' ' 230' ' ' HIS . 0.3 OUTLIER 59.82 34.49 21.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.929 -180.0 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . 0.547 ' OD2' ' CZ ' ' A' ' 185' ' ' PHE . 11.6 t0 -62.3 176.51 0.6 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.845 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.678 HD21 ' CE1' ' A' ' 238' ' ' TYR . 30.9 mt -134.87 107.22 7.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.903 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 234' ' ' LEU . . . . . 0.84 HD11 ' HG2' ' A' ' 181' ' ' GLU . 6.0 tt -114.35 112.45 23.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.935 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 57.75 40.44 92.83 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.477 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 62.3 mttt 68.93 53.21 0.49 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.774 0.321 . . . . 0.0 110.946 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 19.0 mmt180 -156.16 117.3 3.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.926 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 238' ' ' TYR . . . . . 0.678 ' CE1' HD21 ' A' ' 233' ' ' LEU . 98.8 m-85 -69.96 125.85 27.97 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.887 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 74.0 mt -121.31 137.39 55.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.138 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -97.79 163.61 12.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.868 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 41.2 mt -142.91 138.8 30.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.913 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -148.35 138.88 22.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.87 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 64.6 mtm180 -56.81 132.46 52.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.876 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 5.6 t -130.37 163.21 27.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.877 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 68.0 p -134.8 160.06 39.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.152 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -44.69 -49.72 10.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.102 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -60.36 -44.06 95.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.094 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . 0.494 ' O ' HG23 ' A' ' 252' ' ' VAL . 10.8 tt0 -54.92 -52.27 63.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.917 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 0.465 ' CG2' HG21 ' A' ' 167' ' ' ILE . 97.3 t -46.7 -62.06 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.141 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 250' ' ' GLN . . . . . 0.403 ' HA ' HD12 ' A' ' 253' ' ' LEU . 19.7 mt-30 -48.92 -44.06 40.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.908 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 251' ' ' GLN . . . . . 0.471 ' HA ' ' ND2' ' A' ' 254' ' ' ASN . 23.8 mt-30 -66.59 -20.04 65.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.931 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 252' ' ' VAL . . . . . 0.494 HG23 ' O ' ' A' ' 248' ' ' GLU . 72.8 t -88.91 -24.39 6.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.162 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 253' ' ' LEU . . . . . 0.426 HD11 HG12 ' A' ' 249' ' ' VAL . 10.9 mt -85.2 -39.78 17.43 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.893 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 254' ' ' ASN . . . . . 0.471 ' ND2' ' HA ' ' A' ' 251' ' ' GLN . 0.5 OUTLIER -65.47 -38.62 90.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.909 179.922 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . 0.444 ' NH2' HG13 ' A' ' 252' ' ' VAL . 30.2 ptt180 -63.79 -37.89 89.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.898 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -80.57 -40.29 26.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.874 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 41.4 t . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.837 -179.786 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.892 0.377 . . . . 0.0 110.89 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.401 HG22 HD21 ' A' ' 200' ' ' LEU . 89.9 t -70.56 -42.26 78.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.146 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' ' 156' ' ' VAL . . . -37.57 -59.22 0.8 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.142 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 11.9 mm100 -56.97 -49.9 74.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.897 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' PHE . . . . . 0.51 ' CE2' ' HG ' ' A' ' 216' ' ' LEU . 58.8 t80 -47.8 -42.71 26.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.838 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 79.9 mt -86.32 -17.25 35.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.883 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 5.6 t -65.14 -30.87 71.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.844 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . 0.533 ' HG3' HD13 ' A' ' 216' ' ' LEU . 0.4 OUTLIER -53.14 129.38 30.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.943 179.903 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -102.93 151.78 22.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.866 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 67.1 m-80 61.85 49.73 4.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.879 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 22.2 mm-40 -131.09 168.08 18.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.887 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 45.5 t -125.06 109.22 21.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.133 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' ILE . . . . . 0.564 HG21 ' CG2' ' A' ' 249' ' ' VAL . 96.8 mt -79.37 139.7 17.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.148 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 66.7 t -123.67 130.46 74.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.132 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 52.1 ttp180 -88.26 105.37 17.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.911 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' MET . . . . . 0.521 ' CE ' HD21 ' A' ' 173' ' ' LEU . 98.8 mtp -94.36 129.48 41.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.914 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 40.7 mtt180 -128.99 147.08 50.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.872 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 81.26 35.96 22.2 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.475 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.521 HD21 ' CE ' ' A' ' 170' ' ' MET . 25.9 mt -86.01 125.64 67.86 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.588 0.709 . . . . 0.0 110.915 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_exo -47.99 140.29 18.93 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.691 2.26 . . . . 0.0 112.363 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -53.84 -19.85 4.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.879 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 50.0 p -94.97 -19.43 20.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.14 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -56.87 125.47 22.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.096 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 1.6 p -134.22 171.14 14.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.114 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.431 ' N ' ' CZ ' ' A' ' 201' ' ' PHE . . . -43.24 -55.69 3.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.081 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -48.33 -33.96 9.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.925 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . 0.49 ' HG3' HD11 ' A' ' 234' ' ' LEU . 0.8 OUTLIER -71.59 -44.3 64.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.902 -179.92 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.401 ' O ' ' C ' ' A' ' 183' ' ' VAL . 40.3 t -65.68 -50.19 72.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.102 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.401 ' C ' ' O ' ' A' ' 182' ' ' VAL . 44.7 t -37.52 -42.25 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.109 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -81.54 -39.51 24.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.115 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.543 ' CE2' ' HD3' ' A' ' 229' ' ' LYS . 60.6 t80 -43.86 -58.35 2.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.87 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' PHE . . . . . 0.401 ' CE1' ' CE2' ' A' ' 185' ' ' PHE . 73.6 m-85 -92.81 -23.66 18.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.859 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -50.16 -22.26 4.74 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.495 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 9.6 mm-40 -50.25 -75.9 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.867 0.365 . . . . 0.0 110.913 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . 0.556 ' CE1' ' HB3' ' A' ' 225' ' ' ASN . 0.3 OUTLIER -118.41 -0.29 11.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.899 179.981 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 190' ' ' CYS . . . . . 0.542 ' HG ' ' CD2' ' A' ' 189' ' ' HIS . 94.8 m -128.48 91.9 42.43 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.602 0.715 . . . . 0.0 110.886 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 191' ' ' PRO . . . . . 0.42 ' HD2' ' HA ' ' A' ' 190' ' ' CYS . 53.8 Cg_endo -69.75 135.74 31.26 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.73 2.286 . . . . 0.0 112.346 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . 0.544 HG23 ' O ' ' A' ' 216' ' ' LEU . 62.1 mt -92.6 145.54 7.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.138 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 88.6 m -67.13 104.33 1.41 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.107 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 87.93 -15.32 55.99 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.502 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 73.57 -119.63 6.63 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.504 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.79 -21.32 2.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.748 0.309 . . . . 0.0 110.895 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -87.03 -25.52 24.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.885 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . 0.445 ' HA2' HD12 ' A' ' 216' ' ' LEU . . . -88.65 33.11 4.27 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.462 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 29.0 mt -138.72 153.15 25.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.822 0.344 . . . . 0.0 111.144 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.401 HD21 HG22 ' A' ' 156' ' ' VAL . 14.0 tp -146.96 113.0 5.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.921 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 201' ' ' PHE . . . . . 0.431 ' CZ ' ' N ' ' A' ' 179' ' ' ALA . 35.9 m-85 -93.72 121.51 35.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.895 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.406 ' CB ' ' OD2' ' A' ' 212' ' ' ASP . 42.1 t -74.39 123.46 29.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.161 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . 0.573 ' HA ' HG23 ' A' ' 210' ' ' THR . 0.7 OUTLIER -134.18 137.08 44.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.096 -179.947 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -46.09 158.42 0.37 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.69 0.757 . . . . 0.0 110.915 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.7 3.04 2.97 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.66 2.24 . . . . 0.0 112.387 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -113.03 -10.05 13.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.882 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 99.92 58.85 0.87 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.459 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 11.2 mmm180 -142.3 143.38 27.01 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.614 0.721 . . . . 0.0 110.86 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.66 109.6 2.33 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.721 2.281 . . . . 0.0 112.371 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . 0.576 ' HB ' ' CE2' ' A' ' 256' ' ' PHE . 19.8 p -73.43 -32.01 64.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.156 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 112.97 -30.28 7.51 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.487 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 212' ' ' ASP . . . . . 0.406 ' OD2' ' CB ' ' A' ' 202' ' ' VAL . 1.0 OUTLIER -88.45 163.98 15.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.785 0.326 . . . . 0.0 110.876 -179.975 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -162.76 177.37 9.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.091 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . 0.786 ' CE2' HG13 ' A' ' 249' ' ' VAL . 41.2 m-85 -142.35 139.41 31.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.87 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 6.2 t -123.0 156.89 28.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.15 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 0.544 ' O ' HG23 ' A' ' 192' ' ' ILE . 32.4 mt -109.92 138.8 45.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.922 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -130.12 133.9 46.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.858 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . 0.66 ' HB3' ' CE2' ' A' ' 222' ' ' TYR . . . -44.81 -64.53 0.68 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.136 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 219' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -144.23 160.2 41.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.835 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -40.92 -29.51 0.1 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.893 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -47.57 -49.89 25.37 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.9 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 222' ' ' TYR . . . . . 0.66 ' CE2' ' HB3' ' A' ' 218' ' ' ALA . 30.1 m-85 -78.03 -50.99 11.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.893 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . 0.49 ' O ' ' HB3' ' A' ' 226' ' ' ALA . . . -44.85 -57.08 3.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.158 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 224' ' ' GLN . . . . . 0.542 ' HA ' HD12 ' A' ' 227' ' ' LEU . 8.6 mm-40 -48.52 -60.92 2.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.914 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . 0.556 ' HB3' ' CE1' ' A' ' 189' ' ' HIS . 30.3 m-20 -51.86 -21.51 2.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.915 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . 0.49 ' HB3' ' O ' ' A' ' 223' ' ' ALA . . . -83.24 -33.86 25.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.094 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . 0.542 HD12 ' HA ' ' A' ' 224' ' ' GLN . 32.2 mt -60.67 -28.9 68.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.924 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 228' ' ' ARG . . . . . 0.408 HH11 ' CB ' ' A' ' 228' ' ' ARG . 0.0 OUTLIER -61.11 -18.06 55.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.878 179.946 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . 0.543 ' HD3' ' CE2' ' A' ' 185' ' ' PHE . 16.2 mttm -80.02 0.19 32.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.891 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 230' ' ' HIS . . . . . 0.482 ' N ' HD12 ' A' ' 241' ' ' LEU . 8.6 t60 -32.66 126.93 0.29 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.872 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 43.7 mtmt 61.84 37.1 15.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.938 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -60.72 -174.93 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.852 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.612 HD21 ' CD1' ' A' ' 238' ' ' TYR . 33.0 mt -138.8 105.64 5.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.907 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 234' ' ' LEU . . . . . 0.539 HD23 ' C ' ' A' ' 234' ' ' LEU . 7.1 tt -113.35 114.8 27.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.873 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 59.22 37.67 92.13 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.494 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 33.3 mttt 69.14 52.37 0.49 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.774 0.321 . . . . 0.0 110.898 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 23.3 mmt180 -156.24 115.26 3.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.835 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 238' ' ' TYR . . . . . 0.612 ' CD1' HD21 ' A' ' 233' ' ' LEU . 97.3 m-85 -63.71 128.22 34.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.95 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 0.457 HD13 HD23 ' A' ' 173' ' ' LEU . 97.4 mt -127.04 129.71 71.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.08 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 240' ' ' GLU . . . . . 0.576 ' HB3' ' CE2' ' A' ' 242' ' ' PHE . 3.9 mp0 -85.33 171.92 11.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.85 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . 0.595 ' O ' ' CD1' ' A' ' 242' ' ' PHE . 21.3 mt -154.46 138.75 16.64 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.909 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 242' ' ' PHE . . . . . 0.595 ' CD1' ' O ' ' A' ' 241' ' ' LEU . 6.6 m-85 -158.45 123.43 4.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.878 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . 0.496 ' O ' ' CG ' ' A' ' 243' ' ' ARG . 21.2 ptt180 -60.89 117.33 5.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.85 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 1.7 t -112.49 168.52 9.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.858 -179.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.6 p -109.45 173.83 6.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.168 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 246' ' ' ALA . . . . . 0.549 ' HA ' HD12 ' A' ' 167' ' ' ILE . . . -61.63 -63.74 1.17 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.1 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -43.76 -49.67 7.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.074 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -47.27 -57.64 4.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.863 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 0.786 HG13 ' CE2' ' A' ' 214' ' ' PHE . 97.8 t -44.65 -61.68 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.136 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 250' ' ' GLN . . . . . 0.631 ' HA ' HD12 ' A' ' 253' ' ' LEU . 53.1 mt-30 -47.59 -29.55 2.98 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.916 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -82.4 -26.43 32.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.933 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 252' ' ' VAL . . . . . 0.425 ' O ' HG12 ' A' ' 252' ' ' VAL . 53.3 t -82.63 -15.31 11.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.131 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 253' ' ' LEU . . . . . 0.631 HD12 ' HA ' ' A' ' 250' ' ' GLN . 13.4 mt -86.82 -43.06 12.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.887 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 254' ' ' ASN . . . . . 0.5 ' OD1' ' N ' ' A' ' 255' ' ' ARG . 0.6 OUTLIER -61.67 -44.49 96.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.85 179.943 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . 0.5 ' N ' ' OD1' ' A' ' 254' ' ' ASN . 11.4 ptm180 -54.17 -31.03 51.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.84 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 256' ' ' PHE . . . . . 0.576 ' CE2' ' HB ' ' A' ' 210' ' ' THR . 16.7 m-85 -91.34 -36.84 13.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.87 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 33.4 t . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.895 -179.805 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.885 0.374 . . . . 0.0 110.846 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.558 HG22 HD21 ' A' ' 200' ' ' LEU . 79.0 t -43.34 -39.13 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.154 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -45.46 -48.08 13.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.065 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -69.83 -42.07 74.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.909 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' PHE . . . . . 0.475 ' CD2' ' HB2' ' A' ' 200' ' ' LEU . 41.2 t80 -56.07 -41.77 75.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.899 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 91.0 mt -85.56 -26.05 26.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.903 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 31.6 t -54.62 -26.51 33.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.881 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 18.2 mmmt -61.99 128.77 37.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.873 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -105.99 154.08 21.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.861 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 62.35 49.35 4.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.858 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 24.3 mm-40 -137.21 153.47 50.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.92 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 55.7 t -108.03 119.8 58.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.149 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' ILE . . . . . 0.462 HD12 ' N ' ' A' ' 246' ' ' ALA . 10.8 mt -90.66 147.83 4.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.156 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 95.6 t -128.53 141.43 46.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.127 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 29.0 ttp85 -95.51 107.17 19.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.877 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' MET . . . . . 0.478 ' CE ' HD21 ' A' ' 173' ' ' LEU . 89.7 mtp -92.56 127.11 37.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.932 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . 0.423 ' O ' HG23 ' A' ' 239' ' ' ILE . 3.8 tpt180 -123.83 144.89 49.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.881 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . 0.401 ' N ' ' HG3' ' A' ' 171' ' ' ARG . . . 79.01 33.63 36.02 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.464 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.763 ' CD1' ' HB3' ' A' ' 213' ' ' ALA . 21.8 mt -81.39 119.33 75.38 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.574 0.702 . . . . 0.0 110.896 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . 0.481 ' O ' ' N ' ' A' ' 177' ' ' ALA . 65.2 Cg_exo -47.94 130.0 18.95 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.695 2.263 . . . . 0.0 112.368 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 34.7 m-85 -41.49 -41.07 1.98 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.889 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 65.3 p -75.52 -29.47 59.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.157 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . 0.481 ' N ' ' O ' ' A' ' 174' ' ' PRO . . . -45.74 112.62 0.49 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.085 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -113.4 170.36 8.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.127 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -46.5 -56.53 5.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.112 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -45.43 -30.18 1.3 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.856 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . 0.636 ' HG3' HD11 ' A' ' 234' ' ' LEU . 2.2 tp10 -71.59 -41.61 68.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.885 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.45 HG12 HD11 ' A' ' 192' ' ' ILE . 55.8 t -69.25 -47.41 73.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.107 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.432 ' C ' ' O ' ' A' ' 182' ' ' VAL . 70.8 t -35.26 -54.25 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.08 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -74.78 -39.2 61.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.086 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.476 ' CD1' HD12 ' A' ' 234' ' ' LEU . 59.2 t80 -41.54 -58.27 1.97 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.87 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -94.3 -21.32 19.07 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.871 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -49.15 -25.78 5.81 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.463 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -48.3 -72.77 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.836 0.351 . . . . 0.0 110.91 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 14.2 m170 -118.26 -15.52 9.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.894 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 63.8 m -118.41 85.17 25.13 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.638 0.732 . . . . 0.0 110.94 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 191' ' ' PRO . . . . . 0.462 ' HD2' ' CD1' ' A' ' 222' ' ' TYR . 53.3 Cg_endo -69.75 139.9 41.39 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.686 2.257 . . . . 0.0 112.348 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . 0.65 HG23 ' O ' ' A' ' 216' ' ' LEU . 49.6 mt -91.82 144.69 8.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.135 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 55.0 m -67.3 108.28 2.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.157 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 86.94 -22.18 15.8 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.447 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.409 ' O ' ' N ' ' A' ' 198' ' ' GLY . . . 82.52 -126.56 7.51 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.484 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . 0.423 ' HA ' HD12 ' A' ' 199' ' ' ILE . 8.8 ptpt -46.48 -22.25 0.25 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.767 0.318 . . . . 0.0 110.894 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -82.23 -33.69 29.17 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.912 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . 0.465 ' HA2' HD12 ' A' ' 216' ' ' LEU . . . -84.98 35.4 3.11 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.466 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.423 HD12 ' HA ' ' A' ' 196' ' ' LYS . 27.5 mt -138.8 139.92 39.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.828 0.347 . . . . 0.0 111.148 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.558 HD21 HG22 ' A' ' 156' ' ' VAL . 14.5 tp -137.19 111.83 8.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.939 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -90.43 123.43 34.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.901 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 59.0 t -73.51 118.32 18.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.144 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -127.95 137.14 52.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.124 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -45.99 158.75 0.35 Allowed Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.63 0.729 . . . . 0.0 110.918 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.83 3.58 2.72 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.631 2.221 . . . . 0.0 112.327 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -112.4 -21.28 11.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.861 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 113.53 56.41 0.41 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.525 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 7.6 mpt_? -143.53 146.5 35.84 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.554 0.692 . . . . 0.0 110.904 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 111.17 2.74 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.669 2.246 . . . . 0.0 112.363 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . 0.566 ' HB ' ' CE2' ' A' ' 256' ' ' PHE . 62.0 p -73.09 -14.03 61.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.152 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 97.57 -31.33 7.93 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.523 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -90.38 168.4 11.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.827 0.346 . . . . 0.0 110.832 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . 0.763 ' HB3' ' CD1' ' A' ' 173' ' ' LEU . . . -165.01 174.86 10.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.12 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . 0.498 ' HZ ' HG21 ' A' ' 252' ' ' VAL . 56.4 m-85 -137.71 151.37 48.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.899 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 215' ' ' VAL . . . . . 0.402 ' CG2' ' SD ' ' A' ' 170' ' ' MET . 6.9 t -134.76 155.0 37.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.129 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 0.65 ' O ' HG23 ' A' ' 192' ' ' ILE . 29.5 mt -108.48 144.05 36.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.915 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -136.41 141.33 43.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.9 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -53.9 -57.17 11.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.156 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 219' ' ' CYS . . . . . . . . . . . . . 95.2 m -136.4 -179.22 5.55 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.887 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -70.14 -28.62 65.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.921 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -48.02 -50.01 29.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.904 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 222' ' ' TYR . . . . . 0.462 ' CD1' ' HD2' ' A' ' 191' ' ' PRO . 29.6 m-85 -74.0 -49.73 23.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.921 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -47.64 -56.75 6.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.107 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -55.87 -52.74 63.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.91 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -49.96 -31.73 13.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.917 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -75.41 -35.77 60.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.09 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 89.8 mt -52.43 -39.6 61.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.921 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 34.8 mtt85 -54.99 -26.0 33.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.843 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . 0.458 ' O ' ' C ' ' A' ' 230' ' ' HIS . 6.9 mtpm? -69.86 -2.48 12.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.922 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 230' ' ' HIS . . . . . 0.519 ' CE1' ' HD3' ' A' ' 231' ' ' LYS . 12.0 t60 -33.86 136.67 0.11 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.845 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.519 ' HD3' ' CE1' ' A' ' 230' ' ' HIS . 1.2 mmmp? 62.96 29.43 16.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.909 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . 0.423 ' OD1' ' NZ ' ' A' ' 229' ' ' LYS . 2.7 t70 -58.34 -179.69 0.06 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.88 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.617 HD21 ' CD1' ' A' ' 238' ' ' TYR . 30.2 mt -138.19 107.78 6.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.925 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 234' ' ' LEU . . . . . 0.636 HD11 ' HG3' ' A' ' 181' ' ' GLU . 6.1 tt -117.83 111.2 18.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.915 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 60.12 43.23 98.54 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.47 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 64.66 53.8 1.5 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.723 0.297 . . . . 0.0 110.915 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 237' ' ' ARG . . . . . 0.438 ' CB ' ' HG3' ' A' ' 174' ' ' PRO . 14.2 mmt85 -156.65 115.48 3.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.877 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 238' ' ' TYR . . . . . 0.617 ' CD1' HD21 ' A' ' 233' ' ' LEU . 97.2 m-85 -69.69 123.68 22.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.975 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 0.489 HD13 HD23 ' A' ' 173' ' ' LEU . 37.9 mt -119.74 145.9 25.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.132 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 240' ' ' GLU . . . . . 0.464 ' HB3' ' CZ ' ' A' ' 242' ' ' PHE . 38.9 mt-10 -111.35 159.51 17.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.829 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 17.0 mt -136.58 123.87 21.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.98 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 242' ' ' PHE . . . . . 0.464 ' CZ ' ' HB3' ' A' ' 240' ' ' GLU . 4.1 m-85 -131.05 129.57 42.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.855 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 70.2 mtt180 -42.61 150.8 0.14 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.943 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 1.3 t -152.18 156.06 39.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.869 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 50.6 p -131.11 165.92 22.22 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.109 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 246' ' ' ALA . . . . . 0.462 ' N ' HD12 ' A' ' 167' ' ' ILE . . . -48.41 -52.74 20.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.121 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -58.6 -47.92 82.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.098 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -51.64 -55.54 18.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.849 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 0.437 ' CG2' HG21 ' A' ' 167' ' ' ILE . 91.2 t -42.45 -65.21 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.161 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 250' ' ' GLN . . . . . 0.62 ' HA ' HD12 ' A' ' 253' ' ' LEU . 30.4 mt-30 -38.08 -57.84 1.02 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.93 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -52.33 -44.25 65.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.927 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 252' ' ' VAL . . . . . 0.498 HG21 ' HZ ' ' A' ' 214' ' ' PHE . 91.1 t -59.95 -31.43 47.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.105 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 253' ' ' LEU . . . . . 0.62 HD12 ' HA ' ' A' ' 250' ' ' GLN . 7.9 mt -79.51 -39.46 31.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.945 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 16.6 m-80 -66.97 -49.0 66.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.904 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . 0.475 ' HG3' ' N ' ' A' ' 256' ' ' PHE . 2.7 ptm85 -53.35 -43.5 67.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.826 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 256' ' ' PHE . . . . . 0.566 ' CE2' ' HB ' ' A' ' 210' ' ' THR . 13.1 m-85 -76.34 -37.59 57.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.862 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 24.1 p . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.813 -179.749 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.866 0.365 . . . . 0.0 110.935 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 90.2 t -63.44 -47.4 91.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.156 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -40.01 -61.07 0.92 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.105 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -59.13 -40.69 86.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.909 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' PHE . . . . . 0.526 ' CE2' ' HG ' ' A' ' 216' ' ' LEU . 49.2 t80 -56.41 -40.55 74.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.873 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 86.6 mt -87.94 -24.37 23.61 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.868 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 28.7 t -58.72 -27.38 64.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.843 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . 0.527 ' HG3' HD13 ' A' ' 216' ' ' LEU . 28.6 mmmt -60.75 125.74 24.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.872 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -101.26 150.46 22.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.89 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 34.8 m-20 62.51 49.4 4.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.882 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.9 mm-40 -133.9 143.6 48.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.899 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 48.6 t -100.22 107.23 20.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.188 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 36.7 mt -75.95 134.13 29.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.143 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 57.9 t -116.22 128.46 73.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.127 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 45.8 ttp180 -88.35 108.25 19.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.884 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' MET . . . . . 0.485 ' CE ' HD21 ' A' ' 173' ' ' LEU . 97.0 mtp -92.6 113.33 25.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.859 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 8.3 ttp180 -117.21 139.28 50.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.912 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 91.38 25.04 24.81 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.507 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.894 HD23 HD13 ' A' ' 239' ' ' ILE . 19.5 mt -80.27 129.01 71.14 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.612 0.72 . . . . 0.0 110.919 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . 0.434 ' HG3' ' CB ' ' A' ' 237' ' ' ARG . 64.8 Cg_exo -47.92 136.35 22.92 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.75 2.3 . . . . 0.0 112.335 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 8.8 m-30 -50.98 -19.97 1.2 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.86 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . 0.539 ' O ' HG23 ' A' ' 178' ' ' THR . 64.1 p -94.98 -28.77 14.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.098 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -41.85 120.64 1.58 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.083 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . 0.539 HG23 ' O ' ' A' ' 176' ' ' THR . 40.1 p -116.01 179.56 3.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.164 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -54.12 -48.57 70.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.111 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -52.84 -42.29 65.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.875 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -58.87 -37.14 75.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.895 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.506 HG12 ' CD1' ' A' ' 192' ' ' ILE . 15.5 t -73.21 -47.25 47.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.121 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 42.8 t -39.83 -49.82 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.067 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.428 ' O ' ' C ' ' A' ' 185' ' ' PHE . . . -74.25 -44.71 51.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.106 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.491 ' HD1' HD12 ' A' ' 234' ' ' LEU . 53.9 t80 -36.42 -60.56 0.57 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.864 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' PHE . . . . . 0.473 ' CZ ' ' CD2' ' A' ' 185' ' ' PHE . 42.4 m-85 -95.06 -25.0 16.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.885 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -49.15 -21.31 2.56 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.469 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 42.0 tt0 -55.18 -70.66 0.1 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.816 0.341 . . . . 0.0 110.908 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 20.3 m80 -118.21 -16.72 9.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.853 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 190' ' ' CYS . . . . . 0.423 ' SG ' ' HB2' ' A' ' 226' ' ' ALA . 70.9 m -120.36 87.26 40.15 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.603 0.716 . . . . 0.0 110.86 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 130.55 19.6 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.692 2.261 . . . . 0.0 112.331 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . 0.506 ' CD1' HG12 ' A' ' 182' ' ' VAL . 54.7 mt -78.1 144.57 11.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.15 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 29.3 m -71.29 104.43 3.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.183 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 91.98 -17.17 57.64 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.497 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.414 ' O ' ' N ' ' A' ' 198' ' ' GLY . . . 70.22 -124.12 13.21 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.516 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 31.4 mtmm -46.09 -30.58 1.94 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.679 0.276 . . . . 0.0 110.859 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -78.13 -32.01 50.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.893 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 195' ' ' GLY . . . -88.46 29.65 5.62 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.492 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 70.2 mt -131.4 142.12 44.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.89 0.376 . . . . 0.0 111.127 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 13.0 tp -139.7 111.74 7.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.919 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -96.27 119.26 34.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.909 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.466 HG23 ' HA ' ' A' ' 213' ' ' ALA . 21.7 t -71.51 130.18 35.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.109 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -140.59 137.59 33.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.151 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -48.76 158.88 0.6 Allowed Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.681 0.753 . . . . 0.0 110.903 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 3.05 2.99 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.74 2.293 . . . . 0.0 112.357 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -112.37 -15.29 13.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.864 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 112.25 9.89 18.93 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.501 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -89.64 140.67 28.16 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.603 0.716 . . . . 0.0 110.855 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 115.59 4.16 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.651 2.234 . . . . 0.0 112.339 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . 0.549 ' HB ' ' CE2' ' A' ' 256' ' ' PHE . 69.8 p -80.24 -21.49 42.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.107 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 95.3 -46.38 2.01 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.515 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 212' ' ' ASP . . . . . 0.434 ' OD2' HG11 ' A' ' 202' ' ' VAL . 1.1 p-10 -68.64 154.64 41.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.816 0.341 . . . . 0.0 110.875 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . 0.466 ' HA ' HG23 ' A' ' 202' ' ' VAL . . . -153.53 -175.27 5.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.096 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . 0.447 ' HZ ' HG11 ' A' ' 252' ' ' VAL . 52.8 m-85 -150.63 139.49 20.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.851 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 215' ' ' VAL . . . . . 0.542 HG12 ' N ' ' A' ' 216' ' ' LEU . 21.4 t -125.69 162.34 28.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.132 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 0.542 ' N ' HG12 ' A' ' 215' ' ' VAL . 31.2 mt -112.48 137.23 50.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.919 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -132.5 138.88 47.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.844 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . 0.832 ' HB3' ' CD2' ' A' ' 222' ' ' TYR . . . -48.39 -65.72 0.52 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.147 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 219' ' ' CYS . . . . . . . . . . . . . 2.6 m -154.85 174.81 14.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.845 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . 0.405 ' HA ' ' HB3' ' A' ' 223' ' ' ALA . 1.7 mp0 -39.81 -42.73 1.33 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.915 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -41.14 -43.31 2.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.896 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 222' ' ' TYR . . . . . 0.832 ' CD2' ' HB3' ' A' ' 218' ' ' ALA . 57.1 m-85 -92.35 -46.27 7.78 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.912 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . 0.405 ' HB3' ' HA ' ' A' ' 220' ' ' GLU . . . -52.14 -64.12 0.92 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.104 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 224' ' ' GLN . . . . . 0.692 ' HA ' HD12 ' A' ' 227' ' ' LEU . 23.0 mm-40 -50.65 -55.93 14.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.945 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . 0.439 ' O ' ' CG ' ' A' ' 228' ' ' ARG . 24.2 m-20 -52.14 -21.24 3.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.903 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . 0.423 ' HB2' ' SG ' ' A' ' 190' ' ' CYS . . . -93.83 -34.19 13.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.089 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . 0.692 HD12 ' HA ' ' A' ' 224' ' ' GLN . 63.4 mt -57.65 -32.77 67.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.886 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 228' ' ' ARG . . . . . 0.439 ' CG ' ' O ' ' A' ' 225' ' ' ASN . 3.0 ptm180 -58.52 -13.05 4.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.879 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . 0.456 ' O ' ' C ' ' A' ' 230' ' ' HIS . 16.1 mtpp -86.13 -0.37 55.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.924 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 230' ' ' HIS . . . . . 0.556 ' CE1' ' HG3' ' A' ' 231' ' ' LYS . 48.2 t60 -33.94 131.54 0.27 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.879 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.556 ' HG3' ' CE1' ' A' ' 230' ' ' HIS . 36.8 mttp 62.37 35.36 15.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.879 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -62.01 -176.37 0.09 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.878 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.708 HD21 ' CE1' ' A' ' 238' ' ' TYR . 31.7 mt -133.9 112.42 11.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.893 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 234' ' ' LEU . . . . . 0.571 HD23 ' C ' ' A' ' 234' ' ' LEU . 7.3 tt -121.47 117.89 27.98 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.919 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 57.05 36.35 73.74 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.508 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 26.9 mmtm 69.13 50.73 0.56 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.806 0.336 . . . . 0.0 110.889 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 237' ' ' ARG . . . . . 0.434 ' CB ' ' HG3' ' A' ' 174' ' ' PRO . 44.7 mmt-85 -156.06 115.28 3.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.826 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 238' ' ' TYR . . . . . 0.708 ' CE1' HD21 ' A' ' 233' ' ' LEU . 97.5 m-85 -66.58 136.36 55.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.949 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 0.894 HD13 HD23 ' A' ' 173' ' ' LEU . 79.2 mt -135.88 126.21 42.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.154 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 240' ' ' GLU . . . . . 0.584 ' HB3' ' CZ ' ' A' ' 242' ' ' PHE . 6.7 mp0 -84.81 166.33 17.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.908 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . 0.451 ' O ' ' CD1' ' A' ' 242' ' ' PHE . 15.1 mt -148.13 134.03 19.1 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.89 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 242' ' ' PHE . . . . . 0.584 ' CZ ' ' HB3' ' A' ' 240' ' ' GLU . 7.3 m-85 -145.42 120.92 10.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.886 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . 0.486 ' O ' ' CG ' ' A' ' 243' ' ' ARG . 18.4 ptt-85 -57.15 118.25 4.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.883 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 7.5 t -114.4 -174.98 2.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.887 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . 0.956 ' O ' HG23 ' A' ' 249' ' ' VAL . 67.8 p -135.64 179.16 6.51 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.162 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -60.86 -53.62 55.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.091 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -52.95 -58.17 7.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.146 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . 0.508 ' O ' HG23 ' A' ' 252' ' ' VAL . 1.9 tp10 -49.44 -55.92 11.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.893 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 0.956 HG23 ' O ' ' A' ' 245' ' ' THR . 97.3 t -39.68 -65.58 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.149 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 250' ' ' GLN . . . . . 0.432 ' O ' ' N ' ' A' ' 253' ' ' LEU . 52.2 mt-30 -37.55 -66.72 0.23 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.885 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 28.9 mm-40 -40.97 -39.69 1.23 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.941 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 252' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 248' ' ' GLU . 28.3 t -65.04 -39.44 85.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.125 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 253' ' ' LEU . . . . . 0.432 ' N ' ' O ' ' A' ' 250' ' ' GLN . 7.1 mt -76.89 -36.17 56.87 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.919 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -71.43 -49.77 38.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.89 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . 0.541 ' CG ' ' N ' ' A' ' 256' ' ' PHE . 5.2 ptm180 -49.66 -50.75 42.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.83 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 256' ' ' PHE . . . . . 0.549 ' CE2' ' HB ' ' A' ' 210' ' ' THR . 12.4 m-85 -65.04 -33.6 76.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.877 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 14.2 m . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.849 -179.793 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.884 0.373 . . . . 0.0 110.876 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.537 HG22 HD21 ' A' ' 200' ' ' LEU . 76.6 t -60.39 -36.99 72.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.147 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -43.68 -62.25 1.15 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.076 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -60.83 -42.54 97.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.93 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' PHE . . . . . 0.531 ' CE2' ' HG ' ' A' ' 216' ' ' LEU . 59.6 t80 -52.7 -38.85 61.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.853 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 82.9 mt -89.96 -29.03 18.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.946 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 1.7 t -52.04 -33.34 38.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.852 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . 0.58 ' HG3' HD13 ' A' ' 216' ' ' LEU . 27.4 mmmt -45.5 116.68 1.22 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.868 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -84.55 149.96 25.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.869 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 47.71 44.85 17.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.907 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 0.567 ' OE1' HG21 ' A' ' 193' ' ' THR . 0.4 OUTLIER -117.1 153.13 33.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.907 -179.974 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 46.8 t -106.23 139.06 28.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.157 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' ILE . . . . . 0.531 HG21 HG21 ' A' ' 249' ' ' VAL . 26.0 mt -113.07 137.22 46.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.113 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.477 HG21 ' CE1' ' A' ' 217' ' ' PHE . 94.1 t -114.2 138.23 44.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.123 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 39.9 ttt-85 -93.81 109.25 20.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.893 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' MET . . . . . 0.48 ' CE ' HD21 ' A' ' 173' ' ' LEU . 83.6 mtp -99.51 126.39 45.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.908 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 11.0 mtp85 -127.15 145.17 50.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.866 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 81.5 32.63 30.29 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.482 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.827 ' CD1' ' HB3' ' A' ' 213' ' ' ALA . 22.1 mt -82.84 121.28 77.5 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.658 0.742 . . . . 0.0 110.929 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . 0.485 ' O ' ' N ' ' A' ' 176' ' ' THR . 66.6 Cg_exo -48.02 121.44 5.97 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.661 2.24 . . . . 0.0 112.333 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . 0.591 ' CD2' ' HG2' ' A' ' 209' ' ' PRO . 3.4 m-85 -37.21 -29.13 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.859 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . 0.485 ' N ' ' O ' ' A' ' 174' ' ' PRO . 73.7 p -80.83 -44.01 19.14 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.161 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . 0.476 ' N ' ' O ' ' A' ' 174' ' ' PRO . . . -34.27 125.45 0.49 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.064 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . 0.404 HG23 ' O ' ' A' ' 176' ' ' THR . 12.0 p -118.49 177.07 4.96 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.151 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.445 ' O ' HG23 ' A' ' 183' ' ' VAL . . . -52.46 -44.91 65.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.113 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -56.18 -41.54 75.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.885 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -57.83 -39.38 77.54 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.882 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.502 HG12 ' CD1' ' A' ' 192' ' ' ILE . 54.7 t -71.99 -52.39 25.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.112 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 179' ' ' ALA . 89.9 t -35.13 -47.27 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.14 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -79.65 -39.33 31.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.138 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.612 ' CD1' HD12 ' A' ' 234' ' ' LEU . 58.2 t80 -41.33 -58.78 1.74 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.903 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' PHE . . . . . 0.491 ' O ' ' N ' ' A' ' 190' ' ' CYS . 63.1 m-85 -96.41 -23.32 16.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.915 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -52.68 -21.15 8.83 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.498 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 188' ' ' GLN . . . . . 0.485 ' NE2' ' O ' ' A' ' 185' ' ' PHE . 1.5 pt20 -59.19 -60.04 4.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.858 0.361 . . . . 0.0 110.91 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . 0.6 ' CE1' ' SG ' ' A' ' 190' ' ' CYS . 0.3 OUTLIER -119.02 -29.11 5.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.843 179.968 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 190' ' ' CYS . . . . . 0.6 ' SG ' ' CE1' ' A' ' 189' ' ' HIS . 93.1 m -116.54 89.78 28.66 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.632 0.729 . . . . 0.0 110.853 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 191' ' ' PRO . . . . . 0.444 ' HD2' ' CD1' ' A' ' 222' ' ' TYR . 53.5 Cg_endo -69.8 132.65 23.73 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.67 2.246 . . . . 0.0 112.305 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . 0.641 HG23 ' O ' ' A' ' 216' ' ' LEU . 59.4 mt -82.9 145.17 8.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.105 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . 0.567 HG21 ' OE1' ' A' ' 165' ' ' GLN . 98.0 m -63.68 102.14 0.42 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.138 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 88.38 -16.92 51.28 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.476 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.455 ' O ' ' N ' ' A' ' 198' ' ' GLY . . . 75.3 -129.18 10.34 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.502 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 3.9 pttm -41.23 -37.07 0.87 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.762 0.315 . . . . 0.0 110.912 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -70.87 -37.39 73.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.896 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . 0.536 ' HA2' HD12 ' A' ' 216' ' ' LEU . . . -83.06 36.21 2.73 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.534 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 72.1 mt -139.0 148.91 23.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.83 0.348 . . . . 0.0 111.111 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.537 HD21 HG22 ' A' ' 156' ' ' VAL . 23.5 tp -137.4 120.94 17.18 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.912 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -101.92 111.37 23.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.883 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.435 HG11 ' OD2' ' A' ' 212' ' ' ASP . 59.7 t -66.09 136.29 26.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.137 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -142.83 141.4 31.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.12 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . 0.453 ' N ' HG23 ' A' ' 210' ' ' THR . 21.0 m-85 -47.58 159.42 0.44 Allowed Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.718 0.77 . . . . 0.0 110.886 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 4.18 2.34 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.641 2.227 . . . . 0.0 112.324 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -111.8 -23.42 10.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.839 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 115.05 49.18 0.51 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.516 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 76.4 mtp180 -134.5 147.1 61.98 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.578 0.704 . . . . 0.0 110.886 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 209' ' ' PRO . . . . . 0.591 ' HG2' ' CD2' ' A' ' 175' ' ' PHE . 54.2 Cg_endo -69.72 99.62 0.76 Allowed 'Trans proline' 0 N--CA 1.465 -0.174 0 C-N-CA 122.682 2.255 . . . . 0.0 112.396 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . 0.453 HG23 ' N ' ' A' ' 204' ' ' TYR . 65.8 p -60.4 -33.3 72.29 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.137 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 115.33 -30.2 6.87 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.486 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 212' ' ' ASP . . . . . 0.435 ' OD2' HG11 ' A' ' 202' ' ' VAL . 1.3 p-10 -85.65 163.34 18.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.797 0.332 . . . . 0.0 110.876 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . 0.827 ' HB3' ' CD1' ' A' ' 173' ' ' LEU . . . -166.69 159.25 13.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.082 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . 0.492 ' CD2' HG13 ' A' ' 249' ' ' VAL . 71.8 m-85 -124.62 162.78 23.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.903 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 215' ' ' VAL . . . . . 0.597 HG12 ' N ' ' A' ' 216' ' ' LEU . 43.3 t -140.34 163.95 22.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.091 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 0.641 ' O ' HG23 ' A' ' 192' ' ' ILE . 62.3 mt -115.2 145.38 42.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.902 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . 0.477 ' CE1' HG21 ' A' ' 168' ' ' VAL . 80.1 m-85 -141.89 131.58 24.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.869 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . 0.486 ' HA ' ' NE2' ' A' ' 165' ' ' GLN . . . -42.77 -54.14 4.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.116 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 219' ' ' CYS . . . . . . . . . . . . . 5.0 m -157.15 179.99 8.76 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.888 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . 0.44 ' HA ' ' HB3' ' A' ' 223' ' ' ALA . 0.7 OUTLIER -52.69 -39.48 61.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.915 -179.961 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . 0.422 ' C ' ' O ' ' A' ' 220' ' ' GLU . 29.7 tt0 -36.89 -49.51 0.81 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.897 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 222' ' ' TYR . . . . . 0.444 ' CD1' ' HD2' ' A' ' 191' ' ' PRO . 42.7 m-85 -87.84 -46.98 8.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.933 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . 0.526 ' O ' ' HB3' ' A' ' 226' ' ' ALA . . . -52.99 -62.53 1.59 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.077 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 56.1 mm-40 -47.45 -61.72 1.78 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.934 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 30.6 m-20 -45.44 -31.96 1.94 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.905 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . 0.526 ' HB3' ' O ' ' A' ' 223' ' ' ALA . . . -69.55 -38.05 77.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.089 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 29.0 mt -51.84 -29.34 19.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.934 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 8.9 mpt_? -61.39 -30.03 70.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.851 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . 0.589 ' HE3' ' CE2' ' A' ' 185' ' ' PHE . 20.1 mtpp -71.55 -0.83 11.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.868 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 230' ' ' HIS . . . . . 0.449 ' C ' ' O ' ' A' ' 229' ' ' LYS . 20.9 t60 -34.28 129.71 0.37 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.892 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.41 ' HG3' ' CE1' ' A' ' 230' ' ' HIS . 39.6 mtmt 62.63 39.67 11.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.879 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -67.09 -175.17 0.42 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.871 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.67 HD21 ' CE2' ' A' ' 238' ' ' TYR . 30.6 mt -135.9 109.8 8.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.927 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 234' ' ' LEU . . . . . 0.612 HD12 ' CD1' ' A' ' 185' ' ' PHE . 7.1 tt -117.85 117.71 30.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.913 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 54.71 38.69 64.72 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.459 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 38.4 mttp 68.86 50.54 0.62 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.767 0.318 . . . . 0.0 110.929 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 19.6 mmt180 -155.04 115.58 3.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.888 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 238' ' ' TYR . . . . . 0.67 ' CE2' HD21 ' A' ' 233' ' ' LEU . 95.7 m-85 -67.92 131.25 45.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.959 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 0.467 HD13 HD23 ' A' ' 173' ' ' LEU . 75.1 mt -129.76 133.83 64.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.119 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 240' ' ' GLU . . . . . 0.465 ' HB3' ' CZ ' ' A' ' 242' ' ' PHE . 7.4 mp0 -94.18 170.97 9.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.901 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . 0.524 ' O ' ' CG ' ' A' ' 242' ' ' PHE . 14.9 mt -150.78 153.38 35.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.931 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 242' ' ' PHE . . . . . 0.524 ' CG ' ' O ' ' A' ' 241' ' ' LEU . 3.7 m-85 -162.12 151.62 16.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.845 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . 0.474 ' CZ ' ' HB2' ' A' ' 243' ' ' ARG . 12.6 mtm105 -65.76 118.39 9.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.874 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . 0.443 ' HB3' HG22 ' A' ' 167' ' ' ILE . 1.0 OUTLIER -111.19 160.42 16.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.889 -179.785 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 40.1 p -132.97 155.8 48.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.146 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 246' ' ' ALA . . . . . 0.503 ' N ' HD12 ' A' ' 167' ' ' ILE . . . -43.17 -53.15 5.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.114 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -56.8 -51.86 67.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.052 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -48.19 -54.73 12.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.939 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 0.531 HG21 HG21 ' A' ' 167' ' ' ILE . 59.9 t -48.81 -65.87 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.133 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 250' ' ' GLN . . . . . 0.905 ' HA ' HD12 ' A' ' 253' ' ' LEU . 86.8 mt-30 -38.41 -46.1 1.1 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.954 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -62.67 -51.88 65.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.858 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 73.4 t -54.92 -34.89 32.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.093 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 253' ' ' LEU . . . . . 0.905 HD12 ' HA ' ' A' ' 250' ' ' GLN . 14.9 mt -64.62 -49.56 70.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.91 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 254' ' ' ASN . . . . . 0.496 ' OD1' ' N ' ' A' ' 255' ' ' ARG . 0.6 OUTLIER -64.66 -41.55 96.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.911 179.888 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . 0.496 ' N ' ' OD1' ' A' ' 254' ' ' ASN . 25.9 ttt180 -47.67 -46.74 29.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.894 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -83.65 -41.94 17.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.879 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 1.9 t . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.845 -179.808 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.903 0.382 . . . . 0.0 110.867 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.595 HG22 HD21 ' A' ' 200' ' ' LEU . 75.3 t -83.24 -36.11 12.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.1 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -43.44 -53.32 5.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.1 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -59.9 -53.25 60.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.915 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' PHE . . . . . 0.504 ' CE1' ' HG ' ' A' ' 216' ' ' LEU . 83.3 t80 -46.12 -39.26 9.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.873 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 95.6 mt -87.9 -27.07 22.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.888 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 29.0 t -49.79 -24.79 2.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.813 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . 0.457 ' CB ' ' HG3' ' A' ' 165' ' ' GLN . 35.4 mmtt -70.3 117.57 12.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.853 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . 0.477 ' HG3' ' ND2' ' A' ' 164' ' ' ASN . 4.7 pt-20 -91.4 153.95 19.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.918 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . 0.477 ' ND2' ' HG3' ' A' ' 163' ' ' GLU . 72.7 m-20 61.16 49.04 5.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.885 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 0.457 ' HG3' ' CB ' ' A' ' 162' ' ' LYS . 1.8 mm-40 -128.62 151.8 49.08 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.902 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 48.5 t -109.15 109.03 26.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.174 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' ILE . . . . . 0.581 HG21 ' CG2' ' A' ' 249' ' ' VAL . 45.4 mt -80.12 143.43 12.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.185 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 86.0 t -123.46 133.66 68.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.15 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 11.0 ttt85 -89.94 106.36 18.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.858 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' MET . . . . . 0.593 ' CE ' HD21 ' A' ' 173' ' ' LEU . 91.3 mtp -97.92 125.57 42.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.904 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 47.2 mtp180 -126.57 136.55 52.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.878 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 96.92 17.6 32.11 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.473 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.593 HD21 ' CE ' ' A' ' 170' ' ' MET . 20.7 mt -71.24 116.71 49.8 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.593 0.711 . . . . 0.0 110.912 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . 0.681 ' O ' ' HB3' ' A' ' 177' ' ' ALA . 64.9 Cg_exo -47.99 134.08 23.51 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.672 2.248 . . . . 0.0 112.361 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . 0.453 ' C ' ' O ' ' A' ' 174' ' ' PRO . 19.3 m-85 -34.55 -68.55 0.11 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.893 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -47.63 -40.06 18.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.144 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . 0.681 ' HB3' ' O ' ' A' ' 174' ' ' PRO . . . -38.19 128.07 1.33 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.12 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . 0.405 ' C ' ' CZ ' ' A' ' 201' ' ' PHE . 1.7 p -141.67 179.85 6.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.179 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.522 ' O ' HG23 ' A' ' 183' ' ' VAL . . . -47.21 -46.58 24.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.084 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -53.4 -33.13 52.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.924 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . 0.476 ' CD ' HD21 ' A' ' 234' ' ' LEU . 5.5 mm-40 -76.26 -34.04 59.14 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.874 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.477 HG12 HD11 ' A' ' 192' ' ' ILE . 85.1 t -74.2 -51.79 22.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.142 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.522 HG23 ' O ' ' A' ' 179' ' ' ALA . 94.4 t -34.73 -50.55 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.135 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -78.41 -33.5 48.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.127 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.781 ' HD2' HD12 ' A' ' 234' ' ' LEU . 25.1 t80 -47.08 -61.19 2.0 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.863 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -89.9 -21.69 22.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.912 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -49.03 -21.25 2.36 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.451 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -53.24 -75.42 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.86 0.362 . . . . 0.0 110.916 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 11.1 m-70 -118.17 -5.45 10.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.824 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 82.4 m -126.54 87.5 56.27 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-O 121.61 0.719 . . . . 0.0 110.894 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 191' ' ' PRO . . . . . 0.561 ' HD2' ' CD1' ' A' ' 222' ' ' TYR . 52.8 Cg_endo -69.81 131.54 21.38 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.709 2.272 . . . . 0.0 112.279 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . 0.481 HG23 ' O ' ' A' ' 216' ' ' LEU . 51.3 mt -82.74 142.76 13.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.134 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . 0.429 HG21 ' OE1' ' A' ' 165' ' ' GLN . 47.5 m -67.25 105.92 1.88 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.17 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 87.5 -19.84 30.23 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.493 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.465 ' O ' ' N ' ' A' ' 198' ' ' GLY . . . 78.04 -126.3 7.62 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.507 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 34.4 mtmt -42.9 -33.47 0.78 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.75 0.309 . . . . 0.0 110.873 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -74.27 -34.62 63.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.916 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . 0.57 ' HA2' HD12 ' A' ' 216' ' ' LEU . . . -82.98 36.65 2.7 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.495 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 77.5 mt -138.68 151.24 23.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.881 0.372 . . . . 0.0 111.104 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.595 HD21 HG22 ' A' ' 156' ' ' VAL . 13.4 tp -147.98 111.05 4.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.894 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 201' ' ' PHE . . . . . 0.405 ' CZ ' ' C ' ' A' ' 178' ' ' THR . 53.4 m-85 -93.16 127.65 38.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.902 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 62.0 t -79.73 115.97 23.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.154 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . 0.576 ' HA ' HG23 ' A' ' 210' ' ' THR . 0.7 OUTLIER -125.19 137.55 54.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.105 -179.914 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . 0.636 ' CD1' HG22 ' A' ' 210' ' ' THR . 29.1 m-85 -41.81 159.23 0.19 Allowed Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.694 0.759 . . . . 0.0 110.897 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 2.88 3.14 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.67 2.247 . . . . 0.0 112.379 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -113.43 -18.67 11.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.87 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 110.87 61.51 0.49 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.465 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 37.6 mmt-85 -145.97 145.97 26.82 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.608 0.718 . . . . 0.0 110.886 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 104.02 1.25 Allowed 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.683 2.255 . . . . 0.0 112.38 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . 0.636 HG22 ' CD1' ' A' ' 204' ' ' TYR . 21.0 p -68.42 -31.0 70.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.135 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 114.5 -34.36 4.94 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.504 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -87.61 154.12 20.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.814 0.34 . . . . 0.0 110.872 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . 0.55 ' HB3' ' CD1' ' A' ' 173' ' ' LEU . . . -154.27 175.88 12.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.109 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . 0.663 ' CE2' HG13 ' A' ' 249' ' ' VAL . 60.7 m-85 -138.16 158.32 44.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.876 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 6.6 t -140.64 157.15 23.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.092 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 0.57 HD12 ' HA2' ' A' ' 198' ' ' GLY . 44.7 mt -108.33 141.14 40.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.93 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -135.36 132.5 37.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.904 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -42.65 -66.45 0.36 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.046 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 219' ' ' CYS . . . . . . . . . . . . . 1.9 m -135.01 176.57 8.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.932 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -65.45 -7.37 13.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.855 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -67.85 -37.79 82.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.897 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 222' ' ' TYR . . . . . 0.561 ' CD1' ' HD2' ' A' ' 191' ' ' PRO . 46.5 m-85 -86.52 -39.22 16.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.964 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . 0.434 ' O ' ' HB3' ' A' ' 226' ' ' ALA . . . -59.46 -60.8 3.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.097 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 224' ' ' GLN . . . . . 0.403 ' HA ' HD12 ' A' ' 227' ' ' LEU . 83.4 mt-30 -45.2 -53.98 7.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.934 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 71.1 m-20 -58.69 -25.73 63.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.874 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . 0.434 ' HB3' ' O ' ' A' ' 223' ' ' ALA . . . -75.93 -23.75 55.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.052 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . 0.403 HD12 ' HA ' ' A' ' 224' ' ' GLN . 37.0 mt -68.24 -33.14 73.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.911 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 38.9 mtp180 -60.14 -14.99 19.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.9 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . 0.446 ' O ' ' C ' ' A' ' 230' ' ' HIS . 21.8 mtpp -80.56 -3.42 50.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.854 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 230' ' ' HIS . . . . . 0.491 ' CD2' ' HG2' ' A' ' 231' ' ' LYS . 72.2 t60 -34.16 146.34 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.871 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.491 ' HG2' ' CD2' ' A' ' 230' ' ' HIS . 3.9 mmpt? 53.04 26.84 5.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.892 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -56.47 -177.33 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.86 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.633 HD21 ' CE2' ' A' ' 238' ' ' TYR . 30.8 mt -139.96 105.12 5.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.936 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 234' ' ' LEU . . . . . 0.781 HD12 ' HD2' ' A' ' 185' ' ' PHE . 6.8 tt -115.53 112.53 22.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.956 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 62.17 34.35 88.83 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.467 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 4.3 mmmm 71.05 52.12 0.27 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.744 0.307 . . . . 0.0 110.893 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 21.2 mmt180 -155.02 115.6 3.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.852 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 238' ' ' TYR . . . . . 0.633 ' CE2' HD21 ' A' ' 233' ' ' LEU . 92.1 m-85 -70.63 117.18 11.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.916 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 0.531 HG22 ' N ' ' A' ' 240' ' ' GLU . 57.6 mt -111.73 159.83 11.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.142 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 240' ' ' GLU . . . . . 0.531 ' N ' HG22 ' A' ' 239' ' ' ILE . 13.7 mt-10 -114.23 167.58 10.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.867 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . 0.546 ' O ' ' CD1' ' A' ' 242' ' ' PHE . 54.0 mt -146.05 143.73 29.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.919 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 242' ' ' PHE . . . . . 0.546 ' CD1' ' O ' ' A' ' 241' ' ' LEU . 9.4 m-85 -159.3 137.13 10.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.865 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 63.0 mtp85 -53.67 141.46 26.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.859 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 8.8 t -138.18 157.41 46.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.85 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 71.7 p -129.3 157.77 40.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.164 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 246' ' ' ALA . . . . . 0.561 ' N ' HD12 ' A' ' 167' ' ' ILE . . . -38.17 -55.78 1.26 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.131 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -54.07 -55.56 26.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.101 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 32.5 tp10 -42.18 -51.49 4.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.929 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 0.663 HG13 ' CE2' ' A' ' 214' ' ' PHE . 85.9 t -54.69 -63.76 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.172 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 250' ' ' GLN . . . . . 0.788 ' HA ' HD12 ' A' ' 253' ' ' LEU . 32.4 mt-30 -43.01 -33.02 0.73 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.934 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -73.14 -50.54 22.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.914 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 96.9 t -56.9 -37.07 52.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.111 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 253' ' ' LEU . . . . . 0.788 HD12 ' HA ' ' A' ' 250' ' ' GLN . 16.0 mt -60.75 -50.93 71.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.881 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 254' ' ' ASN . . . . . 0.463 ' C ' ' OD1' ' A' ' 254' ' ' ASN . 0.6 OUTLIER -60.7 -40.47 92.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.882 179.973 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . 0.46 ' N ' ' OD1' ' A' ' 254' ' ' ASN . 21.4 ttt85 -42.92 -55.43 3.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.883 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 256' ' ' PHE . . . . . 0.547 ' CE2' ' HB ' ' A' ' 210' ' ' THR . 67.4 m-85 -74.79 -47.24 31.9 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.896 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 68.7 m . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.897 -179.802 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.858 0.361 . . . . 0.0 110.859 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.651 HG22 HD21 ' A' ' 200' ' ' LEU . 72.3 t -60.92 -43.22 95.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.12 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.402 ' C ' ' O ' ' A' ' 156' ' ' VAL . . . -37.46 -61.03 0.63 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.127 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -57.66 -48.62 78.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.907 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' PHE . . . . . 0.497 ' CE1' ' HG ' ' A' ' 216' ' ' LEU . 66.2 t80 -47.68 -38.44 15.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.872 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 85.3 mt -90.57 -27.36 19.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.959 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 30.2 t -50.7 -36.51 36.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.854 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 39.7 mmtt -54.4 124.89 17.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.89 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -99.0 151.74 20.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.881 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 62.35 39.21 12.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.886 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -124.65 147.27 48.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.888 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 48.9 t -100.25 131.68 47.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.116 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' ILE . . . . . 0.773 HD12 ' N ' ' A' ' 246' ' ' ALA . 33.6 mt -101.17 143.8 13.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.176 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 96.8 t -128.26 136.6 59.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.121 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . 0.485 ' N ' ' HB2' ' A' ' 244' ' ' SER . 20.8 ttt85 -90.72 111.92 23.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.891 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' MET . . . . . 0.708 ' CE ' HD21 ' A' ' 173' ' ' LEU . 83.2 mtp -98.42 117.08 32.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.857 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 5.7 ttt-85 -120.99 140.66 51.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.833 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 89.91 23.43 32.83 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.512 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.708 HD21 ' CE ' ' A' ' 170' ' ' MET . 22.9 mt -79.18 129.62 72.01 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.564 0.697 . . . . 0.0 110.917 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . 0.467 ' HG3' ' CB ' ' A' ' 237' ' ' ARG . 65.1 Cg_exo -47.94 154.75 2.0 Allowed 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.661 2.241 . . . . 0.0 112.345 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -60.09 -50.17 74.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.833 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . 0.457 ' O ' ' C ' ' A' ' 177' ' ' ALA . 0.0 OUTLIER -68.77 -39.07 80.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.135 -179.877 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . 0.691 ' HB1' ' HG2' ' A' ' 181' ' ' GLU . . . -33.53 124.25 0.42 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.072 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . 0.432 ' O ' ' C ' ' A' ' 179' ' ' ALA . 1.4 p -135.7 176.62 8.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.146 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.501 ' N ' ' CZ ' ' A' ' 201' ' ' PHE . . . -35.14 -44.98 0.27 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.121 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -56.66 -49.33 75.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.926 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . 0.691 ' HG2' ' HB1' ' A' ' 177' ' ' ALA . 0.0 OUTLIER -55.07 -33.48 62.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.869 -179.93 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.655 HG12 ' CD1' ' A' ' 192' ' ' ILE . 93.7 t -79.29 -60.03 2.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.156 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 179' ' ' ALA . 73.4 t -34.34 -39.89 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.134 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -85.77 -39.31 17.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.049 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.575 ' HD1' HD12 ' A' ' 234' ' ' LEU . 63.1 t80 -46.06 -59.58 2.78 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.825 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 186' ' ' PHE . . . . . 0.403 ' CE1' ' HE2' ' A' ' 185' ' ' PHE . 77.2 m-85 -91.79 -22.1 20.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.854 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -50.36 -18.25 2.24 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.511 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -58.49 -70.3 0.15 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.843 0.354 . . . . 0.0 110.882 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -118.15 -15.58 9.82 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.858 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 190' ' ' CYS . . . . . 0.409 ' SG ' ' CB ' ' A' ' 225' ' ' ASN . 70.8 m -120.26 86.69 38.66 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.65 0.738 . . . . 0.0 110.888 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 130.37 19.22 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.663 2.242 . . . . 0.0 112.361 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . 0.655 ' CD1' HG12 ' A' ' 182' ' ' VAL . 50.3 mt -82.14 146.2 7.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.161 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 85.6 m -66.89 105.78 1.71 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.148 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 87.41 -20.14 28.27 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.453 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.401 ' O ' ' N ' ' A' ' 198' ' ' GLY . . . 78.84 -126.66 7.63 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.446 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 16.6 ptmt -45.29 -34.43 2.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.746 0.308 . . . . 0.0 110.874 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -73.72 -32.8 64.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.867 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . 0.433 ' HA2' HD12 ' A' ' 216' ' ' LEU . . . -86.69 37.6 3.16 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.5 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.466 HD13 ' HB ' ' A' ' 182' ' ' VAL . 48.0 mt -141.83 146.31 23.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.865 0.364 . . . . 0.0 111.164 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.651 HD21 HG22 ' A' ' 156' ' ' VAL . 19.5 tp -134.4 118.14 17.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.91 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 201' ' ' PHE . . . . . 0.501 ' CZ ' ' N ' ' A' ' 179' ' ' ALA . 62.8 m-85 -99.53 114.51 27.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.91 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 22.7 t -70.06 114.23 7.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.179 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . 0.511 ' HA ' HG23 ' A' ' 210' ' ' THR . 0.7 OUTLIER -124.86 137.21 54.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.12 -179.922 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -43.49 158.22 0.25 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.705 0.764 . . . . 0.0 110.882 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 3.01 3.01 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.683 2.256 . . . . 0.0 112.355 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -112.08 -21.05 11.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.829 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 112.5 57.53 0.44 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.462 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 33.2 mmt-85 -141.89 144.61 33.12 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.598 0.713 . . . . 0.0 110.896 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.7 105.67 1.52 Allowed 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.635 2.224 . . . . 0.0 112.381 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . 0.565 ' HB ' ' CE1' ' A' ' 256' ' ' PHE . 27.2 p -69.07 -32.31 71.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.158 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 114.0 -34.1 5.13 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.442 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -84.68 162.76 19.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.815 0.341 . . . . 0.0 110.862 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -162.89 175.51 11.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.065 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . 0.659 ' CE2' HG13 ' A' ' 249' ' ' VAL . 80.8 m-85 -140.76 136.65 32.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.885 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 215' ' ' VAL . . . . . 0.432 HG12 ' N ' ' A' ' 216' ' ' LEU . 5.4 t -115.92 159.33 15.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.096 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 0.53 ' O ' HG23 ' A' ' 192' ' ' ILE . 29.3 mt -112.37 145.25 40.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.927 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -140.12 137.0 34.13 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.9 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . 0.641 ' HB3' ' CE2' ' A' ' 222' ' ' TYR . . . -48.48 -50.06 33.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.123 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 219' ' ' CYS . . . . . . . . . . . . . 2.0 t -154.2 177.48 11.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.913 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -57.84 -23.89 54.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.893 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -50.75 -54.66 21.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.879 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 222' ' ' TYR . . . . . 0.641 ' CE2' ' HB3' ' A' ' 218' ' ' ALA . 61.3 m-85 -71.84 -48.63 44.8 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.936 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . 0.456 ' O ' ' HB3' ' A' ' 226' ' ' ALA . . . -47.36 -52.03 17.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.074 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -51.75 -62.75 1.44 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.908 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . 0.409 ' CB ' ' SG ' ' A' ' 190' ' ' CYS . 38.2 m-20 -48.42 -23.7 1.03 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.898 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . 0.456 ' HB3' ' O ' ' A' ' 223' ' ' ALA . . . -81.31 -40.3 23.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.098 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 95.9 mt -52.28 -39.0 59.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.899 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 37.2 mtt-85 -55.62 -27.85 51.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.861 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . 0.454 ' O ' ' C ' ' A' ' 230' ' ' HIS . 20.7 mtpp -70.62 -2.77 15.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.898 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 230' ' ' HIS . . . . . 0.559 ' CE1' ' HG3' ' A' ' 231' ' ' LYS . 15.7 t60 -33.91 129.19 0.34 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.87 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.559 ' HG3' ' CE1' ' A' ' 230' ' ' HIS . 30.9 mttt 63.07 39.62 9.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.896 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -67.38 -175.1 0.45 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.849 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.638 HD21 ' CE2' ' A' ' 238' ' ' TYR . 29.6 mt -138.08 110.1 7.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.951 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 234' ' ' LEU . . . . . 0.575 HD12 ' HD1' ' A' ' 185' ' ' PHE . 8.0 tt -121.65 113.94 20.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.894 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 59.13 40.98 96.37 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.456 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . 0.436 ' NZ ' ' HA ' ' A' ' 236' ' ' LYS . 0.0 OUTLIER 65.36 52.4 1.43 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.762 0.315 . . . . 0.0 110.907 -179.967 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 237' ' ' ARG . . . . . 0.467 ' CB ' ' HG3' ' A' ' 174' ' ' PRO . 21.2 mmt180 -156.29 115.13 3.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.815 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 238' ' ' TYR . . . . . 0.638 ' CE2' HD21 ' A' ' 233' ' ' LEU . 93.7 m-85 -69.75 127.3 32.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.91 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 0.498 HD13 HD23 ' A' ' 173' ' ' LEU . 62.1 mt -122.22 134.26 66.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.09 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 240' ' ' GLU . . . . . 0.58 ' HB3' ' CZ ' ' A' ' 242' ' ' PHE . 6.5 mp0 -103.1 149.39 24.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.898 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . 0.517 ' O ' ' CD1' ' A' ' 242' ' ' PHE . 14.3 mt -124.62 149.56 46.95 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.964 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 242' ' ' PHE . . . . . 0.58 ' CZ ' ' HB3' ' A' ' 240' ' ' GLU . 13.6 m-85 -156.84 132.38 9.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.841 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 57.5 mtm180 -48.09 133.04 15.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.901 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . 0.485 ' HB2' ' N ' ' A' ' 169' ' ' ARG . 3.4 t -130.48 157.59 42.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.825 -179.744 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . 0.424 ' O ' ' C ' ' A' ' 246' ' ' ALA . 82.1 p -133.45 150.05 51.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.161 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 246' ' ' ALA . . . . . 0.773 ' N ' HD12 ' A' ' 167' ' ' ILE . . . -35.67 -51.94 0.67 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.096 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -59.41 -50.97 71.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.096 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 18.1 tp10 -47.31 -50.28 22.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.903 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 0.659 HG13 ' CE2' ' A' ' 214' ' ' PHE . 98.5 t -53.48 -64.58 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.148 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 250' ' ' GLN . . . . . 0.749 ' HA ' HD12 ' A' ' 253' ' ' LEU . 68.4 mt-30 -43.22 -34.96 1.26 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.934 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 251' ' ' GLN . . . . . 0.5 ' O ' ' ND2' ' A' ' 254' ' ' ASN . 27.5 mt-30 -74.34 -33.31 63.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.879 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 252' ' ' VAL . . . . . 0.471 ' HA ' ' NE ' ' A' ' 255' ' ' ARG . 79.1 t -79.67 -19.06 12.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.133 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 253' ' ' LEU . . . . . 0.749 HD12 ' HA ' ' A' ' 250' ' ' GLN . 17.0 mt -80.81 -46.39 15.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.879 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 254' ' ' ASN . . . . . 0.5 ' ND2' ' O ' ' A' ' 251' ' ' GLN . 1.3 p30 -58.16 -50.06 74.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.857 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . 0.474 ' N ' ' CG ' ' A' ' 254' ' ' ASN . 17.3 ptp180 -49.31 -47.18 47.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.856 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 256' ' ' PHE . . . . . 0.565 ' CE1' ' HB ' ' A' ' 210' ' ' THR . 10.3 m-85 -73.8 -37.45 64.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.855 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 1.4 t . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.822 -179.759 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 . . . . . 0 C--O 1.23 0.065 0 CA-C-O 120.935 0.397 . . . . 0.0 110.907 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.441 ' O ' ' C ' ' A' ' 157' ' ' ALA . 75.5 t -77.29 -50.42 20.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.117 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.441 ' C ' ' O ' ' A' ' 156' ' ' VAL . . . -34.75 -57.32 0.53 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.101 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 76.1 mm-40 -62.13 -45.87 91.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.889 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' PHE . . . . . 0.431 ' CE2' ' HG ' ' A' ' 216' ' ' LEU . 20.1 t80 -52.89 -42.4 65.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.883 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 56.3 mt -82.06 -29.27 31.96 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.916 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 22.9 t -48.28 -43.33 32.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.902 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . 0.706 ' HG3' HD13 ' A' ' 216' ' ' LEU . 0.2 OUTLIER -38.6 130.26 1.38 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.942 179.897 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -106.61 145.54 31.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.883 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . 0.448 ' O ' ' NE2' ' A' ' 165' ' ' GLN . 49.1 m-80 63.28 37.71 10.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.891 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 0.448 ' NE2' ' O ' ' A' ' 164' ' ' ASN . 2.2 mp0 -122.54 153.81 38.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.904 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 83.9 t -108.36 137.56 39.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.135 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' ILE . . . . . 0.475 HD12 ' N ' ' A' ' 246' ' ' ALA . 28.6 mt -104.84 139.23 26.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.07 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 82.6 t -120.49 133.35 67.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.154 179.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 39.3 ttp180 -88.51 104.72 17.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.839 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' MET . . . . . 0.855 ' CE ' HD21 ' A' ' 173' ' ' LEU . 83.3 mtp -97.39 131.57 43.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.884 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 2.1 ttt85 -135.65 140.48 44.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.852 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 93.23 16.59 46.42 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.504 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.855 HD21 ' CE ' ' A' ' 170' ' ' MET . 25.5 mt -72.09 128.95 88.47 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.606 0.717 . . . . 0.0 110.925 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . 0.464 ' HG3' ' CB ' ' A' ' 237' ' ' ARG . 64.3 Cg_exo -47.91 144.61 11.44 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.682 2.255 . . . . 0.0 112.357 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . 0.558 ' CD1' ' HG3' ' A' ' 209' ' ' PRO . 6.7 t80 -49.35 -41.69 39.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.88 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . 0.45 ' O ' ' C ' ' A' ' 177' ' ' ALA . 7.6 p -76.25 -45.41 32.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.158 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . 0.45 ' C ' ' O ' ' A' ' 176' ' ' THR . . . -33.41 104.55 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.117 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -111.66 177.7 4.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.118 -179.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.447 ' N ' ' CE1' ' A' ' 201' ' ' PHE . . . -45.42 -51.08 11.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.14 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -50.22 -38.87 42.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.916 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . 0.735 ' HG3' HD11 ' A' ' 234' ' ' LEU . 2.6 tp10 -64.65 -41.85 95.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.898 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.481 ' O ' ' N ' ' A' ' 185' ' ' PHE . 94.5 t -64.96 -54.22 32.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.133 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.453 ' C ' ' O ' ' A' ' 182' ' ' VAL . 43.2 t -33.86 -55.72 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.112 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -70.72 -34.33 71.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.095 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.532 ' CE2' ' HD3' ' A' ' 229' ' ' LYS . 63.6 t80 -51.13 -61.11 2.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.904 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -89.58 -20.4 23.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.913 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -49.16 -18.5 1.29 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.474 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 38.4 mm-40 -55.9 -75.17 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.796 0.332 . . . . 0.0 110.921 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -118.34 -3.78 10.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.845 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 71.4 m -128.7 87.09 55.82 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.579 0.704 . . . . 0.0 110.851 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 191' ' ' PRO . . . . . 0.577 ' HD2' ' CD1' ' A' ' 222' ' ' TYR . 54.1 Cg_endo -69.74 143.3 50.5 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.719 2.279 . . . . 0.0 112.38 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . 0.591 HG23 ' O ' ' A' ' 216' ' ' LEU . 63.1 mt -97.71 143.07 13.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.102 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 88.6 m -66.72 101.41 0.8 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.134 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 89.64 -15.8 58.02 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.428 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 73.01 -118.21 6.28 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.483 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 39.4 mtmt -51.16 -32.71 24.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.73 0.3 . . . . 0.0 110.864 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -75.22 -22.54 57.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.904 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . 0.67 ' HA2' HD12 ' A' ' 216' ' ' LEU . . . -99.25 35.25 4.82 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.442 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 60.5 mt -137.45 139.22 43.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.88 0.371 . . . . 0.0 111.132 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 12.9 tp -133.44 123.08 24.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.946 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 201' ' ' PHE . . . . . 0.447 ' CE1' ' N ' ' A' ' 179' ' ' ALA . 75.8 m-85 -104.26 124.77 49.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.854 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 55.6 t -79.9 136.31 23.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.082 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . 0.429 ' HA ' HG23 ' A' ' 210' ' ' THR . 0.8 OUTLIER -143.21 136.59 28.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.138 179.99 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . 0.59 ' CD1' ' HB3' ' A' ' 208' ' ' ARG . 16.7 m-85 -40.31 160.65 0.12 Allowed Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.68 0.752 . . . . 0.0 110.901 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.74 3.22 2.89 Favored 'Trans proline' 0 N--CA 1.465 -0.176 0 C-N-CA 122.724 2.283 . . . . 0.0 112.32 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -117.31 -28.45 6.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.878 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 127.69 42.93 0.25 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.485 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 208' ' ' ARG . . . . . 0.59 ' HB3' ' CD1' ' A' ' 204' ' ' TYR . 10.8 ttm180 -117.3 142.01 29.53 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.639 0.733 . . . . 0.0 110.876 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 209' ' ' PRO . . . . . 0.558 ' HG3' ' CD1' ' A' ' 175' ' ' PHE . 54.0 Cg_endo -69.74 93.27 0.52 Allowed 'Trans proline' 0 C--O 1.232 0.22 0 C-N-CA 122.734 2.29 . . . . 0.0 112.342 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . 0.572 ' HB ' ' CE2' ' A' ' 256' ' ' PHE . 69.6 p -60.12 -9.45 3.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.097 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 81.36 -42.42 2.76 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.48 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -69.1 165.32 20.55 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.8 0.333 . . . . 0.0 110.892 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -165.34 -177.82 4.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.088 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . 0.562 ' CE2' HG13 ' A' ' 249' ' ' VAL . 51.2 m-85 -145.97 138.68 25.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.9 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 215' ' ' VAL . . . . . 0.411 HG12 ' N ' ' A' ' 216' ' ' LEU . 10.0 t -121.63 156.71 25.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.168 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 0.706 HD13 ' HG3' ' A' ' 162' ' ' LYS . 49.5 mt -110.85 138.58 47.07 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.936 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -129.91 137.15 50.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.879 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -49.81 -46.66 51.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.084 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 219' ' ' CYS . . . . . . . . . . . . . 10.2 m -154.14 171.57 18.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.893 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . 0.41 ' O ' ' C ' ' A' ' 221' ' ' GLU . 6.8 tp10 -57.6 -40.75 79.77 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.873 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . 0.41 ' C ' ' O ' ' A' ' 220' ' ' GLU . 26.6 tt0 -36.79 -49.54 0.79 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.885 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 222' ' ' TYR . . . . . 0.577 ' CD1' ' HD2' ' A' ' 191' ' ' PRO . 20.9 m-85 -74.54 -50.07 19.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.892 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . 0.518 ' O ' ' HB3' ' A' ' 226' ' ' ALA . . . -44.82 -54.52 6.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.117 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -48.41 -62.42 1.5 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.954 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 41.3 m-20 -49.54 -28.96 6.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.871 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . 0.518 ' HB3' ' O ' ' A' ' 223' ' ' ALA . . . -70.42 -43.21 70.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.038 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 29.0 mt -54.35 -30.28 51.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.934 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 60.8 mtp85 -58.65 -22.22 56.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.841 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . 0.532 ' HD3' ' CE2' ' A' ' 185' ' ' PHE . 16.7 mttm -78.93 -1.71 36.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.9 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 230' ' ' HIS . . . . . 0.546 ' CE1' ' HD3' ' A' ' 231' ' ' LYS . 21.6 t60 -33.86 127.0 0.41 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.886 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.546 ' HD3' ' CE1' ' A' ' 230' ' ' HIS . 0.3 OUTLIER 68.75 32.56 4.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.877 179.978 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -61.91 178.69 0.33 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.881 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.621 HD21 ' CD1' ' A' ' 238' ' ' TYR . 31.1 mt -135.18 109.74 8.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.943 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 234' ' ' LEU . . . . . 0.735 HD11 ' HG3' ' A' ' 181' ' ' GLU . 6.5 tt -117.68 114.15 22.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.905 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 58.4 37.59 88.25 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.482 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 9.6 mmpt? 70.56 52.73 0.32 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.78 0.324 . . . . 0.0 110.889 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 237' ' ' ARG . . . . . 0.464 ' CB ' ' HG3' ' A' ' 174' ' ' PRO . 50.4 mmt-85 -155.47 116.06 3.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.85 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 238' ' ' TYR . . . . . 0.621 ' CD1' HD21 ' A' ' 233' ' ' LEU . 89.6 m-85 -68.61 125.39 26.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.904 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 0.776 HD13 HD23 ' A' ' 173' ' ' LEU . 64.1 mt -120.94 134.53 64.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.116 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 240' ' ' GLU . . . . . 0.496 ' HB3' ' CZ ' ' A' ' 242' ' ' PHE . 38.8 mp0 -96.24 170.21 9.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.85 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 75.1 mt -145.71 139.96 26.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.946 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 242' ' ' PHE . . . . . 0.496 ' CZ ' ' HB3' ' A' ' 240' ' ' GLU . 8.6 m-85 -152.14 130.87 12.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.877 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 57.4 mtm180 -52.25 136.17 31.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.846 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 1.1 t -136.9 166.37 23.79 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.869 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . 0.444 ' O ' HG23 ' A' ' 249' ' ' VAL . 74.1 p -135.91 165.05 26.54 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.142 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 246' ' ' ALA . . . . . 0.475 ' N ' HD12 ' A' ' 167' ' ' ILE . . . -49.02 -53.55 19.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.076 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -55.6 -50.89 68.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.09 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -50.06 -50.98 46.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.931 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 0.562 HG13 ' CE2' ' A' ' 214' ' ' PHE . 92.2 t -47.36 -61.97 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.101 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 250' ' ' GLN . . . . . 0.549 ' HA ' HD12 ' A' ' 253' ' ' LEU . 34.4 mt-30 -48.19 -33.03 7.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.902 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 251' ' ' GLN . . . . . 0.427 ' HA ' ' ND2' ' A' ' 254' ' ' ASN . 53.0 mt-30 -76.82 -25.94 53.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.92 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 95.0 t -82.25 -21.71 9.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.135 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 253' ' ' LEU . . . . . 0.549 HD12 ' HA ' ' A' ' 250' ' ' GLN . 10.7 mt -84.19 -43.54 14.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.905 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 254' ' ' ASN . . . . . 0.494 ' OD1' ' N ' ' A' ' 255' ' ' ARG . 0.5 OUTLIER -65.11 -42.08 94.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.846 179.973 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . 0.494 ' N ' ' OD1' ' A' ' 254' ' ' ASN . 1.8 ptm85 -58.38 -41.86 85.76 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.855 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 256' ' ' PHE . . . . . 0.572 ' CE2' ' HB ' ' A' ' 210' ' ' THR . 11.7 m-85 -75.65 -46.0 33.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.921 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 66.5 m . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.835 -179.81 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.856 0.36 . . . . 0.0 110.905 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.445 HG22 HD21 ' A' ' 200' ' ' LEU . 26.7 t -68.55 -41.46 83.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.077 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.439 ' C ' ' O ' ' A' ' 156' ' ' VAL . . . -33.73 -69.94 0.08 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.108 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . 0.498 ' O ' ' N ' ' A' ' 161' ' ' SER . 3.8 pt20 -48.82 -60.17 2.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.947 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 21.4 t80 -39.4 -40.67 0.84 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.921 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 98.6 mt -89.07 -22.92 22.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.934 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . 0.498 ' N ' ' O ' ' A' ' 158' ' ' GLN . 7.7 t -59.95 -20.93 60.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.853 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . 0.476 ' HG3' HD13 ' A' ' 216' ' ' LEU . 25.3 mmmt -69.83 118.27 12.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.926 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 50.3 mm-40 -96.98 158.02 15.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.916 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 62.43 42.18 9.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.868 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 36.1 mm-40 -126.7 172.6 10.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.911 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.462 HG11 ' CB ' ' A' ' 223' ' ' ALA . 86.6 t -128.54 106.45 14.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.11 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' ILE . . . . . 0.548 HD12 ' N ' ' A' ' 246' ' ' ALA . 70.0 mt -77.67 141.63 15.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.169 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 43.7 t -122.77 133.94 67.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.103 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . 0.449 ' N ' ' HB2' ' A' ' 244' ' ' SER . 29.6 ttp180 -91.43 101.44 14.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.876 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' MET . . . . . 0.547 ' CE ' HD21 ' A' ' 173' ' ' LEU . 99.3 mtp -94.9 127.25 40.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.895 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 13.5 ttm180 -126.07 141.49 51.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.884 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 89.91 24.92 28.56 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.501 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.929 HD23 HD13 ' A' ' 239' ' ' ILE . 19.9 mt -78.45 123.29 85.7 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.638 0.732 . . . . 0.0 110.907 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_exo -48.0 141.77 16.63 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.67 2.246 . . . . 0.0 112.341 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . 0.558 ' CD1' ' HG3' ' A' ' 209' ' ' PRO . 9.1 t80 -53.97 -26.18 24.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.892 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 7.2 p -89.69 -14.3 35.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.095 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -65.15 110.16 2.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.125 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . 0.437 ' O ' ' N ' ' A' ' 181' ' ' GLU . 0.8 OUTLIER -118.96 167.16 12.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.134 -179.925 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 178' ' ' THR . . . -35.42 -42.43 0.21 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.122 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -57.07 -47.69 80.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.89 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . 0.437 ' N ' ' O ' ' A' ' 178' ' ' THR . 3.9 mp0 -61.0 -37.49 82.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.879 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.477 HG12 HD11 ' A' ' 192' ' ' ILE . 76.1 t -69.85 -54.23 20.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.119 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.448 ' C ' ' O ' ' A' ' 182' ' ' VAL . 28.1 t -33.78 -50.66 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.125 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -73.54 -44.22 58.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.086 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -39.13 -61.31 0.78 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.903 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -92.27 -21.42 20.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.873 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -49.11 -18.9 1.35 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.495 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -56.25 -75.21 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.803 0.335 . . . . 0.0 110.923 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -118.25 -7.57 10.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.851 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 79.4 m -124.41 86.4 55.0 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.557 0.694 . . . . 0.0 110.876 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 191' ' ' PRO . . . . . 0.571 ' HD2' ' CD1' ' A' ' 222' ' ' TYR . 53.5 Cg_endo -69.78 140.32 42.3 Favored 'Trans proline' 0 C--O 1.231 0.148 0 C-N-CA 122.715 2.276 . . . . 0.0 112.308 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . 0.591 HG23 ' O ' ' A' ' 216' ' ' LEU . 57.2 mt -91.5 144.29 9.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.149 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 35.9 m -73.24 105.72 4.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.139 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 91.33 -17.78 54.53 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.478 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 72.09 -121.09 8.22 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.472 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 24.0 mtmm -49.74 -28.46 6.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.731 0.301 . . . . 0.0 110.87 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -77.74 -27.66 50.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.886 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . 0.449 ' HA2' HD12 ' A' ' 216' ' ' LEU . . . -93.62 40.4 2.79 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.524 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 56.9 mt -144.04 149.77 17.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.885 0.374 . . . . 0.0 111.087 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.445 HD21 HG22 ' A' ' 156' ' ' VAL . 14.1 tp -148.46 119.63 7.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.897 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -98.71 117.62 33.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.89 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 42.7 t -73.49 133.63 31.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.124 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . 0.539 ' HA ' HG23 ' A' ' 210' ' ' THR . 0.8 OUTLIER -138.39 137.9 37.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.159 -179.971 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . 0.502 ' CD2' HG22 ' A' ' 210' ' ' THR . 35.1 m-85 -47.24 158.63 0.45 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.663 0.744 . . . . 0.0 110.916 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 3.14 2.98 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.651 2.234 . . . . 0.0 112.343 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -110.29 -20.51 12.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.825 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 113.72 38.02 1.23 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.506 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 77.6 mtt180 -121.63 146.86 46.53 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.612 0.72 . . . . 0.0 110.854 -179.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 209' ' ' PRO . . . . . 0.558 ' HG3' ' CD1' ' A' ' 175' ' ' PHE . 53.6 Cg_endo -69.79 112.02 2.97 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.672 2.248 . . . . 0.0 112.348 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . 0.539 HG23 ' HA ' ' A' ' 203' ' ' THR . 53.7 p -76.59 -6.8 53.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.173 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 80.73 -37.14 2.29 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.467 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -75.85 159.01 31.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.844 0.354 . . . . 0.0 110.861 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . 0.554 ' HB3' ' CD1' ' A' ' 173' ' ' LEU . . . -159.31 -177.91 6.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.075 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . 0.459 ' CE2' HG13 ' A' ' 249' ' ' VAL . 58.0 m-85 -145.59 143.85 30.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.885 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 4.4 t -131.9 155.47 41.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.142 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 0.591 ' O ' HG23 ' A' ' 192' ' ' ILE . 37.5 mt -106.1 135.09 48.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.916 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -127.19 147.26 50.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.88 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . 0.63 ' HB3' ' HD2' ' A' ' 222' ' ' TYR . . . -54.31 -63.76 1.05 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.127 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 219' ' ' CYS . . . . . . . . . . . . . 2.2 t -153.58 172.63 16.91 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.87 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -44.89 -35.71 2.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.891 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . 0.566 ' OE2' ' CD1' ' A' ' 222' ' ' TYR . 6.0 tm-20 -45.27 -44.73 11.54 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.915 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 222' ' ' TYR . . . . . 0.63 ' HD2' ' HB3' ' A' ' 218' ' ' ALA . 35.1 m-85 -88.71 -47.48 8.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.872 -179.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . 0.462 ' CB ' HG11 ' A' ' 166' ' ' VAL . . . -52.15 -60.0 3.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.113 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 43.9 mm-40 -47.22 -50.68 20.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.914 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 20.4 m-20 -60.48 -23.66 64.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.925 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . 0.446 ' HB3' ' O ' ' A' ' 223' ' ' ALA . . . -76.15 -40.32 52.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.132 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 29.2 mt -54.41 -30.74 53.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.94 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 6.7 mtp-105 -58.84 -25.28 63.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.881 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . 0.462 ' O ' ' C ' ' A' ' 230' ' ' HIS . 19.1 mtpp -76.37 -0.92 24.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.887 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 230' ' ' HIS . . . . . 0.488 ' CE1' ' HG3' ' A' ' 231' ' ' LYS . 13.7 t60 -33.54 133.37 0.17 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.833 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.488 ' HG3' ' CE1' ' A' ' 230' ' ' HIS . 47.0 mtmt 59.13 40.35 21.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.904 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -66.64 -177.01 0.53 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.834 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.576 HD21 ' CD1' ' A' ' 238' ' ' TYR . 31.3 mt -136.48 105.03 5.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.909 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 234' ' ' LEU . . . . . 0.623 HD23 ' C ' ' A' ' 234' ' ' LEU . 6.6 tt -116.35 113.67 23.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.921 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 60.55 39.42 96.42 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.514 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 4.4 mmmm 66.69 53.39 0.91 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.76 0.314 . . . . 0.0 110.882 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 20.4 mmt180 -156.21 115.47 3.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.877 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 238' ' ' TYR . . . . . 0.576 ' CD1' HD21 ' A' ' 233' ' ' LEU . 95.7 m-85 -68.64 117.36 10.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.916 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 0.929 HD13 HD23 ' A' ' 173' ' ' LEU . 17.7 mt -113.81 129.9 68.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.178 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 240' ' ' GLU . . . . . 0.725 ' O ' HD23 ' A' ' 241' ' ' LEU . 0.5 OUTLIER -89.99 175.27 7.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.869 -179.998 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . 0.725 HD23 ' O ' ' A' ' 240' ' ' GLU . 38.5 mt -151.57 144.65 24.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.907 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 242' ' ' PHE . . . . . 0.48 ' CD1' ' O ' ' A' ' 241' ' ' LEU . 15.0 m-85 -156.89 129.17 7.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.885 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . 0.475 ' CZ ' ' HB2' ' A' ' 243' ' ' ARG . 17.0 mtm105 -48.25 138.74 9.36 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.876 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . 0.449 ' HB2' ' N ' ' A' ' 169' ' ' ARG . 1.0 OUTLIER -136.25 160.46 38.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.861 -179.778 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 53.5 p -132.83 155.83 48.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.173 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 246' ' ' ALA . . . . . 0.548 ' N ' HD12 ' A' ' 167' ' ' ILE . . . -40.51 -58.65 1.52 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.058 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -53.44 -55.69 23.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.114 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -46.02 -46.06 16.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.885 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 0.486 HG21 HD13 ' A' ' 167' ' ' ILE . 98.2 t -51.62 -62.54 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.126 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 250' ' ' GLN . . . . . 0.497 ' HA ' HD12 ' A' ' 253' ' ' LEU . 49.5 mt-30 -47.66 -33.38 6.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.898 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 251' ' ' GLN . . . . . 0.499 ' O ' ' ND2' ' A' ' 254' ' ' ASN . 29.4 mm-40 -76.76 -26.3 54.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.921 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 43.1 t -82.38 -21.64 9.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.114 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 253' ' ' LEU . . . . . 0.497 HD12 ' HA ' ' A' ' 250' ' ' GLN . 10.5 mt -85.41 -43.24 13.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.875 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 254' ' ' ASN . . . . . 0.499 ' ND2' ' O ' ' A' ' 251' ' ' GLN . 0.4 OUTLIER -65.22 -46.0 82.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.876 179.962 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . 0.401 ' N ' ' CG ' ' A' ' 254' ' ' ASN . 7.5 ptm180 -48.68 -30.72 5.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.896 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -88.42 -32.39 18.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.886 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 32.3 t . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.845 -179.767 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.9 0.381 . . . . 0.0 110.897 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.498 ' O ' ' N ' ' A' ' 159' ' ' PHE . 20.5 t -73.55 -58.03 5.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.141 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.443 ' C ' ' O ' ' A' ' 156' ' ' VAL . . . -34.07 -57.17 0.48 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.087 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 82.3 mt-30 -67.28 -33.79 76.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.931 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' PHE . . . . . 0.498 ' N ' ' O ' ' A' ' 156' ' ' VAL . 71.4 t80 -62.76 -39.49 94.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.867 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.443 HD22 ' HB1' ' A' ' 246' ' ' ALA . 82.8 mt -90.21 -17.13 28.09 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.884 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 13.1 t -55.45 -31.84 62.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.845 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . 0.544 ' HG3' HD13 ' A' ' 216' ' ' LEU . 25.6 mmtt -60.98 118.12 6.33 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.95 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -97.33 136.88 37.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.88 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 74.53 43.99 0.24 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.891 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 0.47 ' NE2' ' HA ' ' A' ' 165' ' ' GLN . 8.5 mm100 -122.87 176.16 6.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.92 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.407 HG11 ' CB ' ' A' ' 223' ' ' ALA . 15.8 t -129.14 119.68 49.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.112 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' ILE . . . . . 0.479 HD12 ' N ' ' A' ' 246' ' ' ALA . 14.6 mt -93.21 149.57 4.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.084 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 57.5 t -130.93 137.01 56.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.123 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 50.7 ttt-85 -92.27 109.4 20.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.854 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' MET . . . . . 0.641 ' CE ' HD21 ' A' ' 173' ' ' LEU . 96.6 mtp -102.05 120.63 40.73 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.846 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 3.3 ttt85 -122.76 139.38 54.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.884 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 90.53 28.24 17.35 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.502 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.675 HD23 HD13 ' A' ' 239' ' ' ILE . 30.4 mt -82.52 127.37 70.88 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.607 0.718 . . . . 0.0 110.836 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . 0.493 ' HG3' ' CB ' ' A' ' 237' ' ' ARG . 65.9 Cg_exo -48.06 126.2 12.92 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.665 2.243 . . . . 0.0 112.32 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . 0.58 ' CE2' ' HG2' ' A' ' 209' ' ' PRO . 3.8 m-85 -44.06 -24.19 0.14 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.882 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 67.3 p -86.37 -37.16 18.7 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.133 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . 0.401 ' N ' ' O ' ' A' ' 174' ' ' PRO . . . -49.21 124.68 9.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.093 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . 0.651 HG22 ' H ' ' A' ' 179' ' ' ALA . 0.2 OUTLIER -123.76 -173.67 2.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.127 -179.925 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.651 ' H ' HG22 ' A' ' 178' ' ' THR . . . -51.35 -48.05 62.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.085 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -56.76 -33.44 66.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.878 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . 0.715 ' OE2' HD21 ' A' ' 234' ' ' LEU . 4.0 mm-40 -72.41 -22.91 61.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.9 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.651 HG12 HD11 ' A' ' 192' ' ' ILE . 93.9 t -87.21 -48.5 15.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.182 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 44.7 t -39.95 -42.53 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.098 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -81.34 -44.19 17.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.064 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.616 ' HD2' HD12 ' A' ' 234' ' ' LEU . 18.3 t80 -40.01 -58.14 1.48 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.862 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 186' ' ' PHE . . . . . 0.449 ' CE1' ' CE1' ' A' ' 185' ' ' PHE . 79.3 m-85 -94.34 -22.99 17.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.874 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -49.29 -21.63 2.97 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.505 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 -54.3 -70.88 0.09 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.834 0.349 . . . . 0.0 110.968 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 6.6 m-70 -118.02 -15.49 9.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.881 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 82.8 m -120.35 86.4 38.58 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.612 0.72 . . . . 0.0 110.909 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 191' ' ' PRO . . . . . 0.406 ' HD2' ' CD1' ' A' ' 222' ' ' TYR . 53.8 Cg_endo -69.78 134.35 27.73 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.685 2.256 . . . . 0.0 112.374 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . 0.666 HG23 ' O ' ' A' ' 216' ' ' LEU . 48.2 mt -84.12 143.31 12.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.176 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 93.5 m -68.06 106.24 2.31 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.135 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 89.72 -20.55 34.62 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.475 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 78.62 -125.65 7.19 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.498 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . 0.438 ' HA ' HD12 ' A' ' 199' ' ' ILE . 4.7 ptpt -49.49 -21.72 1.02 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.742 0.306 . . . . 0.0 110.845 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -83.54 -30.88 26.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.903 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . 0.503 ' HA2' HD12 ' A' ' 216' ' ' LEU . . . -89.77 39.64 3.1 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.491 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.438 HD12 ' HA ' ' A' ' 196' ' ' LYS . 42.6 mt -139.94 149.36 22.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.894 0.378 . . . . 0.0 111.139 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 13.4 tp -143.24 113.16 7.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.937 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 201' ' ' PHE . . . . . 0.426 ' CE1' HG21 ' A' ' 199' ' ' ILE . 49.2 m-85 -95.22 112.38 24.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.854 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.454 HG11 ' OD2' ' A' ' 212' ' ' ASP . 22.9 t -64.12 118.98 7.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.096 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -127.66 138.29 52.78 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.132 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -45.9 158.49 0.35 Allowed Pre-proline 0 C--N 1.328 -0.369 0 CA-C-O 121.719 0.771 . . . . 0.0 110.925 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 2.88 3.12 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.694 2.263 . . . . 0.0 112.379 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -111.45 -15.34 13.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.866 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 105.9 61.94 0.62 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.518 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 41.7 mtt180 -150.9 149.58 25.65 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.587 0.708 . . . . 0.0 110.861 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 209' ' ' PRO . . . . . 0.58 ' HG2' ' CE2' ' A' ' 175' ' ' PHE . 53.3 Cg_endo -69.84 121.0 7.67 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.655 2.237 . . . . 0.0 112.347 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . 0.531 ' HB ' ' CE2' ' A' ' 256' ' ' PHE . 72.0 p -90.21 -3.95 57.52 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.157 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 89.27 -41.18 3.02 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.473 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 212' ' ' ASP . . . . . 0.454 ' OD2' HG11 ' A' ' 202' ' ' VAL . 1.2 p-10 -77.24 158.29 30.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.816 0.341 . . . . 0.0 110.881 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . 0.448 ' HB3' HD12 ' A' ' 173' ' ' LEU . . . -162.03 177.07 10.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.103 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . 0.59 ' CE2' HG13 ' A' ' 249' ' ' VAL . 47.7 m-85 -140.17 153.6 46.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.908 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 14.8 t -136.41 151.88 28.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.128 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 0.666 ' O ' HG23 ' A' ' 192' ' ' ILE . 33.2 mt -105.68 150.55 25.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.881 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -142.66 147.31 35.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.941 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . 0.454 ' HB3' ' CD2' ' A' ' 222' ' ' TYR . . . -54.71 -66.96 0.31 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.112 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 219' ' ' CYS . . . . . . . . . . . . . 6.4 p -133.22 175.31 9.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.928 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -61.49 -24.41 66.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.869 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -58.83 -29.91 67.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.922 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 222' ' ' TYR . . . . . 0.454 ' CD2' ' HB3' ' A' ' 218' ' ' ALA . 34.9 m-85 -91.99 -40.16 11.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.932 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . 0.407 ' CB ' HG11 ' A' ' 166' ' ' VAL . . . -64.18 -51.38 64.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.087 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 224' ' ' GLN . . . . . 0.4 ' HA ' ' CD1' ' A' ' 227' ' ' LEU . 12.7 mm-40 -55.81 -53.95 50.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.92 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 -54.52 -26.3 30.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.917 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -74.84 -28.58 60.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.086 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . 0.4 ' CD1' ' HA ' ' A' ' 224' ' ' GLN . 26.1 mt -59.92 -29.17 68.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.852 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 30.2 mtp85 -59.55 -28.82 67.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.837 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . 0.513 ' HD2' ' CE1' ' A' ' 185' ' ' PHE . 20.0 mtmt -74.91 -1.03 20.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.889 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 230' ' ' HIS . . . . . 0.555 ' CE1' ' HG3' ' A' ' 231' ' ' LYS . 34.7 t60 -33.3 129.85 0.25 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.856 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.555 ' HG3' ' CE1' ' A' ' 230' ' ' HIS . 49.9 mtmt 62.04 37.17 14.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.926 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -63.37 179.59 0.42 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.838 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.663 HD21 ' CE1' ' A' ' 238' ' ' TYR . 33.6 mt -131.61 106.33 8.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.932 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 234' ' ' LEU . . . . . 0.715 HD21 ' OE2' ' A' ' 181' ' ' GLU . 7.7 tt -116.2 114.53 24.55 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.932 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 60.68 34.35 86.06 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.506 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 32.4 mtpt 71.19 52.15 0.26 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.795 0.331 . . . . 0.0 110.908 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 237' ' ' ARG . . . . . 0.493 ' CB ' ' HG3' ' A' ' 174' ' ' PRO . 18.5 mmt180 -155.77 115.36 3.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.884 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 238' ' ' TYR . . . . . 0.663 ' CE1' HD21 ' A' ' 233' ' ' LEU . 97.6 m-85 -67.44 119.23 11.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.921 -179.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 0.675 HD13 HD23 ' A' ' 173' ' ' LEU . 80.0 mt -115.61 126.93 73.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.105 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 240' ' ' GLU . . . . . 0.476 ' HB3' ' CE2' ' A' ' 242' ' ' PHE . 37.2 mt-10 -86.13 171.61 11.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.903 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 18.8 mt -152.21 139.41 19.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.915 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 242' ' ' PHE . . . . . 0.476 ' CE2' ' HB3' ' A' ' 240' ' ' GLU . 16.5 m-85 -153.35 126.78 8.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.915 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 61.2 mtm180 -39.85 155.02 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.912 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 19.0 t -156.66 160.7 39.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.827 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 18.0 p -135.86 167.36 21.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.153 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 246' ' ' ALA . . . . . 0.479 ' N ' HD12 ' A' ' 167' ' ' ILE . . . -42.46 -58.52 2.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.091 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -54.0 -56.33 18.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.109 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . 0.952 ' O ' HG23 ' A' ' 252' ' ' VAL . 22.5 tp10 -40.66 -46.26 2.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.877 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 0.59 HG13 ' CE2' ' A' ' 214' ' ' PHE . 99.1 t -61.57 -60.72 2.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.16 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 250' ' ' GLN . . . . . 0.544 ' HA ' HD12 ' A' ' 253' ' ' LEU . 59.9 mt-30 -38.27 -61.18 0.7 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.876 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 251' ' ' GLN . . . . . 0.454 ' CG ' ' O ' ' A' ' 248' ' ' GLU . 7.8 pt20 -53.47 -44.26 68.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.906 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 252' ' ' VAL . . . . . 0.952 HG23 ' O ' ' A' ' 248' ' ' GLU . 92.5 t -59.96 -40.57 83.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.136 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 253' ' ' LEU . . . . . 0.544 HD12 ' HA ' ' A' ' 250' ' ' GLN . 34.6 mt -59.43 -50.84 72.39 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.901 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 254' ' ' ASN . . . . . 0.5 ' OD1' ' N ' ' A' ' 255' ' ' ARG . 0.6 OUTLIER -61.92 -40.18 94.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.89 179.924 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . 0.5 ' N ' ' OD1' ' A' ' 254' ' ' ASN . 43.2 ttt180 -40.59 -58.47 1.59 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.847 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 256' ' ' PHE . . . . . 0.531 ' CE2' ' HB ' ' A' ' 210' ' ' THR . 55.9 m-85 -74.14 -53.94 8.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.871 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 257' ' ' SER . . . . . 0.425 ' C ' ' O ' ' A' ' 256' ' ' PHE . 29.5 t . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.88 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.329 0 N-CA-C 112.497 -0.241 . . . . 0.0 112.497 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 57.9 m -111.35 129.72 55.91 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.886 0.374 . . . . 0.0 110.904 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 1.3 t -80.17 156.03 27.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.882 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -163.69 -49.15 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.462 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 87.4 p -62.16 -49.64 75.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.827 0.346 . . . . 0.0 110.799 -179.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 66.7 m -113.97 108.75 17.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.86 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 140.96 61.23 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.505 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 93.88 103.8 1.73 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.509 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -78.38 80.46 1.41 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.483 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 3.6 m -151.95 116.74 5.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.804 0.335 . . . . 0.0 111.13 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 4.2 m -82.2 170.6 15.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.839 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 54.7 m-80 -60.73 -42.94 98.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.876 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -63.76 -44.87 92.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.903 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 94.1 t -59.32 -47.43 90.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.145 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -37.52 -56.79 0.99 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.072 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -61.59 -40.23 94.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.914 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -59.71 -41.17 90.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.849 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 88.1 mt -87.95 -19.17 27.61 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.915 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 29.5 t -61.62 -22.28 65.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.844 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 39.5 mmtm -72.37 118.55 15.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.931 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -97.46 155.67 16.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.92 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 2.8 m120 63.34 45.64 4.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.884 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 24.0 mm-40 -132.05 149.22 52.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.9 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 55.9 t -103.27 108.04 23.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.129 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . 0.458 HD13 HG21 ' A' ' 249' ' ' VAL . 86.8 mt -78.04 141.79 15.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.135 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 92.9 t -122.23 129.28 75.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.113 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 32.5 ttp180 -88.33 106.94 18.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.888 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' MET . . . . . 0.69 ' CE ' HD21 ' A' ' 173' ' ' LEU . 96.9 mtp -94.9 126.35 40.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.858 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 26.1 mtt180 -128.03 142.79 51.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.882 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 79.36 45.19 8.94 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.436 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.744 HD23 HD13 ' A' ' 239' ' ' ILE . 21.1 mt -93.42 133.68 27.96 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.553 0.692 . . . . 0.0 110.953 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . 0.462 ' HG3' ' CB ' ' A' ' 237' ' ' ARG . 64.9 Cg_exo -47.98 133.57 23.26 Favored 'Trans proline' 0 N--CA 1.465 -0.168 0 C-N-CA 122.737 2.291 . . . . 0.0 112.318 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -53.99 -19.26 4.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.836 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 74.7 p -96.29 -22.41 17.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.16 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -60.7 125.97 25.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.078 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -125.89 178.26 5.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.127 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.608 ' O ' HG23 ' A' ' 183' ' ' VAL . . . -45.87 -42.69 12.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.069 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -58.21 -41.8 84.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.926 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -61.82 -42.28 98.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.886 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.449 ' O ' ' C ' ' A' ' 183' ' ' VAL . 47.1 t -65.06 -54.4 29.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.099 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.608 HG23 ' O ' ' A' ' 179' ' ' ALA . 91.4 t -33.99 -52.02 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.131 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.419 ' O ' ' C ' ' A' ' 185' ' ' PHE . . . -72.89 -45.74 56.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.093 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.768 ' HD2' HD12 ' A' ' 234' ' ' LEU . 35.2 t80 -36.89 -62.46 0.48 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.875 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' PHE . . . . . 0.511 ' CE1' ' CE1' ' A' ' 185' ' ' PHE . 55.3 m-85 -91.38 -20.81 21.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.869 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -49.01 -23.32 3.62 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.54 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 30.2 mm-40 -50.64 -74.03 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.827 0.346 . . . . 0.0 110.952 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 29.4 m170 -118.19 -18.17 9.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.877 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 58.6 m -115.05 84.24 10.65 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.635 0.731 . . . . 0.0 110.867 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' PRO . . . . . 0.435 ' HD2' ' CD1' ' A' ' 222' ' ' TYR . 53.3 Cg_endo -69.77 142.89 49.12 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.705 2.27 . . . . 0.0 112.31 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . 0.563 HG23 ' O ' ' A' ' 216' ' ' LEU . 62.6 mt -94.11 144.99 8.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.113 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 87.1 m -70.38 96.5 1.15 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.183 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 95.85 -2.74 64.48 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.508 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 52.8 -120.01 11.14 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.499 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.27 -27.43 2.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.765 0.316 . . . . 0.0 110.893 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 43.9 mm-40 -80.02 -29.98 39.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.85 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -95.23 41.29 2.52 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.497 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 61.9 mt -141.88 140.54 30.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.828 0.347 . . . . 0.0 111.112 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 13.2 tp -135.91 117.49 14.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.972 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -97.15 115.65 27.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.917 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.557 HG23 ' HA ' ' A' ' 213' ' ' ALA . 14.2 t -70.01 121.92 20.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.151 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . 0.436 ' HA ' HG23 ' A' ' 210' ' ' THR . 0.8 OUTLIER -131.45 137.99 48.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.151 -179.969 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . 0.428 ' CD2' HG22 ' A' ' 210' ' ' THR . 28.0 m-85 -46.45 158.57 0.39 Allowed Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.673 0.749 . . . . 0.0 110.932 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 2.87 3.13 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.689 2.259 . . . . 0.0 112.372 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -109.37 -21.3 12.58 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.875 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 112.01 49.27 0.63 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.466 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -133.7 144.02 50.18 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.645 0.736 . . . . 0.0 110.862 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 101.79 0.96 Allowed 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.664 2.243 . . . . 0.0 112.354 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . 0.436 HG23 ' HA ' ' A' ' 203' ' ' THR . 46.0 p -66.45 -25.18 66.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.128 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 104.74 -37.71 3.65 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.471 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' ASP . . . . . 0.472 ' OD2' HG11 ' A' ' 202' ' ' VAL . 1.6 p-10 -78.09 155.7 30.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.771 0.32 . . . . 0.0 110.929 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . 0.557 ' HA ' HG23 ' A' ' 202' ' ' VAL . . . -157.5 -179.1 7.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.119 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . 0.452 ' CE2' HG13 ' A' ' 249' ' ' VAL . 77.6 m-85 -144.5 140.36 28.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.819 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . 0.407 HG12 ' N ' ' A' ' 216' ' ' LEU . 4.6 t -124.28 158.99 30.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.133 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.563 ' O ' HG23 ' A' ' 192' ' ' ILE . 30.4 mt -111.3 142.54 43.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.958 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -135.44 129.52 33.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.916 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -39.64 -64.48 0.48 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.075 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' CYS . . . . . . . . . . . . . 85.3 m -138.93 -175.34 4.11 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.89 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -71.2 -8.74 55.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.917 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -68.28 -34.62 76.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.922 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' TYR . . . . . 0.435 ' CD1' ' HD2' ' A' ' 191' ' ' PRO . 19.6 m-85 -92.42 -48.88 6.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.92 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -49.76 -53.59 24.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.075 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' GLN . . . . . 0.56 ' HA ' HD12 ' A' ' 227' ' ' LEU . 29.5 mt-30 -52.76 -60.16 3.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.897 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -49.76 -28.57 6.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.915 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -76.23 -36.04 58.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.078 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . 0.56 HD12 ' HA ' ' A' ' 224' ' ' GLN . 43.8 mt -55.35 -36.51 66.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.93 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 3.9 mtp-105 -58.23 -18.98 30.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.883 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . 0.459 ' O ' ' C ' ' A' ' 230' ' ' HIS . 23.7 mtpp -78.78 -2.54 40.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.872 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' HIS . . . . . 0.542 ' CD2' ' HG2' ' A' ' 231' ' ' LYS . 78.5 t60 -33.89 136.88 0.11 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.857 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.542 ' HG2' ' CD2' ' A' ' 230' ' ' HIS . 23.1 mmtm 62.16 31.08 17.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.857 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -59.69 -176.24 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.823 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.874 HD21 ' CE1' ' A' ' 238' ' ' TYR . 31.6 mt -140.06 110.42 6.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.93 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . 0.768 HD12 ' HD2' ' A' ' 185' ' ' PHE . 6.8 tt -119.64 114.16 21.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.91 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 58.26 36.1 81.36 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.497 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 38.7 mttp 71.21 52.13 0.26 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.744 0.306 . . . . 0.0 110.912 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' ARG . . . . . 0.462 ' CB ' ' HG3' ' A' ' 174' ' ' PRO . 19.6 mmt180 -155.79 115.46 3.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.901 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' TYR . . . . . 0.874 ' CE1' HD21 ' A' ' 233' ' ' LEU . 83.5 m-85 -69.72 133.0 47.0 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.955 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 0.744 HD13 HD23 ' A' ' 173' ' ' LEU . 70.7 mt -131.69 141.04 46.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.134 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . 0.578 ' HB3' ' CZ ' ' A' ' 242' ' ' PHE . 24.6 mt-10 -92.89 178.33 5.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.906 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . 0.593 ' O ' ' CD1' ' A' ' 242' ' ' PHE . 51.0 mt -157.64 137.35 12.21 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.893 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' PHE . . . . . 0.593 ' CD1' ' O ' ' A' ' 241' ' ' LEU . 5.2 m-85 -157.53 122.8 4.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.871 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . 0.492 ' O ' ' CG ' ' A' ' 243' ' ' ARG . 19.9 ptt180 -59.57 112.58 1.84 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.873 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 1.7 t -106.98 164.32 12.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.866 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . 0.594 ' O ' HG23 ' A' ' 249' ' ' VAL . 33.7 p -110.19 166.51 10.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.166 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -54.38 -61.53 2.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.079 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -45.44 -56.26 5.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.083 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -45.7 -55.78 6.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.89 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.594 HG23 ' O ' ' A' ' 245' ' ' THR . 99.8 t -41.72 -59.88 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.138 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' GLN . . . . . 0.479 ' HA ' HD12 ' A' ' 253' ' ' LEU . 33.8 mt-30 -47.83 -42.56 26.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.882 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' GLN . . . . . 0.494 ' O ' ' ND2' ' A' ' 254' ' ' ASN . 35.4 mm-40 -68.46 -22.6 64.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.952 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 76.7 t -85.1 -21.1 8.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.11 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.479 HD12 ' HA ' ' A' ' 250' ' ' GLN . 10.9 mt -87.38 -42.18 13.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.945 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . 0.494 ' ND2' ' O ' ' A' ' 251' ' ' GLN . 0.5 OUTLIER -64.47 -43.41 94.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.898 179.906 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -53.76 -42.36 68.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.888 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -80.87 -34.02 33.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.848 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . 0.405 ' O ' ' C ' ' A' ' 258' ' ' SER . 20.6 m -73.32 138.88 45.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.875 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . 0.432 ' O ' ' C ' ' A' ' 259' ' ' ALA . 88.4 p 37.63 39.18 0.18 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.903 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 259' ' ' ALA . . . . . 0.432 ' C ' ' O ' ' A' ' 258' ' ' SER . . . -35.12 130.56 0.45 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.103 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 9.6 t -103.88 39.18 1.67 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.877 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . 0.42 ' HA3' ' C ' ' A' ' 262' ' ' PRO . . . -153.19 -70.64 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.524 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 262' ' ' PRO . . . . . 0.42 ' C ' ' HA3' ' A' ' 261' ' ' GLY . 54.2 Cg_endo -69.7 -11.96 11.93 Favored 'Cis proline' 0 C--N 1.341 0.18 0 C-N-CA 122.691 -1.795 . . . . 0.0 112.338 0.002 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 32.4 t -55.63 147.01 19.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.872 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 60.6 p -93.93 42.05 1.09 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.898 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.349 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.508 -179.967 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.345 0 N-CA-C 112.466 -0.254 . . . . 0.0 112.466 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 88.7 p -169.81 148.24 3.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.883 0.373 . . . . 0.0 110.885 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 5.6 t -57.39 143.87 38.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.885 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -163.52 -59.41 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.454 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.8 m -87.73 125.65 34.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.867 0.365 . . . . 0.0 110.812 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 9.8 t -120.98 138.32 54.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.886 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -123.2 164.58 16.15 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.477 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 138.44 -69.39 0.49 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.467 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -116.17 161.39 12.96 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.474 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.54 HG22 HG23 ' A' ' 156' ' ' VAL . 0.7 OUTLIER -117.2 -25.56 7.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.773 0.32 . . . . 0.0 111.115 -179.862 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . 0.424 ' C ' ' O ' ' A' ' 152' ' ' THR . 77.4 p -36.27 -42.2 0.3 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.862 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . 0.416 ' O ' ' HB3' ' A' ' 157' ' ' ALA . 14.3 t-20 -67.26 -57.57 6.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.865 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -51.07 -47.89 61.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.9 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.54 HG23 HG22 ' A' ' 152' ' ' THR . 76.8 t -66.43 -36.75 78.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.151 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.416 ' HB3' ' O ' ' A' ' 154' ' ' ASN . . . -44.32 -51.37 8.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.079 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -61.37 -51.11 70.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.929 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' PHE . . . . . 0.502 ' CE1' ' HG ' ' A' ' 216' ' ' LEU . 85.3 t80 -46.24 -46.1 17.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.875 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 92.0 mt -84.5 -18.55 35.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.918 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 17.6 t -56.82 -25.38 55.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.845 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . 0.557 ' HG3' HD13 ' A' ' 216' ' ' LEU . 28.3 mmtt -71.04 131.78 44.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.886 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -110.01 156.97 19.79 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.847 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 3.5 m120 65.03 36.17 7.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.882 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 22.2 mm-40 -124.95 160.08 29.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.91 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 25.3 t -111.6 115.71 50.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.174 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 19.3 mt -86.99 140.27 16.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.14 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.404 HG21 ' CE2' ' A' ' 217' ' ' PHE . 30.0 t -122.17 137.26 56.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.157 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 51.4 ttp180 -92.29 112.51 24.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.84 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' MET . . . . . 0.48 ' CE ' HD21 ' A' ' 173' ' ' LEU . 98.9 mtp -107.29 111.64 24.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.917 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 10.3 ptm180 -118.92 133.96 55.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.835 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 100.6 18.21 21.58 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.47 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.752 HD23 HD13 ' A' ' 239' ' ' ILE . 31.0 mt -73.85 133.16 79.47 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.633 0.73 . . . . 0.0 110.91 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . 0.448 ' HG3' ' CB ' ' A' ' 237' ' ' ARG . 65.8 Cg_exo -48.0 135.08 23.92 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.642 2.228 . . . . 0.0 112.369 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 3.3 m-30 -49.71 -35.11 20.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.884 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.421 ' O ' ' C ' ' A' ' 177' ' ' ALA . 22.8 p -77.68 -43.96 29.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.153 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.429 ' HA ' ' CD ' ' A' ' 181' ' ' GLU . . . -35.55 128.97 0.59 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.087 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 3.9 p -124.54 -178.7 4.21 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.132 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -56.75 -41.78 78.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.098 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -58.84 -34.97 72.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.904 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . 0.429 ' CD ' ' HA ' ' A' ' 177' ' ' ALA . 36.4 mt-10 -69.52 -37.37 77.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.885 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.588 HG12 ' CD1' ' A' ' 192' ' ' ILE . 26.1 t -68.93 -47.01 78.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.176 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 37.7 t -37.95 -49.4 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.096 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.423 ' O ' ' C ' ' A' ' 185' ' ' PHE . . . -74.28 -44.84 51.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.105 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.619 ' CE1' ' CE1' ' A' ' 186' ' ' PHE . 5.7 t80 -36.89 -64.07 0.38 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.829 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' PHE . . . . . 0.619 ' CE1' ' CE1' ' A' ' 185' ' ' PHE . 59.9 m-85 -89.19 -21.64 23.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.899 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -49.62 -26.15 7.36 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.514 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 16.5 tt0 -48.98 -70.91 0.08 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.863 0.363 . . . . 0.0 110.971 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 65.9 m80 -118.27 -16.6 9.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.869 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' CYS . . . . . 0.438 ' N ' ' O ' ' A' ' 186' ' ' PHE . 74.4 m -120.11 85.36 35.35 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.569 0.699 . . . . 0.0 110.818 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' PRO . . . . . 0.458 ' HD2' ' CD1' ' A' ' 222' ' ' TYR . 53.8 Cg_endo -69.78 130.04 18.62 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.701 2.268 . . . . 0.0 112.338 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . 0.588 ' CD1' HG12 ' A' ' 182' ' ' VAL . 53.2 mt -79.03 142.92 13.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.122 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 21.9 m -66.74 98.66 0.54 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.164 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 89.22 -3.92 84.3 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.465 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.412 ' O ' ' N ' ' A' ' 198' ' ' GLY . . . 58.24 -117.46 10.56 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.497 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 4.3 ptpp? -47.38 -28.67 2.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.779 0.323 . . . . 0.0 110.924 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -78.48 -29.85 46.99 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.932 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . 0.419 ' HA2' HD12 ' A' ' 216' ' ' LEU . . . -95.69 41.43 2.46 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.469 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.411 HG21 ' CE2' ' A' ' 201' ' ' PHE . 75.9 mt -140.7 138.3 35.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.833 0.349 . . . . 0.0 111.128 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 14.3 tp -132.99 113.03 12.34 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.915 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' PHE . . . . . 0.411 ' CE2' HG21 ' A' ' 199' ' ' ILE . 81.3 m-85 -96.58 110.81 23.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.855 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 22.0 t -67.41 127.36 28.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.128 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -132.48 141.57 48.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.168 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 -45.78 158.12 0.36 Allowed Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.686 0.755 . . . . 0.0 110.964 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 3.21 2.92 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.707 2.271 . . . . 0.0 112.355 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -112.68 -16.07 12.87 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.891 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 106.94 62.98 0.58 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.501 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 35.2 mtt180 -151.77 151.15 27.85 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.646 0.736 . . . . 0.0 110.861 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 122.42 9.09 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.701 2.268 . . . . 0.0 112.352 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 42.9 p -90.84 -21.42 21.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.123 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 104.35 -35.49 5.01 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.494 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -80.68 156.54 26.26 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.838 0.351 . . . . 0.0 110.829 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -160.74 172.87 16.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.099 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -140.23 149.13 42.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.869 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . 0.437 HG12 ' N ' ' A' ' 216' ' ' LEU . 8.1 t -131.49 159.34 43.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.179 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.557 HD13 ' HG3' ' A' ' 162' ' ' LYS . 36.9 mt -108.79 143.2 38.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.918 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . 0.404 ' CE2' HG21 ' A' ' 168' ' ' VAL . 76.9 m-85 -136.4 145.24 45.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.895 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -59.03 -62.35 1.95 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.072 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' CYS . . . . . . . . . . . . . 66.7 m -141.14 179.34 6.81 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.918 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -57.83 -36.48 72.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.877 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -40.07 -45.76 2.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.897 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' TYR . . . . . 0.458 ' CD1' ' HD2' ' A' ' 191' ' ' PRO . 24.0 m-85 -84.44 -49.9 8.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.919 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -53.49 -63.29 1.2 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.098 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 85.9 mm-40 -49.28 -52.65 26.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.882 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 61.8 m-20 -59.18 -26.33 64.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.92 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -75.27 -28.51 59.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.117 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 26.8 mt -62.37 -29.41 70.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.897 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 65.0 mtp180 -60.87 -19.5 60.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.871 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . 0.544 ' HD2' ' CE1' ' A' ' 185' ' ' PHE . 20.3 mtmm -83.02 0.69 43.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.881 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' HIS . . . . . 0.466 ' C ' ' O ' ' A' ' 229' ' ' LYS . 67.9 t60 -33.4 135.13 0.12 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.866 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.411 ' HG3' ' NE2' ' A' ' 230' ' ' HIS . 13.2 mttm 60.8 32.2 20.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.897 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . 0.475 ' OD2' ' CE2' ' A' ' 185' ' ' PHE . 15.3 t0 -55.64 175.47 0.08 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.838 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.68 HD21 ' CE1' ' A' ' 238' ' ' TYR . 30.5 mt -130.88 106.57 8.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.909 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . 0.523 HD23 ' C ' ' A' ' 234' ' ' LEU . 6.5 tt -114.38 114.31 25.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.903 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 56.49 42.72 90.23 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.526 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 22.8 mmtp 65.54 52.55 1.34 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.767 0.318 . . . . 0.0 110.877 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' ARG . . . . . 0.448 ' CB ' ' HG3' ' A' ' 174' ' ' PRO . 19.1 mmt180 -156.27 115.38 3.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.876 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' TYR . . . . . 0.68 ' CE1' HD21 ' A' ' 233' ' ' LEU . 97.6 m-85 -68.49 131.48 45.34 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.916 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 0.752 HD13 HD23 ' A' ' 173' ' ' LEU . 56.5 mt -129.1 128.28 66.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.13 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . 0.491 ' HB3' ' CZ ' ' A' ' 242' ' ' PHE . 36.7 mt-10 -88.22 159.71 18.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.9 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . 0.511 ' O ' ' CD1' ' A' ' 242' ' ' PHE . 15.2 mt -141.7 146.3 35.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.899 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' PHE . . . . . 0.511 ' CD1' ' O ' ' A' ' 241' ' ' LEU . 9.7 m-85 -158.49 155.33 28.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.825 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 72.9 mtm180 -69.29 135.61 50.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.873 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 11.2 t -134.89 163.64 29.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.834 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . 0.413 ' O ' ' C ' ' A' ' 246' ' ' ALA . 72.6 p -139.77 156.57 46.69 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.136 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' ALA . . . . . 0.413 ' C ' ' O ' ' A' ' 245' ' ' THR . . . -36.24 -52.23 0.8 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.07 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -56.87 -52.39 65.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.081 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . 0.426 ' O ' HG23 ' A' ' 252' ' ' VAL . 6.4 tp10 -49.78 -49.91 46.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.959 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 97.0 t -49.47 -66.48 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.129 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 250' ' ' GLN . . . . . 0.477 ' HA ' HD12 ' A' ' 253' ' ' LEU . 55.9 mt-30 -40.69 -42.98 1.85 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.91 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -63.87 -48.12 77.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.92 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 252' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 248' ' ' GLU . 96.0 t -57.83 -46.05 87.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.148 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.477 HD12 ' HA ' ' A' ' 250' ' ' GLN . 16.5 mt -57.32 -49.59 75.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.942 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 14.4 m-20 -60.11 -51.17 70.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.861 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 30.6 ttt180 -38.91 -52.11 1.77 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.905 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 256' ' ' PHE . . . . . 0.585 ' O ' ' HB2' ' A' ' 259' ' ' ALA . 56.3 m-85 -69.63 -50.4 44.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.912 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 8.6 m -50.54 161.21 0.34 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.828 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 5.6 t 40.11 49.02 2.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.887 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 259' ' ' ALA . . . . . 0.585 ' HB2' ' O ' ' A' ' 256' ' ' PHE . . . -99.47 92.35 5.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.102 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 12.5 t -60.17 117.95 5.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.878 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -174.74 -165.17 30.72 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.455 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 262' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 115.19 2.31 Favored 'Cis proline' 0 C--O 1.231 0.153 0 C-N-CA 122.72 -1.783 . . . . 0.0 112.327 0.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 12.7 m -152.43 146.03 24.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.828 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 1.2 t -102.18 175.28 5.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.831 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.275 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.435 179.959 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.344 0 N-CA-C 112.506 -0.237 . . . . 0.0 112.506 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 64.6 m -131.37 -46.24 0.99 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.862 0.363 . . . . 0.0 110.9 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 2.5 m -91.45 120.92 32.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.881 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -102.79 -53.37 0.91 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.481 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.4 t -44.49 130.12 6.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.908 0.385 . . . . 0.0 110.875 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 59.0 m -121.01 128.5 52.75 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.851 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -101.46 177.27 27.06 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.492 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -46.64 105.76 0.11 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.481 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 130.39 89.33 0.52 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.482 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -95.69 111.05 23.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.781 0.324 . . . . 0.0 111.12 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 20.2 m -128.35 -45.61 1.36 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.859 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . 0.475 ' OD1' ' N ' ' A' ' 155' ' ' GLU . 11.3 p30 -68.55 -52.19 34.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.901 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.475 ' N ' ' OD1' ' A' ' 154' ' ' ASN . 18.5 tt0 -53.28 -47.07 69.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.836 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.484 HG22 HD21 ' A' ' 200' ' ' LEU . 69.0 t -68.12 -44.51 84.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.15 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.425 ' C ' ' O ' ' A' ' 156' ' ' VAL . . . -36.11 -59.71 0.6 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.073 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 41.7 mm-40 -57.27 -49.88 74.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.891 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -46.33 -39.96 11.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.878 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.5 HD13 HE21 ' A' ' 250' ' ' GLN . 83.6 mt -91.33 -18.0 25.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.929 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 28.4 t -58.5 -22.65 55.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.839 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 19.8 mmtp -73.22 120.77 19.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.877 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -96.15 158.32 15.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.871 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 59.93 47.67 9.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.856 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 25.3 mm-40 -131.74 156.28 46.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.921 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 29.9 t -111.14 105.66 19.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.101 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . 0.633 HD13 HG21 ' A' ' 249' ' ' VAL . 66.4 mt -77.71 135.18 26.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.141 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 91.1 t -114.15 128.79 70.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.08 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 7.7 ttp-105 -88.35 106.09 18.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.857 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' MET . . . . . 0.694 ' CE ' HD21 ' A' ' 173' ' ' LEU . 99.3 mtp -95.57 138.32 33.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.88 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 73.7 mtt-85 -134.4 139.89 45.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.869 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 83.91 39.39 9.46 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.493 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.694 HD21 ' CE ' ' A' ' 170' ' ' MET . 24.1 mt -89.34 126.25 59.14 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.665 0.745 . . . . 0.0 110.889 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . 0.439 ' HG3' ' CB ' ' A' ' 237' ' ' ARG . 65.7 Cg_exo -47.99 132.78 22.84 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.684 2.256 . . . . 0.0 112.326 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . 0.561 ' CD1' ' HG3' ' A' ' 209' ' ' PRO . 10.3 t80 -45.19 -34.78 2.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.899 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 9.2 p -82.46 -30.34 30.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.14 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -52.84 107.0 0.19 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.116 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 5.7 p -113.02 178.16 4.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.155 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -46.48 -39.63 11.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.071 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -60.2 -34.63 73.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.875 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 38.5 mm-40 -75.38 -23.74 57.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.883 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.483 HG12 ' CD1' ' A' ' 192' ' ' ILE . 74.8 t -83.23 -47.2 18.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.17 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 54.8 t -41.47 -44.12 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.125 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -81.47 -37.06 28.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.08 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.696 ' HD2' HD12 ' A' ' 234' ' ' LEU . 19.9 t80 -45.69 -62.96 1.08 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.858 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' PHE . . . . . 0.507 ' CE1' ' CE1' ' A' ' 185' ' ' PHE . 68.7 m-85 -89.41 -20.9 23.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.911 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -49.67 -16.9 1.19 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.461 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 25.1 tp60 -58.94 -72.85 0.09 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.825 0.345 . . . . 0.0 110.878 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 23.3 m80 -118.28 -9.31 10.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.878 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 71.3 m -125.46 86.94 56.47 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.543 0.687 . . . . 0.0 110.9 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 141.35 45.04 Favored 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.708 2.272 . . . . 0.0 112.381 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . 0.698 HG23 ' O ' ' A' ' 216' ' ' LEU . 61.4 mt -95.78 141.99 14.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.116 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 14.8 m -65.38 102.98 0.74 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.168 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 89.15 -16.96 54.41 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.485 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.4 ' O ' ' N ' ' A' ' 198' ' ' GLY . . . 72.85 -122.43 8.25 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.456 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . 0.607 ' HA ' HD12 ' A' ' 199' ' ' ILE . 15.4 ptmt -46.38 -36.15 6.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.746 0.308 . . . . 0.0 110.903 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -69.85 -31.01 68.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.871 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 195' ' ' GLY . . . -91.99 39.55 3.01 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.52 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.607 HD12 ' HA ' ' A' ' 196' ' ' LYS . 48.5 mt -139.99 145.49 26.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.824 0.345 . . . . 0.0 111.116 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.484 HD21 HG22 ' A' ' 156' ' ' VAL . 15.2 tp -143.33 124.32 14.38 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.926 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -103.5 123.66 47.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.875 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 44.6 t -78.96 140.09 17.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.142 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . 0.497 ' HA ' HG23 ' A' ' 210' ' ' THR . 0.8 OUTLIER -144.79 139.15 27.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.155 -179.986 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -49.48 159.13 0.7 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.657 0.741 . . . . 0.0 110.914 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 3.24 2.88 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.673 2.248 . . . . 0.0 112.346 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -110.51 -20.83 12.43 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.863 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 114.15 34.27 1.67 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.427 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -116.16 143.62 31.34 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.621 0.724 . . . . 0.0 110.848 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . 0.561 ' HG3' ' CD1' ' A' ' 175' ' ' PHE . 53.9 Cg_endo -69.77 107.79 1.94 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.699 2.266 . . . . 0.0 112.348 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . 0.497 HG23 ' HA ' ' A' ' 203' ' ' THR . 44.9 p -73.18 -5.65 40.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.117 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 79.42 -40.56 2.21 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.48 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -69.42 161.5 29.29 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.787 0.327 . . . . 0.0 110.852 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . 0.514 ' HB3' ' CD1' ' A' ' 173' ' ' LEU . . . -164.28 -179.15 5.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.105 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -144.88 144.95 31.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.886 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . 0.445 HG12 ' N ' ' A' ' 216' ' ' LEU . 6.1 t -131.69 160.14 42.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.147 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.698 ' O ' HG23 ' A' ' 192' ' ' ILE . 37.6 mt -108.8 140.92 41.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.924 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -135.81 125.19 24.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.884 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -38.1 -73.44 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.081 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' CYS . . . . . . . . . . . . . 69.5 m -123.63 174.05 7.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.873 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -64.56 -32.91 74.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.932 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -41.28 -44.65 2.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.896 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -77.7 -43.92 29.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.906 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -50.8 -54.96 19.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.063 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 -50.55 -54.57 21.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.894 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . 0.433 ' HA ' ' NE ' ' A' ' 228' ' ' ARG . 55.0 m-20 -54.98 -27.62 45.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.912 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -76.68 -39.83 50.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.073 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 86.4 mt -55.18 -38.32 68.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.9 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . 0.433 ' NE ' ' HA ' ' A' ' 225' ' ' ASN . 50.4 mtm180 -57.99 -24.26 57.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.883 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . 0.463 ' O ' ' C ' ' A' ' 230' ' ' HIS . 28.1 mtpt -77.01 -1.52 29.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.907 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' HIS . . . . . 0.466 ' CD2' ' HG2' ' A' ' 231' ' ' LYS . 85.9 t60 -33.6 138.15 0.08 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.856 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.466 ' HG2' ' CD2' ' A' ' 230' ' ' HIS . 37.4 mmtt 62.37 25.67 15.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.937 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -52.25 -179.02 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.876 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.7 HD21 ' CE1' ' A' ' 238' ' ' TYR . 31.2 mt -139.5 107.34 5.66 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.951 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . 0.708 HD23 ' C ' ' A' ' 234' ' ' LEU . 5.4 tt -117.64 114.63 23.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.895 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 59.77 37.0 91.8 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.466 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 28.0 mmtt 68.47 52.24 0.62 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.742 0.306 . . . . 0.0 110.893 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' ARG . . . . . 0.439 ' CB ' ' HG3' ' A' ' 174' ' ' PRO . 43.6 mmt-85 -156.19 115.36 3.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.883 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' TYR . . . . . 0.7 ' CE1' HD21 ' A' ' 233' ' ' LEU . 93.8 m-85 -67.84 134.81 51.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.933 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 0.429 HD13 HD23 ' A' ' 173' ' ' LEU . 60.2 mt -132.98 136.32 55.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.133 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . 0.641 ' O ' HD23 ' A' ' 241' ' ' LEU . 66.3 mt-10 -89.33 172.6 8.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.921 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . 0.641 HD23 ' O ' ' A' ' 240' ' ' GLU . 18.4 mt -153.99 139.24 17.51 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.905 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' PHE . . . . . 0.599 ' CD1' ' O ' ' A' ' 241' ' ' LEU . 5.7 m-85 -159.13 122.87 3.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.865 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . 0.493 ' O ' ' CG ' ' A' ' 243' ' ' ARG . 19.0 ptt-85 -61.05 118.06 6.29 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.861 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 16.3 t -114.08 -179.22 3.57 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.86 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 71.3 p -127.83 162.2 27.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.137 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -50.58 -56.13 13.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.058 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -50.2 -52.31 36.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.145 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -49.79 -57.77 6.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.879 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.633 HG21 HD13 ' A' ' 167' ' ' ILE . 95.1 t -38.78 -66.81 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.135 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 250' ' ' GLN . . . . . 0.5 HE21 HD13 ' A' ' 160' ' ' LEU . 50.3 mt-30 -38.64 -48.79 1.5 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.948 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -60.32 -44.56 95.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.93 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 98.7 t -60.76 -44.93 98.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.146 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.424 HD12 ' HA ' ' A' ' 250' ' ' GLN . 17.3 mt -58.39 -49.43 77.28 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.915 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -61.07 -47.02 88.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.89 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 57.2 ttt180 -41.93 -44.04 3.3 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.883 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 256' ' ' PHE . . . . . 0.435 ' CE1' ' HB ' ' A' ' 210' ' ' THR . 49.9 m-85 -73.44 -40.08 64.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.911 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 5.4 m -60.3 -54.44 45.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.896 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 13.6 t -72.54 -50.6 24.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.863 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 259' ' ' ALA . . . . . . . . . . . . . . . 44.15 41.16 4.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.091 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 25.3 m -121.5 84.69 2.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.814 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 45.76 -171.13 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.477 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 262' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.79 179.39 22.5 Favored 'Cis proline' 0 C--N 1.342 0.202 0 C-N-CA 122.635 -1.819 . . . . 0.0 112.335 0.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 46.0 p -78.04 -47.81 17.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.871 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 17.3 m 50.4 42.29 25.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.895 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.293 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.478 -179.996 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.309 0 N-CA-C 112.487 -0.245 . . . . 0.0 112.487 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 78.7 p -44.29 110.83 0.24 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.886 0.374 . . . . 0.0 110.853 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 45.0 m -121.95 144.84 48.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.846 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -161.71 162.54 34.07 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.48 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 36.1 t -94.81 101.33 13.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.895 0.378 . . . . 0.0 110.905 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 78.4 p -90.8 159.81 16.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.857 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -152.13 -90.39 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.494 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -174.62 114.76 0.52 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.454 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -134.1 -85.96 0.25 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.486 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.453 HG22 HG23 ' A' ' 156' ' ' VAL . 1.9 m -97.58 25.09 6.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.79 0.328 . . . . 0.0 111.123 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 10.5 t -82.06 -4.72 57.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.858 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 69.8 m-20 -95.97 -44.72 7.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.911 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -73.91 -28.53 61.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.916 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.594 HG22 HD21 ' A' ' 200' ' ' LEU . 73.7 t -79.55 -43.07 23.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.156 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -41.07 -58.05 1.86 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.112 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -59.66 -44.42 93.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.94 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 28.1 t80 -53.49 -42.61 67.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.897 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 86.6 mt -88.97 -16.44 31.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.93 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 8.5 t -61.38 -32.29 72.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.843 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 43.3 mmtt -61.05 126.45 27.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.872 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -102.33 152.87 20.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.858 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 11.3 m-20 68.92 38.82 1.97 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.888 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 0.6 ' OE1' HG21 ' A' ' 193' ' ' THR . 5.4 mm-40 -128.8 146.08 51.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.923 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 60.8 t -100.31 106.48 19.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.125 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 36.0 mt -77.19 138.86 19.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.11 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 96.1 t -123.06 130.8 74.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.107 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . 0.537 ' HG3' ' CE1' ' A' ' 214' ' ' PHE . 25.6 ttm180 -88.34 113.08 23.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.857 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' MET . . . . . 0.518 ' CE ' HD21 ' A' ' 173' ' ' LEU . 97.8 mtp -98.15 126.51 43.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.873 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.62 ' O ' HG23 ' A' ' 239' ' ' ILE . 24.2 mtt180 -123.51 157.5 33.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.877 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 73.79 21.93 78.75 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.479 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.527 HD23 HD13 ' A' ' 239' ' ' ILE . 19.8 mt -74.39 127.5 87.5 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.616 0.722 . . . . 0.0 110.913 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_exo -47.96 149.32 5.73 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.666 2.244 . . . . 0.0 112.349 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 10.8 m-30 -62.49 -26.1 68.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.899 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 63.5 p -90.47 -25.62 20.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.152 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -44.91 126.52 5.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.076 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 5.9 p -125.17 176.49 6.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.15 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -57.12 -36.18 70.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.113 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -68.71 -15.83 63.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.922 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -88.53 -22.43 23.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.86 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.487 HG12 ' CD1' ' A' ' 192' ' ' ILE . 22.4 t -83.94 -52.79 12.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.16 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.425 ' C ' ' O ' ' A' ' 182' ' ' VAL . 47.7 t -36.04 -47.51 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.138 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -74.71 -36.6 62.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.101 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.605 ' HD2' HD12 ' A' ' 234' ' ' LEU . 15.5 t80 -48.51 -59.27 3.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.877 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' PHE . . . . . 0.572 ' CE1' ' CE1' ' A' ' 185' ' ' PHE . 57.2 m-85 -92.18 -21.31 20.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.898 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -49.13 -19.16 1.47 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.481 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 12.4 mm100 -56.35 -75.19 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.866 0.365 . . . . 0.0 110.949 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 2.5 t-160 -117.49 -6.28 11.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.869 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 87.0 m -126.86 86.31 59.03 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.552 0.692 . . . . 0.0 110.9 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 133.62 26.1 Favored 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.689 2.259 . . . . 0.0 112.357 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . 0.553 HG23 ' O ' ' A' ' 216' ' ' LEU . 57.9 mt -85.26 145.58 7.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.129 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . 0.6 HG21 ' OE1' ' A' ' 165' ' ' GLN . 90.9 m -73.66 107.43 5.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.105 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 93.16 -21.85 37.91 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.459 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 78.72 -122.89 6.0 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.476 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.77 -20.71 9.09 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.719 0.295 . . . . 0.0 110.89 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -85.22 -24.87 27.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.895 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . 0.443 ' HA2' HD12 ' A' ' 216' ' ' LEU . . . -93.4 40.27 2.82 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.46 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.41 HG22 ' N ' ' A' ' 200' ' ' LEU . 35.2 mt -142.75 153.0 17.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.896 0.379 . . . . 0.0 111.104 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.594 HD21 HG22 ' A' ' 156' ' ' VAL . 13.3 tp -146.34 110.96 5.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.925 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -92.89 109.81 21.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.871 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.486 HG23 ' HA ' ' A' ' 213' ' ' ALA . 11.0 t -70.99 128.05 33.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.121 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -133.04 142.66 48.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.134 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . 0.448 ' N ' HG23 ' A' ' 210' ' ' THR . 27.1 m-85 -51.4 159.12 1.22 Allowed Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.708 0.766 . . . . 0.0 110.943 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 3.4 2.78 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.648 2.232 . . . . 0.0 112.38 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -112.55 -21.32 11.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.867 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 118.03 9.69 9.59 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.489 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -92.48 141.45 24.75 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.581 0.705 . . . . 0.0 110.887 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 106.49 1.67 Allowed 'Trans proline' 0 C--O 1.233 0.225 0 C-N-CA 122.69 2.26 . . . . 0.0 112.333 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . 0.527 ' HB ' ' CE1' ' A' ' 256' ' ' PHE . 71.0 p -66.11 -23.4 66.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.131 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 95.49 -22.59 38.07 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.501 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' ASP . . . . . 0.428 ' OD1' ' CZ ' ' A' ' 256' ' ' PHE . 1.0 OUTLIER -90.16 157.03 17.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.776 0.322 . . . . 0.0 110.899 -179.988 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . 0.486 ' HA ' HG23 ' A' ' 202' ' ' VAL . . . -159.37 178.73 9.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.107 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . 0.537 ' CE1' ' HG3' ' A' ' 169' ' ' ARG . 55.4 m-85 -143.64 145.65 32.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.909 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . 0.45 HG12 ' N ' ' A' ' 216' ' ' LEU . 4.0 t -131.9 162.02 40.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.137 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.553 ' O ' HG23 ' A' ' 192' ' ' ILE . 45.3 mt -111.8 137.45 49.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.903 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -130.12 142.39 50.6 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.881 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . 0.853 ' HB3' ' CD2' ' A' ' 222' ' ' TYR . . . -50.32 -61.66 2.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.093 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' CYS . . . . . . . . . . . . . 1.9 t -153.11 175.3 13.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.833 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -49.2 -31.31 8.32 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.891 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -51.57 -36.07 43.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.918 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' TYR . . . . . 0.853 ' CD2' ' HB3' ' A' ' 218' ' ' ALA . 33.3 m-85 -92.02 -41.51 10.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.926 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -56.81 -54.41 46.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.114 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 10.2 mm-40 -50.37 -52.11 40.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.893 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 22.4 m-20 -58.6 -23.84 59.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.858 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -79.48 -45.88 18.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.112 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 57.3 mt -52.13 -35.67 49.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.898 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 65.5 mtp180 -56.77 -29.56 62.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.912 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . 0.465 ' O ' ' C ' ' A' ' 230' ' ' HIS . 16.3 mtpp -74.7 -0.69 18.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.896 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' HIS . . . . . 0.537 ' CD2' ' HG2' ' A' ' 231' ' ' LYS . 86.3 t60 -33.35 141.39 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.842 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.537 ' HG2' ' CD2' ' A' ' 230' ' ' HIS . 13.1 mmtp 59.78 26.62 15.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.9 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -53.42 177.96 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.853 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.582 HD21 ' CD1' ' A' ' 238' ' ' TYR . 32.9 mt -136.58 105.03 5.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.97 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . 0.605 HD12 ' HD2' ' A' ' 185' ' ' PHE . 7.0 tt -113.94 115.53 27.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.9 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 59.17 37.18 91.39 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.484 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 62.9 mttt 69.08 52.57 0.49 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.809 0.338 . . . . 0.0 110.877 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 23.2 mmt180 -155.99 117.26 3.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.879 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' TYR . . . . . 0.582 ' CD1' HD21 ' A' ' 233' ' ' LEU . 96.1 m-85 -69.17 133.99 48.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.95 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 0.62 HG23 ' O ' ' A' ' 171' ' ' ARG . 76.2 mt -132.59 135.96 56.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.136 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . 0.558 ' HB3' ' CZ ' ' A' ' 242' ' ' PHE . 6.8 mt-10 -87.38 179.38 6.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.878 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . 0.59 ' O ' ' CD1' ' A' ' 242' ' ' PHE . 54.8 mt -158.29 132.62 8.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.889 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' PHE . . . . . 0.59 ' CD1' ' O ' ' A' ' 241' ' ' LEU . 6.7 m-85 -154.03 123.05 6.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.861 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . 0.486 ' O ' ' CG ' ' A' ' 243' ' ' ARG . 20.5 ptt180 -59.72 116.46 4.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.893 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 1.9 t -103.89 175.37 5.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.814 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 52.9 p -127.98 150.06 50.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.107 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -40.44 -59.35 1.34 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.056 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -52.36 -51.27 59.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.127 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . 0.408 ' O ' ' N ' ' A' ' 251' ' ' GLN . 13.3 tp10 -52.21 -57.29 10.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.942 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.526 HG13 ' CE2' ' A' ' 214' ' ' PHE . 86.9 t -36.85 -60.13 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.122 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 250' ' ' GLN . . . . . 0.412 ' HA ' HD12 ' A' ' 253' ' ' LEU . 41.7 mt-30 -49.89 -40.37 42.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.896 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 251' ' ' GLN . . . . . 0.499 ' O ' ' ND2' ' A' ' 254' ' ' ASN . 41.9 mt-30 -69.7 -19.88 63.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.943 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 69.0 t -88.64 -26.82 5.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.111 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.412 HD12 ' HA ' ' A' ' 250' ' ' GLN . 10.5 mt -81.46 -39.17 25.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.91 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . 0.499 ' ND2' ' O ' ' A' ' 251' ' ' GLN . 0.7 OUTLIER -66.41 -45.43 79.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.885 179.918 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . 0.507 ' CG ' ' N ' ' A' ' 256' ' ' PHE . 6.0 ptm180 -48.07 -48.72 33.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.87 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 256' ' ' PHE . . . . . 0.527 ' CE1' ' HB ' ' A' ' 210' ' ' THR . 12.9 m-85 -64.58 -41.83 96.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.891 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 57.8 m -71.39 152.07 43.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.893 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 1.9 m 38.43 32.98 0.06 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.823 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 259' ' ' ALA . . . . . . . . . . . . . . . -64.95 138.47 58.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.077 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 67.9 m -113.49 -53.29 2.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.885 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 72.71 -168.57 53.05 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.513 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 262' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.75 -40.62 1.07 Allowed 'Cis proline' 0 C--N 1.342 0.203 0 C-N-CA 122.698 -1.793 . . . . 0.0 112.349 0.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 22.1 t -97.82 -55.2 2.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.886 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 58.8 m -89.31 126.63 35.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.843 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.341 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.504 179.989 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 N-CA-C 112.478 -0.249 . . . . 0.0 112.478 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 99.9 p -54.53 130.13 38.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.89 0.376 . . . . 0.0 110.895 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 27.4 p -98.47 111.44 23.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.863 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -85.23 -45.98 5.72 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.46 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 38.3 p -149.53 146.38 27.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.856 0.36 . . . . 0.0 110.839 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 89.3 p -45.24 -43.9 10.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.837 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -83.64 -76.07 1.17 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.524 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 41.61 -105.57 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.539 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.471 ' O ' ' ND2' ' A' ' 154' ' ' ASN . . . -111.66 162.62 12.38 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.504 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.89 HG22 HG23 ' A' ' 156' ' ' VAL . 2.8 m -91.46 -38.45 12.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.811 0.339 . . . . 0.0 111.165 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . 0.426 ' C ' ' O ' ' A' ' 152' ' ' THR . 64.5 p -35.13 -34.56 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.853 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . 0.471 ' ND2' ' O ' ' A' ' 151' ' ' GLY . 3.3 m-80 -61.52 -56.8 16.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.896 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -69.6 -35.57 75.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.884 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.89 HG23 HG22 ' A' ' 152' ' ' THR . 74.4 t -63.41 -36.51 76.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.11 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -38.9 -63.89 0.49 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.098 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 89.7 mm-40 -57.58 -48.09 80.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.903 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 28.0 t80 -47.68 -41.81 23.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.857 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 33.0 mt -83.98 -31.95 25.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.91 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 18.1 t -47.3 -41.24 18.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.85 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . 0.687 ' HG3' HD13 ' A' ' 216' ' ' LEU . 0.7 OUTLIER -38.39 129.57 1.35 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.904 179.908 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -110.63 133.63 53.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.862 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 74.24 43.33 0.29 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.884 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 10.4 mm100 -128.38 168.02 16.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.939 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.414 HG11 ' CB ' ' A' ' 223' ' ' ALA . 55.6 t -118.71 141.33 38.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.111 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . 0.583 HD12 ' N ' ' A' ' 246' ' ' ALA . 8.6 mt -111.61 143.92 20.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.103 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 97.9 t -127.14 133.72 67.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.087 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 70.2 ttt180 -91.14 112.83 24.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.868 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' MET . . . . . 0.46 ' CE ' HD21 ' A' ' 173' ' ' LEU . 91.0 mtp -100.43 149.56 23.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.89 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 35.0 mtp180 -146.75 133.87 20.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.909 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 96.51 19.28 28.02 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.513 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.523 ' CD1' ' HB3' ' A' ' 213' ' ' ALA . 24.3 mt -71.18 121.12 83.29 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.639 0.733 . . . . 0.0 110.907 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . 0.413 ' HG3' ' CB ' ' A' ' 237' ' ' ARG . 64.9 Cg_exo -47.97 131.66 21.43 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.703 2.269 . . . . 0.0 112.326 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . 0.554 ' CD1' ' HG3' ' A' ' 209' ' ' PRO . 11.6 t80 -37.52 -49.42 1.06 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.885 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.424 ' O ' ' C ' ' A' ' 177' ' ' ALA . 14.4 p -68.39 -44.98 73.91 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.141 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' A' ' 176' ' ' THR . . . -35.72 111.25 0.13 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.104 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -115.48 -177.16 3.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.161 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.409 ' HB1' ' HA ' ' A' ' 196' ' ' LYS . . . -50.01 -47.87 52.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.12 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . 0.407 ' CG ' ' OE2' ' A' ' 181' ' ' GLU . 5.7 pt-20 -51.67 -40.01 59.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.923 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . 0.407 ' OE2' ' CG ' ' A' ' 180' ' ' GLU . 0.1 OUTLIER -65.94 -36.99 84.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.876 -179.95 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.505 HG12 HD11 ' A' ' 192' ' ' ILE . 89.9 t -69.47 -50.36 51.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.155 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.418 ' C ' ' O ' ' A' ' 182' ' ' VAL . 34.4 t -35.55 -50.89 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.161 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -75.4 -42.28 54.17 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.127 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.715 ' HD2' HD12 ' A' ' 234' ' ' LEU . 10.2 t80 -40.2 -62.03 0.8 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.906 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' PHE . . . . . 0.527 ' CE1' ' CE1' ' A' ' 185' ' ' PHE . 72.8 m-85 -92.81 -21.08 20.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.908 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -49.28 -17.26 1.04 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.535 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -57.95 -72.4 0.09 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.829 0.347 . . . . 0.0 110.931 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 29.5 m170 -118.22 -10.88 10.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.889 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 74.2 m -125.27 85.34 58.43 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.584 0.707 . . . . 0.0 110.89 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 146.54 60.67 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.694 2.263 . . . . 0.0 112.362 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . 0.762 HG23 ' O ' ' A' ' 216' ' ' LEU . 56.0 mt -98.43 143.52 12.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.156 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 89.1 m -67.99 101.21 1.08 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.182 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 92.23 -12.18 70.26 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.485 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 68.22 -123.48 17.6 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.461 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . 0.409 ' HA ' ' HB1' ' A' ' 179' ' ' ALA . 13.9 pttp -49.23 -29.46 5.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.766 0.317 . . . . 0.0 110.921 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -75.6 -31.35 59.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.879 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -94.29 41.83 2.54 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.464 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.557 HG12 HG13 ' A' ' 215' ' ' VAL . 87.0 mt -140.35 147.84 22.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.887 0.375 . . . . 0.0 111.117 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 13.4 tp -141.57 127.09 18.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.89 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -105.43 120.71 42.27 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.889 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.443 HG23 ' HA ' ' A' ' 213' ' ' ALA . 20.1 t -78.69 134.19 28.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.088 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . 0.501 ' HA ' HG23 ' A' ' 210' ' ' THR . 0.8 OUTLIER -138.55 136.61 36.24 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.09 -179.974 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . 0.646 ' N ' HG23 ' A' ' 210' ' ' THR . 33.4 m-85 -46.8 158.71 0.4 Allowed Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.618 0.723 . . . . 0.0 110.955 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 3.49 2.75 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.669 2.246 . . . . 0.0 112.354 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -112.9 -19.13 12.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.817 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 120.43 -3.74 12.31 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.492 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.0 140.45 62.2 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.574 0.702 . . . . 0.0 110.895 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . 0.554 ' HG3' ' CD1' ' A' ' 175' ' ' PHE . 54.4 Cg_endo -69.72 102.67 1.05 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.672 2.248 . . . . 0.0 112.37 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . 0.646 HG23 ' N ' ' A' ' 204' ' ' TYR . 37.6 p -61.39 -13.29 18.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.173 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 82.63 -39.62 2.7 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.525 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -71.05 161.6 30.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.834 0.349 . . . . 0.0 110.848 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . 0.523 ' HB3' ' CD1' ' A' ' 173' ' ' LEU . . . -160.41 -177.6 6.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.115 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -148.06 137.49 22.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.852 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . 0.557 HG13 HG12 ' A' ' 199' ' ' ILE . 3.3 t -124.09 165.68 20.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.084 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.762 ' O ' HG23 ' A' ' 192' ' ' ILE . 47.7 mt -116.96 145.62 43.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.935 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -134.31 151.5 51.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.84 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -60.0 -59.22 5.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.135 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' CYS . . . . . . . . . . . . . 1.8 t -144.48 177.71 8.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.854 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . 0.487 ' HA ' ' HB3' ' A' ' 223' ' ' ALA . 13.7 mp0 -58.71 -35.36 72.53 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.865 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -43.55 -38.5 2.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.924 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -92.98 -34.69 13.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.933 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.487 ' HB3' ' HA ' ' A' ' 220' ' ' GLU . . . -61.6 -59.67 4.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.135 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' GLN . . . . . 0.455 ' HA ' HD12 ' A' ' 227' ' ' LEU . 3.1 pt20 -60.41 -37.17 79.99 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.957 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 14.4 m-20 -68.03 -24.03 65.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.874 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -79.89 -32.52 40.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.087 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . 0.455 HD12 ' HA ' ' A' ' 224' ' ' GLN . 20.2 mt -56.18 -31.52 63.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.947 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 9.1 mtp-105 -59.8 -18.37 43.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.866 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . 0.595 ' HE3' ' CE1' ' A' ' 185' ' ' PHE . 24.8 mtpp -82.06 -1.16 47.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.873 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' HIS . . . . . 0.61 ' N ' HD12 ' A' ' 241' ' ' LEU . 75.6 t60 -34.3 136.98 0.12 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.897 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.448 ' HG2' ' CD2' ' A' ' 230' ' ' HIS . 24.1 mmtt 59.35 36.29 23.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.908 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -62.97 -176.99 0.14 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.902 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.661 HD21 ' CE1' ' A' ' 238' ' ' TYR . 30.8 mt -137.83 117.31 12.89 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.896 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . 0.715 HD12 ' HD2' ' A' ' 185' ' ' PHE . 6.6 tt -126.77 112.25 15.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.935 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 59.51 36.2 88.44 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.498 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 30.3 mttp 71.69 52.62 0.22 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.783 0.325 . . . . 0.0 110.861 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' ARG . . . . . 0.413 ' CB ' ' HG3' ' A' ' 174' ' ' PRO . 59.5 mmt-85 -156.39 115.35 3.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.876 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' TYR . . . . . 0.661 ' CE1' HD21 ' A' ' 233' ' ' LEU . 96.8 m-85 -68.68 136.66 53.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.908 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 79.5 mt -132.87 131.34 59.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.111 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . 0.468 ' HB3' ' CZ ' ' A' ' 242' ' ' PHE . 43.4 mt-10 -92.43 161.78 14.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.874 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . 0.61 HD12 ' N ' ' A' ' 230' ' ' HIS . 20.2 mt -136.87 140.15 42.17 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.892 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' PHE . . . . . 0.499 ' CD1' ' O ' ' A' ' 241' ' ' LEU . 22.6 m-85 -153.14 128.22 9.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.82 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 20.3 mtp180 -44.04 153.48 0.14 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.884 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 1.1 t -152.55 160.13 43.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.901 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 41.6 p -138.41 157.67 45.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.088 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' ALA . . . . . 0.583 ' N ' HD12 ' A' ' 167' ' ' ILE . . . -37.45 -59.06 0.8 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.114 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -53.27 -56.59 15.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.151 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . 0.741 ' O ' HG23 ' A' ' 252' ' ' VAL . 11.7 tp10 -44.59 -51.95 8.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.878 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.418 ' O ' ' N ' ' A' ' 252' ' ' VAL . 98.4 t -47.02 -66.79 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.139 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 250' ' ' GLN . . . . . 0.586 ' HA ' HD12 ' A' ' 253' ' ' LEU . 50.7 mt-30 -43.25 -50.06 6.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.929 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 51.1 mm-40 -59.67 -30.18 68.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.918 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 252' ' ' VAL . . . . . 0.741 HG23 ' O ' ' A' ' 248' ' ' GLU . 92.7 t -75.92 -36.98 33.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.1 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.586 HD12 ' HA ' ' A' ' 250' ' ' GLN . 8.5 mt -68.47 -37.73 80.41 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.893 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -66.28 -59.53 3.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.868 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . 0.476 ' HG3' ' N ' ' A' ' 256' ' ' PHE . 0.4 OUTLIER -41.21 -38.08 1.05 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.898 -179.94 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 256' ' ' PHE . . . . . 0.476 ' N ' ' HG3' ' A' ' 255' ' ' ARG . 10.2 m-85 -81.71 -53.1 6.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.868 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 34.7 t -52.86 -58.5 6.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.83 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 37.4 m -89.78 89.05 7.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.828 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 259' ' ' ALA . . . . . . . . . . . . . . . -114.13 -41.96 3.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.134 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 27.0 p -130.71 130.03 43.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.872 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 262' ' ' PRO . . . 81.99 82.53 0.85 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.514 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 262' ' ' PRO . . . . . 0.499 ' O ' ' N ' ' A' ' 261' ' ' GLY . 53.5 Cg_endo -69.76 173.51 44.3 Favored 'Cis proline' 0 C--N 1.342 0.189 0 C-N-CA 122.677 -1.801 . . . . 0.0 112.355 0.059 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 69.8 p -128.96 156.93 42.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.845 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 43.8 p -60.05 129.98 44.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.827 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.492 179.971 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.258 0 N-CA-C 112.471 -0.252 . . . . 0.0 112.471 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 93.6 p -118.77 142.93 47.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.872 0.368 . . . . 0.0 110.834 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 12.9 t -107.67 141.56 38.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.866 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 131.1 -151.53 19.69 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.537 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 19.0 m -72.66 -43.87 62.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.931 0.396 . . . . 0.0 110.885 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 85.5 p -91.91 147.01 23.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.846 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 96.0 -107.09 3.47 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.448 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -143.48 -148.52 4.93 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.495 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 64.84 102.08 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.473 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.829 HG22 HG23 ' A' ' 156' ' ' VAL . 2.3 m -90.77 107.18 19.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.754 0.311 . . . . 0.0 111.14 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 62.3 p -126.79 -36.94 2.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.848 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -72.58 -52.41 15.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.902 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -64.53 -46.03 84.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.894 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.829 HG23 HG22 ' A' ' 152' ' ' THR . 57.5 t -54.73 -43.29 65.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.168 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -43.49 -50.96 6.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.11 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 46.4 mm-40 -65.21 -37.25 86.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.939 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' PHE . . . . . 0.567 ' CE1' ' HG ' ' A' ' 216' ' ' LEU . 64.0 t80 -60.14 -41.32 92.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.886 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 86.3 mt -90.98 -16.59 27.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.893 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 46.5 t -62.62 -35.79 80.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.841 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . 0.489 ' HD2' HD13 ' A' ' 216' ' ' LEU . 12.5 mttp -58.99 120.13 8.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.895 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 37.6 mp0 -94.61 155.83 16.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.852 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 11.1 m-80 63.45 48.89 3.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.866 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 4.9 mm100 -131.87 162.21 31.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.878 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.725 HG11 ' CB ' ' A' ' 223' ' ' ALA . 89.5 t -116.73 111.13 33.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.138 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . 0.71 HG21 HG21 ' A' ' 249' ' ' VAL . 30.5 mt -85.33 142.09 13.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.082 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 40.8 t -127.51 142.52 43.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.155 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 30.0 ttp180 -91.75 115.18 27.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.863 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' MET . . . . . 0.897 ' CE ' HD21 ' A' ' 173' ' ' LEU . 66.9 mtp -102.63 125.39 49.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.919 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.432 ' HB2' ' NH1' ' A' ' 171' ' ' ARG . 3.3 ttm105 -131.4 139.73 49.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.84 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 90.23 23.09 32.97 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.494 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.897 HD21 ' CE ' ' A' ' 170' ' ' MET . 26.3 mt -74.9 128.03 85.88 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.589 0.709 . . . . 0.0 110.924 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . 0.484 ' HG3' ' CB ' ' A' ' 237' ' ' ARG . 64.7 Cg_exo -48.01 130.83 20.56 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.719 2.279 . . . . 0.0 112.36 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -47.93 -22.71 0.62 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.877 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 41.4 p -91.57 -29.39 16.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.118 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -48.77 137.95 11.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.043 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -139.38 171.82 13.71 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.114 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.477 ' N ' ' CZ ' ' A' ' 201' ' ' PHE . . . -47.04 -47.38 22.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.106 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -57.02 -26.66 60.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.882 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . 0.817 ' HG2' HD11 ' A' ' 234' ' ' LEU . 6.7 tt0 -79.71 -35.58 38.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.898 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.405 HG12 HD11 ' A' ' 192' ' ' ILE . 48.1 t -74.01 -42.45 52.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.117 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 45.6 t -42.24 -45.81 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.153 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -81.66 -32.49 31.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.102 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.5 ' HD2' HD12 ' A' ' 234' ' ' LEU . 41.2 t80 -49.27 -59.44 3.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.863 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -90.51 -24.32 20.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.829 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -48.97 -22.14 2.83 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.516 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 33.1 tp60 -53.08 -70.85 0.08 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.864 0.364 . . . . 0.0 110.884 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 8.9 m80 -118.3 -15.33 9.75 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.862 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 74.7 m -119.88 88.24 39.78 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.592 0.71 . . . . 0.0 110.839 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' PRO . . . . . 0.501 ' HD2' ' CD1' ' A' ' 222' ' ' TYR . 53.7 Cg_endo -69.8 131.62 21.57 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.679 2.253 . . . . 0.0 112.289 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . 0.748 HG23 ' O ' ' A' ' 216' ' ' LEU . 55.7 mt -83.25 142.12 13.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.155 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 87.8 m -65.32 102.66 0.7 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.152 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 88.34 -17.43 48.07 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.476 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.424 ' O ' ' N ' ' A' ' 198' ' ' GLY . . . 78.35 -128.2 8.59 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.476 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 17.2 ptmt -44.94 -29.48 0.83 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.748 0.309 . . . . 0.0 110.885 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -74.34 -34.67 63.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.884 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . 0.923 ' HA2' HD12 ' A' ' 216' ' ' LEU . . . -86.37 21.24 18.18 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.47 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 76.8 mt -123.56 146.22 29.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.808 0.337 . . . . 0.0 111.133 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.416 HD21 HG22 ' A' ' 156' ' ' VAL . 16.3 tp -142.32 123.18 14.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.869 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' PHE . . . . . 0.477 ' CZ ' ' N ' ' A' ' 179' ' ' ALA . 68.1 m-85 -104.24 112.34 25.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.887 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 25.8 t -66.57 122.55 17.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.124 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -131.83 140.34 49.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.155 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -45.79 158.31 0.35 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.685 0.755 . . . . 0.0 110.898 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 3.02 3.04 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.662 2.241 . . . . 0.0 112.339 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -112.15 -16.33 13.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.864 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 106.14 62.82 0.61 Allowed Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.439 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 7.3 mtt85 -148.26 144.26 18.53 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.602 0.715 . . . . 0.0 110.901 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 108.64 2.12 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.692 2.261 . . . . 0.0 112.318 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 74.1 p -74.02 -29.98 62.21 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.117 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 114.63 -37.04 3.68 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.498 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -78.6 169.37 18.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.836 0.35 . . . . 0.0 110.857 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . 0.441 ' HB3' ' CD1' ' A' ' 173' ' ' LEU . . . -170.99 174.07 4.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.145 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . 0.53 ' CE2' HG13 ' A' ' 249' ' ' VAL . 66.7 m-85 -139.55 136.78 34.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.865 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . 0.443 HG12 ' N ' ' A' ' 216' ' ' LEU . 12.6 t -117.61 158.0 18.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.156 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.923 HD12 ' HA2' ' A' ' 198' ' ' GLY . 72.2 mt -115.3 139.56 49.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.933 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -132.29 149.47 52.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.86 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . 0.679 ' HB3' ' CD2' ' A' ' 222' ' ' TYR . . . -49.87 -65.67 0.52 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.124 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' CYS . . . . . . . . . . . . . 1.8 t -141.57 179.14 6.99 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.876 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . 0.404 ' C ' ' OE1' ' A' ' 220' ' ' GLU . 0.0 OUTLIER -60.21 -16.4 32.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.875 -179.892 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -63.2 -47.48 82.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.87 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' TYR . . . . . 0.679 ' CD2' ' HB3' ' A' ' 218' ' ' ALA . 62.4 m-85 -78.44 -46.35 20.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.92 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.725 ' CB ' HG11 ' A' ' 166' ' ' VAL . . . -50.22 -50.35 49.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.066 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 23.6 mm-40 -54.28 -53.09 58.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.93 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 55.0 m-20 -57.6 -25.62 60.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.873 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -74.96 -30.76 61.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.151 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 69.5 mt -62.47 -35.37 79.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.908 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 66.1 mtp85 -56.53 -22.06 30.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.842 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . 0.481 ' CE ' ' CE1' ' A' ' 185' ' ' PHE . 21.2 mtpp -75.03 -2.78 28.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.876 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' HIS . . . . . 0.536 ' CD2' ' HG2' ' A' ' 231' ' ' LYS . 84.9 t60 -34.0 135.8 0.14 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.843 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.536 ' HG2' ' CD2' ' A' ' 230' ' ' HIS . 21.9 mmtt 62.59 29.22 16.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.875 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . 0.425 ' OD2' ' CE2' ' A' ' 185' ' ' PHE . 3.2 t70 -56.01 178.35 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.841 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.64 HD21 ' CE1' ' A' ' 238' ' ' TYR . 30.6 mt -137.71 105.02 5.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.927 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . 0.817 HD11 ' HG2' ' A' ' 181' ' ' GLU . 5.8 tt -113.59 108.16 16.77 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.876 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 60.84 44.06 98.49 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.49 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 6.8 mmmm 65.85 54.98 0.99 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.765 0.317 . . . . 0.0 110.932 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' ARG . . . . . 0.484 ' CB ' ' HG3' ' A' ' 174' ' ' PRO . 17.5 mmt85 -156.84 115.11 3.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.863 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' TYR . . . . . 0.64 ' CE1' HD21 ' A' ' 233' ' ' LEU . 97.3 m-85 -70.4 120.81 16.61 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.952 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 0.66 HD13 HD23 ' A' ' 173' ' ' LEU . 19.8 mt -116.27 137.8 48.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.154 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -101.1 171.18 7.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.905 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . 0.401 ' O ' ' CD1' ' A' ' 242' ' ' PHE . 28.8 mt -147.2 145.26 29.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.873 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' PHE . . . . . 0.401 ' CD1' ' O ' ' A' ' 241' ' ' LEU . 28.7 m-85 -155.75 129.43 8.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.878 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 42.4 mtm180 -44.62 140.88 2.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.846 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 9.2 t -140.6 148.4 40.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.857 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . 0.405 ' O ' HG23 ' A' ' 249' ' ' VAL . 43.0 p -119.88 161.21 21.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.133 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -48.22 -48.68 34.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.104 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -58.87 -53.79 54.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.065 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . 0.496 ' O ' HG23 ' A' ' 252' ' ' VAL . 8.9 tp10 -49.07 -50.84 34.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.886 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.71 HG21 HG21 ' A' ' 167' ' ' ILE . 95.0 t -50.8 -61.92 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.141 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 59.3 mt-30 -44.7 -50.02 10.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.879 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -58.64 -38.63 78.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.932 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 252' ' ' VAL . . . . . 0.496 HG23 ' O ' ' A' ' 248' ' ' GLU . 69.4 t -67.92 -44.31 85.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.115 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.559 HD11 HG12 ' A' ' 249' ' ' VAL . 9.6 mt -65.77 -45.45 82.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.93 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 42.2 m-20 -68.7 -27.23 65.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.884 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . 0.469 ' HD3' ' N ' ' A' ' 256' ' ' PHE . 0.6 OUTLIER -72.58 -53.32 12.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.866 -179.965 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 256' ' ' PHE . . . . . 0.469 ' N ' ' HD3' ' A' ' 255' ' ' ARG . 11.1 m-85 -59.44 -44.36 92.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.931 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 91.7 p -58.62 -39.2 79.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.872 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 9.0 t -114.05 71.49 0.75 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.862 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 259' ' ' ALA . . . . . . . . . . . . . . . -102.8 148.04 26.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.113 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 2.0 t -63.38 120.91 12.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.888 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -148.72 -167.98 14.2 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.533 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 262' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.73 116.18 2.64 Favored 'Cis proline' 0 C--N 1.341 0.141 0 C-N-CA 122.695 -1.794 . . . . 0.0 112.345 0.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 5.7 t -169.33 143.5 2.9 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.818 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 83.2 p -104.94 167.85 9.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.902 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.347 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.483 -179.976 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.249 0 N-CA-C 112.46 -0.256 . . . . 0.0 112.46 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 3.1 m -53.65 -52.81 58.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.847 0.356 . . . . 0.0 110.794 -179.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 4.0 m -109.97 -56.51 2.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.874 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -54.21 150.54 15.11 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.483 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 26.5 m -147.91 121.98 9.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.906 0.384 . . . . 0.0 110.826 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 35.9 m -147.8 143.32 27.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.888 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 117.57 179.94 17.37 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.505 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 155.1 159.26 9.19 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.472 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 51.18 -115.0 3.23 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.526 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.477 HG22 ' HB ' ' A' ' 156' ' ' VAL . 17.8 m -134.28 142.65 47.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.794 0.33 . . . . 0.0 111.14 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 1.1 t -73.48 137.55 44.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.89 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -40.72 -58.97 1.5 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.869 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -44.41 -39.76 4.95 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.927 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.477 ' HB ' HG22 ' A' ' 152' ' ' THR . 99.3 t -75.09 -47.0 38.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.125 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.417 ' C ' ' O ' ' A' ' 156' ' ' VAL . . . -36.83 -58.19 0.77 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.101 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 27.6 mm-40 -58.02 -50.46 73.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.907 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' PHE . . . . . 0.474 ' CE2' ' HG ' ' A' ' 216' ' ' LEU . 47.3 t80 -50.41 -42.82 54.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.863 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.454 HD12 HG12 ' A' ' 156' ' ' VAL . 62.6 mt -85.79 -21.21 28.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.906 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . 0.417 ' N ' ' O ' ' A' ' 157' ' ' ALA . 15.6 t -58.12 -24.53 59.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.846 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . 0.451 ' HG3' HD13 ' A' ' 216' ' ' LEU . 24.2 mmmt -65.52 131.1 45.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.893 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -109.66 154.99 22.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.923 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 63.19 42.72 6.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.892 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 20.5 mm-40 -127.86 156.57 42.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.914 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 47.1 t -108.63 100.76 11.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.158 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . 0.546 HG21 HG21 ' A' ' 249' ' ' VAL . 49.3 mt -75.27 140.27 17.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.099 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 39.0 t -127.92 134.21 65.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.117 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . 0.543 ' HG3' ' CE1' ' A' ' 214' ' ' PHE . 18.1 ttm180 -90.1 125.43 35.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.872 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' MET . . . . . 0.658 ' HE2' HD21 ' A' ' 173' ' ' LEU . 59.5 mtp -115.41 111.8 21.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.893 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -114.8 151.66 33.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.884 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 84.23 16.7 66.33 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.502 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.807 HD23 HD13 ' A' ' 239' ' ' ILE . 19.7 mt -71.57 133.99 84.5 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.615 0.721 . . . . 0.0 110.886 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . 0.485 ' O ' ' N ' ' A' ' 177' ' ' ALA . 65.3 Cg_exo -47.99 127.57 15.02 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.675 2.25 . . . . 0.0 112.328 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . 0.436 ' C ' ' O ' ' A' ' 174' ' ' PRO . 11.2 m-85 -34.68 -45.37 0.24 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.865 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.753 ' O ' HG23 ' A' ' 178' ' ' THR . 0.0 OUTLIER -74.56 -39.0 62.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.098 -179.894 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.485 ' N ' ' O ' ' A' ' 174' ' ' PRO . . . -33.78 122.54 0.45 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.071 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.753 HG23 ' O ' ' A' ' 176' ' ' THR . 25.9 p -132.46 173.04 11.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.113 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.496 ' N ' ' CZ ' ' A' ' 201' ' ' PHE . . . -42.22 -47.52 4.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.044 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -51.26 -37.74 48.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.866 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . 0.518 ' OE1' HD21 ' A' ' 234' ' ' LEU . 56.7 mm-40 -70.52 -34.91 72.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.867 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.548 HG12 ' CD1' ' A' ' 192' ' ' ILE . 92.4 t -71.29 -53.59 20.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.16 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.444 ' C ' ' O ' ' A' ' 182' ' ' VAL . 76.4 t -34.05 -47.36 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.143 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -80.96 -41.47 22.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.106 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.793 ' HD2' HD12 ' A' ' 234' ' ' LEU . 4.9 t80 -40.03 -59.03 1.3 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.895 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -95.17 -21.94 18.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.901 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -49.33 -19.09 1.64 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.506 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -56.78 -70.82 0.11 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.817 0.341 . . . . 0.0 110.882 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 29.7 m-70 -118.21 -15.46 9.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.877 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 79.4 m -121.15 87.51 44.16 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.57 0.7 . . . . 0.0 110.852 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 140.75 43.53 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.706 2.27 . . . . 0.0 112.34 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . 0.567 HG23 ' O ' ' A' ' 216' ' ' LEU . 63.1 mt -94.58 140.73 16.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.181 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 57.7 m -62.97 101.8 0.3 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.178 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 89.41 -16.24 56.6 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.483 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.481 ' O ' ' N ' ' A' ' 198' ' ' GLY . . . 67.91 -126.0 23.08 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.462 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 16.8 ptmt -42.31 -27.07 0.13 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.737 0.303 . . . . 0.0 110.906 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -81.74 -36.23 28.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.872 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . 0.481 ' N ' ' O ' ' A' ' 195' ' ' GLY . . . -85.16 34.82 3.19 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.47 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.482 HD13 ' HB ' ' A' ' 182' ' ' VAL . 62.5 mt -135.05 149.26 28.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.901 0.381 . . . . 0.0 111.118 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 13.4 tp -142.51 115.23 8.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.913 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' PHE . . . . . 0.496 ' CZ ' ' N ' ' A' ' 179' ' ' ALA . 46.9 m-85 -96.8 124.42 40.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.862 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 48.0 t -77.21 120.89 28.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.14 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -129.88 137.23 50.3 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.152 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . 0.695 ' CD2' HG22 ' A' ' 210' ' ' THR . 34.9 m-85 -45.39 158.59 0.31 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.689 0.756 . . . . 0.0 110.892 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.81 2.61 3.41 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.63 2.22 . . . . 0.0 112.355 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -111.12 -16.51 13.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.857 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 107.14 53.7 0.69 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.482 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 12.0 mmm180 -138.35 143.7 39.84 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.621 0.724 . . . . 0.0 110.854 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 111.53 2.84 Favored 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.711 2.274 . . . . 0.0 112.357 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . 0.695 HG22 ' CD2' ' A' ' 204' ' ' TYR . 68.3 p -75.26 -27.84 59.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.175 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 108.41 -27.42 13.85 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.493 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -91.38 154.89 18.88 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.766 0.317 . . . . 0.0 110.894 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -155.78 -177.82 6.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.1 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . 0.603 ' CE2' HG13 ' A' ' 249' ' ' VAL . 81.1 m-85 -144.29 151.38 39.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.914 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 4.1 t -133.55 157.5 42.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.161 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.567 ' O ' HG23 ' A' ' 192' ' ' ILE . 29.7 mt -109.62 145.95 35.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.957 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -137.11 126.02 24.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.883 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -41.43 -50.34 3.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.115 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' CYS . . . . . . . . . . . . . 72.7 m -152.91 173.15 15.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.84 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -59.56 -35.78 74.91 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.839 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -37.68 -51.45 1.23 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.893 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -79.46 -42.12 26.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.945 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -48.01 -54.79 11.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.122 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -50.19 -58.79 4.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.883 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 48.8 m-20 -53.32 -22.91 8.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.872 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -88.74 -19.54 25.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.131 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 95.2 mt -72.41 -42.77 64.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.947 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 1.5 ptm180 -55.58 -19.11 9.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.823 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . 0.454 ' O ' ' C ' ' A' ' 230' ' ' HIS . 24.7 mtpp -72.81 -3.4 25.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.89 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' HIS . . . . . 0.454 ' C ' ' O ' ' A' ' 229' ' ' LYS . 83.6 t60 -34.35 138.17 0.1 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.855 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 18.0 mmtp 61.02 29.98 19.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.909 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -57.06 174.97 0.15 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.864 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.683 HD21 ' CE2' ' A' ' 238' ' ' TYR . 31.0 mt -131.07 108.94 10.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.914 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . 0.793 HD12 ' HD2' ' A' ' 185' ' ' PHE . 6.6 tt -118.34 114.65 23.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.894 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 56.4 44.0 90.03 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.479 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.433 ' NZ ' ' HA ' ' A' ' 236' ' ' LYS . 0.0 OUTLIER 63.74 52.75 2.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.802 0.334 . . . . 0.0 110.904 -179.997 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' ARG . . . . . 0.422 ' CB ' ' HG3' ' A' ' 174' ' ' PRO . 19.6 mmt180 -156.44 115.19 3.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.855 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' TYR . . . . . 0.683 ' CE2' HD21 ' A' ' 233' ' ' LEU . 92.2 m-85 -70.51 126.13 28.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.963 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 0.807 HD13 HD23 ' A' ' 173' ' ' LEU . 66.2 mt -122.7 136.76 58.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.123 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . 0.511 ' HB3' ' CZ ' ' A' ' 242' ' ' PHE . 24.2 mp0 -96.68 158.94 15.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.883 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . 0.443 ' C ' ' CG ' ' A' ' 242' ' ' PHE . 14.5 mt -136.85 147.77 46.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.961 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' PHE . . . . . 0.511 ' CZ ' ' HB3' ' A' ' 240' ' ' GLU . 7.3 m-85 -158.52 139.47 12.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.84 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 22.8 mtm180 -64.3 128.65 36.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.869 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 1.8 t -128.02 167.21 17.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.854 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . 0.449 ' O ' ' C ' ' A' ' 246' ' ' ALA . 34.1 p -131.55 148.21 52.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.099 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 246' ' ' ALA . . . . . 0.522 ' N ' HD12 ' A' ' 167' ' ' ILE . . . -34.1 -52.41 0.45 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.101 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -55.7 -54.3 45.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.09 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 -49.2 -56.01 10.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.868 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.603 HG13 ' CE2' ' A' ' 214' ' ' PHE . 59.2 t -44.04 -64.5 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.135 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 250' ' ' GLN . . . . . 0.722 ' HA ' HD12 ' A' ' 253' ' ' LEU . 25.2 mt-30 -39.69 -41.9 1.15 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.898 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 251' ' ' GLN . . . . . 0.474 ' HA ' ' ND2' ' A' ' 254' ' ' ASN . 38.9 mm-40 -68.19 -35.17 77.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.902 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 252' ' ' VAL . . . . . 0.486 ' N ' ' O ' ' A' ' 249' ' ' VAL . 82.6 t -71.22 -19.43 20.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.105 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.722 HD12 ' HA ' ' A' ' 250' ' ' GLN . 7.5 mt -86.57 -40.93 14.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.926 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . 0.474 ' ND2' ' HA ' ' A' ' 251' ' ' GLN . 0.4 OUTLIER -75.1 -41.83 57.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.902 179.879 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . 0.569 ' CD ' ' CD1' ' A' ' 256' ' ' PHE . 0.0 OUTLIER -60.09 -25.08 65.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.824 -179.955 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 256' ' ' PHE . . . . . 0.569 ' CD1' ' CD ' ' A' ' 255' ' ' ARG . 6.6 m-85 -90.6 -38.11 13.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.83 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 40.6 t -70.09 157.69 37.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.849 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 96.2 p 38.57 35.92 0.12 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.857 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 259' ' ' ALA . . . . . . . . . . . . . . . -84.27 147.59 27.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.092 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 90.4 p -95.11 -20.24 19.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.859 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . 0.462 ' HA3' ' N ' ' A' ' 263' ' ' SER . . . -151.97 -71.48 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.5 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 262' ' ' PRO . . . . . 0.426 ' C ' ' HA3' ' A' ' 261' ' ' GLY . 53.8 Cg_endo -69.77 -3.91 7.99 Favored 'Cis proline' 0 C--N 1.341 0.169 0 C-N-CA 122.679 -1.801 . . . . 0.0 112.329 0.058 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . 0.462 ' N ' ' HA3' ' A' ' 261' ' ' GLY . 37.1 m -146.76 158.65 43.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.915 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 47.6 p -136.47 134.59 37.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.825 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.31 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.488 179.993 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.334 0 N-CA-C 112.498 -0.241 . . . . 0.0 112.498 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 68.4 m -98.18 -49.95 4.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.893 0.377 . . . . 0.0 110.868 -179.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 83.4 p -48.75 -45.04 39.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.833 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 73.19 79.41 0.49 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.499 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 20.3 m -76.32 133.4 40.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.872 0.368 . . . . 0.0 110.858 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 28.7 m -158.33 176.14 12.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.875 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -152.95 95.5 0.16 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.492 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 143.24 96.87 0.24 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.526 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 55.78 179.69 0.36 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.502 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.852 HG22 HG23 ' A' ' 156' ' ' VAL . 17.1 m -111.56 119.86 40.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.769 0.319 . . . . 0.0 111.141 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 15.8 m -134.68 -42.86 0.75 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.871 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 -65.66 -48.88 70.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.93 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -67.71 -40.55 84.26 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.9 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.852 HG23 HG22 ' A' ' 152' ' ' THR . 90.9 t -64.36 -42.92 96.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.142 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.408 ' C ' ' O ' ' A' ' 156' ' ' VAL . . . -37.55 -58.69 0.85 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.084 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -60.03 -50.06 75.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.89 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -48.75 -41.72 33.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.862 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.591 HD13 HE21 ' A' ' 250' ' ' GLN . 82.0 mt -85.52 -22.52 28.12 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.931 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 44.3 t -53.76 -33.1 54.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.888 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . 0.519 ' HG3' HD13 ' A' ' 216' ' ' LEU . 42.1 mmtt -60.17 103.92 0.27 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.843 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -86.79 157.53 19.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.893 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 63.49 30.69 15.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.882 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 0.477 ' NE2' ' HA ' ' A' ' 218' ' ' ALA . 8.8 mm100 -121.13 148.21 44.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.881 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 4.6 t -99.17 116.83 43.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.137 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . 0.471 HD12 ' N ' ' A' ' 246' ' ' ALA . 73.2 mt -88.55 147.12 5.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.115 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.506 HG21 ' CE1' ' A' ' 217' ' ' PHE . 96.1 t -127.65 126.18 66.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.108 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 70.8 ttt180 -88.14 110.19 20.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.888 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' MET . . . . . 0.694 ' CE ' HD21 ' A' ' 173' ' ' LEU . 97.4 mtp -97.13 113.01 24.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.892 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 2.1 ttt85 -111.1 141.63 44.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.869 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 89.36 21.08 42.48 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.476 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.843 HD23 HD13 ' A' ' 239' ' ' ILE . 23.0 mt -74.79 123.89 89.28 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.588 0.708 . . . . 0.0 110.958 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_exo -47.97 145.01 10.98 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.683 2.255 . . . . 0.0 112.359 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . 0.554 ' CD1' ' HG3' ' A' ' 209' ' ' PRO . 10.4 t80 -57.0 -30.66 64.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.9 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 6.2 p -86.49 -15.88 38.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.137 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -67.53 117.41 9.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.084 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -124.35 175.24 7.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.119 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.455 ' N ' ' CZ ' ' A' ' 201' ' ' PHE . . . -41.11 -50.34 3.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.103 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -49.68 -40.23 39.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.874 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -69.36 -30.74 68.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.872 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.571 HG12 ' CD1' ' A' ' 192' ' ' ILE . 74.5 t -75.81 -55.52 11.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.1 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.45 ' C ' ' O ' ' A' ' 182' ' ' VAL . 54.5 t -33.98 -44.68 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.1 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.442 ' O ' ' C ' ' A' ' 185' ' ' PHE . . . -79.24 -47.46 15.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.124 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.576 ' HD2' HD12 ' A' ' 234' ' ' LEU . 15.8 t80 -35.32 -60.51 0.48 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.888 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' PHE . . . . . 0.404 ' CE1' ' CE1' ' A' ' 185' ' ' PHE . 50.5 m-85 -94.35 -20.54 19.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.88 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -49.1 -17.36 0.94 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.501 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 8.8 mm100 -59.24 -72.35 0.1 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.824 0.345 . . . . 0.0 110.88 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 28.8 m170 -117.81 -16.47 9.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.88 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 86.7 m -117.38 85.64 20.42 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.647 0.736 . . . . 0.0 110.889 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' PRO . . . . . 0.441 ' HD2' ' CD1' ' A' ' 222' ' ' TYR . 53.9 Cg_endo -69.79 135.78 31.24 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.715 2.277 . . . . 0.0 112.314 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . 0.571 ' CD1' HG12 ' A' ' 182' ' ' VAL . 61.9 mt -87.47 141.16 14.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.187 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 41.2 m -66.21 103.09 0.92 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.138 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 91.77 -16.97 58.06 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.476 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.401 ' O ' ' N ' ' A' ' 198' ' ' GLY . . . 72.13 -125.19 10.67 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.482 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 14.4 ptmt -47.36 -30.03 2.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.784 0.326 . . . . 0.0 110.943 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -75.49 -30.51 59.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.877 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 195' ' ' GLY . . . -92.82 41.22 2.75 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.498 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.473 HD13 ' HB ' ' A' ' 182' ' ' VAL . 62.6 mt -142.68 144.48 24.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.828 0.347 . . . . 0.0 111.16 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.427 HD21 HG22 ' A' ' 156' ' ' VAL . 15.6 tp -139.64 121.66 15.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.9 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' PHE . . . . . 0.455 ' CZ ' ' N ' ' A' ' 179' ' ' ALA . 65.0 m-85 -101.7 112.21 24.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.883 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 39.0 t -70.4 138.15 22.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.129 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . 0.65 ' HA ' HG23 ' A' ' 210' ' ' THR . 0.8 OUTLIER -143.66 138.1 28.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.146 -179.926 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . 0.572 ' CD1' HG22 ' A' ' 210' ' ' THR . 32.4 m-85 -48.08 159.29 0.5 Allowed Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.699 0.762 . . . . 0.0 110.917 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.81 3.97 2.49 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.644 2.229 . . . . 0.0 112.296 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . 0.435 ' HB3' ' NH1' ' A' ' 208' ' ' ARG . 62.0 m-20 -112.46 -23.71 10.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.895 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 123.65 4.19 8.2 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.508 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' ARG . . . . . 0.435 ' NH1' ' HB3' ' A' ' 206' ' ' ASP . 0.0 OUTLIER -84.75 141.3 38.32 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.576 0.703 . . . . 0.0 110.917 -179.854 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . 0.554 ' HG3' ' CD1' ' A' ' 175' ' ' PHE . 53.6 Cg_endo -69.72 110.33 2.52 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.693 2.262 . . . . 0.0 112.367 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . 0.65 HG23 ' HA ' ' A' ' 203' ' ' THR . 34.1 p -71.31 -10.85 60.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.175 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 79.89 -40.18 2.27 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.445 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -70.35 154.26 42.1 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.878 0.37 . . . . 0.0 110.874 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . 0.461 ' HB3' ' CD1' ' A' ' 173' ' ' LEU . . . -152.06 179.55 8.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.118 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . 0.611 ' CE2' HG13 ' A' ' 249' ' ' VAL . 73.9 m-85 -146.79 130.6 17.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.89 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . 0.515 HG12 ' N ' ' A' ' 216' ' ' LEU . 19.7 t -118.18 161.03 17.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.15 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.528 ' O ' HG23 ' A' ' 192' ' ' ILE . 26.9 mt -110.17 139.26 45.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.939 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . 0.506 ' CE1' HG21 ' A' ' 168' ' ' VAL . 81.2 m-85 -133.15 130.55 39.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.87 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . 0.477 ' HA ' ' NE2' ' A' ' 165' ' ' GLN . . . -44.78 -57.4 3.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.106 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' CYS . . . . . . . . . . . . . 85.6 m -151.92 161.1 43.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.837 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -45.06 -30.3 1.04 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.877 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -43.45 -41.91 4.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.846 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' TYR . . . . . 0.441 ' CD1' ' HD2' ' A' ' 191' ' ' PRO . 61.1 m-85 -90.25 -47.73 7.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.91 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.416 ' O ' ' HB3' ' A' ' 226' ' ' ALA . . . -49.66 -60.87 2.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.064 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' GLN . . . . . 0.666 ' HA ' HD12 ' A' ' 227' ' ' LEU . 64.4 mm-40 -45.44 -57.71 3.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.889 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 55.3 m-20 -55.95 -26.65 48.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.868 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . 0.416 ' HB3' ' O ' ' A' ' 223' ' ' ALA . . . -77.46 -39.53 46.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.065 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . 0.666 HD12 ' HA ' ' A' ' 224' ' ' GLN . 29.5 mt -52.88 -31.27 38.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.951 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 75.0 mtt180 -58.91 -26.71 64.57 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.891 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . 0.458 ' O ' ' C ' ' A' ' 230' ' ' HIS . 26.8 mtpp -71.72 -2.58 17.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.897 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' HIS . . . . . 0.538 ' CG ' ' HG2' ' A' ' 231' ' ' LYS . 19.6 t60 -33.96 139.38 0.07 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.894 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.538 ' HG2' ' CG ' ' A' ' 230' ' ' HIS . 0.1 OUTLIER 60.16 35.51 21.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.869 179.966 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -65.8 175.48 1.92 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.865 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.564 HD21 ' CE1' ' A' ' 238' ' ' TYR . 30.4 mt -131.35 101.19 5.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.87 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . 0.689 HD23 ' C ' ' A' ' 234' ' ' LEU . 5.7 tt -112.1 111.45 22.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.923 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 63.5 37.91 95.51 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.492 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 33.0 mmtm 67.35 54.22 0.72 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.766 0.317 . . . . 0.0 110.88 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 20.4 mmt180 -156.44 116.08 3.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.838 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' TYR . . . . . 0.564 ' CE1' HD21 ' A' ' 233' ' ' LEU . 96.7 m-85 -69.83 116.22 9.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.896 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 0.843 HD13 HD23 ' A' ' 173' ' ' LEU . 41.1 mt -115.9 140.6 36.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.134 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . 0.575 ' HB3' ' CZ ' ' A' ' 242' ' ' PHE . 16.7 mt-10 -93.26 -178.51 4.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.888 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . 0.559 ' O ' ' CD1' ' A' ' 242' ' ' PHE . 61.6 mt -158.01 132.82 8.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.909 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' PHE . . . . . 0.575 ' CZ ' ' HB3' ' A' ' 240' ' ' GLU . 4.6 m-85 -152.88 120.44 5.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.856 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 18.0 ptt180 -60.95 126.98 29.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.906 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 5.4 t -119.71 176.68 5.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.868 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . 0.401 ' O ' ' C ' ' A' ' 246' ' ' ALA . 82.2 p -127.64 151.02 49.46 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.135 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 246' ' ' ALA . . . . . 0.471 ' N ' HD12 ' A' ' 167' ' ' ILE . . . -37.92 -57.2 1.05 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.09 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -53.21 -51.76 61.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.121 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -50.45 -54.81 19.22 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.886 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.611 HG13 ' CE2' ' A' ' 214' ' ' PHE . 78.4 t -43.82 -61.39 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.152 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 250' ' ' GLN . . . . . 0.766 ' HA ' HD12 ' A' ' 253' ' ' LEU . 34.6 mt-30 -44.05 -42.73 6.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.969 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 251' ' ' GLN . . . . . 0.407 ' HA ' ' ND2' ' A' ' 254' ' ' ASN . 60.6 mm-40 -65.58 -30.14 70.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.905 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 252' ' ' VAL . . . . . 0.417 ' N ' ' O ' ' A' ' 249' ' ' VAL . 85.9 t -78.93 -20.12 12.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.145 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.766 HD12 ' HA ' ' A' ' 250' ' ' GLN . 10.6 mt -84.38 -41.63 16.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.93 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . 0.49 ' C ' ' OD1' ' A' ' 254' ' ' ASN . 0.6 OUTLIER -67.93 -40.86 83.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.89 179.876 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . 0.473 ' N ' ' OD1' ' A' ' 254' ' ' ASN . 8.0 ptm180 -55.35 -42.71 74.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.816 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 256' ' ' PHE . . . . . 0.405 ' N ' ' CG ' ' A' ' 255' ' ' ARG . 12.8 m-85 -78.9 -51.02 10.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.862 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 41.7 m -52.16 -68.43 0.17 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.84 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 29.5 m -77.47 59.18 1.85 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.848 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 259' ' ' ALA . . . . . . . . . . . . . . . -110.18 76.5 0.99 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.105 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 87.3 p -109.91 -47.67 3.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.835 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . 0.439 ' HA2' ' C ' ' A' ' 262' ' ' PRO . . . 128.82 169.98 12.69 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.489 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 262' ' ' PRO . . . . . 0.439 ' C ' ' HA2' ' A' ' 261' ' ' GLY . 53.1 Cg_endo -69.75 134.42 29.4 Favored 'Cis proline' 0 C--N 1.342 0.197 0 C-N-CA 122.665 -1.806 . . . . 0.0 112.37 0.057 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 3.7 m -123.88 175.69 6.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.855 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 1.5 t 51.56 41.31 28.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.91 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.299 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.476 -179.985 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.325 0 N-CA-C 112.456 -0.258 . . . . 0.0 112.456 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 2.6 t -76.91 138.69 39.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.818 0.342 . . . . 0.0 110.857 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 19.7 m -81.16 122.27 27.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.842 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 179.83 -79.75 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.515 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 2.2 m -67.38 137.31 55.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.887 0.375 . . . . 0.0 110.868 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 18.9 t -119.69 173.61 6.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.883 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 99.32 -129.0 9.75 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.502 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -168.95 -73.44 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.486 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -138.33 -131.7 2.91 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.466 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.539 HG22 HG23 ' A' ' 156' ' ' VAL . 1.6 m -122.92 46.89 2.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.771 0.32 . . . . 0.0 111.121 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 93.2 p -98.03 -36.86 9.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.899 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . 0.47 ' O ' ' NE2' ' A' ' 158' ' ' GLN . 20.8 m120 -66.83 -45.71 77.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.919 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -70.69 -39.84 73.25 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.868 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.539 HG23 HG22 ' A' ' 152' ' ' THR . 34.0 t -65.53 -40.19 87.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.119 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -41.45 -60.86 1.17 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.13 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . 0.47 ' NE2' ' O ' ' A' ' 154' ' ' ASN . 15.2 mp0 -56.23 -44.44 79.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.873 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -52.34 -41.34 62.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.852 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 75.4 mt -89.29 -19.71 24.99 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.89 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 45.9 t -59.75 -20.94 59.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.833 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . 0.465 ' HG3' HD13 ' A' ' 216' ' ' LEU . 38.8 mmtt -74.95 102.59 4.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.918 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -82.24 158.82 23.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.903 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 66.8 m-20 60.63 47.04 8.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.937 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 0.602 ' OE1' HG21 ' A' ' 193' ' ' THR . 10.6 mm-40 -132.2 164.87 25.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.937 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 39.5 t -118.47 115.82 49.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.139 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . 0.473 HD12 ' N ' ' A' ' 246' ' ' ALA . 9.5 mt -88.48 141.54 14.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.125 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 59.2 t -119.08 140.49 42.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.151 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . 0.465 ' N ' ' HB2' ' A' ' 244' ' ' SER . 27.1 ttp180 -95.78 101.68 13.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.869 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' MET . . . . . 0.594 ' HE2' HD21 ' A' ' 173' ' ' LEU . 88.1 mtp -92.58 137.56 32.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.871 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -137.98 129.96 28.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.874 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 98.31 21.97 16.03 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.493 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.866 HD23 HD13 ' A' ' 239' ' ' ILE . 22.1 mt -76.04 120.97 84.04 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.657 0.741 . . . . 0.0 110.946 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . 0.482 ' O ' ' HB3' ' A' ' 177' ' ' ALA . 65.6 Cg_exo -48.02 139.36 20.51 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.659 2.239 . . . . 0.0 112.336 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . 0.559 ' CD1' ' HG3' ' A' ' 209' ' ' PRO . 9.8 t80 -47.56 -42.53 23.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.859 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 7.3 p -72.21 -20.61 61.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.157 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.482 ' HB3' ' O ' ' A' ' 174' ' ' PRO . . . -60.99 105.99 0.54 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.113 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.415 ' O ' ' C ' ' A' ' 179' ' ' ALA . 73.7 p -116.74 173.59 6.55 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.158 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.415 ' C ' ' O ' ' A' ' 178' ' ' THR . . . -36.8 -46.46 0.61 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.089 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -55.47 -49.2 73.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.92 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -57.75 -34.24 69.33 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.887 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.54 HG12 HD11 ' A' ' 192' ' ' ILE . 89.0 t -74.78 -53.95 15.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.11 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.428 ' C ' ' O ' ' A' ' 182' ' ' VAL . 50.4 t -35.22 -52.06 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.131 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -73.66 -36.96 65.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.112 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.655 ' HD2' HD12 ' A' ' 234' ' ' LEU . 21.0 t80 -47.28 -58.03 4.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.88 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' PHE . . . . . 0.444 ' CE1' ' CE1' ' A' ' 185' ' ' PHE . 86.5 m-85 -96.28 -21.36 17.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.926 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -49.05 -24.16 4.34 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.443 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 3.5 tp-100 -49.61 -75.11 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.808 0.337 . . . . 0.0 110.891 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 -118.33 -7.63 10.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.869 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 78.0 m -126.09 84.34 61.66 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.587 0.708 . . . . 0.0 110.918 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' PRO . . . . . 0.494 ' HD2' ' CD1' ' A' ' 222' ' ' TYR . 54.0 Cg_endo -69.79 139.28 39.76 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.655 2.237 . . . . 0.0 112.377 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . 0.637 HG23 ' O ' ' A' ' 216' ' ' LEU . 57.8 mt -88.76 144.67 8.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.152 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . 0.602 HG21 ' OE1' ' A' ' 165' ' ' GLN . 17.9 m -70.18 104.7 2.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.173 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 91.72 -15.48 61.52 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.462 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 68.82 -120.22 10.69 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.46 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 43.9 mtmt -48.5 -33.77 10.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.783 0.325 . . . . 0.0 110.901 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -75.07 -27.59 60.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.874 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . 0.448 ' HA2' HD12 ' A' ' 216' ' ' LEU . . . -94.05 40.4 2.76 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.505 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 55.8 mt -143.0 146.28 21.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.847 0.356 . . . . 0.0 111.14 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 14.5 tp -146.6 122.34 10.55 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.951 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -102.09 121.41 42.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.882 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 60.6 t -72.78 140.17 18.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.149 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -142.9 138.83 30.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.159 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . 0.474 ' N ' HG23 ' A' ' 210' ' ' THR . 30.3 m-85 -50.79 159.08 0.99 Allowed Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.614 0.721 . . . . 0.0 110.966 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 3.73 2.62 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.711 2.274 . . . . 0.0 112.334 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -111.92 -18.52 12.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.907 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 110.4 44.18 1.01 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.499 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -126.78 143.72 47.55 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.571 0.701 . . . . 0.0 110.868 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . 0.559 ' HG3' ' CD1' ' A' ' 175' ' ' PHE . 53.4 Cg_endo -69.76 95.68 0.56 Allowed 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.686 2.258 . . . . 0.0 112.328 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . 0.633 HG21 ' CD2' ' A' ' 256' ' ' PHE . 33.5 p -60.27 -10.29 4.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.154 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 88.01 -45.73 3.34 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.485 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -66.85 161.67 23.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.768 0.318 . . . . 0.0 110.904 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . 0.561 ' HB3' ' CD1' ' A' ' 173' ' ' LEU . . . -161.27 -175.26 4.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.075 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . 0.451 ' CE2' HG13 ' A' ' 249' ' ' VAL . 56.5 m-85 -146.22 151.73 38.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.857 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . 0.427 HG12 ' N ' ' A' ' 216' ' ' LEU . 4.5 t -138.71 159.91 30.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.162 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.637 ' O ' HG23 ' A' ' 192' ' ' ILE . 43.0 mt -109.68 145.8 35.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.905 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -140.29 143.0 35.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.899 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . 0.418 ' HB3' ' CD2' ' A' ' 222' ' ' TYR . . . -53.85 -66.7 0.35 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.112 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' CYS . . . . . . . . . . . . . 30.1 m -138.31 -175.09 3.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.915 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -62.89 -37.36 86.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.873 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 18.8 tp10 -43.27 -41.2 3.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.9 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' TYR . . . . . 0.494 ' CD1' ' HD2' ' A' ' 191' ' ' PRO . 55.9 m-85 -86.05 -47.58 9.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.934 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -56.31 -63.75 1.09 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.107 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' GLN . . . . . 0.737 ' HA ' HD12 ' A' ' 227' ' ' LEU . 20.4 mt-30 -46.65 -52.6 13.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.905 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 22.3 m-20 -55.38 -26.34 40.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.872 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -80.78 -34.55 34.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.121 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . 0.737 HD12 ' HA ' ' A' ' 224' ' ' GLN . 38.3 mt -54.54 -30.11 52.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.943 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 36.8 mtp180 -63.87 -20.74 66.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.845 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . 0.459 ' O ' ' C ' ' A' ' 230' ' ' HIS . 19.8 mtpp -75.75 -1.92 27.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.926 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' HIS . . . . . 0.519 ' CE1' ' HG2' ' A' ' 231' ' ' LYS . 57.1 t60 -33.9 136.9 0.11 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.874 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.519 ' HG2' ' CE1' ' A' ' 230' ' ' HIS . 0.0 OUTLIER 61.76 30.54 18.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.852 179.96 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . 0.452 ' OD2' ' CE2' ' A' ' 185' ' ' PHE . 8.4 t70 -57.84 173.64 0.3 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.877 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.64 HD21 ' CE1' ' A' ' 238' ' ' TYR . 30.7 mt -132.58 104.33 6.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.899 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . 0.679 HD23 ' C ' ' A' ' 234' ' ' LEU . 5.8 tt -115.24 114.42 25.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.935 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 60.7 39.56 96.81 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.438 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 31.0 mtmm 65.3 53.0 1.35 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.789 0.328 . . . . 0.0 110.876 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' ARG . . . . . 0.482 ' CB ' ' HG3' ' A' ' 174' ' ' PRO . 12.4 mmt85 -156.09 116.09 3.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.877 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' TYR . . . . . 0.64 ' CE1' HD21 ' A' ' 233' ' ' LEU . 97.2 m-85 -68.6 135.61 51.74 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.918 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 0.866 HD13 HD23 ' A' ' 173' ' ' LEU . 60.2 mt -133.51 134.36 56.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.168 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . 0.54 ' O ' HD23 ' A' ' 241' ' ' LEU . 46.8 mt-10 -90.27 175.87 6.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.884 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . 0.54 HD23 ' O ' ' A' ' 240' ' ' GLU . 63.6 mt -156.67 138.19 14.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.912 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' PHE . . . . . 0.497 ' CD1' ' O ' ' A' ' 241' ' ' LEU . 20.9 m-85 -155.19 127.85 7.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.852 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 46.5 mtm180 -39.98 136.97 1.03 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.909 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . 0.465 ' HB2' ' N ' ' A' ' 169' ' ' ARG . 3.6 t -132.57 154.67 49.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.844 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 26.4 p -132.09 156.77 45.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.173 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 246' ' ' ALA . . . . . 0.473 ' N ' HD12 ' A' ' 167' ' ' ILE . . . -42.17 -57.15 2.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.128 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -53.76 -41.13 66.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.115 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . 0.474 ' O ' HG23 ' A' ' 252' ' ' VAL . 2.6 tp10 -61.15 -49.99 75.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.886 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.451 HG13 ' CE2' ' A' ' 214' ' ' PHE . 95.4 t -53.24 -64.97 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.105 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 250' ' ' GLN . . . . . 0.773 ' HA ' HD12 ' A' ' 253' ' ' LEU . 28.4 mt-30 -42.57 -34.09 0.81 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.929 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 251' ' ' GLN . . . . . 0.45 ' HA ' ' ND2' ' A' ' 254' ' ' ASN . 64.4 mt-30 -73.58 -47.73 38.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.891 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 252' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 248' ' ' GLU . 75.2 t -57.69 -35.13 49.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.11 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.773 HD12 ' HA ' ' A' ' 250' ' ' GLN . 10.9 mt -65.81 -48.83 70.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.872 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . 0.485 ' C ' ' OD1' ' A' ' 254' ' ' ASN . 0.6 OUTLIER -67.12 -41.37 86.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.891 179.95 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . 0.47 ' N ' ' OD1' ' A' ' 254' ' ' ASN . 13.7 ttm180 -54.78 -41.39 70.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.868 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 256' ' ' PHE . . . . . 0.633 ' CD2' HG21 ' A' ' 210' ' ' THR . 12.8 m-85 -80.49 -47.12 14.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.851 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 51.1 m -61.91 -20.5 63.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.837 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 42.3 m -109.87 61.34 0.6 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.837 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 259' ' ' ALA . . . . . . . . . . . . . . . -111.44 76.34 0.97 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.115 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 33.9 t -40.12 -44.62 1.84 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.85 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . 0.417 ' HA2' ' C ' ' A' ' 262' ' ' PRO . . . -57.5 172.49 2.77 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.487 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 262' ' ' PRO . . . . . 0.417 ' C ' ' HA2' ' A' ' 261' ' ' GLY . 53.9 Cg_endo -69.74 171.82 51.83 Favored 'Cis proline' 0 C--N 1.341 0.179 0 C-N-CA 122.659 -1.809 . . . . 0.0 112.355 -0.027 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 28.5 m 48.79 45.51 21.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.889 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 56.1 p -44.81 152.98 0.19 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.85 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.515 179.984 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.28 0 N-CA-C 112.479 -0.248 . . . . 0.0 112.479 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . 0.441 ' O ' ' C ' ' A' ' 145' ' ' SER . 41.6 t -49.37 131.26 20.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.876 0.37 . . . . 0.0 110.805 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.441 ' C ' ' O ' ' A' ' 144' ' ' SER . 23.0 t -35.28 -55.55 0.63 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.868 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 144.9 150.71 5.28 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.439 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 12.9 m -130.5 149.88 51.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.899 0.38 . . . . 0.0 110.827 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 31.2 t -79.15 97.03 6.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.818 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -177.92 -173.25 43.19 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.482 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -171.24 -156.67 11.97 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.418 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -85.21 -167.36 43.19 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.472 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.692 HG22 HG21 ' A' ' 156' ' ' VAL . 5.3 t -69.73 -23.4 63.4 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.768 0.318 . . . . 0.0 111.161 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 70.5 m -156.66 151.68 26.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.827 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -38.5 -48.47 1.4 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.947 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -54.63 -49.78 69.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.879 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.692 HG21 HG22 ' A' ' 152' ' ' THR . 73.5 t -65.07 -41.61 92.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.123 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -43.24 -60.06 1.83 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.101 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 83.2 mm-40 -62.33 -36.67 82.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.922 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' PHE . . . . . 0.427 ' CD1' ' HB2' ' A' ' 200' ' ' LEU . 76.7 t80 -60.62 -38.74 85.74 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.875 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 86.2 mt -94.59 -15.98 23.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.922 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 10.9 t -55.13 -40.37 70.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.865 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . 0.692 ' HD2' HD13 ' A' ' 216' ' ' LEU . 14.5 mttp -52.84 116.0 2.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.891 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 39.4 mp0 -80.9 162.51 23.91 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.856 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 43.74 51.03 6.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.869 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 0.806 ' OE1' HG21 ' A' ' 193' ' ' THR . 0.2 OUTLIER -124.16 156.76 36.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.896 -179.967 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 60.7 t -110.47 133.24 56.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.117 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . 0.618 HG21 HG21 ' A' ' 249' ' ' VAL . 56.3 mt -109.53 131.11 61.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.094 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 44.5 t -114.3 133.41 60.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.102 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . 0.413 ' N ' ' HB2' ' A' ' 244' ' ' SER . 61.6 ttt180 -90.03 110.94 21.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.87 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' MET . . . . . 0.61 ' CE ' HD21 ' A' ' 173' ' ' LEU . 90.0 mtp -98.16 126.58 43.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.912 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 14.2 ttm180 -127.01 142.31 51.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.873 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 83.46 36.34 14.61 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.498 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.683 HD23 HD13 ' A' ' 239' ' ' ILE . 28.0 mt -87.64 130.43 47.11 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.64 0.733 . . . . 0.0 110.894 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . 0.459 ' HG3' ' CB ' ' A' ' 237' ' ' ARG . 66.2 Cg_exo -47.99 122.5 7.35 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.67 2.247 . . . . 0.0 112.309 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -39.57 -29.81 0.06 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.862 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.403 ' O ' ' C ' ' A' ' 177' ' ' ALA . 31.6 p -80.67 -41.79 23.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.18 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.444 ' N ' ' O ' ' A' ' 174' ' ' PRO . . . -36.69 126.64 0.86 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.087 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -123.53 -174.91 3.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.116 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.08 -50.53 73.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.066 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -53.39 -34.66 58.58 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.901 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -65.57 -40.76 93.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.929 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.485 HG12 HD11 ' A' ' 192' ' ' ILE . 76.1 t -68.33 -51.59 46.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.168 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.414 ' C ' ' O ' ' A' ' 182' ' ' VAL . 41.1 t -36.48 -49.11 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.153 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -76.36 -39.6 53.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.079 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.8 ' HD2' HD12 ' A' ' 234' ' ' LEU . 9.0 t80 -42.09 -59.06 1.88 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.909 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' PHE . . . . . 0.453 ' CE1' ' CE1' ' A' ' 185' ' ' PHE . 69.6 m-85 -95.57 -21.95 17.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.867 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -49.24 -22.59 3.51 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.451 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 77.3 mm-40 -52.64 -71.76 0.06 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.838 0.352 . . . . 0.0 110.884 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 33.2 m80 -118.08 -17.2 9.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.829 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 99.7 m -118.27 83.94 21.53 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.608 0.718 . . . . 0.0 110.89 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 130.96 20.2 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.731 2.287 . . . . 0.0 112.311 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . 0.633 HG23 ' O ' ' A' ' 216' ' ' LEU . 48.4 mt -79.46 146.11 8.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.13 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . 0.806 HG21 ' OE1' ' A' ' 165' ' ' GLN . 53.8 m -67.71 109.08 3.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.098 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 85.11 -22.85 8.86 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.491 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.408 ' O ' ' N ' ' A' ' 198' ' ' GLY . . . 79.64 -125.37 6.93 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.472 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 20.7 mtmm -46.0 -23.72 0.34 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.785 0.326 . . . . 0.0 110.896 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -81.67 -35.22 30.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.887 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . 0.817 ' HA2' HD12 ' A' ' 216' ' ' LEU . . . -86.21 26.36 6.3 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.483 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 68.9 mt -125.78 140.13 49.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.854 0.359 . . . . 0.0 111.107 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.427 ' HB2' ' CD1' ' A' ' 159' ' ' PHE . 14.6 tp -136.17 112.26 9.68 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.893 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -92.86 112.94 25.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.898 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.644 HG11 ' OD2' ' A' ' 212' ' ' ASP . 23.5 t -67.38 114.68 4.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.085 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -126.4 137.19 53.41 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.154 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -43.79 158.67 0.25 Allowed Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.686 0.755 . . . . 0.0 110.929 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 2.84 3.15 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.728 2.285 . . . . 0.0 112.338 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -112.66 -16.98 12.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.915 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 108.38 60.43 0.54 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.535 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 59.7 mtt-85 -147.58 145.98 23.19 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.581 0.705 . . . . 0.0 110.877 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 112.47 3.08 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.71 2.273 . . . . 0.0 112.368 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . 0.541 ' HB ' ' CE1' ' A' ' 256' ' ' PHE . 80.4 p -79.65 -10.84 59.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.152 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 95.06 -32.56 6.04 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.488 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' ASP . . . . . 0.644 ' OD2' HG11 ' A' ' 202' ' ' VAL . 1.2 p-10 -84.6 164.72 18.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.781 0.324 . . . . 0.0 110.893 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . 0.521 ' HA ' HG23 ' A' ' 202' ' ' VAL . . . -161.72 -179.06 6.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.066 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . 0.699 ' CE2' HG13 ' A' ' 249' ' ' VAL . 59.6 m-85 -146.79 133.01 19.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.896 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . 0.478 HG12 ' N ' ' A' ' 216' ' ' LEU . 14.4 t -118.56 159.75 18.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.105 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.817 HD12 ' HA2' ' A' ' 198' ' ' GLY . 51.6 mt -112.18 149.84 31.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.929 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -145.51 139.27 26.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.893 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . 0.566 ' HB3' ' CD1' ' A' ' 222' ' ' TYR . . . -44.79 -57.26 3.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.054 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' CYS . . . . . . . . . . . . . 1.8 t -160.93 -178.38 6.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.925 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 10.6 mp0 -48.3 -34.4 10.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.919 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -54.98 -33.09 62.19 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.903 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' TYR . . . . . 0.566 ' CD1' ' HB3' ' A' ' 218' ' ' ALA . 6.5 m-85 -93.52 -42.88 8.99 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.966 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.29 -62.17 2.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.134 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' GLN . . . . . 0.624 ' HA ' HD12 ' A' ' 227' ' ' LEU . 33.8 mt-30 -45.6 -59.21 2.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.921 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 38.1 m-20 -48.41 -22.15 0.66 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.922 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -92.81 -35.07 13.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.119 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . 0.624 HD12 ' HA ' ' A' ' 224' ' ' GLN . 86.1 mt -54.11 -37.76 64.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.933 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . 0.489 ' CZ ' ' HB2' ' A' ' 228' ' ' ARG . 0.2 OUTLIER -58.12 -24.7 59.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.82 179.954 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . 0.533 ' CE ' ' CE1' ' A' ' 185' ' ' PHE . 24.5 mtpp -67.25 -4.08 9.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.889 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' HIS . . . . . 0.528 ' CG ' ' HG2' ' A' ' 231' ' ' LYS . 23.6 t60 -34.33 134.18 0.21 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.878 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.528 ' HG2' ' CG ' ' A' ' 230' ' ' HIS . 0.2 OUTLIER 67.34 27.62 8.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.921 179.999 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -58.19 179.28 0.07 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.845 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.711 HD21 ' CE2' ' A' ' 238' ' ' TYR . 31.3 mt -135.67 110.66 8.84 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.939 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . 0.8 HD12 ' HD2' ' A' ' 185' ' ' PHE . 6.8 tt -119.9 115.46 23.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.936 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 57.04 39.39 89.58 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.492 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 23.3 mmtm 67.39 52.18 0.83 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.814 0.34 . . . . 0.0 110.899 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' ARG . . . . . 0.459 ' CB ' ' HG3' ' A' ' 174' ' ' PRO . 23.3 mmt180 -156.17 115.33 3.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.868 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' TYR . . . . . 0.711 ' CE2' HD21 ' A' ' 233' ' ' LEU . 96.0 m-85 -69.26 128.46 36.69 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.915 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 0.683 HD13 HD23 ' A' ' 173' ' ' LEU . 70.7 mt -123.52 138.62 52.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.137 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -99.95 165.76 11.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.887 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . 0.533 ' O ' ' CD1' ' A' ' 242' ' ' PHE . 18.6 mt -141.67 149.44 40.6 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.914 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 242' ' ' PHE . . . . . 0.533 ' CD1' ' O ' ' A' ' 241' ' ' LEU . 26.8 m-85 -155.65 130.26 9.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.914 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 24.9 mtp180 -52.54 122.85 9.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.889 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . 0.413 ' HB2' ' N ' ' A' ' 169' ' ' ARG . 3.5 t -117.84 173.64 6.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.848 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 39.8 p -149.25 161.67 41.56 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.16 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -42.89 -60.24 1.68 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.072 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -53.13 -47.92 68.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.073 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -52.43 -54.74 28.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.817 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.699 HG13 ' CE2' ' A' ' 214' ' ' PHE . 94.0 t -51.79 -63.29 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.145 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 250' ' ' GLN . . . . . 0.749 ' HA ' HD12 ' A' ' 253' ' ' LEU . 22.9 mt-30 -46.87 -31.23 2.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.907 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 60.5 mt-30 -77.89 -28.65 49.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.935 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 252' ' ' VAL . . . . . 0.419 ' O ' HG12 ' A' ' 252' ' ' VAL . 55.6 t -82.36 -15.17 12.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.152 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.749 HD12 ' HA ' ' A' ' 250' ' ' GLN . 13.1 mt -86.85 -42.68 13.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.883 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . 0.497 ' OD1' ' N ' ' A' ' 255' ' ' ARG . 0.7 OUTLIER -61.0 -43.28 99.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.917 179.944 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . 0.497 ' N ' ' OD1' ' A' ' 254' ' ' ASN . 15.5 ptm180 -58.7 -52.43 65.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.872 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 256' ' ' PHE . . . . . 0.541 ' CE1' ' HB ' ' A' ' 210' ' ' THR . 11.1 m-85 -67.66 -37.47 82.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.89 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 44.2 t -64.71 -34.82 79.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.865 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 22.9 t -123.59 86.58 2.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.845 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 259' ' ' ALA . . . . . . . . . . . . . . . -115.26 -37.04 4.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.1 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 1.6 t -49.67 134.38 20.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.877 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . 0.506 ' HA3' ' C ' ' A' ' 262' ' ' PRO . . . 143.48 -81.95 0.22 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.515 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 262' ' ' PRO . . . . . 0.506 ' C ' ' HA3' ' A' ' 261' ' ' GLY . 53.6 Cg_endo -69.75 177.92 27.18 Favored 'Cis proline' 0 C--N 1.341 0.17 0 C-N-CA 122.749 -1.771 . . . . 0.0 112.361 0.019 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 93.7 p -122.33 103.44 8.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.828 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 94.5 p -145.93 170.93 15.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.867 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.335 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.485 -179.964 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.285 0 N-CA-C 112.439 -0.264 . . . . 0.0 112.439 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 4.3 m -96.29 -60.53 1.6 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.892 0.377 . . . . 0.0 110.829 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 8.1 t -91.89 127.91 37.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.886 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -142.05 177.86 21.15 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.492 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . 0.485 ' O ' ' N ' ' A' ' 149' ' ' GLY . 3.9 t -130.38 121.89 26.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.846 0.355 . . . . 0.0 110.845 -179.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 17.8 t -40.08 92.89 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.847 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . 0.485 ' N ' ' O ' ' A' ' 147' ' ' SER . . . -97.52 -119.35 3.88 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.489 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -96.88 97.32 1.99 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.492 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 115.61 162.83 13.56 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.459 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 4.6 m -44.82 141.92 1.96 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.813 0.339 . . . . 0.0 111.126 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 3.3 t -45.95 145.79 1.41 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.814 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -61.34 -32.09 71.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.854 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -75.95 -50.25 15.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.916 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.807 HG22 HD21 ' A' ' 200' ' ' LEU . 48.7 t -51.74 -33.28 15.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.116 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -48.36 -66.96 0.31 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.088 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 12.6 mm-40 -57.23 -28.31 62.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.923 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' PHE . . . . . 0.434 ' CE2' ' HG ' ' A' ' 216' ' ' LEU . 48.0 t80 -68.04 -36.89 80.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.889 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 81.6 mt -92.67 -20.82 20.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.926 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 3.4 t -53.16 -37.18 61.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.844 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . 0.592 ' HG3' HD13 ' A' ' 216' ' ' LEU . 56.9 mmtt -50.97 127.98 20.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.912 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -103.31 137.82 40.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.861 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 4.7 m120 70.55 43.47 0.77 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.859 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 6.2 mp0 -125.75 156.48 39.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.941 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 38.9 t -108.5 136.45 44.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.139 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . 0.465 HG21 ' CG2' ' A' ' 249' ' ' VAL . 52.0 mt -109.19 142.24 22.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.14 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 21.4 t -124.7 140.08 48.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.125 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 30.2 ttt-85 -92.09 108.89 20.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.858 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' MET . . . . . 0.646 ' CE ' HD21 ' A' ' 173' ' ' LEU . 80.6 mtp -93.93 129.9 40.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.882 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 17.8 ttm180 -132.9 140.32 47.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.826 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 89.34 24.63 30.74 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.55 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.646 HD21 ' CE ' ' A' ' 170' ' ' MET . 24.0 mt -77.27 123.73 87.03 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.582 0.706 . . . . 0.0 110.917 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_exo -47.94 125.21 11.17 Favored 'Trans proline' 0 N--CA 1.465 -0.169 0 C-N-CA 122.717 2.278 . . . . 0.0 112.343 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -37.5 -33.51 0.07 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.888 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.562 ' O ' HG23 ' A' ' 178' ' ' THR . 75.0 p -78.07 -50.71 11.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.119 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.444 ' C ' ' O ' ' A' ' 176' ' ' THR . . . -33.7 130.31 0.28 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.103 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.562 HG23 ' O ' ' A' ' 176' ' ' THR . 16.9 p -132.06 178.7 6.59 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.119 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.429 ' O ' HG23 ' A' ' 183' ' ' VAL . . . -49.37 -46.14 46.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.1 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -56.51 -28.62 60.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.867 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . 0.84 ' HG2' HD11 ' A' ' 234' ' ' LEU . 4.5 tt0 -76.08 -44.15 40.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.879 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.526 ' HB ' HD13 ' A' ' 199' ' ' ILE . 54.8 t -63.7 -45.37 97.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.127 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 179' ' ' ALA . 54.6 t -37.19 -46.68 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.135 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -81.06 -37.82 28.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.093 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.547 ' CZ ' ' OD2' ' A' ' 232' ' ' ASP . 68.7 t80 -43.05 -57.03 3.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.882 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -94.6 -21.78 18.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.871 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -49.39 -17.81 1.29 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.713 -0.755 . . . . 0.0 112.514 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 15.9 mm-40 -56.13 -74.81 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.792 0.33 . . . . 0.0 110.89 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -118.27 -5.03 10.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.845 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 72.9 m -129.29 85.0 60.59 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.655 0.741 . . . . 0.0 110.921 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' PRO . . . . . 0.429 ' HD2' ' CD1' ' A' ' 222' ' ' TYR . 53.5 Cg_endo -69.74 130.47 19.43 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.711 2.274 . . . . 0.0 112.336 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . 0.546 HG23 ' O ' ' A' ' 216' ' ' LEU . 52.7 mt -80.9 144.56 10.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.17 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 91.1 m -67.59 99.68 0.8 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.144 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 95.36 -11.96 68.39 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.481 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 70.31 -126.07 15.51 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.524 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 4.5 ptmm? -48.37 -26.49 2.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.737 0.303 . . . . 0.0 110.909 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -77.92 -30.7 50.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.911 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . 0.427 ' HA2' HD12 ' A' ' 216' ' ' LEU . . . -89.4 39.5 3.11 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.472 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.526 HD13 ' HB ' ' A' ' 182' ' ' VAL . 72.8 mt -140.76 137.62 35.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.842 0.353 . . . . 0.0 111.146 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.807 HD21 HG22 ' A' ' 156' ' ' VAL . 15.3 tp -132.45 114.13 13.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.931 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' PHE . . . . . 0.4 ' CZ ' ' N ' ' A' ' 179' ' ' ALA . 54.4 m-85 -93.27 121.88 35.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.863 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.427 HG11 ' OD2' ' A' ' 212' ' ' ASP . 95.9 t -73.46 118.52 18.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.119 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -126.89 138.03 53.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.189 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . 0.805 ' CD2' HG22 ' A' ' 210' ' ' THR . 35.8 m-85 -45.92 158.45 0.36 Allowed Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.664 0.745 . . . . 0.0 110.943 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.82 2.9 3.14 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.714 2.276 . . . . 0.0 112.318 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -109.42 -21.89 12.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.859 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 112.24 52.82 0.51 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.488 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 5.2 mpt_? -140.18 145.48 41.93 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.586 0.708 . . . . 0.0 110.874 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 107.44 1.85 Allowed 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.708 2.272 . . . . 0.0 112.347 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . 0.805 HG22 ' CD2' ' A' ' 204' ' ' TYR . 69.5 p -70.82 -29.59 65.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.155 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 115.08 -42.25 1.96 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.496 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' ASP . . . . . 0.427 ' OD2' HG11 ' A' ' 202' ' ' VAL . 1.7 p-10 -74.39 169.38 17.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.822 0.344 . . . . 0.0 110.867 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . 0.503 ' HB3' ' CD1' ' A' ' 173' ' ' LEU . . . -168.95 171.17 8.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.112 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -136.12 143.41 44.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.867 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 4.1 t -124.42 156.95 32.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.092 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.592 HD13 ' HG3' ' A' ' 162' ' ' LYS . 28.8 mt -108.22 151.06 26.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.953 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -144.19 135.37 25.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.893 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -49.06 -58.59 4.67 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.102 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 219' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -144.73 170.93 15.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.882 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -55.68 -27.27 49.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.881 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 23.0 tp10 -51.34 -36.27 42.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.907 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 222' ' ' TYR . . . . . 0.429 ' CD1' ' HD2' ' A' ' 191' ' ' PRO . 52.9 m-85 -91.84 -47.49 7.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.911 -179.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -52.57 -57.39 10.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.101 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 224' ' ' GLN . . . . . 0.446 ' HA ' HD12 ' A' ' 227' ' ' LEU . 60.0 mt-30 -50.08 -48.56 53.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.916 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 18.8 m-20 -63.15 -23.96 67.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.887 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -77.12 -22.71 52.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.093 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . 0.446 HD12 ' HA ' ' A' ' 224' ' ' GLN . 17.8 mt -70.51 -32.74 70.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.947 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 65.8 mtp180 -58.93 -12.33 4.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.874 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . 0.453 ' O ' ' C ' ' A' ' 230' ' ' HIS . 28.1 mttp -83.46 -1.73 54.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.926 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 230' ' ' HIS . . . . . 0.453 ' C ' ' O ' ' A' ' 229' ' ' LYS . 10.5 t60 -33.65 137.06 0.1 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.887 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.446 ' HG2' ' CG ' ' A' ' 230' ' ' HIS . 0.3 OUTLIER 59.82 34.49 21.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.929 -180.0 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . 0.547 ' OD2' ' CZ ' ' A' ' 185' ' ' PHE . 11.6 t0 -62.3 176.51 0.6 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.845 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.678 HD21 ' CE1' ' A' ' 238' ' ' TYR . 30.9 mt -134.87 107.22 7.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.903 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . 0.84 HD11 ' HG2' ' A' ' 181' ' ' GLU . 6.0 tt -114.35 112.45 23.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.935 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 57.75 40.44 92.83 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.477 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 62.3 mttt 68.93 53.21 0.49 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.774 0.321 . . . . 0.0 110.946 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 19.0 mmt180 -156.16 117.3 3.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.926 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 238' ' ' TYR . . . . . 0.678 ' CE1' HD21 ' A' ' 233' ' ' LEU . 98.8 m-85 -69.96 125.85 27.97 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.887 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 74.0 mt -121.31 137.39 55.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.138 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -97.79 163.61 12.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.868 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 41.2 mt -142.91 138.8 30.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.913 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -148.35 138.88 22.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.87 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 64.6 mtm180 -56.81 132.46 52.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.876 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 5.6 t -130.37 163.21 27.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.877 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 68.0 p -134.8 160.06 39.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.152 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -44.69 -49.72 10.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.102 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -60.36 -44.06 95.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.094 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . 0.494 ' O ' HG23 ' A' ' 252' ' ' VAL . 10.8 tt0 -54.92 -52.27 63.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.917 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.465 ' CG2' HG21 ' A' ' 167' ' ' ILE . 97.3 t -46.7 -62.06 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.141 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 250' ' ' GLN . . . . . 0.403 ' HA ' HD12 ' A' ' 253' ' ' LEU . 19.7 mt-30 -48.92 -44.06 40.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.908 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 251' ' ' GLN . . . . . 0.471 ' HA ' ' ND2' ' A' ' 254' ' ' ASN . 23.8 mt-30 -66.59 -20.04 65.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.931 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 252' ' ' VAL . . . . . 0.494 HG23 ' O ' ' A' ' 248' ' ' GLU . 72.8 t -88.91 -24.39 6.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.162 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.426 HD11 HG12 ' A' ' 249' ' ' VAL . 10.9 mt -85.2 -39.78 17.43 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.893 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . 0.471 ' ND2' ' HA ' ' A' ' 251' ' ' GLN . 0.5 OUTLIER -65.47 -38.62 90.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.909 179.922 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . 0.444 ' NH2' HG13 ' A' ' 252' ' ' VAL . 30.2 ptt180 -63.79 -37.89 89.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.898 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -80.57 -40.29 26.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.874 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 41.4 t -62.69 -44.67 95.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.837 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 63.5 m -101.15 40.22 1.31 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.878 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 259' ' ' ALA . . . . . . . . . . . . . . . -67.41 -37.55 83.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.115 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 58.1 p -102.05 163.44 12.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.899 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . 0.403 ' HA3' ' C ' ' A' ' 262' ' ' PRO . . . -159.69 -69.17 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.456 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 262' ' ' PRO . . . . . 0.403 ' C ' ' HA3' ' A' ' 261' ' ' GLY . 53.8 Cg_endo -69.76 160.95 87.17 Favored 'Cis proline' 0 C--N 1.341 0.17 0 C-N-CA 122.654 -1.811 . . . . 0.0 112.332 0.074 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 2.7 p -163.42 151.92 13.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.862 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 60.6 p -102.34 133.21 47.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.846 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.299 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.478 -179.993 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.361 0 N-CA-C 112.441 -0.263 . . . . 0.0 112.441 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 88.4 p -109.43 105.19 14.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.881 0.372 . . . . 0.0 110.89 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 87.5 p -147.12 140.07 25.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.844 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -88.78 53.57 4.02 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.459 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 65.0 p -132.43 116.6 17.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.906 0.384 . . . . 0.0 110.856 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 66.0 p -97.11 116.13 28.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.8 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -113.39 -64.25 0.45 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.489 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -99.78 -81.52 1.6 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.795 -0.716 . . . . 0.0 112.479 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -92.9 126.97 8.79 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.46 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.481 HG22 HG23 ' A' ' 156' ' ' VAL . 23.9 m -71.26 120.54 16.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.821 0.343 . . . . 0.0 111.147 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 28.9 p -129.24 -45.98 1.23 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.799 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -68.55 -54.03 19.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.92 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.449 ' HB3' ' CG2' ' A' ' 152' ' ' THR . 21.9 tt0 -50.65 -47.07 58.67 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.89 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.481 HG23 HG22 ' A' ' 152' ' ' THR . 89.9 t -70.56 -42.26 78.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.146 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' ' 156' ' ' VAL . . . -37.57 -59.22 0.8 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.142 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 11.9 mm100 -56.97 -49.9 74.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.897 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' PHE . . . . . 0.51 ' CE2' ' HG ' ' A' ' 216' ' ' LEU . 58.8 t80 -47.8 -42.71 26.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.838 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 79.9 mt -86.32 -17.25 35.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.883 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 5.6 t -65.14 -30.87 71.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.844 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . 0.533 ' HG3' HD13 ' A' ' 216' ' ' LEU . 0.4 OUTLIER -53.14 129.38 30.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.943 179.903 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -102.93 151.78 22.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.866 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 67.1 m-80 61.85 49.73 4.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.879 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 22.2 mm-40 -131.09 168.08 18.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.887 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 45.5 t -125.06 109.22 21.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.133 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . 0.564 HG21 ' CG2' ' A' ' 249' ' ' VAL . 96.8 mt -79.37 139.7 17.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.148 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 66.7 t -123.67 130.46 74.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.132 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 52.1 ttp180 -88.26 105.37 17.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.911 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' MET . . . . . 0.521 ' CE ' HD21 ' A' ' 173' ' ' LEU . 98.8 mtp -94.36 129.48 41.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.914 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 40.7 mtt180 -128.99 147.08 50.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.872 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 81.26 35.96 22.2 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.475 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.521 HD21 ' CE ' ' A' ' 170' ' ' MET . 25.9 mt -86.01 125.64 67.86 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.588 0.709 . . . . 0.0 110.915 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_exo -47.99 140.29 18.93 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.691 2.26 . . . . 0.0 112.363 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -53.84 -19.85 4.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.879 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 50.0 p -94.97 -19.43 20.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.14 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -56.87 125.47 22.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.096 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 1.6 p -134.22 171.14 14.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.114 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.431 ' N ' ' CZ ' ' A' ' 201' ' ' PHE . . . -43.24 -55.69 3.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.081 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -48.33 -33.96 9.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.925 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . 0.49 ' HG3' HD11 ' A' ' 234' ' ' LEU . 0.8 OUTLIER -71.59 -44.3 64.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.902 -179.92 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.401 ' O ' ' C ' ' A' ' 183' ' ' VAL . 40.3 t -65.68 -50.19 72.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.102 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.401 ' C ' ' O ' ' A' ' 182' ' ' VAL . 44.7 t -37.52 -42.25 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.109 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -81.54 -39.51 24.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.115 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.543 ' CE2' ' HD3' ' A' ' 229' ' ' LYS . 60.6 t80 -43.86 -58.35 2.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.87 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' PHE . . . . . 0.401 ' CE1' ' CE2' ' A' ' 185' ' ' PHE . 73.6 m-85 -92.81 -23.66 18.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.859 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -50.16 -22.26 4.74 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.495 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 9.6 mm-40 -50.25 -75.9 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.867 0.365 . . . . 0.0 110.913 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . 0.556 ' CE1' ' HB3' ' A' ' 225' ' ' ASN . 0.3 OUTLIER -118.41 -0.29 11.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.899 179.981 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' CYS . . . . . 0.542 ' HG ' ' CD2' ' A' ' 189' ' ' HIS . 94.8 m -128.48 91.9 42.43 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.602 0.715 . . . . 0.0 110.886 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' PRO . . . . . 0.42 ' HD2' ' HA ' ' A' ' 190' ' ' CYS . 53.8 Cg_endo -69.75 135.74 31.26 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.73 2.286 . . . . 0.0 112.346 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . 0.544 HG23 ' O ' ' A' ' 216' ' ' LEU . 62.1 mt -92.6 145.54 7.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.138 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 88.6 m -67.13 104.33 1.41 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.107 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 87.93 -15.32 55.99 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.502 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 73.57 -119.63 6.63 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.504 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.79 -21.32 2.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.748 0.309 . . . . 0.0 110.895 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -87.03 -25.52 24.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.885 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . 0.445 ' HA2' HD12 ' A' ' 216' ' ' LEU . . . -88.65 33.11 4.27 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.462 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 29.0 mt -138.72 153.15 25.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.822 0.344 . . . . 0.0 111.144 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.401 HD21 HG22 ' A' ' 156' ' ' VAL . 14.0 tp -146.96 113.0 5.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.921 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' PHE . . . . . 0.431 ' CZ ' ' N ' ' A' ' 179' ' ' ALA . 35.9 m-85 -93.72 121.51 35.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.895 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.406 ' CB ' ' OD2' ' A' ' 212' ' ' ASP . 42.1 t -74.39 123.46 29.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.161 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . 0.573 ' HA ' HG23 ' A' ' 210' ' ' THR . 0.7 OUTLIER -134.18 137.08 44.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.096 -179.947 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -46.09 158.42 0.37 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.69 0.757 . . . . 0.0 110.915 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.7 3.04 2.97 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.66 2.24 . . . . 0.0 112.387 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -113.03 -10.05 13.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.882 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 99.92 58.85 0.87 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.459 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 11.2 mmm180 -142.3 143.38 27.01 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.614 0.721 . . . . 0.0 110.86 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.66 109.6 2.33 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.721 2.281 . . . . 0.0 112.371 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . 0.576 ' HB ' ' CE2' ' A' ' 256' ' ' PHE . 19.8 p -73.43 -32.01 64.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.156 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 112.97 -30.28 7.51 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.487 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 212' ' ' ASP . . . . . 0.406 ' OD2' ' CB ' ' A' ' 202' ' ' VAL . 1.0 OUTLIER -88.45 163.98 15.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.785 0.326 . . . . 0.0 110.876 -179.975 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -162.76 177.37 9.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.091 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . 0.786 ' CE2' HG13 ' A' ' 249' ' ' VAL . 41.2 m-85 -142.35 139.41 31.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.87 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 6.2 t -123.0 156.89 28.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.15 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.544 ' O ' HG23 ' A' ' 192' ' ' ILE . 32.4 mt -109.92 138.8 45.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.922 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -130.12 133.9 46.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.858 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . 0.66 ' HB3' ' CE2' ' A' ' 222' ' ' TYR . . . -44.81 -64.53 0.68 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.136 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 219' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -144.23 160.2 41.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.835 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -40.92 -29.51 0.1 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.893 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -47.57 -49.89 25.37 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.9 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 222' ' ' TYR . . . . . 0.66 ' CE2' ' HB3' ' A' ' 218' ' ' ALA . 30.1 m-85 -78.03 -50.99 11.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.893 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.49 ' O ' ' HB3' ' A' ' 226' ' ' ALA . . . -44.85 -57.08 3.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.158 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 224' ' ' GLN . . . . . 0.542 ' HA ' HD12 ' A' ' 227' ' ' LEU . 8.6 mm-40 -48.52 -60.92 2.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.914 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . 0.556 ' HB3' ' CE1' ' A' ' 189' ' ' HIS . 30.3 m-20 -51.86 -21.51 2.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.915 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . 0.49 ' HB3' ' O ' ' A' ' 223' ' ' ALA . . . -83.24 -33.86 25.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.094 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . 0.542 HD12 ' HA ' ' A' ' 224' ' ' GLN . 32.2 mt -60.67 -28.9 68.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.924 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . 0.408 HH11 ' CB ' ' A' ' 228' ' ' ARG . 0.0 OUTLIER -61.11 -18.06 55.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.878 179.946 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . 0.543 ' HD3' ' CE2' ' A' ' 185' ' ' PHE . 16.2 mttm -80.02 0.19 32.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.891 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 230' ' ' HIS . . . . . 0.482 ' N ' HD12 ' A' ' 241' ' ' LEU . 8.6 t60 -32.66 126.93 0.29 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.872 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 43.7 mtmt 61.84 37.1 15.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.938 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -60.72 -174.93 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.852 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.612 HD21 ' CD1' ' A' ' 238' ' ' TYR . 33.0 mt -138.8 105.64 5.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.907 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . 0.539 HD23 ' C ' ' A' ' 234' ' ' LEU . 7.1 tt -113.35 114.8 27.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.873 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 59.22 37.67 92.13 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.494 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 33.3 mttt 69.14 52.37 0.49 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.774 0.321 . . . . 0.0 110.898 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 23.3 mmt180 -156.24 115.26 3.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.835 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 238' ' ' TYR . . . . . 0.612 ' CD1' HD21 ' A' ' 233' ' ' LEU . 97.3 m-85 -63.71 128.22 34.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.95 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 0.457 HD13 HD23 ' A' ' 173' ' ' LEU . 97.4 mt -127.04 129.71 71.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.08 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . 0.576 ' HB3' ' CE2' ' A' ' 242' ' ' PHE . 3.9 mp0 -85.33 171.92 11.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.85 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . 0.595 ' O ' ' CD1' ' A' ' 242' ' ' PHE . 21.3 mt -154.46 138.75 16.64 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.909 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 242' ' ' PHE . . . . . 0.595 ' CD1' ' O ' ' A' ' 241' ' ' LEU . 6.6 m-85 -158.45 123.43 4.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.878 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . 0.496 ' O ' ' CG ' ' A' ' 243' ' ' ARG . 21.2 ptt180 -60.89 117.33 5.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.85 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 1.7 t -112.49 168.52 9.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.858 -179.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.6 p -109.45 173.83 6.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.168 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 246' ' ' ALA . . . . . 0.549 ' HA ' HD12 ' A' ' 167' ' ' ILE . . . -61.63 -63.74 1.17 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.1 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -43.76 -49.67 7.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.074 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -47.27 -57.64 4.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.863 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.786 HG13 ' CE2' ' A' ' 214' ' ' PHE . 97.8 t -44.65 -61.68 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.136 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 250' ' ' GLN . . . . . 0.631 ' HA ' HD12 ' A' ' 253' ' ' LEU . 53.1 mt-30 -47.59 -29.55 2.98 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.916 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -82.4 -26.43 32.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.933 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 252' ' ' VAL . . . . . 0.425 ' O ' HG12 ' A' ' 252' ' ' VAL . 53.3 t -82.63 -15.31 11.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.131 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.631 HD12 ' HA ' ' A' ' 250' ' ' GLN . 13.4 mt -86.82 -43.06 12.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.887 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . 0.5 ' OD1' ' N ' ' A' ' 255' ' ' ARG . 0.6 OUTLIER -61.67 -44.49 96.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.85 179.943 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . 0.5 ' N ' ' OD1' ' A' ' 254' ' ' ASN . 11.4 ptm180 -54.17 -31.03 51.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.84 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 256' ' ' PHE . . . . . 0.576 ' CE2' ' HB ' ' A' ' 210' ' ' THR . 16.7 m-85 -91.34 -36.84 13.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.87 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 33.4 t -63.29 -74.22 0.1 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.895 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 46.3 m -92.91 64.83 4.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.879 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 259' ' ' ALA . . . . . . . . . . . . . . . -72.16 114.87 10.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.093 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 30.9 t -109.09 -53.09 2.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.894 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . 0.411 ' HA3' ' C ' ' A' ' 262' ' ' PRO . . . 158.75 -69.48 0.26 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.519 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 262' ' ' PRO . . . . . 0.411 ' C ' ' HA3' ' A' ' 261' ' ' GLY . 53.7 Cg_endo -69.77 -38.64 1.56 Allowed 'Cis proline' 0 C--N 1.342 0.209 0 C-N-CA 122.654 -1.811 . . . . 0.0 112.359 0.021 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 14.2 t -147.97 156.26 42.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.808 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 8.5 t 48.41 46.46 20.51 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.856 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.298 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.457 179.989 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 N-CA-C 112.496 -0.242 . . . . 0.0 112.496 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 70.2 p -44.11 99.91 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.875 0.369 . . . . 0.0 110.866 -179.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 6.4 t -147.65 163.86 35.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.916 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -116.54 83.76 0.35 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.479 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 80.3 p -80.82 149.74 29.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.869 0.366 . . . . 0.0 110.855 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 8.5 t -101.22 -61.05 1.42 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.871 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 144.21 112.45 0.83 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.458 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -168.0 73.99 0.14 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.49 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 107.8 -176.78 20.86 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.449 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.738 HG22 HG23 ' A' ' 156' ' ' VAL . 0.3 OUTLIER -110.27 -14.68 14.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.852 0.358 . . . . 0.0 111.17 -179.886 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 24.3 m -62.72 -30.13 71.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.802 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . 0.498 ' O ' ' HB3' ' A' ' 157' ' ' ALA . 2.7 t30 -76.3 -57.53 3.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.935 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.606 ' OE2' HG23 ' A' ' 152' ' ' THR . 5.0 pt-20 -55.53 -60.13 3.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.846 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.738 HG23 HG22 ' A' ' 152' ' ' THR . 79.0 t -43.34 -39.13 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.154 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.498 ' HB3' ' O ' ' A' ' 154' ' ' ASN . . . -45.46 -48.08 13.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.065 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -69.83 -42.07 74.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.909 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' PHE . . . . . 0.475 ' CD2' ' HB2' ' A' ' 200' ' ' LEU . 41.2 t80 -56.07 -41.77 75.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.899 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 91.0 mt -85.56 -26.05 26.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.903 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 31.6 t -54.62 -26.51 33.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.881 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 18.2 mmmt -61.99 128.77 37.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.873 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -105.99 154.08 21.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.861 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 62.35 49.35 4.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.858 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 24.3 mm-40 -137.21 153.47 50.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.92 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 55.7 t -108.03 119.8 58.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.149 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . 0.462 HD12 ' N ' ' A' ' 246' ' ' ALA . 10.8 mt -90.66 147.83 4.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.156 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 95.6 t -128.53 141.43 46.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.127 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 29.0 ttp85 -95.51 107.17 19.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.877 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' MET . . . . . 0.478 ' CE ' HD21 ' A' ' 173' ' ' LEU . 89.7 mtp -92.56 127.11 37.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.932 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.423 ' O ' HG23 ' A' ' 239' ' ' ILE . 3.8 tpt180 -123.83 144.89 49.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.881 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . 0.401 ' N ' ' HG3' ' A' ' 171' ' ' ARG . . . 79.01 33.63 36.02 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.464 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.763 ' CD1' ' HB3' ' A' ' 213' ' ' ALA . 21.8 mt -81.39 119.33 75.38 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.574 0.702 . . . . 0.0 110.896 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . 0.481 ' O ' ' N ' ' A' ' 177' ' ' ALA . 65.2 Cg_exo -47.94 130.0 18.95 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.695 2.263 . . . . 0.0 112.368 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 34.7 m-85 -41.49 -41.07 1.98 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.889 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 65.3 p -75.52 -29.47 59.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.157 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.481 ' N ' ' O ' ' A' ' 174' ' ' PRO . . . -45.74 112.62 0.49 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.085 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -113.4 170.36 8.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.127 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -46.5 -56.53 5.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.112 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -45.43 -30.18 1.3 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.856 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . 0.636 ' HG3' HD11 ' A' ' 234' ' ' LEU . 2.2 tp10 -71.59 -41.61 68.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.885 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.45 HG12 HD11 ' A' ' 192' ' ' ILE . 55.8 t -69.25 -47.41 73.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.107 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.432 ' C ' ' O ' ' A' ' 182' ' ' VAL . 70.8 t -35.26 -54.25 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.08 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -74.78 -39.2 61.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.086 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.476 ' CD1' HD12 ' A' ' 234' ' ' LEU . 59.2 t80 -41.54 -58.27 1.97 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.87 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -94.3 -21.32 19.07 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.871 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -49.15 -25.78 5.81 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.463 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -48.3 -72.77 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.836 0.351 . . . . 0.0 110.91 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 14.2 m170 -118.26 -15.52 9.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.894 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 63.8 m -118.41 85.17 25.13 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.638 0.732 . . . . 0.0 110.94 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' PRO . . . . . 0.462 ' HD2' ' CD1' ' A' ' 222' ' ' TYR . 53.3 Cg_endo -69.75 139.9 41.39 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.686 2.257 . . . . 0.0 112.348 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . 0.65 HG23 ' O ' ' A' ' 216' ' ' LEU . 49.6 mt -91.82 144.69 8.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.135 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 55.0 m -67.3 108.28 2.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.157 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 86.94 -22.18 15.8 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.447 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.409 ' O ' ' N ' ' A' ' 198' ' ' GLY . . . 82.52 -126.56 7.51 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.484 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . 0.423 ' HA ' HD12 ' A' ' 199' ' ' ILE . 8.8 ptpt -46.48 -22.25 0.25 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.767 0.318 . . . . 0.0 110.894 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -82.23 -33.69 29.17 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.912 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . 0.465 ' HA2' HD12 ' A' ' 216' ' ' LEU . . . -84.98 35.4 3.11 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.466 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.423 HD12 ' HA ' ' A' ' 196' ' ' LYS . 27.5 mt -138.8 139.92 39.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.828 0.347 . . . . 0.0 111.148 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.558 HD21 HG22 ' A' ' 156' ' ' VAL . 14.5 tp -137.19 111.83 8.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.939 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -90.43 123.43 34.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.901 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 59.0 t -73.51 118.32 18.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.144 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -127.95 137.14 52.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.124 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -45.99 158.75 0.35 Allowed Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.63 0.729 . . . . 0.0 110.918 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.83 3.58 2.72 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.631 2.221 . . . . 0.0 112.327 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -112.4 -21.28 11.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.861 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 113.53 56.41 0.41 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.525 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 7.6 mpt_? -143.53 146.5 35.84 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.554 0.692 . . . . 0.0 110.904 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 111.17 2.74 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.669 2.246 . . . . 0.0 112.363 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . 0.566 ' HB ' ' CE2' ' A' ' 256' ' ' PHE . 62.0 p -73.09 -14.03 61.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.152 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 97.57 -31.33 7.93 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.523 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -90.38 168.4 11.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.827 0.346 . . . . 0.0 110.832 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . 0.763 ' HB3' ' CD1' ' A' ' 173' ' ' LEU . . . -165.01 174.86 10.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.12 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . 0.498 ' HZ ' HG21 ' A' ' 252' ' ' VAL . 56.4 m-85 -137.71 151.37 48.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.899 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . 0.402 ' CG2' ' SD ' ' A' ' 170' ' ' MET . 6.9 t -134.76 155.0 37.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.129 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.65 ' O ' HG23 ' A' ' 192' ' ' ILE . 29.5 mt -108.48 144.05 36.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.915 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -136.41 141.33 43.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.9 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -53.9 -57.17 11.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.156 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 219' ' ' CYS . . . . . . . . . . . . . 95.2 m -136.4 -179.22 5.55 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.887 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -70.14 -28.62 65.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.921 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -48.02 -50.01 29.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.904 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 222' ' ' TYR . . . . . 0.462 ' CD1' ' HD2' ' A' ' 191' ' ' PRO . 29.6 m-85 -74.0 -49.73 23.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.921 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -47.64 -56.75 6.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.107 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -55.87 -52.74 63.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.91 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -49.96 -31.73 13.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.917 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -75.41 -35.77 60.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.09 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 89.8 mt -52.43 -39.6 61.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.921 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 34.8 mtt85 -54.99 -26.0 33.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.843 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . 0.458 ' O ' ' C ' ' A' ' 230' ' ' HIS . 6.9 mtpm? -69.86 -2.48 12.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.922 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 230' ' ' HIS . . . . . 0.519 ' CE1' ' HD3' ' A' ' 231' ' ' LYS . 12.0 t60 -33.86 136.67 0.11 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.845 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.519 ' HD3' ' CE1' ' A' ' 230' ' ' HIS . 1.2 mmmp? 62.96 29.43 16.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.909 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . 0.423 ' OD1' ' NZ ' ' A' ' 229' ' ' LYS . 2.7 t70 -58.34 -179.69 0.06 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.88 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.617 HD21 ' CD1' ' A' ' 238' ' ' TYR . 30.2 mt -138.19 107.78 6.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.925 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . 0.636 HD11 ' HG3' ' A' ' 181' ' ' GLU . 6.1 tt -117.83 111.2 18.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.915 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 60.12 43.23 98.54 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.47 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 64.66 53.8 1.5 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.723 0.297 . . . . 0.0 110.915 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 237' ' ' ARG . . . . . 0.438 ' CB ' ' HG3' ' A' ' 174' ' ' PRO . 14.2 mmt85 -156.65 115.48 3.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.877 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 238' ' ' TYR . . . . . 0.617 ' CD1' HD21 ' A' ' 233' ' ' LEU . 97.2 m-85 -69.69 123.68 22.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.975 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 0.489 HD13 HD23 ' A' ' 173' ' ' LEU . 37.9 mt -119.74 145.9 25.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.132 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . 0.464 ' HB3' ' CZ ' ' A' ' 242' ' ' PHE . 38.9 mt-10 -111.35 159.51 17.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.829 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 17.0 mt -136.58 123.87 21.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.98 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 242' ' ' PHE . . . . . 0.464 ' CZ ' ' HB3' ' A' ' 240' ' ' GLU . 4.1 m-85 -131.05 129.57 42.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.855 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 70.2 mtt180 -42.61 150.8 0.14 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.943 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 1.3 t -152.18 156.06 39.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.869 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 50.6 p -131.11 165.92 22.22 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.109 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 246' ' ' ALA . . . . . 0.462 ' N ' HD12 ' A' ' 167' ' ' ILE . . . -48.41 -52.74 20.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.121 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -58.6 -47.92 82.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.098 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -51.64 -55.54 18.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.849 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.437 ' CG2' HG21 ' A' ' 167' ' ' ILE . 91.2 t -42.45 -65.21 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.161 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 250' ' ' GLN . . . . . 0.62 ' HA ' HD12 ' A' ' 253' ' ' LEU . 30.4 mt-30 -38.08 -57.84 1.02 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.93 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -52.33 -44.25 65.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.927 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 252' ' ' VAL . . . . . 0.498 HG21 ' HZ ' ' A' ' 214' ' ' PHE . 91.1 t -59.95 -31.43 47.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.105 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.62 HD12 ' HA ' ' A' ' 250' ' ' GLN . 7.9 mt -79.51 -39.46 31.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.945 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 16.6 m-80 -66.97 -49.0 66.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.904 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . 0.475 ' HG3' ' N ' ' A' ' 256' ' ' PHE . 2.7 ptm85 -53.35 -43.5 67.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.826 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 256' ' ' PHE . . . . . 0.566 ' CE2' ' HB ' ' A' ' 210' ' ' THR . 13.1 m-85 -76.34 -37.59 57.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.862 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 24.1 p -73.58 160.38 31.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.813 -179.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 62.7 m 63.97 31.05 13.98 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.848 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 259' ' ' ALA . . . . . . . . . . . . . . . -116.22 143.62 45.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.108 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 1.9 t -124.14 173.19 8.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.82 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -106.4 -163.42 22.67 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.482 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 262' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 -35.98 2.5 Favored 'Cis proline' 0 C--N 1.341 0.175 0 C-N-CA 122.671 -1.804 . . . . 0.0 112.369 0.063 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 2.5 m 63.5 44.09 5.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.867 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 33.5 t -144.35 150.38 37.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.83 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.274 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.488 -179.997 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.31 0 N-CA-C 112.521 -0.231 . . . . 0.0 112.521 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 3.8 m -117.95 139.57 50.97 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.884 0.373 . . . . 0.0 110.848 -179.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 26.0 t -75.33 -61.64 1.83 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.858 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 108.49 -110.75 3.14 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.477 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 36.1 m 44.58 41.52 4.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.937 0.399 . . . . 0.0 110.9 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 22.8 t -150.59 146.32 26.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.834 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 100.54 169.7 28.99 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.47 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -64.19 -97.17 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.484 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -75.53 136.64 20.45 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.47 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 2.1 m -69.38 115.81 9.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.793 0.33 . . . . 0.0 111.125 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 18.5 m -130.04 -50.59 1.12 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.831 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -64.49 -50.94 65.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.903 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -51.99 -51.16 59.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.935 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 90.2 t -63.44 -47.4 91.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.156 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -40.01 -61.07 0.92 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.105 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -59.13 -40.69 86.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.909 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' PHE . . . . . 0.526 ' CE2' ' HG ' ' A' ' 216' ' ' LEU . 49.2 t80 -56.41 -40.55 74.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.873 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 86.6 mt -87.94 -24.37 23.61 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.868 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 28.7 t -58.72 -27.38 64.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.843 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . 0.527 ' HG3' HD13 ' A' ' 216' ' ' LEU . 28.6 mmmt -60.75 125.74 24.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.872 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -101.26 150.46 22.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.89 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 34.8 m-20 62.51 49.4 4.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.882 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.9 mm-40 -133.9 143.6 48.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.899 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 48.6 t -100.22 107.23 20.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.188 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 36.7 mt -75.95 134.13 29.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.143 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 57.9 t -116.22 128.46 73.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.127 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 45.8 ttp180 -88.35 108.25 19.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.884 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' MET . . . . . 0.485 ' CE ' HD21 ' A' ' 173' ' ' LEU . 97.0 mtp -92.6 113.33 25.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.859 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 8.3 ttp180 -117.21 139.28 50.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.912 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 91.38 25.04 24.81 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.507 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.894 HD23 HD13 ' A' ' 239' ' ' ILE . 19.5 mt -80.27 129.01 71.14 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.612 0.72 . . . . 0.0 110.919 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . 0.434 ' HG3' ' CB ' ' A' ' 237' ' ' ARG . 64.8 Cg_exo -47.92 136.35 22.92 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.75 2.3 . . . . 0.0 112.335 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 8.8 m-30 -50.98 -19.97 1.2 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.86 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.539 ' O ' HG23 ' A' ' 178' ' ' THR . 64.1 p -94.98 -28.77 14.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.098 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -41.85 120.64 1.58 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.083 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.539 HG23 ' O ' ' A' ' 176' ' ' THR . 40.1 p -116.01 179.56 3.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.164 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -54.12 -48.57 70.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.111 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -52.84 -42.29 65.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.875 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -58.87 -37.14 75.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.895 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.506 HG12 ' CD1' ' A' ' 192' ' ' ILE . 15.5 t -73.21 -47.25 47.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.121 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 42.8 t -39.83 -49.82 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.067 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.428 ' O ' ' C ' ' A' ' 185' ' ' PHE . . . -74.25 -44.71 51.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.106 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.491 ' HD1' HD12 ' A' ' 234' ' ' LEU . 53.9 t80 -36.42 -60.56 0.57 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.864 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' PHE . . . . . 0.473 ' CZ ' ' CD2' ' A' ' 185' ' ' PHE . 42.4 m-85 -95.06 -25.0 16.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.885 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -49.15 -21.31 2.56 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.469 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 42.0 tt0 -55.18 -70.66 0.1 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.816 0.341 . . . . 0.0 110.908 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 20.3 m80 -118.21 -16.72 9.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.853 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' CYS . . . . . 0.423 ' SG ' ' HB2' ' A' ' 226' ' ' ALA . 70.9 m -120.36 87.26 40.15 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.603 0.716 . . . . 0.0 110.86 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 130.55 19.6 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.692 2.261 . . . . 0.0 112.331 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . 0.506 ' CD1' HG12 ' A' ' 182' ' ' VAL . 54.7 mt -78.1 144.57 11.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.15 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 29.3 m -71.29 104.43 3.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.183 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 91.98 -17.17 57.64 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.497 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.414 ' O ' ' N ' ' A' ' 198' ' ' GLY . . . 70.22 -124.12 13.21 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.516 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 31.4 mtmm -46.09 -30.58 1.94 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.679 0.276 . . . . 0.0 110.859 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -78.13 -32.01 50.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.893 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 195' ' ' GLY . . . -88.46 29.65 5.62 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.492 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 70.2 mt -131.4 142.12 44.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.89 0.376 . . . . 0.0 111.127 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 13.0 tp -139.7 111.74 7.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.919 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -96.27 119.26 34.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.909 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.466 HG23 ' HA ' ' A' ' 213' ' ' ALA . 21.7 t -71.51 130.18 35.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.109 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -140.59 137.59 33.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.151 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -48.76 158.88 0.6 Allowed Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.681 0.753 . . . . 0.0 110.903 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 3.05 2.99 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.74 2.293 . . . . 0.0 112.357 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -112.37 -15.29 13.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.864 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 112.25 9.89 18.93 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.501 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -89.64 140.67 28.16 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.603 0.716 . . . . 0.0 110.855 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 115.59 4.16 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.651 2.234 . . . . 0.0 112.339 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . 0.549 ' HB ' ' CE2' ' A' ' 256' ' ' PHE . 69.8 p -80.24 -21.49 42.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.107 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 95.3 -46.38 2.01 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.515 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 212' ' ' ASP . . . . . 0.434 ' OD2' HG11 ' A' ' 202' ' ' VAL . 1.1 p-10 -68.64 154.64 41.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.816 0.341 . . . . 0.0 110.875 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . 0.466 ' HA ' HG23 ' A' ' 202' ' ' VAL . . . -153.53 -175.27 5.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.096 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . 0.447 ' HZ ' HG11 ' A' ' 252' ' ' VAL . 52.8 m-85 -150.63 139.49 20.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.851 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . 0.542 HG12 ' N ' ' A' ' 216' ' ' LEU . 21.4 t -125.69 162.34 28.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.132 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.542 ' N ' HG12 ' A' ' 215' ' ' VAL . 31.2 mt -112.48 137.23 50.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.919 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -132.5 138.88 47.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.844 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . 0.832 ' HB3' ' CD2' ' A' ' 222' ' ' TYR . . . -48.39 -65.72 0.52 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.147 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 219' ' ' CYS . . . . . . . . . . . . . 2.6 m -154.85 174.81 14.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.845 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . 0.405 ' HA ' ' HB3' ' A' ' 223' ' ' ALA . 1.7 mp0 -39.81 -42.73 1.33 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.915 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -41.14 -43.31 2.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.896 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 222' ' ' TYR . . . . . 0.832 ' CD2' ' HB3' ' A' ' 218' ' ' ALA . 57.1 m-85 -92.35 -46.27 7.78 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.912 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.405 ' HB3' ' HA ' ' A' ' 220' ' ' GLU . . . -52.14 -64.12 0.92 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.104 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 224' ' ' GLN . . . . . 0.692 ' HA ' HD12 ' A' ' 227' ' ' LEU . 23.0 mm-40 -50.65 -55.93 14.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.945 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . 0.439 ' O ' ' CG ' ' A' ' 228' ' ' ARG . 24.2 m-20 -52.14 -21.24 3.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.903 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . 0.423 ' HB2' ' SG ' ' A' ' 190' ' ' CYS . . . -93.83 -34.19 13.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.089 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . 0.692 HD12 ' HA ' ' A' ' 224' ' ' GLN . 63.4 mt -57.65 -32.77 67.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.886 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . 0.439 ' CG ' ' O ' ' A' ' 225' ' ' ASN . 3.0 ptm180 -58.52 -13.05 4.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.879 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . 0.456 ' O ' ' C ' ' A' ' 230' ' ' HIS . 16.1 mtpp -86.13 -0.37 55.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.924 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 230' ' ' HIS . . . . . 0.556 ' CE1' ' HG3' ' A' ' 231' ' ' LYS . 48.2 t60 -33.94 131.54 0.27 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.879 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.556 ' HG3' ' CE1' ' A' ' 230' ' ' HIS . 36.8 mttp 62.37 35.36 15.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.879 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -62.01 -176.37 0.09 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.878 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.708 HD21 ' CE1' ' A' ' 238' ' ' TYR . 31.7 mt -133.9 112.42 11.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.893 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . 0.571 HD23 ' C ' ' A' ' 234' ' ' LEU . 7.3 tt -121.47 117.89 27.98 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.919 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 57.05 36.35 73.74 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.508 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 26.9 mmtm 69.13 50.73 0.56 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.806 0.336 . . . . 0.0 110.889 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 237' ' ' ARG . . . . . 0.434 ' CB ' ' HG3' ' A' ' 174' ' ' PRO . 44.7 mmt-85 -156.06 115.28 3.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.826 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 238' ' ' TYR . . . . . 0.708 ' CE1' HD21 ' A' ' 233' ' ' LEU . 97.5 m-85 -66.58 136.36 55.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.949 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 0.894 HD13 HD23 ' A' ' 173' ' ' LEU . 79.2 mt -135.88 126.21 42.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.154 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . 0.584 ' HB3' ' CZ ' ' A' ' 242' ' ' PHE . 6.7 mp0 -84.81 166.33 17.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.908 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . 0.451 ' O ' ' CD1' ' A' ' 242' ' ' PHE . 15.1 mt -148.13 134.03 19.1 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.89 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 242' ' ' PHE . . . . . 0.584 ' CZ ' ' HB3' ' A' ' 240' ' ' GLU . 7.3 m-85 -145.42 120.92 10.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.886 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . 0.486 ' O ' ' CG ' ' A' ' 243' ' ' ARG . 18.4 ptt-85 -57.15 118.25 4.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.883 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 7.5 t -114.4 -174.98 2.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.887 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . 0.956 ' O ' HG23 ' A' ' 249' ' ' VAL . 67.8 p -135.64 179.16 6.51 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.162 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -60.86 -53.62 55.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.091 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -52.95 -58.17 7.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.146 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . 0.508 ' O ' HG23 ' A' ' 252' ' ' VAL . 1.9 tp10 -49.44 -55.92 11.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.893 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.956 HG23 ' O ' ' A' ' 245' ' ' THR . 97.3 t -39.68 -65.58 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.149 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 250' ' ' GLN . . . . . 0.432 ' O ' ' N ' ' A' ' 253' ' ' LEU . 52.2 mt-30 -37.55 -66.72 0.23 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.885 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 28.9 mm-40 -40.97 -39.69 1.23 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.941 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 252' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 248' ' ' GLU . 28.3 t -65.04 -39.44 85.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.125 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.432 ' N ' ' O ' ' A' ' 250' ' ' GLN . 7.1 mt -76.89 -36.17 56.87 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.919 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -71.43 -49.77 38.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.89 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . 0.541 ' CG ' ' N ' ' A' ' 256' ' ' PHE . 5.2 ptm180 -49.66 -50.75 42.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.83 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 256' ' ' PHE . . . . . 0.549 ' CE2' ' HB ' ' A' ' 210' ' ' THR . 12.4 m-85 -65.04 -33.6 76.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.877 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 14.2 m -72.82 136.55 45.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.849 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 23.1 t 61.28 53.22 3.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.9 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 259' ' ' ALA . . . . . . . . . . . . . . . -73.44 111.39 8.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.085 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 6.7 t -58.78 -67.9 0.32 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.863 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 134.54 -162.76 24.67 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.43 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 262' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 173.13 45.88 Favored 'Cis proline' 0 C--N 1.341 0.179 0 C-N-CA 122.705 -1.79 . . . . 0.0 112.341 0.061 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 47.1 t -64.34 -34.62 78.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.862 -179.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 23.3 t -63.62 140.82 58.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.85 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.313 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.494 -179.973 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.381 0 N-CA-C 112.541 -0.223 . . . . 0.0 112.541 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 7.6 t -121.41 131.89 54.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.849 0.357 . . . . 0.0 110.869 -179.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 16.3 t -147.64 133.23 18.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.868 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 96.69 170.58 34.27 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.501 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 17.4 t -99.27 80.43 2.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.887 0.375 . . . . 0.0 110.852 -179.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 2.2 t 56.34 31.11 18.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.826 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -94.7 97.55 2.17 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.486 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 151.74 -68.6 0.32 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.469 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 168.14 -144.76 9.1 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.463 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.698 HG22 HG23 ' A' ' 156' ' ' VAL . 1.5 m -130.77 -41.63 1.16 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.818 0.342 . . . . 0.0 111.108 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . 0.43 ' C ' ' O ' ' A' ' 152' ' ' THR . 44.3 t -35.31 -36.08 0.06 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.818 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . 0.413 ' N ' ' O ' ' A' ' 152' ' ' THR . 4.4 p-10 -57.98 -58.07 10.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.883 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -68.44 -38.79 81.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.876 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.698 HG23 HG22 ' A' ' 152' ' ' THR . 76.6 t -60.39 -36.99 72.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.147 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -43.68 -62.25 1.15 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.076 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -60.83 -42.54 97.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.93 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' PHE . . . . . 0.531 ' CE2' ' HG ' ' A' ' 216' ' ' LEU . 59.6 t80 -52.7 -38.85 61.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.853 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 82.9 mt -89.96 -29.03 18.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.946 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 1.7 t -52.04 -33.34 38.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.852 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . 0.58 ' HG3' HD13 ' A' ' 216' ' ' LEU . 27.4 mmmt -45.5 116.68 1.22 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.868 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -84.55 149.96 25.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.869 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 47.71 44.85 17.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.907 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 0.567 ' OE1' HG21 ' A' ' 193' ' ' THR . 0.4 OUTLIER -117.1 153.13 33.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.907 -179.974 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 46.8 t -106.23 139.06 28.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.157 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . 0.531 HG21 HG21 ' A' ' 249' ' ' VAL . 26.0 mt -113.07 137.22 46.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.113 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.477 HG21 ' CE1' ' A' ' 217' ' ' PHE . 94.1 t -114.2 138.23 44.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.123 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 39.9 ttt-85 -93.81 109.25 20.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.893 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' MET . . . . . 0.48 ' CE ' HD21 ' A' ' 173' ' ' LEU . 83.6 mtp -99.51 126.39 45.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.908 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 11.0 mtp85 -127.15 145.17 50.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.866 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 81.5 32.63 30.29 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.482 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.827 ' CD1' ' HB3' ' A' ' 213' ' ' ALA . 22.1 mt -82.84 121.28 77.5 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.658 0.742 . . . . 0.0 110.929 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . 0.485 ' O ' ' N ' ' A' ' 176' ' ' THR . 66.6 Cg_exo -48.02 121.44 5.97 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.661 2.24 . . . . 0.0 112.333 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . 0.591 ' CD2' ' HG2' ' A' ' 209' ' ' PRO . 3.4 m-85 -37.21 -29.13 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.859 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.485 ' N ' ' O ' ' A' ' 174' ' ' PRO . 73.7 p -80.83 -44.01 19.14 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.161 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.476 ' N ' ' O ' ' A' ' 174' ' ' PRO . . . -34.27 125.45 0.49 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.064 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.404 HG23 ' O ' ' A' ' 176' ' ' THR . 12.0 p -118.49 177.07 4.96 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.151 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.445 ' O ' HG23 ' A' ' 183' ' ' VAL . . . -52.46 -44.91 65.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.113 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -56.18 -41.54 75.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.885 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -57.83 -39.38 77.54 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.882 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.502 HG12 ' CD1' ' A' ' 192' ' ' ILE . 54.7 t -71.99 -52.39 25.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.112 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 179' ' ' ALA . 89.9 t -35.13 -47.27 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.14 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -79.65 -39.33 31.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.138 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.612 ' CD1' HD12 ' A' ' 234' ' ' LEU . 58.2 t80 -41.33 -58.78 1.74 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.903 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' PHE . . . . . 0.491 ' O ' ' N ' ' A' ' 190' ' ' CYS . 63.1 m-85 -96.41 -23.32 16.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.915 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -52.68 -21.15 8.83 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.498 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' GLN . . . . . 0.485 ' NE2' ' O ' ' A' ' 185' ' ' PHE . 1.5 pt20 -59.19 -60.04 4.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.858 0.361 . . . . 0.0 110.91 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . 0.6 ' CE1' ' SG ' ' A' ' 190' ' ' CYS . 0.3 OUTLIER -119.02 -29.11 5.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.843 179.968 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' CYS . . . . . 0.6 ' SG ' ' CE1' ' A' ' 189' ' ' HIS . 93.1 m -116.54 89.78 28.66 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.632 0.729 . . . . 0.0 110.853 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' PRO . . . . . 0.444 ' HD2' ' CD1' ' A' ' 222' ' ' TYR . 53.5 Cg_endo -69.8 132.65 23.73 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.67 2.246 . . . . 0.0 112.305 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . 0.641 HG23 ' O ' ' A' ' 216' ' ' LEU . 59.4 mt -82.9 145.17 8.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.105 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . 0.567 HG21 ' OE1' ' A' ' 165' ' ' GLN . 98.0 m -63.68 102.14 0.42 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.138 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 88.38 -16.92 51.28 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.476 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.455 ' O ' ' N ' ' A' ' 198' ' ' GLY . . . 75.3 -129.18 10.34 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.502 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 3.9 pttm -41.23 -37.07 0.87 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.762 0.315 . . . . 0.0 110.912 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -70.87 -37.39 73.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.896 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . 0.536 ' HA2' HD12 ' A' ' 216' ' ' LEU . . . -83.06 36.21 2.73 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.534 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 72.1 mt -139.0 148.91 23.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.83 0.348 . . . . 0.0 111.111 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.537 HD21 HG22 ' A' ' 156' ' ' VAL . 23.5 tp -137.4 120.94 17.18 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.912 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -101.92 111.37 23.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.883 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.435 HG11 ' OD2' ' A' ' 212' ' ' ASP . 59.7 t -66.09 136.29 26.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.137 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -142.83 141.4 31.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.12 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . 0.453 ' N ' HG23 ' A' ' 210' ' ' THR . 21.0 m-85 -47.58 159.42 0.44 Allowed Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.718 0.77 . . . . 0.0 110.886 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 4.18 2.34 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.641 2.227 . . . . 0.0 112.324 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -111.8 -23.42 10.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.839 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 115.05 49.18 0.51 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.516 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 76.4 mtp180 -134.5 147.1 61.98 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.578 0.704 . . . . 0.0 110.886 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . 0.591 ' HG2' ' CD2' ' A' ' 175' ' ' PHE . 54.2 Cg_endo -69.72 99.62 0.76 Allowed 'Trans proline' 0 N--CA 1.465 -0.174 0 C-N-CA 122.682 2.255 . . . . 0.0 112.396 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . 0.453 HG23 ' N ' ' A' ' 204' ' ' TYR . 65.8 p -60.4 -33.3 72.29 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.137 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 115.33 -30.2 6.87 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.486 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 212' ' ' ASP . . . . . 0.435 ' OD2' HG11 ' A' ' 202' ' ' VAL . 1.3 p-10 -85.65 163.34 18.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.797 0.332 . . . . 0.0 110.876 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . 0.827 ' HB3' ' CD1' ' A' ' 173' ' ' LEU . . . -166.69 159.25 13.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.082 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . 0.492 ' CD2' HG13 ' A' ' 249' ' ' VAL . 71.8 m-85 -124.62 162.78 23.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.903 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . 0.597 HG12 ' N ' ' A' ' 216' ' ' LEU . 43.3 t -140.34 163.95 22.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.091 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.641 ' O ' HG23 ' A' ' 192' ' ' ILE . 62.3 mt -115.2 145.38 42.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.902 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . 0.477 ' CE1' HG21 ' A' ' 168' ' ' VAL . 80.1 m-85 -141.89 131.58 24.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.869 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . 0.486 ' HA ' ' NE2' ' A' ' 165' ' ' GLN . . . -42.77 -54.14 4.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.116 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 219' ' ' CYS . . . . . . . . . . . . . 5.0 m -157.15 179.99 8.76 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.888 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . 0.44 ' HA ' ' HB3' ' A' ' 223' ' ' ALA . 0.7 OUTLIER -52.69 -39.48 61.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.915 -179.961 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . 0.422 ' C ' ' O ' ' A' ' 220' ' ' GLU . 29.7 tt0 -36.89 -49.51 0.81 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.897 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 222' ' ' TYR . . . . . 0.444 ' CD1' ' HD2' ' A' ' 191' ' ' PRO . 42.7 m-85 -87.84 -46.98 8.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.933 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.526 ' O ' ' HB3' ' A' ' 226' ' ' ALA . . . -52.99 -62.53 1.59 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.077 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 56.1 mm-40 -47.45 -61.72 1.78 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.934 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 30.6 m-20 -45.44 -31.96 1.94 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.905 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . 0.526 ' HB3' ' O ' ' A' ' 223' ' ' ALA . . . -69.55 -38.05 77.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.089 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 29.0 mt -51.84 -29.34 19.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.934 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 8.9 mpt_? -61.39 -30.03 70.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.851 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . 0.589 ' HE3' ' CE2' ' A' ' 185' ' ' PHE . 20.1 mtpp -71.55 -0.83 11.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.868 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 230' ' ' HIS . . . . . 0.449 ' C ' ' O ' ' A' ' 229' ' ' LYS . 20.9 t60 -34.28 129.71 0.37 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.892 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.41 ' HG3' ' CE1' ' A' ' 230' ' ' HIS . 39.6 mtmt 62.63 39.67 11.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.879 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -67.09 -175.17 0.42 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.871 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.67 HD21 ' CE2' ' A' ' 238' ' ' TYR . 30.6 mt -135.9 109.8 8.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.927 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . 0.612 HD12 ' CD1' ' A' ' 185' ' ' PHE . 7.1 tt -117.85 117.71 30.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.913 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 54.71 38.69 64.72 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.459 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 38.4 mttp 68.86 50.54 0.62 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.767 0.318 . . . . 0.0 110.929 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 19.6 mmt180 -155.04 115.58 3.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.888 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 238' ' ' TYR . . . . . 0.67 ' CE2' HD21 ' A' ' 233' ' ' LEU . 95.7 m-85 -67.92 131.25 45.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.959 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 0.467 HD13 HD23 ' A' ' 173' ' ' LEU . 75.1 mt -129.76 133.83 64.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.119 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . 0.465 ' HB3' ' CZ ' ' A' ' 242' ' ' PHE . 7.4 mp0 -94.18 170.97 9.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.901 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . 0.524 ' O ' ' CG ' ' A' ' 242' ' ' PHE . 14.9 mt -150.78 153.38 35.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.931 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 242' ' ' PHE . . . . . 0.524 ' CG ' ' O ' ' A' ' 241' ' ' LEU . 3.7 m-85 -162.12 151.62 16.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.845 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . 0.474 ' CZ ' ' HB2' ' A' ' 243' ' ' ARG . 12.6 mtm105 -65.76 118.39 9.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.874 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . 0.443 ' HB3' HG22 ' A' ' 167' ' ' ILE . 1.0 OUTLIER -111.19 160.42 16.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.889 -179.785 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 40.1 p -132.97 155.8 48.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.146 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 246' ' ' ALA . . . . . 0.503 ' N ' HD12 ' A' ' 167' ' ' ILE . . . -43.17 -53.15 5.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.114 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -56.8 -51.86 67.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.052 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -48.19 -54.73 12.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.939 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.531 HG21 HG21 ' A' ' 167' ' ' ILE . 59.9 t -48.81 -65.87 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.133 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 250' ' ' GLN . . . . . 0.905 ' HA ' HD12 ' A' ' 253' ' ' LEU . 86.8 mt-30 -38.41 -46.1 1.1 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.954 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -62.67 -51.88 65.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.858 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 73.4 t -54.92 -34.89 32.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.093 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.905 HD12 ' HA ' ' A' ' 250' ' ' GLN . 14.9 mt -64.62 -49.56 70.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.91 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . 0.496 ' OD1' ' N ' ' A' ' 255' ' ' ARG . 0.6 OUTLIER -64.66 -41.55 96.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.911 179.888 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . 0.496 ' N ' ' OD1' ' A' ' 254' ' ' ASN . 25.9 ttt180 -47.67 -46.74 29.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.894 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -83.65 -41.94 17.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.879 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 1.9 t -70.29 155.57 40.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.845 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 14.1 t 45.83 41.98 8.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.836 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 259' ' ' ALA . . . . . . . . . . . . . . . -98.9 111.43 23.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.114 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 3.6 m -100.58 -54.81 2.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.858 -179.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 134.5 179.08 16.11 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.492 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 262' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 151.09 90.98 Favored 'Cis proline' 0 C--O 1.231 0.168 0 C-N-CA 122.714 -1.786 . . . . 0.0 112.36 -0.001 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 5.4 t -66.09 163.42 17.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.864 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 79.6 p -150.12 131.82 14.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.862 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.373 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.502 179.976 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.34 0 N-CA-C 112.516 -0.233 . . . . 0.0 112.516 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 65.7 p -91.03 42.66 1.11 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.88 0.371 . . . . 0.0 110.886 -179.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 6.1 t -172.94 146.33 1.52 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.817 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -156.12 139.5 6.61 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.509 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 11.8 t -122.7 -50.54 1.96 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.881 0.372 . . . . 0.0 110.874 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 12.5 t -64.42 108.03 1.52 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.839 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -105.99 106.35 2.58 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.51 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -79.01 -163.27 24.86 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.515 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -130.88 -146.5 5.88 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.501 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.455 ' CG2' ' HB3' ' A' ' 155' ' ' GLU . 20.4 m -136.89 125.14 23.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.764 0.316 . . . . 0.0 111.184 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 19.8 m -131.8 -51.04 0.98 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.823 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 10.8 p-10 -65.33 -55.61 17.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.908 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.455 ' HB3' ' CG2' ' A' ' 152' ' ' THR . 28.1 tt0 -48.71 -37.28 18.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.867 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.595 HG22 HD21 ' A' ' 200' ' ' LEU . 75.3 t -83.24 -36.11 12.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.1 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -43.44 -53.32 5.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.1 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -59.9 -53.25 60.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.915 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' PHE . . . . . 0.504 ' CE1' ' HG ' ' A' ' 216' ' ' LEU . 83.3 t80 -46.12 -39.26 9.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.873 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 95.6 mt -87.9 -27.07 22.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.888 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 29.0 t -49.79 -24.79 2.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.813 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . 0.457 ' CB ' ' HG3' ' A' ' 165' ' ' GLN . 35.4 mmtt -70.3 117.57 12.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.853 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . 0.477 ' HG3' ' ND2' ' A' ' 164' ' ' ASN . 4.7 pt-20 -91.4 153.95 19.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.918 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . 0.477 ' ND2' ' HG3' ' A' ' 163' ' ' GLU . 72.7 m-20 61.16 49.04 5.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.885 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 0.457 ' HG3' ' CB ' ' A' ' 162' ' ' LYS . 1.8 mm-40 -128.62 151.8 49.08 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.902 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 48.5 t -109.15 109.03 26.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.174 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . 0.581 HG21 ' CG2' ' A' ' 249' ' ' VAL . 45.4 mt -80.12 143.43 12.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.185 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 86.0 t -123.46 133.66 68.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.15 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 11.0 ttt85 -89.94 106.36 18.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.858 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' MET . . . . . 0.593 ' CE ' HD21 ' A' ' 173' ' ' LEU . 91.3 mtp -97.92 125.57 42.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.904 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 47.2 mtp180 -126.57 136.55 52.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.878 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 96.92 17.6 32.11 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.473 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.593 HD21 ' CE ' ' A' ' 170' ' ' MET . 20.7 mt -71.24 116.71 49.8 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.593 0.711 . . . . 0.0 110.912 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . 0.681 ' O ' ' HB3' ' A' ' 177' ' ' ALA . 64.9 Cg_exo -47.99 134.08 23.51 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.672 2.248 . . . . 0.0 112.361 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . 0.453 ' C ' ' O ' ' A' ' 174' ' ' PRO . 19.3 m-85 -34.55 -68.55 0.11 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.893 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -47.63 -40.06 18.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.144 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.681 ' HB3' ' O ' ' A' ' 174' ' ' PRO . . . -38.19 128.07 1.33 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.12 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.405 ' C ' ' CZ ' ' A' ' 201' ' ' PHE . 1.7 p -141.67 179.85 6.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.179 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.522 ' O ' HG23 ' A' ' 183' ' ' VAL . . . -47.21 -46.58 24.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.084 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -53.4 -33.13 52.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.924 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . 0.476 ' CD ' HD21 ' A' ' 234' ' ' LEU . 5.5 mm-40 -76.26 -34.04 59.14 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.874 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.477 HG12 HD11 ' A' ' 192' ' ' ILE . 85.1 t -74.2 -51.79 22.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.142 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.522 HG23 ' O ' ' A' ' 179' ' ' ALA . 94.4 t -34.73 -50.55 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.135 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -78.41 -33.5 48.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.127 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.781 ' HD2' HD12 ' A' ' 234' ' ' LEU . 25.1 t80 -47.08 -61.19 2.0 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.863 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -89.9 -21.69 22.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.912 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -49.03 -21.25 2.36 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.451 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -53.24 -75.42 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.86 0.362 . . . . 0.0 110.916 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 11.1 m-70 -118.17 -5.45 10.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.824 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 82.4 m -126.54 87.5 56.27 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-O 121.61 0.719 . . . . 0.0 110.894 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' PRO . . . . . 0.561 ' HD2' ' CD1' ' A' ' 222' ' ' TYR . 52.8 Cg_endo -69.81 131.54 21.38 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.709 2.272 . . . . 0.0 112.279 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . 0.481 HG23 ' O ' ' A' ' 216' ' ' LEU . 51.3 mt -82.74 142.76 13.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.134 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . 0.429 HG21 ' OE1' ' A' ' 165' ' ' GLN . 47.5 m -67.25 105.92 1.88 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.17 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 87.5 -19.84 30.23 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.493 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.465 ' O ' ' N ' ' A' ' 198' ' ' GLY . . . 78.04 -126.3 7.62 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.507 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 34.4 mtmt -42.9 -33.47 0.78 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.75 0.309 . . . . 0.0 110.873 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -74.27 -34.62 63.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.916 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . 0.57 ' HA2' HD12 ' A' ' 216' ' ' LEU . . . -82.98 36.65 2.7 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.495 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 77.5 mt -138.68 151.24 23.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.881 0.372 . . . . 0.0 111.104 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.595 HD21 HG22 ' A' ' 156' ' ' VAL . 13.4 tp -147.98 111.05 4.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.894 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' PHE . . . . . 0.405 ' CZ ' ' C ' ' A' ' 178' ' ' THR . 53.4 m-85 -93.16 127.65 38.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.902 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 62.0 t -79.73 115.97 23.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.154 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . 0.576 ' HA ' HG23 ' A' ' 210' ' ' THR . 0.7 OUTLIER -125.19 137.55 54.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.105 -179.914 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . 0.636 ' CD1' HG22 ' A' ' 210' ' ' THR . 29.1 m-85 -41.81 159.23 0.19 Allowed Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.694 0.759 . . . . 0.0 110.897 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 2.88 3.14 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.67 2.247 . . . . 0.0 112.379 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -113.43 -18.67 11.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.87 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 110.87 61.51 0.49 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.465 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 37.6 mmt-85 -145.97 145.97 26.82 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.608 0.718 . . . . 0.0 110.886 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 104.02 1.25 Allowed 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.683 2.255 . . . . 0.0 112.38 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . 0.636 HG22 ' CD1' ' A' ' 204' ' ' TYR . 21.0 p -68.42 -31.0 70.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.135 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 114.5 -34.36 4.94 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.504 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -87.61 154.12 20.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.814 0.34 . . . . 0.0 110.872 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . 0.55 ' HB3' ' CD1' ' A' ' 173' ' ' LEU . . . -154.27 175.88 12.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.109 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . 0.663 ' CE2' HG13 ' A' ' 249' ' ' VAL . 60.7 m-85 -138.16 158.32 44.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.876 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 6.6 t -140.64 157.15 23.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.092 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.57 HD12 ' HA2' ' A' ' 198' ' ' GLY . 44.7 mt -108.33 141.14 40.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.93 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -135.36 132.5 37.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.904 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -42.65 -66.45 0.36 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.046 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 219' ' ' CYS . . . . . . . . . . . . . 1.9 m -135.01 176.57 8.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.932 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -65.45 -7.37 13.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.855 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -67.85 -37.79 82.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.897 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 222' ' ' TYR . . . . . 0.561 ' CD1' ' HD2' ' A' ' 191' ' ' PRO . 46.5 m-85 -86.52 -39.22 16.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.964 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.434 ' O ' ' HB3' ' A' ' 226' ' ' ALA . . . -59.46 -60.8 3.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.097 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 224' ' ' GLN . . . . . 0.403 ' HA ' HD12 ' A' ' 227' ' ' LEU . 83.4 mt-30 -45.2 -53.98 7.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.934 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 71.1 m-20 -58.69 -25.73 63.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.874 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . 0.434 ' HB3' ' O ' ' A' ' 223' ' ' ALA . . . -75.93 -23.75 55.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.052 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . 0.403 HD12 ' HA ' ' A' ' 224' ' ' GLN . 37.0 mt -68.24 -33.14 73.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.911 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 38.9 mtp180 -60.14 -14.99 19.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.9 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . 0.446 ' O ' ' C ' ' A' ' 230' ' ' HIS . 21.8 mtpp -80.56 -3.42 50.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.854 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 230' ' ' HIS . . . . . 0.491 ' CD2' ' HG2' ' A' ' 231' ' ' LYS . 72.2 t60 -34.16 146.34 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.871 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.491 ' HG2' ' CD2' ' A' ' 230' ' ' HIS . 3.9 mmpt? 53.04 26.84 5.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.892 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -56.47 -177.33 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.86 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.633 HD21 ' CE2' ' A' ' 238' ' ' TYR . 30.8 mt -139.96 105.12 5.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.936 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . 0.781 HD12 ' HD2' ' A' ' 185' ' ' PHE . 6.8 tt -115.53 112.53 22.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.956 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 62.17 34.35 88.83 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.467 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 4.3 mmmm 71.05 52.12 0.27 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.744 0.307 . . . . 0.0 110.893 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 21.2 mmt180 -155.02 115.6 3.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.852 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 238' ' ' TYR . . . . . 0.633 ' CE2' HD21 ' A' ' 233' ' ' LEU . 92.1 m-85 -70.63 117.18 11.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.916 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 0.531 HG22 ' N ' ' A' ' 240' ' ' GLU . 57.6 mt -111.73 159.83 11.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.142 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . 0.531 ' N ' HG22 ' A' ' 239' ' ' ILE . 13.7 mt-10 -114.23 167.58 10.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.867 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . 0.546 ' O ' ' CD1' ' A' ' 242' ' ' PHE . 54.0 mt -146.05 143.73 29.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.919 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 242' ' ' PHE . . . . . 0.546 ' CD1' ' O ' ' A' ' 241' ' ' LEU . 9.4 m-85 -159.3 137.13 10.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.865 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 63.0 mtp85 -53.67 141.46 26.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.859 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 8.8 t -138.18 157.41 46.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.85 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 71.7 p -129.3 157.77 40.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.164 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 246' ' ' ALA . . . . . 0.561 ' N ' HD12 ' A' ' 167' ' ' ILE . . . -38.17 -55.78 1.26 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.131 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -54.07 -55.56 26.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.101 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 32.5 tp10 -42.18 -51.49 4.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.929 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.663 HG13 ' CE2' ' A' ' 214' ' ' PHE . 85.9 t -54.69 -63.76 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.172 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 250' ' ' GLN . . . . . 0.788 ' HA ' HD12 ' A' ' 253' ' ' LEU . 32.4 mt-30 -43.01 -33.02 0.73 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.934 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 251' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -73.14 -50.54 22.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.914 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 96.9 t -56.9 -37.07 52.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.111 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.788 HD12 ' HA ' ' A' ' 250' ' ' GLN . 16.0 mt -60.75 -50.93 71.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.881 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . 0.463 ' C ' ' OD1' ' A' ' 254' ' ' ASN . 0.6 OUTLIER -60.7 -40.47 92.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.882 179.973 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . 0.46 ' N ' ' OD1' ' A' ' 254' ' ' ASN . 21.4 ttt85 -42.92 -55.43 3.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.883 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 256' ' ' PHE . . . . . 0.547 ' CE2' ' HB ' ' A' ' 210' ' ' THR . 67.4 m-85 -74.79 -47.24 31.9 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.896 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 68.7 m -45.65 -59.67 2.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.897 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 40.9 t -62.61 -44.11 97.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.826 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 259' ' ' ALA . . . . . . . . . . . . . . . 48.17 41.0 14.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.098 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 23.2 t -98.25 -52.38 3.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.863 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . 0.437 ' HA3' ' C ' ' A' ' 262' ' ' PRO . . . -145.4 -72.66 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.499 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 262' ' ' PRO . . . . . 0.437 ' C ' ' HA3' ' A' ' 261' ' ' GLY . 53.5 Cg_endo -69.73 -34.65 2.98 Favored 'Cis proline' 0 C--N 1.341 0.174 0 C-N-CA 122.676 -1.802 . . . . 0.0 112.34 0.046 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 77.1 p -99.06 97.95 9.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.853 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 68.5 m -39.55 149.9 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.865 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.318 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.468 -179.965 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.287 0 N-CA-C 112.505 -0.238 . . . . 0.0 112.505 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 88.9 p -150.57 124.11 9.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.913 0.387 . . . . 0.0 110.883 -179.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 46.7 p -168.46 143.56 3.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.836 -179.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -152.98 158.66 28.04 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.506 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 20.7 t -99.92 81.2 2.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.862 0.363 . . . . 0.0 110.855 -179.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 90.8 p -114.61 175.93 5.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.86 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -91.88 -145.74 16.31 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.529 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 84.57 154.0 19.73 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.478 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -54.52 162.73 3.9 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.477 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 1.011 HG22 HG23 ' A' ' 156' ' ' VAL . 5.5 m -43.5 -36.55 2.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.768 0.318 . . . . 0.0 111.138 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . 0.434 ' C ' ' O ' ' A' ' 152' ' ' THR . 31.3 p -34.68 -37.12 0.06 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.872 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . 0.407 ' N ' ' O ' ' A' ' 152' ' ' THR . 13.8 m120 -60.17 -58.36 8.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.919 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -66.93 -39.29 87.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.859 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 1.011 HG23 HG22 ' A' ' 152' ' ' THR . 72.3 t -60.92 -43.22 95.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.12 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.402 ' C ' ' O ' ' A' ' 156' ' ' VAL . . . -37.46 -61.03 0.63 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.127 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -57.66 -48.62 78.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.907 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' PHE . . . . . 0.497 ' CE1' ' HG ' ' A' ' 216' ' ' LEU . 66.2 t80 -47.68 -38.44 15.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.872 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 85.3 mt -90.57 -27.36 19.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.959 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 30.2 t -50.7 -36.51 36.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.854 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 39.7 mmtt -54.4 124.89 17.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.89 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -99.0 151.74 20.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.881 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 62.35 39.21 12.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.886 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -124.65 147.27 48.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.888 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 48.9 t -100.25 131.68 47.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.116 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . 0.773 HD12 ' N ' ' A' ' 246' ' ' ALA . 33.6 mt -101.17 143.8 13.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.176 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 96.8 t -128.26 136.6 59.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.121 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . 0.485 ' N ' ' HB2' ' A' ' 244' ' ' SER . 20.8 ttt85 -90.72 111.92 23.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.891 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' MET . . . . . 0.708 ' CE ' HD21 ' A' ' 173' ' ' LEU . 83.2 mtp -98.42 117.08 32.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.857 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 5.7 ttt-85 -120.99 140.66 51.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.833 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 89.91 23.43 32.83 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.512 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.708 HD21 ' CE ' ' A' ' 170' ' ' MET . 22.9 mt -79.18 129.62 72.01 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.564 0.697 . . . . 0.0 110.917 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . 0.467 ' HG3' ' CB ' ' A' ' 237' ' ' ARG . 65.1 Cg_exo -47.94 154.75 2.0 Allowed 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.661 2.241 . . . . 0.0 112.345 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -60.09 -50.17 74.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.833 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.457 ' O ' ' C ' ' A' ' 177' ' ' ALA . 0.0 OUTLIER -68.77 -39.07 80.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.135 -179.877 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.691 ' HB1' ' HG2' ' A' ' 181' ' ' GLU . . . -33.53 124.25 0.42 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.072 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.432 ' O ' ' C ' ' A' ' 179' ' ' ALA . 1.4 p -135.7 176.62 8.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.146 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.501 ' N ' ' CZ ' ' A' ' 201' ' ' PHE . . . -35.14 -44.98 0.27 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.121 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -56.66 -49.33 75.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.926 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . 0.691 ' HG2' ' HB1' ' A' ' 177' ' ' ALA . 0.0 OUTLIER -55.07 -33.48 62.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.869 -179.93 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.655 HG12 ' CD1' ' A' ' 192' ' ' ILE . 93.7 t -79.29 -60.03 2.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.156 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 179' ' ' ALA . 73.4 t -34.34 -39.89 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.134 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -85.77 -39.31 17.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.049 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.575 ' HD1' HD12 ' A' ' 234' ' ' LEU . 63.1 t80 -46.06 -59.58 2.78 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.825 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' PHE . . . . . 0.403 ' CE1' ' HE2' ' A' ' 185' ' ' PHE . 77.2 m-85 -91.79 -22.1 20.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.854 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -50.36 -18.25 2.24 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.511 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -58.49 -70.3 0.15 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.843 0.354 . . . . 0.0 110.882 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -118.15 -15.58 9.82 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.858 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' CYS . . . . . 0.409 ' SG ' ' CB ' ' A' ' 225' ' ' ASN . 70.8 m -120.26 86.69 38.66 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.65 0.738 . . . . 0.0 110.888 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 130.37 19.22 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.663 2.242 . . . . 0.0 112.361 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . 0.655 ' CD1' HG12 ' A' ' 182' ' ' VAL . 50.3 mt -82.14 146.2 7.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.161 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 85.6 m -66.89 105.78 1.71 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.148 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 87.41 -20.14 28.27 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.453 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.401 ' O ' ' N ' ' A' ' 198' ' ' GLY . . . 78.84 -126.66 7.63 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.446 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 16.6 ptmt -45.29 -34.43 2.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.746 0.308 . . . . 0.0 110.874 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -73.72 -32.8 64.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.867 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . 0.433 ' HA2' HD12 ' A' ' 216' ' ' LEU . . . -86.69 37.6 3.16 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.5 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.466 HD13 ' HB ' ' A' ' 182' ' ' VAL . 48.0 mt -141.83 146.31 23.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.865 0.364 . . . . 0.0 111.164 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.651 HD21 HG22 ' A' ' 156' ' ' VAL . 19.5 tp -134.4 118.14 17.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.91 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' PHE . . . . . 0.501 ' CZ ' ' N ' ' A' ' 179' ' ' ALA . 62.8 m-85 -99.53 114.51 27.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.91 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 22.7 t -70.06 114.23 7.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.179 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . 0.511 ' HA ' HG23 ' A' ' 210' ' ' THR . 0.7 OUTLIER -124.86 137.21 54.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.12 -179.922 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -43.49 158.22 0.25 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.705 0.764 . . . . 0.0 110.882 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 3.01 3.01 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.683 2.256 . . . . 0.0 112.355 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -112.08 -21.05 11.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.829 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 112.5 57.53 0.44 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.462 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 33.2 mmt-85 -141.89 144.61 33.12 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.598 0.713 . . . . 0.0 110.896 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.7 105.67 1.52 Allowed 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.635 2.224 . . . . 0.0 112.381 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . 0.565 ' HB ' ' CE1' ' A' ' 256' ' ' PHE . 27.2 p -69.07 -32.31 71.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.158 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 114.0 -34.1 5.13 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.442 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -84.68 162.76 19.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.815 0.341 . . . . 0.0 110.862 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -162.89 175.51 11.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.065 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . 0.659 ' CE2' HG13 ' A' ' 249' ' ' VAL . 80.8 m-85 -140.76 136.65 32.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.885 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . 0.432 HG12 ' N ' ' A' ' 216' ' ' LEU . 5.4 t -115.92 159.33 15.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.096 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.53 ' O ' HG23 ' A' ' 192' ' ' ILE . 29.3 mt -112.37 145.25 40.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.927 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -140.12 137.0 34.13 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.9 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . 0.641 ' HB3' ' CE2' ' A' ' 222' ' ' TYR . . . -48.48 -50.06 33.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.123 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 219' ' ' CYS . . . . . . . . . . . . . 2.0 t -154.2 177.48 11.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.913 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -57.84 -23.89 54.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.893 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -50.75 -54.66 21.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.879 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 222' ' ' TYR . . . . . 0.641 ' CE2' ' HB3' ' A' ' 218' ' ' ALA . 61.3 m-85 -71.84 -48.63 44.8 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.936 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.456 ' O ' ' HB3' ' A' ' 226' ' ' ALA . . . -47.36 -52.03 17.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.074 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -51.75 -62.75 1.44 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.908 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . 0.409 ' CB ' ' SG ' ' A' ' 190' ' ' CYS . 38.2 m-20 -48.42 -23.7 1.03 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.898 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . 0.456 ' HB3' ' O ' ' A' ' 223' ' ' ALA . . . -81.31 -40.3 23.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.098 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 95.9 mt -52.28 -39.0 59.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.899 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 37.2 mtt-85 -55.62 -27.85 51.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.861 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . 0.454 ' O ' ' C ' ' A' ' 230' ' ' HIS . 20.7 mtpp -70.62 -2.77 15.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.898 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 230' ' ' HIS . . . . . 0.559 ' CE1' ' HG3' ' A' ' 231' ' ' LYS . 15.7 t60 -33.91 129.19 0.34 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.87 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.559 ' HG3' ' CE1' ' A' ' 230' ' ' HIS . 30.9 mttt 63.07 39.62 9.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.896 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -67.38 -175.1 0.45 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.849 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.638 HD21 ' CE2' ' A' ' 238' ' ' TYR . 29.6 mt -138.08 110.1 7.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.951 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . 0.575 HD12 ' HD1' ' A' ' 185' ' ' PHE . 8.0 tt -121.65 113.94 20.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.894 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 59.13 40.98 96.37 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.456 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.436 ' NZ ' ' HA ' ' A' ' 236' ' ' LYS . 0.0 OUTLIER 65.36 52.4 1.43 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.762 0.315 . . . . 0.0 110.907 -179.967 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 237' ' ' ARG . . . . . 0.467 ' CB ' ' HG3' ' A' ' 174' ' ' PRO . 21.2 mmt180 -156.29 115.13 3.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.815 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 238' ' ' TYR . . . . . 0.638 ' CE2' HD21 ' A' ' 233' ' ' LEU . 93.7 m-85 -69.75 127.3 32.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.91 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 0.498 HD13 HD23 ' A' ' 173' ' ' LEU . 62.1 mt -122.22 134.26 66.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.09 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . 0.58 ' HB3' ' CZ ' ' A' ' 242' ' ' PHE . 6.5 mp0 -103.1 149.39 24.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.898 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . 0.517 ' O ' ' CD1' ' A' ' 242' ' ' PHE . 14.3 mt -124.62 149.56 46.95 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.964 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 242' ' ' PHE . . . . . 0.58 ' CZ ' ' HB3' ' A' ' 240' ' ' GLU . 13.6 m-85 -156.84 132.38 9.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.841 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 57.5 mtm180 -48.09 133.04 15.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.901 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . 0.485 ' HB2' ' N ' ' A' ' 169' ' ' ARG . 3.4 t -130.48 157.59 42.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.825 -179.744 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . 0.424 ' O ' ' C ' ' A' ' 246' ' ' ALA . 82.1 p -133.45 150.05 51.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.161 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 246' ' ' ALA . . . . . 0.773 ' N ' HD12 ' A' ' 167' ' ' ILE . . . -35.67 -51.94 0.67 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.096 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -59.41 -50.97 71.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.096 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 18.1 tp10 -47.31 -50.28 22.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.903 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.659 HG13 ' CE2' ' A' ' 214' ' ' PHE . 98.5 t -53.48 -64.58 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.148 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 250' ' ' GLN . . . . . 0.749 ' HA ' HD12 ' A' ' 253' ' ' LEU . 68.4 mt-30 -43.22 -34.96 1.26 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.934 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 251' ' ' GLN . . . . . 0.5 ' O ' ' ND2' ' A' ' 254' ' ' ASN . 27.5 mt-30 -74.34 -33.31 63.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.879 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 252' ' ' VAL . . . . . 0.471 ' HA ' ' NE ' ' A' ' 255' ' ' ARG . 79.1 t -79.67 -19.06 12.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.133 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.749 HD12 ' HA ' ' A' ' 250' ' ' GLN . 17.0 mt -80.81 -46.39 15.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.879 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . 0.5 ' ND2' ' O ' ' A' ' 251' ' ' GLN . 1.3 p30 -58.16 -50.06 74.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.857 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . 0.474 ' N ' ' CG ' ' A' ' 254' ' ' ASN . 17.3 ptp180 -49.31 -47.18 47.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.856 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 256' ' ' PHE . . . . . 0.565 ' CE1' ' HB ' ' A' ' 210' ' ' THR . 10.3 m-85 -73.8 -37.45 64.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.855 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 1.4 t -76.53 138.08 39.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.822 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 1.5 t 64.62 39.92 6.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.859 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 259' ' ' ALA . . . . . . . . . . . . . . . -105.5 125.77 51.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.076 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . 0.504 ' O ' ' N ' ' A' ' 263' ' ' SER . 49.2 m -127.88 148.77 50.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.837 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . 0.469 ' HA3' ' C ' ' A' ' 262' ' ' PRO . . . 120.75 -76.8 0.32 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.484 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 262' ' ' PRO . . . . . 0.469 ' C ' ' HA3' ' A' ' 261' ' ' GLY . 54.1 Cg_endo -69.78 145.29 79.05 Favored 'Cis proline' 0 C--N 1.342 0.201 0 C-N-CA 122.667 -1.805 . . . . 0.0 112.337 0.059 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . 0.504 ' N ' ' O ' ' A' ' 260' ' ' SER . 58.4 m -77.39 95.18 4.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.881 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 16.2 t -51.44 -53.92 32.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.836 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.344 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.506 -179.979 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.365 0 N-CA-C 112.512 -0.235 . . . . 0.0 112.512 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 23.3 t 66.84 44.79 2.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.923 0.392 . . . . 0.0 110.871 -179.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 81.5 p -98.06 127.94 44.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.879 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 167.53 145.98 4.73 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.499 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.3 t -91.84 136.42 33.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.817 0.342 . . . . 0.0 110.884 -179.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 56.1 p -51.19 155.31 1.37 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.86 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 126.14 78.27 0.29 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.472 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -122.26 -146.01 7.17 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.521 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -142.65 -168.39 11.82 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.52 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.468 HG23 ' HB ' ' A' ' 156' ' ' VAL . 99.0 m -132.26 124.17 28.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.866 0.365 . . . . 0.0 111.112 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . 0.457 ' O ' ' N ' ' A' ' 156' ' ' VAL . 52.5 p -86.13 149.17 25.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.888 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . 0.407 ' C ' ' O ' ' A' ' 153' ' ' SER . 16.9 t30 -37.7 -50.69 1.21 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.892 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -51.48 -40.56 59.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.907 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.468 ' HB ' HG23 ' A' ' 152' ' ' THR . 75.5 t -77.29 -50.42 20.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.117 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.441 ' C ' ' O ' ' A' ' 156' ' ' VAL . . . -34.75 -57.32 0.53 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.101 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 76.1 mm-40 -62.13 -45.87 91.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.889 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' PHE . . . . . 0.431 ' CE2' ' HG ' ' A' ' 216' ' ' LEU . 20.1 t80 -52.89 -42.4 65.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.883 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 56.3 mt -82.06 -29.27 31.96 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.916 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 22.9 t -48.28 -43.33 32.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.902 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . 0.706 ' HG3' HD13 ' A' ' 216' ' ' LEU . 0.2 OUTLIER -38.6 130.26 1.38 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.942 179.897 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -106.61 145.54 31.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.883 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . 0.448 ' O ' ' NE2' ' A' ' 165' ' ' GLN . 49.1 m-80 63.28 37.71 10.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.891 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 0.448 ' NE2' ' O ' ' A' ' 164' ' ' ASN . 2.2 mp0 -122.54 153.81 38.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.904 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 83.9 t -108.36 137.56 39.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.135 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . 0.475 HD12 ' N ' ' A' ' 246' ' ' ALA . 28.6 mt -104.84 139.23 26.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.07 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 82.6 t -120.49 133.35 67.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.154 179.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 39.3 ttp180 -88.51 104.72 17.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.839 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' MET . . . . . 0.855 ' CE ' HD21 ' A' ' 173' ' ' LEU . 83.3 mtp -97.39 131.57 43.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.884 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 2.1 ttt85 -135.65 140.48 44.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.852 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 93.23 16.59 46.42 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.504 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.855 HD21 ' CE ' ' A' ' 170' ' ' MET . 25.5 mt -72.09 128.95 88.47 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.606 0.717 . . . . 0.0 110.925 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . 0.464 ' HG3' ' CB ' ' A' ' 237' ' ' ARG . 64.3 Cg_exo -47.91 144.61 11.44 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.682 2.255 . . . . 0.0 112.357 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . 0.558 ' CD1' ' HG3' ' A' ' 209' ' ' PRO . 6.7 t80 -49.35 -41.69 39.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.88 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.45 ' O ' ' C ' ' A' ' 177' ' ' ALA . 7.6 p -76.25 -45.41 32.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.158 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.45 ' C ' ' O ' ' A' ' 176' ' ' THR . . . -33.41 104.55 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.117 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -111.66 177.7 4.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.118 -179.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.447 ' N ' ' CE1' ' A' ' 201' ' ' PHE . . . -45.42 -51.08 11.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.14 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -50.22 -38.87 42.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.916 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . 0.735 ' HG3' HD11 ' A' ' 234' ' ' LEU . 2.6 tp10 -64.65 -41.85 95.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.898 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.481 ' O ' ' N ' ' A' ' 185' ' ' PHE . 94.5 t -64.96 -54.22 32.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.133 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.453 ' C ' ' O ' ' A' ' 182' ' ' VAL . 43.2 t -33.86 -55.72 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.112 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -70.72 -34.33 71.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.095 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.532 ' CE2' ' HD3' ' A' ' 229' ' ' LYS . 63.6 t80 -51.13 -61.11 2.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.904 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -89.58 -20.4 23.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.913 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -49.16 -18.5 1.29 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.474 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 38.4 mm-40 -55.9 -75.17 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.796 0.332 . . . . 0.0 110.921 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -118.34 -3.78 10.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.845 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 71.4 m -128.7 87.09 55.82 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.579 0.704 . . . . 0.0 110.851 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' PRO . . . . . 0.577 ' HD2' ' CD1' ' A' ' 222' ' ' TYR . 54.1 Cg_endo -69.74 143.3 50.5 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.719 2.279 . . . . 0.0 112.38 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . 0.591 HG23 ' O ' ' A' ' 216' ' ' LEU . 63.1 mt -97.71 143.07 13.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.102 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 88.6 m -66.72 101.41 0.8 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.134 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 89.64 -15.8 58.02 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.428 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 73.01 -118.21 6.28 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.483 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 39.4 mtmt -51.16 -32.71 24.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.73 0.3 . . . . 0.0 110.864 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -75.22 -22.54 57.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.904 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . 0.67 ' HA2' HD12 ' A' ' 216' ' ' LEU . . . -99.25 35.25 4.82 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.442 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 60.5 mt -137.45 139.22 43.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.88 0.371 . . . . 0.0 111.132 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 12.9 tp -133.44 123.08 24.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.946 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' PHE . . . . . 0.447 ' CE1' ' N ' ' A' ' 179' ' ' ALA . 75.8 m-85 -104.26 124.77 49.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.854 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 55.6 t -79.9 136.31 23.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.082 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . 0.429 ' HA ' HG23 ' A' ' 210' ' ' THR . 0.8 OUTLIER -143.21 136.59 28.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.138 179.99 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . 0.59 ' CD1' ' HB3' ' A' ' 208' ' ' ARG . 16.7 m-85 -40.31 160.65 0.12 Allowed Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.68 0.752 . . . . 0.0 110.901 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.74 3.22 2.89 Favored 'Trans proline' 0 N--CA 1.465 -0.176 0 C-N-CA 122.724 2.283 . . . . 0.0 112.32 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -117.31 -28.45 6.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.878 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 127.69 42.93 0.25 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.485 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 208' ' ' ARG . . . . . 0.59 ' HB3' ' CD1' ' A' ' 204' ' ' TYR . 10.8 ttm180 -117.3 142.01 29.53 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.639 0.733 . . . . 0.0 110.876 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . 0.558 ' HG3' ' CD1' ' A' ' 175' ' ' PHE . 54.0 Cg_endo -69.74 93.27 0.52 Allowed 'Trans proline' 0 C--O 1.232 0.22 0 C-N-CA 122.734 2.29 . . . . 0.0 112.342 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . 0.572 ' HB ' ' CE2' ' A' ' 256' ' ' PHE . 69.6 p -60.12 -9.45 3.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.097 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 81.36 -42.42 2.76 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.48 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -69.1 165.32 20.55 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.8 0.333 . . . . 0.0 110.892 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -165.34 -177.82 4.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.088 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . 0.562 ' CE2' HG13 ' A' ' 249' ' ' VAL . 51.2 m-85 -145.97 138.68 25.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.9 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . 0.411 HG12 ' N ' ' A' ' 216' ' ' LEU . 10.0 t -121.63 156.71 25.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.168 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.706 HD13 ' HG3' ' A' ' 162' ' ' LYS . 49.5 mt -110.85 138.58 47.07 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.936 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -129.91 137.15 50.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.879 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -49.81 -46.66 51.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.084 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 219' ' ' CYS . . . . . . . . . . . . . 10.2 m -154.14 171.57 18.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.893 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . 0.41 ' O ' ' C ' ' A' ' 221' ' ' GLU . 6.8 tp10 -57.6 -40.75 79.77 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.873 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . 0.41 ' C ' ' O ' ' A' ' 220' ' ' GLU . 26.6 tt0 -36.79 -49.54 0.79 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.885 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 222' ' ' TYR . . . . . 0.577 ' CD1' ' HD2' ' A' ' 191' ' ' PRO . 20.9 m-85 -74.54 -50.07 19.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.892 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.518 ' O ' ' HB3' ' A' ' 226' ' ' ALA . . . -44.82 -54.52 6.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.117 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -48.41 -62.42 1.5 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.954 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 41.3 m-20 -49.54 -28.96 6.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.871 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . 0.518 ' HB3' ' O ' ' A' ' 223' ' ' ALA . . . -70.42 -43.21 70.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.038 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 29.0 mt -54.35 -30.28 51.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.934 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 60.8 mtp85 -58.65 -22.22 56.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.841 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . 0.532 ' HD3' ' CE2' ' A' ' 185' ' ' PHE . 16.7 mttm -78.93 -1.71 36.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.9 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 230' ' ' HIS . . . . . 0.546 ' CE1' ' HD3' ' A' ' 231' ' ' LYS . 21.6 t60 -33.86 127.0 0.41 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.886 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.546 ' HD3' ' CE1' ' A' ' 230' ' ' HIS . 0.3 OUTLIER 68.75 32.56 4.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.877 179.978 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -61.91 178.69 0.33 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.881 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.621 HD21 ' CD1' ' A' ' 238' ' ' TYR . 31.1 mt -135.18 109.74 8.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.943 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . 0.735 HD11 ' HG3' ' A' ' 181' ' ' GLU . 6.5 tt -117.68 114.15 22.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.905 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 58.4 37.59 88.25 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.482 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 9.6 mmpt? 70.56 52.73 0.32 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.78 0.324 . . . . 0.0 110.889 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 237' ' ' ARG . . . . . 0.464 ' CB ' ' HG3' ' A' ' 174' ' ' PRO . 50.4 mmt-85 -155.47 116.06 3.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.85 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 238' ' ' TYR . . . . . 0.621 ' CD1' HD21 ' A' ' 233' ' ' LEU . 89.6 m-85 -68.61 125.39 26.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.904 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 0.776 HD13 HD23 ' A' ' 173' ' ' LEU . 64.1 mt -120.94 134.53 64.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.116 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . 0.496 ' HB3' ' CZ ' ' A' ' 242' ' ' PHE . 38.8 mp0 -96.24 170.21 9.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.85 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 75.1 mt -145.71 139.96 26.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.946 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 242' ' ' PHE . . . . . 0.496 ' CZ ' ' HB3' ' A' ' 240' ' ' GLU . 8.6 m-85 -152.14 130.87 12.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.877 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 57.4 mtm180 -52.25 136.17 31.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.846 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 1.1 t -136.9 166.37 23.79 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.869 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . 0.444 ' O ' HG23 ' A' ' 249' ' ' VAL . 74.1 p -135.91 165.05 26.54 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.142 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 246' ' ' ALA . . . . . 0.475 ' N ' HD12 ' A' ' 167' ' ' ILE . . . -49.02 -53.55 19.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.076 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -55.6 -50.89 68.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.09 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -50.06 -50.98 46.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.931 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.562 HG13 ' CE2' ' A' ' 214' ' ' PHE . 92.2 t -47.36 -61.97 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.101 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 250' ' ' GLN . . . . . 0.549 ' HA ' HD12 ' A' ' 253' ' ' LEU . 34.4 mt-30 -48.19 -33.03 7.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.902 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 251' ' ' GLN . . . . . 0.427 ' HA ' ' ND2' ' A' ' 254' ' ' ASN . 53.0 mt-30 -76.82 -25.94 53.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.92 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 95.0 t -82.25 -21.71 9.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.135 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.549 HD12 ' HA ' ' A' ' 250' ' ' GLN . 10.7 mt -84.19 -43.54 14.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.905 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . 0.494 ' OD1' ' N ' ' A' ' 255' ' ' ARG . 0.5 OUTLIER -65.11 -42.08 94.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.846 179.973 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . 0.494 ' N ' ' OD1' ' A' ' 254' ' ' ASN . 1.8 ptm85 -58.38 -41.86 85.76 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.855 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 256' ' ' PHE . . . . . 0.572 ' CE2' ' HB ' ' A' ' 210' ' ' THR . 11.7 m-85 -75.65 -46.0 33.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.921 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 66.5 m -59.39 -35.31 73.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.835 -179.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 36.0 t -101.37 76.62 1.71 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.85 -179.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 259' ' ' ALA . . . . . . . . . . . . . . . -121.81 32.18 5.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.094 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 59.9 p -125.89 172.56 9.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.858 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -172.64 -178.43 42.72 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.449 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 262' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 128.42 12.53 Favored 'Cis proline' 0 C--N 1.342 0.19 0 C-N-CA 122.671 -1.804 . . . . 0.0 112.386 0.066 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 4.0 t -108.15 132.97 53.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.846 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 24.8 t -61.77 -51.59 67.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.89 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.364 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.512 179.98 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 N-CA-C 112.541 -0.224 . . . . 0.0 112.541 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 2.3 m -154.53 131.27 10.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.86 0.362 . . . . 0.0 110.834 -179.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 43.2 p -133.93 42.08 2.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.843 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 58.35 -147.4 39.05 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.469 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 70.3 m -122.84 122.05 37.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.903 0.382 . . . . 0.0 110.816 -179.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 24.5 m -109.92 -55.27 2.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.847 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -154.69 -120.25 0.72 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.462 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -113.7 157.31 15.04 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.525 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 164.46 171.09 30.28 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.507 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.547 HG22 HG23 ' A' ' 156' ' ' VAL . 1.5 m -81.56 -27.48 34.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.823 0.344 . . . . 0.0 111.192 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 66.7 m -41.62 -24.81 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.826 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . 0.442 ' N ' ' O ' ' A' ' 152' ' ' THR . 1.7 t-20 -74.6 -52.71 11.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.904 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -68.06 -37.18 80.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.905 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.547 HG23 HG22 ' A' ' 152' ' ' THR . 26.7 t -68.55 -41.46 83.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.077 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.439 ' C ' ' O ' ' A' ' 156' ' ' VAL . . . -33.73 -69.94 0.08 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.108 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . 0.498 ' O ' ' N ' ' A' ' 161' ' ' SER . 3.8 pt20 -48.82 -60.17 2.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.947 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 21.4 t80 -39.4 -40.67 0.84 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.921 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 98.6 mt -89.07 -22.92 22.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.934 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . 0.498 ' N ' ' O ' ' A' ' 158' ' ' GLN . 7.7 t -59.95 -20.93 60.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.853 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . 0.476 ' HG3' HD13 ' A' ' 216' ' ' LEU . 25.3 mmmt -69.83 118.27 12.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.926 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 50.3 mm-40 -96.98 158.02 15.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.916 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 62.43 42.18 9.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.868 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 36.1 mm-40 -126.7 172.6 10.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.911 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.462 HG11 ' CB ' ' A' ' 223' ' ' ALA . 86.6 t -128.54 106.45 14.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.11 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . 0.548 HD12 ' N ' ' A' ' 246' ' ' ALA . 70.0 mt -77.67 141.63 15.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.169 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 43.7 t -122.77 133.94 67.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.103 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . 0.449 ' N ' ' HB2' ' A' ' 244' ' ' SER . 29.6 ttp180 -91.43 101.44 14.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.876 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' MET . . . . . 0.547 ' CE ' HD21 ' A' ' 173' ' ' LEU . 99.3 mtp -94.9 127.25 40.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.895 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 13.5 ttm180 -126.07 141.49 51.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.884 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 89.91 24.92 28.56 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.501 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.929 HD23 HD13 ' A' ' 239' ' ' ILE . 19.9 mt -78.45 123.29 85.7 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.638 0.732 . . . . 0.0 110.907 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_exo -48.0 141.77 16.63 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.67 2.246 . . . . 0.0 112.341 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . 0.558 ' CD1' ' HG3' ' A' ' 209' ' ' PRO . 9.1 t80 -53.97 -26.18 24.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.892 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 7.2 p -89.69 -14.3 35.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.095 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -65.15 110.16 2.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.125 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.437 ' O ' ' N ' ' A' ' 181' ' ' GLU . 0.8 OUTLIER -118.96 167.16 12.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.134 -179.925 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 178' ' ' THR . . . -35.42 -42.43 0.21 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.122 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -57.07 -47.69 80.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.89 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . 0.437 ' N ' ' O ' ' A' ' 178' ' ' THR . 3.9 mp0 -61.0 -37.49 82.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.879 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.477 HG12 HD11 ' A' ' 192' ' ' ILE . 76.1 t -69.85 -54.23 20.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.119 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.448 ' C ' ' O ' ' A' ' 182' ' ' VAL . 28.1 t -33.78 -50.66 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.125 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -73.54 -44.22 58.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.086 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -39.13 -61.31 0.78 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.903 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -92.27 -21.42 20.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.873 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -49.11 -18.9 1.35 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.495 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -56.25 -75.21 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.803 0.335 . . . . 0.0 110.923 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -118.25 -7.57 10.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.851 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 79.4 m -124.41 86.4 55.0 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.557 0.694 . . . . 0.0 110.876 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' PRO . . . . . 0.571 ' HD2' ' CD1' ' A' ' 222' ' ' TYR . 53.5 Cg_endo -69.78 140.32 42.3 Favored 'Trans proline' 0 C--O 1.231 0.148 0 C-N-CA 122.715 2.276 . . . . 0.0 112.308 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . 0.591 HG23 ' O ' ' A' ' 216' ' ' LEU . 57.2 mt -91.5 144.29 9.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.149 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 35.9 m -73.24 105.72 4.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.139 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 91.33 -17.78 54.53 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.478 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 72.09 -121.09 8.22 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.472 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 24.0 mtmm -49.74 -28.46 6.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.731 0.301 . . . . 0.0 110.87 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -77.74 -27.66 50.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.886 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . 0.449 ' HA2' HD12 ' A' ' 216' ' ' LEU . . . -93.62 40.4 2.79 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.524 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 56.9 mt -144.04 149.77 17.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.885 0.374 . . . . 0.0 111.087 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.445 HD21 HG22 ' A' ' 156' ' ' VAL . 14.1 tp -148.46 119.63 7.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.897 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -98.71 117.62 33.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.89 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 42.7 t -73.49 133.63 31.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.124 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . 0.539 ' HA ' HG23 ' A' ' 210' ' ' THR . 0.8 OUTLIER -138.39 137.9 37.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.159 -179.971 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . 0.502 ' CD2' HG22 ' A' ' 210' ' ' THR . 35.1 m-85 -47.24 158.63 0.45 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.663 0.744 . . . . 0.0 110.916 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 3.14 2.98 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.651 2.234 . . . . 0.0 112.343 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -110.29 -20.51 12.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.825 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 113.72 38.02 1.23 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.506 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 77.6 mtt180 -121.63 146.86 46.53 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.612 0.72 . . . . 0.0 110.854 -179.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . 0.558 ' HG3' ' CD1' ' A' ' 175' ' ' PHE . 53.6 Cg_endo -69.79 112.02 2.97 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.672 2.248 . . . . 0.0 112.348 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . 0.539 HG23 ' HA ' ' A' ' 203' ' ' THR . 53.7 p -76.59 -6.8 53.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.173 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 80.73 -37.14 2.29 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.467 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -75.85 159.01 31.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.844 0.354 . . . . 0.0 110.861 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . 0.554 ' HB3' ' CD1' ' A' ' 173' ' ' LEU . . . -159.31 -177.91 6.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.075 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . 0.459 ' CE2' HG13 ' A' ' 249' ' ' VAL . 58.0 m-85 -145.59 143.85 30.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.885 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 4.4 t -131.9 155.47 41.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.142 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.591 ' O ' HG23 ' A' ' 192' ' ' ILE . 37.5 mt -106.1 135.09 48.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.916 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -127.19 147.26 50.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.88 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . 0.63 ' HB3' ' HD2' ' A' ' 222' ' ' TYR . . . -54.31 -63.76 1.05 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.127 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 219' ' ' CYS . . . . . . . . . . . . . 2.2 t -153.58 172.63 16.91 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.87 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -44.89 -35.71 2.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.891 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . 0.566 ' OE2' ' CD1' ' A' ' 222' ' ' TYR . 6.0 tm-20 -45.27 -44.73 11.54 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.915 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 222' ' ' TYR . . . . . 0.63 ' HD2' ' HB3' ' A' ' 218' ' ' ALA . 35.1 m-85 -88.71 -47.48 8.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.872 -179.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.462 ' CB ' HG11 ' A' ' 166' ' ' VAL . . . -52.15 -60.0 3.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.113 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 43.9 mm-40 -47.22 -50.68 20.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.914 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 20.4 m-20 -60.48 -23.66 64.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.925 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . 0.446 ' HB3' ' O ' ' A' ' 223' ' ' ALA . . . -76.15 -40.32 52.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.132 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 29.2 mt -54.41 -30.74 53.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.94 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 6.7 mtp-105 -58.84 -25.28 63.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.881 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . 0.462 ' O ' ' C ' ' A' ' 230' ' ' HIS . 19.1 mtpp -76.37 -0.92 24.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.887 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 230' ' ' HIS . . . . . 0.488 ' CE1' ' HG3' ' A' ' 231' ' ' LYS . 13.7 t60 -33.54 133.37 0.17 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.833 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.488 ' HG3' ' CE1' ' A' ' 230' ' ' HIS . 47.0 mtmt 59.13 40.35 21.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.904 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -66.64 -177.01 0.53 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.834 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.576 HD21 ' CD1' ' A' ' 238' ' ' TYR . 31.3 mt -136.48 105.03 5.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.909 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . 0.623 HD23 ' C ' ' A' ' 234' ' ' LEU . 6.6 tt -116.35 113.67 23.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.921 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 60.55 39.42 96.42 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.514 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 4.4 mmmm 66.69 53.39 0.91 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.76 0.314 . . . . 0.0 110.882 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 20.4 mmt180 -156.21 115.47 3.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.877 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 238' ' ' TYR . . . . . 0.576 ' CD1' HD21 ' A' ' 233' ' ' LEU . 95.7 m-85 -68.64 117.36 10.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.916 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 0.929 HD13 HD23 ' A' ' 173' ' ' LEU . 17.7 mt -113.81 129.9 68.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.178 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . 0.725 ' O ' HD23 ' A' ' 241' ' ' LEU . 0.5 OUTLIER -89.99 175.27 7.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.869 -179.998 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . 0.725 HD23 ' O ' ' A' ' 240' ' ' GLU . 38.5 mt -151.57 144.65 24.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.907 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 242' ' ' PHE . . . . . 0.48 ' CD1' ' O ' ' A' ' 241' ' ' LEU . 15.0 m-85 -156.89 129.17 7.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.885 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . 0.475 ' CZ ' ' HB2' ' A' ' 243' ' ' ARG . 17.0 mtm105 -48.25 138.74 9.36 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.876 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . 0.449 ' HB2' ' N ' ' A' ' 169' ' ' ARG . 1.0 OUTLIER -136.25 160.46 38.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.861 -179.778 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 53.5 p -132.83 155.83 48.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.173 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 246' ' ' ALA . . . . . 0.548 ' N ' HD12 ' A' ' 167' ' ' ILE . . . -40.51 -58.65 1.52 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.058 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -53.44 -55.69 23.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.114 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -46.02 -46.06 16.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.885 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.486 HG21 HD13 ' A' ' 167' ' ' ILE . 98.2 t -51.62 -62.54 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.126 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 250' ' ' GLN . . . . . 0.497 ' HA ' HD12 ' A' ' 253' ' ' LEU . 49.5 mt-30 -47.66 -33.38 6.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.898 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 251' ' ' GLN . . . . . 0.499 ' O ' ' ND2' ' A' ' 254' ' ' ASN . 29.4 mm-40 -76.76 -26.3 54.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.921 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 43.1 t -82.38 -21.64 9.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.114 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.497 HD12 ' HA ' ' A' ' 250' ' ' GLN . 10.5 mt -85.41 -43.24 13.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.875 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . 0.499 ' ND2' ' O ' ' A' ' 251' ' ' GLN . 0.4 OUTLIER -65.22 -46.0 82.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.876 179.962 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . 0.401 ' N ' ' CG ' ' A' ' 254' ' ' ASN . 7.5 ptm180 -48.68 -30.72 5.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.896 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -88.42 -32.39 18.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.886 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 32.3 t -70.99 -32.78 69.7 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.845 -179.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 2.6 m -101.47 49.82 0.86 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.837 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 259' ' ' ALA . . . . . . . . . . . . . . . -93.76 89.79 6.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.105 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . 0.44 ' C ' ' HA ' ' A' ' 262' ' ' PRO . 4.7 t -140.05 141.02 36.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.877 -179.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . 0.417 ' HA3' ' C ' ' A' ' 262' ' ' PRO . . . 127.02 -69.87 0.51 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.478 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 262' ' ' PRO . . . . . 0.44 ' HA ' ' C ' ' A' ' 260' ' ' SER . 53.1 Cg_endo -69.8 -14.31 12.55 Favored 'Cis proline' 0 C--N 1.341 0.183 0 C-N-CA 122.66 -1.808 . . . . 0.0 112.347 0.109 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 1.1 t 37.04 45.26 0.44 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.86 -179.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 19.3 t -70.64 93.6 0.94 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.869 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.343 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.501 -179.937 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.306 0 N-CA-C 112.45 -0.26 . . . . 0.0 112.45 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 3.2 m -107.17 -50.96 2.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.881 0.372 . . . . 0.0 110.821 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 84.3 p -137.75 144.25 41.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.814 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 58.92 64.75 4.01 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.488 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 55.8 p -103.74 42.06 1.22 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.891 0.377 . . . . 0.0 110.887 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 7.1 t -95.72 -63.24 1.18 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.9 -179.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 80.0 -76.7 2.0 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.487 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 154.3 -146.53 14.75 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.505 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -41.65 -56.8 3.51 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.466 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.41 ' CG2' ' HB ' ' A' ' 156' ' ' VAL . 27.9 m -39.9 128.66 2.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.82 0.343 . . . . 0.0 111.11 -179.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . 0.45 ' O ' ' C ' ' A' ' 154' ' ' ASN . 48.1 m -78.85 142.29 36.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.913 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . 0.45 ' C ' ' O ' ' A' ' 153' ' ' SER . 4.5 m120 -34.41 -62.6 0.33 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.917 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -42.83 -42.16 3.52 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.897 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.498 ' O ' ' N ' ' A' ' 159' ' ' PHE . 20.5 t -73.55 -58.03 5.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.141 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.443 ' C ' ' O ' ' A' ' 156' ' ' VAL . . . -34.07 -57.17 0.48 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.087 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 82.3 mt-30 -67.28 -33.79 76.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.931 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' PHE . . . . . 0.498 ' N ' ' O ' ' A' ' 156' ' ' VAL . 71.4 t80 -62.76 -39.49 94.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.867 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.443 HD22 ' HB1' ' A' ' 246' ' ' ALA . 82.8 mt -90.21 -17.13 28.09 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.884 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 13.1 t -55.45 -31.84 62.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.845 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . 0.544 ' HG3' HD13 ' A' ' 216' ' ' LEU . 25.6 mmtt -60.98 118.12 6.33 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.95 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -97.33 136.88 37.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.88 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 74.53 43.99 0.24 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.891 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 0.47 ' NE2' ' HA ' ' A' ' 165' ' ' GLN . 8.5 mm100 -122.87 176.16 6.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.92 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.407 HG11 ' CB ' ' A' ' 223' ' ' ALA . 15.8 t -129.14 119.68 49.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.112 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . 0.479 HD12 ' N ' ' A' ' 246' ' ' ALA . 14.6 mt -93.21 149.57 4.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.084 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 57.5 t -130.93 137.01 56.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.123 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 50.7 ttt-85 -92.27 109.4 20.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.854 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' MET . . . . . 0.641 ' CE ' HD21 ' A' ' 173' ' ' LEU . 96.6 mtp -102.05 120.63 40.73 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.846 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 3.3 ttt85 -122.76 139.38 54.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.884 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 90.53 28.24 17.35 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.502 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.675 HD23 HD13 ' A' ' 239' ' ' ILE . 30.4 mt -82.52 127.37 70.88 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.607 0.718 . . . . 0.0 110.836 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . 0.493 ' HG3' ' CB ' ' A' ' 237' ' ' ARG . 65.9 Cg_exo -48.06 126.2 12.92 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.665 2.243 . . . . 0.0 112.32 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . 0.58 ' CE2' ' HG2' ' A' ' 209' ' ' PRO . 3.8 m-85 -44.06 -24.19 0.14 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.882 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 67.3 p -86.37 -37.16 18.7 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.133 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.401 ' N ' ' O ' ' A' ' 174' ' ' PRO . . . -49.21 124.68 9.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.093 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.651 HG22 ' H ' ' A' ' 179' ' ' ALA . 0.2 OUTLIER -123.76 -173.67 2.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.127 -179.925 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.651 ' H ' HG22 ' A' ' 178' ' ' THR . . . -51.35 -48.05 62.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.085 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -56.76 -33.44 66.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.878 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . 0.715 ' OE2' HD21 ' A' ' 234' ' ' LEU . 4.0 mm-40 -72.41 -22.91 61.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.9 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.651 HG12 HD11 ' A' ' 192' ' ' ILE . 93.9 t -87.21 -48.5 15.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.182 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 44.7 t -39.95 -42.53 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.098 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -81.34 -44.19 17.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.064 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.616 ' HD2' HD12 ' A' ' 234' ' ' LEU . 18.3 t80 -40.01 -58.14 1.48 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.862 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' PHE . . . . . 0.449 ' CE1' ' CE1' ' A' ' 185' ' ' PHE . 79.3 m-85 -94.34 -22.99 17.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.874 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -49.29 -21.63 2.97 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.505 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 -54.3 -70.88 0.09 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.834 0.349 . . . . 0.0 110.968 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 6.6 m-70 -118.02 -15.49 9.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.881 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 82.8 m -120.35 86.4 38.58 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.612 0.72 . . . . 0.0 110.909 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' PRO . . . . . 0.406 ' HD2' ' CD1' ' A' ' 222' ' ' TYR . 53.8 Cg_endo -69.78 134.35 27.73 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.685 2.256 . . . . 0.0 112.374 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . 0.666 HG23 ' O ' ' A' ' 216' ' ' LEU . 48.2 mt -84.12 143.31 12.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.176 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 93.5 m -68.06 106.24 2.31 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.135 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 89.72 -20.55 34.62 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.475 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 78.62 -125.65 7.19 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.498 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . 0.438 ' HA ' HD12 ' A' ' 199' ' ' ILE . 4.7 ptpt -49.49 -21.72 1.02 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.742 0.306 . . . . 0.0 110.845 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -83.54 -30.88 26.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.903 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . 0.503 ' HA2' HD12 ' A' ' 216' ' ' LEU . . . -89.77 39.64 3.1 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.491 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.438 HD12 ' HA ' ' A' ' 196' ' ' LYS . 42.6 mt -139.94 149.36 22.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.894 0.378 . . . . 0.0 111.139 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 13.4 tp -143.24 113.16 7.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.937 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' PHE . . . . . 0.426 ' CE1' HG21 ' A' ' 199' ' ' ILE . 49.2 m-85 -95.22 112.38 24.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.854 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.454 HG11 ' OD2' ' A' ' 212' ' ' ASP . 22.9 t -64.12 118.98 7.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.096 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -127.66 138.29 52.78 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.132 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -45.9 158.49 0.35 Allowed Pre-proline 0 C--N 1.328 -0.369 0 CA-C-O 121.719 0.771 . . . . 0.0 110.925 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 2.88 3.12 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.694 2.263 . . . . 0.0 112.379 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -111.45 -15.34 13.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.866 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 105.9 61.94 0.62 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.518 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 41.7 mtt180 -150.9 149.58 25.65 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.587 0.708 . . . . 0.0 110.861 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . 0.58 ' HG2' ' CE2' ' A' ' 175' ' ' PHE . 53.3 Cg_endo -69.84 121.0 7.67 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.655 2.237 . . . . 0.0 112.347 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . 0.531 ' HB ' ' CE2' ' A' ' 256' ' ' PHE . 72.0 p -90.21 -3.95 57.52 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.157 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 89.27 -41.18 3.02 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.473 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 212' ' ' ASP . . . . . 0.454 ' OD2' HG11 ' A' ' 202' ' ' VAL . 1.2 p-10 -77.24 158.29 30.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.816 0.341 . . . . 0.0 110.881 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . 0.448 ' HB3' HD12 ' A' ' 173' ' ' LEU . . . -162.03 177.07 10.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.103 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . 0.59 ' CE2' HG13 ' A' ' 249' ' ' VAL . 47.7 m-85 -140.17 153.6 46.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.908 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 14.8 t -136.41 151.88 28.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.128 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.666 ' O ' HG23 ' A' ' 192' ' ' ILE . 33.2 mt -105.68 150.55 25.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.881 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -142.66 147.31 35.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.941 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . 0.454 ' HB3' ' CD2' ' A' ' 222' ' ' TYR . . . -54.71 -66.96 0.31 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.112 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 219' ' ' CYS . . . . . . . . . . . . . 6.4 p -133.22 175.31 9.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.928 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -61.49 -24.41 66.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.869 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -58.83 -29.91 67.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.922 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 222' ' ' TYR . . . . . 0.454 ' CD2' ' HB3' ' A' ' 218' ' ' ALA . 34.9 m-85 -91.99 -40.16 11.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.932 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.407 ' CB ' HG11 ' A' ' 166' ' ' VAL . . . -64.18 -51.38 64.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.087 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 224' ' ' GLN . . . . . 0.4 ' HA ' ' CD1' ' A' ' 227' ' ' LEU . 12.7 mm-40 -55.81 -53.95 50.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.92 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 -54.52 -26.3 30.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.917 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -74.84 -28.58 60.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.086 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . 0.4 ' CD1' ' HA ' ' A' ' 224' ' ' GLN . 26.1 mt -59.92 -29.17 68.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.852 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 30.2 mtp85 -59.55 -28.82 67.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.837 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . 0.513 ' HD2' ' CE1' ' A' ' 185' ' ' PHE . 20.0 mtmt -74.91 -1.03 20.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.889 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 230' ' ' HIS . . . . . 0.555 ' CE1' ' HG3' ' A' ' 231' ' ' LYS . 34.7 t60 -33.3 129.85 0.25 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.856 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.555 ' HG3' ' CE1' ' A' ' 230' ' ' HIS . 49.9 mtmt 62.04 37.17 14.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.926 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -63.37 179.59 0.42 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.838 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.663 HD21 ' CE1' ' A' ' 238' ' ' TYR . 33.6 mt -131.61 106.33 8.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.932 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . 0.715 HD21 ' OE2' ' A' ' 181' ' ' GLU . 7.7 tt -116.2 114.53 24.55 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.932 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 60.68 34.35 86.06 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.506 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 32.4 mtpt 71.19 52.15 0.26 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.795 0.331 . . . . 0.0 110.908 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 237' ' ' ARG . . . . . 0.493 ' CB ' ' HG3' ' A' ' 174' ' ' PRO . 18.5 mmt180 -155.77 115.36 3.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.884 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 238' ' ' TYR . . . . . 0.663 ' CE1' HD21 ' A' ' 233' ' ' LEU . 97.6 m-85 -67.44 119.23 11.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.921 -179.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 0.675 HD13 HD23 ' A' ' 173' ' ' LEU . 80.0 mt -115.61 126.93 73.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.105 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . 0.476 ' HB3' ' CE2' ' A' ' 242' ' ' PHE . 37.2 mt-10 -86.13 171.61 11.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.903 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 18.8 mt -152.21 139.41 19.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.915 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 242' ' ' PHE . . . . . 0.476 ' CE2' ' HB3' ' A' ' 240' ' ' GLU . 16.5 m-85 -153.35 126.78 8.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.915 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 61.2 mtm180 -39.85 155.02 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.912 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 19.0 t -156.66 160.7 39.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.827 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 18.0 p -135.86 167.36 21.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.153 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 246' ' ' ALA . . . . . 0.479 ' N ' HD12 ' A' ' 167' ' ' ILE . . . -42.46 -58.52 2.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.091 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -54.0 -56.33 18.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.109 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . 0.952 ' O ' HG23 ' A' ' 252' ' ' VAL . 22.5 tp10 -40.66 -46.26 2.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.877 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.59 HG13 ' CE2' ' A' ' 214' ' ' PHE . 99.1 t -61.57 -60.72 2.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.16 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 250' ' ' GLN . . . . . 0.544 ' HA ' HD12 ' A' ' 253' ' ' LEU . 59.9 mt-30 -38.27 -61.18 0.7 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.876 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 251' ' ' GLN . . . . . 0.454 ' CG ' ' O ' ' A' ' 248' ' ' GLU . 7.8 pt20 -53.47 -44.26 68.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.906 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 252' ' ' VAL . . . . . 0.952 HG23 ' O ' ' A' ' 248' ' ' GLU . 92.5 t -59.96 -40.57 83.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.136 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.544 HD12 ' HA ' ' A' ' 250' ' ' GLN . 34.6 mt -59.43 -50.84 72.39 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.901 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . 0.5 ' OD1' ' N ' ' A' ' 255' ' ' ARG . 0.6 OUTLIER -61.92 -40.18 94.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.89 179.924 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . 0.5 ' N ' ' OD1' ' A' ' 254' ' ' ASN . 43.2 ttt180 -40.59 -58.47 1.59 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.847 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 256' ' ' PHE . . . . . 0.531 ' CE2' ' HB ' ' A' ' 210' ' ' THR . 55.9 m-85 -74.14 -53.94 8.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.871 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . 0.425 ' C ' ' O ' ' A' ' 256' ' ' PHE . 29.5 t -36.18 -44.86 0.42 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.88 -179.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 16.5 t -121.17 80.37 1.64 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.853 -179.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 259' ' ' ALA . . . . . . . . . . . . . . . -103.46 -54.56 2.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.138 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 2.5 t -78.37 87.43 4.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.867 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . 0.456 ' HA3' ' C ' ' A' ' 262' ' ' PRO . . . -97.22 -74.11 1.17 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.504 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 262' ' ' PRO . . . . . 0.456 ' C ' ' HA3' ' A' ' 261' ' ' GLY . 53.3 Cg_endo -69.76 178.63 24.8 Favored 'Cis proline' 0 C--N 1.341 0.156 0 C-N-CA 122.676 -1.802 . . . . 0.0 112.367 0.016 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 5.6 t -107.54 -58.46 1.96 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.832 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 7.6 t -82.5 125.06 30.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.87 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.363 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.491 -179.954 . . . . . . . . 0 0 . 1 stop_ save_